data_2lgj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lgj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.7 pm0 . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.961 -0.385 . . . . 72.049999999999997 109.961 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 15.7 Cg_exo -68.39 111.01 2.4 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.816 2.344 . . . . 74.099999999999994 112.246 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.21 153.0 42.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 75.129999999999995 110.175 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.29 115.37 27.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.049 0.452 . . . . 64.200000000000003 110.881 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.442 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 50.3 t -105.53 116.44 49.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.258 -0.645 . . . . 63.350000000000001 109.258 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.811 ' HB ' HG23 ' A' ' 92' ' ' VAL . 45.8 t -102.19 122.5 54.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.877 0.37 . . . . 72.329999999999998 110.81 -176.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.595 ' O ' ' HD2' ' A' ' 65' ' ' PRO . . . -103.63 122.1 7.31 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.537 -0.839 . . . . 75.519999999999996 111.698 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.18 116.69 19.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.948 0.404 . . . . 65.420000000000002 110.44 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.434 ' C ' HD21 ' A' ' 12' ' ' ASN . . . -129.94 145.67 16.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.168 -0.773 . . . . 72.540000000000006 111.168 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.434 HD21 ' C ' ' A' ' 11' ' ' GLY . 1.2 m120 -124.58 73.75 61.93 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.915 0.357 . . . . 73.430000000000007 110.914 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.76 109.45 1.07 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.601 2.201 . . . . 74.200000000000003 112.471 176.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 17' ' ' TYR . . . -146.9 172.28 27.42 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.399 -0.68 . . . . 64.409999999999997 111.399 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.48 -53.25 7.33 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.257 2.638 . . . . 73.329999999999998 112.304 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 m -112.03 -10.41 13.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.601 0.715 . . . . 71.209999999999994 109.67 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.719 ' HE1' ' HB3' ' A' ' 151' ' ' LEU . 93.0 m-85 -81.37 -17.12 50.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.389 -0.823 . . . . 73.540000000000006 111.458 -174.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.624 ' HA ' HD22 ' A' ' 23' ' ' ASN . . . -79.54 1.38 26.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.042 0.449 . . . . 70.400000000000006 110.711 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.58 18.23 13.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.663 -0.699 . . . . 74.439999999999998 109.955 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -103.44 -169.85 1.7 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.277 0.561 . . . . 75.430000000000007 111.137 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -86.81 -0.23 56.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.743 -0.662 . . . . 72.219999999999999 110.208 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 2.8 m170 -89.6 11.37 19.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 111.928 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.624 HD22 ' HA ' ' A' ' 18' ' ' ALA . 13.5 m120 -109.87 20.1 18.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.806 -0.179 . . . . 55.450000000000003 111.124 -175.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.545 ' H ' HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -50.0 -48.91 52.24 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.487 0.492 . . . . 74.430000000000007 111.933 -173.501 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.05 -58.74 8.28 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.665 -0.698 . . . . 75.430000000000007 114.39 -171.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 23' ' ' ASN . 49.2 p90 -86.23 -22.6 26.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.336 0.568 . . . . 72.010000000000005 111.863 -174.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 23.1 mmt -71.25 -42.18 69.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.8 0.333 . . . . 75.230000000000004 111.121 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.3 t -80.04 -41.52 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.733 0.301 . . . . 72.230000000000004 111.026 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.58 -28.02 69.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.378 -0.374 . . . . 74.310000000000002 111.521 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 17.0 t70 -56.52 -50.17 72.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 64.239999999999995 111.312 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 m -75.97 -33.18 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.333 0.494 . . . . 75.230000000000004 112.333 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.479 HD13 ' N ' ' A' ' 33' ' ' ALA . 4.4 pp -78.67 -35.9 44.53 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.512 -0.475 . . . . 75.420000000000002 111.095 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.479 ' N ' HD13 ' A' ' 32' ' ' LEU . . . -71.3 -36.68 71.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 64.200000000000003 110.247 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.52 -30.43 74.47 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.847 -0.692 . . . . 73.319999999999993 112.845 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -83.96 -37.38 22.34 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.422 0.527 . . . . 74.409999999999997 112.422 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.2 tp -72.7 -15.22 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.256 0.55 . . . . 74.25 110.581 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.51 59.98 0.96 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.661 -0.975 . . . . 61.130000000000003 110.661 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.9 m -142.55 128.81 19.89 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.118 0.485 . . . . 71.340000000000003 111.349 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.14 150.72 26.85 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.808 -0.633 . . . . 63.299999999999997 109.971 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 30' ' ' ASP . 89.1 m-85 -89.44 139.56 30.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.703 0.287 . . . . 74.530000000000001 110.613 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 41' ' ' LYS . 11.6 mptt -110.57 135.82 50.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.274 -0.421 . . . . 73.510000000000005 110.004 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 56.2 t -100.19 106.39 19.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.923 -0.58 . . . . 73.420000000000002 110.407 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -116.95 77.1 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.26 -0.644 . . . . 75.200000000000003 109.26 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 96.6 mttt -55.56 105.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.334 -0.848 . . . . 74.430000000000007 112.638 -171.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 32.1 ttmt 168.29 -88.99 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 124.471 1.107 . . . . 74.319999999999993 108.694 174.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 45' ' ' LYS . 13.8 m -106.05 -14.98 15.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.409 0.623 . . . . 72.439999999999998 109.985 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.85 43.01 1.6 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.29 -0.868 . . . . 52.32 112.193 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 42' ' ' VAL . . . -51.45 -45.44 62.7 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.708 0.262 . . . . 71.439999999999998 111.708 -171.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.664 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 40.2 mt-10 -130.09 116.44 18.52 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.755 -0.461 . . . . 74.239999999999995 109.755 171.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.55 135.64 46.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.084 0.468 . . . . 73.040000000000006 111.154 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 8.3 p -128.59 133.39 66.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.959 -0.564 . . . . 74.400000000000006 110.334 172.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.584 HG21 HG23 ' A' ' 61' ' ' VAL . 68.4 p -105.0 107.57 18.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.036 0.446 . . . . 74.209999999999994 110.361 174.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -128.11 158.48 21.53 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.074 -0.81 . . . . 31.219999999999999 111.074 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.1 ptt180 -120.66 104.98 10.35 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.42 0.628 . . . . 73.450000000000003 111.614 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.813 HD11 ' HA ' ' A' ' 174' ' ' GLU . 1.6 pp -104.22 146.72 28.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.524 -0.762 . . . . 72.319999999999993 109.241 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 71.05 -32.44 0.25 Allowed 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.608 0.567 . . . . 70.400000000000006 111.991 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 154.5 -40.89 0.63 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.166 -0.54 . . . . 62.350000000000001 112.191 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.7 m -89.4 137.17 32.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.831 0.348 . . . . 73.319999999999993 111.098 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 23.0 t -81.79 129.83 34.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.347 -0.388 . . . . 54.530000000000001 110.23 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.15 163.88 18.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.226 -0.443 . . . . 74.409999999999997 110.375 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.584 HG23 HG21 ' A' ' 52' ' ' THR . 57.9 t -107.54 112.4 39.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.367 -0.379 . . . . 73.409999999999997 110.296 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.453 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . 5.6 mp -95.36 111.95 23.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.645 -0.502 . . . . 72.030000000000001 109.645 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.7 135.67 50.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.945 -0.57 . . . . 51.5 110.609 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.664 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -123.71 117.37 27.54 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.047 -0.524 . . . . 74.040000000000006 110.073 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HD2' ' O ' ' A' ' 9' ' ' GLY . 29.0 Cg_endo -65.8 122.77 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.922 1.748 . . . . 73.310000000000002 110.795 171.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -95.67 9.2 41.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.029 0.919 . . . . 75.420000000000002 108.528 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.45 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . 43.2 m -100.84 179.82 4.28 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.093 -1.412 . . . . 73.530000000000001 109.006 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -74.13 162.02 29.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.441 -0.345 . . . . 75.430000000000007 110.47 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.438 ' HG3' ' OD1' ' A' ' 116' ' ' ASN . 26.8 ptt? -59.57 -24.8 64.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.357 -0.383 . . . . 74.420000000000002 111.298 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.53 -35.15 73.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.225 0.536 . . . . 72.040000000000006 110.56 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.45 ' OE1' ' HB3' ' A' ' 67' ' ' CYS . 29.2 mt-10 -98.07 -2.46 40.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.615 -0.72 . . . . 72.140000000000001 111.189 -173.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.7 t -60.12 -43.08 95.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.435 -0.348 . . . . 70.549999999999997 111.496 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.401 ' HA2' HG21 ' A' ' 121' ' ' VAL . . . -63.02 -20.69 62.81 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.947 -0.644 . . . . 74.519999999999996 112.846 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.495 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 3.1 mpt_? -86.29 -12.22 50.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.795 0.331 . . . . 74.310000000000002 110.837 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.787 HE21 ' HA ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -86.69 -47.32 9.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.245 -0.434 . . . . 71.310000000000002 110.936 -178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.69 -42.69 97.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.792 -0.64 . . . . 72.219999999999999 111.942 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.73 -67.3 1.98 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.982 -0.554 . . . . 72.549999999999997 114.097 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.01 -36.98 79.94 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.604 2.203 . . . . 75.420000000000002 112.838 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.38 -43.73 98.13 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.272 -0.422 . . . . 75.040000000000006 110.471 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.31 75.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 72.510000000000005 111.309 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.83 -34.09 74.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 72.120000000000005 111.523 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -62.2 -41.85 98.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.827 0.346 . . . . 71.420000000000002 111.291 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -98.17 3.89 49.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.488 -0.324 . . . . 73.140000000000001 111.5 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t 58.34 39.47 25.41 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.017 -0.538 . . . . 53.350000000000001 110.82 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.466 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 18.3 m -108.69 134.64 20.23 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.101 -0.5 . . . . 62.310000000000002 110.579 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 13.0 Cg_exo -69.93 122.5 9.13 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.74 2.294 . . . . 74.450000000000003 111.939 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -78.49 18.32 0.97 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.965 2.443 . . . . 73.230000000000004 112.5 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -81.59 -61.89 1.8 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.314 0.578 . . . . 75.430000000000007 110.145 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -87.71 68.95 9.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.616 -0.72 . . . . 75.030000000000001 110.085 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 pt -115.2 150.56 17.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.904 -0.589 . . . . 71.439999999999998 110.958 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 m -112.6 127.99 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 110.387 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.811 HG23 ' HB ' ' A' ' 8' ' ' VAL . 47.4 t -124.53 121.49 61.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 110.377 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.457 ' CG2' ' HA2' ' A' ' 9' ' ' GLY . 7.2 tt -84.31 123.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.751 0.31 . . . . 72.439999999999998 110.207 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -153.76 150.08 28.13 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.892 0.377 . . . . 71.040000000000006 111.009 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.443 ' HB3' HD21 ' A' ' 24' ' ' LEU . 9.9 p-10 -84.68 141.29 30.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.72 -0.673 . . . . 70.030000000000001 110.592 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.505 ' OE1' ' HB2' ' A' ' 112' ' ' GLU . 53.3 mm-40 -148.7 155.8 41.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.197 0.523 . . . . 75.409999999999997 111.63 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.29 2.12 37.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.232 -0.894 . . . . 65.219999999999999 111.881 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -49.35 -44.84 45.02 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.556 0.535 . . . . 70.409999999999997 111.355 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.8 HD12 ' HG2' ' A' ' 103' ' ' ARG . 7.6 pt -139.13 173.85 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 74.439999999999998 110.847 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.78 163.22 27.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.182 -0.463 . . . . 54.149999999999999 111.08 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.664 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 4.3 t80 -70.79 126.64 30.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.054 -0.521 . . . . 75.329999999999998 110.521 -176.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 161' ' ' GLU . . . 145.72 -45.37 0.82 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.572 -0.611 . . . . 72.219999999999999 111.572 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.8 ' HG2' HD12 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -119.98 160.49 22.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.512 -0.551 . . . . 75.400000000000006 109.512 178.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.642 HG21 ' HA ' ' A' ' 135' ' ' ILE . 39.8 pt -127.67 157.29 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.809 0.338 . . . . 74.120000000000005 111.189 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -130.71 125.1 33.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.048 -0.523 . . . . 75.409999999999997 110.591 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.668 HD13 ' HE1' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -101.24 111.51 23.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.424 -0.584 . . . . 72.420000000000002 109.424 175.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.665 ' HD3' ' HD2' ' A' ' 134' ' ' ARG . 16.0 ptmt -143.61 153.57 42.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.472 -0.786 . . . . 75.109999999999999 110.445 -169.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.519 HD13 ' O ' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -100.24 114.06 27.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.595 0.712 . . . . 75.109999999999999 110.825 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.53 178.86 38.9 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.861 -0.895 . . . . 75.239999999999995 110.861 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.54 ' HA2' HD13 ' A' ' 118' ' ' LEU . . . -166.81 86.56 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.047 -1.073 . . . . 71.140000000000001 113.593 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.4 74.94 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.934 -0.65 . . . . 64.140000000000001 111.942 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.505 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 3.3 mp0 -143.53 -82.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.554 0.216 . . . . 74.450000000000003 111.027 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -104.73 -69.67 0.77 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.706 -0.759 . . . . 63.310000000000002 113.046 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.21 69.14 3.32 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.026 -0.607 . . . . 70.200000000000003 112.054 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -55.72 -48.04 75.85 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.746 0.276 . . . . 75.329999999999998 111.746 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.438 ' OD1' ' HG3' ' A' ' 69' ' ' MET . 24.8 t-20 -61.58 -45.01 95.94 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.729 0.27 . . . . 73.329999999999998 111.729 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.54 -23.73 72.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.733 -0.746 . . . . 71.409999999999997 112.405 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.54 HD13 ' HA2' ' A' ' 110' ' ' GLY . 46.1 mt -83.23 -45.87 13.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.211 0.529 . . . . 74.439999999999998 109.693 174.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -65.35 -44.77 86.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.207 -0.906 . . . . 74.439999999999998 111.821 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.5 t -52.41 -47.21 66.43 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.938 0.399 . . . . 75.299999999999997 111.098 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.658 ' HB ' HH22 ' A' ' 132' ' ' ARG . 36.5 t -78.18 -44.28 27.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.262 -0.426 . . . . 75.099999999999994 110.928 -177.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.58 98.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.293 -0.412 . . . . 74.129999999999995 111.539 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.5 t -73.61 -30.28 62.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.261 -0.427 . . . . 70.439999999999998 110.711 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.47 -42.27 68.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 74.329999999999998 110.519 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.2 mt -76.68 -21.36 55.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 74.219999999999999 110.258 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.72 13.52 82.27 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.902 -0.59 . . . . 64.430000000000007 112.043 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.8 t -165.0 169.53 16.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.858 -0.423 . . . . 74.109999999999999 109.858 -176.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -96.72 -106.51 0.16 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.733 -0.469 . . . . 75.340000000000003 109.733 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 67.56 -10.33 0.38 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.119 0.785 . . . . 72.129999999999995 113.119 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -76.57 129.27 36.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.361 0.6 . . . . 75.340000000000003 111.464 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.668 ' HE1' HD13 ' A' ' 106' ' ' LEU . 51.2 t-80 -98.96 87.0 3.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.881 -0.599 . . . . 74.120000000000005 109.734 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.658 HH22 ' HB ' ' A' ' 121' ' ' VAL . 93.5 mtt180 -90.48 156.06 18.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 74.510000000000005 111.389 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.79 112.14 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.729 -0.668 . . . . 75.340000000000003 109.581 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.665 ' HD2' ' HD3' ' A' ' 107' ' ' LYS . 70.3 mtt85 -94.15 114.2 26.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.033 -0.531 . . . . 72.340000000000003 110.925 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.642 ' HA ' HG21 ' A' ' 104' ' ' ILE . 2.0 mp -83.26 118.22 30.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 108.708 -0.849 . . . . 72.120000000000005 108.708 173.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -66.87 118.65 10.75 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.626 -0.797 . . . . 74.239999999999995 111.627 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.574 ' HA ' ' HD2' ' A' ' 101' ' ' PHE . 35.0 m -109.9 1.13 9.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.145 0.497 . . . . 72.040000000000006 110.556 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.48 175.16 49.58 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.827 -0.701 . . . . 74.25 111.972 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.06 104.3 54.63 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.168 -0.308 . . . . 75.420000000000002 110.168 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HG2' ' HB3' ' A' ' 146' ' ' PRO . 72.0 Cg_exo -50.05 114.61 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.068 2.512 . . . . 63.439999999999998 112.085 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.34 127.96 14.85 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.869 2.379 . . . . 74.310000000000002 112.16 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 172.05 175.79 40.46 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.127 -0.789 . . . . 73.140000000000001 111.127 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -94.92 -6.69 42.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.441 0.639 . . . . 75.420000000000002 109.781 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -101.03 159.82 14.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.575 -0.739 . . . . 75.230000000000004 109.265 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.42 139.56 94.55 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.012 -0.366 . . . . 75.219999999999999 110.012 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.471 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 92.7 Cg_exo -47.65 -19.39 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.664 2.909 . . . . 73.519999999999996 113.722 177.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -47.19 -40.42 16.02 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.024 0.53 . . . . 55.439999999999998 112.029 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.64 -31.37 41.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.41 -0.359 . . . . 72.420000000000002 111.674 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.471 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 77.2 m-85 -84.07 -31.94 25.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.274 -0.421 . . . . 71.5 111.624 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.04 -4.81 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.049 0.452 . . . . 75.329999999999998 111.805 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.719 ' HB3' ' HE1' ' A' ' 17' ' ' TYR . 90.5 mt -86.91 -12.5 47.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.453 -0.34 . . . . 71.230000000000004 111.266 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -160.89 107.64 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.203 0.525 . . . . 75.329999999999998 110.068 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -131.81 148.96 52.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.077 -0.511 . . . . 74.319999999999993 110.378 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -146.47 35.88 0.97 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.402 0.62 . . . . 73.140000000000001 109.999 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.644 ' O ' ' HG2' ' A' ' 158' ' ' GLU . 84.8 m -86.23 115.25 23.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.701 -0.682 . . . . 70.420000000000002 110.418 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.96 -20.85 59.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 73.420000000000002 111.89 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.24 70.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 65.510000000000005 111.813 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 155' ' ' THR . 15.2 pt-20 -71.4 -21.95 61.93 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.263 0.554 . . . . 72.310000000000002 110.446 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.509 ' HA ' HG22 ' A' ' 162' ' ' VAL . 16.3 mmm-85 -78.18 -25.19 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.653 -0.703 . . . . 73.319999999999993 110.655 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.36 80.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.691 . . . . 72.219999999999999 112.102 -174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.62 ' HB2' ' HD1' ' A' ' 101' ' ' PHE . 6.0 mm-40 -105.38 7.78 33.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.072 0.397 . . . . 74.349999999999994 112.072 -175.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 163' ' ' PRO . 70.3 t -57.35 -52.38 74.66 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.669 -0.205 . . . . 73.120000000000005 111.084 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 13.7 Cg_endo -57.28 -33.62 96.4 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.108 1.872 . . . . 74.219999999999999 112.187 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.5 m -64.96 -43.42 92.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.937 -0.574 . . . . 75.319999999999993 110.61 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.3 -38.59 82.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.42 . . . . 74.209999999999994 110.763 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 162' ' ' VAL . 91.7 t -57.31 -54.04 35.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.553 -0.294 . . . . 73.400000000000006 111.205 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -61.19 -42.09 97.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.369 -0.378 . . . . 75.219999999999999 111.517 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.58 ' NE2' ' HB2' ' A' ' 191' ' ' TRP . 13.8 mm-40 -66.26 -49.52 66.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.482 -0.326 . . . . 75.129999999999995 111.314 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.0 96.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.448 -0.342 . . . . 74.219999999999999 111.593 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.5 -34.93 79.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.798 0.332 . . . . 72.540000000000006 111.553 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -80.63 -43.85 19.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.946 0.403 . . . . 75.239999999999995 110.794 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.27 -39.21 92.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 61.539999999999999 111.894 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.8 p -65.01 -38.86 92.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.744 0.307 . . . . 72.040000000000006 111.45 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.813 ' HA ' HD11 ' A' ' 55' ' ' LEU . 41.6 tt0 -73.55 -44.21 57.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.39 -0.368 . . . . 73.239999999999995 110.629 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 44.5 tp -64.73 -27.93 69.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.492 -0.322 . . . . 74.219999999999999 111.023 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.0 tp -57.24 -45.63 83.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 73.450000000000003 110.766 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.58 -32.4 14.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.012 -0.54 . . . . 75.120000000000005 110.305 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.52 -48.04 82.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.722 -0.672 . . . . 51.310000000000002 111.82 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -129.11 -67.72 0.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.077 -0.249 . . . . 75.519999999999996 111.381 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.64 -170.01 37.99 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.379 -0.915 . . . . 72.019999999999996 112.41 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.708 ' H ' HD22 ' A' ' 181' ' ' LEU . 1.8 pt? -81.82 -35.71 29.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.312 0.066 . . . . 73.510000000000005 110.98 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.549 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 4.9 mm-40 -54.46 -56.67 24.29 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 112.278 0.473 . . . . 74.239999999999995 112.278 -178.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 50.1 Cg_exo -56.26 -34.48 93.75 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.807 1.671 . . . . 73.439999999999998 112.138 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.96 -55.01 9.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.996 -0.547 . . . . 71.299999999999997 111.453 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.605 ' HG2' ' O ' ' A' ' 181' ' ' LEU . 11.6 pt20 -69.38 -21.41 63.8 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 111.718 0.266 . . . . 64.450000000000003 111.718 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.51 -38.22 68.17 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.705 -0.398 . . . . 73.049999999999997 110.662 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 85.0 m -66.96 -44.27 80.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 62.299999999999997 111.489 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.472 HG23 ' HA ' ' A' ' 185' ' ' GLN . 32.6 m -70.4 -16.82 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.43 . . . . 74.310000000000002 111.249 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -94.17 -13.5 26.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 75.340000000000003 110.034 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -93.27 -33.33 13.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 71.540000000000006 110.848 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.58 ' HB2' ' NE2' ' A' ' 168' ' ' GLN . 76.6 m95 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.526 -0.75 . . . . 73.310000000000002 109.552 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.746 -0.464 . . . . 75.120000000000005 109.746 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HB3' HG23 ' A' ' 61' ' ' VAL . 51.4 Cg_exo -54.88 123.64 14.26 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.118 2.546 . . . . 75.120000000000005 112.927 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.844 HD11 ' HG2' ' A' ' 89' ' ' GLN . 2.1 mm? -84.44 133.02 34.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.45 -0.574 . . . . 65.519999999999996 109.45 177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 79' ' ' LEU . 59.2 tp -93.6 117.53 30.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.015 0.436 . . . . 74.329999999999998 111.156 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.98 118.78 59.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.536 -0.756 . . . . 75.099999999999994 109.589 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.585 HG11 ' HB2' ' A' ' 63' ' ' ALA . 29.4 m -122.01 155.82 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.986 0.422 . . . . 74.010000000000005 111.022 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.97 163.95 30.27 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.797 -0.716 . . . . 64.129999999999995 111.983 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.725 HD21 ' HA ' ' A' ' 69' ' ' MET . 2.5 mt -68.92 106.4 2.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.914 0.388 . . . . 72.230000000000004 110.898 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.661 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -77.75 -141.57 1.61 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.823 -0.626 . . . . 63.140000000000001 112.253 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -97.78 99.71 7.19 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.067 0.46 . . . . 73.420000000000002 110.671 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.739 ' HB3' ' HA ' ' A' ' 68' ' ' TYR . 5.5 Cg_exo -78.77 -8.19 15.7 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.359 2.706 . . . . 74.430000000000007 112.887 -176.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.95 173.3 23.58 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.694 -0.765 . . . . 74.239999999999995 112.131 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.93 -54.8 2.4 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.032 2.488 . . . . 74.540000000000006 112.419 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 m -59.75 -35.62 74.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 73.140000000000001 111.601 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -74.89 -17.18 60.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.426 . . . . 73.239999999999995 111.296 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.42 -7.49 51.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.004 0.431 . . . . 63.450000000000003 110.861 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -92.96 -10.22 37.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 110.263 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.722 HG22 ' H ' ' A' ' 153' ' ' ASN . 36.5 p -102.71 -169.38 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 72.409999999999997 110.741 -175.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.711 ' HG3' HD22 ' A' ' 24' ' ' LEU . 1.3 tpp180 -92.12 1.78 56.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.035 0.445 . . . . 75.239999999999995 110.123 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.453 ' CE1' HG22 ' A' ' 150' ' ' VAL . 30.8 m80 -76.8 11.36 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.26 0.467 . . . . 54.520000000000003 112.26 -174.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -123.43 20.23 9.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.953 0.406 . . . . 63.020000000000003 110.144 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.758 HD12 HG12 ' A' ' 93' ' ' ILE . 1.1 pp -61.54 -24.26 66.51 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.982 -0.554 . . . . 74.319999999999993 111.968 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.621 ' N ' HD13 ' A' ' 24' ' ' LEU . . . -69.47 -47.96 47.3 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.995 -0.842 . . . . 73.549999999999997 110.995 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.661 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 88.8 t80 -61.05 -36.02 78.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.838 0.351 . . . . 61.32 110.217 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 61.8 mtt -61.34 -49.6 76.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 74.430000000000007 111.668 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.11 -47.67 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.056 0.391 . . . . 73.200000000000003 112.056 -174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.693 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -63.09 -38.87 92.91 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.405 0.521 . . . . 72.549999999999997 112.405 -171.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.65 -41.86 75.0 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.994 0.426 . . . . 75.430000000000007 111.125 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.447 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 22.9 m -79.65 -26.61 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.602 0.593 . . . . 73.409999999999997 112.602 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -67.66 -28.28 67.57 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.892 -0.323 . . . . 75.030000000000001 111.214 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 38' ' ' SER . . . -69.46 -41.96 75.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.143 0.496 . . . . 53.219999999999999 110.699 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.7 -18.13 71.83 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.003 -0.618 . . . . 64.239999999999995 112.86 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 8.2 mmt180 -61.17 -46.46 90.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.125 0.417 . . . . 74.409999999999997 112.125 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.433 HD11 ' H ' ' A' ' 36' ' ' ILE . 4.2 mp -73.23 -15.76 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.455 0.645 . . . . 73.530000000000001 110.407 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.99 12.92 26.53 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 110.765 -0.934 . . . . 62.200000000000003 110.765 -173.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 66.3 m -86.23 147.67 26.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.002 -0.599 . . . . 63.200000000000003 110.434 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.77 127.99 52.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.298 -0.41 . . . . 74.329999999999998 110.305 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -85.66 151.45 23.87 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.331 -0.618 . . . . 74.409999999999997 109.331 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -155.15 168.24 27.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.096 0.474 . . . . 73.349999999999994 110.914 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 5.1 p -84.16 117.77 30.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.71 -0.677 . . . . 75.530000000000001 109.766 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.572 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 5.8 t-80 -103.37 110.68 22.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.569 -0.9 . . . . 63.140000000000001 108.569 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -68.83 83.56 0.3 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 73.239999999999995 110.181 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.807 ' HE3' ' HB3' ' A' ' 82' ' ' PHE . 28.2 tptt -105.19 -95.13 0.34 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.909 -0.587 . . . . 74.549999999999997 109.513 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.523 ' HB3' ' CE2' ' A' ' 82' ' ' PHE . 9.6 p -108.16 -42.06 4.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 118.661 -1.216 . . . . 73.150000000000006 113.233 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.23 -25.62 0.46 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 118.544 -1.788 . . . . 45.25 117.025 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 64' ' ' LYS . . . -139.76 -176.75 4.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 114.829 1.418 . . . . 72.5 114.829 -156.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.684 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 34.4 mt-10 -76.18 143.05 41.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.413 -1.267 . . . . 65.340000000000003 109.407 173.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 43' ' ' HIS . 93.8 t -142.8 133.19 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.993 -0.373 . . . . 74.409999999999997 109.993 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 62' ' ' LEU . 3.2 p -125.08 125.3 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.507 -0.553 . . . . 72.010000000000005 109.507 172.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -103.24 121.1 42.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.244 0.545 . . . . 72.25 110.035 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.01 157.58 23.47 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.215 -0.754 . . . . 74.030000000000001 111.215 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 7.0 ptt180 -109.98 103.42 12.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.511 0.672 . . . . 75.230000000000004 110.915 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.758 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 3.1 pp -113.06 151.81 30.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.091 -0.959 . . . . 71.120000000000005 109.153 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.28 -57.85 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.831 0.707 . . . . 73.430000000000007 110.993 -172.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.84 -38.67 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.146 -0.549 . . . . 61.140000000000001 112.273 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -93.45 140.66 29.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.76 0.314 . . . . 64.310000000000002 110.867 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 25.9 m -77.64 121.63 24.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.352 -0.385 . . . . 74.030000000000001 110.066 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.3 171.7 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.899 0.38 . . . . 74.400000000000006 111.408 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 4' ' ' PRO . 77.6 t -117.82 111.57 35.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 75.540000000000006 110.137 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.693 HD12 ' HB2' ' A' ' 29' ' ' ALA . 3.0 tm? -98.68 119.88 38.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.18 -0.674 . . . . 75.230000000000004 109.18 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.585 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -108.85 137.87 46.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.347 -0.388 . . . . 64.439999999999998 110.922 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.684 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 54.6 mtpt -114.0 92.61 26.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.998 -0.546 . . . . 75.319999999999993 110.957 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.4 138.79 51.91 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.863 2.376 . . . . 63.25 112.184 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -109.73 16.81 21.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.506 0.669 . . . . 73.150000000000006 109.351 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 59.7 m -114.8 179.99 3.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.333 -0.848 . . . . 74.299999999999997 111.231 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.739 ' HA ' ' HB3' ' A' ' 13' ' ' PRO . 97.7 m-85 -70.25 175.54 4.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.609 . . . . 73.340000000000003 112.031 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.725 ' HA ' HD21 ' A' ' 10' ' ' LEU . 27.3 ptt? -67.46 -31.06 70.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.752 -0.658 . . . . 71.129999999999995 112.344 -173.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -72.2 -30.76 65.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.44 0.638 . . . . 72.329999999999998 109.96 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 51.2 mm-40 -80.2 -22.27 42.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.528 -0.76 . . . . 71.319999999999993 111.355 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.0 p -56.3 -45.23 80.33 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.216 0.322 . . . . 73.200000000000003 111.467 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 121' ' ' VAL . . . -73.88 -28.15 65.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.665 -0.779 . . . . 74.299999999999997 112.257 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -78.73 -11.32 59.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.859 0.362 . . . . 73.340000000000003 110.612 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 31.0 mm-40 -65.5 -30.27 71.02 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.101 0.477 . . . . 73.409999999999997 110.021 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.5 t -67.47 -21.73 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.467 -0.788 . . . . 75.430000000000007 110.897 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.54 -72.28 0.55 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 116.018 -0.537 . . . . 65.230000000000004 112.879 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.95 -30.2 48.59 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.442 2.095 . . . . 54.32 112.037 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.505 HD11 HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -59.28 -40.36 85.87 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.748 -0.66 . . . . 74.400000000000006 110.689 -176.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.97 -30.89 70.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 64.010000000000005 112.108 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.26 -41.21 34.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 62.310000000000002 111.131 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.807 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 55.2 m-85 -71.63 -43.08 66.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.491 0.552 . . . . 74.040000000000006 112.491 -172.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.604 ' CE1' ' HG2' ' A' ' 45' ' ' LYS . 95.3 m-85 -97.68 -16.88 19.76 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.739 -0.384 . . . . 74.540000000000006 111.201 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 t 63.96 33.46 12.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.199 0.523 . . . . 75.510000000000005 110.382 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.47 HG23 HD22 ' A' ' 6' ' ' LEU . 25.7 m -69.0 149.7 97.77 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.472 -0.786 . . . . 75.430000000000007 111.362 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.84 117.01 4.28 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.745 2.296 . . . . 75.430000000000007 112.402 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.91 -1.87 10.11 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.032 2.488 . . . . 64.219999999999999 112.633 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -95.32 -25.47 16.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.127 -0.488 . . . . 75.510000000000005 110.342 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.844 ' HG2' HD11 ' A' ' 5' ' ' LEU . 7.5 tp60 -92.57 -11.05 35.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.635 . . . . 73.310000000000002 111.106 -174.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.504 HD11 HD21 ' A' ' 6' ' ' LEU . 5.3 tp -52.62 113.73 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.729 0.776 . . . . 70.510000000000005 111.776 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 9.3 p -116.76 138.79 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.301 -0.863 . . . . 74.219999999999999 110.147 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 7.7 p -132.6 134.06 59.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.67 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.758 HG12 HD12 ' A' ' 24' ' ' LEU . 7.7 tt -89.9 124.53 42.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.827 -0.624 . . . . 75.120000000000005 109.967 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -140.53 162.12 36.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.889 0.376 . . . . 74.439999999999998 110.767 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.53 153.01 23.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.719 -0.673 . . . . 74.310000000000002 110.252 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.923 ' HG3' ' HD2' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -140.84 121.35 14.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.938 0.399 . . . . 73.409999999999997 111.41 -178.506 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.709 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.8 pt? -84.91 -12.24 53.83 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.67 -0.696 . . . . 71.230000000000004 110.765 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.64 -39.17 93.0 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.151 0.501 . . . . 71.340000000000003 110.108 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.609 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.8 pt -104.81 154.11 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 74.439999999999998 110.052 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.575 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 6.9 p-10 -88.37 -170.09 2.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.102 0.477 . . . . 75.219999999999999 112.018 -171.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.777 ' HD2' ' HB3' ' A' ' 158' ' ' GLU . 68.1 m-85 -62.97 119.65 9.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.363 -0.835 . . . . 72.230000000000004 112.526 -168.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.69 -0.16 82.39 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.813 -0.708 . . . . 72.0 113.363 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.498 ' O ' HD11 ' A' ' 99' ' ' ILE . 33.0 mmt180 -88.94 96.09 10.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 117.069 0.434 . . . . 75.209999999999994 110.192 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.644 HD11 ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -103.34 137.35 32.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.92 0.39 . . . . 74.439999999999998 110.666 -179.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -145.61 125.74 13.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.997 -0.547 . . . . 75.200000000000003 110.062 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 106' ' ' LEU . 1.0 OUTLIER -100.21 130.22 46.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.342 -0.614 . . . . 75.409999999999997 109.342 172.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 181' ' ' LEU . 1.5 tmtm? -155.41 154.2 31.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.266 0.555 . . . . 75.0 111.637 -171.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.465 HD23 HD11 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -83.95 92.95 7.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.343 0.592 . . . . 75.150000000000006 109.561 171.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.04 176.58 37.46 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.623 -0.717 . . . . 71.129999999999995 111.435 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.79 170.41 27.91 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.615 -0.802 . . . . 75.150000000000006 112.673 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.2 -169.19 34.68 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.447 -0.661 . . . . 64.329999999999998 111.447 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -134.26 -11.73 2.49 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.754 -0.379 . . . . 70.120000000000005 110.781 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -108.31 138.91 14.91 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.72 -0.752 . . . . 74.340000000000003 111.354 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.13 56.32 18.83 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.578 -0.82 . . . . 74.109999999999999 111.773 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -53.74 -38.93 64.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.06 0.393 . . . . 70.420000000000002 112.06 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -58.24 -53.72 55.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.724 0.297 . . . . 64.319999999999993 111.274 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.65 -28.81 73.95 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.007 -0.616 . . . . 60.149999999999999 112.831 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.1 mt -82.48 -46.12 13.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.654 0.264 . . . . 73.420000000000002 111.488 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -77.56 -21.48 52.45 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.879 -0.328 . . . . 75.400000000000006 110.879 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 t -63.27 -37.85 88.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.513 -0.551 . . . . 75.400000000000006 109.513 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.478 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 45.2 t -66.79 -31.01 51.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.801 -0.636 . . . . 71.019999999999996 110.202 176.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.6 -52.33 10.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.852 -0.613 . . . . 73.530000000000001 111.001 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 62.7 m -66.78 -22.75 66.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 73.219999999999999 111.772 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.32 -54.91 29.57 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 111.872 0.323 . . . . 73.340000000000003 111.872 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.651 ' H ' HD23 ' A' ' 125' ' ' LEU . 2.2 pt? -106.71 -17.73 14.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 75.340000000000003 111.369 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.54 40.24 2.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.242 -0.98 . . . . 71.450000000000003 112.936 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -110.26 171.82 7.23 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.505 -0.554 . . . . 73.230000000000004 109.505 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -114.22 38.88 2.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.488 0.185 . . . . 75.329999999999998 111.127 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 63.38 34.89 12.64 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.373 -0.376 . . . . 75.219999999999999 111.117 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -64.67 -13.11 52.7 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.132 -0.486 . . . . 71.400000000000006 112.303 -173.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 48.1 m80 -146.86 99.29 3.17 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.232 -0.293 . . . . 74.239999999999995 110.366 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 143.82 49.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.815 0.341 . . . . 75.140000000000001 110.822 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 34.3 t -116.94 120.59 65.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.812 -0.44 . . . . 73.319999999999993 109.812 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.923 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 44.0 mtm180 -107.32 117.58 34.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.676 0.274 . . . . 73.140000000000001 111.027 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.419 HD12 HG13 ' A' ' 93' ' ' ILE . 1.9 mp -103.51 115.11 44.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.762 -0.459 . . . . 75.530000000000001 109.762 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.609 ' HA2' HG13 ' A' ' 99' ' ' ILE . . . -62.13 113.63 5.98 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.872 -0.604 . . . . 62.420000000000002 112.879 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 p -101.66 -17.22 6.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.226 0.536 . . . . 71.230000000000004 109.648 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 88.49 -171.99 40.57 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.718 -0.753 . . . . 63.130000000000003 111.4 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -135.06 111.96 11.14 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 120.901 0.382 . . . . 73.430000000000007 110.197 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.695 ' HD2' ' HB3' ' A' ' 146' ' ' PRO . 23.8 Cg_exo -63.67 114.99 2.79 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.108 2.539 . . . . 71.239999999999995 112.441 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.16 139.32 7.08 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.319 2.679 . . . . 65.530000000000001 112.347 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -173.32 -151.91 8.44 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.43 -0.668 . . . . 75.109999999999999 111.43 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.13 -8.17 49.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.449 0.642 . . . . 74.519999999999996 109.688 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.412 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 71.6 mmtt -116.89 156.11 27.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.198 -0.91 . . . . 70.400000000000006 109.795 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.34 143.29 97.27 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.885 -0.598 . . . . 72.209999999999994 110.03 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.695 ' HB3' ' HD2' ' A' ' 140' ' ' PRO . 82.9 Cg_exo -47.0 -26.06 4.57 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.364 2.71 . . . . 74.230000000000004 113.016 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.05 -31.16 39.96 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.956 -0.565 . . . . 71.400000000000006 111.916 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.13 -50.9 6.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.488 -0.324 . . . . 74.540000000000006 111.422 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 153' ' ' ASN . 74.6 m-85 -64.99 -27.43 68.82 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.201 0.445 . . . . 74.299999999999997 112.201 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.453 HG22 ' CE1' ' A' ' 22' ' ' HIS . 6.2 p -69.36 -9.13 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.889 0.376 . . . . 74.209999999999994 111.558 -174.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.37 -24.5 36.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.603 -0.271 . . . . 73.140000000000001 110.897 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.6 87.77 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.842 0.83 . . . . 74.450000000000003 109.647 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.722 ' H ' HG22 ' A' ' 20' ' ' THR . 3.7 t-20 -137.84 122.23 18.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.426 -0.806 . . . . 75.109999999999999 110.77 -174.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -134.35 133.83 41.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.639 -0.71 . . . . 74.430000000000007 109.407 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.51 HG23 ' H ' ' A' ' 157' ' ' ALA . 59.9 m -145.61 134.04 21.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.86 0.362 . . . . 72.409999999999997 110.471 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.04 -31.43 67.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.325 -0.398 . . . . 64.329999999999998 111.505 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.51 ' H ' HG23 ' A' ' 155' ' ' THR . . . -59.89 -40.73 89.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 73.340000000000003 111.9 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.777 ' HB3' ' HD2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -85.14 -17.75 36.29 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.035 -0.266 . . . . 74.340000000000003 111.361 -177.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 155' ' ' THR . 4.7 mmt180 -72.15 -24.62 61.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 75.439999999999998 110.927 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.68 -17.1 61.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 72.040000000000006 111.127 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 165' ' ' ILE . 25.0 mm-40 -92.66 -18.49 22.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 62.43 111.103 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.7 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 67.1 t -55.98 -56.99 24.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.594 0.59 . . . . 64.329999999999998 112.594 -174.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.7 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 32.2 Cg_exo -59.12 -30.12 92.34 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.135 1.89 . . . . 62.0 112.322 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.9 m -67.2 -46.3 74.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.949 -0.569 . . . . 72.140000000000001 110.555 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 161' ' ' GLU . 72.4 mt -70.02 -53.97 21.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.717 -0.674 . . . . 73.299999999999997 111.215 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.78 -57.94 9.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.383 0.512 . . . . 72.439999999999998 112.383 -172.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -62.88 -45.52 92.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.874 0.324 . . . . 74.450000000000003 111.874 -174.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -74.32 -32.02 62.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.798 0.295 . . . . 70.239999999999995 111.798 -173.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.29 -25.43 67.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.618 0.229 . . . . 65.120000000000005 111.618 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.23 74.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 73.310000000000002 111.289 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.4 -43.69 76.69 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.338 0.59 . . . . 61.530000000000001 110.766 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.7 -31.75 69.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.597 -0.729 . . . . 62.420000000000002 111.678 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.1 m -55.72 -43.09 76.19 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.776 0.322 . . . . 74.239999999999995 111.803 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.758 ' HG2' ' HB2' ' A' ' 55' ' ' LEU . 42.6 mt-10 -68.54 -28.65 67.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.754 0.311 . . . . 71.25 111.075 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.05 -25.77 65.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.352 -0.385 . . . . 75.430000000000007 111.051 -175.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.73 -37.81 88.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.188 0.518 . . . . 72.319999999999993 110.278 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -80.0 -39.9 20.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.678 -0.692 . . . . 75.420000000000002 110.091 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.49 -56.6 10.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.807 -0.633 . . . . 75.319999999999993 111.448 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -115.57 -77.09 0.57 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.079 -0.509 . . . . 75.340000000000003 110.208 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.32 -171.39 40.02 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.107 -0.797 . . . . 74.540000000000006 111.107 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 107' ' ' LYS . 4.3 pp -91.13 -18.49 24.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.035 0.418 . . . . 74.120000000000005 110.32 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -58.63 -51.79 79.3 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.747 -0.66 . . . . 75.409999999999997 111.829 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.01 -29.81 26.8 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.351 1.367 . . . . 72.209999999999994 112.027 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.15 -43.81 66.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 63.530000000000001 111.809 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -58.8 -24.0 61.22 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.779 0.323 . . . . 65.109999999999999 111.303 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -77.65 -57.12 3.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.34 -0.391 . . . . 75.409999999999997 111.298 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -66.95 -31.01 71.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.383 -0.371 . . . . 73.310000000000002 111.876 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 8.1 p -71.42 -29.36 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.055 0.391 . . . . 75.430000000000007 112.055 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -94.03 0.06 55.74 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.46 -0.496 . . . . 72.430000000000007 110.636 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.49 -0.96 54.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 112.018 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 74.3 m95 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.697 -0.668 . . . . 74.349999999999994 110.64 -178.256 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.363 -0.236 . . . . 75.230000000000004 110.363 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' A' ' 59' ' ' SER . 22.6 Cg_exo -64.71 106.4 0.74 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.598 2.199 . . . . 73.450000000000003 111.596 176.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.41 ' HG ' HG13 ' A' ' 60' ' ' VAL . 4.0 pp -89.94 153.77 20.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.304 -0.407 . . . . 73.120000000000005 111.021 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.447 ' HB3' HG12 ' A' ' 90' ' ' ILE . 62.9 tp -97.46 124.74 41.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.848 -0.615 . . . . 74.340000000000003 110.5 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.1 t -105.27 119.12 53.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.13 -0.486 . . . . 70.340000000000003 109.77 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.72 117.08 46.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.02 0.438 . . . . 74.329999999999998 110.801 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -127.9 128.72 6.13 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.371 -0.692 . . . . 65.209999999999994 111.371 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -72.56 118.94 16.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.759 -0.46 . . . . 73.450000000000003 109.759 -178.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.94 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -77.12 -158.4 9.21 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.206 -0.452 . . . . 73.549999999999997 113.069 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.47 91.36 9.95 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.619 0.723 . . . . 70.25 111.002 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 11' ' ' GLY . 2.0 Cg_endo -82.92 -8.95 10.96 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.215 2.61 . . . . 73.439999999999998 112.932 -176.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.19 160.92 29.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.826 -0.702 . . . . 70.430000000000007 112.229 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.42 -30.59 52.95 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.109 2.539 . . . . 75.140000000000001 112.482 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 p -73.24 -43.61 60.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.987 0.422 . . . . 73.239999999999995 111.2 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -59.89 -40.15 87.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.773 -0.648 . . . . 73.129999999999995 111.51 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.23 -3.71 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 75.409999999999997 111.771 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -111.45 8.29 21.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.352 -0.386 . . . . 75.109999999999999 110.424 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.537 HG22 ' H ' ' A' ' 153' ' ' ASN . 71.4 p -113.65 159.75 19.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 73.319999999999993 111.038 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -78.46 -20.16 51.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 64.439999999999998 111.672 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -76.73 -19.7 57.36 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.785 -0.366 . . . . 72.319999999999993 111.476 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 27' ' ' MET . 7.0 m120 -85.08 33.27 0.54 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.227 0.537 . . . . 75.150000000000006 111.042 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 pp -66.07 -17.26 64.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.552 -0.749 . . . . 74.239999999999995 111.521 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.12 -34.24 78.55 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.195 -0.526 . . . . 74.230000000000004 111.962 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.94 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 54.6 t80 -90.11 -53.89 4.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.459 . . . . 75.25 109.841 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 85.7 mmm -56.89 -38.11 72.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.905 -1.043 . . . . 73.439999999999998 112.554 -169.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.557 HG22 HG22 ' A' ' 166' ' ' VAL . 62.1 t -88.84 -41.9 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.798 0.332 . . . . 73.030000000000001 111.739 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.49 -22.42 47.49 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.189 0.44 . . . . 64.430000000000007 112.189 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -72.2 -39.28 68.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.732 0.301 . . . . 73.120000000000005 111.468 -175.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.41 -36.64 75.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 75.019999999999996 111.868 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.99 -27.08 62.52 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.771 0.319 . . . . 75.120000000000005 110.971 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.43 68.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.112 0.482 . . . . 75.230000000000004 110.309 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.16 -29.34 56.78 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.474 -0.869 . . . . 74.319999999999993 112.244 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -79.89 -21.87 43.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.342 0.497 . . . . 74.439999999999998 112.342 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.2 tp -78.15 -14.69 13.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.315 0.578 . . . . 75.430000000000007 110.335 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.31 41.03 2.87 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.121 -0.792 . . . . 54.530000000000001 111.121 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 62.8 m -135.3 150.08 49.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.229 -0.486 . . . . 65.549999999999997 110.684 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.97 136.24 52.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.687 0.279 . . . . 72.010000000000005 110.731 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.438 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 26.9 p90 -91.93 146.82 23.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.614 -0.513 . . . . 75.340000000000003 109.614 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.449 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 18.9 ptmt -155.39 166.87 32.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 74.010000000000005 111.155 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.22 128.31 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.469 -0.787 . . . . 73.540000000000006 111.314 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -101.9 106.13 17.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.234 -1.025 . . . . 72.209999999999994 108.234 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -57.91 154.26 12.64 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.502 0.556 . . . . 74.340000000000003 112.502 -166.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt 76.66 -47.55 0.54 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.387 1.075 . . . . 75.200000000000003 110.086 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 p -95.09 25.08 4.42 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.141 -0.936 . . . . 73.400000000000006 108.737 171.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.37 41.39 0.01 OUTLIER Glycine 0 CA--C 1.533 1.166 0 N-CA-C 119.238 2.455 . . . . 71.120000000000005 119.238 -159.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.02 140.1 29.84 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.847 -1.168 . . . . 74.140000000000001 107.847 163.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.51 120.12 19.63 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.723 -0.391 . . . . 71.230000000000004 110.553 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.466 HG23 ' HH ' ' A' ' 83' ' ' TYR . 33.2 m -126.05 145.18 33.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.78 -0.646 . . . . 74.209999999999994 111.272 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 62' ' ' LEU . 4.8 p -125.41 117.05 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.834 -0.621 . . . . 74.310000000000002 110.228 172.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.5 p -91.08 116.27 28.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.191 -0.459 . . . . 71.329999999999998 110.546 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.35 175.25 28.64 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.935 -0.65 . . . . 73.219999999999999 111.604 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 25.6 ptt85 -126.77 115.75 19.85 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.093 0.473 . . . . 74.219999999999999 110.922 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.9 mt -103.09 124.72 49.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.764 -0.653 . . . . 63.420000000000002 109.705 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 72.28 -53.01 0.7 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.823 0.702 . . . . 74.409999999999997 111.373 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.24 -52.13 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.115 -0.564 . . . . 71.329999999999998 111.986 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.705 ' HB ' HG22 ' A' ' 177' ' ' ILE . 17.8 m -72.62 138.67 46.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.857 0.36 . . . . 75.530000000000001 110.889 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 10.8 t -85.75 139.79 31.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.553 -0.536 . . . . 71.530000000000001 109.553 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 HG13 ' HG ' ' A' ' 5' ' ' LEU . 31.6 m -130.07 155.01 41.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.341 -0.391 . . . . 71.530000000000001 110.72 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.4 t -111.25 106.83 21.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.845 -0.616 . . . . 73.430000000000007 109.638 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 3.4 tm? -91.78 115.78 28.34 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.299 -0.63 . . . . 75.049999999999997 109.299 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.27 142.24 48.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.239 -0.437 . . . . 51.140000000000001 111.385 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.544 ' HE2' ' CD2' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -139.14 127.25 13.52 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 75.450000000000003 110.387 175.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 13.0 Cg_exo -70.75 153.34 64.44 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.992 2.462 . . . . 75.409999999999997 112.023 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -93.96 -19.24 21.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.462 0.649 . . . . 75.25 110.0 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 60.4 m -101.94 159.26 15.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.217 -0.901 . . . . 75.019999999999996 109.463 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.416 ' HB2' ' H ' ' A' ' 69' ' ' MET . 17.2 p90 -78.05 -169.38 1.56 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.876 0.369 . . . . 65.219999999999999 111.522 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.806 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 18.9 ptp -52.75 -22.06 4.82 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.625 0.972 . . . . 70.150000000000006 113.625 -170.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -62.82 -49.62 74.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.791 0.329 . . . . 63.520000000000003 110.809 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.88 -0.11 21.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.011 0.375 . . . . 64.409999999999997 112.011 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 p -60.64 -42.77 97.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.927 0.394 . . . . 72.329999999999998 111.04 -176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.39 -21.17 78.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.945 -0.645 . . . . 72.530000000000001 112.769 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -80.63 -33.38 35.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.57 0.224 . . . . 71.239999999999995 111.391 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -74.9 -14.9 60.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.704 0.288 . . . . 75.319999999999993 111.617 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.21 -25.21 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.172 0.51 . . . . 65.519999999999996 110.304 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.69 -68.55 1.62 Allowed Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.881 -0.6 . . . . 63.32 112.865 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.82 -37.71 95.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.853 2.369 . . . . 74.099999999999994 112.462 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -55.87 -52.04 65.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 73.450000000000003 110.484 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.98 -44.75 83.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 65.400000000000006 112.012 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -72.77 -37.85 67.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.926 0.343 . . . . 75.329999999999998 111.926 -174.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -60.28 -47.49 85.76 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.75 0.309 . . . . 74.409999999999997 111.314 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.466 ' HH ' HG23 ' A' ' 50' ' ' VAL . 71.2 m-85 -84.39 -15.14 47.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.934 -0.307 . . . . 74.329999999999998 110.791 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.2 m 59.78 47.61 10.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.863 -0.608 . . . . 71.430000000000007 110.693 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 29.4 m -94.42 148.8 35.61 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.642 -0.708 . . . . 74.299999999999997 110.321 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 11.2 Cg_exo -71.19 115.33 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.807 2.338 . . . . 75.239999999999995 111.969 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.46 ' HA ' HG13 ' A' ' 90' ' ' ILE . 28.8 Cg_exo -62.78 -19.53 68.73 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.006 2.471 . . . . 72.400000000000006 112.124 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -66.98 -21.7 65.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.86 -0.609 . . . . 74.540000000000006 110.684 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 89' ' ' GLN . 15.6 mm-40 -98.01 5.63 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.384 . . . . 73.430000000000007 111.413 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.46 HG13 ' HA ' ' A' ' 87' ' ' PRO . 59.5 mt -69.22 130.92 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.109 0.48 . . . . 74.519999999999996 111.165 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 7.0 p -120.0 132.67 69.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 73.430000000000007 109.325 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.68 129.71 75.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.543 0.687 . . . . 74.319999999999993 111.649 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.13 113.1 29.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.167 -0.924 . . . . 75.439999999999998 109.174 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -135.26 154.28 51.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.277 0.561 . . . . 73.140000000000001 111.905 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.87 129.53 34.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.628 -1.169 . . . . 73.549999999999997 110.899 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -129.47 138.45 51.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.016 0.436 . . . . 54.240000000000002 110.659 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.55 -0.03 44.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.88 -0.6 . . . . 74.129999999999995 110.919 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -58.67 -45.7 88.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.313 -0.858 . . . . 73.239999999999995 112.431 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.574 HD11 ' HG3' ' A' ' 105' ' ' ARG . 2.9 pt -122.22 174.92 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.307 0.575 . . . . 75.120000000000005 112.507 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.97 171.43 14.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.826 -1.079 . . . . 71.019999999999996 111.615 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -63.89 132.69 51.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.203 -0.908 . . . . 73.299999999999997 110.671 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.06 10.67 66.05 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.604 -0.808 . . . . 72.120000000000005 113.217 173.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.3 mmt-85 -123.0 153.56 39.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.103 0.452 . . . . 72.040000000000006 110.345 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.641 HD12 HG21 ' A' ' 188' ' ' VAL . 44.2 pt -138.81 149.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 74.5 110.874 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.574 ' HG3' HD11 ' A' ' 99' ' ' ILE . 99.0 mtt180 -127.15 128.06 45.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.936 -0.575 . . . . 74.319999999999993 109.903 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.429 HD22 ' HB3' ' A' ' 185' ' ' GLN . 8.1 mp -109.75 110.19 21.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 72.519999999999996 110.953 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -157.68 148.4 21.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.053 -0.721 . . . . 74.219999999999999 109.053 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.3 pt? -73.66 125.12 27.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.776 -0.453 . . . . 73.409999999999997 109.776 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.76 -177.14 41.06 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.848 -0.692 . . . . 70.219999999999999 112.022 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.37 -164.73 39.28 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.962 -0.637 . . . . 54.43 112.628 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.35 152.36 22.07 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.381 -0.688 . . . . 55.229999999999997 111.381 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -113.32 7.53 17.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.776 0.288 . . . . 75.209999999999994 110.995 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -68.61 -86.77 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.701 -0.762 . . . . 62.329999999999998 111.855 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.4 73.93 1.32 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.916 -0.659 . . . . 74.430000000000007 111.66 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.614 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -48.97 -66.43 0.4 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.488 0.715 . . . . 75.230000000000004 112.69 -174.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.544 ' HB2' ' SD ' ' A' ' 69' ' ' MET . 13.0 m120 -55.04 -43.63 73.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 72.430000000000007 111.527 -174.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.806 ' HA2' ' HB2' ' A' ' 69' ' ' MET . . . -62.9 -48.75 78.26 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.851 -0.613 . . . . 60.310000000000002 113.271 -176.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.74 -29.01 68.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.436 0.16 . . . . 74.310000000000002 111.291 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 115' ' ' HIS . 10.2 mmm180 -65.96 -42.27 90.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.657 0.265 . . . . 73.329999999999998 110.642 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -64.86 -47.79 76.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.387 -0.37 . . . . 74.120000000000005 110.549 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.28 -47.47 92.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 74.519999999999996 110.903 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.74 -31.28 72.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.891 -0.595 . . . . 71.530000000000001 111.844 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.2 t -80.34 -33.69 37.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.708 0.29 . . . . 64.109999999999999 110.918 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.21 -45.9 53.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 62.450000000000003 111.025 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.89 -38.53 45.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.479 . . . . 74.140000000000001 110.943 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.97 -12.52 63.78 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 121.116 -0.564 . . . . 54.140000000000001 113.168 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.494 ' C ' ' HD2' ' A' ' 128' ' ' LYS . 14.6 t -141.9 173.73 11.24 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.129 -0.323 . . . . 74.409999999999997 110.129 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.494 ' HD2' ' C ' ' A' ' 127' ' ' THR . 13.2 mptt -125.22 -115.25 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.436 -0.347 . . . . 72.299999999999997 110.224 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 61.93 21.77 12.55 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.94 0.496 . . . . 72.450000000000003 111.613 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -90.25 160.97 15.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.19 -0.459 . . . . 71.319999999999993 110.275 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 33.2 m80 -87.18 99.89 12.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.122 -0.696 . . . . 74.329999999999998 109.122 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -111.75 136.31 51.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.975 0.416 . . . . 74.510000000000005 111.108 -174.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.03 127.11 59.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.016 -0.538 . . . . 74.340000000000003 109.782 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.459 ' HG2' ' NH1' ' A' ' 132' ' ' ARG . 5.2 mtm180 -93.36 96.83 10.19 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.685 -0.487 . . . . 75.120000000000005 109.685 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.505 ' HA ' HG22 ' A' ' 104' ' ' ILE . 51.4 mt -90.19 127.75 42.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.422 -0.354 . . . . 73.150000000000006 110.48 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.498 ' CA ' HG13 ' A' ' 99' ' ' ILE . . . -72.52 97.82 0.81 Allowed Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.987 -0.552 . . . . 75.519999999999996 112.545 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.8 p -88.65 -10.29 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.464 -0.569 . . . . 71.019999999999996 109.464 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.23 152.98 28.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.56 -0.745 . . . . 74.310000000000002 112.279 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 21.1 ptp180 -107.46 119.85 49.39 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.067 0.46 . . . . 73.049999999999997 110.235 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.465 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 32.5 Cg_exo -59.58 125.28 17.44 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.954 2.436 . . . . 64.340000000000003 112.746 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 1.9 Cg_endo -83.79 137.71 7.82 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.45 2.767 . . . . 73.409999999999997 112.374 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.09 -168.01 24.97 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.181 -0.767 . . . . 74.420000000000002 111.181 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -87.81 -24.38 23.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.631 -0.507 . . . . 75.129999999999995 109.631 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 42.4 mmtm -75.58 101.19 4.83 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.535 -0.913 . . . . 74.129999999999995 108.535 168.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.723 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 6.8 p-10 -73.1 168.49 24.43 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.916 -0.584 . . . . 74.340000000000003 110.41 -174.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.723 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 5.2 Cg_exo -35.99 -44.87 0.86 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.402 3.401 . . . . 71.310000000000002 114.274 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.42 68.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.236 0.458 . . . . 64.140000000000001 112.236 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.52 -43.77 11.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.847 0.356 . . . . 71.319999999999993 111.372 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 144' ' ' LYS . 2.6 m-85 -84.02 -19.43 34.49 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.869 0.692 . . . . 75.140000000000001 112.869 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.476 HG11 HD11 ' A' ' 151' ' ' LEU . 7.0 p -63.1 -25.56 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 112.201 0.445 . . . . 62.240000000000002 112.201 -173.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.476 HD11 HG11 ' A' ' 150' ' ' VAL . 6.0 mp -85.96 -10.24 55.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.659 0.266 . . . . 73.219999999999999 111.421 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.0 87.07 1.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.792 0.806 . . . . 74.209999999999994 109.438 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.537 ' H ' HG22 ' A' ' 20' ' ' THR . 23.8 t-20 -128.94 122.36 30.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.471 -0.786 . . . . 75.439999999999998 111.613 -170.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -155.31 134.86 12.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.386 -0.825 . . . . 74.209999999999994 109.199 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.582 HG21 ' H ' ' A' ' 157' ' ' ALA . 47.2 m -152.86 138.97 18.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.672 0.272 . . . . 72.230000000000004 110.605 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.91 -33.0 48.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 61.310000000000002 111.337 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.582 ' H ' HG21 ' A' ' 155' ' ' THR . . . -65.96 -49.24 68.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.903 -0.589 . . . . 72.310000000000002 111.568 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.425 ' HG3' ' HB ' ' A' ' 155' ' ' THR . 3.0 pp20? -72.64 -22.04 61.0 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 120.849 -0.34 . . . . 74.040000000000006 111.252 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 155' ' ' THR . 16.4 mmt180 -56.59 -39.89 74.33 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.195 0.522 . . . . 65.019999999999996 110.34 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.45 -31.97 71.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.69 -0.686 . . . . 73.25 111.189 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.93 1.13 57.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 111.887 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.456 ' HB ' ' CD ' ' A' ' 163' ' ' PRO . 92.5 t -57.33 -57.87 21.96 Favored Pre-proline 0 C--O 1.233 0.229 0 C-N-CA 121.086 -0.245 . . . . 63.43 110.496 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.456 ' CD ' ' HB ' ' A' ' 162' ' ' VAL . 18.8 Cg_endo -61.07 -36.75 80.39 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.668 1.579 . . . . 72.109999999999999 111.476 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -56.18 -53.37 57.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.594 -0.73 . . . . 72.519999999999996 111.421 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.4 mt -64.3 -49.75 79.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.289 -0.414 . . . . 75.109999999999999 111.008 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.557 HG22 HG22 ' A' ' 28' ' ' VAL . 97.6 t -57.22 -51.59 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.409 -0.359 . . . . 75.239999999999995 111.552 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.48 -49.87 73.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.503 -0.317 . . . . 75.430000000000007 111.754 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.539 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . 10.3 mm-40 -67.71 -36.78 81.25 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.027 -0.269 . . . . 74.549999999999997 111.498 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.24 75.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.61 0.243 . . . . 73.349999999999994 110.61 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.69 64.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.001 0.429 . . . . 61.539999999999999 111.301 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.42 -45.7 17.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.295 -0.411 . . . . 70.409999999999997 110.709 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.35 -33.96 70.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.068 -0.514 . . . . 73.340000000000003 111.979 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 176' ' ' LEU . 3.4 p -61.71 -27.4 68.68 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.865 0.32 . . . . 75.329999999999998 111.865 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -63.38 -44.76 93.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.701 0.286 . . . . 73.230000000000004 110.355 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 38.3 tp -74.65 -28.91 61.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 74.439999999999998 110.261 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.827 HD21 ' HA ' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -54.54 -49.02 71.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.366 -0.834 . . . . 72.439999999999998 109.306 174.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.705 HG22 ' HB ' ' A' ' 58' ' ' THR . 65.5 mt -79.7 -25.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.114 -0.948 . . . . 74.129999999999995 111.079 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.4 -43.68 72.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.008 -0.542 . . . . 73.109999999999999 112.158 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.22 -65.04 0.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.861 -0.336 . . . . 72.310000000000002 111.092 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -161.89 173.41 38.23 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.283 -0.96 . . . . 74.420000000000002 112.439 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.827 ' HA ' HD21 ' A' ' 176' ' ' LEU . 2.4 pt? -83.2 -30.6 27.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.723 0.297 . . . . 72.439999999999998 111.557 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 39.4 mt-10 -67.72 -49.31 39.64 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.098 0.407 . . . . 63.310000000000002 112.098 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 52.7 Cg_exo -55.76 -28.79 68.63 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.062 1.841 . . . . 73.209999999999994 112.228 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.69 -50.26 18.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 63.32 110.995 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.584 ' HG3' ' O ' ' A' ' 182' ' ' GLU . 1.4 pp0? -64.23 -32.9 74.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.766 0.317 . . . . 75.099999999999994 110.197 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -61.77 -23.08 65.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.905 -0.589 . . . . 74.310000000000002 111.099 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 26.4 m -87.15 -41.01 14.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.765 0.317 . . . . 72.200000000000003 111.605 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.641 HG21 HD12 ' A' ' 104' ' ' ILE . 17.8 m -96.41 -12.77 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 114.35 1.241 . . . . 74.239999999999995 114.35 -171.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -69.45 -28.59 66.24 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.913 0.708 . . . . 71.230000000000004 112.913 -171.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -133.66 -10.73 2.75 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.122 0.416 . . . . 74.099999999999994 112.122 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 19.4 m0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 119.012 -0.518 . . . . 70.510000000000005 110.234 -176.835 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.343 0.592 . . . . 73.310000000000002 109.819 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.538 ' HG2' HG11 ' A' ' 85' ' ' VAL . 6.7 Cg_endo -89.41 110.82 0.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.093 2.529 . . . . 75.530000000000001 113.191 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.633 HD12 HG21 ' A' ' 177' ' ' ILE . 91.7 mt -76.52 128.93 35.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 72.439999999999998 110.281 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.559 ' HA ' HG21 ' A' ' 61' ' ' VAL . 22.9 tp -96.72 114.55 26.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.041 0.448 . . . . 71.439999999999998 110.781 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.776 ' HB ' HD12 ' A' ' 62' ' ' LEU . 21.2 t -105.21 111.56 35.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.728 -0.669 . . . . 70.120000000000005 109.83 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 76' ' ' VAL . 49.5 t -104.48 117.47 50.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.077 -0.511 . . . . 73.219999999999999 110.147 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.454 ' HA2' HG13 ' A' ' 93' ' ' ILE . . . -106.2 -142.91 11.15 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.448 -0.882 . . . . 73.209999999999994 112.622 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.469 ' H ' ' HA3' ' A' ' 25' ' ' GLY . 2.2 tt -117.47 122.57 44.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.448 -0.945 . . . . 73.430000000000007 108.448 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -76.31 169.9 54.86 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.945 -0.645 . . . . 73.230000000000004 113.424 -172.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' A' ' 18' ' ' ALA . 44.9 t-20 -109.28 109.26 60.46 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.234 -0.654 . . . . 75.299999999999997 109.234 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 6.3 Cg_exo -74.25 -61.8 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.231 2.62 . . . . 73.530000000000001 113.62 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.72 -168.09 11.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.202 -0.999 . . . . 75.450000000000003 113.362 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.02 -56.68 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.392 2.728 . . . . 73.329999999999998 113.378 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 m -61.78 -30.78 71.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.993 0.425 . . . . 72.519999999999996 111.518 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -83.59 -8.0 59.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.213 -0.448 . . . . 75.510000000000005 111.04 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.448 ' HA ' HD22 ' A' ' 12' ' ' ASN . . . -81.28 -16.6 52.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 74.340000000000003 111.411 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.843 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 9.7 mmpt? -111.34 8.13 21.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.428 -0.351 . . . . 75.400000000000006 111.374 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.6 p -110.47 163.21 13.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.523 0.677 . . . . 73.310000000000002 112.173 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.869 HH21 ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -54.8 -33.47 61.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.428 -1.26 . . . . 75.219999999999999 113.465 -174.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -86.14 9.93 15.98 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.099 0.777 . . . . 73.450000000000003 113.099 -165.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.73 13.46 19.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.31 0.576 . . . . 72.030000000000001 110.556 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.869 ' HG ' HH21 ' A' ' 21' ' ' ARG . 0.0 OUTLIER -50.28 -31.35 14.0 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.182 0.808 . . . . 70.099999999999994 113.182 -173.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.469 ' HA3' ' H ' ' A' ' 10' ' ' LEU . . . -62.47 -42.64 99.69 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.823 -0.704 . . . . 65.129999999999995 112.536 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.461 ' CE2' ' HE3' ' A' ' 64' ' ' LYS . 56.3 t80 -67.13 -40.42 86.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.137 0.494 . . . . 73.430000000000007 110.439 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.81 ' HA ' ' HE3' ' A' ' 27' ' ' MET . 4.8 mmt -65.36 -45.86 82.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.732 . . . . 74.209999999999994 111.381 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.73 HG11 HD22 ' A' ' 32' ' ' LEU . 57.9 t -68.15 -32.47 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.48 -0.327 . . . . 74.129999999999995 111.285 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.1 70.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.048 0.388 . . . . 54.32 112.048 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.27 -38.61 68.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.602 -0.272 . . . . 73.329999999999998 111.509 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.542 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 30.3 m -74.94 -33.38 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.091 0.404 . . . . 74.5 112.091 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.73 HD22 HG11 ' A' ' 28' ' ' VAL . 4.3 pp -70.93 -38.59 72.91 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 120.63 -0.428 . . . . 75.109999999999999 110.34 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.423 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -75.11 -36.89 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.231 0.539 . . . . 70.310000000000002 110.061 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.83 -18.28 45.87 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.497 -0.774 . . . . 74.150000000000006 113.067 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 15.3 mmt85 -68.67 -36.45 78.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.39 . . . . 74.010000000000005 111.17 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.428 HD13 ' N ' ' A' ' 36' ' ' ILE . 3.1 mp -88.17 -15.07 9.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.713 0.768 . . . . 74.319999999999993 109.703 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.35 24.9 9.8 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.616 -0.993 . . . . 71.129999999999995 110.616 -175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.5 m -99.24 123.23 43.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.845 -0.677 . . . . 72.219999999999999 111.021 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.48 134.63 14.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.471 -0.331 . . . . 74.140000000000001 110.707 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.42 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 3.0 t80 -142.85 177.99 7.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.591 -0.522 . . . . 73.329999999999998 109.591 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 41' ' ' LYS . 20.8 ptmt -123.39 174.14 7.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.702 -0.226 . . . . 74.219999999999999 110.446 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.792 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 6.3 p -49.8 128.29 6.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.262 0.553 . . . . 70.129999999999995 110.602 174.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -106.86 109.92 21.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.964 -0.562 . . . . 75.349999999999994 110.513 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -53.16 154.44 3.12 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.652 0.595 . . . . 72.409999999999997 111.993 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 tptp 80.26 -41.73 0.21 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.362 1.065 . . . . 74.310000000000002 109.625 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.9 p -104.93 26.58 9.06 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.366 -1.288 . . . . 74.420000000000002 108.109 171.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.45 41.44 0.01 OUTLIER Glycine 0 N--CA 1.477 1.424 0 N-CA-C 119.72 2.648 . . . . 73.219999999999999 119.72 -154.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.02 168.63 9.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.14 -1.43 . . . . 74.430000000000007 107.14 160.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.792 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 46.0 mt-10 -77.64 124.18 27.6 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.065 -0.654 . . . . 73.25 109.737 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -133.54 138.85 50.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.928 -0.578 . . . . 75.430000000000007 109.995 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.61 HG11 ' HB2' ' A' ' 62' ' ' LEU . 3.4 p -122.11 115.99 47.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.356 0.598 . . . . 71.310000000000002 110.241 173.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.0 m -99.47 136.06 39.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.529 -0.759 . . . . 74.530000000000001 110.183 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -175.09 -160.07 22.37 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.24 -0.744 . . . . 61.409999999999997 111.24 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -131.91 144.08 50.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.742 0.306 . . . . 74.349999999999994 110.195 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.743 ' HG ' HG22 ' A' ' 60' ' ' VAL . 79.9 mt -118.3 123.67 45.92 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.842 -0.799 . . . . 75.099999999999994 108.842 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.651 ' HB1' ' HG2' ' A' ' 174' ' ' GLU . . . 70.18 -52.44 0.64 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.961 0.788 . . . . 61.020000000000003 111.274 -173.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.4 -40.82 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.327 -0.709 . . . . 75.239999999999995 111.327 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.671 ' HB ' HG22 ' A' ' 177' ' ' ILE . 20.6 m -65.54 144.57 56.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.42 -0.39 . . . . 73.239999999999995 110.724 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -76.18 142.72 41.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.312 -0.404 . . . . 72.430000000000007 110.499 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.743 HG22 ' HG ' ' A' ' 55' ' ' LEU . 29.4 m -138.33 150.81 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.255 0.55 . . . . 74.209999999999994 111.5 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 6' ' ' LEU . 3.6 m -129.76 112.14 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.526 -0.761 . . . . 74.420000000000002 109.904 173.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.776 HD12 ' HB ' ' A' ' 7' ' ' VAL . 4.1 mm? -92.49 128.07 38.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.797 -0.638 . . . . 73.510000000000005 109.992 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.14 122.25 46.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.173 0.511 . . . . 71.329999999999998 110.532 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.461 ' HE3' ' CE2' ' A' ' 26' ' ' PHE . 6.9 ptmt -130.26 91.53 38.46 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.509 -0.769 . . . . 73.329999999999998 110.045 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.74 177.1 9.12 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.071 2.514 . . . . 64.019999999999996 112.812 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 20.3 mmt85 -109.35 13.3 24.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.46 -0.791 . . . . 75.099999999999994 109.044 175.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.518 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 61.2 m -102.26 178.91 4.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.947 -1.024 . . . . 71.349999999999994 109.923 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -85.36 -165.11 1.12 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 110.125 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -80.7 -19.62 44.69 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.705 0.261 . . . . 73.420000000000002 111.705 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -73.47 -61.71 1.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.222 0.534 . . . . 74.329999999999998 110.833 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.518 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 1.1 pm0 -82.69 6.6 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.987 -0.551 . . . . 71.310000000000002 111.792 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.6 p -67.54 -34.08 76.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.985 0.422 . . . . 75.209999999999994 110.069 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.96 -20.75 74.89 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.806 -0.634 . . . . 75.019999999999996 112.612 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 mmm180 -74.25 -19.62 60.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.997 0.427 . . . . 73.540000000000006 110.473 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -87.34 -8.01 57.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 71.219999999999999 110.789 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.551 HG21 HG22 ' A' ' 8' ' ' VAL . 74.0 t -66.67 -36.95 78.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 75.409999999999997 110.659 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.11 9.43 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.811 -0.632 . . . . 63.240000000000002 112.939 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.56 -18.73 56.19 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.834 2.356 . . . . 72.120000000000005 113.187 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.57 -51.29 7.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.01 0.433 . . . . 74.219999999999999 110.077 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.593 ' HA ' HG23 ' A' ' 85' ' ' VAL . . . -53.46 -63.48 1.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.55 -0.75 . . . . 74.329999999999998 113.018 -172.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -72.82 -22.88 60.74 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.353 0.501 . . . . 72.420000000000002 112.353 -170.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -77.76 -28.85 50.71 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.915 -0.314 . . . . 75.239999999999995 111.224 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -102.93 5.45 38.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.798 0.332 . . . . 74.420000000000002 110.938 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.7 t 65.58 28.7 11.28 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.522 -0.763 . . . . 72.530000000000001 111.976 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 80' ' ' ALA . 6.3 m -80.38 136.22 53.01 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.626 -0.43 . . . . 73.129999999999995 110.464 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.774 ' HD2' ' HG3' ' A' ' 89' ' ' GLN . 30.1 Cg_exo -63.29 155.11 63.77 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.651 2.234 . . . . 75.040000000000006 111.748 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.34 -56.77 2.42 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.011 2.474 . . . . 70.019999999999996 112.689 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.15 55.22 2.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.049 0.452 . . . . 62.539999999999999 111.827 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.774 ' HG3' ' HD2' ' A' ' 86' ' ' PRO . 22.9 mm-40 -129.36 16.13 6.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.795 -0.639 . . . . 73.310000000000002 109.422 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.92 123.91 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.478 -0.783 . . . . 75.219999999999999 111.86 -172.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.43 114.76 29.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.701 -0.681 . . . . 71.010000000000005 109.512 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.633 HG21 HG12 ' A' ' 121' ' ' VAL . 61.3 t -109.52 123.24 65.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.131 -0.486 . . . . 74.109999999999999 111.313 -175.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.867 HG21 ' HB ' ' A' ' 133' ' ' VAL . 30.8 pt -107.72 117.33 53.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.952 -0.567 . . . . 74.430000000000007 110.271 177.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -132.79 162.25 31.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.064 0.459 . . . . 74.349999999999994 111.375 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -84.76 121.75 28.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.327 -0.851 . . . . 60.420000000000002 109.53 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 114' ' ' GLY . 1.5 mm-40 -127.5 135.74 50.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.289 0.566 . . . . 73.530000000000001 111.998 -171.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.29 -7.02 59.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.579 -0.737 . . . . 71.040000000000006 110.218 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.48 -34.92 64.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.318 -0.855 . . . . 75.530000000000001 111.513 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.509 ' HB ' ' HA3' ' A' ' 136' ' ' GLY . 1.1 mp -111.02 141.37 26.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.096 -0.502 . . . . 74.519999999999996 109.716 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.643 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 41.9 m-20 -67.93 147.02 53.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.355 -0.609 . . . . 73.420000000000002 109.355 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.709 ' HE1' ' HB2' ' A' ' 161' ' ' GLU . 13.8 t80 -63.03 137.55 58.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.099 0.476 . . . . 73.439999999999998 111.323 -171.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.514 ' O ' ' HD3' ' A' ' 103' ' ' ARG . . . 133.51 -39.84 1.67 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.576 -0.738 . . . . 70.400000000000006 112.067 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.514 ' HD3' ' O ' ' A' ' 102' ' ' GLY . 62.1 mmt-85 -131.96 164.51 25.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.715 0.293 . . . . 65.329999999999998 110.305 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.707 HG23 ' HA ' ' A' ' 135' ' ' ILE . 37.2 pt -117.62 160.85 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 71.450000000000003 110.618 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.462 ' HD2' HG13 ' A' ' 99' ' ' ILE . 92.6 mtt180 -123.23 129.52 51.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.994 0.426 . . . . 73.5 110.923 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.583 ' HG ' HG13 ' A' ' 133' ' ' VAL . 4.7 mp -114.53 129.77 56.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.906 -0.588 . . . . 72.319999999999993 109.823 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -155.52 153.47 30.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.701 0.286 . . . . 73.209999999999994 110.283 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.748 ' H ' HD21 ' A' ' 108' ' ' LEU . 1.3 pt? -87.43 94.09 9.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.571 . . . . 71.430000000000007 110.11 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.51 ' O ' ' HD3' ' A' ' 132' ' ' ARG . . . 172.81 -150.55 12.62 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.795 -0.639 . . . . 71.040000000000006 111.797 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.87 -157.05 25.35 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.935 -0.65 . . . . 64.310000000000002 112.223 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.658 ' HA3' HD13 ' A' ' 118' ' ' LEU . . . -130.91 132.05 6.7 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.106 -0.569 . . . . 71.25 111.867 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -112.73 6.79 18.33 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.742 0.275 . . . . 72.310000000000002 111.742 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.41 -92.26 1.55 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.527 -0.845 . . . . 73.420000000000002 111.341 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 116' ' ' ASN . . . -69.11 -45.09 63.46 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.883 -0.887 . . . . 74.310000000000002 110.883 174.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 76.0 t60 70.52 -24.59 0.16 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.869 0.692 . . . . 73.349999999999994 112.869 172.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 114' ' ' GLY . 28.5 t-20 -51.52 -66.35 0.4 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.694 0.627 . . . . 61.409999999999997 112.694 -173.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.93 -10.21 85.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.144 -1.027 . . . . 73.420000000000002 113.037 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.658 HD13 ' HA3' ' A' ' 111' ' ' GLY . 94.7 mt -84.36 -38.08 20.75 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.704 -0.292 . . . . 71.219999999999999 111.372 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 120' ' ' SER . 6.6 ptm180 -65.25 -37.16 86.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 75.310000000000002 110.845 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.435 ' N ' ' HG3' ' A' ' 119' ' ' ARG . 10.0 m -60.02 -41.4 92.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.994 -0.548 . . . . 75.019999999999996 110.774 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.633 HG12 HG21 ' A' ' 92' ' ' VAL . 59.9 t -69.63 -40.33 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 75.140000000000001 110.163 177.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.419 ' HA ' HH22 ' A' ' 132' ' ' ARG . . . -63.48 -46.66 85.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.836 -0.62 . . . . 61.32 111.045 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.1 m -72.23 -27.9 62.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.292 -0.413 . . . . 75.409999999999997 111.751 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.61 66.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.93 0.395 . . . . 72.310000000000002 111.033 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.6 mt -82.27 -32.21 29.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.897 -0.592 . . . . 64.519999999999996 110.793 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 108.12 -11.64 37.27 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.96 -0.564 . . . . 74.209999999999994 111.787 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.2 t -166.01 177.56 6.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.451 -0.574 . . . . 74.010000000000005 109.451 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.622 ' HD2' ' N ' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -60.21 -30.26 69.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.847 0.356 . . . . 74.120000000000005 110.408 174.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.622 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 9.2 t30 66.11 -13.88 0.15 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.213 1.005 . . . . 75.209999999999994 112.948 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 128' ' ' LYS . 3.4 t80 175.37 -84.5 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 122.464 0.306 . . . . 75.239999999999995 110.273 175.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -161.01 161.39 31.47 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.791 0.329 . . . . 72.340000000000003 111.737 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' A' ' 109' ' ' GLY . 5.6 mpt_? -132.3 166.19 22.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.947 -0.57 . . . . 73.439999999999998 109.603 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.867 ' HB ' HG21 ' A' ' 93' ' ' ILE . 59.0 t -123.44 124.92 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.24 -0.436 . . . . 75.129999999999995 109.825 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.462 ' CB ' HD11 ' A' ' 99' ' ' ILE . 98.1 mtt180 -98.74 115.65 29.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.954 -0.566 . . . . 72.409999999999997 110.009 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.707 ' HA ' HG23 ' A' ' 104' ' ' ILE . 2.7 mp -87.89 117.59 32.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.341 -0.614 . . . . 74.409999999999997 109.341 176.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.509 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . -72.5 108.75 2.59 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.905 -0.664 . . . . 62.43 113.555 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.496 ' HA ' ' CD2' ' A' ' 101' ' ' PHE . 15.0 p -92.35 -16.21 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.562 0.696 . . . . 74.140000000000001 109.888 174.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.643 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 89.98 169.75 43.73 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.453 -0.794 . . . . 34.119999999999997 111.851 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.405 ' O ' ' HD3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -102.85 101.48 21.21 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 110.194 -0.298 . . . . 75.230000000000004 110.194 177.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 138' ' ' GLY . 2.9 Cg_exo -76.36 110.41 3.06 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.813 2.342 . . . . 75.200000000000003 111.388 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 139' ' ' ARG . 87.5 Cg_endo -80.25 143.96 16.1 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.554 2.169 . . . . 74.540000000000006 111.863 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 178.91 179.32 48.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.596 -0.811 . . . . 63.539999999999999 112.008 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -102.01 -4.13 26.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.64 0.733 . . . . 75.510000000000005 109.946 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -116.87 148.22 41.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.177 -1.416 . . . . 73.230000000000004 107.177 167.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -61.18 138.24 94.4 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.683 0.278 . . . . 61.450000000000003 110.777 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.609 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 18.5 Cg_endo -58.86 -9.59 7.92 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.246 2.631 . . . . 74.430000000000007 112.097 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.31 59.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.305 -0.861 . . . . 51.350000000000001 111.597 176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.33 -23.5 24.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 71.209999999999994 111.606 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.609 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 92.7 m-85 -84.09 -34.36 24.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.872 0.368 . . . . 70.099999999999994 111.245 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.71 -18.35 22.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 74.409999999999997 111.726 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.44 HD11 ' HG2' ' A' ' 152' ' ' GLU . 4.5 pp -86.28 -8.85 57.43 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.808 -0.357 . . . . 74.129999999999995 111.395 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 10.6 pt-20 -156.97 102.64 2.0 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.252 0.549 . . . . 75.530000000000001 110.775 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -134.54 136.69 43.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.706 -0.398 . . . . 73.409999999999997 110.586 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -122.42 19.07 10.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.029 -0.532 . . . . 74.310000000000002 110.538 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.523 ' O ' ' HG3' ' A' ' 158' ' ' GLU . 96.9 m -62.17 120.85 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.852 -0.613 . . . . 72.450000000000003 110.732 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.32 79.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 74.530000000000001 111.743 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.85 -53.78 53.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.11 -0.495 . . . . 74.219999999999999 111.524 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.566 ' O ' HG22 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -67.85 -37.2 81.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.661 -0.245 . . . . 71.209999999999994 110.95 -176.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -58.68 -29.17 66.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 73.209999999999994 111.312 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.02 -18.81 35.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.33 -0.395 . . . . 74.150000000000006 111.535 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.709 ' HB2' ' HE1' ' A' ' 101' ' ' PHE . 40.3 mt-10 -99.08 -6.7 27.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.68 0.276 . . . . 64.540000000000006 111.363 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 158' ' ' GLU . 89.8 t -69.75 -58.53 5.45 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.626 -0.261 . . . . 75.450000000000003 111.673 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 18.5 Cg_endo -59.58 -35.21 96.02 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.3 2.0 . . . . 72.439999999999998 112.878 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.6 p -62.1 -42.71 99.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 74.439999999999998 111.177 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.1 mt -65.62 -47.05 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 74.549999999999997 110.492 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.43 -50.84 78.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 74.010000000000005 111.48 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -60.79 -45.57 93.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 73.209999999999994 111.556 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -73.87 -26.23 60.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.696 0.284 . . . . 72.25 111.603 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.06 68.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.526 -0.306 . . . . 73.040000000000006 111.465 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.51 -51.42 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.511 -0.313 . . . . 72.129999999999995 111.33 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.59 -46.69 88.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.122 0.487 . . . . 65.420000000000002 110.488 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.89 -47.26 78.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.807 -0.633 . . . . 75.129999999999995 111.601 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.7 m -64.09 -39.87 94.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 74.420000000000002 110.917 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.651 ' HG2' ' HB1' ' A' ' 56' ' ' ALA . 21.8 tt0 -61.14 -47.31 86.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.602 -0.272 . . . . 64.310000000000002 110.41 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.9 tp -68.26 -31.31 70.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 74.439999999999998 111.242 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.686 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.9 tt -62.73 -46.16 89.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.377 0.608 . . . . 75.5 109.551 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.671 HG22 ' HB ' ' A' ' 58' ' ' THR . 79.2 mt -73.52 -25.26 20.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.235 -0.893 . . . . 70.409999999999997 110.4 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.24 -68.19 0.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.76 -0.654 . . . . 72.420000000000002 111.815 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -144.24 -40.58 0.27 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.856 0.687 . . . . 75.519999999999996 112.856 -172.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.686 ' O ' ' HA ' ' A' ' 176' ' ' LEU . . . -106.38 114.4 4.42 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.759 -1.21 . . . . 73.310000000000002 113.663 -170.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.42 ' HA ' ' HG ' ' A' ' 176' ' ' LEU . 6.1 tt -91.22 -54.41 3.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.456 -0.572 . . . . 55.450000000000003 109.456 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -70.31 -40.73 12.37 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 74.439999999999998 111.741 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -48.28 -38.8 34.46 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.026 1.817 . . . . 70.25 112.27 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -65.81 -43.33 88.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.095 -0.502 . . . . 73.049999999999997 110.636 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -57.81 -45.71 85.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.957 0.408 . . . . 72.299999999999997 110.508 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -66.03 -49.73 66.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 72.420000000000002 111.617 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 184' ' ' ALA . 12.1 t -60.54 -38.02 83.09 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.093 -0.243 . . . . 74.129999999999995 111.509 -174.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.708 ' HA ' ' HD1' ' A' ' 191' ' ' TRP . 72.0 t -60.23 -28.45 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.987 0.423 . . . . 74.420000000000002 111.106 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -76.34 -10.47 59.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.376 -0.375 . . . . 73.400000000000006 111.035 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -115.73 13.29 16.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.126 0.417 . . . . 50.200000000000003 112.126 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.708 ' HD1' ' HA ' ' A' ' 188' ' ' VAL . 93.1 m95 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.652 -0.689 . . . . 75.230000000000004 110.077 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.62 0.248 . . . . 71.129999999999995 110.695 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 59' ' ' SER . 56.2 Cg_endo -92.55 107.26 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.187 2.591 . . . . 74.219999999999999 112.097 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.709 HD22 HG22 ' A' ' 177' ' ' ILE . 4.3 pp -89.21 157.71 18.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.307 -0.406 . . . . 75.430000000000007 110.647 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.414 ' HB2' HG12 ' A' ' 85' ' ' VAL . 47.5 tp -117.91 120.85 39.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.048 0.451 . . . . 74.439999999999998 111.281 -174.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.717 ' HB ' HD21 ' A' ' 62' ' ' LEU . 48.5 t -112.16 110.49 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.943 -0.571 . . . . 73.230000000000004 109.613 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.725 ' HB ' HG21 ' A' ' 92' ' ' VAL . 47.8 t -110.3 124.32 66.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 110.2 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.38 157.37 15.0 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.416 -0.897 . . . . 62.130000000000003 111.368 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.441 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -64.15 107.62 1.34 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.595 -0.891 . . . . 74.030000000000001 108.595 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.586 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -74.15 -176.89 35.76 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.673 -0.694 . . . . 73.340000000000003 113.523 -172.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -111.33 98.3 39.34 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.601 -0.518 . . . . 75.120000000000005 109.601 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.474 ' HB2' ' OH ' ' A' ' 17' ' ' TYR . 14.5 Cg_exo -67.8 -31.35 32.15 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.857 2.371 . . . . 71.439999999999998 112.445 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.78 -176.22 43.83 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.589 -0.815 . . . . 71.109999999999999 112.248 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.37 -159.43 0.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.907 2.405 . . . . 70.439999999999998 112.312 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m 70.64 -70.82 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.081 -0.509 . . . . 75.299999999999997 111.324 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' OH ' ' HB2' ' A' ' 13' ' ' PRO . 28.7 p90 -88.63 3.51 50.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.965 0.412 . . . . 75.310000000000002 110.99 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.79 -1.57 4.04 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.879 -0.6 . . . . 70.129999999999995 112.371 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -100.62 18.5 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.33 . . . . 75.209999999999994 110.751 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.8 p -100.56 167.28 10.45 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.908 -0.405 . . . . 72.219999999999999 109.908 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 24' ' ' LEU . 22.4 ptt180 -84.38 -0.38 52.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.531 -0.304 . . . . 74.209999999999994 110.944 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.633 ' CD2' ' HA ' ' A' ' 150' ' ' VAL . 97.8 m-70 -86.21 -29.75 22.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.824 0.345 . . . . 72.109999999999999 110.944 -172.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -88.26 28.31 1.1 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.323 0.582 . . . . 75.540000000000006 109.88 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 2.4 pt? -67.28 -27.15 66.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.563 -0.744 . . . . 73.340000000000003 111.318 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.441 ' HA3' ' N ' ' A' ' 10' ' ' LEU . . . -59.23 -44.41 96.48 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.81 -0.709 . . . . 64.319999999999993 111.896 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.586 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 56.8 t80 -65.19 -35.8 82.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.743 0.306 . . . . 73.25 110.521 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 82.9 mmm -83.26 -47.27 11.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.704 -0.68 . . . . 74.310000000000002 111.989 -171.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.4 t -63.41 -42.12 95.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.14 0.495 . . . . 73.120000000000005 110.256 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.504 ' HB2' ' HE2' ' A' ' 64' ' ' LYS . . . -67.18 -20.95 65.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.964 -0.562 . . . . 61.229999999999997 110.718 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' HZ2' ' A' ' 64' ' ' LYS . 21.7 t70 -77.16 -43.17 34.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.978 -0.555 . . . . 71.030000000000001 111.031 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 36.0 m -71.23 -37.87 67.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.53 -0.305 . . . . 72.420000000000002 111.568 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.73 -24.83 62.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.042 0.449 . . . . 74.420000000000002 110.472 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 38' ' ' SER . . . -66.45 -46.74 75.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 71.319999999999993 110.158 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.76 -18.57 61.94 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.866 -0.607 . . . . 74.540000000000006 112.395 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 14.3 mmt85 -76.1 -58.15 3.45 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.766 0.284 . . . . 70.430000000000007 111.766 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.29 -15.4 14.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.873 0.368 . . . . 74.140000000000001 111.199 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.09 45.86 2.97 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.653 -0.979 . . . . 74.239999999999995 110.653 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.9 t -110.19 121.24 44.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.756 -0.722 . . . . 74.219999999999999 110.358 -173.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.83 126.62 55.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.347 -0.388 . . . . 72.25 110.242 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.446 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 48.4 p90 -106.0 137.81 43.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.044 0.45 . . . . 71.329999999999998 110.251 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -127.41 168.07 15.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.947 -0.57 . . . . 74.329999999999998 110.369 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.714 HG23 ' HG2' ' A' ' 49' ' ' GLU . 38.8 t -86.07 102.38 11.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.46 -0.57 . . . . 75.439999999999998 109.46 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.443 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 21.1 t-80 -79.58 85.03 5.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.921 -0.77 . . . . 75.230000000000004 108.921 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -66.55 96.8 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.559 0.695 . . . . 75.420000000000002 111.017 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 167.78 -55.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.47 -2.048 . . . . 73.420000000000002 105.47 -173.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.3 p -105.53 28.91 6.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.569 -2.105 . . . . 74.150000000000006 107.348 168.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 43' ' ' HIS . . . -49.92 43.27 0.01 OUTLIER Glycine 0 N--CA 1.476 1.356 0 N-CA-C 120.087 2.795 . . . . 71.450000000000003 120.087 -150.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.13 163.75 15.32 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.791 -1.189 . . . . 71.030000000000001 107.791 161.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.714 ' HG2' HG23 ' A' ' 42' ' ' VAL . 43.5 mt-10 -80.86 117.07 21.18 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.391 -0.524 . . . . 72.450000000000003 109.957 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.693 HG11 ' HA ' ' A' ' 63' ' ' ALA . 31.1 m -138.34 150.92 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 71.219999999999999 111.501 -173.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.28 137.71 56.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.774 -0.648 . . . . 73.120000000000005 109.961 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -111.3 125.64 54.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.688 0.28 . . . . 65.420000000000002 111.312 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.52 -167.75 24.46 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.007 -0.615 . . . . 74.230000000000004 111.621 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -136.96 104.38 5.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.084 0.442 . . . . 75.310000000000002 110.144 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HG ' HG23 ' A' ' 60' ' ' VAL . 88.6 mt -89.78 131.19 35.86 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.619 -0.511 . . . . 73.439999999999998 109.619 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.85 9.01 4.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.228 -0.442 . . . . 73.340000000000003 111.564 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.75 -28.17 13.02 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.041 -0.599 . . . . 74.340000000000003 112.473 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.555 ' HB ' ' CG2' ' A' ' 177' ' ' ILE . 9.8 m -84.03 139.08 32.75 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.211 -0.292 . . . . 75.120000000000005 110.211 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.536 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 20.3 m -70.47 132.12 45.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.841 0.353 . . . . 45.530000000000001 110.601 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.564 HG23 ' HG ' ' A' ' 55' ' ' LEU . 34.1 m -126.44 136.47 60.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.124 0.488 . . . . 72.120000000000005 111.132 -176.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.2 112.71 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.829 -0.623 . . . . 75.0 109.629 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.717 HD21 ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -94.99 119.78 34.08 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.358 -0.608 . . . . 63.229999999999997 109.358 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.693 ' HA ' HG11 ' A' ' 50' ' ' VAL . . . -111.87 124.28 52.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.962 0.41 . . . . 72.140000000000001 111.587 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.504 ' HE2' ' HB2' ' A' ' 29' ' ' ALA . 91.5 mttt -119.88 107.28 40.34 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.051 -0.522 . . . . 63.450000000000003 110.242 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.449 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 4.7 Cg_exo -75.12 151.57 39.17 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.961 2.441 . . . . 73.510000000000005 112.405 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -110.44 16.53 21.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.288 0.566 . . . . 73.340000000000003 109.714 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.693 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 58.4 m -112.8 168.86 9.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.722 -0.672 . . . . 73.209999999999994 110.882 -174.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -72.23 173.84 8.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.054 -0.521 . . . . 75.340000000000003 110.73 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -19.24 65.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.379 -0.373 . . . . 75.540000000000006 111.699 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -87.91 -19.99 26.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.359 0.599 . . . . 72.420000000000002 110.163 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 36.6 mt-10 -100.46 -28.16 13.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.021 -0.536 . . . . 72.239999999999995 110.957 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.4 ' O ' HG21 ' A' ' 76' ' ' VAL . 14.0 p -57.73 -37.62 73.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 52.020000000000003 111.177 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.24 -32.38 76.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.181 -0.533 . . . . 65.439999999999998 112.412 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.638 HH11 ' HB2' ' A' ' 124' ' ' ALA . 26.8 mmt180 -76.73 -31.36 57.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.748 0.309 . . . . 74.430000000000007 110.698 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 78.8 mm-40 -69.66 -28.66 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 72.540000000000006 110.861 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 72' ' ' SER . 46.6 t -66.52 -30.27 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 74.140000000000001 110.773 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.62 -67.1 2.32 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 116.044 -0.525 . . . . 45.520000000000003 113.154 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.54 -43.46 39.33 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.442 2.095 . . . . 73.049999999999997 112.227 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -54.88 -51.59 65.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 110.755 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.49 84.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.119 -0.492 . . . . 44.43 111.547 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -77.49 -31.87 53.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 111.724 0.268 . . . . 74.340000000000003 111.724 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -65.86 -46.45 78.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.615 0.245 . . . . 73.540000000000006 111.262 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -90.8 -17.08 27.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.669 -0.241 . . . . 71.230000000000004 111.313 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.0 t 59.98 72.77 0.51 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.443 0.639 . . . . 75.519999999999996 110.47 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.445 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 27.8 m -98.15 139.73 21.43 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 73.239999999999995 111.188 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 13.1 Cg_exo -70.57 129.53 16.89 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.909 2.406 . . . . 71.349999999999994 111.797 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 18.3 Cg_exo -67.33 -4.4 11.73 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.133 2.555 . . . . 73.420000000000002 113.292 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -89.6 -12.18 40.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.876 0.37 . . . . 63.039999999999999 110.745 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.424 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 9.3 mm-40 -129.73 45.01 2.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.414 0.626 . . . . 75.450000000000003 110.566 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.561 HG23 ' HB3' ' A' ' 131' ' ' HIS . 10.4 tt -120.54 127.7 75.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.819 -0.628 . . . . 74.319999999999993 109.864 175.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.37 146.21 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.131 -0.486 . . . . 63.409999999999997 110.456 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.725 HG21 ' HB ' ' A' ' 8' ' ' VAL . 86.1 t -134.07 124.23 45.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.848 0.356 . . . . 73.109999999999999 110.744 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 mm -75.23 130.65 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.61 -0.723 . . . . 73.109999999999999 111.689 -175.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -143.42 141.9 31.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 74.310000000000002 110.166 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.636 ' HB2' HG21 ' A' ' 137' ' ' VAL . 4.6 p-10 -87.29 122.32 30.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.928 -0.767 . . . . 73.439999999999998 108.928 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.455 ' OE1' ' HD2' ' A' ' 134' ' ' ARG . 10.5 tp10 -99.62 118.63 36.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.675 -0.693 . . . . 62.43 110.982 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.3 pp -82.59 -20.7 35.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.474 -0.784 . . . . 70.049999999999997 111.253 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -78.63 -20.45 50.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.1 0.476 . . . . 65.439999999999998 110.742 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.438 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 66.0 mt -102.28 122.92 55.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 109.777 176.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.441 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 13.6 m-20 -62.13 149.87 40.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.281 -0.418 . . . . 63.409999999999997 110.839 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.861 ' HD2' ' HA ' ' A' ' 137' ' ' VAL . 29.4 t80 -65.61 133.76 51.85 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.18 -0.464 . . . . 75.120000000000005 110.918 -174.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.93 -62.29 0.32 Allowed Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.827 -0.624 . . . . 72.129999999999995 112.294 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -126.3 165.38 19.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.716 0.293 . . . . 75.209999999999994 110.263 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.637 HG23 ' HA ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER -118.57 159.18 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 110.173 -178.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -144.82 163.0 35.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.029 0.442 . . . . 74.409999999999997 110.94 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.0 mt -108.62 152.56 24.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.737 -0.665 . . . . 64.230000000000004 109.602 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -129.58 105.1 7.84 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.835 -0.346 . . . . 73.329999999999998 110.914 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 181' ' ' LEU . 85.6 mt -110.33 91.84 3.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 75.510000000000005 109.987 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.65 -132.18 2.71 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.058 -0.817 . . . . 71.340000000000003 111.058 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.63 109.58 3.24 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.718 -0.953 . . . . 74.540000000000006 110.718 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.75 161.33 31.77 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.074 -1.06 . . . . 55.350000000000001 112.977 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.62 171.01 10.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.279 -0.461 . . . . 72.129999999999995 110.413 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.93 45.36 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.187 -0.765 . . . . 54.219999999999999 111.187 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.35 81.72 1.31 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.58 -1.008 . . . . 74.439999999999998 110.58 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -52.07 -50.56 61.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.444 0.535 . . . . 75.430000000000007 112.444 -170.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.55 -3.03 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.808 -0.357 . . . . 71.5 111.409 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.1 -33.59 7.65 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.954 -0.859 . . . . 72.299999999999997 110.954 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.8 -30.19 65.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.531 -0.544 . . . . 74.5 109.531 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -51.33 -50.28 59.75 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.153 -0.93 . . . . 73.019999999999996 111.683 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.2 p -72.81 -45.35 58.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.891 0.377 . . . . 75.439999999999998 111.326 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.61 HG13 ' HE1' ' A' ' 131' ' ' HIS . 59.3 t -65.79 -47.96 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.069 -0.514 . . . . 65.049999999999997 111.87 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.41 ' HA ' HD22 ' A' ' 129' ' ' ASN . . . -63.3 -38.48 91.31 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.987 0.366 . . . . 61.240000000000002 111.987 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.9 p -76.6 -29.21 56.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.631 -0.259 . . . . 53.32 111.193 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.638 ' HB2' HH11 ' A' ' 74' ' ' ARG . . . -79.35 -49.46 12.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 111.676 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -84.67 -41.78 15.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.352 -0.385 . . . . 72.329999999999998 111.536 -174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.95 -12.6 65.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.808 -0.711 . . . . 61.210000000000001 112.357 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.1 t -71.96 164.4 26.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.887 0.375 . . . . 74.120000000000005 110.793 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.86 -11.82 60.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 74.099999999999994 110.64 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 122' ' ' ALA . 86.9 m-20 66.09 79.14 0.25 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.579 -0.737 . . . . 72.510000000000005 112.329 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.416 ' HB3' HD23 ' A' ' 108' ' ' LEU . 99.3 m-85 -83.56 -22.85 32.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.212 0.53 . . . . 74.230000000000004 110.032 174.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.61 ' HE1' HG13 ' A' ' 121' ' ' VAL . 13.1 p80 -68.63 87.61 0.34 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.445 -0.798 . . . . 70.310000000000002 112.347 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -142.89 109.56 5.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.257 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.4 t -101.87 109.02 24.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.637 -0.875 . . . . 75.409999999999997 108.637 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.455 ' HD2' ' OE1' ' A' ' 96' ' ' GLU . 38.9 mtm180 -99.1 106.43 18.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.071 0.462 . . . . 75.530000000000001 110.93 -175.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.637 ' HA ' HG23 ' A' ' 104' ' ' ILE . 3.0 mp -85.1 114.78 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.701 -0.681 . . . . 74.219999999999999 109.362 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.738 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -65.29 101.93 0.61 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.768 -0.729 . . . . 63.310000000000002 111.583 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.861 ' HA ' ' HD2' ' A' ' 101' ' ' PHE . 3.5 m -111.2 -7.37 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.255 0.465 . . . . 74.230000000000004 112.255 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 86.87 167.68 44.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 73.129999999999995 112.72 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.463 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.5 ptm180 -111.48 124.34 32.82 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.044 0.449 . . . . 73.349999999999994 110.984 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 9.5 Cg_endo -90.07 115.37 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.57 2.846 . . . . 74.540000000000006 112.259 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -93.23 155.9 2.58 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.962 2.441 . . . . 75.319999999999993 113.18 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.62 -161.78 29.97 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.258 -0.737 . . . . 53.340000000000003 111.258 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -78.12 -19.31 54.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.196 0.522 . . . . 71.219999999999999 110.161 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -108.38 150.74 26.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.478 -0.783 . . . . 75.049999999999997 109.451 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.23 164.02 56.65 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.325 -0.398 . . . . 73.129999999999995 110.251 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.536 ' HA ' ' CD1' ' A' ' 149' ' ' PHE . 62.6 Cg_exo -53.58 -14.33 4.88 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.14 2.56 . . . . 74.319999999999993 113.292 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.94 -22.79 63.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 74.239999999999995 111.567 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.75 -26.87 22.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.394 0.616 . . . . 72.299999999999997 110.473 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 146' ' ' PRO . 68.5 m-85 -64.42 -15.95 61.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.044 -0.98 . . . . 72.129999999999995 112.038 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.633 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 33.6 m -55.48 -28.75 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 111.859 0.318 . . . . 71.420000000000002 111.859 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.492 ' HG ' HG23 ' A' ' 150' ' ' VAL . 86.6 mt -105.58 -27.15 11.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.921 0.391 . . . . 75.5 110.871 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -128.59 93.52 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.491 0.663 . . . . 72.319999999999993 110.272 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 149' ' ' PHE . 3.8 t30 -125.11 101.31 6.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.634 . . . . 74.5 110.491 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -132.13 102.13 5.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.286 0.565 . . . . 63.200000000000003 110.527 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.879 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 6.5 m -125.73 132.38 52.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.011 -0.541 . . . . 64.420000000000002 109.887 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.76 73.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.971 0.415 . . . . 72.049999999999997 110.868 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.65 -38.95 93.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.832 -0.622 . . . . 75.239999999999995 112.044 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.879 ' HG2' ' HB ' ' A' ' 155' ' ' THR . 10.5 pt-20 -72.58 -40.45 66.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.876 -0.33 . . . . 75.409999999999997 111.261 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.432 ' HA ' HG21 ' A' ' 162' ' ' VAL . 25.6 mmm180 -66.82 -34.34 77.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.85 0.357 . . . . 75.219999999999999 110.808 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.49 62.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.428 -0.805 . . . . 75.109999999999999 112.376 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.634 ' HB2' ' HE1' ' A' ' 101' ' ' PHE . 59.7 mm-40 -100.68 13.38 34.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.337 0.495 . . . . 73.340000000000003 112.337 -174.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.604 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 55.2 t -54.38 -52.47 68.96 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.035 -0.266 . . . . 74.310000000000002 110.798 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 53.9 Cg_exo -54.55 -25.89 43.0 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.142 1.895 . . . . 75.510000000000005 113.24 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.5 m -74.28 -48.21 29.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.057 0.456 . . . . 73.25 110.684 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.24 -33.59 64.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.962 -0.563 . . . . 74.530000000000001 111.34 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.507 HG21 ' O ' ' A' ' 162' ' ' VAL . 98.1 t -53.35 -39.1 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.835 0.35 . . . . 75.519999999999996 111.419 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -71.57 -50.07 34.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.46 -0.336 . . . . 73.120000000000005 111.29 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.528 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . 9.1 mm-40 -60.84 -42.78 98.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.783 0.325 . . . . 71.109999999999999 111.385 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.13 -22.98 67.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.237 -0.438 . . . . 61.310000000000002 111.641 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.39 -44.16 15.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.855 0.36 . . . . 51.039999999999999 111.742 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -85.05 -36.29 21.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.555 -0.293 . . . . 73.530000000000001 111.618 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.33 -43.67 73.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.843 0.312 . . . . 72.230000000000004 111.843 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.506 ' HA ' HD12 ' A' ' 176' ' ' LEU . 22.0 p -63.05 -31.49 72.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 65.519999999999996 111.69 -175.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.45 -26.4 66.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.278 -0.419 . . . . 73.109999999999999 110.821 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.72 -29.76 66.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.708 0.29 . . . . 74.310000000000002 110.593 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 173' ' ' THR . 8.3 mp -64.66 -36.5 84.47 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.482 0.658 . . . . 70.310000000000002 109.502 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.709 HG22 HD22 ' A' ' 5' ' ' LEU . 34.5 mt -76.99 -37.36 26.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.892 -1.049 . . . . 74.5 110.023 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.85 -48.84 67.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.57 -0.741 . . . . 61.240000000000002 111.364 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -133.22 -67.56 0.62 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.431 -0.35 . . . . 73.030000000000001 111.201 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.4 -178.32 46.09 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.749 -0.739 . . . . 73.400000000000006 111.886 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 108' ' ' LEU . 3.7 pp -89.87 -12.94 37.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.965 0.412 . . . . 74.019999999999996 110.584 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.703 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 6.5 tm-20 -53.68 -54.13 49.62 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.508 -0.769 . . . . 74.329999999999998 111.797 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 11.0 Cg_exo -71.19 -31.98 13.69 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 121.644 1.563 . . . . 62.200000000000003 112.176 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.59 -26.01 57.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 64.129999999999995 112.322 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 19.7 pt20 -62.29 -22.65 66.2 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.475 0.179 . . . . 74.150000000000006 111.444 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -85.98 -48.01 9.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.749 0.309 . . . . 73.420000000000002 110.657 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.6 m -53.22 -40.55 64.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.765 -0.652 . . . . 72.540000000000006 111.749 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.2 -12.75 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.62 0.6 . . . . 74.109999999999999 112.62 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -117.45 -28.58 6.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.614 0.245 . . . . 75.219999999999999 111.54 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.55 -17.15 39.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.586 -0.279 . . . . 72.319999999999993 111.607 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.3 m95 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.637 -0.697 . . . . 74.510000000000005 110.271 -179.535 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.0 mp0 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.632 0.253 . . . . 73.310000000000002 110.554 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 2.9 Cg_exo -76.21 117.85 4.77 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.137 2.558 . . . . 70.209999999999994 112.307 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.697 HD21 HG21 ' A' ' 177' ' ' ILE . 4.2 pp -121.89 149.25 43.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.291 -0.413 . . . . 73.040000000000006 110.246 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.469 ' HB3' HG12 ' A' ' 90' ' ' ILE . 64.8 tp -97.56 136.21 38.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.318 -0.401 . . . . 73.230000000000004 110.476 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.7 t -117.42 112.61 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.829 -0.434 . . . . 75.109999999999999 109.829 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.67 128.61 62.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 74.129999999999995 110.723 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.538 ' HA2' HG21 ' A' ' 93' ' ' ILE . . . -103.38 -177.06 26.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.198 -0.525 . . . . 72.519999999999996 112.095 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.549 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -142.53 158.74 43.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.362 . . . . 73.340000000000003 110.926 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 22' ' ' HIS . . . 155.86 -158.28 28.43 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.449 -0.661 . . . . 60.399999999999999 111.449 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 61.0 t30 -163.08 105.32 1.01 Allowed Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.116 -0.328 . . . . 72.340000000000003 110.116 176.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.2 142.25 41.27 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.751 2.301 . . . . 72.420000000000002 112.271 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.62 177.92 39.9 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.754 -0.736 . . . . 44.149999999999999 111.849 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.4 -66.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.699 2.266 . . . . 71.150000000000006 112.083 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 m -76.7 -25.56 53.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.319 0.581 . . . . 75.040000000000006 110.113 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.586 ' HA ' HG22 ' A' ' 20' ' ' THR . 80.9 m-85 -70.71 -23.14 62.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.567 -0.742 . . . . 71.450000000000003 111.748 -175.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.4 -17.27 63.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 73.120000000000005 110.28 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -106.73 20.63 18.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.604 -0.725 . . . . 74.25 111.277 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 17' ' ' TYR . 72.2 p -99.95 166.91 10.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.238 0.542 . . . . 74.439999999999998 110.385 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.519 ' HB3' HG21 ' A' ' 150' ' ' VAL . 17.5 tpt85 -93.76 1.56 56.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.912 -0.586 . . . . 74.319999999999993 111.1 -175.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.444 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 1.5 t-160 -106.81 11.04 30.56 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.909 -0.316 . . . . 71.129999999999995 111.549 -173.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -103.38 13.63 33.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 64.409999999999997 111.332 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.4 pt? -55.06 -39.96 69.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.837 -0.62 . . . . 74.319999999999993 112.144 -174.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA3' HD11 ' A' ' 10' ' ' LEU . . . -61.2 -55.29 30.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.034 -0.603 . . . . 71.310000000000002 112.971 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.528 ' CE1' ' HD2' ' A' ' 65' ' ' PRO . 20.1 m-30 -61.4 -39.52 91.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.717 0.294 . . . . 74.319999999999993 111.315 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.883 ' HE2' ' HA ' ' A' ' 27' ' ' MET . 16.3 mmt -68.83 -49.58 57.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.376 -0.374 . . . . 72.120000000000005 111.457 -176.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.27 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.359 . . . . 73.019999999999996 110.673 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.535 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -63.62 -34.93 78.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 73.420000000000002 111.446 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.38 -40.7 50.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.215 -0.448 . . . . 71.030000000000001 111.164 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.5 m -79.56 -21.13 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.547 0.573 . . . . 72.420000000000002 112.547 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -70.37 -26.05 63.54 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.326 -0.549 . . . . 74.129999999999995 110.712 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.411 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -71.54 -24.26 61.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.352 0.596 . . . . 51.340000000000003 110.158 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.64 -18.12 67.71 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.451 -0.795 . . . . 74.340000000000003 112.6 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -69.56 -32.44 71.22 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.046 0.45 . . . . 75.310000000000002 111.186 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 36' ' ' ILE . 4.2 mp -86.03 -15.57 10.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.989 -0.745 . . . . 75.25 108.989 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.76 41.04 15.97 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.711 -1.356 . . . . 73.299999999999997 109.711 -171.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 t -126.55 135.54 51.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.887 -0.656 . . . . 75.129999999999995 111.038 -169.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.04 128.31 9.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.045 -0.525 . . . . 75.25 110.215 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.531 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 7.3 t80 -107.86 -158.1 0.64 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.731 -0.47 . . . . 75.439999999999998 109.731 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -135.19 173.07 12.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 72.230000000000004 111.474 -171.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.435 ' HB ' ' OE2' ' A' ' 49' ' ' GLU . 2.7 p -70.52 108.26 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.585 -0.734 . . . . 73.5 111.216 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.464 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 17.4 t60 -102.25 75.67 1.51 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.256 -1.016 . . . . 74.409999999999997 108.256 174.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -56.31 122.29 11.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.598 -0.728 . . . . 73.049999999999997 112.174 -168.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -134.76 -90.93 0.33 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.662 -0.699 . . . . 71.340000000000003 109.496 168.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 78' ' ' PRO . 8.6 m -107.83 -41.25 5.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 118.898 -1.121 . . . . 73.239999999999995 111.556 171.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.79 1.68 4.73 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.369 -0.443 . . . . 73.540000000000006 112.573 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.526 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -75.58 99.4 4.26 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 115.585 1.698 . . . . 72.319999999999993 115.585 -154.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 20.7 mt-10 -116.28 115.46 25.98 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.357 -1.72 . . . . 74.5 106.357 151.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 31.8 m -137.56 151.27 26.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.257 -0.577 . . . . 75.430000000000007 112.384 -167.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 62' ' ' LEU . 5.9 p -124.63 125.83 70.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.418 -0.956 . . . . 74.239999999999995 108.418 166.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.5 m -103.17 113.08 26.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.078 0.466 . . . . 73.019999999999996 111.169 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.29 -161.22 8.97 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.811 -0.916 . . . . 63.299999999999997 110.811 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -138.34 129.68 27.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.291 0.545 . . . . 75.420000000000002 110.953 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.9 mt -102.87 117.03 33.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.035 -0.728 . . . . 74.109999999999999 109.035 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.44 -46.46 0.62 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.98 0.8 . . . . 72.239999999999995 111.66 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.83 -37.79 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.206 -0.521 . . . . 64.239999999999995 111.881 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.28 133.68 46.24 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.878 0.37 . . . . 70.329999999999998 111.294 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.5 p -74.07 125.74 28.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 72.230000000000004 110.756 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.594 HG11 HD13 ' A' ' 5' ' ' LEU . 33.6 m -111.23 136.44 47.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.102 -0.499 . . . . 74.129999999999995 110.896 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 t -102.76 101.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.759 -0.83 . . . . 75.150000000000006 108.759 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 3.3 tm? -91.09 111.57 23.1 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.169 -0.678 . . . . 73.310000000000002 109.169 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . . . -109.33 123.58 49.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.981 -0.554 . . . . 64.540000000000006 111.297 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.628 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -122.99 90.2 50.42 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.677 0.751 . . . . 75.230000000000004 109.674 175.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HD2' ' CE1' ' A' ' 26' ' ' PHE . 16.4 Cg_exo -68.95 166.67 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.704 2.269 . . . . 64.530000000000001 112.679 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -105.0 14.41 29.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.663 0.744 . . . . 75.329999999999998 109.06 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 63.3 m -102.16 138.51 39.01 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.73 -1.123 . . . . 74.519999999999996 108.866 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -66.65 166.8 12.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.093 0.473 . . . . 74.200000000000003 111.545 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.4 ptp -46.68 -31.56 2.99 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.39 1.256 . . . . 70.209999999999994 114.39 -169.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -77.99 -50.44 12.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.872 0.368 . . . . 73.319999999999993 111.142 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -78.56 -24.45 45.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.286 -0.416 . . . . 73.239999999999995 111.454 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.3 t -56.68 -39.4 73.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.388 -0.369 . . . . 74.540000000000006 110.433 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.07 -29.37 74.72 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.932 -0.576 . . . . 74.239999999999995 113.077 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -41.85 88.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.157 0.503 . . . . 74.299999999999997 110.914 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -84.22 -0.05 50.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.803 -0.635 . . . . 74.430000000000007 111.86 -171.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.2 t -70.74 -40.46 76.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.803 0.335 . . . . 73.200000000000003 110.444 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.97 -59.03 11.56 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 115.964 -0.562 . . . . 73.019999999999996 112.822 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HB2' ' OG ' ' A' ' 46' ' ' SER . 10.1 Cg_endo -56.2 -37.82 95.99 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.7 2.267 . . . . 74.439999999999998 112.749 175.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.526 HD22 ' HB2' ' A' ' 48' ' ' ALA . 2.9 tm? -69.11 -44.61 72.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.647 -0.251 . . . . 74.349999999999994 111.255 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.52 86.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.0 0.37 . . . . 53.420000000000002 112.0 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -72.9 -20.43 61.08 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.822 0.304 . . . . 75.019999999999996 111.822 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -71.07 -28.7 64.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.854 0.359 . . . . 74.420000000000002 110.753 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.02 0.01 37.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 72.129999999999995 110.169 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t 62.24 24.29 14.44 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.443 -0.798 . . . . 75.239999999999995 111.426 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.476 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 18.5 m -88.04 131.85 41.67 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.887 0.375 . . . . 75.299999999999997 111.09 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 19.4 Cg_exo -67.38 127.94 17.45 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.832 2.354 . . . . 75.439999999999998 111.605 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.681 ' HA ' HD13 ' A' ' 90' ' ' ILE . 39.7 Cg_exo -57.63 -27.51 77.46 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.991 2.46 . . . . 73.239999999999995 113.055 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -64.46 -27.68 69.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.48 -0.327 . . . . 71.030000000000001 111.659 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -103.88 17.59 23.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.159 0.504 . . . . 73.439999999999998 110.761 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.714 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 58.9 mt -90.45 145.45 7.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.403 -0.591 . . . . 65.5 109.403 175.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 m -118.12 134.67 61.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.164 0.507 . . . . 75.209999999999994 110.254 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.79 115.92 47.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.086 -0.506 . . . . 75.420000000000002 110.543 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.538 HG21 ' HA2' ' A' ' 9' ' ' GLY . 6.8 tt -87.67 126.02 41.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.923 -0.58 . . . . 75.409999999999997 109.542 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.99 173.5 11.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.399 0.618 . . . . 73.439999999999998 110.649 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -85.55 152.61 23.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.176 -0.92 . . . . 72.530000000000001 110.521 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.865 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 22.5 tt0 -123.35 94.72 4.34 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.423 0.63 . . . . 75.450000000000003 110.169 174.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.818 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.9 pt? -83.57 -0.33 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.332 -0.849 . . . . 73.329999999999998 110.073 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' CG ' HH12 ' A' ' 134' ' ' ARG . 1.6 m-20 -68.42 -36.42 79.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.711 . . . . 71.510000000000005 109.678 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 mm -123.29 149.19 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.515 -0.766 . . . . 75.109999999999999 110.244 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.782 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 8.8 p-10 -75.42 155.03 36.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 64.439999999999998 110.973 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.629 ' HD2' ' HB2' ' A' ' 158' ' ' GLU . 6.0 t80 -68.03 138.73 56.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.718 -0.674 . . . . 73.530000000000001 111.577 -173.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 160.07 -35.62 0.45 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.342 -0.845 . . . . 45.43 111.081 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -148.55 164.89 32.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 70.340000000000003 110.455 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.583 HD12 HG23 ' A' ' 188' ' ' VAL . 2.4 pp -118.21 162.97 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.382 -0.599 . . . . 74.129999999999995 109.382 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -141.0 153.32 45.5 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.702 -0.399 . . . . 75.140000000000001 110.446 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.636 HD23 ' HB2' ' A' ' 181' ' ' LEU . 60.3 tp -113.04 124.9 53.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.844 -0.616 . . . . 74.129999999999995 109.434 176.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -155.41 126.69 7.21 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.002 -0.74 . . . . 74.310000000000002 109.002 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 130' ' ' PHE . 88.0 mt -76.73 88.0 3.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.579 0.704 . . . . 74.310000000000002 109.638 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.6 147.72 5.16 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.31 -1.116 . . . . 75.299999999999997 110.31 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 132' ' ' ARG . . . 178.86 112.44 0.34 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.692 -1.242 . . . . 54.219999999999999 113.061 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.57 76.06 0.17 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.308 -0.717 . . . . 73.200000000000003 111.308 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -171.77 149.73 2.57 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.201 -0.666 . . . . 73.420000000000002 109.201 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.22 -67.77 2.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.959 -0.639 . . . . 72.120000000000005 111.825 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.93 69.3 3.27 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.901 -0.88 . . . . 70.510000000000005 110.901 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -48.45 -54.86 12.59 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.661 0.784 . . . . 73.230000000000004 111.734 -173.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -85.6 -41.6 15.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.258 -0.428 . . . . 55.520000000000003 110.981 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.81 -37.26 90.07 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 116.13 -0.487 . . . . 74.0 113.703 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.3 -27.89 29.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.972 0.386 . . . . 73.329999999999998 111.347 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -79.43 -36.7 38.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.499 -0.318 . . . . 73.530000000000001 111.568 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.9 m -58.76 -38.21 77.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 74.409999999999997 111.138 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.02 -42.93 82.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.987 0.422 . . . . 71.200000000000003 110.477 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.61 82.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.022 -0.536 . . . . 72.230000000000004 110.766 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t -63.42 -41.77 98.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 63.149999999999999 110.768 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.3 -32.09 69.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.31 -0.405 . . . . 65.409999999999997 111.672 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.53 -7.71 40.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.789 0.328 . . . . 74.420000000000002 111.669 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.45 -11.77 69.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.851 -0.69 . . . . 73.319999999999993 113.408 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 129' ' ' ASN . 15.4 t -169.88 177.97 4.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.832 0.316 . . . . 74.450000000000003 110.184 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.811 ' H ' ' HD2' ' A' ' 128' ' ' LYS . 8.9 mptt -56.13 -57.3 12.78 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.088 -0.708 . . . . 70.099999999999994 109.088 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.448 ' HB2' HG21 ' A' ' 127' ' ' THR . 8.9 t-20 67.32 24.35 9.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.337 -0.847 . . . . 64.420000000000002 111.946 166.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.491 ' HB3' HD21 ' A' ' 108' ' ' LEU . 54.9 m-85 63.52 -130.72 0.44 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.074 -0.512 . . . . 75.230000000000004 111.817 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.714 ' HB3' ' O ' ' A' ' 90' ' ' ILE . 4.6 p80 34.44 85.95 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.456 1.28 . . . . 73.519999999999996 114.456 -173.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.544 ' HD2' ' O ' ' A' ' 131' ' ' HIS . 9.3 mpt_? -135.58 108.46 7.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.867 -0.606 . . . . 75.340000000000003 110.187 171.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.466 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 46.4 t -112.7 100.2 10.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.431 -0.952 . . . . 71.120000000000005 108.431 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.865 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 69.7 mtp180 -109.98 124.85 52.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 72.409999999999997 112.021 -169.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.448 HD11 ' N ' ' A' ' 135' ' ' ILE . 3.1 mp -97.0 107.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.293 -0.867 . . . . 74.540000000000006 109.282 174.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -62.56 111.99 4.52 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 120.977 -0.63 . . . . 72.150000000000006 111.7 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.41 -10.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 111.968 0.359 . . . . 72.299999999999997 111.968 -175.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.782 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 151.89 130.08 1.58 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.063 -1.065 . . . . 65.230000000000004 112.433 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.578 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 28.5 ptt180 -86.03 159.69 53.73 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 110.238 -0.282 . . . . 74.340000000000003 110.238 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.598 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 51.6 Cg_exo -53.47 122.17 10.77 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.764 2.309 . . . . 74.439999999999998 112.799 -177.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.91 8.06 3.98 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.942 2.428 . . . . 71.349999999999994 112.24 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.0 -128.0 1.7 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.076 -0.583 . . . . 74.030000000000001 111.934 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -46.1 17.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.008 0.432 . . . . 74.340000000000003 110.543 -177.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 17.3 mmtp -87.69 133.14 33.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.533 0.683 . . . . 74.400000000000006 110.531 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.588 ' HB2' HD11 ' A' ' 97' ' ' LEU . 2.6 p-10 -74.63 158.64 84.7 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 114.773 -1.103 . . . . 72.25 110.781 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.598 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 32.5 Cg_exo -58.69 -16.22 29.71 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.958 2.438 . . . . 72.409999999999997 113.26 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.487 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -68.39 -21.19 64.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 72.329999999999998 111.317 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.41 -34.55 18.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.9 0.381 . . . . 72.219999999999999 111.233 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -84.35 -19.16 34.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.078 0.466 . . . . 73.420000000000002 111.331 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.519 HG21 ' HB3' ' A' ' 21' ' ' ARG . 5.2 p -72.17 5.15 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.596 -0.729 . . . . 74.010000000000005 112.391 -172.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.92 -5.86 37.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.013 0.375 . . . . 71.209999999999994 112.013 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -160.89 144.53 13.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.911 0.386 . . . . 73.239999999999995 111.492 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 67.31 -173.92 0.19 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.15 -0.932 . . . . 73.420000000000002 112.621 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -156.72 171.48 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 75.140000000000001 109.51 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.8 ' HB ' ' HG3' ' A' ' 158' ' ' GLU . 25.1 m -102.5 120.07 39.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.864 0.364 . . . . 72.349999999999994 110.944 -175.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.69 67.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 71.120000000000005 111.523 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.39 70.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 71.140000000000001 111.504 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.8 ' HG3' ' HB ' ' A' ' 155' ' ' THR . 1.5 pp20? -79.83 -20.83 45.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.692 0.282 . . . . 75.099999999999994 111.208 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.475 ' HA ' HG22 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -61.4 -20.36 62.97 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.241 0.543 . . . . 75.530000000000001 110.199 177.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.61 81.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.62 -0.718 . . . . 65.340000000000003 111.318 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -85.66 -7.86 58.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.41 . . . . 73.340000000000003 111.501 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.775 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 93.8 t -57.74 -59.07 14.23 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 111.953 0.353 . . . . 74.010000000000005 111.953 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.775 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 44.6 Cg_exo -57.37 -36.0 98.87 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.047 1.831 . . . . 65.540000000000006 112.129 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.5 m -71.35 -44.78 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.85 -0.614 . . . . 74.329999999999998 111.291 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 162' ' ' VAL . 7.1 tp -67.52 -30.1 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 73.319999999999993 111.035 -175.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 162' ' ' VAL . 92.8 t -64.88 -48.82 82.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.318 . . . . 75.109999999999999 110.473 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -63.21 -44.25 95.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 72.310000000000002 110.332 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.47 -45.45 90.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 71.439999999999998 111.093 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.6 -30.91 69.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 72.450000000000003 111.432 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -56.82 -49.35 75.64 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.143 0.277 . . . . 65.010000000000005 111.61 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.69 -43.1 98.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 73.439999999999998 111.094 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.68 69.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.817 -0.629 . . . . 61.340000000000003 111.573 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.457 ' O ' HG12 ' A' ' 177' ' ' ILE . 18.2 p -69.0 -39.04 79.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.964 0.357 . . . . 71.450000000000003 111.964 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -66.17 -40.26 90.38 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.029 -0.268 . . . . 72.219999999999999 110.87 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.4 tp -73.19 -30.89 63.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.986 0.422 . . . . 75.209999999999994 110.158 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.6 -49.3 77.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.554 -0.748 . . . . 73.150000000000006 109.427 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.697 HG21 HD21 ' A' ' 5' ' ' LEU . 45.1 mm -64.67 -31.37 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.143 -0.935 . . . . 62.32 111.207 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.5 -68.71 0.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 111.804 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -158.06 -38.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.751 0.31 . . . . 71.239999999999995 111.388 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -115.37 116.32 3.67 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.284 -0.96 . . . . 63.130000000000003 113.303 -173.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.636 ' HB2' HD23 ' A' ' 106' ' ' LEU . 4.2 pp -89.59 -20.51 23.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.363 0.601 . . . . 74.430000000000007 109.894 174.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.486 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 41.0 mt-10 -63.99 -50.13 71.19 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.39 -0.823 . . . . 54.240000000000002 111.691 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 13.9 Cg_endo -58.28 -32.38 95.82 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.91 1.74 . . . . 73.409999999999997 111.924 174.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.518 ' HA ' HG22 ' A' ' 187' ' ' THR . . . -64.28 -41.88 96.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.022 -0.535 . . . . 74.450000000000003 110.464 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.554 ' HG2' ' HB3' ' A' ' 106' ' ' LEU . 25.3 mt-30 -57.76 -34.69 69.83 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.098 -0.501 . . . . 73.430000000000007 110.553 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.49 -53.32 6.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.715 -0.675 . . . . 72.129999999999995 111.23 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 184' ' ' ALA . 8.8 t -62.46 -48.18 80.78 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.011 0.375 . . . . 73.219999999999999 112.011 -173.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.583 HG23 HD12 ' A' ' 104' ' ' ILE . 5.1 p -68.7 -14.07 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.96 0.41 . . . . 71.420000000000002 111.56 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -86.59 -8.18 57.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.117 0.484 . . . . 71.040000000000006 109.98 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -102.58 -17.7 15.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 74.420000000000002 111.878 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.559 ' HD1' ' HA ' ' A' ' 188' ' ' VAL . 90.8 m95 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.654 -0.688 . . . . 74.549999999999997 110.738 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 110.132 -0.321 . . . . 72.109999999999999 110.132 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 59' ' ' SER . 9.5 Cg_endo -52.75 129.81 34.32 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.3 2.667 . . . . 72.349999999999994 113.228 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.33 143.16 30.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 72.239999999999995 110.329 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.485 HD23 HG23 ' A' ' 90' ' ' ILE . 59.3 tp -96.93 109.95 22.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.911 -0.403 . . . . 74.430000000000007 109.911 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.8 115.31 31.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.723 -0.473 . . . . 74.450000000000003 109.723 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.86 114.26 45.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.107 -0.497 . . . . 72.239999999999995 110.251 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.29 134.33 7.78 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.688 -0.768 . . . . 65.420000000000002 111.241 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.14 115.81 4.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.919 0.39 . . . . 74.400000000000006 110.044 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.841 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -87.04 -145.65 9.63 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.581 -0.736 . . . . 75.340000000000003 112.82 -174.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -102.41 136.5 19.37 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 110.618 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 90.3 Cg_endo -89.52 -153.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.883 2.389 . . . . 65.299999999999997 111.239 172.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -75.04 -174.03 33.34 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.842 -0.694 . . . . 62.039999999999999 112.54 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.25 160.21 20.17 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.005 2.47 . . . . 75.25 112.344 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.2 m 72.77 -58.22 0.61 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.155 -0.475 . . . . 74.430000000000007 111.821 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.87 -13.58 60.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.382 . . . . 75.230000000000004 111.509 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.12 0.6 31.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.212 0.529 . . . . 73.219999999999999 110.715 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -105.09 20.41 18.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.691 -0.686 . . . . 73.340000000000003 109.957 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.6 p -100.33 175.4 5.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.965 -0.561 . . . . 74.409999999999997 110.791 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.552 ' HD3' ' O ' ' A' ' 153' ' ' ASN . 0.7 OUTLIER -81.59 1.66 32.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.468 -0.333 . . . . 75.519999999999996 111.734 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.4 ' CE1' HG22 ' A' ' 150' ' ' VAL . 21.2 m170 -105.92 11.82 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.41 0.522 . . . . 71.400000000000006 112.41 -173.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -96.2 14.17 24.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.087 0.47 . . . . 63.119999999999997 110.032 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.96 -33.08 71.44 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.61 -0.723 . . . . 70.230000000000004 111.987 -174.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.06 -48.5 85.77 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.666 -0.778 . . . . 73.109999999999999 111.691 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.841 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 85.9 t80 -60.67 -46.11 91.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.831 0.348 . . . . 71.439999999999998 110.904 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 96.2 mmm -59.23 -50.41 74.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.835 -0.621 . . . . 72.010000000000005 111.704 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.45 -40.12 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 73.430000000000007 111.025 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.589 ' HB1' HD23 ' A' ' 62' ' ' LEU . . . -66.07 -34.76 78.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.858 0.361 . . . . 74.150000000000006 111.362 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -71.69 -44.67 63.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.254 -0.43 . . . . 72.439999999999998 111.428 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.0 m -65.59 -34.25 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.159 0.429 . . . . 75.549999999999997 112.159 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -79.92 -29.03 39.72 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.539 -0.464 . . . . 73.400000000000006 110.73 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.413 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -67.77 -40.46 84.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.995 0.426 . . . . 71.230000000000004 110.035 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.33 -18.9 70.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.988 -0.625 . . . . 70.209999999999994 112.364 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -75.78 -54.32 7.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.723 0.297 . . . . 71.420000000000002 111.751 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 tp -67.13 -15.44 19.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.028 -0.533 . . . . 73.019999999999996 111.229 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.82 62.54 0.93 Allowed Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.592 -1.003 . . . . 73.349999999999994 110.592 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.54 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 32.1 m -151.86 156.17 39.62 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.087 0.47 . . . . 74.319999999999993 111.786 -169.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.4 144.49 31.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.623 -0.717 . . . . 72.030000000000001 109.089 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.676 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 40.4 p90 -108.01 149.43 28.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.108 0.48 . . . . 75.430000000000007 111.575 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -155.16 172.93 17.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.353 -0.84 . . . . 73.109999999999999 109.67 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.9 126.33 5.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.676 0.75 . . . . 72.420000000000002 112.125 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -137.18 158.95 43.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.364 -0.835 . . . . 73.540000000000006 110.715 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.665 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 1.6 tpmt? 63.22 -87.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 72.400000000000006 111.845 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.39 -87.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.745 1.387 . . . . 73.129999999999995 114.745 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.498 ' OG ' ' HB2' ' A' ' 78' ' ' PRO . 51.8 p -91.45 -37.0 13.45 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.826 1.787 . . . . 72.530000000000001 115.826 -156.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.19 -7.49 4.46 Favored Glycine 0 CA--C 1.508 -0.372 0 C-N-CA 119.459 -1.353 . . . . 75.209999999999994 114.223 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HB3' HG22 ' A' ' 50' ' ' VAL . . . -95.61 110.37 22.48 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.27 1.211 . . . . 75.439999999999998 114.27 -160.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.758 ' HG3' ' HD2' ' A' ' 66' ' ' ARG . 53.6 mt-10 -97.94 114.32 26.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.709 -1.589 . . . . 74.329999999999998 106.709 155.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 48' ' ' ALA . 66.9 t -124.24 139.24 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.11 0.481 . . . . 75.25 111.823 -166.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 2.8 p -115.9 115.29 48.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.298 -1.001 . . . . 74.030000000000001 108.298 168.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -96.32 117.45 30.85 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.147 -0.479 . . . . 72.219999999999999 110.889 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.57 -169.96 22.64 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.032 -0.827 . . . . 64.25 111.032 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 54' ' ' ARG . 14.8 ptt180 -141.3 139.72 33.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.04 0.448 . . . . 74.409999999999997 110.61 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 57' ' ' GLY . 96.5 mt -118.42 136.98 53.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.198 -0.668 . . . . 63.210000000000001 109.198 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 72.1 -29.56 0.2 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.739 0.649 . . . . 70.120000000000005 112.212 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 145.15 -14.18 1.89 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.106 -0.568 . . . . 75.200000000000003 111.701 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.4 m -102.35 132.45 48.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.615 0.245 . . . . 74.109999999999999 110.492 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 17.4 m -69.85 145.15 52.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.255 -0.429 . . . . 71.430000000000007 110.656 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 177' ' ' ILE . 15.5 m -136.78 143.59 34.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.077 0.465 . . . . 73.420000000000002 110.919 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.07 101.98 13.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.741 -0.663 . . . . 65.439999999999998 109.673 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.589 HD23 ' HB1' ' A' ' 29' ' ' ALA . 53.0 tp -94.9 98.95 11.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.258 0.551 . . . . 74.319999999999993 110.996 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.12 167.5 11.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.643 -0.708 . . . . 74.340000000000003 110.213 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -154.45 134.0 7.63 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.573 0.225 . . . . 71.420000000000002 110.653 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.443 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 26.4 Cg_exo -63.98 142.19 80.5 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.809 2.34 . . . . 75.349999999999994 111.502 173.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.758 ' HD2' ' HG3' ' A' ' 49' ' ' GLU . 42.8 mtp180 -110.34 16.67 21.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.797 0.808 . . . . 75.239999999999995 109.751 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 70.1 m -133.62 161.46 34.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.767 -1.106 . . . . 73.310000000000002 109.026 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -70.04 165.87 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.18 0.514 . . . . 71.239999999999995 112.163 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.585 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . 21.9 ptt? -46.47 -44.77 17.81 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.787 1.403 . . . . 73.549999999999997 114.787 -167.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -67.09 -33.07 74.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.099 0.409 . . . . 73.239999999999995 111.24 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -96.96 0.97 49.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 73.400000000000006 111.094 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.6 t -65.12 -22.45 66.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.376 -0.375 . . . . 75.420000000000002 111.151 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.14 -30.13 76.9 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.975 -0.631 . . . . 74.109999999999999 112.605 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -85.04 -3.17 58.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.955 0.407 . . . . 75.510000000000005 110.909 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.443 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 22.8 mm-40 -82.31 -52.36 7.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 110.298 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.43 -21.44 6.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.803 -0.635 . . . . 72.400000000000006 110.679 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.36 -73.29 0.38 Allowed Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.159 -0.473 . . . . 54.32 113.525 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.498 ' HB2' ' OG ' ' A' ' 46' ' ' SER . 50.6 Cg_exo -56.01 -35.63 94.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.63 2.22 . . . . 72.019999999999996 112.008 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.605 HD12 ' HG2' ' A' ' 44' ' ' LYS . 64.1 tp -57.94 -54.29 48.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.574 -0.739 . . . . 71.5 111.856 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.687 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . . . -62.81 -30.15 71.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.018 0.437 . . . . 71.340000000000003 111.892 -175.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.943 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 9.4 mmpt? -73.23 -24.21 60.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.248 -0.433 . . . . 74.049999999999997 111.677 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -72.39 -58.69 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.8 0.296 . . . . 73.109999999999999 111.8 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.687 ' CE1' ' HA ' ' A' ' 80' ' ' ALA . 1.5 p90 -77.74 -11.37 59.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.631 -0.428 . . . . 74.010000000000005 111.176 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.1 t 65.93 34.55 7.08 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.808 0.67 . . . . 74.409999999999997 112.808 166.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.578 HG23 ' CD1' ' A' ' 83' ' ' TYR . 18.4 m -101.65 136.0 19.67 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 120.043 -0.663 . . . . 71.140000000000001 110.024 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 20.0 Cg_exo -66.47 150.83 84.07 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.69 2.26 . . . . 75.319999999999993 111.976 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.94 41.35 0.64 Allowed 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.099 2.533 . . . . 72.340000000000003 112.57 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -95.47 -47.76 6.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.954 -0.566 . . . . 70.540000000000006 109.897 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -83.46 34.86 0.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.627 -0.715 . . . . 75.319999999999993 111.266 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 131' ' ' HIS . 46.3 pt -105.74 143.32 17.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 72.409999999999997 110.708 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.69 118.13 44.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.819 -0.628 . . . . 70.329999999999998 109.847 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.0 t -96.92 120.11 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 74.150000000000006 111.263 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 tt -98.54 111.42 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.534 0.683 . . . . 62.140000000000001 109.481 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -154.69 164.8 38.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 74.549999999999997 109.944 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.81 153.74 25.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.474 0.654 . . . . 74.129999999999995 111.444 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.486 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 30.0 tt0 -119.88 94.54 4.43 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.113 -1.069 . . . . 74.019999999999996 108.113 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.636 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 2.4 pt? -60.78 -27.99 68.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.244 -0.889 . . . . 70.219999999999999 112.552 -170.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.39 -10.76 60.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.134 0.492 . . . . 73.409999999999997 110.858 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.2 mm -107.92 135.51 46.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 74.010000000000005 109.841 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.417 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 14.8 m-20 -66.44 154.22 40.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.102 0.477 . . . . 71.349999999999994 111.686 -176.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.688 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 34.7 p90 -65.41 143.51 57.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.216 -0.902 . . . . 65.200000000000003 111.164 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.03 -67.57 0.51 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.408 -0.901 . . . . 75.129999999999995 112.689 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -116.74 155.67 28.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.795 0.331 . . . . 74.109999999999999 110.196 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.584 HG23 ' HA ' ' A' ' 135' ' ' ILE . 40.9 pt -116.75 165.4 12.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.134 -0.485 . . . . 75.420000000000002 110.692 -178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.428 ' HG3' ' HB2' ' A' ' 134' ' ' ARG . 38.4 ptt180 -142.52 170.21 16.13 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.077 -0.712 . . . . 73.120000000000005 109.077 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 181' ' ' LEU . 5.7 mp -128.75 119.32 24.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.061 0.458 . . . . 75.239999999999995 110.8 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -143.05 127.03 17.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.778 -0.646 . . . . 72.109999999999999 109.912 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.703 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.0 pt? -72.48 121.75 20.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.798 -0.637 . . . . 64.319999999999993 109.936 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.68 -173.6 41.35 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.874 -0.679 . . . . 73.200000000000003 111.488 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.12 -154.32 16.17 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.437 -0.411 . . . . 75.310000000000002 112.789 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.472 ' HA3' HD12 ' A' ' 118' ' ' LEU . . . -110.78 81.49 0.29 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.764 -0.731 . . . . 71.329999999999998 112.221 177.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -53.83 142.65 23.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.782 0.325 . . . . 74.430000000000007 110.434 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.34 -48.43 4.03 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.918 -0.658 . . . . 54.009999999999998 112.536 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.03 -59.46 3.65 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.994 -0.622 . . . . 62.119999999999997 111.816 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.4 m80 65.62 -74.49 0.06 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.378 0.671 . . . . 75.420000000000002 112.492 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -38.03 -56.89 1.11 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.242 1.017 . . . . 74.430000000000007 113.472 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.585 ' HA3' ' HB2' ' A' ' 69' ' ' MET . . . -62.45 -64.78 3.59 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.798 -0.715 . . . . 74.109999999999999 113.679 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.472 HD12 ' HA3' ' A' ' 111' ' ' GLY . 85.5 mt -68.09 -28.36 67.29 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.83 0.307 . . . . 75.400000000000006 111.83 -173.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -67.0 -39.92 87.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.31 -0.256 . . . . 71.340000000000003 110.31 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.2 t -64.13 -43.83 94.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.978 0.418 . . . . 74.310000000000002 110.08 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 t -67.18 -46.22 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 75.400000000000006 110.711 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 127' ' ' THR . . . -61.81 -41.48 97.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.743 -0.662 . . . . 72.230000000000004 111.754 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 m -66.26 -29.36 69.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.476 -0.329 . . . . 73.409999999999997 111.496 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.97 -46.94 17.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.903 0.382 . . . . 72.099999999999994 111.077 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.34 -35.81 54.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.516 . . . . 75.120000000000005 111.731 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.37 40.12 4.3 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.487 -0.863 . . . . 64.420000000000002 111.367 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 11.5 t -129.88 176.29 8.16 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.244 -0.28 . . . . 75.530000000000001 110.244 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -138.48 21.73 2.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.79 0.329 . . . . 74.340000000000003 110.148 177.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.42 78.93 0.27 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.446 -0.797 . . . . 74.340000000000003 110.233 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -71.83 -25.21 61.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.715 -0.675 . . . . 75.349999999999994 111.404 -176.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 85.4 m-70 -140.85 120.49 13.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.724 -0.473 . . . . 75.099999999999994 109.724 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -153.49 152.12 30.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.945 0.402 . . . . 73.400000000000006 110.767 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.0 t -94.22 143.46 11.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.785 -0.643 . . . . 73.540000000000006 109.744 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.486 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 12.0 mmt180 -103.82 93.5 4.93 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.412 -0.588 . . . . 73.150000000000006 109.412 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.584 ' HA ' HG23 ' A' ' 104' ' ' ILE . 65.1 mt -92.7 108.14 19.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 110.627 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -71.17 109.74 2.96 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.637 -0.792 . . . . 75.450000000000003 111.855 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.0 m -109.61 -6.95 11.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.013 0.435 . . . . 72.120000000000005 110.602 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 87.2 170.57 46.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.828 -0.701 . . . . 50.409999999999997 112.321 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.636 ' HD2' ' O ' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -141.49 131.67 12.93 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.592 -0.521 . . . . 72.319999999999993 109.592 176.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 28.9 Cg_endo -64.81 110.78 1.54 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.526 2.151 . . . . 71.349999999999994 111.93 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 6.1 Cg_exo -78.3 69.44 7.6 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.067 2.511 . . . . 74.420000000000002 111.82 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.03 -176.68 42.31 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.699 -0.682 . . . . 51.020000000000003 111.429 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.47 -15.25 29.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.006 0.432 . . . . 75.420000000000002 109.914 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -93.67 159.22 15.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.041 -0.527 . . . . 74.439999999999998 109.66 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.49 142.42 91.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.719 -0.475 . . . . 74.099999999999994 109.719 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -52.08 -11.92 1.2 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.434 2.756 . . . . 72.230000000000004 113.744 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.14 -31.23 51.82 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.802 0.334 . . . . 63.43 111.403 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.73 -31.48 19.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.385 -0.37 . . . . 75.230000000000004 111.636 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -84.16 -19.68 33.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.245 -0.434 . . . . 73.140000000000001 111.713 -175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.4 HG22 ' CE1' ' A' ' 22' ' ' HIS . 11.9 p -65.01 -23.39 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.386 -0.37 . . . . 72.409999999999997 111.92 -175.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.7 mt -94.15 -11.46 30.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.447 -0.342 . . . . 71.319999999999993 111.91 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.13 110.72 2.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.339 0.59 . . . . 71.010000000000005 111.015 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.552 ' O ' ' HD3' ' A' ' 21' ' ' ARG . 22.9 t-20 -160.28 121.97 3.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.801 -0.636 . . . . 70.25 110.562 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -164.76 100.28 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.835 0.71 . . . . 72.019999999999996 109.727 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.24 175.52 5.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.882 -0.599 . . . . 75.319999999999993 111.063 -174.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.65 -20.6 46.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 64.420000000000002 111.628 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . . . -66.13 -50.26 64.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.176 -0.465 . . . . 72.040000000000006 111.477 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.529 ' O ' HG21 ' A' ' 162' ' ' VAL . 1.6 mp0 -60.54 -30.36 69.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 71.340000000000003 111.206 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -55.75 -28.76 57.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 112.078 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.22 60.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.674 0.273 . . . . 70.439999999999998 111.658 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -111.92 -7.86 14.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.351 0.5 . . . . 74.329999999999998 112.351 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 158' ' ' GLU . 92.3 t -56.46 -56.68 29.35 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 121.111 -0.235 . . . . 74.5 110.916 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 20.1 Cg_endo -61.47 -34.47 85.96 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.983 1.789 . . . . 52.109999999999999 111.844 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.5 m -59.49 -42.14 91.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.865 -0.607 . . . . 75.329999999999998 110.904 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.6 mt -77.32 -52.83 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 75.439999999999998 111.378 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.1 t -53.9 -47.41 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.382 0.512 . . . . 73.230000000000004 112.382 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -56.89 -52.11 66.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.984 0.421 . . . . 73.340000000000003 110.478 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -74.26 -41.62 60.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.789 -0.641 . . . . 74.129999999999995 111.604 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.52 -56.48 21.63 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.957 0.355 . . . . 73.25 111.957 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.94 -31.37 66.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.035 0.445 . . . . 71.230000000000004 111.66 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -80.92 -45.85 16.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.939 -0.573 . . . . 72.319999999999993 111.144 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.81 -30.87 65.98 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.374 0.509 . . . . 65.439999999999998 112.374 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.607 ' HA ' HD12 ' A' ' 176' ' ' LEU . 86.2 m -54.02 -32.0 52.93 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.219 0.451 . . . . 75.099999999999994 112.219 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.98 -33.27 75.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 75.439999999999998 110.638 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.3 tp -73.14 -27.13 61.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 72.010000000000005 111.268 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 173' ' ' THR . 8.6 mp -66.93 -35.77 80.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.066 0.46 . . . . 74.150000000000006 110.112 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.598 HD11 HG11 ' A' ' 60' ' ' VAL . 50.0 mt -80.45 -25.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.604 -0.726 . . . . 71.129999999999995 109.899 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.16 -43.19 68.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.615 -0.72 . . . . 71.230000000000004 111.075 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -134.6 -73.17 0.47 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.371 -0.377 . . . . 71.140000000000001 110.405 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 176' ' ' LEU . . . -177.55 -157.97 19.59 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.248 -0.977 . . . . 74.439999999999998 112.789 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.687 ' HB2' HD21 ' A' ' 106' ' ' LEU . 2.5 pt? -89.83 -5.09 57.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.556 -0.322 . . . . 75.409999999999997 110.799 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.792 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 7.0 mm-40 -55.15 -56.97 22.52 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.853 -0.612 . . . . 71.099999999999994 111.859 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 2.9 Cg_exo -75.2 -26.58 10.47 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.744 1.629 . . . . 75.329999999999998 111.633 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.464 ' O ' HG21 ' A' ' 188' ' ' VAL . . . -65.15 -53.3 47.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.65 -0.705 . . . . 65.219999999999999 111.232 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -60.97 -21.12 63.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 73.510000000000005 111.157 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -78.35 -55.28 5.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.371 -0.377 . . . . 73.150000000000006 110.591 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.9 t -71.64 -30.18 65.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.323 0.49 . . . . 72.349999999999994 112.323 -173.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 184' ' ' ALA . 22.8 m -82.18 -12.55 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.117 -0.364 . . . . 72.230000000000004 111.56 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -109.42 -31.49 7.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.389 -0.368 . . . . 65.420000000000002 110.945 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.44 -24.24 46.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.379 . . . . 63.109999999999999 112.02 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 72.3 m95 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.469 -0.777 . . . . 74.239999999999995 110.175 179.425 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 109.465 -0.568 . . . . 73.129999999999995 109.465 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.17 108.21 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.486 2.124 . . . . 65.409999999999997 112.295 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.72 152.69 18.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.007 -0.542 . . . . 74.010000000000005 111.157 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.3 tp -97.39 116.87 30.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.968 -0.56 . . . . 75.340000000000003 109.49 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.29 110.41 31.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 74.310000000000002 110.048 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.554 HG11 HG23 ' A' ' 76' ' ' VAL . 43.5 t -121.89 132.82 70.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.588 -0.278 . . . . 74.150000000000006 110.504 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.491 ' HA2' ' HB ' ' A' ' 93' ' ' ILE . . . -122.13 130.78 8.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.936 -0.649 . . . . 33.549999999999997 111.8 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -72.63 144.19 47.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.238 0.542 . . . . 74.209999999999994 111.116 -176.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.581 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -156.94 -177.67 30.28 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.786 -0.721 . . . . 65.549999999999997 111.709 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.536 ' OD1' ' HE3' ' A' ' 69' ' ' MET . 86.7 m-20 -127.37 83.25 66.53 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 110.248 -0.278 . . . . 73.519999999999996 110.248 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.9 93.62 0.1 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.8 2.334 . . . . 74.239999999999995 112.224 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.51 158.93 31.02 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.698 -0.683 . . . . 54.340000000000003 111.401 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.16 -68.1 0.07 OUTLIER 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 123.163 2.575 . . . . 75.310000000000002 113.106 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 p -75.66 -26.74 57.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.934 0.397 . . . . 74.319999999999993 111.523 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -70.24 -24.19 63.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.981 -0.554 . . . . 73.549999999999997 111.282 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.411 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . . . -73.61 -9.35 58.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.262 -0.426 . . . . 75.030000000000001 111.405 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -94.8 18.6 11.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.245 -0.434 . . . . 75.420000000000002 110.773 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.6 p -111.34 148.87 32.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.043 0.449 . . . . 73.340000000000003 111.016 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.559 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 30.5 ptt-85 -71.31 -5.73 34.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.066 -0.515 . . . . 75.530000000000001 110.557 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.524 ' CG ' HG22 ' A' ' 150' ' ' VAL . 30.6 t-80 -91.45 2.29 56.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.294 0.569 . . . . 70.25 109.949 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 18' ' ' ALA . 63.5 t30 -98.8 18.07 17.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.818 0.818 . . . . 73.129999999999995 109.206 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.4 -38.16 88.58 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.247 -0.888 . . . . 75.510000000000005 112.318 -173.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.547 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -62.51 -46.24 94.2 Favored Glycine 0 C--N 1.329 0.152 0 C-N-CA 120.529 -0.843 . . . . 64.340000000000003 112.426 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.581 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 82.5 t80 -65.08 -38.77 91.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.163 0.506 . . . . 75.319999999999993 110.706 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.4 mmt -81.92 -37.69 26.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.913 -0.585 . . . . 73.549999999999997 112.534 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 31' ' ' VAL . 53.3 t -62.23 -37.75 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.951 0.405 . . . . 74.099999999999994 110.34 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.54 78.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.023 -0.535 . . . . 72.010000000000005 110.696 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -75.61 -48.95 20.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.109 -0.496 . . . . 65.230000000000004 111.289 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' A' ' 28' ' ' VAL . 35.1 m -63.15 -40.78 90.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.538 -0.301 . . . . 72.299999999999997 111.654 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.448 HD21 ' HB1' ' A' ' 169' ' ' ALA . 66.8 mt -66.06 -41.34 90.92 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.695 0.283 . . . . 75.409999999999997 110.814 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.83 -47.5 85.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.062 -0.517 . . . . 62.310000000000002 110.468 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.89 -27.94 71.06 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.884 -0.674 . . . . 64.540000000000006 112.857 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 18.0 mmm180 -73.18 -42.83 62.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.006 0.373 . . . . 73.5 112.006 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.71 -14.89 13.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.441 0.639 . . . . 74.109999999999999 110.264 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.12 58.91 1.43 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 110.539 -1.024 . . . . 74.530000000000001 110.539 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.6 m -137.98 126.59 23.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.045 -0.577 . . . . 73.530000000000001 111.718 -171.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.88 143.03 24.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.591 -0.732 . . . . 74.430000000000007 109.429 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.602 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 2.7 t80 -141.8 -146.0 0.18 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.246 -0.279 . . . . 73.209999999999994 110.246 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -155.51 173.26 16.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.788 0.327 . . . . 73.140000000000001 111.579 -169.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 47' ' ' GLY . 2.6 p -54.09 132.2 16.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.509 -0.768 . . . . 71.019999999999996 110.079 169.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -137.23 133.98 35.72 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.713 -0.395 . . . . 72.439999999999998 111.676 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 64.27 -172.79 0.17 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.565 -0.743 . . . . 72.019999999999996 112.195 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.513 ' C ' ' H ' ' A' ' 47' ' ' GLY . 33.5 ttpt -79.92 -15.01 58.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.802 0.81 . . . . 74.140000000000001 109.079 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' A' ' 82' ' ' PHE . 9.7 p -81.75 25.4 0.55 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.638 -1.164 . . . . 74.310000000000002 109.238 170.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 45' ' ' LYS . . . -54.23 43.68 0.01 OUTLIER Glycine 0 C--N 1.34 0.769 0 N-CA-C 118.253 2.061 . . . . 73.530000000000001 118.253 -167.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.13 174.36 6.43 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 118.268 1.034 . . . . 63.240000000000002 108.212 165.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 58.0 mt-10 -72.1 116.52 12.61 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.065 -0.654 . . . . 74.230000000000004 109.866 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.602 ' O ' ' HB3' ' A' ' 40' ' ' PHE . 58.6 t -124.96 135.68 63.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 110.125 -0.324 . . . . 73.510000000000005 110.125 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' A' ' 62' ' ' LEU . 3.1 p -125.71 110.97 25.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.339 0.59 . . . . 71.239999999999995 110.006 172.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 m -84.26 111.85 19.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.974 -0.557 . . . . 74.239999999999995 110.121 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -138.58 171.43 23.5 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.884 -0.675 . . . . 64.430000000000007 111.737 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -131.31 110.53 11.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.224 0.535 . . . . 75.140000000000001 111.137 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.508 ' HB3' ' HG2' ' A' ' 174' ' ' GLU . 6.9 mp -111.94 153.33 26.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.136 -0.69 . . . . 72.299999999999997 109.136 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.97 -73.36 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.844 0.715 . . . . 74.420000000000002 111.331 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.67 23.11 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.051 -0.595 . . . . 73.140000000000001 112.477 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.7 m -140.88 141.38 34.62 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.548 -0.383 . . . . 75.409999999999997 110.62 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.8 p -83.73 118.53 23.95 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.993 0.425 . . . . 72.019999999999996 110.008 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.52 155.72 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.975 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -97.03 100.54 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.907 -0.588 . . . . 63.109999999999999 109.731 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB3' HG12 ' A' ' 51' ' ' VAL . 48.6 tp -95.05 115.28 27.22 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.339 -0.615 . . . . 75.420000000000002 109.339 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HB3' HG21 ' A' ' 8' ' ' VAL . . . -124.82 145.17 49.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.467 0.651 . . . . 74.420000000000002 112.295 -173.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -111.11 142.11 25.64 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.939 -1.028 . . . . 74.109999999999999 108.42 173.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 18.8 Cg_exo -65.95 152.59 81.0 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.368 2.045 . . . . 74.049999999999997 111.904 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -93.95 5.46 51.63 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.626 -0.879 . . . . 71.219999999999999 108.626 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.891 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 77.3 m -134.59 173.84 11.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.368 -1.287 . . . . 71.150000000000006 109.824 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.452 ' HD2' ' SD ' ' A' ' 69' ' ' MET . 17.3 p90 -85.35 -173.71 4.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 74.200000000000003 110.542 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.536 ' HE3' ' OD1' ' A' ' 12' ' ' ASN . 1.7 pmm? -48.55 -46.24 38.69 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.388 0.885 . . . . 74.430000000000007 113.388 -170.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -66.16 -62.35 1.53 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 75.519999999999996 111.735 -173.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.891 ' HG3' ' HB3' ' A' ' 67' ' ' CYS . 6.2 pt-20 -87.48 18.91 3.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.469 . . . . 72.310000000000002 111.299 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.1 t -65.33 -39.2 92.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.342 -0.614 . . . . 73.230000000000004 109.342 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.51 -23.57 66.93 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.738 -0.665 . . . . 73.450000000000003 112.188 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -71.92 -17.27 62.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.74 0.305 . . . . 72.150000000000006 110.425 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -95.88 -42.62 8.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 64.519999999999996 110.537 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.554 HG23 HG11 ' A' ' 8' ' ' VAL . 25.7 t -62.23 -38.54 81.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.983 -0.553 . . . . 74.0 111.236 -177.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.33 -64.56 4.27 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.879 -0.6 . . . . 65.209999999999994 113.257 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.05 -41.23 70.17 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.646 2.23 . . . . 74.109999999999999 112.31 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.1 tp -54.85 -48.65 72.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.28 -0.418 . . . . 74.420000000000002 111.113 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.83 88.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.167 -0.47 . . . . 75.219999999999999 111.334 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -75.98 -35.22 59.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.177 -0.465 . . . . 75.299999999999997 111.291 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.402 ' HD2' ' HB3' ' A' ' 46' ' ' SER . 21.5 m-85 -71.74 -20.14 61.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.78 0.324 . . . . 72.420000000000002 111.086 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -98.74 -1.37 40.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.292 -0.413 . . . . 75.430000000000007 110.871 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m 59.73 29.61 19.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.643 -0.708 . . . . 72.439999999999998 111.767 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.23 149.06 35.29 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 73.230000000000004 110.601 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.524 ' O ' HG23 ' A' ' 90' ' ' ILE . 14.1 Cg_exo -70.35 110.31 2.64 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.079 2.519 . . . . 74.400000000000006 112.046 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.493 ' HB3' HD23 ' A' ' 125' ' ' LEU . 23.1 Cg_exo -65.1 -11.92 32.21 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.158 2.572 . . . . 75.420000000000002 112.42 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -78.94 -43.29 24.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.261 -0.427 . . . . 73.129999999999995 110.174 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -96.63 0.71 50.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 112.155 -170.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.551 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 40.2 pt -75.47 174.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.806 -0.357 . . . . 62.43 110.425 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 p -119.88 125.26 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.331 0.586 . . . . 73.510000000000005 110.98 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 131' ' ' HIS . 98.1 t -119.32 123.8 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 73.329999999999998 110.448 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.491 ' HB ' ' HA2' ' A' ' 9' ' ' GLY . 48.8 mm -75.57 130.63 36.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.693 -0.685 . . . . 75.340000000000003 109.6 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.408 ' HE1' ' HA3' ' A' ' 114' ' ' GLY . 31.5 t-80 -136.6 157.58 46.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.118 0.485 . . . . 74.099999999999994 110.469 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -86.77 152.76 22.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.875 -0.602 . . . . 71.530000000000001 110.688 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.727 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 26.9 tt0 -128.07 93.78 3.76 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.915 -0.772 . . . . 65.230000000000004 108.915 168.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 139' ' ' ARG . 4.0 pp -84.02 0.09 49.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.027 -0.988 . . . . 71.319999999999993 112.04 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' HB2' ' HA2' ' A' ' 113' ' ' GLY . 27.9 t70 -87.08 -38.94 16.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.163 0.506 . . . . 74.219999999999999 110.351 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.44 152.06 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.462 -0.79 . . . . 73.329999999999998 109.852 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.479 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 5.1 p-10 -64.39 159.97 20.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.377 0.608 . . . . 71.200000000000003 111.61 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 0.8 OUTLIER -72.59 135.69 45.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.132 -0.94 . . . . 75.510000000000005 112.027 -176.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.02 -64.06 0.53 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.235 -0.983 . . . . 62.310000000000002 113.278 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -85.88 145.62 27.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.797 0.332 . . . . 72.409999999999997 110.839 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.564 HG12 HG23 ' A' ' 188' ' ' VAL . 30.7 pt -117.27 149.85 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.481 -0.562 . . . . 74.120000000000005 109.481 174.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -157.03 137.22 12.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.852 0.358 . . . . 72.510000000000005 110.949 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 4.0 pp -96.68 153.47 17.85 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.757 -0.46 . . . . 72.420000000000002 109.757 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -147.39 115.54 6.56 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.771 -0.455 . . . . 73.209999999999994 109.771 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 129' ' ' ASN . 0.7 OUTLIER -80.91 90.12 5.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.828 0.823 . . . . 75.219999999999999 110.326 177.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.28 -127.09 1.63 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.385 -0.825 . . . . 62.509999999999998 111.385 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.08 163.17 32.96 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.299 -0.721 . . . . 75.420000000000002 111.299 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.8 94.66 0.68 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.641 -0.79 . . . . 64.409999999999997 112.492 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.91 142.12 12.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.136 0.494 . . . . 72.430000000000007 111.334 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 98' ' ' ASP . . . 96.88 -76.12 0.7 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.041 -0.599 . . . . 63.25 112.972 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.408 ' HA3' ' HE1' ' A' ' 94' ' ' HIS . . . -80.28 63.78 4.09 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.046 -0.597 . . . . 73.340000000000003 112.93 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -62.67 -27.1 69.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.778 0.288 . . . . 74.140000000000001 111.778 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -65.51 -29.93 70.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.312 0.577 . . . . 73.319999999999993 110.786 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.43 20.56 29.97 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.59 -0.814 . . . . 74.129999999999995 112.308 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 33.5 mt -84.5 -59.51 2.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.881 -0.328 . . . . 72.430000000000007 111.276 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 119' ' ' ARG . 3.7 mpt_? -73.65 -35.78 65.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.35 -0.386 . . . . 75.219999999999999 110.58 -174.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 p -56.42 -43.96 79.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 63.009999999999998 111.233 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.433 ' HB ' HH22 ' A' ' 132' ' ' ARG . 48.9 t -85.33 -41.62 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 73.340000000000003 111.889 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.37 -47.16 71.2 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.051 0.389 . . . . 64.140000000000001 112.051 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.2 m -66.93 -24.53 66.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.659 0.266 . . . . 73.200000000000003 111.18 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.43 -45.6 37.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.758 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.552 HD21 HG11 ' A' ' 76' ' ' VAL . 90.6 mt -72.58 -34.98 67.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 73.430000000000007 110.384 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.61 -12.56 20.86 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.907 -0.663 . . . . 73.239999999999995 113.15 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -169.56 177.57 4.53 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.167 0.508 . . . . 75.040000000000006 111.579 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 2.5 mptt -110.34 -110.97 0.33 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.587 -0.894 . . . . 75.439999999999998 108.587 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 4.3 t-20 64.96 -9.89 0.18 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.708 0.803 . . . . 64.310000000000002 113.054 174.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.436 ' H ' ' C ' ' A' ' 128' ' ' LYS . 10.4 t80 -179.79 -157.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.659 -0.867 . . . . 71.140000000000001 108.659 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.585 ' O ' ' HD2' ' A' ' 132' ' ' ARG . 11.6 p-80 44.87 41.08 4.86 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.937 0.895 . . . . 71.409999999999997 113.067 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 131' ' ' HIS . 2.7 mpt_? -131.01 107.03 8.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.786 -0.643 . . . . 71.540000000000006 109.906 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 106' ' ' LEU . 58.8 t -119.18 109.95 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.943 -0.762 . . . . 72.430000000000007 108.943 174.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.727 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 90.2 mtm180 -92.14 122.64 34.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.088 0.471 . . . . 75.140000000000001 111.651 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 135' ' ' ILE . 2.1 mp -99.88 115.03 40.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.946 -0.761 . . . . 71.430000000000007 108.946 172.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -63.52 109.13 2.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.881 -0.676 . . . . 71.310000000000002 111.472 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.559 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 30.8 m -101.4 -18.7 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.562 0.22 . . . . 74.409999999999997 111.491 -176.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 107.92 139.66 9.08 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.424 -0.893 . . . . 75.219999999999999 112.664 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 6.1 ptp180 -80.88 133.5 54.86 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.032 0.444 . . . . 73.420000000000002 111.586 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 22.3 Cg_exo -65.23 128.99 21.66 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.303 2.669 . . . . 64.409999999999997 112.499 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 5.9 Cg_exo -78.86 45.67 1.97 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.191 2.594 . . . . 73.510000000000005 112.272 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.87 143.74 10.95 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.044 -0.823 . . . . 71.140000000000001 111.044 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.441 ' HA ' ' HD3' ' A' ' 143' ' ' ARG . 18.1 mmt180 -89.58 58.39 4.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.513 0.673 . . . . 75.129999999999995 111.446 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -131.0 160.49 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.101 -0.954 . . . . 75.510000000000005 109.296 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -66.49 141.09 96.9 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.263 -0.643 . . . . 71.120000000000005 109.263 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.8 -14.37 1.22 Allowed 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.552 2.835 . . . . 75.040000000000006 113.915 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.32 28.62 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.588 0.355 . . . . 75.239999999999995 111.813 174.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.75 -41.63 13.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.146 0.498 . . . . 74.409999999999997 111.228 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -73.61 -19.81 60.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 73.299999999999997 111.76 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.524 HG22 ' CG ' ' A' ' 22' ' ' HIS . 14.5 p -65.21 -22.52 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.246 -0.434 . . . . 74.340000000000003 111.49 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.52 -27.76 13.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.62 -0.264 . . . . 72.140000000000001 111.36 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -165.43 109.7 0.86 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.259 0.552 . . . . 71.239999999999995 111.467 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -164.27 31.79 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.823 -0.626 . . . . 73.120000000000005 110.125 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -60.23 124.57 20.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.311 0.577 . . . . 74.150000000000006 111.142 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.17 176.32 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.459 -0.791 . . . . 72.219999999999999 110.289 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.65 -54.46 5.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.837 0.351 . . . . 74.439999999999998 111.741 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.39 -23.77 66.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.208 0.818 . . . . 71.319999999999993 113.208 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.71 -23.7 66.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.067 0.461 . . . . 74.310000000000002 110.698 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.457 ' HA ' HG22 ' A' ' 162' ' ' VAL . 22.7 mmm180 -69.41 -22.37 63.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.747 -0.661 . . . . 75.209999999999994 111.417 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.36 -33.21 73.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.281 -0.418 . . . . 74.200000000000003 111.711 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 165' ' ' ILE . 8.9 mm-40 -97.04 1.48 50.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.885 0.328 . . . . 64.0 111.885 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' A' ' 163' ' ' PRO . 95.1 t -60.82 -53.39 64.65 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.772 -0.194 . . . . 75.120000000000005 111.373 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 30.7 Cg_endo -64.64 -25.62 61.78 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.772 1.648 . . . . 74.439999999999998 111.794 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.1 m -63.32 -51.17 67.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.624 -0.716 . . . . 75.430000000000007 110.945 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 161' ' ' GLU . 78.9 mt -54.49 -38.17 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.938 -0.573 . . . . 75.25 111.727 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.25 -51.44 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 63.409999999999997 111.363 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -80.97 -30.44 35.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.406 -0.361 . . . . 74.319999999999993 111.563 -176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -67.12 -43.18 83.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 72.200000000000003 110.961 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.448 ' HB1' HD21 ' A' ' 32' ' ' LEU . . . -60.09 -37.9 81.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 73.310000000000002 111.29 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.78 92.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.896 0.379 . . . . 64.209999999999994 111.548 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.81 -41.61 78.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.85 0.357 . . . . 74.420000000000002 110.977 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.75 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.042 -0.527 . . . . 71.549999999999997 112.279 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 23.6 p -62.86 -48.63 78.19 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.218 0.451 . . . . 65.239999999999995 112.218 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.508 ' HG2' ' HB3' ' A' ' 55' ' ' LEU . 40.3 mt-10 -64.99 -29.66 70.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.742 -0.208 . . . . 75.129999999999995 111.347 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 184' ' ' ALA . 22.0 tp -74.54 -31.77 62.23 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.749 -0.38 . . . . 70.439999999999998 110.38 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.668 HD22 ' HA ' ' A' ' 181' ' ' LEU . 70.6 mt -62.18 -45.1 94.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.245 0.545 . . . . 75.319999999999993 110.121 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 59.8 mt -71.02 -28.63 33.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.367 -0.833 . . . . 75.230000000000004 110.274 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -59.06 5.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.556 -0.747 . . . . 62.350000000000001 111.186 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -178.1 -49.61 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.849 0.314 . . . . 75.510000000000005 111.849 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.14 116.82 5.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.637 -0.792 . . . . 61.25 113.71 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.668 ' HA ' HD22 ' A' ' 176' ' ' LEU . 10.2 mp -77.63 -44.24 28.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.01 0.433 . . . . 75.319999999999993 110.658 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 45.5 mt-10 -72.56 -44.07 9.34 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.195 -0.457 . . . . 74.040000000000006 111.697 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -52.12 -35.89 64.03 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.532 1.488 . . . . 75.109999999999999 111.918 170.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.52 ' HA ' HD23 ' A' ' 175' ' ' LEU . . . -73.31 -38.01 65.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.38 -0.373 . . . . 74.439999999999998 111.682 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 3.4 pt20 -71.36 -27.49 63.39 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.535 -0.466 . . . . 75.439999999999998 109.906 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -86.34 -32.09 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 75.349999999999994 111.69 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 184' ' ' ALA . 13.1 t -61.87 -50.42 72.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.96 -0.296 . . . . 70.439999999999998 111.062 -176.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.564 HG23 HG12 ' A' ' 104' ' ' ILE . 9.4 p -67.39 -26.45 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 121.569 0.7 . . . . 73.209999999999994 110.299 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -69.69 -31.7 69.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.377 -0.829 . . . . 73.340000000000003 110.318 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -93.61 -6.58 46.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.886 -0.597 . . . . 40.509999999999998 111.75 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.9 m95 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.664 -0.684 . . . . 73.349999999999994 110.585 175.843 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 8.8 pt-20 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.239 0.542 . . . . 73.120000000000005 109.778 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.882 ' HB2' HG21 ' A' ' 61' ' ' VAL . 56.4 Cg_endo -92.27 117.28 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.987 2.458 . . . . 73.409999999999997 113.318 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.627 ' HB2' HG13 ' A' ' 60' ' ' VAL . 70.9 mt -67.67 145.17 55.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 74.420000000000002 109.935 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.587 HD23 HG12 ' A' ' 90' ' ' ILE . 57.3 tp -93.32 109.36 20.91 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.107 -0.331 . . . . 72.420000000000002 110.107 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.58 113.12 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.496 . . . . 74.109999999999999 110.366 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.02 164.1 22.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.232 -0.44 . . . . 74.239999999999995 110.602 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.29 -178.66 39.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.601 -0.809 . . . . 51.039999999999999 112.25 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.466 HD21 ' CE1' ' A' ' 94' ' ' HIS . 86.3 mt -67.55 126.48 29.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.69 0.281 . . . . 73.540000000000006 110.966 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.98 177.73 52.09 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.934 -0.651 . . . . 40.140000000000001 113.149 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 30.0 t-20 -124.63 108.06 28.94 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 110.048 -0.353 . . . . 64.439999999999998 110.048 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 4.6 Cg_exo -76.75 -33.26 3.05 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.41 2.74 . . . . 73.349999999999994 114.117 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.92 147.81 15.01 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.889 -1.148 . . . . 61.530000000000001 113.104 -174.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.02 -31.83 94.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.553 2.835 . . . . 74.109999999999999 113.34 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 m -61.05 -39.14 88.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.293 0.568 . . . . 72.420000000000002 110.879 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.563 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 91.0 m-85 -97.17 2.5 51.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.53 -0.759 . . . . 74.109999999999999 110.52 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.41 ' HB1' HD22 ' A' ' 12' ' ' ASN . . . -71.28 -18.46 62.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.763 0.653 . . . . 72.040000000000006 112.763 -171.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -92.53 18.84 7.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.697 0.284 . . . . 73.430000000000007 111.228 -175.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.626 HG21 ' O ' ' A' ' 151' ' ' LEU . 59.8 p -113.95 -174.08 2.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.277 0.56 . . . . 71.549999999999997 111.904 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.569 ' HD2' ' HB ' ' A' ' 137' ' ' VAL . 5.0 ptt180 -94.47 1.53 55.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.513 -0.767 . . . . 75.340000000000003 112.85 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.608 ' HB3' HG22 ' A' ' 150' ' ' VAL . 3.6 p-80 -94.74 10.8 33.68 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.414 -0.515 . . . . 74.329999999999998 111.496 -176.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -139.15 35.04 2.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.075 0.464 . . . . 74.540000000000006 110.757 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.9 mt -56.04 -46.56 78.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.427 -0.806 . . . . 74.230000000000004 111.796 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.94 -51.19 60.67 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.999 -0.546 . . . . 70.030000000000001 113.013 -174.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -57.82 -38.3 75.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 73.310000000000002 111.289 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 90.1 mtp -73.01 -54.43 8.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.56 -0.291 . . . . 74.299999999999997 111.388 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.445 HG13 HD21 ' A' ' 32' ' ' LEU . 57.7 t -61.21 -44.2 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 74.019999999999996 111.558 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -58.78 -53.24 60.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 60.520000000000003 112.138 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.73 -37.12 81.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.169 0.433 . . . . 60.039999999999999 112.169 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.63 -32.02 34.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.603 -0.439 . . . . 65.209999999999994 112.117 -175.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.506 HD11 ' N ' ' A' ' 33' ' ' ALA . 4.6 pp -76.41 -33.27 58.82 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.462 -0.495 . . . . 71.329999999999998 110.577 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.506 ' N ' HD11 ' A' ' 32' ' ' LEU . . . -70.0 -34.04 72.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.263 0.554 . . . . 65.230000000000004 110.279 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.88 -18.68 57.51 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.508 -0.769 . . . . 74.430000000000007 113.088 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -64.02 -39.38 93.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.026 0.413 . . . . 73.319999999999993 111.651 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' ' 36' ' ' ILE . 3.9 mp -83.11 -14.47 11.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.702 0.763 . . . . 74.439999999999998 109.553 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.98 13.69 54.04 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.87 -1.292 . . . . 71.010000000000005 109.87 -171.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.2 m -87.71 113.19 23.16 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.307 -0.946 . . . . 75.439999999999998 111.197 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.91 128.32 9.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.282 -0.417 . . . . 75.310000000000002 110.782 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.523 ' CD1' HG23 ' A' ' 51' ' ' VAL . 4.5 m-85 -102.76 -157.36 0.61 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.973 -0.558 . . . . 65.319999999999993 109.721 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -140.91 172.36 12.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.818 -0.353 . . . . 74.239999999999995 110.961 -173.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.793 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 3.3 p -55.83 105.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.748 0.785 . . . . 74.340000000000003 110.464 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.582 ' HD2' ' HG2' ' A' ' 45' ' ' LYS . 8.0 t60 -104.76 145.05 30.91 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.501 -0.772 . . . . 74.120000000000005 109.433 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -65.97 -77.11 0.07 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.176 -0.466 . . . . 65.299999999999997 111.277 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.582 ' HG2' ' HD2' ' A' ' 43' ' ' HIS . 28.8 mmmt 47.26 -133.27 1.18 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.501 -0.555 . . . . 74.219999999999999 109.501 -172.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 p -105.97 -39.46 6.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.389 -0.925 . . . . 65.409999999999997 112.725 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.718 ' HA3' ' HB3' ' A' ' 75' ' ' GLN . . . -133.01 -24.18 0.73 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 118.4 -1.857 . . . . 70.420000000000002 117.055 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.72 162.01 36.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.678 1.362 . . . . 72.120000000000005 114.678 -160.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.793 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 23.0 mt-10 -74.94 135.98 41.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.182 -1.372 . . . . 73.540000000000006 108.75 170.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.43 HG22 ' HH ' ' A' ' 83' ' ' TYR . 17.2 m -125.61 140.11 49.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.002 0.43 . . . . 73.519999999999996 111.654 -174.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.755 HG12 ' HB3' ' A' ' 62' ' ' LEU . 2.4 p -124.41 114.76 42.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.717 -0.674 . . . . 75.409999999999997 109.953 171.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 m -95.65 131.22 42.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 74.430000000000007 110.505 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.23 -161.16 29.38 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.374 -0.69 . . . . 74.140000000000001 111.374 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -131.41 132.69 44.55 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.896 0.379 . . . . 73.310000000000002 110.458 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.1 mt -102.93 126.56 50.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.983 -0.553 . . . . 64.420000000000002 109.593 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 178' ' ' ALA . . . 68.97 -47.92 0.58 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.009 0.818 . . . . 70.239999999999995 111.778 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.11 -41.62 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.079 -0.581 . . . . 70.329999999999998 112.397 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.668 ' HB ' HG22 ' A' ' 177' ' ' ILE . 6.8 m -84.46 141.52 30.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.781 0.324 . . . . 65.040000000000006 110.965 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 3.7 p -70.22 143.3 52.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 74.109999999999999 111.353 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.662 HG11 HD11 ' A' ' 177' ' ' ILE . 20.5 m -143.67 158.14 16.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.081 0.467 . . . . 74.219999999999999 111.297 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.882 HG21 ' HB2' ' A' ' 4' ' ' PRO . 85.0 t -112.07 104.93 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.675 -0.693 . . . . 72.319999999999993 109.186 172.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.755 ' HB3' HG12 ' A' ' 51' ' ' VAL . 3.0 tm? -95.84 118.72 33.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.552 -0.536 . . . . 72.349999999999994 109.552 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -134.64 131.15 37.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.733 -0.667 . . . . 71.209999999999994 109.96 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -127.59 135.23 27.15 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.942 0.401 . . . . 72.129999999999995 110.882 -178.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 1.4 Cg_endo -83.8 164.45 13.86 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.104 2.536 . . . . 72.109999999999999 111.918 176.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 68.3 mtt180 -112.19 17.1 19.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.37 0.605 . . . . 73.420000000000002 109.82 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 52.9 m -112.03 164.2 13.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.477 -0.783 . . . . 65.010000000000005 110.146 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -66.18 167.95 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.282 -0.417 . . . . 74.049999999999997 110.998 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 19.3 ptp -55.23 -32.44 62.28 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.855 0.687 . . . . 74.340000000000003 112.855 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -72.1 -24.33 61.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.11 0.481 . . . . 75.519999999999996 110.585 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 12.5 mm-40 -102.91 -10.3 19.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.923 -0.581 . . . . 72.019999999999996 110.996 -175.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' HG22 ' A' ' 76' ' ' VAL . 19.5 m -61.56 -51.8 67.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 73.109999999999999 111.676 -173.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.841 ' HA3' ' HA ' ' A' ' 121' ' ' VAL . . . -62.03 -23.83 64.25 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.193 -0.527 . . . . 53.0 113.276 -174.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -61.97 -37.9 86.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.039 0.447 . . . . 74.530000000000001 110.974 -176.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.718 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 12.9 mm100 -92.19 -20.43 21.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.931 -0.577 . . . . 74.319999999999993 110.996 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 72' ' ' SER . 95.7 t -73.69 -36.27 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 75.310000000000002 111.015 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.683 ' HA2' ' HB3' ' A' ' 125' ' ' LEU . . . -52.12 -68.45 1.56 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.991 -0.549 . . . . 74.019999999999996 112.973 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -58.11 -28.85 85.21 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.629 2.22 . . . . 74.310000000000002 112.495 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.94 -48.78 77.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 73.519999999999996 110.24 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.55 90.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.004 -0.544 . . . . 64.040000000000006 111.491 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.66 -20.19 59.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.288 -0.415 . . . . 73.409999999999997 111.564 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.575 ' HD2' ' HE3' ' A' ' 45' ' ' LYS . 4.8 m-30 -74.21 -20.19 60.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.497 -0.32 . . . . 74.230000000000004 110.728 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.43 ' HH ' HG22 ' A' ' 50' ' ' VAL . 84.2 m-85 -106.99 -11.74 15.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.51 -0.314 . . . . 71.150000000000006 110.833 176.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.0 t 61.74 36.3 16.41 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.627 -0.715 . . . . 71.319999999999993 110.529 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.4 m -74.11 142.76 79.53 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 110.619 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.89 128.32 25.12 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.869 2.38 . . . . 74.099999999999994 112.079 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.55 -9.39 18.0 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.02 2.48 . . . . 72.030000000000001 112.633 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -83.68 -12.75 55.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.113 -0.494 . . . . 73.450000000000003 110.903 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -105.31 24.79 11.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 75.230000000000004 111.186 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.587 HG12 HD23 ' A' ' 6' ' ' LEU . 62.6 mt -89.07 109.84 20.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.412 . . . . 73.409999999999997 111.196 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 131' ' ' HIS . 32.6 m -113.42 141.7 28.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.468 -0.568 . . . . 73.439999999999998 109.468 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.01 130.16 51.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.318 0.58 . . . . 64.120000000000005 111.989 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.1 mm -85.28 118.0 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.55 -0.75 . . . . 74.329999999999998 109.291 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.466 ' CE1' HD21 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -137.61 170.26 16.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.411 0.624 . . . . 73.219999999999999 111.482 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -90.35 145.71 24.74 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.703 -1.135 . . . . 65.019999999999996 111.973 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.447 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 7.2 mm-40 -140.43 119.42 12.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.624 -0.716 . . . . 73.310000000000002 109.778 169.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 139' ' ' ARG . 1.7 pp -83.77 -0.15 49.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.523 -0.762 . . . . 73.510000000000005 112.529 -174.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.405 ' OD2' HG13 ' A' ' 99' ' ' ILE . 3.4 p-10 -77.29 -10.85 59.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 71.209999999999994 111.383 -174.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.405 HG13 ' OD2' ' A' ' 98' ' ' ASP . 61.3 mt -135.17 149.72 29.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.956 -0.757 . . . . 71.209999999999994 108.956 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.05 179.1 7.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.453 -0.573 . . . . 75.349999999999994 109.453 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -66.17 123.79 20.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.091 0.472 . . . . 73.150000000000006 110.382 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.18 -118.13 0.78 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.789 -0.925 . . . . 75.010000000000005 110.789 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HA ' HE22 ' A' ' 168' ' ' GLN . 7.8 ppt_? -83.4 132.99 34.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.265 0.533 . . . . 73.530000000000001 110.064 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.3 pt -97.69 166.16 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.995 -0.548 . . . . 63.509999999999998 110.703 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -126.6 127.85 45.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.235 0.54 . . . . 75.010000000000005 110.785 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.671 HD13 HG23 ' A' ' 188' ' ' VAL . 10.0 mp -104.71 111.88 24.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.979 -0.555 . . . . 72.299999999999997 110.947 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -143.58 135.77 26.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.581 -0.736 . . . . 75.040000000000006 109.201 176.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.5 pp -85.75 125.73 33.45 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 74.329999999999998 110.015 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.58 179.26 38.56 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.654 -0.703 . . . . 61.149999999999999 111.544 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.1 -156.95 6.8 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.011 -0.614 . . . . 74.549999999999997 112.594 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.604 ' HA3' HD12 ' A' ' 118' ' ' LEU . . . -78.8 130.98 10.34 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.021 -0.609 . . . . 75.230000000000004 112.141 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -105.91 -30.92 9.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.77 0.319 . . . . 74.209999999999994 110.467 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.79 -4.86 63.26 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.843 -0.694 . . . . 75.010000000000005 112.862 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.2 103.58 0.09 OUTLIER Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.019 -0.61 . . . . 61.210000000000001 112.525 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.64 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 32.0 m-70 -138.83 142.42 38.66 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.04 -0.356 . . . . 74.420000000000002 110.04 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -66.89 -44.84 79.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 72.530000000000001 111.243 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.34 11.91 3.69 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.056 -0.592 . . . . 74.510000000000005 113.664 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.64 ' HG ' ' HB2' ' A' ' 115' ' ' HIS . 95.9 mt -84.28 -51.35 7.07 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.606 -0.35 . . . . 75.310000000000002 110.599 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -79.02 -28.78 43.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.928 -0.578 . . . . 70.209999999999994 110.821 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.6 m -61.86 -32.72 73.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.081 0.467 . . . . 74.239999999999995 110.777 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.841 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 68.3 t -84.4 -47.26 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.445 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.451 ' HA ' ' CG2' ' A' ' 127' ' ' THR . . . -57.5 -55.79 30.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.759 -0.655 . . . . 73.340000000000003 112.45 -174.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.6 m -66.52 -21.64 66.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.024 0.379 . . . . 75.510000000000005 112.024 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.82 -52.09 64.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.803 0.297 . . . . 74.209999999999994 111.803 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.683 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 1.4 pt? -110.17 3.75 20.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.786 -0.366 . . . . 75.349999999999994 111.385 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.92 20.04 61.98 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.68 -0.772 . . . . 64.099999999999994 112.852 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.451 ' CG2' ' HA ' ' A' ' 122' ' ' ALA . 13.0 t -85.91 167.47 15.08 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.927 -0.397 . . . . 74.019999999999996 109.927 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.44 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 12.0 mptt -119.82 8.21 11.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.438 -0.346 . . . . 75.329999999999998 110.16 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 59.58 62.99 1.61 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.756 -0.656 . . . . 74.519999999999996 109.67 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -57.91 -70.58 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.282 -0.872 . . . . 74.319999999999993 111.718 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.775 ' HB3' HG13 ' A' ' 91' ' ' VAL . 34.8 t60 -99.55 86.71 3.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.115 0.483 . . . . 75.540000000000006 109.964 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -96.16 121.94 38.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.833 -0.621 . . . . 75.430000000000007 110.402 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -83.24 126.96 40.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.158 -0.682 . . . . 74.239999999999995 109.158 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -106.64 103.03 12.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.111 -0.495 . . . . 75.040000000000006 110.833 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 66.8 mt -96.53 128.06 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.879 -0.6 . . . . 64.420000000000002 109.857 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.95 115.3 7.11 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.818 -0.706 . . . . 74.200000000000003 111.81 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.569 ' HB ' ' HD2' ' A' ' 21' ' ' ARG . 35.0 m -100.88 -20.38 5.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.703 0.287 . . . . 74.439999999999998 111.061 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.31 151.4 1.73 Allowed Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.067 -0.515 . . . . 74.109999999999999 112.857 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.518 ' HG2' ' HB2' ' A' ' 97' ' ' LEU . 1.6 ppt_? -158.52 138.06 8.47 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.635 -0.332 . . . . 74.519999999999996 110.174 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 22.9 Cg_endo -93.54 134.14 0.97 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.218 2.612 . . . . 73.239999999999995 112.036 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.33 132.12 24.99 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.224 1.95 . . . . 73.140000000000001 111.718 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -159.04 179.17 34.86 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.562 -0.828 . . . . 74.109999999999999 111.858 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 143' ' ' ARG . 2.9 mpt_? -87.62 9.89 19.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.494 0.664 . . . . 75.120000000000005 110.106 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -124.73 131.59 53.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.873 -1.058 . . . . 74.329999999999998 108.431 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.9 149.95 62.61 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.944 0.402 . . . . 74.519999999999996 110.82 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.667 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 41.4 Cg_endo -66.92 4.6 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.345 2.697 . . . . 64.030000000000001 114.093 -172.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.549 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . -61.24 -39.22 89.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 73.430000000000007 110.636 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.72 -36.17 62.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.166 0.508 . . . . 72.239999999999995 110.543 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.667 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 95.8 m-85 -71.29 -24.61 62.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 74.310000000000002 111.513 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 22' ' ' HIS . 9.0 p -85.31 -15.21 10.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.887 0.375 . . . . 73.329999999999998 110.872 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.626 ' O ' HG21 ' A' ' 20' ' ' THR . 87.4 mt -84.01 -37.83 21.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.415 -0.357 . . . . 71.209999999999994 111.766 -177.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -162.96 101.28 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.401 0.619 . . . . 74.150000000000006 111.482 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -160.06 115.21 2.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.714 -0.675 . . . . 75.340000000000003 110.196 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -134.19 145.04 48.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.727 -0.669 . . . . 74.329999999999998 109.612 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.499 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 0.2 OUTLIER -137.68 -160.01 1.01 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.226 -0.287 . . . . 74.530000000000001 110.226 -175.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.465 ' H ' HG22 ' A' ' 155' ' ' THR . . . -82.45 -29.0 30.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.835 0.35 . . . . 64.049999999999997 111.31 176.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.15 -60.54 2.19 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.095 0.776 . . . . 65.319999999999993 113.095 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -34.7 69.1 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.966 0.358 . . . . 70.099999999999994 111.966 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 155' ' ' THR . 7.2 mmp_? -60.79 -31.31 70.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.906 0.384 . . . . 75.329999999999998 110.678 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.38 -28.03 65.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 64.340000000000003 111.391 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -87.87 -19.05 27.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.011 -0.54 . . . . 74.299999999999997 111.102 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.634 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 88.7 t -50.63 -55.37 27.08 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 112.821 0.675 . . . . 74.530000000000001 112.821 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.634 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 77.5 Cg_exo -51.48 -33.8 48.87 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.364 2.043 . . . . 72.540000000000006 112.992 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.0 m -80.21 -46.7 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.458 . . . . 75.230000000000004 110.787 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.452 ' HA ' ' HB3' ' A' ' 168' ' ' GLN . 1.6 mp -59.51 -34.57 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 74.120000000000005 111.906 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 162' ' ' VAL . 85.6 t -55.37 -46.54 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.902 0.382 . . . . 64.019999999999996 111.152 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -79.11 -37.56 38.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 110.221 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.533 HE22 ' HA ' ' A' ' 103' ' ' ARG . 47.3 tt0 -61.3 -46.86 88.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.478 -0.783 . . . . 74.540000000000006 111.462 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.47 90.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 73.530000000000001 110.623 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.45 90.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.6 . . . . 73.049999999999997 110.729 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.52 -36.08 79.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.229 0.538 . . . . 75.010000000000005 110.605 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 176' ' ' LEU . . . -68.21 -47.74 67.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.717 -0.674 . . . . 75.319999999999993 111.026 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 21.5 p -66.77 -42.69 85.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.577 -0.283 . . . . 74.219999999999999 111.407 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -57.1 -56.42 21.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 74.519999999999996 111.202 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.35 -29.16 67.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.596 -0.274 . . . . 74.340000000000003 111.428 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -60.48 -46.63 89.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.305 0.574 . . . . 74.430000000000007 109.576 178.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.668 HG22 ' HB ' ' A' ' 58' ' ' THR . 62.9 mt -80.09 -30.34 12.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.356 -0.838 . . . . 74.040000000000006 110.809 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.402 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . . . -71.66 -47.39 54.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 70.109999999999999 111.838 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.15 -75.14 0.6 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.3 -0.409 . . . . 64.019999999999996 110.638 -174.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.58 -172.78 38.63 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.42 -0.895 . . . . 64.349999999999994 112.385 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 181' ' ' LEU . 1.1 pt? -94.31 -26.25 16.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.606 0.241 . . . . 75.120000000000005 111.184 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.487 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 39.8 mt-10 -66.91 -47.29 54.0 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 111.981 0.363 . . . . 74.140000000000001 111.981 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 32.9 Cg_endo -65.94 -29.51 49.35 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.373 1.382 . . . . 72.219999999999999 111.877 174.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.66 -48.93 62.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.862 -0.608 . . . . 61.119999999999997 111.304 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.56 ' HA ' HG22 ' A' ' 188' ' ' VAL . 8.2 pt20 -60.99 -33.08 72.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.831 0.348 . . . . 75.239999999999995 111.062 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -69.97 -26.17 63.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.933 0.397 . . . . 73.420000000000002 110.628 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 31.4 m -86.28 -41.82 14.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.094 -0.503 . . . . 75.299999999999997 111.203 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.671 HG23 HD13 ' A' ' 106' ' ' LEU . 33.2 m -71.0 -20.24 21.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.871 0.367 . . . . 65.439999999999998 111.47 -178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -97.23 16.03 21.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.453 0.644 . . . . 72.430000000000007 109.79 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -105.59 17.03 24.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.909 -0.587 . . . . 72.129999999999995 110.286 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 87.3 m95 . . . . . 0 C--O 1.247 0.948 0 CA-C-N 115.681 -0.69 . . . . 73.5 109.962 179.719 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.412 0.149 . . . . 73.219999999999999 110.68 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 59' ' ' SER . 21.5 Cg_exo -64.69 108.82 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.901 2.401 . . . . 72.219999999999999 112.862 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.656 HD13 HG21 ' A' ' 177' ' ' ILE . 87.8 mt -95.24 156.64 16.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.92 -0.582 . . . . 72.420000000000002 109.652 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.584 HD21 HD13 ' A' ' 90' ' ' ILE . 34.1 tp -108.25 120.75 43.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.941 0.4 . . . . 74.140000000000001 110.75 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 t -118.53 116.97 53.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.862 -0.608 . . . . 73.140000000000001 109.883 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.709 ' HB ' HG21 ' A' ' 92' ' ' VAL . 35.3 t -114.81 143.7 23.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.474 -0.33 . . . . 75.450000000000003 110.473 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.58 157.11 20.25 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.824 -0.703 . . . . 72.420000000000002 111.553 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.466 ' H ' ' HA3' ' A' ' 25' ' ' GLY . 61.9 mt -66.43 115.78 6.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 73.409999999999997 109.688 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -83.96 -179.07 51.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.029 -0.605 . . . . 71.129999999999995 113.565 -171.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -94.16 124.16 56.79 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.963 0.411 . . . . 74.25 110.456 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.487 ' HG3' ' CE2' ' A' ' 68' ' ' TYR . 74.2 Cg_endo -88.54 -6.28 6.05 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.759 2.306 . . . . 75.120000000000005 113.469 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.5 171.21 28.39 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.722 -0.751 . . . . 75.439999999999998 112.131 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.4 -52.18 3.51 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.167 2.578 . . . . 74.230000000000004 113.034 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.7 m -61.31 -34.84 75.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 72.209999999999994 111.561 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.533 ' HE1' ' HB3' ' A' ' 151' ' ' LEU . 98.1 m-85 -89.22 -9.39 50.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.316 -0.402 . . . . 74.310000000000002 111.634 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.98 -6.87 45.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.342 . . . . 70.409999999999997 110.954 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.5 11.42 36.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 74.299999999999997 111.101 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -101.88 147.66 26.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.72 -0.845 . . . . 70.109999999999999 108.72 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -0.44 37.71 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.502 -0.479 . . . . 75.120000000000005 111.449 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -76.91 -6.33 52.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.101 0.477 . . . . 61.229999999999997 111.021 -174.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -118.45 34.38 5.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.375 0.607 . . . . 75.219999999999999 110.005 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pp -63.81 -12.67 37.79 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.6 -0.727 . . . . 64.510000000000005 111.451 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.466 ' HA3' ' H ' ' A' ' 10' ' ' LEU . . . -61.09 -47.23 92.22 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.124 -0.79 . . . . 72.129999999999995 111.124 175.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.624 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 83.4 t80 -65.26 -39.65 92.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.825 -0.435 . . . . 75.219999999999999 109.825 175.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 65.2 mtt -59.87 -56.8 17.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.672 -0.694 . . . . 73.209999999999994 110.96 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.435 ' HA ' HG21 ' A' ' 31' ' ' VAL . 94.7 t -59.03 -44.0 90.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.474 -0.33 . . . . 75.540000000000006 110.946 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.657 ' HB1' HD23 ' A' ' 62' ' ' LEU . . . -58.91 -45.24 90.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.948 0.404 . . . . 72.239999999999995 111.023 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.22 -44.6 68.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 72.5 111.559 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 32.8 m -69.17 -31.73 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.956 -0.298 . . . . 72.129999999999995 111.581 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 60.1 mt -71.8 -58.73 3.22 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.939 -0.304 . . . . 72.129999999999995 110.609 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 38' ' ' SER . . . -59.49 -46.72 88.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 52.340000000000003 110.728 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.14 -20.76 69.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.081 -0.58 . . . . 73.140000000000001 113.179 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 40.1 ttp180 -84.44 -33.4 23.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.068 0.434 . . . . 73.430000000000007 110.645 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.51 -36.09 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.191 0.52 . . . . 71.150000000000006 110.04 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.47 68.75 0.29 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.629 -0.989 . . . . 71.150000000000006 110.629 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 57.8 m -152.46 119.91 5.99 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.502 -0.349 . . . . 63.310000000000002 110.793 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.82 127.95 16.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.52 -0.309 . . . . 61.229999999999997 110.404 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.613 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 14.3 m-85 -141.63 172.85 12.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 73.239999999999995 110.123 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -142.84 176.31 9.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 75.439999999999998 111.123 -171.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.8 t -48.06 130.94 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.795 0.665 . . . . 75.239999999999995 112.795 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.506 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 72.1 t60 -109.28 115.46 30.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.49 -0.777 . . . . 72.319999999999993 109.658 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 2.5 tmtp? -68.89 99.92 1.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.944 0.35 . . . . 74.120000000000005 111.944 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 80.2 tttt 160.2 -51.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.1 -1.444 . . . . 73.439999999999998 107.1 173.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 p -102.91 28.6 6.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.218 -1.81 . . . . 65.510000000000005 108.076 173.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 43' ' ' HIS . . . -48.85 44.08 0.01 OUTLIER Glycine 0 N--CA 1.474 1.18 0 N-CA-C 119.81 2.684 . . . . 60.32 119.81 -150.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.47 179.76 4.9 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.333 -1.358 . . . . 73.209999999999994 107.333 159.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.865 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 32.3 mt-10 -80.34 118.0 21.59 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 119.998 -0.681 . . . . 73.239999999999995 109.565 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.741 HG23 ' HH ' ' A' ' 83' ' ' TYR . 30.5 m -121.11 137.73 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.978 0.418 . . . . 73.129999999999995 110.768 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.832 HG13 ' HB3' ' A' ' 62' ' ' LEU . 1.6 p -124.35 110.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.253 0.549 . . . . 75.439999999999998 110.265 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.7 p -92.52 107.93 19.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.733 -0.667 . . . . 73.239999999999995 110.202 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.02 165.01 28.57 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.35 -0.7 . . . . 52.240000000000002 111.35 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 15.5 ptt-85 -104.91 103.85 13.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.537 0.684 . . . . 74.120000000000005 110.611 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.43 135.57 38.12 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.676 -0.861 . . . . 74.129999999999995 108.676 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 62.53 10.74 4.24 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.463 0.477 . . . . 70.209999999999994 111.149 -174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.56 -22.91 34.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.989 -0.624 . . . . 73.439999999999998 112.623 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 m -89.59 122.52 32.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 64.099999999999994 110.845 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.598 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 19.3 m -68.49 116.47 9.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.441 -0.345 . . . . 74.0 110.414 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.401 HG12 HG22 ' A' ' 177' ' ' ILE . 31.0 m -127.68 164.05 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.957 0.408 . . . . 72.430000000000007 110.689 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.01 111.05 34.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.93 -0.577 . . . . 60.329999999999998 109.808 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.832 ' HB3' HG13 ' A' ' 51' ' ' VAL . 64.4 tp -96.82 129.83 44.19 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.534 -0.543 . . . . 74.129999999999995 109.534 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.91 129.27 55.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.217 0.532 . . . . 71.299999999999997 112.049 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.865 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 45.3 mtpt -110.92 92.05 14.05 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.2 -0.909 . . . . 73.219999999999999 109.691 175.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.547 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.7 Cg_endo -83.54 173.03 9.86 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.992 2.461 . . . . 74.5 112.143 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -110.82 12.98 22.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.428 0.633 . . . . 73.430000000000007 109.48 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 60.0 m -130.08 175.15 9.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.558 -0.746 . . . . 75.420000000000002 110.633 -175.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.487 ' CE2' ' HG3' ' A' ' 13' ' ' PRO . 45.9 m-85 -100.25 -169.82 1.78 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.109 -0.496 . . . . 72.200000000000003 110.96 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.574 ' HA ' ' HB2' ' A' ' 72' ' ' SER . 24.9 ptt? -66.8 -20.16 65.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.876 -0.602 . . . . 71.510000000000005 111.537 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -71.87 -25.22 61.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.211 0.529 . . . . 74.129999999999995 109.897 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 18.0 mp0 -105.89 2.42 27.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.717 -0.674 . . . . 75.310000000000002 110.525 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.574 ' HB2' ' HA ' ' A' ' 69' ' ' MET . 27.0 t -60.24 -38.57 83.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.438 -0.346 . . . . 73.019999999999996 110.681 -175.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.82 -20.34 64.14 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.005 -0.617 . . . . 72.239999999999995 112.393 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -85.05 -31.4 23.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.863 0.363 . . . . 72.430000000000007 110.609 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -89.6 -40.65 12.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 71.310000000000002 111.42 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.97 -32.33 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.33 -0.395 . . . . 61.509999999999998 111.102 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.8 -67.83 1.75 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.908 -0.587 . . . . 61.32 113.261 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.07 -39.26 32.55 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.531 2.154 . . . . 72.319999999999993 112.409 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.9 tp -55.32 -58.47 7.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 74.129999999999995 111.731 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.48 68.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.957 0.408 . . . . 75.239999999999995 111.153 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -73.04 -32.7 65.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.817 -0.629 . . . . 74.409999999999997 111.638 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -81.96 -41.78 20.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.873 0.323 . . . . 64.319999999999993 111.873 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.741 ' HH ' HG23 ' A' ' 50' ' ' VAL . 69.0 m-85 -85.45 -17.13 37.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.13 0.418 . . . . 72.540000000000006 112.13 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 t 62.72 71.8 0.51 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.237 0.541 . . . . 74.340000000000003 110.863 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.551 HG21 ' HB2' ' A' ' 6' ' ' LEU . 28.0 m -118.17 158.24 46.86 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.798 -0.637 . . . . 72.030000000000001 109.821 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 35.6 Cg_exo -61.11 111.52 1.11 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.515 2.143 . . . . 71.140000000000001 112.001 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.38 -6.77 19.38 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.707 2.272 . . . . 75.349999999999994 112.267 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -98.27 -12.43 21.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.993 -0.549 . . . . 74.109999999999999 110.457 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 86' ' ' PRO . 79.0 mm-40 -114.49 20.14 15.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 74.239999999999995 110.8 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.586 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 5.8 tt -83.31 134.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.185 -0.461 . . . . 74.129999999999995 110.224 177.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.525 ' HA ' ' CB ' ' A' ' 131' ' ' HIS . 21.6 m -120.9 141.35 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.835 0.35 . . . . 71.299999999999997 110.68 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.709 HG21 ' HB ' ' A' ' 8' ' ' VAL . 45.9 t -132.78 127.34 55.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.316 -0.402 . . . . 73.299999999999997 110.465 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 mm -75.15 139.23 19.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.887 -0.597 . . . . 75.310000000000002 110.708 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -142.45 152.89 43.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.506 -0.316 . . . . 75.430000000000007 110.521 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.97 135.55 42.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.479 -0.934 . . . . 72.519999999999996 108.479 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 99' ' ' ILE . 10.1 tp10 -104.37 127.68 52.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.377 0.608 . . . . 71.129999999999995 111.001 -174.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.536 HD23 ' HG3' ' A' ' 146' ' ' PRO . 3.2 pp -84.26 -13.83 51.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.05 -0.977 . . . . 75.109999999999999 110.775 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.94 -47.67 20.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 70.319999999999993 111.157 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.472 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 56.7 mt -89.74 142.13 13.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.089 -0.505 . . . . 71.549999999999997 110.789 -176.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.89 166.46 18.9 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.509 . . . . 72.530000000000001 110.607 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.638 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 15.4 p90 -64.45 128.72 36.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.247 0.546 . . . . 75.299999999999997 112.164 -174.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.62 -22.94 3.84 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.726 -0.75 . . . . 74.310000000000002 112.958 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.489 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 17.0 mmt180 -132.35 128.34 37.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.265 0.555 . . . . 75.209999999999994 112.451 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.524 HG23 HG22 ' A' ' 135' ' ' ILE . 47.3 pt -107.79 146.77 13.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.334 -0.848 . . . . 73.530000000000001 109.414 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -157.73 125.2 5.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.908 0.385 . . . . 74.540000000000006 110.46 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.75 ' H ' HD21 ' A' ' 106' ' ' LEU . 1.9 pt? -97.91 144.62 27.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.442 -0.344 . . . . 74.439999999999998 110.092 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 104.44 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.179 -0.674 . . . . 72.329999999999998 109.179 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.754 ' H ' HD22 ' A' ' 108' ' ' LEU . 1.6 pt? -93.37 97.47 10.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.396 0.617 . . . . 71.439999999999998 110.758 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.94 -155.21 26.33 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.271 -0.732 . . . . 64.409999999999997 111.271 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.38 123.91 7.95 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.012 -0.613 . . . . 72.319999999999993 112.378 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.31 -176.61 44.64 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.55 -0.62 . . . . 52.439999999999998 111.55 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.61 ' HG2' ' H ' ' A' ' 113' ' ' GLY . 16.7 tt0 -142.76 -152.41 0.41 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.878 -0.415 . . . . 74.310000000000002 109.878 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.61 ' H ' ' HG2' ' A' ' 112' ' ' GLU . . . 139.75 -74.18 0.38 Allowed Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.299 -0.72 . . . . 74.129999999999995 111.299 -175.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.56 ' HA3' ' HE3' ' A' ' 69' ' ' MET . . . -78.08 -6.57 87.54 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.971 -0.633 . . . . 65.400000000000006 111.829 174.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.8 t60 62.74 -87.3 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.774 0.829 . . . . 73.230000000000004 112.595 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -67.08 -46.55 73.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.792 0.329 . . . . 74.409999999999997 111.481 -168.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -60.99 -29.19 70.19 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 120.835 -0.698 . . . . 74.230000000000004 112.464 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.461 ' HB3' HH21 ' A' ' 132' ' ' ARG . 89.6 mt -82.88 -23.77 33.49 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.815 -0.227 . . . . 73.140000000000001 111.099 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -79.11 -39.7 32.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.235 -0.439 . . . . 74.200000000000003 110.634 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.5 t -61.59 -54.31 44.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.802 -0.635 . . . . 61.229999999999997 110.795 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 117' ' ' GLY . 48.4 t -59.5 -41.69 85.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.433 -0.349 . . . . 73.349999999999994 111.101 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.46 -52.09 67.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 75.239999999999995 111.209 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.8 m -71.46 -34.02 69.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.853 -0.612 . . . . 71.030000000000001 111.553 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.08 -36.84 78.04 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.833 0.349 . . . . 74.030000000000001 111.286 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.7 mt -87.31 -31.27 20.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.47 -0.332 . . . . 75.310000000000002 111.138 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.64 40.33 5.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.517 -0.849 . . . . 71.340000000000003 111.951 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.7 t -148.06 176.61 10.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.948 -0.39 . . . . 74.439999999999998 109.948 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -77.62 -5.87 51.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.72 0.295 . . . . 74.340000000000003 110.462 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.7 t30 72.01 81.31 0.15 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.327 -0.851 . . . . 73.430000000000007 111.896 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -71.2 -148.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.798 -0.637 . . . . 75.340000000000003 110.118 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.586 ' HB3' ' O ' ' A' ' 90' ' ' ILE . 32.1 p80 45.13 40.02 4.46 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.86 0.689 . . . . 74.129999999999995 112.86 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.461 HH21 ' HB3' ' A' ' 118' ' ' LEU . 50.3 mtt85 -91.65 107.97 19.58 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.433 -0.58 . . . . 71.25 109.433 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.04 109.43 28.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.628 -0.714 . . . . 71.439999999999998 109.88 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.407 ' HG2' ' OE1' ' A' ' 96' ' ' GLU . 95.4 mtt180 -88.71 100.75 13.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.019 -0.537 . . . . 74.409999999999997 110.889 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.524 HG22 HG23 ' A' ' 104' ' ' ILE . 55.7 mt -93.74 108.64 20.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.035 -0.529 . . . . 74.530000000000001 110.046 175.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -73.33 98.0 0.89 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.032 -0.604 . . . . 65.239999999999995 112.322 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.516 HG13 HG23 ' A' ' 135' ' ' ILE . 3.5 m -110.95 0.97 9.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.702 0.287 . . . . 75.409999999999997 111.484 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 131.88 140.1 4.47 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.264 -0.969 . . . . 54.210000000000001 112.843 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.452 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 7.8 ptp85 -99.46 139.49 20.94 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.656 0.265 . . . . 74.430000000000007 110.506 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 3.0 Cg_exo -75.29 141.36 25.74 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.803 2.336 . . . . 64.409999999999997 111.88 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.38 149.1 88.52 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.575 2.183 . . . . 74.109999999999999 111.58 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.19 44.42 2.15 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.323 -0.465 . . . . 72.209999999999994 113.626 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -82.27 -67.73 0.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.673 -1.232 . . . . 73.230000000000004 107.673 175.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.481 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 22.5 mmtm -131.36 147.97 52.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.621 -1.172 . . . . 73.239999999999995 108.289 166.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.582 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 1.7 p-10 -58.91 157.45 20.35 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 123.335 0.397 . . . . 73.120000000000005 110.699 -175.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.582 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 4.8 Cg_endo -46.1 -28.76 5.66 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 124.192 3.261 . . . . 74.140000000000001 114.149 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.69 -32.11 28.63 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.186 0.439 . . . . 71.530000000000001 112.186 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.57 -57.97 2.75 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.355 0.502 . . . . 65.239999999999995 112.355 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 144' ' ' LYS . 67.6 m-85 -84.03 -19.99 33.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.654 0.983 . . . . 75.310000000000002 113.654 -168.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.0 p -71.63 -5.97 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.169 0.433 . . . . 73.319999999999993 112.169 -171.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.533 ' HB3' ' HE1' ' A' ' 17' ' ' TYR . 87.9 mt -91.12 -1.91 57.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 71.230000000000004 111.424 -176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -138.91 103.06 4.7 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.752 -0.833 . . . . 74.310000000000002 108.752 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -129.34 119.33 23.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.613 -0.722 . . . . 64.219999999999999 112.024 -164.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -169.1 103.08 0.37 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.642 0.734 . . . . 64.230000000000004 110.12 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.532 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 3.1 m -134.99 131.77 37.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.515 . . . . 73.349999999999994 109.928 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.87 -38.02 86.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.758 0.313 . . . . 72.239999999999995 111.085 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.2 92.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.764 -0.653 . . . . 71.409999999999997 112.31 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.532 ' HG2' ' HB ' ' A' ' 155' ' ' THR . 15.2 pt-20 -82.21 -32.85 29.62 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.968 -0.293 . . . . 75.519999999999996 111.155 -175.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.606 ' HA ' HG23 ' A' ' 162' ' ' VAL . 49.5 mtm180 -71.6 -20.09 62.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.754 0.312 . . . . 74.310000000000002 110.694 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.86 -38.71 76.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.933 -0.576 . . . . 63.240000000000002 112.041 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -103.02 7.58 39.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.197 0.443 . . . . 72.519999999999996 112.197 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.606 HG23 ' HA ' ' A' ' 159' ' ' ARG . 77.3 t -58.19 -51.64 80.35 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 121.058 -0.257 . . . . 74.519999999999996 111.34 177.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 12.5 Cg_endo -56.71 -27.61 71.69 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.326 2.018 . . . . 62.32 112.354 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' A' ' 168' ' ' GLN . 9.4 m -68.32 -55.47 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.36 -0.382 . . . . 64.340000000000003 110.121 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.443 HG13 HG22 ' A' ' 104' ' ' ILE . 1.7 mp -56.06 -43.17 74.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.524 -0.762 . . . . 75.310000000000002 111.503 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 162' ' ' VAL . 92.4 t -58.04 -49.94 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.618 0.247 . . . . 75.400000000000006 111.369 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.69 -33.15 70.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.563 -0.289 . . . . 73.530000000000001 111.318 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 164' ' ' THR . 98.7 mt-30 -62.52 -48.13 80.87 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.099 0.476 . . . . 64.439999999999998 109.89 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.14 -41.13 97.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.656 -0.702 . . . . 74.209999999999994 111.194 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.09 87.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.401 -0.363 . . . . 74.340000000000003 111.102 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.09 -36.52 83.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 73.230000000000004 110.784 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.29 -45.93 44.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 72.109999999999999 111.335 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.831 ' HA ' HD13 ' A' ' 176' ' ' LEU . 80.1 m -58.3 -40.57 82.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.228 -0.442 . . . . 74.120000000000005 111.541 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -53.71 -45.31 70.37 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.263 -0.426 . . . . 61.0 111.249 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 183' ' ' PRO . 30.7 tp -81.88 -28.33 33.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.059 -0.257 . . . . 74.230000000000004 111.534 -174.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.831 HD13 ' HA ' ' A' ' 173' ' ' THR . 74.0 mt -52.2 -55.95 17.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.26 0.552 . . . . 74.349999999999994 110.665 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.656 HG21 HD13 ' A' ' 5' ' ' LEU . 6.9 pt -80.97 -23.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.376 -0.829 . . . . 73.439999999999998 111.78 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.77 -45.69 81.56 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 111.748 0.277 . . . . 62.119999999999997 111.748 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -136.65 -61.63 0.67 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.83 0.348 . . . . 73.420000000000002 111.277 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -168.59 170.31 42.17 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.541 -0.838 . . . . 74.209999999999994 112.307 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.716 ' HA ' HD21 ' A' ' 176' ' ' LEU . 3.3 pp -82.71 -31.54 28.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.225 0.454 . . . . 73.430000000000007 112.225 -175.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 14.6 mm-40 -60.66 -54.26 56.43 Favored Pre-proline 0 N--CA 1.468 0.439 0 N-CA-C 112.559 0.577 . . . . 74.120000000000005 112.559 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.428 ' HB2' HD22 ' A' ' 175' ' ' LEU . 19.6 Cg_endo -60.75 -31.19 91.61 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.426 1.417 . . . . 75.040000000000006 111.856 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 188' ' ' VAL . . . -72.15 -45.77 59.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.539 . . . . 72.109999999999999 111.266 -178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 182' ' ' GLU . 1.2 pp0? -67.77 -20.92 65.27 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.145 0.498 . . . . 63.340000000000003 110.542 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.609 ' HA ' ' CE1' ' A' ' 189' ' ' HIS . 0.9 OUTLIER -67.48 -46.94 71.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 71.420000000000002 109.873 171.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 56.2 m -62.35 -33.52 74.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 64.239999999999995 111.143 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 184' ' ' ALA . 94.6 t -54.45 -38.47 41.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 75.349999999999994 111.426 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.609 ' CE1' ' HA ' ' A' ' 186' ' ' ASN . 10.2 p-80 -100.22 9.04 43.35 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.554 -0.459 . . . . 74.540000000000006 110.947 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.51 -34.17 18.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.302 -0.408 . . . . 64.019999999999996 109.946 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 38.7 m95 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.554 -0.748 . . . . 72.540000000000006 110.309 174.923 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.065 -0.346 . . . . 71.230000000000004 110.065 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.28 77.23 0.33 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.663 -0.698 . . . . 55.149999999999999 111.907 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.7 pm0 -91.72 140.91 25.19 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.002 -0.544 . . . . 72.049999999999997 109.961 173.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 15.7 Cg_exo -68.39 111.01 2.4 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.816 2.344 . . . . 74.099999999999994 112.246 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.21 153.0 42.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 75.129999999999995 110.175 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.29 115.37 27.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.049 0.452 . . . . 64.200000000000003 110.881 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.442 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 50.3 t -105.53 116.44 49.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.258 -0.645 . . . . 63.350000000000001 109.258 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.811 ' HB ' HG23 ' A' ' 92' ' ' VAL . 45.8 t -102.19 122.5 54.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.877 0.37 . . . . 72.329999999999998 110.81 -176.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.595 ' O ' ' HD2' ' A' ' 65' ' ' PRO . . . -103.63 122.1 7.31 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.537 -0.839 . . . . 75.519999999999996 111.698 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.18 116.69 19.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.948 0.404 . . . . 65.420000000000002 110.44 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.434 ' C ' HD21 ' A' ' 12' ' ' ASN . . . -129.94 145.67 16.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.168 -0.773 . . . . 72.540000000000006 111.168 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.434 HD21 ' C ' ' A' ' 11' ' ' GLY . 1.2 m120 -124.58 73.75 61.93 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.915 0.357 . . . . 73.430000000000007 110.914 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.76 109.45 1.07 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.601 2.201 . . . . 74.200000000000003 112.471 176.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 17' ' ' TYR . . . -146.9 172.28 27.42 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.399 -0.68 . . . . 64.409999999999997 111.399 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.48 -53.25 7.33 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.257 2.638 . . . . 73.329999999999998 112.304 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 m -112.03 -10.41 13.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.601 0.715 . . . . 71.209999999999994 109.67 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.719 ' HE1' ' HB3' ' A' ' 151' ' ' LEU . 93.0 m-85 -81.37 -17.12 50.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.389 -0.823 . . . . 73.540000000000006 111.458 -174.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.624 ' HA ' HD22 ' A' ' 23' ' ' ASN . . . -79.54 1.38 26.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.042 0.449 . . . . 70.400000000000006 110.711 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.58 18.23 13.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.663 -0.699 . . . . 74.439999999999998 109.955 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -103.44 -169.85 1.7 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.277 0.561 . . . . 75.430000000000007 111.137 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -86.81 -0.23 56.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.743 -0.662 . . . . 72.219999999999999 110.208 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 2.8 m170 -89.6 11.37 19.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 111.928 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.624 HD22 ' HA ' ' A' ' 18' ' ' ALA . 13.5 m120 -109.87 20.1 18.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.806 -0.179 . . . . 55.450000000000003 111.124 -175.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.545 ' H ' HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -50.0 -48.91 52.24 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.487 0.492 . . . . 74.430000000000007 111.933 -173.501 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.05 -58.74 8.28 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.665 -0.698 . . . . 75.430000000000007 114.39 -171.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 23' ' ' ASN . 49.2 p90 -86.23 -22.6 26.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.336 0.568 . . . . 72.010000000000005 111.863 -174.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 23.1 mmt -71.25 -42.18 69.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.8 0.333 . . . . 75.230000000000004 111.121 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.3 t -80.04 -41.52 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.733 0.301 . . . . 72.230000000000004 111.026 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.58 -28.02 69.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.378 -0.374 . . . . 74.310000000000002 111.521 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 17.0 t70 -56.52 -50.17 72.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 64.239999999999995 111.312 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 m -75.97 -33.18 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.333 0.494 . . . . 75.230000000000004 112.333 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.479 HD13 ' N ' ' A' ' 33' ' ' ALA . 4.4 pp -78.67 -35.9 44.53 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.512 -0.475 . . . . 75.420000000000002 111.095 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.479 ' N ' HD13 ' A' ' 32' ' ' LEU . . . -71.3 -36.68 71.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 64.200000000000003 110.247 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.52 -30.43 74.47 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.847 -0.692 . . . . 73.319999999999993 112.845 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -83.96 -37.38 22.34 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.422 0.527 . . . . 74.409999999999997 112.422 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.2 tp -72.7 -15.22 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.256 0.55 . . . . 74.25 110.581 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.51 59.98 0.96 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.661 -0.975 . . . . 61.130000000000003 110.661 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.9 m -142.55 128.81 19.89 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.118 0.485 . . . . 71.340000000000003 111.349 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.14 150.72 26.85 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.808 -0.633 . . . . 63.299999999999997 109.971 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 30' ' ' ASP . 89.1 m-85 -89.44 139.56 30.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.703 0.287 . . . . 74.530000000000001 110.613 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 41' ' ' LYS . 11.6 mptt -110.57 135.82 50.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.274 -0.421 . . . . 73.510000000000005 110.004 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 56.2 t -100.19 106.39 19.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.923 -0.58 . . . . 73.420000000000002 110.407 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -116.95 77.1 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.26 -0.644 . . . . 75.200000000000003 109.26 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 96.6 mttt -55.56 105.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.334 -0.848 . . . . 74.430000000000007 112.638 -171.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 32.1 ttmt 168.29 -88.99 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 124.471 1.107 . . . . 74.319999999999993 108.694 174.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 45' ' ' LYS . 13.8 m -106.05 -14.98 15.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.409 0.623 . . . . 72.439999999999998 109.985 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.85 43.01 1.6 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.29 -0.868 . . . . 52.32 112.193 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 42' ' ' VAL . . . -51.45 -45.44 62.7 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.708 0.262 . . . . 71.439999999999998 111.708 -171.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.664 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 40.2 mt-10 -130.09 116.44 18.52 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.755 -0.461 . . . . 74.239999999999995 109.755 171.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.55 135.64 46.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.084 0.468 . . . . 73.040000000000006 111.154 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.453 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 8.3 p -128.59 133.39 66.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.959 -0.564 . . . . 74.400000000000006 110.334 172.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.584 HG21 HG23 ' A' ' 61' ' ' VAL . 68.4 p -105.0 107.57 18.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.036 0.446 . . . . 74.209999999999994 110.361 174.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -128.11 158.48 21.53 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.074 -0.81 . . . . 31.219999999999999 111.074 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.1 ptt180 -120.66 104.98 10.35 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.42 0.628 . . . . 73.450000000000003 111.614 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.813 HD11 ' HA ' ' A' ' 174' ' ' GLU . 1.6 pp -104.22 146.72 28.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.524 -0.762 . . . . 72.319999999999993 109.241 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 71.05 -32.44 0.25 Allowed 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.608 0.567 . . . . 70.400000000000006 111.991 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 154.5 -40.89 0.63 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.166 -0.54 . . . . 62.350000000000001 112.191 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.7 m -89.4 137.17 32.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.831 0.348 . . . . 73.319999999999993 111.098 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 23.0 t -81.79 129.83 34.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.347 -0.388 . . . . 54.530000000000001 110.23 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.15 163.88 18.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.226 -0.443 . . . . 74.409999999999997 110.375 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.584 HG23 HG21 ' A' ' 52' ' ' THR . 57.9 t -107.54 112.4 39.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.367 -0.379 . . . . 73.409999999999997 110.296 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.453 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . 5.6 mp -95.36 111.95 23.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.645 -0.502 . . . . 72.030000000000001 109.645 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.7 135.67 50.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.945 -0.57 . . . . 51.5 110.609 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.664 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -123.71 117.37 27.54 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.047 -0.524 . . . . 74.040000000000006 110.073 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HD2' ' O ' ' A' ' 9' ' ' GLY . 29.0 Cg_endo -65.8 122.77 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.922 1.748 . . . . 73.310000000000002 110.795 171.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -95.67 9.2 41.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.029 0.919 . . . . 75.420000000000002 108.528 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.45 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . 43.2 m -100.84 179.82 4.28 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.093 -1.412 . . . . 73.530000000000001 109.006 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -74.13 162.02 29.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.441 -0.345 . . . . 75.430000000000007 110.47 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.438 ' HG3' ' OD1' ' A' ' 116' ' ' ASN . 26.8 ptt? -59.57 -24.8 64.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.357 -0.383 . . . . 74.420000000000002 111.298 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.53 -35.15 73.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.225 0.536 . . . . 72.040000000000006 110.56 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.45 ' OE1' ' HB3' ' A' ' 67' ' ' CYS . 29.2 mt-10 -98.07 -2.46 40.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.615 -0.72 . . . . 72.140000000000001 111.189 -173.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.7 t -60.12 -43.08 95.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.435 -0.348 . . . . 70.549999999999997 111.496 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.401 ' HA2' HG21 ' A' ' 121' ' ' VAL . . . -63.02 -20.69 62.81 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.947 -0.644 . . . . 74.519999999999996 112.846 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.495 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 3.1 mpt_? -86.29 -12.22 50.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.795 0.331 . . . . 74.310000000000002 110.837 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.787 HE21 ' HA ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -86.69 -47.32 9.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.245 -0.434 . . . . 71.310000000000002 110.936 -178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.69 -42.69 97.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.792 -0.64 . . . . 72.219999999999999 111.942 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.73 -67.3 1.98 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.982 -0.554 . . . . 72.549999999999997 114.097 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.01 -36.98 79.94 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.604 2.203 . . . . 75.420000000000002 112.838 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.38 -43.73 98.13 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.272 -0.422 . . . . 75.040000000000006 110.471 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.31 75.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 72.510000000000005 111.309 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.83 -34.09 74.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 72.120000000000005 111.523 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -62.2 -41.85 98.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.827 0.346 . . . . 71.420000000000002 111.291 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -98.17 3.89 49.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.488 -0.324 . . . . 73.140000000000001 111.5 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t 58.34 39.47 25.41 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.017 -0.538 . . . . 53.350000000000001 110.82 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.466 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 18.3 m -108.69 134.64 20.23 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.101 -0.5 . . . . 62.310000000000002 110.579 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 13.0 Cg_exo -69.93 122.5 9.13 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.74 2.294 . . . . 74.450000000000003 111.939 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -78.49 18.32 0.97 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.965 2.443 . . . . 73.230000000000004 112.5 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -81.59 -61.89 1.8 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.314 0.578 . . . . 75.430000000000007 110.145 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -87.71 68.95 9.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.616 -0.72 . . . . 75.030000000000001 110.085 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 pt -115.2 150.56 17.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.904 -0.589 . . . . 71.439999999999998 110.958 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 m -112.6 127.99 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 110.387 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.811 HG23 ' HB ' ' A' ' 8' ' ' VAL . 47.4 t -124.53 121.49 61.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 110.377 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.457 ' CG2' ' HA2' ' A' ' 9' ' ' GLY . 7.2 tt -84.31 123.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.751 0.31 . . . . 72.439999999999998 110.207 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -153.76 150.08 28.13 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.892 0.377 . . . . 71.040000000000006 111.009 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.443 ' HB3' HD21 ' A' ' 24' ' ' LEU . 9.9 p-10 -84.68 141.29 30.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.72 -0.673 . . . . 70.030000000000001 110.592 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.505 ' OE1' ' HB2' ' A' ' 112' ' ' GLU . 53.3 mm-40 -148.7 155.8 41.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.197 0.523 . . . . 75.409999999999997 111.63 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.29 2.12 37.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.232 -0.894 . . . . 65.219999999999999 111.881 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -49.35 -44.84 45.02 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.556 0.535 . . . . 70.409999999999997 111.355 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.8 HD12 ' HG2' ' A' ' 103' ' ' ARG . 7.6 pt -139.13 173.85 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 74.439999999999998 110.847 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.78 163.22 27.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.182 -0.463 . . . . 54.149999999999999 111.08 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.664 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 4.3 t80 -70.79 126.64 30.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.054 -0.521 . . . . 75.329999999999998 110.521 -176.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 161' ' ' GLU . . . 145.72 -45.37 0.82 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.572 -0.611 . . . . 72.219999999999999 111.572 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.8 ' HG2' HD12 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -119.98 160.49 22.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.512 -0.551 . . . . 75.400000000000006 109.512 178.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.642 HG21 ' HA ' ' A' ' 135' ' ' ILE . 39.8 pt -127.67 157.29 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.809 0.338 . . . . 74.120000000000005 111.189 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -130.71 125.1 33.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.048 -0.523 . . . . 75.409999999999997 110.591 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.668 HD13 ' HE1' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -101.24 111.51 23.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.424 -0.584 . . . . 72.420000000000002 109.424 175.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.665 ' HD3' ' HD2' ' A' ' 134' ' ' ARG . 16.0 ptmt -143.61 153.57 42.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.472 -0.786 . . . . 75.109999999999999 110.445 -169.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.519 HD13 ' O ' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -100.24 114.06 27.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.595 0.712 . . . . 75.109999999999999 110.825 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.53 178.86 38.9 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.861 -0.895 . . . . 75.239999999999995 110.861 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.54 ' HA2' HD13 ' A' ' 118' ' ' LEU . . . -166.81 86.56 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.047 -1.073 . . . . 71.140000000000001 113.593 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.4 74.94 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.934 -0.65 . . . . 64.140000000000001 111.942 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.505 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 3.3 mp0 -143.53 -82.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.554 0.216 . . . . 74.450000000000003 111.027 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -104.73 -69.67 0.77 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.706 -0.759 . . . . 63.310000000000002 113.046 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.21 69.14 3.32 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.026 -0.607 . . . . 70.200000000000003 112.054 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -55.72 -48.04 75.85 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.746 0.276 . . . . 75.329999999999998 111.746 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.438 ' OD1' ' HG3' ' A' ' 69' ' ' MET . 24.8 t-20 -61.58 -45.01 95.94 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.729 0.27 . . . . 73.329999999999998 111.729 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.54 -23.73 72.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.733 -0.746 . . . . 71.409999999999997 112.405 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.54 HD13 ' HA2' ' A' ' 110' ' ' GLY . 46.1 mt -83.23 -45.87 13.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.211 0.529 . . . . 74.439999999999998 109.693 174.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -65.35 -44.77 86.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.207 -0.906 . . . . 74.439999999999998 111.821 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.5 t -52.41 -47.21 66.43 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.938 0.399 . . . . 75.299999999999997 111.098 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.658 ' HB ' HH22 ' A' ' 132' ' ' ARG . 36.5 t -78.18 -44.28 27.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.262 -0.426 . . . . 75.099999999999994 110.928 -177.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.58 98.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.293 -0.412 . . . . 74.129999999999995 111.539 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.5 t -73.61 -30.28 62.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.261 -0.427 . . . . 70.439999999999998 110.711 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.47 -42.27 68.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 74.329999999999998 110.519 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.2 mt -76.68 -21.36 55.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 74.219999999999999 110.258 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.72 13.52 82.27 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.902 -0.59 . . . . 64.430000000000007 112.043 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.8 t -165.0 169.53 16.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.858 -0.423 . . . . 74.109999999999999 109.858 -176.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -96.72 -106.51 0.16 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.733 -0.469 . . . . 75.340000000000003 109.733 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 67.56 -10.33 0.38 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.119 0.785 . . . . 72.129999999999995 113.119 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -76.57 129.27 36.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.361 0.6 . . . . 75.340000000000003 111.464 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.668 ' HE1' HD13 ' A' ' 106' ' ' LEU . 51.2 t-80 -98.96 87.0 3.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.881 -0.599 . . . . 74.120000000000005 109.734 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.658 HH22 ' HB ' ' A' ' 121' ' ' VAL . 93.5 mtt180 -90.48 156.06 18.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 74.510000000000005 111.389 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.79 112.14 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.729 -0.668 . . . . 75.340000000000003 109.581 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.665 ' HD2' ' HD3' ' A' ' 107' ' ' LYS . 70.3 mtt85 -94.15 114.2 26.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.033 -0.531 . . . . 72.340000000000003 110.925 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.642 ' HA ' HG21 ' A' ' 104' ' ' ILE . 2.0 mp -83.26 118.22 30.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 108.708 -0.849 . . . . 72.120000000000005 108.708 173.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -66.87 118.65 10.75 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.626 -0.797 . . . . 74.239999999999995 111.627 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.574 ' HA ' ' HD2' ' A' ' 101' ' ' PHE . 35.0 m -109.9 1.13 9.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.145 0.497 . . . . 72.040000000000006 110.556 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.48 175.16 49.58 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.827 -0.701 . . . . 74.25 111.972 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.06 104.3 54.63 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.168 -0.308 . . . . 75.420000000000002 110.168 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.422 ' HG2' ' HB3' ' A' ' 146' ' ' PRO . 72.0 Cg_exo -50.05 114.61 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.068 2.512 . . . . 63.439999999999998 112.085 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.34 127.96 14.85 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.869 2.379 . . . . 74.310000000000002 112.16 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 172.05 175.79 40.46 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.127 -0.789 . . . . 73.140000000000001 111.127 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -94.92 -6.69 42.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.441 0.639 . . . . 75.420000000000002 109.781 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -101.03 159.82 14.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.575 -0.739 . . . . 75.230000000000004 109.265 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.42 139.56 94.55 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.012 -0.366 . . . . 75.219999999999999 110.012 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.471 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 92.7 Cg_exo -47.65 -19.39 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.664 2.909 . . . . 73.519999999999996 113.722 177.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -47.19 -40.42 16.02 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.024 0.53 . . . . 55.439999999999998 112.029 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.64 -31.37 41.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.41 -0.359 . . . . 72.420000000000002 111.674 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.471 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 77.2 m-85 -84.07 -31.94 25.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.274 -0.421 . . . . 71.5 111.624 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.04 -4.81 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.049 0.452 . . . . 75.329999999999998 111.805 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.719 ' HB3' ' HE1' ' A' ' 17' ' ' TYR . 90.5 mt -86.91 -12.5 47.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.453 -0.34 . . . . 71.230000000000004 111.266 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -160.89 107.64 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.203 0.525 . . . . 75.329999999999998 110.068 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -131.81 148.96 52.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.077 -0.511 . . . . 74.319999999999993 110.378 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -146.47 35.88 0.97 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.402 0.62 . . . . 73.140000000000001 109.999 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.644 ' O ' ' HG2' ' A' ' 158' ' ' GLU . 84.8 m -86.23 115.25 23.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.701 -0.682 . . . . 70.420000000000002 110.418 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.96 -20.85 59.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 73.420000000000002 111.89 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.04 -30.24 70.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 65.510000000000005 111.813 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 155' ' ' THR . 15.2 pt-20 -71.4 -21.95 61.93 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.263 0.554 . . . . 72.310000000000002 110.446 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.509 ' HA ' HG22 ' A' ' 162' ' ' VAL . 16.3 mmm-85 -78.18 -25.19 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.653 -0.703 . . . . 73.319999999999993 110.655 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.36 80.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.691 . . . . 72.219999999999999 112.102 -174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.62 ' HB2' ' HD1' ' A' ' 101' ' ' PHE . 6.0 mm-40 -105.38 7.78 33.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.072 0.397 . . . . 74.349999999999994 112.072 -175.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 163' ' ' PRO . 70.3 t -57.35 -52.38 74.66 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.669 -0.205 . . . . 73.120000000000005 111.084 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 13.7 Cg_endo -57.28 -33.62 96.4 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.108 1.872 . . . . 74.219999999999999 112.187 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.5 m -64.96 -43.42 92.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.937 -0.574 . . . . 75.319999999999993 110.61 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.3 -38.59 82.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.42 . . . . 74.209999999999994 110.763 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 162' ' ' VAL . 91.7 t -57.31 -54.04 35.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.553 -0.294 . . . . 73.400000000000006 111.205 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -61.19 -42.09 97.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.369 -0.378 . . . . 75.219999999999999 111.517 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.58 ' NE2' ' HB2' ' A' ' 191' ' ' TRP . 13.8 mm-40 -66.26 -49.52 66.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.482 -0.326 . . . . 75.129999999999995 111.314 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.0 96.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.448 -0.342 . . . . 74.219999999999999 111.593 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.5 -34.93 79.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.798 0.332 . . . . 72.540000000000006 111.553 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -80.63 -43.85 19.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.946 0.403 . . . . 75.239999999999995 110.794 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.27 -39.21 92.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 61.539999999999999 111.894 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.8 p -65.01 -38.86 92.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.744 0.307 . . . . 72.040000000000006 111.45 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.813 ' HA ' HD11 ' A' ' 55' ' ' LEU . 41.6 tt0 -73.55 -44.21 57.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.39 -0.368 . . . . 73.239999999999995 110.629 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 44.5 tp -64.73 -27.93 69.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.492 -0.322 . . . . 74.219999999999999 111.023 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.0 tp -57.24 -45.63 83.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 73.450000000000003 110.766 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.58 -32.4 14.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.012 -0.54 . . . . 75.120000000000005 110.305 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.52 -48.04 82.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.722 -0.672 . . . . 51.310000000000002 111.82 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -129.11 -67.72 0.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.077 -0.249 . . . . 75.519999999999996 111.381 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.64 -170.01 37.99 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.379 -0.915 . . . . 72.019999999999996 112.41 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.708 ' H ' HD22 ' A' ' 181' ' ' LEU . 1.8 pt? -81.82 -35.71 29.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.312 0.066 . . . . 73.510000000000005 110.98 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.549 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 4.9 mm-40 -54.46 -56.67 24.29 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 112.278 0.473 . . . . 74.239999999999995 112.278 -178.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 50.1 Cg_exo -56.26 -34.48 93.75 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.807 1.671 . . . . 73.439999999999998 112.138 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.96 -55.01 9.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.996 -0.547 . . . . 71.299999999999997 111.453 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.605 ' HG2' ' O ' ' A' ' 181' ' ' LEU . 11.6 pt20 -69.38 -21.41 63.8 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 111.718 0.266 . . . . 64.450000000000003 111.718 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.51 -38.22 68.17 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.705 -0.398 . . . . 73.049999999999997 110.662 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 85.0 m -66.96 -44.27 80.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 62.299999999999997 111.489 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.472 HG23 ' HA ' ' A' ' 185' ' ' GLN . 32.6 m -70.4 -16.82 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.43 . . . . 74.310000000000002 111.249 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -94.17 -13.5 26.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 75.340000000000003 110.034 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -93.27 -33.33 13.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 71.540000000000006 110.848 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.58 ' HB2' ' NE2' ' A' ' 168' ' ' GLN . 76.6 m95 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.526 -0.75 . . . . 73.310000000000002 109.552 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.006 -0.368 . . . . 72.340000000000003 110.006 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.46 80.11 0.24 Allowed 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.787 0.68 . . . . 72.25 110.54 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.24 145.78 41.04 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.609 -0.723 . . . . 75.120000000000005 109.746 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HB3' HG23 ' A' ' 61' ' ' VAL . 51.4 Cg_exo -54.88 123.64 14.26 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.118 2.546 . . . . 75.120000000000005 112.927 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.844 HD11 ' HG2' ' A' ' 89' ' ' GLN . 2.1 mm? -84.44 133.02 34.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.45 -0.574 . . . . 65.519999999999996 109.45 177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 79' ' ' LEU . 59.2 tp -93.6 117.53 30.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.015 0.436 . . . . 74.329999999999998 111.156 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.98 118.78 59.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.536 -0.756 . . . . 75.099999999999994 109.589 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.585 HG11 ' HB2' ' A' ' 63' ' ' ALA . 29.4 m -122.01 155.82 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.986 0.422 . . . . 74.010000000000005 111.022 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.97 163.95 30.27 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.797 -0.716 . . . . 64.129999999999995 111.983 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.725 HD21 ' HA ' ' A' ' 69' ' ' MET . 2.5 mt -68.92 106.4 2.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.914 0.388 . . . . 72.230000000000004 110.898 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.661 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -77.75 -141.57 1.61 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.823 -0.626 . . . . 63.140000000000001 112.253 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -97.78 99.71 7.19 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.067 0.46 . . . . 73.420000000000002 110.671 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.739 ' HB3' ' HA ' ' A' ' 68' ' ' TYR . 5.5 Cg_exo -78.77 -8.19 15.7 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.359 2.706 . . . . 74.430000000000007 112.887 -176.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.95 173.3 23.58 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.694 -0.765 . . . . 74.239999999999995 112.131 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.93 -54.8 2.4 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.032 2.488 . . . . 74.540000000000006 112.419 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 m -59.75 -35.62 74.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 73.140000000000001 111.601 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -74.89 -17.18 60.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.426 . . . . 73.239999999999995 111.296 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.42 -7.49 51.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.004 0.431 . . . . 63.450000000000003 110.861 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -92.96 -10.22 37.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 110.263 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.722 HG22 ' H ' ' A' ' 153' ' ' ASN . 36.5 p -102.71 -169.38 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 72.409999999999997 110.741 -175.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.711 ' HG3' HD22 ' A' ' 24' ' ' LEU . 1.3 tpp180 -92.12 1.78 56.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.035 0.445 . . . . 75.239999999999995 110.123 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.453 ' CE1' HG22 ' A' ' 150' ' ' VAL . 30.8 m80 -76.8 11.36 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.26 0.467 . . . . 54.520000000000003 112.26 -174.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -123.43 20.23 9.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.953 0.406 . . . . 63.020000000000003 110.144 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.758 HD12 HG12 ' A' ' 93' ' ' ILE . 1.1 pp -61.54 -24.26 66.51 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.982 -0.554 . . . . 74.319999999999993 111.968 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.621 ' N ' HD13 ' A' ' 24' ' ' LEU . . . -69.47 -47.96 47.3 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.995 -0.842 . . . . 73.549999999999997 110.995 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.661 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 88.8 t80 -61.05 -36.02 78.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.838 0.351 . . . . 61.32 110.217 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 61.8 mtt -61.34 -49.6 76.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 74.430000000000007 111.668 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.11 -47.67 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.056 0.391 . . . . 73.200000000000003 112.056 -174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.693 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -63.09 -38.87 92.91 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.405 0.521 . . . . 72.549999999999997 112.405 -171.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.65 -41.86 75.0 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.994 0.426 . . . . 75.430000000000007 111.125 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.447 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 22.9 m -79.65 -26.61 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.602 0.593 . . . . 73.409999999999997 112.602 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -67.66 -28.28 67.57 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.892 -0.323 . . . . 75.030000000000001 111.214 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 38' ' ' SER . . . -69.46 -41.96 75.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.143 0.496 . . . . 53.219999999999999 110.699 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.7 -18.13 71.83 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.003 -0.618 . . . . 64.239999999999995 112.86 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 8.2 mmt180 -61.17 -46.46 90.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.125 0.417 . . . . 74.409999999999997 112.125 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.433 HD11 ' H ' ' A' ' 36' ' ' ILE . 4.2 mp -73.23 -15.76 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.455 0.645 . . . . 73.530000000000001 110.407 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.99 12.92 26.53 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 110.765 -0.934 . . . . 62.200000000000003 110.765 -173.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 66.3 m -86.23 147.67 26.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.002 -0.599 . . . . 63.200000000000003 110.434 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.77 127.99 52.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.298 -0.41 . . . . 74.329999999999998 110.305 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -85.66 151.45 23.87 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.331 -0.618 . . . . 74.409999999999997 109.331 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -155.15 168.24 27.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.096 0.474 . . . . 73.349999999999994 110.914 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 5.1 p -84.16 117.77 30.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.71 -0.677 . . . . 75.530000000000001 109.766 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.572 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 5.8 t-80 -103.37 110.68 22.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.569 -0.9 . . . . 63.140000000000001 108.569 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -68.83 83.56 0.3 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 73.239999999999995 110.181 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.807 ' HE3' ' HB3' ' A' ' 82' ' ' PHE . 28.2 tptt -105.19 -95.13 0.34 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.909 -0.587 . . . . 74.549999999999997 109.513 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.523 ' HB3' ' CE2' ' A' ' 82' ' ' PHE . 9.6 p -108.16 -42.06 4.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 118.661 -1.216 . . . . 73.150000000000006 113.233 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.23 -25.62 0.46 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 118.544 -1.788 . . . . 45.25 117.025 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 64' ' ' LYS . . . -139.76 -176.75 4.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 114.829 1.418 . . . . 72.5 114.829 -156.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.684 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 34.4 mt-10 -76.18 143.05 41.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.413 -1.267 . . . . 65.340000000000003 109.407 173.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 43' ' ' HIS . 93.8 t -142.8 133.19 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.993 -0.373 . . . . 74.409999999999997 109.993 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 62' ' ' LEU . 3.2 p -125.08 125.3 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.507 -0.553 . . . . 72.010000000000005 109.507 172.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -103.24 121.1 42.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.244 0.545 . . . . 72.25 110.035 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.01 157.58 23.47 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.215 -0.754 . . . . 74.030000000000001 111.215 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 7.0 ptt180 -109.98 103.42 12.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.511 0.672 . . . . 75.230000000000004 110.915 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.758 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 3.1 pp -113.06 151.81 30.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.091 -0.959 . . . . 71.120000000000005 109.153 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.28 -57.85 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.831 0.707 . . . . 73.430000000000007 110.993 -172.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.84 -38.67 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.146 -0.549 . . . . 61.140000000000001 112.273 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -93.45 140.66 29.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.76 0.314 . . . . 64.310000000000002 110.867 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 25.9 m -77.64 121.63 24.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.352 -0.385 . . . . 74.030000000000001 110.066 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.3 171.7 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.899 0.38 . . . . 74.400000000000006 111.408 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 4' ' ' PRO . 77.6 t -117.82 111.57 35.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 75.540000000000006 110.137 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.693 HD12 ' HB2' ' A' ' 29' ' ' ALA . 3.0 tm? -98.68 119.88 38.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.18 -0.674 . . . . 75.230000000000004 109.18 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.585 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -108.85 137.87 46.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.347 -0.388 . . . . 64.439999999999998 110.922 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.684 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 54.6 mtpt -114.0 92.61 26.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.998 -0.546 . . . . 75.319999999999993 110.957 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.4 138.79 51.91 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.863 2.376 . . . . 63.25 112.184 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -109.73 16.81 21.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.506 0.669 . . . . 73.150000000000006 109.351 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 59.7 m -114.8 179.99 3.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.333 -0.848 . . . . 74.299999999999997 111.231 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.739 ' HA ' ' HB3' ' A' ' 13' ' ' PRO . 97.7 m-85 -70.25 175.54 4.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.609 . . . . 73.340000000000003 112.031 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.725 ' HA ' HD21 ' A' ' 10' ' ' LEU . 27.3 ptt? -67.46 -31.06 70.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.752 -0.658 . . . . 71.129999999999995 112.344 -173.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -72.2 -30.76 65.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.44 0.638 . . . . 72.329999999999998 109.96 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 51.2 mm-40 -80.2 -22.27 42.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.528 -0.76 . . . . 71.319999999999993 111.355 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.0 p -56.3 -45.23 80.33 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.216 0.322 . . . . 73.200000000000003 111.467 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 121' ' ' VAL . . . -73.88 -28.15 65.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.665 -0.779 . . . . 74.299999999999997 112.257 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -78.73 -11.32 59.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.859 0.362 . . . . 73.340000000000003 110.612 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 31.0 mm-40 -65.5 -30.27 71.02 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.101 0.477 . . . . 73.409999999999997 110.021 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.5 t -67.47 -21.73 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.467 -0.788 . . . . 75.430000000000007 110.897 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.54 -72.28 0.55 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 116.018 -0.537 . . . . 65.230000000000004 112.879 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.95 -30.2 48.59 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.442 2.095 . . . . 54.32 112.037 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.505 HD11 HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -59.28 -40.36 85.87 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.748 -0.66 . . . . 74.400000000000006 110.689 -176.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.97 -30.89 70.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 64.010000000000005 112.108 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.26 -41.21 34.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 62.310000000000002 111.131 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.807 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 55.2 m-85 -71.63 -43.08 66.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.491 0.552 . . . . 74.040000000000006 112.491 -172.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.604 ' CE1' ' HG2' ' A' ' 45' ' ' LYS . 95.3 m-85 -97.68 -16.88 19.76 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.739 -0.384 . . . . 74.540000000000006 111.201 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 t 63.96 33.46 12.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.199 0.523 . . . . 75.510000000000005 110.382 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.47 HG23 HD22 ' A' ' 6' ' ' LEU . 25.7 m -69.0 149.7 97.77 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.472 -0.786 . . . . 75.430000000000007 111.362 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.84 117.01 4.28 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.745 2.296 . . . . 75.430000000000007 112.402 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.91 -1.87 10.11 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.032 2.488 . . . . 64.219999999999999 112.633 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -95.32 -25.47 16.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.127 -0.488 . . . . 75.510000000000005 110.342 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.844 ' HG2' HD11 ' A' ' 5' ' ' LEU . 7.5 tp60 -92.57 -11.05 35.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.635 . . . . 73.310000000000002 111.106 -174.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.504 HD11 HD21 ' A' ' 6' ' ' LEU . 5.3 tp -52.62 113.73 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.729 0.776 . . . . 70.510000000000005 111.776 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 9.3 p -116.76 138.79 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.301 -0.863 . . . . 74.219999999999999 110.147 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 7.7 p -132.6 134.06 59.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.67 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.758 HG12 HD12 ' A' ' 24' ' ' LEU . 7.7 tt -89.9 124.53 42.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.827 -0.624 . . . . 75.120000000000005 109.967 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -140.53 162.12 36.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.889 0.376 . . . . 74.439999999999998 110.767 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.53 153.01 23.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.719 -0.673 . . . . 74.310000000000002 110.252 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.923 ' HG3' ' HD2' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -140.84 121.35 14.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.938 0.399 . . . . 73.409999999999997 111.41 -178.506 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.709 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.8 pt? -84.91 -12.24 53.83 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.67 -0.696 . . . . 71.230000000000004 110.765 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.64 -39.17 93.0 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.151 0.501 . . . . 71.340000000000003 110.108 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.609 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.8 pt -104.81 154.11 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 74.439999999999998 110.052 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.575 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 6.9 p-10 -88.37 -170.09 2.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.102 0.477 . . . . 75.219999999999999 112.018 -171.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.777 ' HD2' ' HB3' ' A' ' 158' ' ' GLU . 68.1 m-85 -62.97 119.65 9.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.363 -0.835 . . . . 72.230000000000004 112.526 -168.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.69 -0.16 82.39 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.813 -0.708 . . . . 72.0 113.363 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.498 ' O ' HD11 ' A' ' 99' ' ' ILE . 33.0 mmt180 -88.94 96.09 10.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 117.069 0.434 . . . . 75.209999999999994 110.192 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.644 HD11 ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -103.34 137.35 32.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.92 0.39 . . . . 74.439999999999998 110.666 -179.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -145.61 125.74 13.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.997 -0.547 . . . . 75.200000000000003 110.062 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 106' ' ' LEU . 1.0 OUTLIER -100.21 130.22 46.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.342 -0.614 . . . . 75.409999999999997 109.342 172.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 181' ' ' LEU . 1.5 tmtm? -155.41 154.2 31.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.266 0.555 . . . . 75.0 111.637 -171.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.465 HD23 HD11 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -83.95 92.95 7.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.343 0.592 . . . . 75.150000000000006 109.561 171.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.04 176.58 37.46 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.623 -0.717 . . . . 71.129999999999995 111.435 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.79 170.41 27.91 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.615 -0.802 . . . . 75.150000000000006 112.673 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.2 -169.19 34.68 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.447 -0.661 . . . . 64.329999999999998 111.447 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -134.26 -11.73 2.49 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.754 -0.379 . . . . 70.120000000000005 110.781 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -108.31 138.91 14.91 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.72 -0.752 . . . . 74.340000000000003 111.354 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.13 56.32 18.83 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.578 -0.82 . . . . 74.109999999999999 111.773 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -53.74 -38.93 64.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.06 0.393 . . . . 70.420000000000002 112.06 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -58.24 -53.72 55.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.724 0.297 . . . . 64.319999999999993 111.274 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.65 -28.81 73.95 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.007 -0.616 . . . . 60.149999999999999 112.831 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.1 mt -82.48 -46.12 13.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.654 0.264 . . . . 73.420000000000002 111.488 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -77.56 -21.48 52.45 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.879 -0.328 . . . . 75.400000000000006 110.879 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 t -63.27 -37.85 88.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.513 -0.551 . . . . 75.400000000000006 109.513 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.478 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 45.2 t -66.79 -31.01 51.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.801 -0.636 . . . . 71.019999999999996 110.202 176.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.6 -52.33 10.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.852 -0.613 . . . . 73.530000000000001 111.001 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 62.7 m -66.78 -22.75 66.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 73.219999999999999 111.772 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.32 -54.91 29.57 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 111.872 0.323 . . . . 73.340000000000003 111.872 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.651 ' H ' HD23 ' A' ' 125' ' ' LEU . 2.2 pt? -106.71 -17.73 14.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 75.340000000000003 111.369 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.54 40.24 2.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.242 -0.98 . . . . 71.450000000000003 112.936 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -110.26 171.82 7.23 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.505 -0.554 . . . . 73.230000000000004 109.505 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -114.22 38.88 2.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.488 0.185 . . . . 75.329999999999998 111.127 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 63.38 34.89 12.64 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.373 -0.376 . . . . 75.219999999999999 111.117 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -64.67 -13.11 52.7 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.132 -0.486 . . . . 71.400000000000006 112.303 -173.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 48.1 m80 -146.86 99.29 3.17 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.232 -0.293 . . . . 74.239999999999995 110.366 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 143.82 49.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.815 0.341 . . . . 75.140000000000001 110.822 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 34.3 t -116.94 120.59 65.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.812 -0.44 . . . . 73.319999999999993 109.812 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.923 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 44.0 mtm180 -107.32 117.58 34.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.676 0.274 . . . . 73.140000000000001 111.027 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.419 HD12 HG13 ' A' ' 93' ' ' ILE . 1.9 mp -103.51 115.11 44.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.762 -0.459 . . . . 75.530000000000001 109.762 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.609 ' HA2' HG13 ' A' ' 99' ' ' ILE . . . -62.13 113.63 5.98 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.872 -0.604 . . . . 62.420000000000002 112.879 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 p -101.66 -17.22 6.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.226 0.536 . . . . 71.230000000000004 109.648 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 88.49 -171.99 40.57 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.718 -0.753 . . . . 63.130000000000003 111.4 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -135.06 111.96 11.14 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 120.901 0.382 . . . . 73.430000000000007 110.197 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.695 ' HD2' ' HB3' ' A' ' 146' ' ' PRO . 23.8 Cg_exo -63.67 114.99 2.79 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.108 2.539 . . . . 71.239999999999995 112.441 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -85.16 139.32 7.08 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.319 2.679 . . . . 65.530000000000001 112.347 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -173.32 -151.91 8.44 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.43 -0.668 . . . . 75.109999999999999 111.43 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.13 -8.17 49.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.449 0.642 . . . . 74.519999999999996 109.688 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.412 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 71.6 mmtt -116.89 156.11 27.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.198 -0.91 . . . . 70.400000000000006 109.795 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.34 143.29 97.27 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.885 -0.598 . . . . 72.209999999999994 110.03 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.695 ' HB3' ' HD2' ' A' ' 140' ' ' PRO . 82.9 Cg_exo -47.0 -26.06 4.57 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.364 2.71 . . . . 74.230000000000004 113.016 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.05 -31.16 39.96 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.956 -0.565 . . . . 71.400000000000006 111.916 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.13 -50.9 6.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.488 -0.324 . . . . 74.540000000000006 111.422 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 153' ' ' ASN . 74.6 m-85 -64.99 -27.43 68.82 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.201 0.445 . . . . 74.299999999999997 112.201 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.453 HG22 ' CE1' ' A' ' 22' ' ' HIS . 6.2 p -69.36 -9.13 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.889 0.376 . . . . 74.209999999999994 111.558 -174.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.37 -24.5 36.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.603 -0.271 . . . . 73.140000000000001 110.897 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.6 87.77 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.842 0.83 . . . . 74.450000000000003 109.647 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.722 ' H ' HG22 ' A' ' 20' ' ' THR . 3.7 t-20 -137.84 122.23 18.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.426 -0.806 . . . . 75.109999999999999 110.77 -174.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -134.35 133.83 41.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.639 -0.71 . . . . 74.430000000000007 109.407 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.51 HG23 ' H ' ' A' ' 157' ' ' ALA . 59.9 m -145.61 134.04 21.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.86 0.362 . . . . 72.409999999999997 110.471 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.04 -31.43 67.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.325 -0.398 . . . . 64.329999999999998 111.505 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.51 ' H ' HG23 ' A' ' 155' ' ' THR . . . -59.89 -40.73 89.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 73.340000000000003 111.9 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.777 ' HB3' ' HD2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -85.14 -17.75 36.29 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.035 -0.266 . . . . 74.340000000000003 111.361 -177.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 155' ' ' THR . 4.7 mmt180 -72.15 -24.62 61.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 75.439999999999998 110.927 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.68 -17.1 61.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 72.040000000000006 111.127 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 165' ' ' ILE . 25.0 mm-40 -92.66 -18.49 22.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 62.43 111.103 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.7 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 67.1 t -55.98 -56.99 24.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.594 0.59 . . . . 64.329999999999998 112.594 -174.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.7 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 32.2 Cg_exo -59.12 -30.12 92.34 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.135 1.89 . . . . 62.0 112.322 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.9 m -67.2 -46.3 74.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.949 -0.569 . . . . 72.140000000000001 110.555 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 161' ' ' GLU . 72.4 mt -70.02 -53.97 21.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.717 -0.674 . . . . 73.299999999999997 111.215 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.78 -57.94 9.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.383 0.512 . . . . 72.439999999999998 112.383 -172.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -62.88 -45.52 92.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.874 0.324 . . . . 74.450000000000003 111.874 -174.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -74.32 -32.02 62.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.798 0.295 . . . . 70.239999999999995 111.798 -173.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.29 -25.43 67.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.618 0.229 . . . . 65.120000000000005 111.618 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.23 74.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 73.310000000000002 111.289 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.4 -43.69 76.69 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.338 0.59 . . . . 61.530000000000001 110.766 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.7 -31.75 69.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.597 -0.729 . . . . 62.420000000000002 111.678 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.1 m -55.72 -43.09 76.19 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.776 0.322 . . . . 74.239999999999995 111.803 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.758 ' HG2' ' HB2' ' A' ' 55' ' ' LEU . 42.6 mt-10 -68.54 -28.65 67.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.754 0.311 . . . . 71.25 111.075 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.05 -25.77 65.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.352 -0.385 . . . . 75.430000000000007 111.051 -175.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.73 -37.81 88.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.188 0.518 . . . . 72.319999999999993 110.278 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -80.0 -39.9 20.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.678 -0.692 . . . . 75.420000000000002 110.091 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.49 -56.6 10.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.807 -0.633 . . . . 75.319999999999993 111.448 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -115.57 -77.09 0.57 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.079 -0.509 . . . . 75.340000000000003 110.208 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.32 -171.39 40.02 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.107 -0.797 . . . . 74.540000000000006 111.107 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 107' ' ' LYS . 4.3 pp -91.13 -18.49 24.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.035 0.418 . . . . 74.120000000000005 110.32 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -58.63 -51.79 79.3 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.747 -0.66 . . . . 75.409999999999997 111.829 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.01 -29.81 26.8 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.351 1.367 . . . . 72.209999999999994 112.027 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.15 -43.81 66.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 63.530000000000001 111.809 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -58.8 -24.0 61.22 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.779 0.323 . . . . 65.109999999999999 111.303 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -77.65 -57.12 3.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.34 -0.391 . . . . 75.409999999999997 111.298 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -66.95 -31.01 71.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.383 -0.371 . . . . 73.310000000000002 111.876 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 8.1 p -71.42 -29.36 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.055 0.391 . . . . 75.430000000000007 112.055 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -94.03 0.06 55.74 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.46 -0.496 . . . . 72.430000000000007 110.636 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.49 -0.96 54.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 112.018 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 74.3 m95 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.697 -0.668 . . . . 74.349999999999994 110.64 -178.256 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.102 -0.333 . . . . 75.109999999999999 110.102 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.54 178.92 4.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.007 -0.368 . . . . 65.409999999999997 110.007 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -92.77 142.84 26.11 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.609 -0.269 . . . . 75.230000000000004 110.363 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' A' ' 59' ' ' SER . 22.6 Cg_exo -64.71 106.4 0.74 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.598 2.199 . . . . 73.450000000000003 111.596 176.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.41 ' HG ' HG13 ' A' ' 60' ' ' VAL . 4.0 pp -89.94 153.77 20.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.304 -0.407 . . . . 73.120000000000005 111.021 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' HB3' HG12 ' A' ' 90' ' ' ILE . 62.9 tp -97.46 124.74 41.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.848 -0.615 . . . . 74.340000000000003 110.5 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.1 t -105.27 119.12 53.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.13 -0.486 . . . . 70.340000000000003 109.77 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.72 117.08 46.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.02 0.438 . . . . 74.329999999999998 110.801 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -127.9 128.72 6.13 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.371 -0.692 . . . . 65.209999999999994 111.371 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -72.56 118.94 16.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.759 -0.46 . . . . 73.450000000000003 109.759 -178.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.94 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -77.12 -158.4 9.21 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.206 -0.452 . . . . 73.549999999999997 113.069 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.47 91.36 9.95 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.619 0.723 . . . . 70.25 111.002 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 11' ' ' GLY . 2.0 Cg_endo -82.92 -8.95 10.96 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.215 2.61 . . . . 73.439999999999998 112.932 -176.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.19 160.92 29.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.826 -0.702 . . . . 70.430000000000007 112.229 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.42 -30.59 52.95 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.109 2.539 . . . . 75.140000000000001 112.482 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 p -73.24 -43.61 60.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.987 0.422 . . . . 73.239999999999995 111.2 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -59.89 -40.15 87.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.773 -0.648 . . . . 73.129999999999995 111.51 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.23 -3.71 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 75.409999999999997 111.771 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -111.45 8.29 21.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.352 -0.386 . . . . 75.109999999999999 110.424 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.537 HG22 ' H ' ' A' ' 153' ' ' ASN . 71.4 p -113.65 159.75 19.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 73.319999999999993 111.038 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -78.46 -20.16 51.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 64.439999999999998 111.672 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -76.73 -19.7 57.36 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.785 -0.366 . . . . 72.319999999999993 111.476 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 27' ' ' MET . 7.0 m120 -85.08 33.27 0.54 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.227 0.537 . . . . 75.150000000000006 111.042 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 pp -66.07 -17.26 64.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.552 -0.749 . . . . 74.239999999999995 111.521 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.12 -34.24 78.55 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.195 -0.526 . . . . 74.230000000000004 111.962 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.94 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 54.6 t80 -90.11 -53.89 4.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.459 . . . . 75.25 109.841 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 85.7 mmm -56.89 -38.11 72.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.905 -1.043 . . . . 73.439999999999998 112.554 -169.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.557 HG22 HG22 ' A' ' 166' ' ' VAL . 62.1 t -88.84 -41.9 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.798 0.332 . . . . 73.030000000000001 111.739 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.49 -22.42 47.49 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.189 0.44 . . . . 64.430000000000007 112.189 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -72.2 -39.28 68.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.732 0.301 . . . . 73.120000000000005 111.468 -175.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.41 -36.64 75.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 75.019999999999996 111.868 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.99 -27.08 62.52 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.771 0.319 . . . . 75.120000000000005 110.971 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.43 68.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.112 0.482 . . . . 75.230000000000004 110.309 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.16 -29.34 56.78 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.474 -0.869 . . . . 74.319999999999993 112.244 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -79.89 -21.87 43.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.342 0.497 . . . . 74.439999999999998 112.342 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.2 tp -78.15 -14.69 13.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.315 0.578 . . . . 75.430000000000007 110.335 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.31 41.03 2.87 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.121 -0.792 . . . . 54.530000000000001 111.121 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 62.8 m -135.3 150.08 49.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.229 -0.486 . . . . 65.549999999999997 110.684 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.97 136.24 52.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.687 0.279 . . . . 72.010000000000005 110.731 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.438 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 26.9 p90 -91.93 146.82 23.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.614 -0.513 . . . . 75.340000000000003 109.614 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.449 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 18.9 ptmt -155.39 166.87 32.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 74.010000000000005 111.155 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.22 128.31 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.469 -0.787 . . . . 73.540000000000006 111.314 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -101.9 106.13 17.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.234 -1.025 . . . . 72.209999999999994 108.234 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -57.91 154.26 12.64 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.502 0.556 . . . . 74.340000000000003 112.502 -166.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt 76.66 -47.55 0.54 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.387 1.075 . . . . 75.200000000000003 110.086 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 p -95.09 25.08 4.42 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.141 -0.936 . . . . 73.400000000000006 108.737 171.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.37 41.39 0.01 OUTLIER Glycine 0 CA--C 1.533 1.166 0 N-CA-C 119.238 2.455 . . . . 71.120000000000005 119.238 -159.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.02 140.1 29.84 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.847 -1.168 . . . . 74.140000000000001 107.847 163.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.51 120.12 19.63 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.723 -0.391 . . . . 71.230000000000004 110.553 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.466 HG23 ' HH ' ' A' ' 83' ' ' TYR . 33.2 m -126.05 145.18 33.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.78 -0.646 . . . . 74.209999999999994 111.272 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 62' ' ' LEU . 4.8 p -125.41 117.05 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.834 -0.621 . . . . 74.310000000000002 110.228 172.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.5 p -91.08 116.27 28.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.191 -0.459 . . . . 71.329999999999998 110.546 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.35 175.25 28.64 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.935 -0.65 . . . . 73.219999999999999 111.604 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 25.6 ptt85 -126.77 115.75 19.85 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.093 0.473 . . . . 74.219999999999999 110.922 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.9 mt -103.09 124.72 49.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.764 -0.653 . . . . 63.420000000000002 109.705 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 72.28 -53.01 0.7 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.823 0.702 . . . . 74.409999999999997 111.373 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.24 -52.13 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.115 -0.564 . . . . 71.329999999999998 111.986 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.705 ' HB ' HG22 ' A' ' 177' ' ' ILE . 17.8 m -72.62 138.67 46.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.857 0.36 . . . . 75.530000000000001 110.889 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 10.8 t -85.75 139.79 31.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.553 -0.536 . . . . 71.530000000000001 109.553 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 HG13 ' HG ' ' A' ' 5' ' ' LEU . 31.6 m -130.07 155.01 41.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.341 -0.391 . . . . 71.530000000000001 110.72 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.4 t -111.25 106.83 21.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.845 -0.616 . . . . 73.430000000000007 109.638 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 3.4 tm? -91.78 115.78 28.34 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.299 -0.63 . . . . 75.049999999999997 109.299 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.27 142.24 48.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.239 -0.437 . . . . 51.140000000000001 111.385 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.544 ' HE2' ' CD2' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -139.14 127.25 13.52 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 75.450000000000003 110.387 175.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 13.0 Cg_exo -70.75 153.34 64.44 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.992 2.462 . . . . 75.409999999999997 112.023 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -93.96 -19.24 21.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.462 0.649 . . . . 75.25 110.0 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 60.4 m -101.94 159.26 15.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.217 -0.901 . . . . 75.019999999999996 109.463 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.416 ' HB2' ' H ' ' A' ' 69' ' ' MET . 17.2 p90 -78.05 -169.38 1.56 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.876 0.369 . . . . 65.219999999999999 111.522 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.806 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 18.9 ptp -52.75 -22.06 4.82 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.625 0.972 . . . . 70.150000000000006 113.625 -170.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -62.82 -49.62 74.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.791 0.329 . . . . 63.520000000000003 110.809 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.88 -0.11 21.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.011 0.375 . . . . 64.409999999999997 112.011 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 p -60.64 -42.77 97.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.927 0.394 . . . . 72.329999999999998 111.04 -176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.39 -21.17 78.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.945 -0.645 . . . . 72.530000000000001 112.769 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -80.63 -33.38 35.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.57 0.224 . . . . 71.239999999999995 111.391 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -74.9 -14.9 60.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.704 0.288 . . . . 75.319999999999993 111.617 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.21 -25.21 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.172 0.51 . . . . 65.519999999999996 110.304 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.69 -68.55 1.62 Allowed Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.881 -0.6 . . . . 63.32 112.865 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.82 -37.71 95.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.853 2.369 . . . . 74.099999999999994 112.462 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -55.87 -52.04 65.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 73.450000000000003 110.484 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.98 -44.75 83.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 65.400000000000006 112.012 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -72.77 -37.85 67.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.926 0.343 . . . . 75.329999999999998 111.926 -174.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -60.28 -47.49 85.76 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.75 0.309 . . . . 74.409999999999997 111.314 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.466 ' HH ' HG23 ' A' ' 50' ' ' VAL . 71.2 m-85 -84.39 -15.14 47.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.934 -0.307 . . . . 74.329999999999998 110.791 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.2 m 59.78 47.61 10.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.863 -0.608 . . . . 71.430000000000007 110.693 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 29.4 m -94.42 148.8 35.61 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.642 -0.708 . . . . 74.299999999999997 110.321 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 11.2 Cg_exo -71.19 115.33 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.807 2.338 . . . . 75.239999999999995 111.969 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.46 ' HA ' HG13 ' A' ' 90' ' ' ILE . 28.8 Cg_exo -62.78 -19.53 68.73 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.006 2.471 . . . . 72.400000000000006 112.124 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -66.98 -21.7 65.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.86 -0.609 . . . . 74.540000000000006 110.684 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 89' ' ' GLN . 15.6 mm-40 -98.01 5.63 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.384 . . . . 73.430000000000007 111.413 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.46 HG13 ' HA ' ' A' ' 87' ' ' PRO . 59.5 mt -69.22 130.92 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.109 0.48 . . . . 74.519999999999996 111.165 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 7.0 p -120.0 132.67 69.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 73.430000000000007 109.325 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.68 129.71 75.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.543 0.687 . . . . 74.319999999999993 111.649 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.13 113.1 29.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.167 -0.924 . . . . 75.439999999999998 109.174 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -135.26 154.28 51.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.277 0.561 . . . . 73.140000000000001 111.905 -174.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.87 129.53 34.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.628 -1.169 . . . . 73.549999999999997 110.899 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -129.47 138.45 51.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.016 0.436 . . . . 54.240000000000002 110.659 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.55 -0.03 44.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.88 -0.6 . . . . 74.129999999999995 110.919 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -58.67 -45.7 88.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.313 -0.858 . . . . 73.239999999999995 112.431 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.574 HD11 ' HG3' ' A' ' 105' ' ' ARG . 2.9 pt -122.22 174.92 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.307 0.575 . . . . 75.120000000000005 112.507 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.97 171.43 14.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.826 -1.079 . . . . 71.019999999999996 111.615 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -63.89 132.69 51.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.203 -0.908 . . . . 73.299999999999997 110.671 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.06 10.67 66.05 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.604 -0.808 . . . . 72.120000000000005 113.217 173.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.3 mmt-85 -123.0 153.56 39.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.103 0.452 . . . . 72.040000000000006 110.345 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.641 HD12 HG21 ' A' ' 188' ' ' VAL . 44.2 pt -138.81 149.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 74.5 110.874 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.574 ' HG3' HD11 ' A' ' 99' ' ' ILE . 99.0 mtt180 -127.15 128.06 45.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.936 -0.575 . . . . 74.319999999999993 109.903 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.429 HD22 ' HB3' ' A' ' 185' ' ' GLN . 8.1 mp -109.75 110.19 21.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 72.519999999999996 110.953 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -157.68 148.4 21.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.053 -0.721 . . . . 74.219999999999999 109.053 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.3 pt? -73.66 125.12 27.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.776 -0.453 . . . . 73.409999999999997 109.776 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.76 -177.14 41.06 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.848 -0.692 . . . . 70.219999999999999 112.022 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.37 -164.73 39.28 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.962 -0.637 . . . . 54.43 112.628 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.35 152.36 22.07 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.381 -0.688 . . . . 55.229999999999997 111.381 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -113.32 7.53 17.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.776 0.288 . . . . 75.209999999999994 110.995 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -68.61 -86.77 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.701 -0.762 . . . . 62.329999999999998 111.855 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.4 73.93 1.32 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.916 -0.659 . . . . 74.430000000000007 111.66 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.614 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -48.97 -66.43 0.4 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.488 0.715 . . . . 75.230000000000004 112.69 -174.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.544 ' HB2' ' SD ' ' A' ' 69' ' ' MET . 13.0 m120 -55.04 -43.63 73.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 72.430000000000007 111.527 -174.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.806 ' HA2' ' HB2' ' A' ' 69' ' ' MET . . . -62.9 -48.75 78.26 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.851 -0.613 . . . . 60.310000000000002 113.271 -176.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.74 -29.01 68.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.436 0.16 . . . . 74.310000000000002 111.291 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 115' ' ' HIS . 10.2 mmm180 -65.96 -42.27 90.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.657 0.265 . . . . 73.329999999999998 110.642 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -64.86 -47.79 76.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.387 -0.37 . . . . 74.120000000000005 110.549 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.28 -47.47 92.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 74.519999999999996 110.903 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.74 -31.28 72.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.891 -0.595 . . . . 71.530000000000001 111.844 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.2 t -80.34 -33.69 37.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.708 0.29 . . . . 64.109999999999999 110.918 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.21 -45.9 53.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 62.450000000000003 111.025 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.89 -38.53 45.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.479 . . . . 74.140000000000001 110.943 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.97 -12.52 63.78 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 121.116 -0.564 . . . . 54.140000000000001 113.168 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.494 ' C ' ' HD2' ' A' ' 128' ' ' LYS . 14.6 t -141.9 173.73 11.24 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.129 -0.323 . . . . 74.409999999999997 110.129 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.494 ' HD2' ' C ' ' A' ' 127' ' ' THR . 13.2 mptt -125.22 -115.25 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.436 -0.347 . . . . 72.299999999999997 110.224 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 61.93 21.77 12.55 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.94 0.496 . . . . 72.450000000000003 111.613 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -90.25 160.97 15.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.19 -0.459 . . . . 71.319999999999993 110.275 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 33.2 m80 -87.18 99.89 12.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.122 -0.696 . . . . 74.329999999999998 109.122 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -111.75 136.31 51.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.975 0.416 . . . . 74.510000000000005 111.108 -174.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.03 127.11 59.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.016 -0.538 . . . . 74.340000000000003 109.782 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.459 ' HG2' ' NH1' ' A' ' 132' ' ' ARG . 5.2 mtm180 -93.36 96.83 10.19 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.685 -0.487 . . . . 75.120000000000005 109.685 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.505 ' HA ' HG22 ' A' ' 104' ' ' ILE . 51.4 mt -90.19 127.75 42.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.422 -0.354 . . . . 73.150000000000006 110.48 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.498 ' CA ' HG13 ' A' ' 99' ' ' ILE . . . -72.52 97.82 0.81 Allowed Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.987 -0.552 . . . . 75.519999999999996 112.545 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.8 p -88.65 -10.29 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.464 -0.569 . . . . 71.019999999999996 109.464 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.23 152.98 28.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.56 -0.745 . . . . 74.310000000000002 112.279 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 21.1 ptp180 -107.46 119.85 49.39 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.067 0.46 . . . . 73.049999999999997 110.235 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.465 ' HG2' ' HA ' ' A' ' 146' ' ' PRO . 32.5 Cg_exo -59.58 125.28 17.44 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.954 2.436 . . . . 64.340000000000003 112.746 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 1.9 Cg_endo -83.79 137.71 7.82 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.45 2.767 . . . . 73.409999999999997 112.374 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.09 -168.01 24.97 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.181 -0.767 . . . . 74.420000000000002 111.181 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -87.81 -24.38 23.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.631 -0.507 . . . . 75.129999999999995 109.631 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 42.4 mmtm -75.58 101.19 4.83 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.535 -0.913 . . . . 74.129999999999995 108.535 168.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.723 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 6.8 p-10 -73.1 168.49 24.43 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.916 -0.584 . . . . 74.340000000000003 110.41 -174.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.723 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 5.2 Cg_exo -35.99 -44.87 0.86 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.402 3.401 . . . . 71.310000000000002 114.274 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.42 68.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.236 0.458 . . . . 64.140000000000001 112.236 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.52 -43.77 11.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.847 0.356 . . . . 71.319999999999993 111.372 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 144' ' ' LYS . 2.6 m-85 -84.02 -19.43 34.49 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.869 0.692 . . . . 75.140000000000001 112.869 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.476 HG11 HD11 ' A' ' 151' ' ' LEU . 7.0 p -63.1 -25.56 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 112.201 0.445 . . . . 62.240000000000002 112.201 -173.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.476 HD11 HG11 ' A' ' 150' ' ' VAL . 6.0 mp -85.96 -10.24 55.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.659 0.266 . . . . 73.219999999999999 111.421 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.0 87.07 1.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.792 0.806 . . . . 74.209999999999994 109.438 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.537 ' H ' HG22 ' A' ' 20' ' ' THR . 23.8 t-20 -128.94 122.36 30.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.471 -0.786 . . . . 75.439999999999998 111.613 -170.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -155.31 134.86 12.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.386 -0.825 . . . . 74.209999999999994 109.199 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.582 HG21 ' H ' ' A' ' 157' ' ' ALA . 47.2 m -152.86 138.97 18.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.672 0.272 . . . . 72.230000000000004 110.605 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.91 -33.0 48.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 61.310000000000002 111.337 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.582 ' H ' HG21 ' A' ' 155' ' ' THR . . . -65.96 -49.24 68.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.903 -0.589 . . . . 72.310000000000002 111.568 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.425 ' HG3' ' HB ' ' A' ' 155' ' ' THR . 3.0 pp20? -72.64 -22.04 61.0 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 120.849 -0.34 . . . . 74.040000000000006 111.252 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 155' ' ' THR . 16.4 mmt180 -56.59 -39.89 74.33 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.195 0.522 . . . . 65.019999999999996 110.34 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.45 -31.97 71.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.69 -0.686 . . . . 73.25 111.189 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.93 1.13 57.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 111.887 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.456 ' HB ' ' CD ' ' A' ' 163' ' ' PRO . 92.5 t -57.33 -57.87 21.96 Favored Pre-proline 0 C--O 1.233 0.229 0 C-N-CA 121.086 -0.245 . . . . 63.43 110.496 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.456 ' CD ' ' HB ' ' A' ' 162' ' ' VAL . 18.8 Cg_endo -61.07 -36.75 80.39 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.668 1.579 . . . . 72.109999999999999 111.476 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -56.18 -53.37 57.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.594 -0.73 . . . . 72.519999999999996 111.421 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.4 mt -64.3 -49.75 79.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.289 -0.414 . . . . 75.109999999999999 111.008 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.557 HG22 HG22 ' A' ' 28' ' ' VAL . 97.6 t -57.22 -51.59 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.409 -0.359 . . . . 75.239999999999995 111.552 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.48 -49.87 73.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.503 -0.317 . . . . 75.430000000000007 111.754 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.539 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . 10.3 mm-40 -67.71 -36.78 81.25 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.027 -0.269 . . . . 74.549999999999997 111.498 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.24 75.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.61 0.243 . . . . 73.349999999999994 110.61 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.69 64.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.001 0.429 . . . . 61.539999999999999 111.301 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.42 -45.7 17.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.295 -0.411 . . . . 70.409999999999997 110.709 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.35 -33.96 70.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.068 -0.514 . . . . 73.340000000000003 111.979 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 176' ' ' LEU . 3.4 p -61.71 -27.4 68.68 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.865 0.32 . . . . 75.329999999999998 111.865 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -63.38 -44.76 93.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.701 0.286 . . . . 73.230000000000004 110.355 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 38.3 tp -74.65 -28.91 61.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 74.439999999999998 110.261 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.827 HD21 ' HA ' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -54.54 -49.02 71.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.366 -0.834 . . . . 72.439999999999998 109.306 174.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.705 HG22 ' HB ' ' A' ' 58' ' ' THR . 65.5 mt -79.7 -25.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.114 -0.948 . . . . 74.129999999999995 111.079 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.4 -43.68 72.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.008 -0.542 . . . . 73.109999999999999 112.158 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.22 -65.04 0.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.861 -0.336 . . . . 72.310000000000002 111.092 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -161.89 173.41 38.23 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.283 -0.96 . . . . 74.420000000000002 112.439 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.827 ' HA ' HD21 ' A' ' 176' ' ' LEU . 2.4 pt? -83.2 -30.6 27.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.723 0.297 . . . . 72.439999999999998 111.557 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 39.4 mt-10 -67.72 -49.31 39.64 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.098 0.407 . . . . 63.310000000000002 112.098 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 52.7 Cg_exo -55.76 -28.79 68.63 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.062 1.841 . . . . 73.209999999999994 112.228 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.69 -50.26 18.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 63.32 110.995 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.584 ' HG3' ' O ' ' A' ' 182' ' ' GLU . 1.4 pp0? -64.23 -32.9 74.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.766 0.317 . . . . 75.099999999999994 110.197 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -61.77 -23.08 65.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.905 -0.589 . . . . 74.310000000000002 111.099 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 26.4 m -87.15 -41.01 14.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.765 0.317 . . . . 72.200000000000003 111.605 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.641 HG21 HD12 ' A' ' 104' ' ' ILE . 17.8 m -96.41 -12.77 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 114.35 1.241 . . . . 74.239999999999995 114.35 -171.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -69.45 -28.59 66.24 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.913 0.708 . . . . 71.230000000000004 112.913 -171.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -133.66 -10.73 2.75 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.122 0.416 . . . . 74.099999999999994 112.122 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 19.4 m0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 119.012 -0.518 . . . . 70.510000000000005 110.234 -176.835 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' HE2' ' HB3' ' A' ' 3' ' ' GLU . 25.7 ptt? . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 109.976 -0.379 . . . . 74.150000000000006 109.976 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -106.02 102.98 12.37 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.212 -0.292 . . . . 71.019999999999996 110.212 173.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 0.4 OUTLIER -106.4 97.57 16.89 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.343 0.592 . . . . 73.310000000000002 109.819 176.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.538 ' HG2' HG11 ' A' ' 85' ' ' VAL . 6.7 Cg_endo -89.41 110.82 0.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.093 2.529 . . . . 75.530000000000001 113.191 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.633 HD12 HG21 ' A' ' 177' ' ' ILE . 91.7 mt -76.52 128.93 35.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 72.439999999999998 110.281 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.559 ' HA ' HG21 ' A' ' 61' ' ' VAL . 22.9 tp -96.72 114.55 26.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.041 0.448 . . . . 71.439999999999998 110.781 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.776 ' HB ' HD12 ' A' ' 62' ' ' LEU . 21.2 t -105.21 111.56 35.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.728 -0.669 . . . . 70.120000000000005 109.83 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 76' ' ' VAL . 49.5 t -104.48 117.47 50.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.077 -0.511 . . . . 73.219999999999999 110.147 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.454 ' HA2' HG13 ' A' ' 93' ' ' ILE . . . -106.2 -142.91 11.15 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.448 -0.882 . . . . 73.209999999999994 112.622 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.469 ' H ' ' HA3' ' A' ' 25' ' ' GLY . 2.2 tt -117.47 122.57 44.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.448 -0.945 . . . . 73.430000000000007 108.448 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -76.31 169.9 54.86 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.945 -0.645 . . . . 73.230000000000004 113.424 -172.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' A' ' 18' ' ' ALA . 44.9 t-20 -109.28 109.26 60.46 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.234 -0.654 . . . . 75.299999999999997 109.234 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 6.3 Cg_exo -74.25 -61.8 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.231 2.62 . . . . 73.530000000000001 113.62 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.72 -168.09 11.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.202 -0.999 . . . . 75.450000000000003 113.362 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.02 -56.68 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.392 2.728 . . . . 73.329999999999998 113.378 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 m -61.78 -30.78 71.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.993 0.425 . . . . 72.519999999999996 111.518 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -83.59 -8.0 59.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.213 -0.448 . . . . 75.510000000000005 111.04 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.448 ' HA ' HD22 ' A' ' 12' ' ' ASN . . . -81.28 -16.6 52.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 74.340000000000003 111.411 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.843 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 9.7 mmpt? -111.34 8.13 21.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.428 -0.351 . . . . 75.400000000000006 111.374 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.6 p -110.47 163.21 13.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.523 0.677 . . . . 73.310000000000002 112.173 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.869 HH21 ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -54.8 -33.47 61.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.428 -1.26 . . . . 75.219999999999999 113.465 -174.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -86.14 9.93 15.98 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.099 0.777 . . . . 73.450000000000003 113.099 -165.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.73 13.46 19.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.31 0.576 . . . . 72.030000000000001 110.556 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.869 ' HG ' HH21 ' A' ' 21' ' ' ARG . 0.0 OUTLIER -50.28 -31.35 14.0 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.182 0.808 . . . . 70.099999999999994 113.182 -173.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.469 ' HA3' ' H ' ' A' ' 10' ' ' LEU . . . -62.47 -42.64 99.69 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.823 -0.704 . . . . 65.129999999999995 112.536 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.461 ' CE2' ' HE3' ' A' ' 64' ' ' LYS . 56.3 t80 -67.13 -40.42 86.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.137 0.494 . . . . 73.430000000000007 110.439 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.81 ' HA ' ' HE3' ' A' ' 27' ' ' MET . 4.8 mmt -65.36 -45.86 82.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.732 . . . . 74.209999999999994 111.381 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.73 HG11 HD22 ' A' ' 32' ' ' LEU . 57.9 t -68.15 -32.47 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.48 -0.327 . . . . 74.129999999999995 111.285 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.1 70.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.048 0.388 . . . . 54.32 112.048 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.27 -38.61 68.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.602 -0.272 . . . . 73.329999999999998 111.509 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.542 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 30.3 m -74.94 -33.38 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.091 0.404 . . . . 74.5 112.091 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.73 HD22 HG11 ' A' ' 28' ' ' VAL . 4.3 pp -70.93 -38.59 72.91 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 120.63 -0.428 . . . . 75.109999999999999 110.34 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.423 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -75.11 -36.89 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.231 0.539 . . . . 70.310000000000002 110.061 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.83 -18.28 45.87 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.497 -0.774 . . . . 74.150000000000006 113.067 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 15.3 mmt85 -68.67 -36.45 78.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.39 . . . . 74.010000000000005 111.17 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.428 HD13 ' N ' ' A' ' 36' ' ' ILE . 3.1 mp -88.17 -15.07 9.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.713 0.768 . . . . 74.319999999999993 109.703 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.35 24.9 9.8 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.616 -0.993 . . . . 71.129999999999995 110.616 -175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.5 m -99.24 123.23 43.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.845 -0.677 . . . . 72.219999999999999 111.021 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.48 134.63 14.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.471 -0.331 . . . . 74.140000000000001 110.707 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.42 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 3.0 t80 -142.85 177.99 7.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.591 -0.522 . . . . 73.329999999999998 109.591 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 41' ' ' LYS . 20.8 ptmt -123.39 174.14 7.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.702 -0.226 . . . . 74.219999999999999 110.446 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.792 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 6.3 p -49.8 128.29 6.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.262 0.553 . . . . 70.129999999999995 110.602 174.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -106.86 109.92 21.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.964 -0.562 . . . . 75.349999999999994 110.513 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -53.16 154.44 3.12 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.652 0.595 . . . . 72.409999999999997 111.993 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 tptp 80.26 -41.73 0.21 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.362 1.065 . . . . 74.310000000000002 109.625 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.9 p -104.93 26.58 9.06 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.366 -1.288 . . . . 74.420000000000002 108.109 171.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.45 41.44 0.01 OUTLIER Glycine 0 N--CA 1.477 1.424 0 N-CA-C 119.72 2.648 . . . . 73.219999999999999 119.72 -154.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.02 168.63 9.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.14 -1.43 . . . . 74.430000000000007 107.14 160.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.792 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 46.0 mt-10 -77.64 124.18 27.6 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.065 -0.654 . . . . 73.25 109.737 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -133.54 138.85 50.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.928 -0.578 . . . . 75.430000000000007 109.995 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.61 HG11 ' HB2' ' A' ' 62' ' ' LEU . 3.4 p -122.11 115.99 47.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.356 0.598 . . . . 71.310000000000002 110.241 173.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.0 m -99.47 136.06 39.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.529 -0.759 . . . . 74.530000000000001 110.183 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -175.09 -160.07 22.37 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.24 -0.744 . . . . 61.409999999999997 111.24 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -131.91 144.08 50.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.742 0.306 . . . . 74.349999999999994 110.195 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.743 ' HG ' HG22 ' A' ' 60' ' ' VAL . 79.9 mt -118.3 123.67 45.92 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.842 -0.799 . . . . 75.099999999999994 108.842 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.651 ' HB1' ' HG2' ' A' ' 174' ' ' GLU . . . 70.18 -52.44 0.64 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.961 0.788 . . . . 61.020000000000003 111.274 -173.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.4 -40.82 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.327 -0.709 . . . . 75.239999999999995 111.327 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.671 ' HB ' HG22 ' A' ' 177' ' ' ILE . 20.6 m -65.54 144.57 56.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.42 -0.39 . . . . 73.239999999999995 110.724 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -76.18 142.72 41.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.312 -0.404 . . . . 72.430000000000007 110.499 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.743 HG22 ' HG ' ' A' ' 55' ' ' LEU . 29.4 m -138.33 150.81 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.255 0.55 . . . . 74.209999999999994 111.5 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 6' ' ' LEU . 3.6 m -129.76 112.14 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.526 -0.761 . . . . 74.420000000000002 109.904 173.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.776 HD12 ' HB ' ' A' ' 7' ' ' VAL . 4.1 mm? -92.49 128.07 38.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.797 -0.638 . . . . 73.510000000000005 109.992 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.14 122.25 46.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.173 0.511 . . . . 71.329999999999998 110.532 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.461 ' HE3' ' CE2' ' A' ' 26' ' ' PHE . 6.9 ptmt -130.26 91.53 38.46 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.509 -0.769 . . . . 73.329999999999998 110.045 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.74 177.1 9.12 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.071 2.514 . . . . 64.019999999999996 112.812 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 20.3 mmt85 -109.35 13.3 24.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.46 -0.791 . . . . 75.099999999999994 109.044 175.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.518 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 61.2 m -102.26 178.91 4.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.947 -1.024 . . . . 71.349999999999994 109.923 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -85.36 -165.11 1.12 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 110.125 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -80.7 -19.62 44.69 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.705 0.261 . . . . 73.420000000000002 111.705 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -73.47 -61.71 1.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.222 0.534 . . . . 74.329999999999998 110.833 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.518 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 1.1 pm0 -82.69 6.6 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.987 -0.551 . . . . 71.310000000000002 111.792 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.6 p -67.54 -34.08 76.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.985 0.422 . . . . 75.209999999999994 110.069 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.96 -20.75 74.89 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.806 -0.634 . . . . 75.019999999999996 112.612 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 mmm180 -74.25 -19.62 60.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.997 0.427 . . . . 73.540000000000006 110.473 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -87.34 -8.01 57.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 71.219999999999999 110.789 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.551 HG21 HG22 ' A' ' 8' ' ' VAL . 74.0 t -66.67 -36.95 78.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 75.409999999999997 110.659 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.11 9.43 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.811 -0.632 . . . . 63.240000000000002 112.939 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.56 -18.73 56.19 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.834 2.356 . . . . 72.120000000000005 113.187 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.57 -51.29 7.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.01 0.433 . . . . 74.219999999999999 110.077 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.593 ' HA ' HG23 ' A' ' 85' ' ' VAL . . . -53.46 -63.48 1.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.55 -0.75 . . . . 74.329999999999998 113.018 -172.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -72.82 -22.88 60.74 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.353 0.501 . . . . 72.420000000000002 112.353 -170.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -77.76 -28.85 50.71 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.915 -0.314 . . . . 75.239999999999995 111.224 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -102.93 5.45 38.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.798 0.332 . . . . 74.420000000000002 110.938 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.7 t 65.58 28.7 11.28 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.522 -0.763 . . . . 72.530000000000001 111.976 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 80' ' ' ALA . 6.3 m -80.38 136.22 53.01 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.626 -0.43 . . . . 73.129999999999995 110.464 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.774 ' HD2' ' HG3' ' A' ' 89' ' ' GLN . 30.1 Cg_exo -63.29 155.11 63.77 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.651 2.234 . . . . 75.040000000000006 111.748 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.34 -56.77 2.42 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.011 2.474 . . . . 70.019999999999996 112.689 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.15 55.22 2.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.049 0.452 . . . . 62.539999999999999 111.827 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.774 ' HG3' ' HD2' ' A' ' 86' ' ' PRO . 22.9 mm-40 -129.36 16.13 6.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.795 -0.639 . . . . 73.310000000000002 109.422 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.92 123.91 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.478 -0.783 . . . . 75.219999999999999 111.86 -172.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.43 114.76 29.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.701 -0.681 . . . . 71.010000000000005 109.512 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.633 HG21 HG12 ' A' ' 121' ' ' VAL . 61.3 t -109.52 123.24 65.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.131 -0.486 . . . . 74.109999999999999 111.313 -175.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.867 HG21 ' HB ' ' A' ' 133' ' ' VAL . 30.8 pt -107.72 117.33 53.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.952 -0.567 . . . . 74.430000000000007 110.271 177.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -132.79 162.25 31.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.064 0.459 . . . . 74.349999999999994 111.375 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -84.76 121.75 28.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.327 -0.851 . . . . 60.420000000000002 109.53 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 114' ' ' GLY . 1.5 mm-40 -127.5 135.74 50.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.289 0.566 . . . . 73.530000000000001 111.998 -171.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.29 -7.02 59.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.579 -0.737 . . . . 71.040000000000006 110.218 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.48 -34.92 64.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.318 -0.855 . . . . 75.530000000000001 111.513 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.509 ' HB ' ' HA3' ' A' ' 136' ' ' GLY . 1.1 mp -111.02 141.37 26.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.096 -0.502 . . . . 74.519999999999996 109.716 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.643 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 41.9 m-20 -67.93 147.02 53.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.355 -0.609 . . . . 73.420000000000002 109.355 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.709 ' HE1' ' HB2' ' A' ' 161' ' ' GLU . 13.8 t80 -63.03 137.55 58.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.099 0.476 . . . . 73.439999999999998 111.323 -171.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.514 ' O ' ' HD3' ' A' ' 103' ' ' ARG . . . 133.51 -39.84 1.67 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.576 -0.738 . . . . 70.400000000000006 112.067 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.514 ' HD3' ' O ' ' A' ' 102' ' ' GLY . 62.1 mmt-85 -131.96 164.51 25.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.715 0.293 . . . . 65.329999999999998 110.305 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.707 HG23 ' HA ' ' A' ' 135' ' ' ILE . 37.2 pt -117.62 160.85 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 71.450000000000003 110.618 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.462 ' HD2' HG13 ' A' ' 99' ' ' ILE . 92.6 mtt180 -123.23 129.52 51.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.994 0.426 . . . . 73.5 110.923 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.583 ' HG ' HG13 ' A' ' 133' ' ' VAL . 4.7 mp -114.53 129.77 56.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.906 -0.588 . . . . 72.319999999999993 109.823 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -155.52 153.47 30.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.701 0.286 . . . . 73.209999999999994 110.283 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.748 ' H ' HD21 ' A' ' 108' ' ' LEU . 1.3 pt? -87.43 94.09 9.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.571 . . . . 71.430000000000007 110.11 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.51 ' O ' ' HD3' ' A' ' 132' ' ' ARG . . . 172.81 -150.55 12.62 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.795 -0.639 . . . . 71.040000000000006 111.797 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.87 -157.05 25.35 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.935 -0.65 . . . . 64.310000000000002 112.223 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.658 ' HA3' HD13 ' A' ' 118' ' ' LEU . . . -130.91 132.05 6.7 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.106 -0.569 . . . . 71.25 111.867 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -112.73 6.79 18.33 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.742 0.275 . . . . 72.310000000000002 111.742 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.41 -92.26 1.55 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.527 -0.845 . . . . 73.420000000000002 111.341 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 116' ' ' ASN . . . -69.11 -45.09 63.46 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.883 -0.887 . . . . 74.310000000000002 110.883 174.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 76.0 t60 70.52 -24.59 0.16 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.869 0.692 . . . . 73.349999999999994 112.869 172.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 114' ' ' GLY . 28.5 t-20 -51.52 -66.35 0.4 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.694 0.627 . . . . 61.409999999999997 112.694 -173.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.93 -10.21 85.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.144 -1.027 . . . . 73.420000000000002 113.037 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.658 HD13 ' HA3' ' A' ' 111' ' ' GLY . 94.7 mt -84.36 -38.08 20.75 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.704 -0.292 . . . . 71.219999999999999 111.372 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 120' ' ' SER . 6.6 ptm180 -65.25 -37.16 86.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 75.310000000000002 110.845 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.435 ' N ' ' HG3' ' A' ' 119' ' ' ARG . 10.0 m -60.02 -41.4 92.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.994 -0.548 . . . . 75.019999999999996 110.774 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.633 HG12 HG21 ' A' ' 92' ' ' VAL . 59.9 t -69.63 -40.33 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 75.140000000000001 110.163 177.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.419 ' HA ' HH22 ' A' ' 132' ' ' ARG . . . -63.48 -46.66 85.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.836 -0.62 . . . . 61.32 111.045 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.1 m -72.23 -27.9 62.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.292 -0.413 . . . . 75.409999999999997 111.751 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.61 66.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.93 0.395 . . . . 72.310000000000002 111.033 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.6 mt -82.27 -32.21 29.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.897 -0.592 . . . . 64.519999999999996 110.793 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 108.12 -11.64 37.27 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.96 -0.564 . . . . 74.209999999999994 111.787 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.2 t -166.01 177.56 6.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.451 -0.574 . . . . 74.010000000000005 109.451 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.622 ' HD2' ' N ' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -60.21 -30.26 69.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.847 0.356 . . . . 74.120000000000005 110.408 174.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.622 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 9.2 t30 66.11 -13.88 0.15 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.213 1.005 . . . . 75.209999999999994 112.948 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 128' ' ' LYS . 3.4 t80 175.37 -84.5 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 122.464 0.306 . . . . 75.239999999999995 110.273 175.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -161.01 161.39 31.47 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.791 0.329 . . . . 72.340000000000003 111.737 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' A' ' 109' ' ' GLY . 5.6 mpt_? -132.3 166.19 22.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.947 -0.57 . . . . 73.439999999999998 109.603 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.867 ' HB ' HG21 ' A' ' 93' ' ' ILE . 59.0 t -123.44 124.92 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.24 -0.436 . . . . 75.129999999999995 109.825 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.462 ' CB ' HD11 ' A' ' 99' ' ' ILE . 98.1 mtt180 -98.74 115.65 29.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.954 -0.566 . . . . 72.409999999999997 110.009 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.707 ' HA ' HG23 ' A' ' 104' ' ' ILE . 2.7 mp -87.89 117.59 32.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.341 -0.614 . . . . 74.409999999999997 109.341 176.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.509 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . -72.5 108.75 2.59 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.905 -0.664 . . . . 62.43 113.555 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.496 ' HA ' ' CD2' ' A' ' 101' ' ' PHE . 15.0 p -92.35 -16.21 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.562 0.696 . . . . 74.140000000000001 109.888 174.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.643 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 89.98 169.75 43.73 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.453 -0.794 . . . . 34.119999999999997 111.851 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.405 ' O ' ' HD3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -102.85 101.48 21.21 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 110.194 -0.298 . . . . 75.230000000000004 110.194 177.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 138' ' ' GLY . 2.9 Cg_exo -76.36 110.41 3.06 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.813 2.342 . . . . 75.200000000000003 111.388 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 139' ' ' ARG . 87.5 Cg_endo -80.25 143.96 16.1 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.554 2.169 . . . . 74.540000000000006 111.863 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 178.91 179.32 48.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.596 -0.811 . . . . 63.539999999999999 112.008 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -102.01 -4.13 26.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.64 0.733 . . . . 75.510000000000005 109.946 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -116.87 148.22 41.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.177 -1.416 . . . . 73.230000000000004 107.177 167.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -61.18 138.24 94.4 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.683 0.278 . . . . 61.450000000000003 110.777 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.609 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 18.5 Cg_endo -58.86 -9.59 7.92 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.246 2.631 . . . . 74.430000000000007 112.097 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.31 59.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.305 -0.861 . . . . 51.350000000000001 111.597 176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.33 -23.5 24.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 71.209999999999994 111.606 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.609 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 92.7 m-85 -84.09 -34.36 24.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.872 0.368 . . . . 70.099999999999994 111.245 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.71 -18.35 22.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 74.409999999999997 111.726 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.44 HD11 ' HG2' ' A' ' 152' ' ' GLU . 4.5 pp -86.28 -8.85 57.43 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.808 -0.357 . . . . 74.129999999999995 111.395 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 10.6 pt-20 -156.97 102.64 2.0 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.252 0.549 . . . . 75.530000000000001 110.775 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -134.54 136.69 43.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.706 -0.398 . . . . 73.409999999999997 110.586 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -122.42 19.07 10.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.029 -0.532 . . . . 74.310000000000002 110.538 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.523 ' O ' ' HG3' ' A' ' 158' ' ' GLU . 96.9 m -62.17 120.85 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.852 -0.613 . . . . 72.450000000000003 110.732 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.32 79.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 74.530000000000001 111.743 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.85 -53.78 53.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.11 -0.495 . . . . 74.219999999999999 111.524 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.566 ' O ' HG22 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -67.85 -37.2 81.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.661 -0.245 . . . . 71.209999999999994 110.95 -176.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -58.68 -29.17 66.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 73.209999999999994 111.312 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.02 -18.81 35.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.33 -0.395 . . . . 74.150000000000006 111.535 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.709 ' HB2' ' HE1' ' A' ' 101' ' ' PHE . 40.3 mt-10 -99.08 -6.7 27.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.68 0.276 . . . . 64.540000000000006 111.363 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 158' ' ' GLU . 89.8 t -69.75 -58.53 5.45 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.626 -0.261 . . . . 75.450000000000003 111.673 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 18.5 Cg_endo -59.58 -35.21 96.02 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.3 2.0 . . . . 72.439999999999998 112.878 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.6 p -62.1 -42.71 99.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 74.439999999999998 111.177 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.1 mt -65.62 -47.05 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 74.549999999999997 110.492 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.43 -50.84 78.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 74.010000000000005 111.48 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -60.79 -45.57 93.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 73.209999999999994 111.556 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -73.87 -26.23 60.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.696 0.284 . . . . 72.25 111.603 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.06 68.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.526 -0.306 . . . . 73.040000000000006 111.465 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.51 -51.42 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.511 -0.313 . . . . 72.129999999999995 111.33 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.59 -46.69 88.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.122 0.487 . . . . 65.420000000000002 110.488 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.89 -47.26 78.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.807 -0.633 . . . . 75.129999999999995 111.601 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.7 m -64.09 -39.87 94.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 74.420000000000002 110.917 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.651 ' HG2' ' HB1' ' A' ' 56' ' ' ALA . 21.8 tt0 -61.14 -47.31 86.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.602 -0.272 . . . . 64.310000000000002 110.41 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.9 tp -68.26 -31.31 70.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 74.439999999999998 111.242 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.686 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.9 tt -62.73 -46.16 89.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.377 0.608 . . . . 75.5 109.551 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.671 HG22 ' HB ' ' A' ' 58' ' ' THR . 79.2 mt -73.52 -25.26 20.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.235 -0.893 . . . . 70.409999999999997 110.4 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.24 -68.19 0.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.76 -0.654 . . . . 72.420000000000002 111.815 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -144.24 -40.58 0.27 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.856 0.687 . . . . 75.519999999999996 112.856 -172.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.686 ' O ' ' HA ' ' A' ' 176' ' ' LEU . . . -106.38 114.4 4.42 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.759 -1.21 . . . . 73.310000000000002 113.663 -170.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.42 ' HA ' ' HG ' ' A' ' 176' ' ' LEU . 6.1 tt -91.22 -54.41 3.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.456 -0.572 . . . . 55.450000000000003 109.456 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -70.31 -40.73 12.37 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 74.439999999999998 111.741 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -48.28 -38.8 34.46 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.026 1.817 . . . . 70.25 112.27 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -65.81 -43.33 88.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.095 -0.502 . . . . 73.049999999999997 110.636 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -57.81 -45.71 85.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.957 0.408 . . . . 72.299999999999997 110.508 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -66.03 -49.73 66.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 72.420000000000002 111.617 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 184' ' ' ALA . 12.1 t -60.54 -38.02 83.09 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.093 -0.243 . . . . 74.129999999999995 111.509 -174.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.708 ' HA ' ' HD1' ' A' ' 191' ' ' TRP . 72.0 t -60.23 -28.45 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.987 0.423 . . . . 74.420000000000002 111.106 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -76.34 -10.47 59.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.376 -0.375 . . . . 73.400000000000006 111.035 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -115.73 13.29 16.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.126 0.417 . . . . 50.200000000000003 112.126 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.708 ' HD1' ' HA ' ' A' ' 188' ' ' VAL . 93.1 m95 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.652 -0.689 . . . . 75.230000000000004 110.077 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 120.872 0.368 . . . . 64.340000000000003 110.275 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.9 126.99 48.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 74.409999999999997 110.483 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -86.5 126.12 65.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.184 -0.462 . . . . 71.129999999999995 110.695 -178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 59' ' ' SER . 56.2 Cg_endo -92.55 107.26 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.187 2.591 . . . . 74.219999999999999 112.097 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.709 HD22 HG22 ' A' ' 177' ' ' ILE . 4.3 pp -89.21 157.71 18.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.307 -0.406 . . . . 75.430000000000007 110.647 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.414 ' HB2' HG12 ' A' ' 85' ' ' VAL . 47.5 tp -117.91 120.85 39.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.048 0.451 . . . . 74.439999999999998 111.281 -174.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.717 ' HB ' HD21 ' A' ' 62' ' ' LEU . 48.5 t -112.16 110.49 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.943 -0.571 . . . . 73.230000000000004 109.613 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.725 ' HB ' HG21 ' A' ' 92' ' ' VAL . 47.8 t -110.3 124.32 66.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 110.2 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.38 157.37 15.0 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.416 -0.897 . . . . 62.130000000000003 111.368 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.441 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -64.15 107.62 1.34 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.595 -0.891 . . . . 74.030000000000001 108.595 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.586 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -74.15 -176.89 35.76 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.673 -0.694 . . . . 73.340000000000003 113.523 -172.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -111.33 98.3 39.34 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.601 -0.518 . . . . 75.120000000000005 109.601 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.474 ' HB2' ' OH ' ' A' ' 17' ' ' TYR . 14.5 Cg_exo -67.8 -31.35 32.15 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.857 2.371 . . . . 71.439999999999998 112.445 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.78 -176.22 43.83 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.589 -0.815 . . . . 71.109999999999999 112.248 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.37 -159.43 0.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.907 2.405 . . . . 70.439999999999998 112.312 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m 70.64 -70.82 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.081 -0.509 . . . . 75.299999999999997 111.324 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' OH ' ' HB2' ' A' ' 13' ' ' PRO . 28.7 p90 -88.63 3.51 50.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.965 0.412 . . . . 75.310000000000002 110.99 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.79 -1.57 4.04 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.879 -0.6 . . . . 70.129999999999995 112.371 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -100.62 18.5 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.33 . . . . 75.209999999999994 110.751 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.8 p -100.56 167.28 10.45 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.908 -0.405 . . . . 72.219999999999999 109.908 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 24' ' ' LEU . 22.4 ptt180 -84.38 -0.38 52.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.531 -0.304 . . . . 74.209999999999994 110.944 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.633 ' CD2' ' HA ' ' A' ' 150' ' ' VAL . 97.8 m-70 -86.21 -29.75 22.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.824 0.345 . . . . 72.109999999999999 110.944 -172.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -88.26 28.31 1.1 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.323 0.582 . . . . 75.540000000000006 109.88 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 2.4 pt? -67.28 -27.15 66.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.563 -0.744 . . . . 73.340000000000003 111.318 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.441 ' HA3' ' N ' ' A' ' 10' ' ' LEU . . . -59.23 -44.41 96.48 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.81 -0.709 . . . . 64.319999999999993 111.896 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.586 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 56.8 t80 -65.19 -35.8 82.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.743 0.306 . . . . 73.25 110.521 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 82.9 mmm -83.26 -47.27 11.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.704 -0.68 . . . . 74.310000000000002 111.989 -171.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.4 t -63.41 -42.12 95.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.14 0.495 . . . . 73.120000000000005 110.256 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.504 ' HB2' ' HE2' ' A' ' 64' ' ' LYS . . . -67.18 -20.95 65.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.964 -0.562 . . . . 61.229999999999997 110.718 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.41 ' HA ' ' HZ2' ' A' ' 64' ' ' LYS . 21.7 t70 -77.16 -43.17 34.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.978 -0.555 . . . . 71.030000000000001 111.031 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 36.0 m -71.23 -37.87 67.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.53 -0.305 . . . . 72.420000000000002 111.568 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.73 -24.83 62.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.042 0.449 . . . . 74.420000000000002 110.472 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 38' ' ' SER . . . -66.45 -46.74 75.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 71.319999999999993 110.158 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.76 -18.57 61.94 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.866 -0.607 . . . . 74.540000000000006 112.395 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 14.3 mmt85 -76.1 -58.15 3.45 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.766 0.284 . . . . 70.430000000000007 111.766 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.29 -15.4 14.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.873 0.368 . . . . 74.140000000000001 111.199 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.09 45.86 2.97 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.653 -0.979 . . . . 74.239999999999995 110.653 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.9 t -110.19 121.24 44.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.756 -0.722 . . . . 74.219999999999999 110.358 -173.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.83 126.62 55.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.347 -0.388 . . . . 72.25 110.242 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.446 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 48.4 p90 -106.0 137.81 43.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.044 0.45 . . . . 71.329999999999998 110.251 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -127.41 168.07 15.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.947 -0.57 . . . . 74.329999999999998 110.369 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.714 HG23 ' HG2' ' A' ' 49' ' ' GLU . 38.8 t -86.07 102.38 11.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.46 -0.57 . . . . 75.439999999999998 109.46 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.443 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 21.1 t-80 -79.58 85.03 5.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.921 -0.77 . . . . 75.230000000000004 108.921 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -66.55 96.8 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.559 0.695 . . . . 75.420000000000002 111.017 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 167.78 -55.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.47 -2.048 . . . . 73.420000000000002 105.47 -173.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.3 p -105.53 28.91 6.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.569 -2.105 . . . . 74.150000000000006 107.348 168.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 43' ' ' HIS . . . -49.92 43.27 0.01 OUTLIER Glycine 0 N--CA 1.476 1.356 0 N-CA-C 120.087 2.795 . . . . 71.450000000000003 120.087 -150.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.13 163.75 15.32 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.791 -1.189 . . . . 71.030000000000001 107.791 161.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.714 ' HG2' HG23 ' A' ' 42' ' ' VAL . 43.5 mt-10 -80.86 117.07 21.18 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.391 -0.524 . . . . 72.450000000000003 109.957 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.693 HG11 ' HA ' ' A' ' 63' ' ' ALA . 31.1 m -138.34 150.92 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 71.219999999999999 111.501 -173.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.28 137.71 56.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.774 -0.648 . . . . 73.120000000000005 109.961 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -111.3 125.64 54.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.688 0.28 . . . . 65.420000000000002 111.312 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.52 -167.75 24.46 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.007 -0.615 . . . . 74.230000000000004 111.621 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -136.96 104.38 5.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.084 0.442 . . . . 75.310000000000002 110.144 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HG ' HG23 ' A' ' 60' ' ' VAL . 88.6 mt -89.78 131.19 35.86 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.619 -0.511 . . . . 73.439999999999998 109.619 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.85 9.01 4.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.228 -0.442 . . . . 73.340000000000003 111.564 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.75 -28.17 13.02 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.041 -0.599 . . . . 74.340000000000003 112.473 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.555 ' HB ' ' CG2' ' A' ' 177' ' ' ILE . 9.8 m -84.03 139.08 32.75 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.211 -0.292 . . . . 75.120000000000005 110.211 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.536 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 20.3 m -70.47 132.12 45.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.841 0.353 . . . . 45.530000000000001 110.601 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.564 HG23 ' HG ' ' A' ' 55' ' ' LEU . 34.1 m -126.44 136.47 60.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.124 0.488 . . . . 72.120000000000005 111.132 -176.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.2 112.71 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.829 -0.623 . . . . 75.0 109.629 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.717 HD21 ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -94.99 119.78 34.08 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.358 -0.608 . . . . 63.229999999999997 109.358 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.693 ' HA ' HG11 ' A' ' 50' ' ' VAL . . . -111.87 124.28 52.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.962 0.41 . . . . 72.140000000000001 111.587 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.504 ' HE2' ' HB2' ' A' ' 29' ' ' ALA . 91.5 mttt -119.88 107.28 40.34 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.051 -0.522 . . . . 63.450000000000003 110.242 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.449 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 4.7 Cg_exo -75.12 151.57 39.17 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.961 2.441 . . . . 73.510000000000005 112.405 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -110.44 16.53 21.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.288 0.566 . . . . 73.340000000000003 109.714 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.693 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 58.4 m -112.8 168.86 9.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.722 -0.672 . . . . 73.209999999999994 110.882 -174.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -72.23 173.84 8.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.054 -0.521 . . . . 75.340000000000003 110.73 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -19.24 65.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.379 -0.373 . . . . 75.540000000000006 111.699 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -87.91 -19.99 26.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.359 0.599 . . . . 72.420000000000002 110.163 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 36.6 mt-10 -100.46 -28.16 13.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.021 -0.536 . . . . 72.239999999999995 110.957 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.4 ' O ' HG21 ' A' ' 76' ' ' VAL . 14.0 p -57.73 -37.62 73.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 52.020000000000003 111.177 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.24 -32.38 76.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.181 -0.533 . . . . 65.439999999999998 112.412 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.638 HH11 ' HB2' ' A' ' 124' ' ' ALA . 26.8 mmt180 -76.73 -31.36 57.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.748 0.309 . . . . 74.430000000000007 110.698 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 78.8 mm-40 -69.66 -28.66 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 72.540000000000006 110.861 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 72' ' ' SER . 46.6 t -66.52 -30.27 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 74.140000000000001 110.773 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.62 -67.1 2.32 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 116.044 -0.525 . . . . 45.520000000000003 113.154 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.54 -43.46 39.33 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.442 2.095 . . . . 73.049999999999997 112.227 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -54.88 -51.59 65.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 110.755 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.49 84.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.119 -0.492 . . . . 44.43 111.547 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -77.49 -31.87 53.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 111.724 0.268 . . . . 74.340000000000003 111.724 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -65.86 -46.45 78.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.615 0.245 . . . . 73.540000000000006 111.262 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -90.8 -17.08 27.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.669 -0.241 . . . . 71.230000000000004 111.313 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.0 t 59.98 72.77 0.51 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.443 0.639 . . . . 75.519999999999996 110.47 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.445 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 27.8 m -98.15 139.73 21.43 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 73.239999999999995 111.188 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 13.1 Cg_exo -70.57 129.53 16.89 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.909 2.406 . . . . 71.349999999999994 111.797 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 18.3 Cg_exo -67.33 -4.4 11.73 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.133 2.555 . . . . 73.420000000000002 113.292 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -89.6 -12.18 40.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.876 0.37 . . . . 63.039999999999999 110.745 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.424 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 9.3 mm-40 -129.73 45.01 2.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.414 0.626 . . . . 75.450000000000003 110.566 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.561 HG23 ' HB3' ' A' ' 131' ' ' HIS . 10.4 tt -120.54 127.7 75.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.819 -0.628 . . . . 74.319999999999993 109.864 175.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.37 146.21 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.131 -0.486 . . . . 63.409999999999997 110.456 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.725 HG21 ' HB ' ' A' ' 8' ' ' VAL . 86.1 t -134.07 124.23 45.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.848 0.356 . . . . 73.109999999999999 110.744 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 mm -75.23 130.65 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.61 -0.723 . . . . 73.109999999999999 111.689 -175.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -143.42 141.9 31.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 74.310000000000002 110.166 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.636 ' HB2' HG21 ' A' ' 137' ' ' VAL . 4.6 p-10 -87.29 122.32 30.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.928 -0.767 . . . . 73.439999999999998 108.928 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.455 ' OE1' ' HD2' ' A' ' 134' ' ' ARG . 10.5 tp10 -99.62 118.63 36.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.675 -0.693 . . . . 62.43 110.982 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.3 pp -82.59 -20.7 35.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.474 -0.784 . . . . 70.049999999999997 111.253 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -78.63 -20.45 50.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.1 0.476 . . . . 65.439999999999998 110.742 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.438 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 66.0 mt -102.28 122.92 55.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 109.777 176.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.441 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 13.6 m-20 -62.13 149.87 40.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.281 -0.418 . . . . 63.409999999999997 110.839 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.861 ' HD2' ' HA ' ' A' ' 137' ' ' VAL . 29.4 t80 -65.61 133.76 51.85 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.18 -0.464 . . . . 75.120000000000005 110.918 -174.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.93 -62.29 0.32 Allowed Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.827 -0.624 . . . . 72.129999999999995 112.294 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -126.3 165.38 19.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.716 0.293 . . . . 75.209999999999994 110.263 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.637 HG23 ' HA ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER -118.57 159.18 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 110.173 -178.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -144.82 163.0 35.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.029 0.442 . . . . 74.409999999999997 110.94 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.0 mt -108.62 152.56 24.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.737 -0.665 . . . . 64.230000000000004 109.602 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -129.58 105.1 7.84 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.835 -0.346 . . . . 73.329999999999998 110.914 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 181' ' ' LEU . 85.6 mt -110.33 91.84 3.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 75.510000000000005 109.987 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.65 -132.18 2.71 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.058 -0.817 . . . . 71.340000000000003 111.058 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.63 109.58 3.24 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.718 -0.953 . . . . 74.540000000000006 110.718 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.75 161.33 31.77 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.074 -1.06 . . . . 55.350000000000001 112.977 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.62 171.01 10.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.279 -0.461 . . . . 72.129999999999995 110.413 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.93 45.36 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.187 -0.765 . . . . 54.219999999999999 111.187 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.35 81.72 1.31 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.58 -1.008 . . . . 74.439999999999998 110.58 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -52.07 -50.56 61.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.444 0.535 . . . . 75.430000000000007 112.444 -170.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.55 -3.03 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.808 -0.357 . . . . 71.5 111.409 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.1 -33.59 7.65 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.954 -0.859 . . . . 72.299999999999997 110.954 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.8 -30.19 65.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.531 -0.544 . . . . 74.5 109.531 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -51.33 -50.28 59.75 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.153 -0.93 . . . . 73.019999999999996 111.683 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.2 p -72.81 -45.35 58.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.891 0.377 . . . . 75.439999999999998 111.326 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.61 HG13 ' HE1' ' A' ' 131' ' ' HIS . 59.3 t -65.79 -47.96 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.069 -0.514 . . . . 65.049999999999997 111.87 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.41 ' HA ' HD22 ' A' ' 129' ' ' ASN . . . -63.3 -38.48 91.31 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.987 0.366 . . . . 61.240000000000002 111.987 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.9 p -76.6 -29.21 56.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.631 -0.259 . . . . 53.32 111.193 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.638 ' HB2' HH11 ' A' ' 74' ' ' ARG . . . -79.35 -49.46 12.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 111.676 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -84.67 -41.78 15.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.352 -0.385 . . . . 72.329999999999998 111.536 -174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.95 -12.6 65.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.808 -0.711 . . . . 61.210000000000001 112.357 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.1 t -71.96 164.4 26.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.887 0.375 . . . . 74.120000000000005 110.793 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.86 -11.82 60.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 74.099999999999994 110.64 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 122' ' ' ALA . 86.9 m-20 66.09 79.14 0.25 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.579 -0.737 . . . . 72.510000000000005 112.329 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.416 ' HB3' HD23 ' A' ' 108' ' ' LEU . 99.3 m-85 -83.56 -22.85 32.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.212 0.53 . . . . 74.230000000000004 110.032 174.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.61 ' HE1' HG13 ' A' ' 121' ' ' VAL . 13.1 p80 -68.63 87.61 0.34 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.445 -0.798 . . . . 70.310000000000002 112.347 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -142.89 109.56 5.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.257 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.4 t -101.87 109.02 24.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.637 -0.875 . . . . 75.409999999999997 108.637 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.455 ' HD2' ' OE1' ' A' ' 96' ' ' GLU . 38.9 mtm180 -99.1 106.43 18.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.071 0.462 . . . . 75.530000000000001 110.93 -175.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.637 ' HA ' HG23 ' A' ' 104' ' ' ILE . 3.0 mp -85.1 114.78 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.701 -0.681 . . . . 74.219999999999999 109.362 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.738 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -65.29 101.93 0.61 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.768 -0.729 . . . . 63.310000000000002 111.583 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.861 ' HA ' ' HD2' ' A' ' 101' ' ' PHE . 3.5 m -111.2 -7.37 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.255 0.465 . . . . 74.230000000000004 112.255 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 86.87 167.68 44.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 73.129999999999995 112.72 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.463 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.5 ptm180 -111.48 124.34 32.82 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.044 0.449 . . . . 73.349999999999994 110.984 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 9.5 Cg_endo -90.07 115.37 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.57 2.846 . . . . 74.540000000000006 112.259 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -93.23 155.9 2.58 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.962 2.441 . . . . 75.319999999999993 113.18 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.62 -161.78 29.97 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.258 -0.737 . . . . 53.340000000000003 111.258 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -78.12 -19.31 54.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.196 0.522 . . . . 71.219999999999999 110.161 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -108.38 150.74 26.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.478 -0.783 . . . . 75.049999999999997 109.451 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.23 164.02 56.65 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.325 -0.398 . . . . 73.129999999999995 110.251 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.536 ' HA ' ' CD1' ' A' ' 149' ' ' PHE . 62.6 Cg_exo -53.58 -14.33 4.88 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.14 2.56 . . . . 74.319999999999993 113.292 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.94 -22.79 63.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 74.239999999999995 111.567 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.75 -26.87 22.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.394 0.616 . . . . 72.299999999999997 110.473 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 146' ' ' PRO . 68.5 m-85 -64.42 -15.95 61.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.044 -0.98 . . . . 72.129999999999995 112.038 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.633 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 33.6 m -55.48 -28.75 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 111.859 0.318 . . . . 71.420000000000002 111.859 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.492 ' HG ' HG23 ' A' ' 150' ' ' VAL . 86.6 mt -105.58 -27.15 11.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.921 0.391 . . . . 75.5 110.871 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -128.59 93.52 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.491 0.663 . . . . 72.319999999999993 110.272 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 149' ' ' PHE . 3.8 t30 -125.11 101.31 6.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.634 . . . . 74.5 110.491 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -132.13 102.13 5.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.286 0.565 . . . . 63.200000000000003 110.527 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.879 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 6.5 m -125.73 132.38 52.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.011 -0.541 . . . . 64.420000000000002 109.887 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.76 73.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.971 0.415 . . . . 72.049999999999997 110.868 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.65 -38.95 93.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.832 -0.622 . . . . 75.239999999999995 112.044 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.879 ' HG2' ' HB ' ' A' ' 155' ' ' THR . 10.5 pt-20 -72.58 -40.45 66.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.876 -0.33 . . . . 75.409999999999997 111.261 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.432 ' HA ' HG21 ' A' ' 162' ' ' VAL . 25.6 mmm180 -66.82 -34.34 77.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.85 0.357 . . . . 75.219999999999999 110.808 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.49 62.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.428 -0.805 . . . . 75.109999999999999 112.376 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.634 ' HB2' ' HE1' ' A' ' 101' ' ' PHE . 59.7 mm-40 -100.68 13.38 34.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.337 0.495 . . . . 73.340000000000003 112.337 -174.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.604 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 55.2 t -54.38 -52.47 68.96 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.035 -0.266 . . . . 74.310000000000002 110.798 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 53.9 Cg_exo -54.55 -25.89 43.0 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.142 1.895 . . . . 75.510000000000005 113.24 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.5 m -74.28 -48.21 29.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.057 0.456 . . . . 73.25 110.684 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.24 -33.59 64.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.962 -0.563 . . . . 74.530000000000001 111.34 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.507 HG21 ' O ' ' A' ' 162' ' ' VAL . 98.1 t -53.35 -39.1 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.835 0.35 . . . . 75.519999999999996 111.419 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -71.57 -50.07 34.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.46 -0.336 . . . . 73.120000000000005 111.29 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.528 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . 9.1 mm-40 -60.84 -42.78 98.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.783 0.325 . . . . 71.109999999999999 111.385 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.13 -22.98 67.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.237 -0.438 . . . . 61.310000000000002 111.641 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.39 -44.16 15.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.855 0.36 . . . . 51.039999999999999 111.742 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -85.05 -36.29 21.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.555 -0.293 . . . . 73.530000000000001 111.618 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.33 -43.67 73.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.843 0.312 . . . . 72.230000000000004 111.843 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.506 ' HA ' HD12 ' A' ' 176' ' ' LEU . 22.0 p -63.05 -31.49 72.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 65.519999999999996 111.69 -175.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.45 -26.4 66.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.278 -0.419 . . . . 73.109999999999999 110.821 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.72 -29.76 66.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.708 0.29 . . . . 74.310000000000002 110.593 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 173' ' ' THR . 8.3 mp -64.66 -36.5 84.47 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.482 0.658 . . . . 70.310000000000002 109.502 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.709 HG22 HD22 ' A' ' 5' ' ' LEU . 34.5 mt -76.99 -37.36 26.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.892 -1.049 . . . . 74.5 110.023 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.85 -48.84 67.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.57 -0.741 . . . . 61.240000000000002 111.364 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -133.22 -67.56 0.62 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.431 -0.35 . . . . 73.030000000000001 111.201 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.4 -178.32 46.09 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.749 -0.739 . . . . 73.400000000000006 111.886 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 108' ' ' LEU . 3.7 pp -89.87 -12.94 37.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.965 0.412 . . . . 74.019999999999996 110.584 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.703 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 6.5 tm-20 -53.68 -54.13 49.62 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.508 -0.769 . . . . 74.329999999999998 111.797 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 11.0 Cg_exo -71.19 -31.98 13.69 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 121.644 1.563 . . . . 62.200000000000003 112.176 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.59 -26.01 57.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 64.129999999999995 112.322 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 19.7 pt20 -62.29 -22.65 66.2 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.475 0.179 . . . . 74.150000000000006 111.444 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -85.98 -48.01 9.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.749 0.309 . . . . 73.420000000000002 110.657 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.6 m -53.22 -40.55 64.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.765 -0.652 . . . . 72.540000000000006 111.749 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.2 -12.75 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.62 0.6 . . . . 74.109999999999999 112.62 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -117.45 -28.58 6.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.614 0.245 . . . . 75.219999999999999 111.54 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.55 -17.15 39.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.586 -0.279 . . . . 72.319999999999993 111.607 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.3 m95 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.637 -0.697 . . . . 74.510000000000005 110.271 -179.535 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.242 0.544 . . . . 75.340000000000003 110.269 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -158.41 42.22 0.27 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.689 -0.687 . . . . 72.519999999999996 109.569 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.0 mp0 -84.44 142.93 40.82 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.611 -0.722 . . . . 73.310000000000002 110.554 -172.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 2.9 Cg_exo -76.21 117.85 4.77 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.137 2.558 . . . . 70.209999999999994 112.307 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.697 HD21 HG21 ' A' ' 177' ' ' ILE . 4.2 pp -121.89 149.25 43.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.291 -0.413 . . . . 73.040000000000006 110.246 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.469 ' HB3' HG12 ' A' ' 90' ' ' ILE . 64.8 tp -97.56 136.21 38.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.318 -0.401 . . . . 73.230000000000004 110.476 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.7 t -117.42 112.61 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.829 -0.434 . . . . 75.109999999999999 109.829 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.67 128.61 62.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 74.129999999999995 110.723 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.538 ' HA2' HG21 ' A' ' 93' ' ' ILE . . . -103.38 -177.06 26.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.198 -0.525 . . . . 72.519999999999996 112.095 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.549 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -142.53 158.74 43.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.362 . . . . 73.340000000000003 110.926 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 22' ' ' HIS . . . 155.86 -158.28 28.43 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.449 -0.661 . . . . 60.399999999999999 111.449 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 61.0 t30 -163.08 105.32 1.01 Allowed Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.116 -0.328 . . . . 72.340000000000003 110.116 176.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.2 142.25 41.27 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.751 2.301 . . . . 72.420000000000002 112.271 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.62 177.92 39.9 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.754 -0.736 . . . . 44.149999999999999 111.849 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.4 -66.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.699 2.266 . . . . 71.150000000000006 112.083 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 m -76.7 -25.56 53.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.319 0.581 . . . . 75.040000000000006 110.113 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.586 ' HA ' HG22 ' A' ' 20' ' ' THR . 80.9 m-85 -70.71 -23.14 62.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.567 -0.742 . . . . 71.450000000000003 111.748 -175.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.4 -17.27 63.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 73.120000000000005 110.28 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -106.73 20.63 18.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.604 -0.725 . . . . 74.25 111.277 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 17' ' ' TYR . 72.2 p -99.95 166.91 10.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.238 0.542 . . . . 74.439999999999998 110.385 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.519 ' HB3' HG21 ' A' ' 150' ' ' VAL . 17.5 tpt85 -93.76 1.56 56.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.912 -0.586 . . . . 74.319999999999993 111.1 -175.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.444 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 1.5 t-160 -106.81 11.04 30.56 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.909 -0.316 . . . . 71.129999999999995 111.549 -173.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -103.38 13.63 33.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 64.409999999999997 111.332 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.4 pt? -55.06 -39.96 69.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.837 -0.62 . . . . 74.319999999999993 112.144 -174.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA3' HD11 ' A' ' 10' ' ' LEU . . . -61.2 -55.29 30.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.034 -0.603 . . . . 71.310000000000002 112.971 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.528 ' CE1' ' HD2' ' A' ' 65' ' ' PRO . 20.1 m-30 -61.4 -39.52 91.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.717 0.294 . . . . 74.319999999999993 111.315 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.883 ' HE2' ' HA ' ' A' ' 27' ' ' MET . 16.3 mmt -68.83 -49.58 57.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.376 -0.374 . . . . 72.120000000000005 111.457 -176.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.27 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.359 . . . . 73.019999999999996 110.673 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.535 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -63.62 -34.93 78.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 73.420000000000002 111.446 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.38 -40.7 50.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.215 -0.448 . . . . 71.030000000000001 111.164 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.5 m -79.56 -21.13 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.547 0.573 . . . . 72.420000000000002 112.547 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -70.37 -26.05 63.54 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.326 -0.549 . . . . 74.129999999999995 110.712 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.411 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -71.54 -24.26 61.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.352 0.596 . . . . 51.340000000000003 110.158 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.64 -18.12 67.71 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.451 -0.795 . . . . 74.340000000000003 112.6 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -69.56 -32.44 71.22 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.046 0.45 . . . . 75.310000000000002 111.186 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 36' ' ' ILE . 4.2 mp -86.03 -15.57 10.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.989 -0.745 . . . . 75.25 108.989 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.76 41.04 15.97 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.711 -1.356 . . . . 73.299999999999997 109.711 -171.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 t -126.55 135.54 51.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.887 -0.656 . . . . 75.129999999999995 111.038 -169.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.04 128.31 9.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.045 -0.525 . . . . 75.25 110.215 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.531 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 7.3 t80 -107.86 -158.1 0.64 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.731 -0.47 . . . . 75.439999999999998 109.731 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -135.19 173.07 12.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 72.230000000000004 111.474 -171.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.435 ' HB ' ' OE2' ' A' ' 49' ' ' GLU . 2.7 p -70.52 108.26 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.585 -0.734 . . . . 73.5 111.216 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.464 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 17.4 t60 -102.25 75.67 1.51 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.256 -1.016 . . . . 74.409999999999997 108.256 174.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -56.31 122.29 11.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.598 -0.728 . . . . 73.049999999999997 112.174 -168.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -134.76 -90.93 0.33 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.662 -0.699 . . . . 71.340000000000003 109.496 168.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 78' ' ' PRO . 8.6 m -107.83 -41.25 5.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 118.898 -1.121 . . . . 73.239999999999995 111.556 171.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.79 1.68 4.73 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.369 -0.443 . . . . 73.540000000000006 112.573 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.526 ' HB2' HD22 ' A' ' 79' ' ' LEU . . . -75.58 99.4 4.26 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 115.585 1.698 . . . . 72.319999999999993 115.585 -154.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.628 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 20.7 mt-10 -116.28 115.46 25.98 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.357 -1.72 . . . . 74.5 106.357 151.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 31.8 m -137.56 151.27 26.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.257 -0.577 . . . . 75.430000000000007 112.384 -167.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 62' ' ' LEU . 5.9 p -124.63 125.83 70.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.418 -0.956 . . . . 74.239999999999995 108.418 166.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.5 m -103.17 113.08 26.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.078 0.466 . . . . 73.019999999999996 111.169 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.29 -161.22 8.97 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.811 -0.916 . . . . 63.299999999999997 110.811 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -138.34 129.68 27.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.291 0.545 . . . . 75.420000000000002 110.953 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.9 mt -102.87 117.03 33.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.035 -0.728 . . . . 74.109999999999999 109.035 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.44 -46.46 0.62 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.98 0.8 . . . . 72.239999999999995 111.66 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.83 -37.79 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.206 -0.521 . . . . 64.239999999999995 111.881 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -71.28 133.68 46.24 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.878 0.37 . . . . 70.329999999999998 111.294 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.5 p -74.07 125.74 28.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 72.230000000000004 110.756 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.594 HG11 HD13 ' A' ' 5' ' ' LEU . 33.6 m -111.23 136.44 47.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.102 -0.499 . . . . 74.129999999999995 110.896 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 t -102.76 101.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.759 -0.83 . . . . 75.150000000000006 108.759 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 3.3 tm? -91.09 111.57 23.1 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.169 -0.678 . . . . 73.310000000000002 109.169 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' GLU . . . -109.33 123.58 49.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.981 -0.554 . . . . 64.540000000000006 111.297 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.628 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -122.99 90.2 50.42 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.677 0.751 . . . . 75.230000000000004 109.674 175.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HD2' ' CE1' ' A' ' 26' ' ' PHE . 16.4 Cg_exo -68.95 166.67 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.704 2.269 . . . . 64.530000000000001 112.679 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -105.0 14.41 29.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.663 0.744 . . . . 75.329999999999998 109.06 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 63.3 m -102.16 138.51 39.01 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.73 -1.123 . . . . 74.519999999999996 108.866 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -66.65 166.8 12.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.093 0.473 . . . . 74.200000000000003 111.545 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.4 ptp -46.68 -31.56 2.99 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.39 1.256 . . . . 70.209999999999994 114.39 -169.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -77.99 -50.44 12.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.872 0.368 . . . . 73.319999999999993 111.142 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -78.56 -24.45 45.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.286 -0.416 . . . . 73.239999999999995 111.454 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.3 t -56.68 -39.4 73.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.388 -0.369 . . . . 74.540000000000006 110.433 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.07 -29.37 74.72 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.932 -0.576 . . . . 74.239999999999995 113.077 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -41.85 88.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.157 0.503 . . . . 74.299999999999997 110.914 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -84.22 -0.05 50.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.803 -0.635 . . . . 74.430000000000007 111.86 -171.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.2 t -70.74 -40.46 76.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.803 0.335 . . . . 73.200000000000003 110.444 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.97 -59.03 11.56 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 115.964 -0.562 . . . . 73.019999999999996 112.822 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HB2' ' OG ' ' A' ' 46' ' ' SER . 10.1 Cg_endo -56.2 -37.82 95.99 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.7 2.267 . . . . 74.439999999999998 112.749 175.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.526 HD22 ' HB2' ' A' ' 48' ' ' ALA . 2.9 tm? -69.11 -44.61 72.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.647 -0.251 . . . . 74.349999999999994 111.255 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.52 86.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.0 0.37 . . . . 53.420000000000002 112.0 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -72.9 -20.43 61.08 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.822 0.304 . . . . 75.019999999999996 111.822 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -71.07 -28.7 64.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.854 0.359 . . . . 74.420000000000002 110.753 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.02 0.01 37.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 72.129999999999995 110.169 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t 62.24 24.29 14.44 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.443 -0.798 . . . . 75.239999999999995 111.426 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.476 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 18.5 m -88.04 131.85 41.67 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.887 0.375 . . . . 75.299999999999997 111.09 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 19.4 Cg_exo -67.38 127.94 17.45 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.832 2.354 . . . . 75.439999999999998 111.605 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.681 ' HA ' HD13 ' A' ' 90' ' ' ILE . 39.7 Cg_exo -57.63 -27.51 77.46 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.991 2.46 . . . . 73.239999999999995 113.055 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -64.46 -27.68 69.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.48 -0.327 . . . . 71.030000000000001 111.659 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -103.88 17.59 23.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.159 0.504 . . . . 73.439999999999998 110.761 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.714 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 58.9 mt -90.45 145.45 7.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.403 -0.591 . . . . 65.5 109.403 175.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 m -118.12 134.67 61.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.164 0.507 . . . . 75.209999999999994 110.254 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.79 115.92 47.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.086 -0.506 . . . . 75.420000000000002 110.543 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.538 HG21 ' HA2' ' A' ' 9' ' ' GLY . 6.8 tt -87.67 126.02 41.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.923 -0.58 . . . . 75.409999999999997 109.542 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.99 173.5 11.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.399 0.618 . . . . 73.439999999999998 110.649 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -85.55 152.61 23.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.176 -0.92 . . . . 72.530000000000001 110.521 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.865 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 22.5 tt0 -123.35 94.72 4.34 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.423 0.63 . . . . 75.450000000000003 110.169 174.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.818 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.9 pt? -83.57 -0.33 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.332 -0.849 . . . . 73.329999999999998 110.073 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.404 ' CG ' HH12 ' A' ' 134' ' ' ARG . 1.6 m-20 -68.42 -36.42 79.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.711 . . . . 71.510000000000005 109.678 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 mm -123.29 149.19 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.515 -0.766 . . . . 75.109999999999999 110.244 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.782 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 8.8 p-10 -75.42 155.03 36.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 64.439999999999998 110.973 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.629 ' HD2' ' HB2' ' A' ' 158' ' ' GLU . 6.0 t80 -68.03 138.73 56.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.718 -0.674 . . . . 73.530000000000001 111.577 -173.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 160.07 -35.62 0.45 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.342 -0.845 . . . . 45.43 111.081 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -148.55 164.89 32.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 70.340000000000003 110.455 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.583 HD12 HG23 ' A' ' 188' ' ' VAL . 2.4 pp -118.21 162.97 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.382 -0.599 . . . . 74.129999999999995 109.382 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -141.0 153.32 45.5 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.702 -0.399 . . . . 75.140000000000001 110.446 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.636 HD23 ' HB2' ' A' ' 181' ' ' LEU . 60.3 tp -113.04 124.9 53.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.844 -0.616 . . . . 74.129999999999995 109.434 176.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -155.41 126.69 7.21 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.002 -0.74 . . . . 74.310000000000002 109.002 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 130' ' ' PHE . 88.0 mt -76.73 88.0 3.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.579 0.704 . . . . 74.310000000000002 109.638 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.6 147.72 5.16 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.31 -1.116 . . . . 75.299999999999997 110.31 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 132' ' ' ARG . . . 178.86 112.44 0.34 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.692 -1.242 . . . . 54.219999999999999 113.061 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.57 76.06 0.17 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.308 -0.717 . . . . 73.200000000000003 111.308 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -171.77 149.73 2.57 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.201 -0.666 . . . . 73.420000000000002 109.201 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.22 -67.77 2.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.959 -0.639 . . . . 72.120000000000005 111.825 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.93 69.3 3.27 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.901 -0.88 . . . . 70.510000000000005 110.901 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -48.45 -54.86 12.59 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.661 0.784 . . . . 73.230000000000004 111.734 -173.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -85.6 -41.6 15.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.258 -0.428 . . . . 55.520000000000003 110.981 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.81 -37.26 90.07 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 116.13 -0.487 . . . . 74.0 113.703 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.3 -27.89 29.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.972 0.386 . . . . 73.329999999999998 111.347 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -79.43 -36.7 38.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.499 -0.318 . . . . 73.530000000000001 111.568 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.9 m -58.76 -38.21 77.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 74.409999999999997 111.138 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.02 -42.93 82.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.987 0.422 . . . . 71.200000000000003 110.477 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.61 82.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.022 -0.536 . . . . 72.230000000000004 110.766 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t -63.42 -41.77 98.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 63.149999999999999 110.768 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.3 -32.09 69.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.31 -0.405 . . . . 65.409999999999997 111.672 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.53 -7.71 40.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.789 0.328 . . . . 74.420000000000002 111.669 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.45 -11.77 69.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.851 -0.69 . . . . 73.319999999999993 113.408 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 129' ' ' ASN . 15.4 t -169.88 177.97 4.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.832 0.316 . . . . 74.450000000000003 110.184 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.811 ' H ' ' HD2' ' A' ' 128' ' ' LYS . 8.9 mptt -56.13 -57.3 12.78 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.088 -0.708 . . . . 70.099999999999994 109.088 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.448 ' HB2' HG21 ' A' ' 127' ' ' THR . 8.9 t-20 67.32 24.35 9.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.337 -0.847 . . . . 64.420000000000002 111.946 166.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.491 ' HB3' HD21 ' A' ' 108' ' ' LEU . 54.9 m-85 63.52 -130.72 0.44 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.074 -0.512 . . . . 75.230000000000004 111.817 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.714 ' HB3' ' O ' ' A' ' 90' ' ' ILE . 4.6 p80 34.44 85.95 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.456 1.28 . . . . 73.519999999999996 114.456 -173.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.544 ' HD2' ' O ' ' A' ' 131' ' ' HIS . 9.3 mpt_? -135.58 108.46 7.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.867 -0.606 . . . . 75.340000000000003 110.187 171.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.466 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 46.4 t -112.7 100.2 10.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.431 -0.952 . . . . 71.120000000000005 108.431 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.865 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 69.7 mtp180 -109.98 124.85 52.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 72.409999999999997 112.021 -169.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.448 HD11 ' N ' ' A' ' 135' ' ' ILE . 3.1 mp -97.0 107.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.293 -0.867 . . . . 74.540000000000006 109.282 174.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -62.56 111.99 4.52 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 120.977 -0.63 . . . . 72.150000000000006 111.7 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.41 -10.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 111.968 0.359 . . . . 72.299999999999997 111.968 -175.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.782 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 151.89 130.08 1.58 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.063 -1.065 . . . . 65.230000000000004 112.433 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.578 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 28.5 ptt180 -86.03 159.69 53.73 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 110.238 -0.282 . . . . 74.340000000000003 110.238 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.598 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 51.6 Cg_exo -53.47 122.17 10.77 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.764 2.309 . . . . 74.439999999999998 112.799 -177.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.91 8.06 3.98 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.942 2.428 . . . . 71.349999999999994 112.24 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.0 -128.0 1.7 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.076 -0.583 . . . . 74.030000000000001 111.934 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -46.1 17.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.008 0.432 . . . . 74.340000000000003 110.543 -177.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 17.3 mmtp -87.69 133.14 33.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.533 0.683 . . . . 74.400000000000006 110.531 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.588 ' HB2' HD11 ' A' ' 97' ' ' LEU . 2.6 p-10 -74.63 158.64 84.7 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 114.773 -1.103 . . . . 72.25 110.781 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.598 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 32.5 Cg_exo -58.69 -16.22 29.71 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.958 2.438 . . . . 72.409999999999997 113.26 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.487 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -68.39 -21.19 64.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 72.329999999999998 111.317 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.41 -34.55 18.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.9 0.381 . . . . 72.219999999999999 111.233 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -84.35 -19.16 34.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.078 0.466 . . . . 73.420000000000002 111.331 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.519 HG21 ' HB3' ' A' ' 21' ' ' ARG . 5.2 p -72.17 5.15 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.596 -0.729 . . . . 74.010000000000005 112.391 -172.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.92 -5.86 37.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.013 0.375 . . . . 71.209999999999994 112.013 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -160.89 144.53 13.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.911 0.386 . . . . 73.239999999999995 111.492 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 67.31 -173.92 0.19 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.15 -0.932 . . . . 73.420000000000002 112.621 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -156.72 171.48 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 75.140000000000001 109.51 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.8 ' HB ' ' HG3' ' A' ' 158' ' ' GLU . 25.1 m -102.5 120.07 39.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.864 0.364 . . . . 72.349999999999994 110.944 -175.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.69 67.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 71.120000000000005 111.523 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.39 70.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 71.140000000000001 111.504 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.8 ' HG3' ' HB ' ' A' ' 155' ' ' THR . 1.5 pp20? -79.83 -20.83 45.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.692 0.282 . . . . 75.099999999999994 111.208 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.475 ' HA ' HG22 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -61.4 -20.36 62.97 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.241 0.543 . . . . 75.530000000000001 110.199 177.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.61 81.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.62 -0.718 . . . . 65.340000000000003 111.318 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -85.66 -7.86 58.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.41 . . . . 73.340000000000003 111.501 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.775 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 93.8 t -57.74 -59.07 14.23 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 111.953 0.353 . . . . 74.010000000000005 111.953 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.775 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 44.6 Cg_exo -57.37 -36.0 98.87 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.047 1.831 . . . . 65.540000000000006 112.129 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.5 m -71.35 -44.78 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.85 -0.614 . . . . 74.329999999999998 111.291 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 162' ' ' VAL . 7.1 tp -67.52 -30.1 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 73.319999999999993 111.035 -175.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 162' ' ' VAL . 92.8 t -64.88 -48.82 82.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.318 . . . . 75.109999999999999 110.473 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -63.21 -44.25 95.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 72.310000000000002 110.332 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.47 -45.45 90.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 71.439999999999998 111.093 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.6 -30.91 69.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 72.450000000000003 111.432 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -56.82 -49.35 75.64 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.143 0.277 . . . . 65.010000000000005 111.61 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.69 -43.1 98.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 73.439999999999998 111.094 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.68 69.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.817 -0.629 . . . . 61.340000000000003 111.573 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.457 ' O ' HG12 ' A' ' 177' ' ' ILE . 18.2 p -69.0 -39.04 79.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.964 0.357 . . . . 71.450000000000003 111.964 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -66.17 -40.26 90.38 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.029 -0.268 . . . . 72.219999999999999 110.87 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.4 tp -73.19 -30.89 63.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.986 0.422 . . . . 75.209999999999994 110.158 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.6 -49.3 77.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.554 -0.748 . . . . 73.150000000000006 109.427 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.697 HG21 HD21 ' A' ' 5' ' ' LEU . 45.1 mm -64.67 -31.37 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.143 -0.935 . . . . 62.32 111.207 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.5 -68.71 0.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 111.804 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -158.06 -38.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.751 0.31 . . . . 71.239999999999995 111.388 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -115.37 116.32 3.67 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.284 -0.96 . . . . 63.130000000000003 113.303 -173.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.636 ' HB2' HD23 ' A' ' 106' ' ' LEU . 4.2 pp -89.59 -20.51 23.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.363 0.601 . . . . 74.430000000000007 109.894 174.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.486 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 41.0 mt-10 -63.99 -50.13 71.19 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.39 -0.823 . . . . 54.240000000000002 111.691 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 13.9 Cg_endo -58.28 -32.38 95.82 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.91 1.74 . . . . 73.409999999999997 111.924 174.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.518 ' HA ' HG22 ' A' ' 187' ' ' THR . . . -64.28 -41.88 96.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.022 -0.535 . . . . 74.450000000000003 110.464 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.554 ' HG2' ' HB3' ' A' ' 106' ' ' LEU . 25.3 mt-30 -57.76 -34.69 69.83 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.098 -0.501 . . . . 73.430000000000007 110.553 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.49 -53.32 6.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.715 -0.675 . . . . 72.129999999999995 111.23 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 184' ' ' ALA . 8.8 t -62.46 -48.18 80.78 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.011 0.375 . . . . 73.219999999999999 112.011 -173.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.583 HG23 HD12 ' A' ' 104' ' ' ILE . 5.1 p -68.7 -14.07 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.96 0.41 . . . . 71.420000000000002 111.56 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -86.59 -8.18 57.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.117 0.484 . . . . 71.040000000000006 109.98 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -102.58 -17.7 15.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 74.420000000000002 111.878 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.559 ' HD1' ' HA ' ' A' ' 188' ' ' VAL . 90.8 m95 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.654 -0.688 . . . . 74.549999999999997 110.738 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptp . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.884 0.373 . . . . 72.209999999999994 110.709 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.45 147.83 49.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.091 -0.504 . . . . 71.420000000000002 110.468 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -91.72 153.66 43.85 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.975 -0.557 . . . . 72.109999999999999 110.132 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 59' ' ' SER . 9.5 Cg_endo -52.75 129.81 34.32 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.3 2.667 . . . . 72.349999999999994 113.228 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.33 143.16 30.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 72.239999999999995 110.329 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.485 HD23 HG23 ' A' ' 90' ' ' ILE . 59.3 tp -96.93 109.95 22.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.911 -0.403 . . . . 74.430000000000007 109.911 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.8 115.31 31.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.723 -0.473 . . . . 74.450000000000003 109.723 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.86 114.26 45.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.107 -0.497 . . . . 72.239999999999995 110.251 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.29 134.33 7.78 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.688 -0.768 . . . . 65.420000000000002 111.241 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.14 115.81 4.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.919 0.39 . . . . 74.400000000000006 110.044 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.841 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -87.04 -145.65 9.63 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.581 -0.736 . . . . 75.340000000000003 112.82 -174.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -102.41 136.5 19.37 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 110.618 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 14' ' ' GLY . 90.3 Cg_endo -89.52 -153.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.883 2.389 . . . . 65.299999999999997 111.239 172.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -75.04 -174.03 33.34 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.842 -0.694 . . . . 62.039999999999999 112.54 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.25 160.21 20.17 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.005 2.47 . . . . 75.25 112.344 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.2 m 72.77 -58.22 0.61 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.155 -0.475 . . . . 74.430000000000007 111.821 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.87 -13.58 60.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.382 . . . . 75.230000000000004 111.509 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.12 0.6 31.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.212 0.529 . . . . 73.219999999999999 110.715 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -105.09 20.41 18.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.691 -0.686 . . . . 73.340000000000003 109.957 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.6 p -100.33 175.4 5.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.965 -0.561 . . . . 74.409999999999997 110.791 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.552 ' HD3' ' O ' ' A' ' 153' ' ' ASN . 0.7 OUTLIER -81.59 1.66 32.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.468 -0.333 . . . . 75.519999999999996 111.734 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.4 ' CE1' HG22 ' A' ' 150' ' ' VAL . 21.2 m170 -105.92 11.82 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.41 0.522 . . . . 71.400000000000006 112.41 -173.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -96.2 14.17 24.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.087 0.47 . . . . 63.119999999999997 110.032 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.96 -33.08 71.44 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.61 -0.723 . . . . 70.230000000000004 111.987 -174.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.06 -48.5 85.77 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.666 -0.778 . . . . 73.109999999999999 111.691 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.841 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 85.9 t80 -60.67 -46.11 91.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.831 0.348 . . . . 71.439999999999998 110.904 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 96.2 mmm -59.23 -50.41 74.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.835 -0.621 . . . . 72.010000000000005 111.704 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.45 -40.12 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 73.430000000000007 111.025 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.589 ' HB1' HD23 ' A' ' 62' ' ' LEU . . . -66.07 -34.76 78.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.858 0.361 . . . . 74.150000000000006 111.362 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -71.69 -44.67 63.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.254 -0.43 . . . . 72.439999999999998 111.428 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.0 m -65.59 -34.25 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.159 0.429 . . . . 75.549999999999997 112.159 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -79.92 -29.03 39.72 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.539 -0.464 . . . . 73.400000000000006 110.73 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.413 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -67.77 -40.46 84.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.995 0.426 . . . . 71.230000000000004 110.035 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.33 -18.9 70.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.988 -0.625 . . . . 70.209999999999994 112.364 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -75.78 -54.32 7.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.723 0.297 . . . . 71.420000000000002 111.751 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 tp -67.13 -15.44 19.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.028 -0.533 . . . . 73.019999999999996 111.229 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.82 62.54 0.93 Allowed Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.592 -1.003 . . . . 73.349999999999994 110.592 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.54 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 32.1 m -151.86 156.17 39.62 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.087 0.47 . . . . 74.319999999999993 111.786 -169.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.4 144.49 31.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.623 -0.717 . . . . 72.030000000000001 109.089 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.676 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 40.4 p90 -108.01 149.43 28.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.108 0.48 . . . . 75.430000000000007 111.575 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -155.16 172.93 17.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.353 -0.84 . . . . 73.109999999999999 109.67 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.9 126.33 5.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.676 0.75 . . . . 72.420000000000002 112.125 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -137.18 158.95 43.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.364 -0.835 . . . . 73.540000000000006 110.715 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.665 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 1.6 tpmt? 63.22 -87.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 72.400000000000006 111.845 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.39 -87.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.745 1.387 . . . . 73.129999999999995 114.745 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.498 ' OG ' ' HB2' ' A' ' 78' ' ' PRO . 51.8 p -91.45 -37.0 13.45 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.826 1.787 . . . . 72.530000000000001 115.826 -156.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.19 -7.49 4.46 Favored Glycine 0 CA--C 1.508 -0.372 0 C-N-CA 119.459 -1.353 . . . . 75.209999999999994 114.223 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HB3' HG22 ' A' ' 50' ' ' VAL . . . -95.61 110.37 22.48 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.27 1.211 . . . . 75.439999999999998 114.27 -160.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.758 ' HG3' ' HD2' ' A' ' 66' ' ' ARG . 53.6 mt-10 -97.94 114.32 26.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.709 -1.589 . . . . 74.329999999999998 106.709 155.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 48' ' ' ALA . 66.9 t -124.24 139.24 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.11 0.481 . . . . 75.25 111.823 -166.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 2.8 p -115.9 115.29 48.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.298 -1.001 . . . . 74.030000000000001 108.298 168.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -96.32 117.45 30.85 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.147 -0.479 . . . . 72.219999999999999 110.889 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.57 -169.96 22.64 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.032 -0.827 . . . . 64.25 111.032 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 54' ' ' ARG . 14.8 ptt180 -141.3 139.72 33.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.04 0.448 . . . . 74.409999999999997 110.61 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 57' ' ' GLY . 96.5 mt -118.42 136.98 53.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.198 -0.668 . . . . 63.210000000000001 109.198 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 72.1 -29.56 0.2 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.739 0.649 . . . . 70.120000000000005 112.212 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 145.15 -14.18 1.89 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.106 -0.568 . . . . 75.200000000000003 111.701 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.4 m -102.35 132.45 48.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.615 0.245 . . . . 74.109999999999999 110.492 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 17.4 m -69.85 145.15 52.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.255 -0.429 . . . . 71.430000000000007 110.656 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 177' ' ' ILE . 15.5 m -136.78 143.59 34.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.077 0.465 . . . . 73.420000000000002 110.919 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.07 101.98 13.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.741 -0.663 . . . . 65.439999999999998 109.673 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.589 HD23 ' HB1' ' A' ' 29' ' ' ALA . 53.0 tp -94.9 98.95 11.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.258 0.551 . . . . 74.319999999999993 110.996 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.12 167.5 11.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.643 -0.708 . . . . 74.340000000000003 110.213 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -154.45 134.0 7.63 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.573 0.225 . . . . 71.420000000000002 110.653 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.443 ' HB3' ' HG3' ' A' ' 75' ' ' GLN . 26.4 Cg_exo -63.98 142.19 80.5 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.809 2.34 . . . . 75.349999999999994 111.502 173.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.758 ' HD2' ' HG3' ' A' ' 49' ' ' GLU . 42.8 mtp180 -110.34 16.67 21.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.797 0.808 . . . . 75.239999999999995 109.751 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 70.1 m -133.62 161.46 34.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.767 -1.106 . . . . 73.310000000000002 109.026 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -70.04 165.87 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.18 0.514 . . . . 71.239999999999995 112.163 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.585 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . 21.9 ptt? -46.47 -44.77 17.81 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.787 1.403 . . . . 73.549999999999997 114.787 -167.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -67.09 -33.07 74.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.099 0.409 . . . . 73.239999999999995 111.24 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -96.96 0.97 49.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 73.400000000000006 111.094 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.6 t -65.12 -22.45 66.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.376 -0.375 . . . . 75.420000000000002 111.151 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.14 -30.13 76.9 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.975 -0.631 . . . . 74.109999999999999 112.605 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -85.04 -3.17 58.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.955 0.407 . . . . 75.510000000000005 110.909 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.443 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 22.8 mm-40 -82.31 -52.36 7.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 110.298 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.43 -21.44 6.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.803 -0.635 . . . . 72.400000000000006 110.679 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.36 -73.29 0.38 Allowed Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.159 -0.473 . . . . 54.32 113.525 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.498 ' HB2' ' OG ' ' A' ' 46' ' ' SER . 50.6 Cg_exo -56.01 -35.63 94.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.63 2.22 . . . . 72.019999999999996 112.008 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.605 HD12 ' HG2' ' A' ' 44' ' ' LYS . 64.1 tp -57.94 -54.29 48.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.574 -0.739 . . . . 71.5 111.856 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.687 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . . . -62.81 -30.15 71.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.018 0.437 . . . . 71.340000000000003 111.892 -175.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.943 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 9.4 mmpt? -73.23 -24.21 60.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.248 -0.433 . . . . 74.049999999999997 111.677 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -72.39 -58.69 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.8 0.296 . . . . 73.109999999999999 111.8 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.687 ' CE1' ' HA ' ' A' ' 80' ' ' ALA . 1.5 p90 -77.74 -11.37 59.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.631 -0.428 . . . . 74.010000000000005 111.176 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.1 t 65.93 34.55 7.08 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.808 0.67 . . . . 74.409999999999997 112.808 166.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.578 HG23 ' CD1' ' A' ' 83' ' ' TYR . 18.4 m -101.65 136.0 19.67 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 120.043 -0.663 . . . . 71.140000000000001 110.024 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 20.0 Cg_exo -66.47 150.83 84.07 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.69 2.26 . . . . 75.319999999999993 111.976 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.94 41.35 0.64 Allowed 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.099 2.533 . . . . 72.340000000000003 112.57 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -95.47 -47.76 6.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.954 -0.566 . . . . 70.540000000000006 109.897 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -83.46 34.86 0.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.627 -0.715 . . . . 75.319999999999993 111.266 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 131' ' ' HIS . 46.3 pt -105.74 143.32 17.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 72.409999999999997 110.708 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.69 118.13 44.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.819 -0.628 . . . . 70.329999999999998 109.847 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.0 t -96.92 120.11 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 74.150000000000006 111.263 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 tt -98.54 111.42 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.534 0.683 . . . . 62.140000000000001 109.481 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -154.69 164.8 38.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 74.549999999999997 109.944 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.81 153.74 25.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.474 0.654 . . . . 74.129999999999995 111.444 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 30.0 tt0 -119.88 94.54 4.43 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.113 -1.069 . . . . 74.019999999999996 108.113 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.636 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 2.4 pt? -60.78 -27.99 68.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.244 -0.889 . . . . 70.219999999999999 112.552 -170.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.39 -10.76 60.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.134 0.492 . . . . 73.409999999999997 110.858 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.2 mm -107.92 135.51 46.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 74.010000000000005 109.841 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.417 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 14.8 m-20 -66.44 154.22 40.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.102 0.477 . . . . 71.349999999999994 111.686 -176.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.688 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 34.7 p90 -65.41 143.51 57.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.216 -0.902 . . . . 65.200000000000003 111.164 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.03 -67.57 0.51 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.408 -0.901 . . . . 75.129999999999995 112.689 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -116.74 155.67 28.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.795 0.331 . . . . 74.109999999999999 110.196 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.584 HG23 ' HA ' ' A' ' 135' ' ' ILE . 40.9 pt -116.75 165.4 12.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.134 -0.485 . . . . 75.420000000000002 110.692 -178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.428 ' HG3' ' HB2' ' A' ' 134' ' ' ARG . 38.4 ptt180 -142.52 170.21 16.13 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.077 -0.712 . . . . 73.120000000000005 109.077 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 181' ' ' LEU . 5.7 mp -128.75 119.32 24.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.061 0.458 . . . . 75.239999999999995 110.8 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -143.05 127.03 17.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.778 -0.646 . . . . 72.109999999999999 109.912 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.703 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.0 pt? -72.48 121.75 20.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.798 -0.637 . . . . 64.319999999999993 109.936 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.68 -173.6 41.35 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.874 -0.679 . . . . 73.200000000000003 111.488 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.12 -154.32 16.17 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.437 -0.411 . . . . 75.310000000000002 112.789 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.472 ' HA3' HD12 ' A' ' 118' ' ' LEU . . . -110.78 81.49 0.29 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.764 -0.731 . . . . 71.329999999999998 112.221 177.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -53.83 142.65 23.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.782 0.325 . . . . 74.430000000000007 110.434 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.34 -48.43 4.03 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.918 -0.658 . . . . 54.009999999999998 112.536 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.03 -59.46 3.65 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.994 -0.622 . . . . 62.119999999999997 111.816 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.4 m80 65.62 -74.49 0.06 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.378 0.671 . . . . 75.420000000000002 112.492 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -38.03 -56.89 1.11 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.242 1.017 . . . . 74.430000000000007 113.472 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.585 ' HA3' ' HB2' ' A' ' 69' ' ' MET . . . -62.45 -64.78 3.59 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.798 -0.715 . . . . 74.109999999999999 113.679 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.472 HD12 ' HA3' ' A' ' 111' ' ' GLY . 85.5 mt -68.09 -28.36 67.29 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.83 0.307 . . . . 75.400000000000006 111.83 -173.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -67.0 -39.92 87.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.31 -0.256 . . . . 71.340000000000003 110.31 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.2 t -64.13 -43.83 94.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.978 0.418 . . . . 74.310000000000002 110.08 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 t -67.18 -46.22 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 75.400000000000006 110.711 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 127' ' ' THR . . . -61.81 -41.48 97.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.743 -0.662 . . . . 72.230000000000004 111.754 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 m -66.26 -29.36 69.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.476 -0.329 . . . . 73.409999999999997 111.496 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.97 -46.94 17.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.903 0.382 . . . . 72.099999999999994 111.077 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.34 -35.81 54.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.516 . . . . 75.120000000000005 111.731 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.37 40.12 4.3 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.487 -0.863 . . . . 64.420000000000002 111.367 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 122' ' ' ALA . 11.5 t -129.88 176.29 8.16 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.244 -0.28 . . . . 75.530000000000001 110.244 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -138.48 21.73 2.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.79 0.329 . . . . 74.340000000000003 110.148 177.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.42 78.93 0.27 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.446 -0.797 . . . . 74.340000000000003 110.233 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -71.83 -25.21 61.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.715 -0.675 . . . . 75.349999999999994 111.404 -176.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 85.4 m-70 -140.85 120.49 13.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.724 -0.473 . . . . 75.099999999999994 109.724 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -153.49 152.12 30.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.945 0.402 . . . . 73.400000000000006 110.767 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.0 t -94.22 143.46 11.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.785 -0.643 . . . . 73.540000000000006 109.744 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.486 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 12.0 mmt180 -103.82 93.5 4.93 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.412 -0.588 . . . . 73.150000000000006 109.412 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.584 ' HA ' HG23 ' A' ' 104' ' ' ILE . 65.1 mt -92.7 108.14 19.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 110.627 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -71.17 109.74 2.96 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.637 -0.792 . . . . 75.450000000000003 111.855 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.0 m -109.61 -6.95 11.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.013 0.435 . . . . 72.120000000000005 110.602 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 87.2 170.57 46.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.828 -0.701 . . . . 50.409999999999997 112.321 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.636 ' HD2' ' O ' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -141.49 131.67 12.93 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.592 -0.521 . . . . 72.319999999999993 109.592 176.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 28.9 Cg_endo -64.81 110.78 1.54 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.526 2.151 . . . . 71.349999999999994 111.93 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 6.1 Cg_exo -78.3 69.44 7.6 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.067 2.511 . . . . 74.420000000000002 111.82 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.03 -176.68 42.31 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.699 -0.682 . . . . 51.020000000000003 111.429 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.47 -15.25 29.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.006 0.432 . . . . 75.420000000000002 109.914 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -93.67 159.22 15.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.041 -0.527 . . . . 74.439999999999998 109.66 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.49 142.42 91.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.719 -0.475 . . . . 74.099999999999994 109.719 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -52.08 -11.92 1.2 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.434 2.756 . . . . 72.230000000000004 113.744 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.14 -31.23 51.82 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.802 0.334 . . . . 63.43 111.403 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.73 -31.48 19.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.385 -0.37 . . . . 75.230000000000004 111.636 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -84.16 -19.68 33.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.245 -0.434 . . . . 73.140000000000001 111.713 -175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.4 HG22 ' CE1' ' A' ' 22' ' ' HIS . 11.9 p -65.01 -23.39 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.386 -0.37 . . . . 72.409999999999997 111.92 -175.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.7 mt -94.15 -11.46 30.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.447 -0.342 . . . . 71.319999999999993 111.91 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.13 110.72 2.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.339 0.59 . . . . 71.010000000000005 111.015 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.552 ' O ' ' HD3' ' A' ' 21' ' ' ARG . 22.9 t-20 -160.28 121.97 3.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.801 -0.636 . . . . 70.25 110.562 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -164.76 100.28 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.835 0.71 . . . . 72.019999999999996 109.727 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.24 175.52 5.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.882 -0.599 . . . . 75.319999999999993 111.063 -174.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.65 -20.6 46.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 64.420000000000002 111.628 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . . . -66.13 -50.26 64.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.176 -0.465 . . . . 72.040000000000006 111.477 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.529 ' O ' HG21 ' A' ' 162' ' ' VAL . 1.6 mp0 -60.54 -30.36 69.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 71.340000000000003 111.206 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -55.75 -28.76 57.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 112.078 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.22 60.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.674 0.273 . . . . 70.439999999999998 111.658 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -111.92 -7.86 14.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.351 0.5 . . . . 74.329999999999998 112.351 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 158' ' ' GLU . 92.3 t -56.46 -56.68 29.35 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 121.111 -0.235 . . . . 74.5 110.916 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 20.1 Cg_endo -61.47 -34.47 85.96 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.983 1.789 . . . . 52.109999999999999 111.844 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.5 m -59.49 -42.14 91.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.865 -0.607 . . . . 75.329999999999998 110.904 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.6 mt -77.32 -52.83 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 75.439999999999998 111.378 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 96.1 t -53.9 -47.41 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.382 0.512 . . . . 73.230000000000004 112.382 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -56.89 -52.11 66.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.984 0.421 . . . . 73.340000000000003 110.478 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -74.26 -41.62 60.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.789 -0.641 . . . . 74.129999999999995 111.604 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.52 -56.48 21.63 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.957 0.355 . . . . 73.25 111.957 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.94 -31.37 66.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.035 0.445 . . . . 71.230000000000004 111.66 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -80.92 -45.85 16.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.939 -0.573 . . . . 72.319999999999993 111.144 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.81 -30.87 65.98 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.374 0.509 . . . . 65.439999999999998 112.374 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.607 ' HA ' HD12 ' A' ' 176' ' ' LEU . 86.2 m -54.02 -32.0 52.93 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.219 0.451 . . . . 75.099999999999994 112.219 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.98 -33.27 75.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 75.439999999999998 110.638 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.3 tp -73.14 -27.13 61.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 72.010000000000005 111.268 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.607 HD12 ' HA ' ' A' ' 173' ' ' THR . 8.6 mp -66.93 -35.77 80.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.066 0.46 . . . . 74.150000000000006 110.112 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.598 HD11 HG11 ' A' ' 60' ' ' VAL . 50.0 mt -80.45 -25.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.604 -0.726 . . . . 71.129999999999995 109.899 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.16 -43.19 68.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.615 -0.72 . . . . 71.230000000000004 111.075 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -134.6 -73.17 0.47 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.371 -0.377 . . . . 71.140000000000001 110.405 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 176' ' ' LEU . . . -177.55 -157.97 19.59 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.248 -0.977 . . . . 74.439999999999998 112.789 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.687 ' HB2' HD21 ' A' ' 106' ' ' LEU . 2.5 pt? -89.83 -5.09 57.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.556 -0.322 . . . . 75.409999999999997 110.799 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.792 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 7.0 mm-40 -55.15 -56.97 22.52 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.853 -0.612 . . . . 71.099999999999994 111.859 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 2.9 Cg_exo -75.2 -26.58 10.47 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.744 1.629 . . . . 75.329999999999998 111.633 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.464 ' O ' HG21 ' A' ' 188' ' ' VAL . . . -65.15 -53.3 47.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.65 -0.705 . . . . 65.219999999999999 111.232 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -60.97 -21.12 63.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 73.510000000000005 111.157 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -78.35 -55.28 5.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.371 -0.377 . . . . 73.150000000000006 110.591 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.9 t -71.64 -30.18 65.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.323 0.49 . . . . 72.349999999999994 112.323 -173.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 184' ' ' ALA . 22.8 m -82.18 -12.55 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.117 -0.364 . . . . 72.230000000000004 111.56 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -109.42 -31.49 7.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.389 -0.368 . . . . 65.420000000000002 110.945 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.44 -24.24 46.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.379 . . . . 63.109999999999999 112.02 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 72.3 m95 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.469 -0.777 . . . . 74.239999999999995 110.175 179.425 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.84 0.352 . . . . 74.120000000000005 110.502 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.88 -165.58 1.24 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.237 -0.438 . . . . 54.509999999999998 110.197 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -89.47 165.3 26.28 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.465 -0.568 . . . . 73.129999999999995 109.465 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.17 108.21 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.486 2.124 . . . . 65.409999999999997 112.295 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.72 152.69 18.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.007 -0.542 . . . . 74.010000000000005 111.157 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.3 tp -97.39 116.87 30.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.968 -0.56 . . . . 75.340000000000003 109.49 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.29 110.41 31.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 74.310000000000002 110.048 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.554 HG11 HG23 ' A' ' 76' ' ' VAL . 43.5 t -121.89 132.82 70.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.588 -0.278 . . . . 74.150000000000006 110.504 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.491 ' HA2' ' HB ' ' A' ' 93' ' ' ILE . . . -122.13 130.78 8.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.936 -0.649 . . . . 33.549999999999997 111.8 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -72.63 144.19 47.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.238 0.542 . . . . 74.209999999999994 111.116 -176.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.581 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -156.94 -177.67 30.28 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.786 -0.721 . . . . 65.549999999999997 111.709 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.536 ' OD1' ' HE3' ' A' ' 69' ' ' MET . 86.7 m-20 -127.37 83.25 66.53 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 110.248 -0.278 . . . . 73.519999999999996 110.248 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.9 93.62 0.1 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.8 2.334 . . . . 74.239999999999995 112.224 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.51 158.93 31.02 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.698 -0.683 . . . . 54.340000000000003 111.401 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.16 -68.1 0.07 OUTLIER 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 123.163 2.575 . . . . 75.310000000000002 113.106 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 p -75.66 -26.74 57.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.934 0.397 . . . . 74.319999999999993 111.523 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -70.24 -24.19 63.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.981 -0.554 . . . . 73.549999999999997 111.282 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.411 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . . . -73.61 -9.35 58.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.262 -0.426 . . . . 75.030000000000001 111.405 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -94.8 18.6 11.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.245 -0.434 . . . . 75.420000000000002 110.773 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.6 p -111.34 148.87 32.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.043 0.449 . . . . 73.340000000000003 111.016 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.559 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 30.5 ptt-85 -71.31 -5.73 34.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.066 -0.515 . . . . 75.530000000000001 110.557 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.524 ' CG ' HG22 ' A' ' 150' ' ' VAL . 30.6 t-80 -91.45 2.29 56.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.294 0.569 . . . . 70.25 109.949 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 18' ' ' ALA . 63.5 t30 -98.8 18.07 17.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.818 0.818 . . . . 73.129999999999995 109.206 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.4 -38.16 88.58 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.247 -0.888 . . . . 75.510000000000005 112.318 -173.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.547 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -62.51 -46.24 94.2 Favored Glycine 0 C--N 1.329 0.152 0 C-N-CA 120.529 -0.843 . . . . 64.340000000000003 112.426 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.581 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 82.5 t80 -65.08 -38.77 91.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.163 0.506 . . . . 75.319999999999993 110.706 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.4 mmt -81.92 -37.69 26.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.913 -0.585 . . . . 73.549999999999997 112.534 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.539 ' HA ' HG22 ' A' ' 31' ' ' VAL . 53.3 t -62.23 -37.75 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.951 0.405 . . . . 74.099999999999994 110.34 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.54 78.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.023 -0.535 . . . . 72.010000000000005 110.696 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -75.61 -48.95 20.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.109 -0.496 . . . . 65.230000000000004 111.289 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' A' ' 28' ' ' VAL . 35.1 m -63.15 -40.78 90.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.538 -0.301 . . . . 72.299999999999997 111.654 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.448 HD21 ' HB1' ' A' ' 169' ' ' ALA . 66.8 mt -66.06 -41.34 90.92 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.695 0.283 . . . . 75.409999999999997 110.814 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.83 -47.5 85.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.062 -0.517 . . . . 62.310000000000002 110.468 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.89 -27.94 71.06 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.884 -0.674 . . . . 64.540000000000006 112.857 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 18.0 mmm180 -73.18 -42.83 62.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.006 0.373 . . . . 73.5 112.006 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.71 -14.89 13.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.441 0.639 . . . . 74.109999999999999 110.264 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.12 58.91 1.43 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 110.539 -1.024 . . . . 74.530000000000001 110.539 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.6 m -137.98 126.59 23.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.045 -0.577 . . . . 73.530000000000001 111.718 -171.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.88 143.03 24.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.591 -0.732 . . . . 74.430000000000007 109.429 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.602 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 2.7 t80 -141.8 -146.0 0.18 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.246 -0.279 . . . . 73.209999999999994 110.246 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -155.51 173.26 16.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.788 0.327 . . . . 73.140000000000001 111.579 -169.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 47' ' ' GLY . 2.6 p -54.09 132.2 16.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.509 -0.768 . . . . 71.019999999999996 110.079 169.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -137.23 133.98 35.72 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.713 -0.395 . . . . 72.439999999999998 111.676 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 64.27 -172.79 0.17 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.565 -0.743 . . . . 72.019999999999996 112.195 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.513 ' C ' ' H ' ' A' ' 47' ' ' GLY . 33.5 ttpt -79.92 -15.01 58.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.802 0.81 . . . . 74.140000000000001 109.079 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' A' ' 82' ' ' PHE . 9.7 p -81.75 25.4 0.55 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.638 -1.164 . . . . 74.310000000000002 109.238 170.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 45' ' ' LYS . . . -54.23 43.68 0.01 OUTLIER Glycine 0 C--N 1.34 0.769 0 N-CA-C 118.253 2.061 . . . . 73.530000000000001 118.253 -167.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.13 174.36 6.43 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 118.268 1.034 . . . . 63.240000000000002 108.212 165.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 58.0 mt-10 -72.1 116.52 12.61 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.065 -0.654 . . . . 74.230000000000004 109.866 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.602 ' O ' ' HB3' ' A' ' 40' ' ' PHE . 58.6 t -124.96 135.68 63.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 110.125 -0.324 . . . . 73.510000000000005 110.125 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' A' ' 62' ' ' LEU . 3.1 p -125.71 110.97 25.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.339 0.59 . . . . 71.239999999999995 110.006 172.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 m -84.26 111.85 19.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.974 -0.557 . . . . 74.239999999999995 110.121 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -138.58 171.43 23.5 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.884 -0.675 . . . . 64.430000000000007 111.737 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -131.31 110.53 11.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.224 0.535 . . . . 75.140000000000001 111.137 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.508 ' HB3' ' HG2' ' A' ' 174' ' ' GLU . 6.9 mp -111.94 153.33 26.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.136 -0.69 . . . . 72.299999999999997 109.136 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.97 -73.36 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.844 0.715 . . . . 74.420000000000002 111.331 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.67 23.11 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.051 -0.595 . . . . 73.140000000000001 112.477 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.7 m -140.88 141.38 34.62 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.548 -0.383 . . . . 75.409999999999997 110.62 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.8 p -83.73 118.53 23.95 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.993 0.425 . . . . 72.019999999999996 110.008 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.52 155.72 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.975 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -97.03 100.54 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.907 -0.588 . . . . 63.109999999999999 109.731 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB3' HG12 ' A' ' 51' ' ' VAL . 48.6 tp -95.05 115.28 27.22 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.339 -0.615 . . . . 75.420000000000002 109.339 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HB3' HG21 ' A' ' 8' ' ' VAL . . . -124.82 145.17 49.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.467 0.651 . . . . 74.420000000000002 112.295 -173.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -111.11 142.11 25.64 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.939 -1.028 . . . . 74.109999999999999 108.42 173.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 18.8 Cg_exo -65.95 152.59 81.0 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.368 2.045 . . . . 74.049999999999997 111.904 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -93.95 5.46 51.63 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.626 -0.879 . . . . 71.219999999999999 108.626 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.891 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 77.3 m -134.59 173.84 11.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.368 -1.287 . . . . 71.150000000000006 109.824 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.452 ' HD2' ' SD ' ' A' ' 69' ' ' MET . 17.3 p90 -85.35 -173.71 4.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 74.200000000000003 110.542 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.536 ' HE3' ' OD1' ' A' ' 12' ' ' ASN . 1.7 pmm? -48.55 -46.24 38.69 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.388 0.885 . . . . 74.430000000000007 113.388 -170.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -66.16 -62.35 1.53 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 75.519999999999996 111.735 -173.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.891 ' HG3' ' HB3' ' A' ' 67' ' ' CYS . 6.2 pt-20 -87.48 18.91 3.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.469 . . . . 72.310000000000002 111.299 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.1 t -65.33 -39.2 92.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.342 -0.614 . . . . 73.230000000000004 109.342 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.51 -23.57 66.93 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.738 -0.665 . . . . 73.450000000000003 112.188 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -71.92 -17.27 62.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.74 0.305 . . . . 72.150000000000006 110.425 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -95.88 -42.62 8.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 64.519999999999996 110.537 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.554 HG23 HG11 ' A' ' 8' ' ' VAL . 25.7 t -62.23 -38.54 81.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.983 -0.553 . . . . 74.0 111.236 -177.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.33 -64.56 4.27 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.879 -0.6 . . . . 65.209999999999994 113.257 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.05 -41.23 70.17 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.646 2.23 . . . . 74.109999999999999 112.31 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.1 tp -54.85 -48.65 72.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.28 -0.418 . . . . 74.420000000000002 111.113 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.83 88.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.167 -0.47 . . . . 75.219999999999999 111.334 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -75.98 -35.22 59.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.177 -0.465 . . . . 75.299999999999997 111.291 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.402 ' HD2' ' HB3' ' A' ' 46' ' ' SER . 21.5 m-85 -71.74 -20.14 61.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.78 0.324 . . . . 72.420000000000002 111.086 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -98.74 -1.37 40.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.292 -0.413 . . . . 75.430000000000007 110.871 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m 59.73 29.61 19.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.643 -0.708 . . . . 72.439999999999998 111.767 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.23 149.06 35.29 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 73.230000000000004 110.601 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.524 ' O ' HG23 ' A' ' 90' ' ' ILE . 14.1 Cg_exo -70.35 110.31 2.64 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.079 2.519 . . . . 74.400000000000006 112.046 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.493 ' HB3' HD23 ' A' ' 125' ' ' LEU . 23.1 Cg_exo -65.1 -11.92 32.21 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.158 2.572 . . . . 75.420000000000002 112.42 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -78.94 -43.29 24.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.261 -0.427 . . . . 73.129999999999995 110.174 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -96.63 0.71 50.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 112.155 -170.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.551 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 40.2 pt -75.47 174.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.806 -0.357 . . . . 62.43 110.425 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 p -119.88 125.26 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.331 0.586 . . . . 73.510000000000005 110.98 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 131' ' ' HIS . 98.1 t -119.32 123.8 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 73.329999999999998 110.448 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.491 ' HB ' ' HA2' ' A' ' 9' ' ' GLY . 48.8 mm -75.57 130.63 36.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.693 -0.685 . . . . 75.340000000000003 109.6 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.408 ' HE1' ' HA3' ' A' ' 114' ' ' GLY . 31.5 t-80 -136.6 157.58 46.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.118 0.485 . . . . 74.099999999999994 110.469 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -86.77 152.76 22.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.875 -0.602 . . . . 71.530000000000001 110.688 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.727 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 26.9 tt0 -128.07 93.78 3.76 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.915 -0.772 . . . . 65.230000000000004 108.915 168.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 139' ' ' ARG . 4.0 pp -84.02 0.09 49.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.027 -0.988 . . . . 71.319999999999993 112.04 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.404 ' HB2' ' HA2' ' A' ' 113' ' ' GLY . 27.9 t70 -87.08 -38.94 16.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.163 0.506 . . . . 74.219999999999999 110.351 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.44 152.06 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.462 -0.79 . . . . 73.329999999999998 109.852 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.479 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 5.1 p-10 -64.39 159.97 20.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.377 0.608 . . . . 71.200000000000003 111.61 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 0.8 OUTLIER -72.59 135.69 45.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.132 -0.94 . . . . 75.510000000000005 112.027 -176.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.02 -64.06 0.53 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.235 -0.983 . . . . 62.310000000000002 113.278 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -85.88 145.62 27.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.797 0.332 . . . . 72.409999999999997 110.839 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.564 HG12 HG23 ' A' ' 188' ' ' VAL . 30.7 pt -117.27 149.85 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.481 -0.562 . . . . 74.120000000000005 109.481 174.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -157.03 137.22 12.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.852 0.358 . . . . 72.510000000000005 110.949 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 4.0 pp -96.68 153.47 17.85 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.757 -0.46 . . . . 72.420000000000002 109.757 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -147.39 115.54 6.56 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.771 -0.455 . . . . 73.209999999999994 109.771 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 129' ' ' ASN . 0.7 OUTLIER -80.91 90.12 5.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.828 0.823 . . . . 75.219999999999999 110.326 177.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.28 -127.09 1.63 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.385 -0.825 . . . . 62.509999999999998 111.385 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.08 163.17 32.96 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.299 -0.721 . . . . 75.420000000000002 111.299 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.8 94.66 0.68 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.641 -0.79 . . . . 64.409999999999997 112.492 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.91 142.12 12.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.136 0.494 . . . . 72.430000000000007 111.334 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 98' ' ' ASP . . . 96.88 -76.12 0.7 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.041 -0.599 . . . . 63.25 112.972 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.408 ' HA3' ' HE1' ' A' ' 94' ' ' HIS . . . -80.28 63.78 4.09 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.046 -0.597 . . . . 73.340000000000003 112.93 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -62.67 -27.1 69.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.778 0.288 . . . . 74.140000000000001 111.778 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -65.51 -29.93 70.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.312 0.577 . . . . 73.319999999999993 110.786 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.43 20.56 29.97 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.59 -0.814 . . . . 74.129999999999995 112.308 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 33.5 mt -84.5 -59.51 2.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.881 -0.328 . . . . 72.430000000000007 111.276 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 119' ' ' ARG . 3.7 mpt_? -73.65 -35.78 65.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.35 -0.386 . . . . 75.219999999999999 110.58 -174.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 p -56.42 -43.96 79.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 63.009999999999998 111.233 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.433 ' HB ' HH22 ' A' ' 132' ' ' ARG . 48.9 t -85.33 -41.62 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 73.340000000000003 111.889 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.37 -47.16 71.2 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.051 0.389 . . . . 64.140000000000001 112.051 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.2 m -66.93 -24.53 66.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.659 0.266 . . . . 73.200000000000003 111.18 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.43 -45.6 37.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.758 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.552 HD21 HG11 ' A' ' 76' ' ' VAL . 90.6 mt -72.58 -34.98 67.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 73.430000000000007 110.384 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.61 -12.56 20.86 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.907 -0.663 . . . . 73.239999999999995 113.15 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -169.56 177.57 4.53 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.167 0.508 . . . . 75.040000000000006 111.579 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 2.5 mptt -110.34 -110.97 0.33 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.587 -0.894 . . . . 75.439999999999998 108.587 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 4.3 t-20 64.96 -9.89 0.18 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.708 0.803 . . . . 64.310000000000002 113.054 174.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.436 ' H ' ' C ' ' A' ' 128' ' ' LYS . 10.4 t80 -179.79 -157.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.659 -0.867 . . . . 71.140000000000001 108.659 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.585 ' O ' ' HD2' ' A' ' 132' ' ' ARG . 11.6 p-80 44.87 41.08 4.86 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.937 0.895 . . . . 71.409999999999997 113.067 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 131' ' ' HIS . 2.7 mpt_? -131.01 107.03 8.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.786 -0.643 . . . . 71.540000000000006 109.906 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 106' ' ' LEU . 58.8 t -119.18 109.95 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.943 -0.762 . . . . 72.430000000000007 108.943 174.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.727 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 90.2 mtm180 -92.14 122.64 34.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.088 0.471 . . . . 75.140000000000001 111.651 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 135' ' ' ILE . 2.1 mp -99.88 115.03 40.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.946 -0.761 . . . . 71.430000000000007 108.946 172.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -63.52 109.13 2.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.881 -0.676 . . . . 71.310000000000002 111.472 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.559 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 30.8 m -101.4 -18.7 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.562 0.22 . . . . 74.409999999999997 111.491 -176.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 107.92 139.66 9.08 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.424 -0.893 . . . . 75.219999999999999 112.664 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 6.1 ptp180 -80.88 133.5 54.86 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.032 0.444 . . . . 73.420000000000002 111.586 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 22.3 Cg_exo -65.23 128.99 21.66 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.303 2.669 . . . . 64.409999999999997 112.499 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 5.9 Cg_exo -78.86 45.67 1.97 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.191 2.594 . . . . 73.510000000000005 112.272 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.87 143.74 10.95 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.044 -0.823 . . . . 71.140000000000001 111.044 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.441 ' HA ' ' HD3' ' A' ' 143' ' ' ARG . 18.1 mmt180 -89.58 58.39 4.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.513 0.673 . . . . 75.129999999999995 111.446 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -131.0 160.49 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.101 -0.954 . . . . 75.510000000000005 109.296 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -66.49 141.09 96.9 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.263 -0.643 . . . . 71.120000000000005 109.263 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.8 -14.37 1.22 Allowed 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.552 2.835 . . . . 75.040000000000006 113.915 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.32 28.62 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.588 0.355 . . . . 75.239999999999995 111.813 174.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.75 -41.63 13.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.146 0.498 . . . . 74.409999999999997 111.228 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -73.61 -19.81 60.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 73.299999999999997 111.76 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.524 HG22 ' CG ' ' A' ' 22' ' ' HIS . 14.5 p -65.21 -22.52 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.246 -0.434 . . . . 74.340000000000003 111.49 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.52 -27.76 13.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.62 -0.264 . . . . 72.140000000000001 111.36 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -165.43 109.7 0.86 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.259 0.552 . . . . 71.239999999999995 111.467 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -164.27 31.79 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.823 -0.626 . . . . 73.120000000000005 110.125 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -60.23 124.57 20.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.311 0.577 . . . . 74.150000000000006 111.142 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.17 176.32 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.459 -0.791 . . . . 72.219999999999999 110.289 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.65 -54.46 5.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.837 0.351 . . . . 74.439999999999998 111.741 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.39 -23.77 66.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.208 0.818 . . . . 71.319999999999993 113.208 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.71 -23.7 66.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.067 0.461 . . . . 74.310000000000002 110.698 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.457 ' HA ' HG22 ' A' ' 162' ' ' VAL . 22.7 mmm180 -69.41 -22.37 63.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.747 -0.661 . . . . 75.209999999999994 111.417 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.36 -33.21 73.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.281 -0.418 . . . . 74.200000000000003 111.711 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 165' ' ' ILE . 8.9 mm-40 -97.04 1.48 50.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.885 0.328 . . . . 64.0 111.885 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' A' ' 163' ' ' PRO . 95.1 t -60.82 -53.39 64.65 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.772 -0.194 . . . . 75.120000000000005 111.373 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 30.7 Cg_endo -64.64 -25.62 61.78 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.772 1.648 . . . . 74.439999999999998 111.794 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.1 m -63.32 -51.17 67.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.624 -0.716 . . . . 75.430000000000007 110.945 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 161' ' ' GLU . 78.9 mt -54.49 -38.17 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.938 -0.573 . . . . 75.25 111.727 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.25 -51.44 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 63.409999999999997 111.363 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -80.97 -30.44 35.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.406 -0.361 . . . . 74.319999999999993 111.563 -176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -67.12 -43.18 83.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 72.200000000000003 110.961 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.448 ' HB1' HD21 ' A' ' 32' ' ' LEU . . . -60.09 -37.9 81.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 73.310000000000002 111.29 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.78 92.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.896 0.379 . . . . 64.209999999999994 111.548 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.81 -41.61 78.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.85 0.357 . . . . 74.420000000000002 110.977 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.75 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.042 -0.527 . . . . 71.549999999999997 112.279 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 23.6 p -62.86 -48.63 78.19 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.218 0.451 . . . . 65.239999999999995 112.218 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.508 ' HG2' ' HB3' ' A' ' 55' ' ' LEU . 40.3 mt-10 -64.99 -29.66 70.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.742 -0.208 . . . . 75.129999999999995 111.347 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 184' ' ' ALA . 22.0 tp -74.54 -31.77 62.23 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.749 -0.38 . . . . 70.439999999999998 110.38 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.668 HD22 ' HA ' ' A' ' 181' ' ' LEU . 70.6 mt -62.18 -45.1 94.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.245 0.545 . . . . 75.319999999999993 110.121 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 59.8 mt -71.02 -28.63 33.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.367 -0.833 . . . . 75.230000000000004 110.274 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -59.06 5.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.556 -0.747 . . . . 62.350000000000001 111.186 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -178.1 -49.61 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.849 0.314 . . . . 75.510000000000005 111.849 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.14 116.82 5.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.637 -0.792 . . . . 61.25 113.71 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.668 ' HA ' HD22 ' A' ' 176' ' ' LEU . 10.2 mp -77.63 -44.24 28.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.01 0.433 . . . . 75.319999999999993 110.658 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 45.5 mt-10 -72.56 -44.07 9.34 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.195 -0.457 . . . . 74.040000000000006 111.697 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -52.12 -35.89 64.03 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.532 1.488 . . . . 75.109999999999999 111.918 170.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.52 ' HA ' HD23 ' A' ' 175' ' ' LEU . . . -73.31 -38.01 65.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.38 -0.373 . . . . 74.439999999999998 111.682 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 3.4 pt20 -71.36 -27.49 63.39 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.535 -0.466 . . . . 75.439999999999998 109.906 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -86.34 -32.09 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 75.349999999999994 111.69 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 184' ' ' ALA . 13.1 t -61.87 -50.42 72.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.96 -0.296 . . . . 70.439999999999998 111.062 -176.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.564 HG23 HG12 ' A' ' 104' ' ' ILE . 9.4 p -67.39 -26.45 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 121.569 0.7 . . . . 73.209999999999994 110.299 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -69.69 -31.7 69.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.377 -0.829 . . . . 73.340000000000003 110.318 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -93.61 -6.58 46.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.886 -0.597 . . . . 40.509999999999998 111.75 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.9 m95 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.664 -0.684 . . . . 73.349999999999994 110.585 175.843 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.747 -0.464 . . . . 75.219999999999999 109.747 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.52 88.04 7.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.942 0.401 . . . . 64.329999999999998 110.558 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 8.8 pt-20 -101.81 105.59 42.24 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.755 -0.657 . . . . 73.120000000000005 109.778 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.882 ' HB2' HG21 ' A' ' 61' ' ' VAL . 56.4 Cg_endo -92.27 117.28 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.987 2.458 . . . . 73.409999999999997 113.318 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.627 ' HB2' HG13 ' A' ' 60' ' ' VAL . 70.9 mt -67.67 145.17 55.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 74.420000000000002 109.935 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.587 HD23 HG12 ' A' ' 90' ' ' ILE . 57.3 tp -93.32 109.36 20.91 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.107 -0.331 . . . . 72.420000000000002 110.107 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.58 113.12 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.496 . . . . 74.109999999999999 110.366 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.02 164.1 22.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.232 -0.44 . . . . 74.239999999999995 110.602 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.29 -178.66 39.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.601 -0.809 . . . . 51.039999999999999 112.25 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.466 HD21 ' CE1' ' A' ' 94' ' ' HIS . 86.3 mt -67.55 126.48 29.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.69 0.281 . . . . 73.540000000000006 110.966 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.98 177.73 52.09 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.934 -0.651 . . . . 40.140000000000001 113.149 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 30.0 t-20 -124.63 108.06 28.94 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 110.048 -0.353 . . . . 64.439999999999998 110.048 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 4.6 Cg_exo -76.75 -33.26 3.05 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.41 2.74 . . . . 73.349999999999994 114.117 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.92 147.81 15.01 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.889 -1.148 . . . . 61.530000000000001 113.104 -174.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.02 -31.83 94.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.553 2.835 . . . . 74.109999999999999 113.34 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 m -61.05 -39.14 88.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.293 0.568 . . . . 72.420000000000002 110.879 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.563 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 91.0 m-85 -97.17 2.5 51.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.53 -0.759 . . . . 74.109999999999999 110.52 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.41 ' HB1' HD22 ' A' ' 12' ' ' ASN . . . -71.28 -18.46 62.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.763 0.653 . . . . 72.040000000000006 112.763 -171.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -92.53 18.84 7.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.697 0.284 . . . . 73.430000000000007 111.228 -175.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.626 HG21 ' O ' ' A' ' 151' ' ' LEU . 59.8 p -113.95 -174.08 2.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.277 0.56 . . . . 71.549999999999997 111.904 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.569 ' HD2' ' HB ' ' A' ' 137' ' ' VAL . 5.0 ptt180 -94.47 1.53 55.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.513 -0.767 . . . . 75.340000000000003 112.85 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.608 ' HB3' HG22 ' A' ' 150' ' ' VAL . 3.6 p-80 -94.74 10.8 33.68 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.414 -0.515 . . . . 74.329999999999998 111.496 -176.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -139.15 35.04 2.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.075 0.464 . . . . 74.540000000000006 110.757 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.9 mt -56.04 -46.56 78.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.427 -0.806 . . . . 74.230000000000004 111.796 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.94 -51.19 60.67 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.999 -0.546 . . . . 70.030000000000001 113.013 -174.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -57.82 -38.3 75.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 73.310000000000002 111.289 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 90.1 mtp -73.01 -54.43 8.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.56 -0.291 . . . . 74.299999999999997 111.388 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.445 HG13 HD21 ' A' ' 32' ' ' LEU . 57.7 t -61.21 -44.2 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 74.019999999999996 111.558 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB2' HD12 ' A' ' 62' ' ' LEU . . . -58.78 -53.24 60.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 60.520000000000003 112.138 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.73 -37.12 81.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.169 0.433 . . . . 60.039999999999999 112.169 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.63 -32.02 34.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.603 -0.439 . . . . 65.209999999999994 112.117 -175.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.506 HD11 ' N ' ' A' ' 33' ' ' ALA . 4.6 pp -76.41 -33.27 58.82 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.462 -0.495 . . . . 71.329999999999998 110.577 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.506 ' N ' HD11 ' A' ' 32' ' ' LEU . . . -70.0 -34.04 72.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.263 0.554 . . . . 65.230000000000004 110.279 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.88 -18.68 57.51 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.508 -0.769 . . . . 74.430000000000007 113.088 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -64.02 -39.38 93.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.026 0.413 . . . . 73.319999999999993 111.651 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' ' 36' ' ' ILE . 3.9 mp -83.11 -14.47 11.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.702 0.763 . . . . 74.439999999999998 109.553 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.98 13.69 54.04 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.87 -1.292 . . . . 71.010000000000005 109.87 -171.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.2 m -87.71 113.19 23.16 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.307 -0.946 . . . . 75.439999999999998 111.197 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.91 128.32 9.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.282 -0.417 . . . . 75.310000000000002 110.782 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.523 ' CD1' HG23 ' A' ' 51' ' ' VAL . 4.5 m-85 -102.76 -157.36 0.61 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.973 -0.558 . . . . 65.319999999999993 109.721 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -140.91 172.36 12.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.818 -0.353 . . . . 74.239999999999995 110.961 -173.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.793 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 3.3 p -55.83 105.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.748 0.785 . . . . 74.340000000000003 110.464 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.582 ' HD2' ' HG2' ' A' ' 45' ' ' LYS . 8.0 t60 -104.76 145.05 30.91 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.501 -0.772 . . . . 74.120000000000005 109.433 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -65.97 -77.11 0.07 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.176 -0.466 . . . . 65.299999999999997 111.277 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.582 ' HG2' ' HD2' ' A' ' 43' ' ' HIS . 28.8 mmmt 47.26 -133.27 1.18 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.501 -0.555 . . . . 74.219999999999999 109.501 -172.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 p -105.97 -39.46 6.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.389 -0.925 . . . . 65.409999999999997 112.725 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.718 ' HA3' ' HB3' ' A' ' 75' ' ' GLN . . . -133.01 -24.18 0.73 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 118.4 -1.857 . . . . 70.420000000000002 117.055 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.72 162.01 36.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.678 1.362 . . . . 72.120000000000005 114.678 -160.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.793 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 23.0 mt-10 -74.94 135.98 41.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.182 -1.372 . . . . 73.540000000000006 108.75 170.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.43 HG22 ' HH ' ' A' ' 83' ' ' TYR . 17.2 m -125.61 140.11 49.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.002 0.43 . . . . 73.519999999999996 111.654 -174.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.755 HG12 ' HB3' ' A' ' 62' ' ' LEU . 2.4 p -124.41 114.76 42.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.717 -0.674 . . . . 75.409999999999997 109.953 171.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 m -95.65 131.22 42.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 74.430000000000007 110.505 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.23 -161.16 29.38 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.374 -0.69 . . . . 74.140000000000001 111.374 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -131.41 132.69 44.55 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.896 0.379 . . . . 73.310000000000002 110.458 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.1 mt -102.93 126.56 50.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.983 -0.553 . . . . 64.420000000000002 109.593 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 178' ' ' ALA . . . 68.97 -47.92 0.58 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.009 0.818 . . . . 70.239999999999995 111.778 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.11 -41.62 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.079 -0.581 . . . . 70.329999999999998 112.397 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.668 ' HB ' HG22 ' A' ' 177' ' ' ILE . 6.8 m -84.46 141.52 30.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.781 0.324 . . . . 65.040000000000006 110.965 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 3.7 p -70.22 143.3 52.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 74.109999999999999 111.353 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.662 HG11 HD11 ' A' ' 177' ' ' ILE . 20.5 m -143.67 158.14 16.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.081 0.467 . . . . 74.219999999999999 111.297 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.882 HG21 ' HB2' ' A' ' 4' ' ' PRO . 85.0 t -112.07 104.93 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.675 -0.693 . . . . 72.319999999999993 109.186 172.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.755 ' HB3' HG12 ' A' ' 51' ' ' VAL . 3.0 tm? -95.84 118.72 33.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.552 -0.536 . . . . 72.349999999999994 109.552 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -134.64 131.15 37.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.733 -0.667 . . . . 71.209999999999994 109.96 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -127.59 135.23 27.15 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.942 0.401 . . . . 72.129999999999995 110.882 -178.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 1.4 Cg_endo -83.8 164.45 13.86 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.104 2.536 . . . . 72.109999999999999 111.918 176.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 68.3 mtt180 -112.19 17.1 19.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.37 0.605 . . . . 73.420000000000002 109.82 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 52.9 m -112.03 164.2 13.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.477 -0.783 . . . . 65.010000000000005 110.146 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -66.18 167.95 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.282 -0.417 . . . . 74.049999999999997 110.998 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 19.3 ptp -55.23 -32.44 62.28 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.855 0.687 . . . . 74.340000000000003 112.855 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -72.1 -24.33 61.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.11 0.481 . . . . 75.519999999999996 110.585 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 12.5 mm-40 -102.91 -10.3 19.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.923 -0.581 . . . . 72.019999999999996 110.996 -175.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' HG22 ' A' ' 76' ' ' VAL . 19.5 m -61.56 -51.8 67.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 73.109999999999999 111.676 -173.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.841 ' HA3' ' HA ' ' A' ' 121' ' ' VAL . . . -62.03 -23.83 64.25 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.193 -0.527 . . . . 53.0 113.276 -174.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -61.97 -37.9 86.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.039 0.447 . . . . 74.530000000000001 110.974 -176.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.718 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 12.9 mm100 -92.19 -20.43 21.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.931 -0.577 . . . . 74.319999999999993 110.996 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 72' ' ' SER . 95.7 t -73.69 -36.27 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 75.310000000000002 111.015 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.683 ' HA2' ' HB3' ' A' ' 125' ' ' LEU . . . -52.12 -68.45 1.56 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.991 -0.549 . . . . 74.019999999999996 112.973 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -58.11 -28.85 85.21 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.629 2.22 . . . . 74.310000000000002 112.495 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.94 -48.78 77.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 73.519999999999996 110.24 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.55 90.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.004 -0.544 . . . . 64.040000000000006 111.491 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.66 -20.19 59.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.288 -0.415 . . . . 73.409999999999997 111.564 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.575 ' HD2' ' HE3' ' A' ' 45' ' ' LYS . 4.8 m-30 -74.21 -20.19 60.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.497 -0.32 . . . . 74.230000000000004 110.728 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.43 ' HH ' HG22 ' A' ' 50' ' ' VAL . 84.2 m-85 -106.99 -11.74 15.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.51 -0.314 . . . . 71.150000000000006 110.833 176.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.0 t 61.74 36.3 16.41 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.627 -0.715 . . . . 71.319999999999993 110.529 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.4 m -74.11 142.76 79.53 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 110.619 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.89 128.32 25.12 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.869 2.38 . . . . 74.099999999999994 112.079 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.55 -9.39 18.0 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.02 2.48 . . . . 72.030000000000001 112.633 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -83.68 -12.75 55.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.113 -0.494 . . . . 73.450000000000003 110.903 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -105.31 24.79 11.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 75.230000000000004 111.186 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.587 HG12 HD23 ' A' ' 6' ' ' LEU . 62.6 mt -89.07 109.84 20.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.412 . . . . 73.409999999999997 111.196 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 131' ' ' HIS . 32.6 m -113.42 141.7 28.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.468 -0.568 . . . . 73.439999999999998 109.468 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.01 130.16 51.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.318 0.58 . . . . 64.120000000000005 111.989 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.1 mm -85.28 118.0 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.55 -0.75 . . . . 74.329999999999998 109.291 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.466 ' CE1' HD21 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -137.61 170.26 16.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.411 0.624 . . . . 73.219999999999999 111.482 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -90.35 145.71 24.74 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.703 -1.135 . . . . 65.019999999999996 111.973 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.447 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 7.2 mm-40 -140.43 119.42 12.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.624 -0.716 . . . . 73.310000000000002 109.778 169.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.518 ' HB2' ' HG2' ' A' ' 139' ' ' ARG . 1.7 pp -83.77 -0.15 49.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.523 -0.762 . . . . 73.510000000000005 112.529 -174.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.405 ' OD2' HG13 ' A' ' 99' ' ' ILE . 3.4 p-10 -77.29 -10.85 59.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 71.209999999999994 111.383 -174.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.405 HG13 ' OD2' ' A' ' 98' ' ' ASP . 61.3 mt -135.17 149.72 29.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.956 -0.757 . . . . 71.209999999999994 108.956 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.05 179.1 7.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.453 -0.573 . . . . 75.349999999999994 109.453 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -66.17 123.79 20.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.091 0.472 . . . . 73.150000000000006 110.382 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.18 -118.13 0.78 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.789 -0.925 . . . . 75.010000000000005 110.789 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HA ' HE22 ' A' ' 168' ' ' GLN . 7.8 ppt_? -83.4 132.99 34.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.265 0.533 . . . . 73.530000000000001 110.064 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.3 pt -97.69 166.16 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.995 -0.548 . . . . 63.509999999999998 110.703 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -126.6 127.85 45.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.235 0.54 . . . . 75.010000000000005 110.785 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.671 HD13 HG23 ' A' ' 188' ' ' VAL . 10.0 mp -104.71 111.88 24.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.979 -0.555 . . . . 72.299999999999997 110.947 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -143.58 135.77 26.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.581 -0.736 . . . . 75.040000000000006 109.201 176.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.5 pp -85.75 125.73 33.45 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 74.329999999999998 110.015 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.58 179.26 38.56 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.654 -0.703 . . . . 61.149999999999999 111.544 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.1 -156.95 6.8 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.011 -0.614 . . . . 74.549999999999997 112.594 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.604 ' HA3' HD12 ' A' ' 118' ' ' LEU . . . -78.8 130.98 10.34 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.021 -0.609 . . . . 75.230000000000004 112.141 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -105.91 -30.92 9.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.77 0.319 . . . . 74.209999999999994 110.467 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.79 -4.86 63.26 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.843 -0.694 . . . . 75.010000000000005 112.862 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.2 103.58 0.09 OUTLIER Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.019 -0.61 . . . . 61.210000000000001 112.525 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.64 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 32.0 m-70 -138.83 142.42 38.66 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.04 -0.356 . . . . 74.420000000000002 110.04 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -66.89 -44.84 79.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 72.530000000000001 111.243 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.34 11.91 3.69 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.056 -0.592 . . . . 74.510000000000005 113.664 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.64 ' HG ' ' HB2' ' A' ' 115' ' ' HIS . 95.9 mt -84.28 -51.35 7.07 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.606 -0.35 . . . . 75.310000000000002 110.599 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -79.02 -28.78 43.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.928 -0.578 . . . . 70.209999999999994 110.821 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.6 m -61.86 -32.72 73.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.081 0.467 . . . . 74.239999999999995 110.777 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.841 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 68.3 t -84.4 -47.26 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.445 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.451 ' HA ' ' CG2' ' A' ' 127' ' ' THR . . . -57.5 -55.79 30.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.759 -0.655 . . . . 73.340000000000003 112.45 -174.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.6 m -66.52 -21.64 66.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.024 0.379 . . . . 75.510000000000005 112.024 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.82 -52.09 64.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.803 0.297 . . . . 74.209999999999994 111.803 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.683 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 1.4 pt? -110.17 3.75 20.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.786 -0.366 . . . . 75.349999999999994 111.385 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.92 20.04 61.98 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.68 -0.772 . . . . 64.099999999999994 112.852 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.451 ' CG2' ' HA ' ' A' ' 122' ' ' ALA . 13.0 t -85.91 167.47 15.08 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.927 -0.397 . . . . 74.019999999999996 109.927 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.44 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 12.0 mptt -119.82 8.21 11.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.438 -0.346 . . . . 75.329999999999998 110.16 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 59.58 62.99 1.61 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.756 -0.656 . . . . 74.519999999999996 109.67 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -57.91 -70.58 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.282 -0.872 . . . . 74.319999999999993 111.718 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.775 ' HB3' HG13 ' A' ' 91' ' ' VAL . 34.8 t60 -99.55 86.71 3.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.115 0.483 . . . . 75.540000000000006 109.964 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -96.16 121.94 38.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.833 -0.621 . . . . 75.430000000000007 110.402 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -83.24 126.96 40.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.158 -0.682 . . . . 74.239999999999995 109.158 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -106.64 103.03 12.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.111 -0.495 . . . . 75.040000000000006 110.833 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 66.8 mt -96.53 128.06 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.879 -0.6 . . . . 64.420000000000002 109.857 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.95 115.3 7.11 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.818 -0.706 . . . . 74.200000000000003 111.81 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.569 ' HB ' ' HD2' ' A' ' 21' ' ' ARG . 35.0 m -100.88 -20.38 5.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.703 0.287 . . . . 74.439999999999998 111.061 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.31 151.4 1.73 Allowed Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.067 -0.515 . . . . 74.109999999999999 112.857 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.518 ' HG2' ' HB2' ' A' ' 97' ' ' LEU . 1.6 ppt_? -158.52 138.06 8.47 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.635 -0.332 . . . . 74.519999999999996 110.174 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 22.9 Cg_endo -93.54 134.14 0.97 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.218 2.612 . . . . 73.239999999999995 112.036 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.33 132.12 24.99 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.224 1.95 . . . . 73.140000000000001 111.718 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -159.04 179.17 34.86 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.562 -0.828 . . . . 74.109999999999999 111.858 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 143' ' ' ARG . 2.9 mpt_? -87.62 9.89 19.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.494 0.664 . . . . 75.120000000000005 110.106 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -124.73 131.59 53.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.873 -1.058 . . . . 74.329999999999998 108.431 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.9 149.95 62.61 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.944 0.402 . . . . 74.519999999999996 110.82 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.667 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 41.4 Cg_endo -66.92 4.6 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.345 2.697 . . . . 64.030000000000001 114.093 -172.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.549 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . -61.24 -39.22 89.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 73.430000000000007 110.636 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.72 -36.17 62.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.166 0.508 . . . . 72.239999999999995 110.543 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.667 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 95.8 m-85 -71.29 -24.61 62.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 74.310000000000002 111.513 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 22' ' ' HIS . 9.0 p -85.31 -15.21 10.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.887 0.375 . . . . 73.329999999999998 110.872 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.626 ' O ' HG21 ' A' ' 20' ' ' THR . 87.4 mt -84.01 -37.83 21.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.415 -0.357 . . . . 71.209999999999994 111.766 -177.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -162.96 101.28 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.401 0.619 . . . . 74.150000000000006 111.482 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -160.06 115.21 2.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.714 -0.675 . . . . 75.340000000000003 110.196 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -134.19 145.04 48.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.727 -0.669 . . . . 74.329999999999998 109.612 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.499 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 0.2 OUTLIER -137.68 -160.01 1.01 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.226 -0.287 . . . . 74.530000000000001 110.226 -175.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.465 ' H ' HG22 ' A' ' 155' ' ' THR . . . -82.45 -29.0 30.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.835 0.35 . . . . 64.049999999999997 111.31 176.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.15 -60.54 2.19 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.095 0.776 . . . . 65.319999999999993 113.095 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -34.7 69.1 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.966 0.358 . . . . 70.099999999999994 111.966 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 155' ' ' THR . 7.2 mmp_? -60.79 -31.31 70.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.906 0.384 . . . . 75.329999999999998 110.678 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.38 -28.03 65.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 64.340000000000003 111.391 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -87.87 -19.05 27.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.011 -0.54 . . . . 74.299999999999997 111.102 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.634 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 88.7 t -50.63 -55.37 27.08 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 112.821 0.675 . . . . 74.530000000000001 112.821 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.634 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 77.5 Cg_exo -51.48 -33.8 48.87 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.364 2.043 . . . . 72.540000000000006 112.992 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.0 m -80.21 -46.7 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.458 . . . . 75.230000000000004 110.787 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.452 ' HA ' ' HB3' ' A' ' 168' ' ' GLN . 1.6 mp -59.51 -34.57 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 74.120000000000005 111.906 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 162' ' ' VAL . 85.6 t -55.37 -46.54 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.902 0.382 . . . . 64.019999999999996 111.152 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -79.11 -37.56 38.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 110.221 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.533 HE22 ' HA ' ' A' ' 103' ' ' ARG . 47.3 tt0 -61.3 -46.86 88.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.478 -0.783 . . . . 74.540000000000006 111.462 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.47 90.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 73.530000000000001 110.623 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.45 90.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.6 . . . . 73.049999999999997 110.729 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.52 -36.08 79.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.229 0.538 . . . . 75.010000000000005 110.605 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 176' ' ' LEU . . . -68.21 -47.74 67.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.717 -0.674 . . . . 75.319999999999993 111.026 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 21.5 p -66.77 -42.69 85.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.577 -0.283 . . . . 74.219999999999999 111.407 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -57.1 -56.42 21.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 74.519999999999996 111.202 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.35 -29.16 67.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.596 -0.274 . . . . 74.340000000000003 111.428 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -60.48 -46.63 89.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.305 0.574 . . . . 74.430000000000007 109.576 178.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.668 HG22 ' HB ' ' A' ' 58' ' ' THR . 62.9 mt -80.09 -30.34 12.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.356 -0.838 . . . . 74.040000000000006 110.809 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.402 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . . . -71.66 -47.39 54.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 70.109999999999999 111.838 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.15 -75.14 0.6 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.3 -0.409 . . . . 64.019999999999996 110.638 -174.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.58 -172.78 38.63 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.42 -0.895 . . . . 64.349999999999994 112.385 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 181' ' ' LEU . 1.1 pt? -94.31 -26.25 16.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.606 0.241 . . . . 75.120000000000005 111.184 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.487 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 39.8 mt-10 -66.91 -47.29 54.0 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 111.981 0.363 . . . . 74.140000000000001 111.981 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 32.9 Cg_endo -65.94 -29.51 49.35 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.373 1.382 . . . . 72.219999999999999 111.877 174.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.66 -48.93 62.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.862 -0.608 . . . . 61.119999999999997 111.304 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.56 ' HA ' HG22 ' A' ' 188' ' ' VAL . 8.2 pt20 -60.99 -33.08 72.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.831 0.348 . . . . 75.239999999999995 111.062 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -69.97 -26.17 63.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.933 0.397 . . . . 73.420000000000002 110.628 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 31.4 m -86.28 -41.82 14.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.094 -0.503 . . . . 75.299999999999997 111.203 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.671 HG23 HD13 ' A' ' 106' ' ' LEU . 33.2 m -71.0 -20.24 21.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.871 0.367 . . . . 65.439999999999998 111.47 -178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -97.23 16.03 21.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.453 0.644 . . . . 72.430000000000007 109.79 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -105.59 17.03 24.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.909 -0.587 . . . . 72.129999999999995 110.286 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 87.3 m95 . . . . . 0 C--O 1.247 0.948 0 CA-C-N 115.681 -0.69 . . . . 73.5 109.962 179.719 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 121.138 0.494 . . . . 75.140000000000001 110.689 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.09 90.62 2.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.638 -0.71 . . . . 74.099999999999994 109.505 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -116.69 151.54 47.31 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.678 -0.692 . . . . 73.219999999999999 110.68 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 59' ' ' SER . 21.5 Cg_exo -64.69 108.82 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.901 2.401 . . . . 72.219999999999999 112.862 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.656 HD13 HG21 ' A' ' 177' ' ' ILE . 87.8 mt -95.24 156.64 16.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.92 -0.582 . . . . 72.420000000000002 109.652 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.584 HD21 HD13 ' A' ' 90' ' ' ILE . 34.1 tp -108.25 120.75 43.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.941 0.4 . . . . 74.140000000000001 110.75 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 t -118.53 116.97 53.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.862 -0.608 . . . . 73.140000000000001 109.883 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.709 ' HB ' HG21 ' A' ' 92' ' ' VAL . 35.3 t -114.81 143.7 23.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.474 -0.33 . . . . 75.450000000000003 110.473 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.58 157.11 20.25 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.824 -0.703 . . . . 72.420000000000002 111.553 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' H ' ' HA3' ' A' ' 25' ' ' GLY . 61.9 mt -66.43 115.78 6.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 73.409999999999997 109.688 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -83.96 -179.07 51.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.029 -0.605 . . . . 71.129999999999995 113.565 -171.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -94.16 124.16 56.79 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.963 0.411 . . . . 74.25 110.456 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.487 ' HG3' ' CE2' ' A' ' 68' ' ' TYR . 74.2 Cg_endo -88.54 -6.28 6.05 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.759 2.306 . . . . 75.120000000000005 113.469 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.5 171.21 28.39 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.722 -0.751 . . . . 75.439999999999998 112.131 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.4 -52.18 3.51 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.167 2.578 . . . . 74.230000000000004 113.034 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.7 m -61.31 -34.84 75.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 72.209999999999994 111.561 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.533 ' HE1' ' HB3' ' A' ' 151' ' ' LEU . 98.1 m-85 -89.22 -9.39 50.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.316 -0.402 . . . . 74.310000000000002 111.634 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.98 -6.87 45.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.342 . . . . 70.409999999999997 110.954 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.5 11.42 36.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 74.299999999999997 111.101 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -101.88 147.66 26.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.72 -0.845 . . . . 70.109999999999999 108.72 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -0.44 37.71 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.502 -0.479 . . . . 75.120000000000005 111.449 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -76.91 -6.33 52.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.101 0.477 . . . . 61.229999999999997 111.021 -174.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -118.45 34.38 5.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.375 0.607 . . . . 75.219999999999999 110.005 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pp -63.81 -12.67 37.79 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.6 -0.727 . . . . 64.510000000000005 111.451 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.466 ' HA3' ' H ' ' A' ' 10' ' ' LEU . . . -61.09 -47.23 92.22 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.124 -0.79 . . . . 72.129999999999995 111.124 175.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.624 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 83.4 t80 -65.26 -39.65 92.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.825 -0.435 . . . . 75.219999999999999 109.825 175.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 65.2 mtt -59.87 -56.8 17.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.672 -0.694 . . . . 73.209999999999994 110.96 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.435 ' HA ' HG21 ' A' ' 31' ' ' VAL . 94.7 t -59.03 -44.0 90.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.474 -0.33 . . . . 75.540000000000006 110.946 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.657 ' HB1' HD23 ' A' ' 62' ' ' LEU . . . -58.91 -45.24 90.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.948 0.404 . . . . 72.239999999999995 111.023 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.22 -44.6 68.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 72.5 111.559 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 32.8 m -69.17 -31.73 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.956 -0.298 . . . . 72.129999999999995 111.581 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 60.1 mt -71.8 -58.73 3.22 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.939 -0.304 . . . . 72.129999999999995 110.609 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 38' ' ' SER . . . -59.49 -46.72 88.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 52.340000000000003 110.728 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.14 -20.76 69.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.081 -0.58 . . . . 73.140000000000001 113.179 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 40.1 ttp180 -84.44 -33.4 23.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.068 0.434 . . . . 73.430000000000007 110.645 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.51 -36.09 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.191 0.52 . . . . 71.150000000000006 110.04 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.47 68.75 0.29 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.629 -0.989 . . . . 71.150000000000006 110.629 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 57.8 m -152.46 119.91 5.99 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.502 -0.349 . . . . 63.310000000000002 110.793 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.82 127.95 16.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.52 -0.309 . . . . 61.229999999999997 110.404 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.613 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 14.3 m-85 -141.63 172.85 12.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 73.239999999999995 110.123 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -142.84 176.31 9.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 75.439999999999998 111.123 -171.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.8 t -48.06 130.94 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.795 0.665 . . . . 75.239999999999995 112.795 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.506 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 72.1 t60 -109.28 115.46 30.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.49 -0.777 . . . . 72.319999999999993 109.658 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 2.5 tmtp? -68.89 99.92 1.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.944 0.35 . . . . 74.120000000000005 111.944 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 80.2 tttt 160.2 -51.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.1 -1.444 . . . . 73.439999999999998 107.1 173.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 p -102.91 28.6 6.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.218 -1.81 . . . . 65.510000000000005 108.076 173.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 43' ' ' HIS . . . -48.85 44.08 0.01 OUTLIER Glycine 0 N--CA 1.474 1.18 0 N-CA-C 119.81 2.684 . . . . 60.32 119.81 -150.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.47 179.76 4.9 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.333 -1.358 . . . . 73.209999999999994 107.333 159.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.865 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 32.3 mt-10 -80.34 118.0 21.59 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 119.998 -0.681 . . . . 73.239999999999995 109.565 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.741 HG23 ' HH ' ' A' ' 83' ' ' TYR . 30.5 m -121.11 137.73 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.978 0.418 . . . . 73.129999999999995 110.768 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.832 HG13 ' HB3' ' A' ' 62' ' ' LEU . 1.6 p -124.35 110.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.253 0.549 . . . . 75.439999999999998 110.265 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.7 p -92.52 107.93 19.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.733 -0.667 . . . . 73.239999999999995 110.202 176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.02 165.01 28.57 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.35 -0.7 . . . . 52.240000000000002 111.35 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 15.5 ptt-85 -104.91 103.85 13.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.537 0.684 . . . . 74.120000000000005 110.611 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.43 135.57 38.12 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.676 -0.861 . . . . 74.129999999999995 108.676 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 62.53 10.74 4.24 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.463 0.477 . . . . 70.209999999999994 111.149 -174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.56 -22.91 34.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.989 -0.624 . . . . 73.439999999999998 112.623 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 m -89.59 122.52 32.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 64.099999999999994 110.845 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.598 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 19.3 m -68.49 116.47 9.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.441 -0.345 . . . . 74.0 110.414 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.401 HG12 HG22 ' A' ' 177' ' ' ILE . 31.0 m -127.68 164.05 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.957 0.408 . . . . 72.430000000000007 110.689 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.01 111.05 34.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.93 -0.577 . . . . 60.329999999999998 109.808 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.832 ' HB3' HG13 ' A' ' 51' ' ' VAL . 64.4 tp -96.82 129.83 44.19 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.534 -0.543 . . . . 74.129999999999995 109.534 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.91 129.27 55.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.217 0.532 . . . . 71.299999999999997 112.049 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.865 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 45.3 mtpt -110.92 92.05 14.05 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.2 -0.909 . . . . 73.219999999999999 109.691 175.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.547 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.7 Cg_endo -83.54 173.03 9.86 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.992 2.461 . . . . 74.5 112.143 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -110.82 12.98 22.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.428 0.633 . . . . 73.430000000000007 109.48 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 60.0 m -130.08 175.15 9.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.558 -0.746 . . . . 75.420000000000002 110.633 -175.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.487 ' CE2' ' HG3' ' A' ' 13' ' ' PRO . 45.9 m-85 -100.25 -169.82 1.78 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.109 -0.496 . . . . 72.200000000000003 110.96 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.574 ' HA ' ' HB2' ' A' ' 72' ' ' SER . 24.9 ptt? -66.8 -20.16 65.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.876 -0.602 . . . . 71.510000000000005 111.537 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -71.87 -25.22 61.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.211 0.529 . . . . 74.129999999999995 109.897 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 18.0 mp0 -105.89 2.42 27.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.717 -0.674 . . . . 75.310000000000002 110.525 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.574 ' HB2' ' HA ' ' A' ' 69' ' ' MET . 27.0 t -60.24 -38.57 83.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.438 -0.346 . . . . 73.019999999999996 110.681 -175.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.82 -20.34 64.14 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.005 -0.617 . . . . 72.239999999999995 112.393 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -85.05 -31.4 23.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.863 0.363 . . . . 72.430000000000007 110.609 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -89.6 -40.65 12.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 71.310000000000002 111.42 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.97 -32.33 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.33 -0.395 . . . . 61.509999999999998 111.102 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.8 -67.83 1.75 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.908 -0.587 . . . . 61.32 113.261 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.07 -39.26 32.55 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.531 2.154 . . . . 72.319999999999993 112.409 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.9 tp -55.32 -58.47 7.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 74.129999999999995 111.731 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.48 68.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.957 0.408 . . . . 75.239999999999995 111.153 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -73.04 -32.7 65.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.817 -0.629 . . . . 74.409999999999997 111.638 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -81.96 -41.78 20.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.873 0.323 . . . . 64.319999999999993 111.873 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.741 ' HH ' HG23 ' A' ' 50' ' ' VAL . 69.0 m-85 -85.45 -17.13 37.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.13 0.418 . . . . 72.540000000000006 112.13 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 t 62.72 71.8 0.51 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.237 0.541 . . . . 74.340000000000003 110.863 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.551 HG21 ' HB2' ' A' ' 6' ' ' LEU . 28.0 m -118.17 158.24 46.86 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.798 -0.637 . . . . 72.030000000000001 109.821 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 35.6 Cg_exo -61.11 111.52 1.11 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.515 2.143 . . . . 71.140000000000001 112.001 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.38 -6.77 19.38 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.707 2.272 . . . . 75.349999999999994 112.267 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -98.27 -12.43 21.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.993 -0.549 . . . . 74.109999999999999 110.457 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 86' ' ' PRO . 79.0 mm-40 -114.49 20.14 15.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 74.239999999999995 110.8 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.586 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 5.8 tt -83.31 134.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.185 -0.461 . . . . 74.129999999999995 110.224 177.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.525 ' HA ' ' CB ' ' A' ' 131' ' ' HIS . 21.6 m -120.9 141.35 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.835 0.35 . . . . 71.299999999999997 110.68 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.709 HG21 ' HB ' ' A' ' 8' ' ' VAL . 45.9 t -132.78 127.34 55.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.316 -0.402 . . . . 73.299999999999997 110.465 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 mm -75.15 139.23 19.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.887 -0.597 . . . . 75.310000000000002 110.708 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -142.45 152.89 43.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.506 -0.316 . . . . 75.430000000000007 110.521 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.97 135.55 42.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.479 -0.934 . . . . 72.519999999999996 108.479 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 99' ' ' ILE . 10.1 tp10 -104.37 127.68 52.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.377 0.608 . . . . 71.129999999999995 111.001 -174.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.536 HD23 ' HG3' ' A' ' 146' ' ' PRO . 3.2 pp -84.26 -13.83 51.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.05 -0.977 . . . . 75.109999999999999 110.775 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.94 -47.67 20.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 70.319999999999993 111.157 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.472 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 56.7 mt -89.74 142.13 13.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.089 -0.505 . . . . 71.549999999999997 110.789 -176.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.89 166.46 18.9 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.509 . . . . 72.530000000000001 110.607 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.638 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 15.4 p90 -64.45 128.72 36.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.247 0.546 . . . . 75.299999999999997 112.164 -174.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.62 -22.94 3.84 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.726 -0.75 . . . . 74.310000000000002 112.958 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.489 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 17.0 mmt180 -132.35 128.34 37.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.265 0.555 . . . . 75.209999999999994 112.451 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.524 HG23 HG22 ' A' ' 135' ' ' ILE . 47.3 pt -107.79 146.77 13.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.334 -0.848 . . . . 73.530000000000001 109.414 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -157.73 125.2 5.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.908 0.385 . . . . 74.540000000000006 110.46 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.75 ' H ' HD21 ' A' ' 106' ' ' LEU . 1.9 pt? -97.91 144.62 27.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.442 -0.344 . . . . 74.439999999999998 110.092 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 104.44 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.179 -0.674 . . . . 72.329999999999998 109.179 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.754 ' H ' HD22 ' A' ' 108' ' ' LEU . 1.6 pt? -93.37 97.47 10.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.396 0.617 . . . . 71.439999999999998 110.758 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.94 -155.21 26.33 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.271 -0.732 . . . . 64.409999999999997 111.271 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.38 123.91 7.95 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.012 -0.613 . . . . 72.319999999999993 112.378 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.31 -176.61 44.64 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.55 -0.62 . . . . 52.439999999999998 111.55 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.61 ' HG2' ' H ' ' A' ' 113' ' ' GLY . 16.7 tt0 -142.76 -152.41 0.41 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.878 -0.415 . . . . 74.310000000000002 109.878 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.61 ' H ' ' HG2' ' A' ' 112' ' ' GLU . . . 139.75 -74.18 0.38 Allowed Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.299 -0.72 . . . . 74.129999999999995 111.299 -175.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.56 ' HA3' ' HE3' ' A' ' 69' ' ' MET . . . -78.08 -6.57 87.54 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.971 -0.633 . . . . 65.400000000000006 111.829 174.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.8 t60 62.74 -87.3 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.774 0.829 . . . . 73.230000000000004 112.595 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -67.08 -46.55 73.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.792 0.329 . . . . 74.409999999999997 111.481 -168.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -60.99 -29.19 70.19 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 120.835 -0.698 . . . . 74.230000000000004 112.464 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.461 ' HB3' HH21 ' A' ' 132' ' ' ARG . 89.6 mt -82.88 -23.77 33.49 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.815 -0.227 . . . . 73.140000000000001 111.099 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -79.11 -39.7 32.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.235 -0.439 . . . . 74.200000000000003 110.634 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.5 t -61.59 -54.31 44.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.802 -0.635 . . . . 61.229999999999997 110.795 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 117' ' ' GLY . 48.4 t -59.5 -41.69 85.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.433 -0.349 . . . . 73.349999999999994 111.101 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.46 -52.09 67.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 75.239999999999995 111.209 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.8 m -71.46 -34.02 69.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.853 -0.612 . . . . 71.030000000000001 111.553 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.08 -36.84 78.04 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.833 0.349 . . . . 74.030000000000001 111.286 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.7 mt -87.31 -31.27 20.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.47 -0.332 . . . . 75.310000000000002 111.138 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.64 40.33 5.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.517 -0.849 . . . . 71.340000000000003 111.951 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.7 t -148.06 176.61 10.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.948 -0.39 . . . . 74.439999999999998 109.948 -177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -77.62 -5.87 51.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.72 0.295 . . . . 74.340000000000003 110.462 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.7 t30 72.01 81.31 0.15 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.327 -0.851 . . . . 73.430000000000007 111.896 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -71.2 -148.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.798 -0.637 . . . . 75.340000000000003 110.118 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.586 ' HB3' ' O ' ' A' ' 90' ' ' ILE . 32.1 p80 45.13 40.02 4.46 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.86 0.689 . . . . 74.129999999999995 112.86 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.461 HH21 ' HB3' ' A' ' 118' ' ' LEU . 50.3 mtt85 -91.65 107.97 19.58 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.433 -0.58 . . . . 71.25 109.433 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.04 109.43 28.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.628 -0.714 . . . . 71.439999999999998 109.88 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.407 ' HG2' ' OE1' ' A' ' 96' ' ' GLU . 95.4 mtt180 -88.71 100.75 13.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.019 -0.537 . . . . 74.409999999999997 110.889 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.524 HG22 HG23 ' A' ' 104' ' ' ILE . 55.7 mt -93.74 108.64 20.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.035 -0.529 . . . . 74.530000000000001 110.046 175.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -73.33 98.0 0.89 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.032 -0.604 . . . . 65.239999999999995 112.322 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.516 HG13 HG23 ' A' ' 135' ' ' ILE . 3.5 m -110.95 0.97 9.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.702 0.287 . . . . 75.409999999999997 111.484 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 131.88 140.1 4.47 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.264 -0.969 . . . . 54.210000000000001 112.843 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.452 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 7.8 ptp85 -99.46 139.49 20.94 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.656 0.265 . . . . 74.430000000000007 110.506 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 3.0 Cg_exo -75.29 141.36 25.74 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.803 2.336 . . . . 64.409999999999997 111.88 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.38 149.1 88.52 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.575 2.183 . . . . 74.109999999999999 111.58 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.19 44.42 2.15 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.323 -0.465 . . . . 72.209999999999994 113.626 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -82.27 -67.73 0.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.673 -1.232 . . . . 73.230000000000004 107.673 175.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.481 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 22.5 mmtm -131.36 147.97 52.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.621 -1.172 . . . . 73.239999999999995 108.289 166.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.582 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 1.7 p-10 -58.91 157.45 20.35 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 123.335 0.397 . . . . 73.120000000000005 110.699 -175.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.582 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 4.8 Cg_endo -46.1 -28.76 5.66 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 124.192 3.261 . . . . 74.140000000000001 114.149 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.69 -32.11 28.63 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.186 0.439 . . . . 71.530000000000001 112.186 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.57 -57.97 2.75 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.355 0.502 . . . . 65.239999999999995 112.355 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 144' ' ' LYS . 67.6 m-85 -84.03 -19.99 33.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.654 0.983 . . . . 75.310000000000002 113.654 -168.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.0 p -71.63 -5.97 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.169 0.433 . . . . 73.319999999999993 112.169 -171.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.533 ' HB3' ' HE1' ' A' ' 17' ' ' TYR . 87.9 mt -91.12 -1.91 57.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 71.230000000000004 111.424 -176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -138.91 103.06 4.7 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.752 -0.833 . . . . 74.310000000000002 108.752 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -129.34 119.33 23.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.613 -0.722 . . . . 64.219999999999999 112.024 -164.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -169.1 103.08 0.37 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.642 0.734 . . . . 64.230000000000004 110.12 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.532 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 3.1 m -134.99 131.77 37.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.515 . . . . 73.349999999999994 109.928 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.87 -38.02 86.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.758 0.313 . . . . 72.239999999999995 111.085 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.2 92.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.764 -0.653 . . . . 71.409999999999997 112.31 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.532 ' HG2' ' HB ' ' A' ' 155' ' ' THR . 15.2 pt-20 -82.21 -32.85 29.62 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.968 -0.293 . . . . 75.519999999999996 111.155 -175.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.606 ' HA ' HG23 ' A' ' 162' ' ' VAL . 49.5 mtm180 -71.6 -20.09 62.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.754 0.312 . . . . 74.310000000000002 110.694 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.86 -38.71 76.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.933 -0.576 . . . . 63.240000000000002 112.041 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -103.02 7.58 39.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.197 0.443 . . . . 72.519999999999996 112.197 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.606 HG23 ' HA ' ' A' ' 159' ' ' ARG . 77.3 t -58.19 -51.64 80.35 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 121.058 -0.257 . . . . 74.519999999999996 111.34 177.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 12.5 Cg_endo -56.71 -27.61 71.69 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.326 2.018 . . . . 62.32 112.354 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' A' ' 168' ' ' GLN . 9.4 m -68.32 -55.47 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.36 -0.382 . . . . 64.340000000000003 110.121 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.443 HG13 HG22 ' A' ' 104' ' ' ILE . 1.7 mp -56.06 -43.17 74.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.524 -0.762 . . . . 75.310000000000002 111.503 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 162' ' ' VAL . 92.4 t -58.04 -49.94 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.618 0.247 . . . . 75.400000000000006 111.369 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.69 -33.15 70.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.563 -0.289 . . . . 73.530000000000001 111.318 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 164' ' ' THR . 98.7 mt-30 -62.52 -48.13 80.87 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.099 0.476 . . . . 64.439999999999998 109.89 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.14 -41.13 97.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.656 -0.702 . . . . 74.209999999999994 111.194 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.09 87.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.401 -0.363 . . . . 74.340000000000003 111.102 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.09 -36.52 83.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 73.230000000000004 110.784 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.29 -45.93 44.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 72.109999999999999 111.335 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.831 ' HA ' HD13 ' A' ' 176' ' ' LEU . 80.1 m -58.3 -40.57 82.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.228 -0.442 . . . . 74.120000000000005 111.541 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -53.71 -45.31 70.37 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.263 -0.426 . . . . 61.0 111.249 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 183' ' ' PRO . 30.7 tp -81.88 -28.33 33.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.059 -0.257 . . . . 74.230000000000004 111.534 -174.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.831 HD13 ' HA ' ' A' ' 173' ' ' THR . 74.0 mt -52.2 -55.95 17.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.26 0.552 . . . . 74.349999999999994 110.665 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.656 HG21 HD13 ' A' ' 5' ' ' LEU . 6.9 pt -80.97 -23.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.376 -0.829 . . . . 73.439999999999998 111.78 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.77 -45.69 81.56 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 111.748 0.277 . . . . 62.119999999999997 111.748 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -136.65 -61.63 0.67 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.83 0.348 . . . . 73.420000000000002 111.277 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -168.59 170.31 42.17 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.541 -0.838 . . . . 74.209999999999994 112.307 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.716 ' HA ' HD21 ' A' ' 176' ' ' LEU . 3.3 pp -82.71 -31.54 28.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.225 0.454 . . . . 73.430000000000007 112.225 -175.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 14.6 mm-40 -60.66 -54.26 56.43 Favored Pre-proline 0 N--CA 1.468 0.439 0 N-CA-C 112.559 0.577 . . . . 74.120000000000005 112.559 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.428 ' HB2' HD22 ' A' ' 175' ' ' LEU . 19.6 Cg_endo -60.75 -31.19 91.61 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.426 1.417 . . . . 75.040000000000006 111.856 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 188' ' ' VAL . . . -72.15 -45.77 59.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.539 . . . . 72.109999999999999 111.266 -178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 182' ' ' GLU . 1.2 pp0? -67.77 -20.92 65.27 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.145 0.498 . . . . 63.340000000000003 110.542 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.609 ' HA ' ' CE1' ' A' ' 189' ' ' HIS . 0.9 OUTLIER -67.48 -46.94 71.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 71.420000000000002 109.873 171.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 56.2 m -62.35 -33.52 74.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 64.239999999999995 111.143 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 184' ' ' ALA . 94.6 t -54.45 -38.47 41.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 75.349999999999994 111.426 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.609 ' CE1' ' HA ' ' A' ' 186' ' ' ASN . 10.2 p-80 -100.22 9.04 43.35 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.554 -0.459 . . . . 74.540000000000006 110.947 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.51 -34.17 18.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.302 -0.408 . . . . 64.019999999999996 109.946 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 38.7 m95 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.554 -0.748 . . . . 72.540000000000006 110.309 174.923 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.7 pm0 . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.961 -0.385 . . . . 64.120000000000005 109.961 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 15.7 Cg_exo -68.39 111.01 2.4 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.816 2.344 . . . . 72.0 112.246 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.21 153.0 42.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.175 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.29 115.37 27.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.049 0.452 . . . . 64.200000000000003 110.881 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.46 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 50.3 t -105.53 116.44 49.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.258 -0.645 . . . . 61.340000000000003 109.258 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.823 ' HB ' HG22 ' A' ' 92' ' ' VAL . 45.8 t -102.19 122.5 54.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.877 0.37 . . . . 61.119999999999997 110.81 -176.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.603 ' O ' ' HD2' ' A' ' 65' ' ' PRO . . . -103.63 122.1 7.31 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.537 -0.839 . . . . 75.519999999999996 111.698 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.18 116.69 19.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.948 0.404 . . . . 65.109999999999999 110.44 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 23' ' ' ASN . . . -129.94 145.67 16.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.168 -0.773 . . . . 72.540000000000006 111.168 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 13.8 m-20 -124.58 73.75 61.93 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.915 0.357 . . . . 73.049999999999997 110.914 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.76 109.45 1.07 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.601 2.201 . . . . 65.129999999999995 112.471 176.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' A' ' 17' ' ' TYR . . . -146.9 172.28 27.42 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.399 -0.68 . . . . 64.409999999999997 111.399 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.48 -53.25 7.33 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.257 2.638 . . . . 72.310000000000002 112.304 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 m -112.03 -10.41 13.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.601 0.715 . . . . 43.210000000000001 109.67 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.727 ' HE1' ' HB3' ' A' ' 151' ' ' LEU . 93.0 m-85 -81.37 -17.12 50.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.389 -0.823 . . . . 73.540000000000006 111.458 -174.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.54 1.38 26.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.042 0.449 . . . . 70.400000000000006 110.711 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -118.58 18.23 13.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.663 -0.699 . . . . 65.349999999999994 109.955 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -103.44 -169.85 1.7 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.277 0.561 . . . . 62.119999999999997 111.137 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -86.81 -0.23 56.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.743 -0.662 . . . . 65.230000000000004 110.208 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 2.8 m170 -89.6 11.37 19.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 111.928 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 26.6 m-80 -109.87 20.1 18.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.806 -0.179 . . . . 54.130000000000003 111.124 -175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.607 ' H ' HD12 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -50.0 -48.91 52.24 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.487 0.492 . . . . 62.43 111.933 -173.501 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.05 -58.74 8.28 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.665 -0.698 . . . . 63.310000000000002 114.39 -171.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 23' ' ' ASN . 49.2 p90 -86.23 -22.6 26.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.336 0.568 . . . . 72.010000000000005 111.863 -174.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 23.1 mmt -71.25 -42.18 69.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.8 0.333 . . . . 73.310000000000002 111.121 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.3 t -80.04 -41.52 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.733 0.301 . . . . 72.140000000000001 111.026 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.58 -28.02 69.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.378 -0.374 . . . . 74.310000000000002 111.521 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 17.0 t70 -56.52 -50.17 72.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 60.229999999999997 111.312 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 m -75.97 -33.18 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.333 0.494 . . . . 75.230000000000004 112.333 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.4 pp -78.67 -35.9 44.53 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.512 -0.475 . . . . 72.510000000000005 111.095 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -71.3 -36.68 71.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 64.200000000000003 110.247 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.52 -30.43 74.47 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.847 -0.692 . . . . 72.430000000000007 112.845 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -83.96 -37.38 22.34 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.422 0.527 . . . . 74.409999999999997 112.422 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.2 tp -72.7 -15.22 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.256 0.55 . . . . 74.25 110.581 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.51 59.98 0.96 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.661 -0.975 . . . . 53.450000000000003 110.661 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.9 m -142.55 128.81 19.89 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.118 0.485 . . . . 51.409999999999997 111.349 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.14 150.72 26.85 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.808 -0.633 . . . . 43.200000000000003 109.971 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 30' ' ' ASP . 89.1 m-85 -89.44 139.56 30.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.703 0.287 . . . . 74.530000000000001 110.613 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 41' ' ' LYS . 11.6 mptt -110.57 135.82 50.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.274 -0.421 . . . . 65.519999999999996 110.004 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 56.2 t -100.19 106.39 19.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.923 -0.58 . . . . 53.210000000000001 110.407 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -116.95 77.1 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.26 -0.644 . . . . 75.200000000000003 109.26 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 96.6 mttt -55.56 105.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.334 -0.848 . . . . 73.400000000000006 112.638 -171.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 32.1 ttmt 168.29 -88.99 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 124.471 1.107 . . . . 73.519999999999996 108.694 174.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 m -106.05 -14.98 15.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.409 0.623 . . . . 72.439999999999998 109.985 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.85 43.01 1.6 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.29 -0.868 . . . . 52.32 112.193 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 42' ' ' VAL . . . -51.45 -45.44 62.7 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.708 0.262 . . . . 71.439999999999998 111.708 -171.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.696 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 40.2 mt-10 -130.09 116.44 18.52 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.755 -0.461 . . . . 74.239999999999995 109.755 171.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.55 135.64 46.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.084 0.468 . . . . 73.040000000000006 111.154 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 8.3 p -128.59 133.39 66.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.959 -0.564 . . . . 61.409999999999997 110.334 172.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.589 HG22 HG22 ' A' ' 61' ' ' VAL . 68.4 p -105.0 107.57 18.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.036 0.446 . . . . 53.310000000000002 110.361 174.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -128.11 158.48 21.53 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.074 -0.81 . . . . 31.120000000000001 111.074 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.1 ptt180 -120.66 104.98 10.35 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.42 0.628 . . . . 73.450000000000003 111.614 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.834 HD13 ' HA ' ' A' ' 174' ' ' GLU . 1.6 pp -104.22 146.72 28.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.524 -0.762 . . . . 72.319999999999993 109.241 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 71.05 -32.44 0.25 Allowed 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.608 0.567 . . . . 63.409999999999997 111.991 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 154.5 -40.89 0.63 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.166 -0.54 . . . . 60.329999999999998 112.191 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.7 m -89.4 137.17 32.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.831 0.348 . . . . 63.420000000000002 111.098 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 23.0 t -81.79 129.83 34.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.347 -0.388 . . . . 54.530000000000001 110.23 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.15 163.88 18.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.226 -0.443 . . . . 74.409999999999997 110.375 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 52' ' ' THR . 57.9 t -107.54 112.4 39.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.367 -0.379 . . . . 73.409999999999997 110.296 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.464 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . 5.6 mp -95.36 111.95 23.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.645 -0.502 . . . . 72.030000000000001 109.645 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.7 135.67 50.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.945 -0.57 . . . . 42.009999999999998 110.609 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.696 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -123.71 117.37 27.54 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.047 -0.524 . . . . 74.040000000000006 110.073 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 9' ' ' GLY . 29.0 Cg_endo -65.8 122.77 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.922 1.748 . . . . 73.310000000000002 110.795 171.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -95.67 9.2 41.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.029 0.919 . . . . 71.439999999999998 108.528 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.46 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . 43.2 m -100.84 179.82 4.28 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.093 -1.412 . . . . 64.120000000000005 109.006 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -74.13 162.02 29.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.441 -0.345 . . . . 70.310000000000002 110.47 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.444 ' HG3' ' OD1' ' A' ' 116' ' ' ASN . 26.8 ptt? -59.57 -24.8 64.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.357 -0.383 . . . . 74.420000000000002 111.298 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.53 -35.15 73.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.225 0.536 . . . . 72.040000000000006 110.56 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.46 ' OE1' ' HB3' ' A' ' 67' ' ' CYS . 29.2 mt-10 -98.07 -2.46 40.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.615 -0.72 . . . . 72.140000000000001 111.189 -173.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.7 t -60.12 -43.08 95.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.435 -0.348 . . . . 70.549999999999997 111.496 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' HA2' HG22 ' A' ' 121' ' ' VAL . . . -63.02 -20.69 62.81 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.947 -0.644 . . . . 74.519999999999996 112.846 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.502 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 3.1 mpt_? -86.29 -12.22 50.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.795 0.331 . . . . 73.519999999999996 110.837 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.812 HE21 ' HA ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -86.69 -47.32 9.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.245 -0.434 . . . . 71.310000000000002 110.936 -178.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.69 -42.69 97.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.792 -0.64 . . . . 72.219999999999999 111.942 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.73 -67.3 1.98 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.982 -0.554 . . . . 42.100000000000001 114.097 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.01 -36.98 79.94 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.604 2.203 . . . . 75.420000000000002 112.838 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.38 -43.73 98.13 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.272 -0.422 . . . . 72.319999999999993 110.471 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.31 75.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 43.109999999999999 111.309 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.83 -34.09 74.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 64.530000000000001 111.523 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -62.2 -41.85 98.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.827 0.346 . . . . 53.140000000000001 111.291 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -98.17 3.89 49.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.488 -0.324 . . . . 73.140000000000001 111.5 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t 58.34 39.47 25.41 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.017 -0.538 . . . . 53.350000000000001 110.82 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.478 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 18.3 m -108.69 134.64 20.23 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.101 -0.5 . . . . 53.329999999999998 110.579 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 13.0 Cg_exo -69.93 122.5 9.13 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.74 2.294 . . . . 44.43 111.939 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -78.49 18.32 0.97 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.965 2.443 . . . . 73.230000000000004 112.5 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -81.59 -61.89 1.8 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.314 0.578 . . . . 50.25 110.145 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -87.71 68.95 9.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.616 -0.72 . . . . 54.030000000000001 110.085 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 pt -115.2 150.56 17.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.904 -0.589 . . . . 60.210000000000001 110.958 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 m -112.6 127.99 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 62.439999999999998 110.387 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.823 HG22 ' HB ' ' A' ' 8' ' ' VAL . 47.4 t -124.53 121.49 61.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 110.377 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.474 ' CG2' ' HA2' ' A' ' 9' ' ' GLY . 7.2 tt -84.31 123.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.751 0.31 . . . . 64.230000000000004 110.207 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -153.76 150.08 28.13 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.892 0.377 . . . . 71.040000000000006 111.009 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.461 ' HB3' HD21 ' A' ' 24' ' ' LEU . 9.9 p-10 -84.68 141.29 30.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.72 -0.673 . . . . 70.030000000000001 110.592 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 112' ' ' GLU . 53.3 mm-40 -148.7 155.8 41.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.197 0.523 . . . . 75.409999999999997 111.63 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.29 2.12 37.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.232 -0.894 . . . . 65.219999999999999 111.881 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -49.35 -44.84 45.02 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.556 0.535 . . . . 64.430000000000007 111.355 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.81 HD12 ' HG2' ' A' ' 103' ' ' ARG . 7.6 pt -139.13 173.85 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 74.439999999999998 110.847 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.411 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 0.8 OUTLIER -75.78 163.22 27.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.182 -0.463 . . . . 54.149999999999999 111.08 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.669 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 4.3 t80 -70.79 126.64 30.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.054 -0.521 . . . . 75.329999999999998 110.521 -176.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 161' ' ' GLU . . . 145.72 -45.37 0.82 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.572 -0.611 . . . . 72.219999999999999 111.572 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.81 ' HG2' HD12 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -119.98 160.49 22.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.512 -0.551 . . . . 74.310000000000002 109.512 178.243 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 135' ' ' ILE . 39.8 pt -127.67 157.29 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.809 0.338 . . . . 74.120000000000005 111.189 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -130.71 125.1 33.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.048 -0.523 . . . . 75.409999999999997 110.591 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -101.24 111.51 23.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.424 -0.584 . . . . 71.329999999999998 109.424 175.618 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.678 ' HD3' ' HD2' ' A' ' 134' ' ' ARG . 16.0 ptmt -143.61 153.57 42.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.472 -0.786 . . . . 74.25 110.445 -169.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -100.24 114.06 27.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.595 0.712 . . . . 75.109999999999999 110.825 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.53 178.86 38.9 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.861 -0.895 . . . . 75.239999999999995 110.861 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.548 ' HA2' HD13 ' A' ' 118' ' ' LEU . . . -166.81 86.56 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.047 -1.073 . . . . 71.140000000000001 113.593 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.4 74.94 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.934 -0.65 . . . . 42.030000000000001 111.942 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.527 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 3.3 mp0 -143.53 -82.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.554 0.216 . . . . 74.400000000000006 111.027 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -104.73 -69.67 0.77 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.706 -0.759 . . . . 42.219999999999999 113.046 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.21 69.14 3.32 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.026 -0.607 . . . . 70.200000000000003 112.054 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -55.72 -48.04 75.85 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.746 0.276 . . . . 75.329999999999998 111.746 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.444 ' OD1' ' HG3' ' A' ' 69' ' ' MET . 24.8 t-20 -61.58 -45.01 95.94 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.729 0.27 . . . . 71.120000000000005 111.729 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.54 -23.73 72.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.733 -0.746 . . . . 44.539999999999999 112.405 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.548 HD13 ' HA2' ' A' ' 110' ' ' GLY . 46.1 mt -83.23 -45.87 13.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.211 0.529 . . . . 73.319999999999993 109.693 174.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -65.35 -44.77 86.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.207 -0.906 . . . . 63.439999999999998 111.821 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.5 t -52.41 -47.21 66.43 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.938 0.399 . . . . 75.299999999999997 111.098 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.668 ' HB ' HH22 ' A' ' 132' ' ' ARG . 36.5 t -78.18 -44.28 27.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.262 -0.426 . . . . 75.099999999999994 110.928 -177.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.58 98.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.293 -0.412 . . . . 74.129999999999995 111.539 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.5 t -73.61 -30.28 62.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.261 -0.427 . . . . 70.439999999999998 110.711 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.47 -42.27 68.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 74.329999999999998 110.519 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.2 mt -76.68 -21.36 55.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 74.219999999999999 110.258 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.72 13.52 82.27 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.902 -0.59 . . . . 64.430000000000007 112.043 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.8 t -165.0 169.53 16.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.858 -0.423 . . . . 73.340000000000003 109.858 -176.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -96.72 -106.51 0.16 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.733 -0.469 . . . . 75.340000000000003 109.733 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.6 t30 67.56 -10.33 0.38 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.119 0.785 . . . . 72.129999999999995 113.119 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -76.57 129.27 36.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.361 0.6 . . . . 75.340000000000003 111.464 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -98.96 87.0 3.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.881 -0.599 . . . . 61.409999999999997 109.734 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.668 HH22 ' HB ' ' A' ' 121' ' ' VAL . 93.5 mtt180 -90.48 156.06 18.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 71.310000000000002 111.389 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 106' ' ' LEU . 46.1 t -99.79 112.14 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.729 -0.668 . . . . 64.030000000000001 109.581 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.678 ' HD2' ' HD3' ' A' ' 107' ' ' LYS . 70.3 mtt85 -94.15 114.2 26.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.033 -0.531 . . . . 60.299999999999997 110.925 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.673 ' HA ' HG22 ' A' ' 104' ' ' ILE . 2.0 mp -83.26 118.22 30.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 108.708 -0.849 . . . . 65.5 108.708 173.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.669 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -66.87 118.65 10.75 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.626 -0.797 . . . . 74.239999999999995 111.627 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.577 ' HA ' ' HD2' ' A' ' 101' ' ' PHE . 35.0 m -109.9 1.13 9.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.145 0.497 . . . . 71.120000000000005 110.556 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 86.48 175.16 49.58 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.827 -0.701 . . . . 74.25 111.972 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.06 104.3 54.63 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.168 -0.308 . . . . 75.420000000000002 110.168 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 72.0 Cg_exo -50.05 114.61 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.068 2.512 . . . . 63.439999999999998 112.085 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 12.0 Cg_exo -70.34 127.96 14.85 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.869 2.379 . . . . 74.310000000000002 112.16 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 172.05 175.79 40.46 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.127 -0.789 . . . . 73.140000000000001 111.127 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -94.92 -6.69 42.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.441 0.639 . . . . 75.420000000000002 109.781 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -101.03 159.82 14.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.575 -0.739 . . . . 75.230000000000004 109.265 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.42 139.56 94.55 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.012 -0.366 . . . . 75.219999999999999 110.012 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.526 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 92.7 Cg_exo -47.65 -19.39 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.664 2.909 . . . . 64.109999999999999 113.722 177.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -47.19 -40.42 16.02 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.024 0.53 . . . . 55.439999999999998 112.029 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.64 -31.37 41.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.41 -0.359 . . . . 72.420000000000002 111.674 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.526 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 77.2 m-85 -84.07 -31.94 25.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.274 -0.421 . . . . 71.5 111.624 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.04 -4.81 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.049 0.452 . . . . 74.310000000000002 111.805 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.727 ' HB3' ' HE1' ' A' ' 17' ' ' TYR . 90.5 mt -86.91 -12.5 47.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.453 -0.34 . . . . 61.5 111.266 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -160.89 107.64 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.203 0.525 . . . . 75.329999999999998 110.068 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -131.81 148.96 52.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.077 -0.511 . . . . 74.319999999999993 110.378 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -146.47 35.88 0.97 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.402 0.62 . . . . 73.140000000000001 109.999 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.646 ' O ' ' HG2' ' A' ' 158' ' ' GLU . 84.8 m -86.23 115.25 23.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.701 -0.682 . . . . 62.229999999999997 110.418 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.96 -20.85 59.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 111.89 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.43 ' H ' HG22 ' A' ' 155' ' ' THR . . . -66.04 -30.24 70.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 44.420000000000002 111.813 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 155' ' ' THR . 15.2 pt-20 -71.4 -21.95 61.93 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.263 0.554 . . . . 65.409999999999997 110.446 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.512 ' HA ' HG23 ' A' ' 162' ' ' VAL . 16.3 mmm-85 -78.18 -25.19 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.653 -0.703 . . . . 63.409999999999997 110.655 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.36 80.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.691 . . . . 72.219999999999999 112.102 -174.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.639 ' HB2' ' HD1' ' A' ' 101' ' ' PHE . 6.0 mm-40 -105.38 7.78 33.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.072 0.397 . . . . 65.120000000000005 112.072 -175.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.522 ' N ' ' HD2' ' A' ' 163' ' ' PRO . 70.3 t -57.35 -52.38 74.66 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.669 -0.205 . . . . 73.120000000000005 111.084 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 13.7 Cg_endo -57.28 -33.62 96.4 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.108 1.872 . . . . 70.219999999999999 112.187 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.5 m -64.96 -43.42 92.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.937 -0.574 . . . . 75.319999999999993 110.61 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.3 -38.59 82.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.42 . . . . 74.209999999999994 110.763 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 162' ' ' VAL . 91.7 t -57.31 -54.04 35.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.553 -0.294 . . . . 73.340000000000003 111.205 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -61.19 -42.09 97.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.369 -0.378 . . . . 75.219999999999999 111.517 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' ' 191' ' ' TRP . 13.8 mm-40 -66.26 -49.52 66.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.482 -0.326 . . . . 74.230000000000004 111.314 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.0 96.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.448 -0.342 . . . . 74.219999999999999 111.593 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.5 -34.93 79.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.798 0.332 . . . . 62.009999999999998 111.553 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -80.63 -43.85 19.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.946 0.403 . . . . 75.239999999999995 110.794 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.27 -39.21 92.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 61.539999999999999 111.894 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.8 p -65.01 -38.86 92.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.744 0.307 . . . . 72.019999999999996 111.45 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.834 ' HA ' HD13 ' A' ' 55' ' ' LEU . 41.6 tt0 -73.55 -44.21 57.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.39 -0.368 . . . . 73.239999999999995 110.629 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 178' ' ' ALA . 44.5 tp -64.73 -27.93 69.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.492 -0.322 . . . . 53.210000000000001 111.023 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.0 tp -57.24 -45.63 83.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 73.450000000000003 110.766 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.58 -32.4 14.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.012 -0.54 . . . . 74.120000000000005 110.305 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 175' ' ' LEU . . . -61.52 -48.04 82.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.722 -0.672 . . . . 51.310000000000002 111.82 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -129.11 -67.72 0.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.077 -0.249 . . . . 74.239999999999995 111.381 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.64 -170.01 37.99 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.379 -0.915 . . . . 43.119999999999997 112.41 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.772 HD23 ' H ' ' A' ' 181' ' ' LEU . 1.8 pt? -81.82 -35.71 29.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.312 0.066 . . . . 73.510000000000005 110.98 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.587 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 4.9 mm-40 -54.46 -56.67 24.29 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 112.278 0.473 . . . . 61.200000000000003 112.278 -178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 50.1 Cg_exo -56.26 -34.48 93.75 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.807 1.671 . . . . 73.420000000000002 112.138 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.96 -55.01 9.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.996 -0.547 . . . . 71.299999999999997 111.453 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 181' ' ' LEU . 11.6 pt20 -69.38 -21.41 63.8 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 111.718 0.266 . . . . 51.310000000000002 111.718 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.51 -38.22 68.17 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.705 -0.398 . . . . 73.049999999999997 110.662 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 85.0 m -66.96 -44.27 80.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 55.310000000000002 111.489 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 185' ' ' GLN . 32.6 m -70.4 -16.82 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.43 . . . . 74.310000000000002 111.249 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -94.17 -13.5 26.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 61.32 110.034 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -93.27 -33.33 13.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 71.540000000000006 110.848 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.598 ' HB2' ' NE2' ' A' ' 168' ' ' GLN . 76.6 m95 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.526 -0.75 . . . . 73.310000000000002 109.552 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.746 -0.464 . . . . 75.120000000000005 109.746 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.531 ' HB3' HG23 ' A' ' 61' ' ' VAL . 51.4 Cg_exo -54.88 123.64 14.26 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.118 2.546 . . . . 75.120000000000005 112.927 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.863 HD12 ' HG2' ' A' ' 89' ' ' GLN . 2.1 mm? -84.44 133.02 34.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.45 -0.574 . . . . 62.25 109.45 177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.53 HD23 HD13 ' A' ' 90' ' ' ILE . 59.2 tp -93.6 117.53 30.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.015 0.436 . . . . 72.150000000000006 111.156 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.98 118.78 59.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.536 -0.756 . . . . 75.099999999999994 109.589 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.615 HG12 ' HB3' ' A' ' 63' ' ' ALA . 29.4 m -122.01 155.82 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.986 0.422 . . . . 52.229999999999997 111.022 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.97 163.95 30.27 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.797 -0.716 . . . . 61.539999999999999 111.983 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.718 HD21 ' HA ' ' A' ' 69' ' ' MET . 2.5 mt -68.92 106.4 2.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.914 0.388 . . . . 65.150000000000006 110.898 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.684 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -77.75 -141.57 1.61 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.823 -0.626 . . . . 63.140000000000001 112.253 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -97.78 99.71 7.19 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.067 0.46 . . . . 73.420000000000002 110.671 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.763 ' HB3' ' HA ' ' A' ' 68' ' ' TYR . 5.5 Cg_exo -78.77 -8.19 15.7 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.359 2.706 . . . . 51.420000000000002 112.887 -176.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.95 173.3 23.58 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.694 -0.765 . . . . 74.239999999999995 112.131 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.93 -54.8 2.4 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.032 2.488 . . . . 72.200000000000003 112.419 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 m -59.75 -35.62 74.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 73.140000000000001 111.601 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -74.89 -17.18 60.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.426 . . . . 71.239999999999995 111.296 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.42 -7.49 51.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.004 0.431 . . . . 43.100000000000001 110.861 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.41 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 3.8 mptp? -92.96 -10.22 37.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 63.399999999999999 110.263 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.75 HG22 ' H ' ' A' ' 153' ' ' ASN . 36.5 p -102.71 -169.38 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 63.340000000000003 110.741 -175.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.74 ' HG3' HD23 ' A' ' 24' ' ' LEU . 1.3 tpp180 -92.12 1.78 56.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.035 0.445 . . . . 75.239999999999995 110.123 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -76.8 11.36 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.26 0.467 . . . . 54.520000000000003 112.26 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -123.43 20.23 9.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.953 0.406 . . . . 55.350000000000001 110.144 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.753 HD13 HG12 ' A' ' 93' ' ' ILE . 1.1 pp -61.54 -24.26 66.51 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.982 -0.554 . . . . 74.319999999999993 111.968 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.606 ' N ' HD12 ' A' ' 24' ' ' LEU . . . -69.47 -47.96 47.3 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.995 -0.842 . . . . 73.549999999999997 110.995 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.684 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 88.8 t80 -61.05 -36.02 78.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.838 0.351 . . . . 61.130000000000003 110.217 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 61.8 mtt -61.34 -49.6 76.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 74.430000000000007 111.668 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.11 -47.67 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.056 0.391 . . . . 73.200000000000003 112.056 -174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.769 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -63.09 -38.87 92.91 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.405 0.521 . . . . 72.549999999999997 112.405 -171.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.65 -41.86 75.0 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.994 0.426 . . . . 75.430000000000007 111.125 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 22.9 m -79.65 -26.61 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.602 0.593 . . . . 73.409999999999997 112.602 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -67.66 -28.28 67.57 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.892 -0.323 . . . . 72.5 111.214 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 38' ' ' SER . . . -69.46 -41.96 75.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.143 0.496 . . . . 51.229999999999997 110.699 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.7 -18.13 71.83 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.003 -0.618 . . . . 63.420000000000002 112.86 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 8.2 mmt180 -61.17 -46.46 90.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.125 0.417 . . . . 73.239999999999995 112.125 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 36' ' ' ILE . 4.2 mp -73.23 -15.76 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.455 0.645 . . . . 73.530000000000001 110.407 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.99 12.92 26.53 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 110.765 -0.934 . . . . 43.039999999999999 110.765 -173.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 66.3 m -86.23 147.67 26.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.002 -0.599 . . . . 63.200000000000003 110.434 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.77 127.99 52.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.298 -0.41 . . . . 73.099999999999994 110.305 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -85.66 151.45 23.87 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.331 -0.618 . . . . 74.409999999999997 109.331 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -155.15 168.24 27.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.096 0.474 . . . . 73.349999999999994 110.914 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 5.1 p -84.16 117.77 30.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.71 -0.677 . . . . 75.530000000000001 109.766 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 5.8 t-80 -103.37 110.68 22.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.569 -0.9 . . . . 63.140000000000001 108.569 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -68.83 83.56 0.3 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 65.340000000000003 110.181 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.823 ' HE3' ' HB3' ' A' ' 82' ' ' PHE . 28.2 tptt -105.19 -95.13 0.34 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.909 -0.587 . . . . 74.010000000000005 109.513 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.534 ' HB3' ' CE2' ' A' ' 82' ' ' PHE . 9.6 p -108.16 -42.06 4.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 118.661 -1.216 . . . . 53.030000000000001 113.233 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.23 -25.62 0.46 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 118.544 -1.788 . . . . 42.399999999999999 117.025 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -139.76 -176.75 4.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 114.829 1.418 . . . . 72.5 114.829 -156.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 34.4 mt-10 -76.18 143.05 41.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.413 -1.267 . . . . 65.340000000000003 109.407 173.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 43' ' ' HIS . 93.8 t -142.8 133.19 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.993 -0.373 . . . . 74.409999999999997 109.993 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 62' ' ' LEU . 3.2 p -125.08 125.3 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.507 -0.553 . . . . 72.010000000000005 109.507 172.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -103.24 121.1 42.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.244 0.545 . . . . 62.509999999999998 110.035 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.01 157.58 23.47 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.215 -0.754 . . . . 70.219999999999999 111.215 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 7.0 ptt180 -109.98 103.42 12.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.511 0.672 . . . . 75.230000000000004 110.915 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.774 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 3.1 pp -113.06 151.81 30.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.091 -0.959 . . . . 61.439999999999998 109.153 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.28 -57.85 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.831 0.707 . . . . 73.430000000000007 110.993 -172.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.84 -38.67 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.146 -0.549 . . . . 60.420000000000002 112.273 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -93.45 140.66 29.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.76 0.314 . . . . 61.140000000000001 110.867 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 25.9 m -77.64 121.63 24.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.352 -0.385 . . . . 72.019999999999996 110.066 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.3 171.7 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.899 0.38 . . . . 44.25 111.408 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 4' ' ' PRO . 77.6 t -117.82 111.57 35.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 72.530000000000001 110.137 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.769 HD11 ' HB1' ' A' ' 29' ' ' ALA . 3.0 tm? -98.68 119.88 38.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.18 -0.674 . . . . 71.019999999999996 109.18 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.615 ' HB3' HG12 ' A' ' 8' ' ' VAL . . . -108.85 137.87 46.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.347 -0.388 . . . . 64.439999999999998 110.922 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 54.6 mtpt -114.0 92.61 26.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.998 -0.546 . . . . 75.319999999999993 110.957 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.4 138.79 51.91 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.863 2.376 . . . . 54.140000000000001 112.184 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -109.73 16.81 21.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.506 0.669 . . . . 64.200000000000003 109.351 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 59.7 m -114.8 179.99 3.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.333 -0.848 . . . . 74.299999999999997 111.231 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.763 ' HA ' ' HB3' ' A' ' 13' ' ' PRO . 97.7 m-85 -70.25 175.54 4.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.609 . . . . 71.040000000000006 112.031 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.718 ' HA ' HD21 ' A' ' 10' ' ' LEU . 27.3 ptt? -67.46 -31.06 70.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.752 -0.658 . . . . 62.140000000000001 112.344 -173.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -72.2 -30.76 65.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.44 0.638 . . . . 44.310000000000002 109.96 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 51.2 mm-40 -80.2 -22.27 42.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.528 -0.76 . . . . 71.319999999999993 111.355 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.0 p -56.3 -45.23 80.33 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.216 0.322 . . . . 72.030000000000001 111.467 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 121' ' ' VAL . . . -73.88 -28.15 65.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.665 -0.779 . . . . 74.299999999999997 112.257 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -78.73 -11.32 59.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.859 0.362 . . . . 73.340000000000003 110.612 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 31.0 mm-40 -65.5 -30.27 71.02 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.101 0.477 . . . . 63.25 110.021 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.5 t -67.47 -21.73 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.467 -0.788 . . . . 75.430000000000007 110.897 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.54 -72.28 0.55 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 116.018 -0.537 . . . . 55.240000000000002 112.879 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.95 -30.2 48.59 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.442 2.095 . . . . 54.32 112.037 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.493 HD12 HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -59.28 -40.36 85.87 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.748 -0.66 . . . . 62.240000000000002 110.689 -176.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.97 -30.89 70.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 64.010000000000005 112.108 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.26 -41.21 34.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 55.299999999999997 111.131 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.823 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 55.2 m-85 -71.63 -43.08 66.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.491 0.552 . . . . 74.040000000000006 112.491 -172.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.609 ' CE1' ' HG2' ' A' ' 45' ' ' LYS . 95.3 m-85 -97.68 -16.88 19.76 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.739 -0.384 . . . . 74.540000000000006 111.201 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 t 63.96 33.46 12.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.199 0.523 . . . . 75.510000000000005 110.382 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.511 HG21 HD22 ' A' ' 6' ' ' LEU . 25.7 m -69.0 149.7 97.77 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.472 -0.786 . . . . 75.430000000000007 111.362 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.84 117.01 4.28 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.745 2.296 . . . . 53.32 112.402 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.91 -1.87 10.11 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.032 2.488 . . . . 50.130000000000003 112.633 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -95.32 -25.47 16.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.127 -0.488 . . . . 55.43 110.342 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.863 ' HG2' HD12 ' A' ' 5' ' ' LEU . 7.5 tp60 -92.57 -11.05 35.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.635 . . . . 72.420000000000002 111.106 -174.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.53 HD13 HD23 ' A' ' 6' ' ' LEU . 5.3 tp -52.62 113.73 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.729 0.776 . . . . 70.510000000000005 111.776 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 9.3 p -116.76 138.79 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.301 -0.863 . . . . 63.100000000000001 110.147 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 7.7 p -132.6 134.06 59.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.151 -0.477 . . . . 74.299999999999997 110.67 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.753 HG12 HD13 ' A' ' 24' ' ' LEU . 7.7 tt -89.9 124.53 42.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.827 -0.624 . . . . 65.239999999999995 109.967 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -140.53 162.12 36.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.889 0.376 . . . . 71.040000000000006 110.767 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.53 153.01 23.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.719 -0.673 . . . . 74.310000000000002 110.252 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.937 ' HG3' ' HD2' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -140.84 121.35 14.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.938 0.399 . . . . 65.310000000000002 111.41 -178.506 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.803 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.8 pt? -84.91 -12.24 53.83 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.67 -0.696 . . . . 71.129999999999995 110.765 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.64 -39.17 93.0 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.151 0.501 . . . . 65.310000000000002 110.108 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.631 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.8 pt -104.81 154.11 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 74.439999999999998 110.052 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.597 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 6.9 p-10 -88.37 -170.09 2.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.102 0.477 . . . . 75.219999999999999 112.018 -171.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.792 ' HD2' ' HB3' ' A' ' 158' ' ' GLU . 68.1 m-85 -62.97 119.65 9.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.363 -0.835 . . . . 72.230000000000004 112.526 -168.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.69 -0.16 82.39 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.813 -0.708 . . . . 65.510000000000005 113.363 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.512 ' O ' HD12 ' A' ' 99' ' ' ILE . 33.0 mmt180 -88.94 96.09 10.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 117.069 0.434 . . . . 74.25 110.192 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.716 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -103.34 137.35 32.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.92 0.39 . . . . 62.130000000000003 110.666 -179.269 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 105' ' ' ARG . 52.0 mtt180 -145.61 125.74 13.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.997 -0.547 . . . . 74.329999999999998 110.062 176.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -100.21 130.22 46.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.342 -0.614 . . . . 75.409999999999997 109.342 172.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.535 ' HA ' HD13 ' A' ' 181' ' ' LEU . 1.5 tmtm? -155.41 154.2 31.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.266 0.555 . . . . 70.540000000000006 111.637 -171.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.474 HD23 HD11 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -83.95 92.95 7.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.343 0.592 . . . . 75.150000000000006 109.561 171.509 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.04 176.58 37.46 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.623 -0.717 . . . . 55.130000000000003 111.435 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.79 170.41 27.91 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.615 -0.802 . . . . 75.150000000000006 112.673 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.2 -169.19 34.68 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.447 -0.661 . . . . 51.049999999999997 111.447 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -134.26 -11.73 2.49 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.754 -0.379 . . . . 70.120000000000005 110.781 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -108.31 138.91 14.91 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.72 -0.752 . . . . 74.340000000000003 111.354 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.13 56.32 18.83 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.578 -0.82 . . . . 72.430000000000007 111.773 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -53.74 -38.93 64.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.06 0.393 . . . . 70.420000000000002 112.06 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -58.24 -53.72 55.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.724 0.297 . . . . 43.219999999999999 111.274 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.65 -28.81 73.95 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.007 -0.616 . . . . 35.009999999999998 112.831 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.1 mt -82.48 -46.12 13.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.654 0.264 . . . . 61.149999999999999 111.488 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -77.56 -21.48 52.45 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.879 -0.328 . . . . 63.329999999999998 110.879 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 t -63.27 -37.85 88.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.513 -0.551 . . . . 75.400000000000006 109.513 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 45.2 t -66.79 -31.01 51.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.801 -0.636 . . . . 63.0 110.202 176.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.6 -52.33 10.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.852 -0.613 . . . . 62.399999999999999 111.001 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 62.7 m -66.78 -22.75 66.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 64.409999999999997 111.772 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.32 -54.91 29.57 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 111.872 0.323 . . . . 44.130000000000003 111.872 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.73 ' H ' HD23 ' A' ' 125' ' ' LEU . 2.2 pt? -106.71 -17.73 14.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 75.340000000000003 111.369 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.54 40.24 2.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.242 -0.98 . . . . 64.200000000000003 112.936 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -110.26 171.82 7.23 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.505 -0.554 . . . . 73.230000000000004 109.505 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -114.22 38.88 2.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.488 0.185 . . . . 53.439999999999998 111.127 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 63.38 34.89 12.64 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.373 -0.376 . . . . 61.539999999999999 111.117 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -64.67 -13.11 52.7 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.132 -0.486 . . . . 42.130000000000003 112.303 -173.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 48.1 m80 -146.86 99.29 3.17 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.232 -0.293 . . . . 65.219999999999999 110.366 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 143.82 49.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.815 0.341 . . . . 75.140000000000001 110.822 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 34.3 t -116.94 120.59 65.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.812 -0.44 . . . . 72.310000000000002 109.812 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.937 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 44.0 mtm180 -107.32 117.58 34.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.676 0.274 . . . . 64.439999999999998 111.027 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.444 HD13 HG13 ' A' ' 93' ' ' ILE . 1.9 mp -103.51 115.11 44.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.762 -0.459 . . . . 74.519999999999996 109.762 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.631 ' HA2' HG13 ' A' ' 99' ' ' ILE . . . -62.13 113.63 5.98 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.872 -0.604 . . . . 40.450000000000003 112.879 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 p -101.66 -17.22 6.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.226 0.536 . . . . 71.230000000000004 109.648 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 88.49 -171.99 40.57 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.718 -0.753 . . . . 62.149999999999999 111.4 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -135.06 111.96 11.14 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 120.901 0.382 . . . . 73.430000000000007 110.197 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 146' ' ' PRO . 23.8 Cg_exo -63.67 114.99 2.79 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.108 2.539 . . . . 71.239999999999995 112.441 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 2.1 Cg_endo -85.16 139.32 7.08 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.319 2.679 . . . . 63.310000000000002 112.347 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -173.32 -151.91 8.44 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.43 -0.668 . . . . 53.130000000000003 111.43 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.13 -8.17 49.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.449 0.642 . . . . 74.420000000000002 109.688 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.421 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 71.6 mmtt -116.89 156.11 27.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.198 -0.91 . . . . 63.539999999999999 109.795 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.34 143.29 97.27 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.885 -0.598 . . . . 72.209999999999994 110.03 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.703 ' HB3' ' HD2' ' A' ' 140' ' ' PRO . 82.9 Cg_exo -47.0 -26.06 4.57 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.364 2.71 . . . . 62.310000000000002 113.016 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.05 -31.16 39.96 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.956 -0.565 . . . . 71.400000000000006 111.916 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.13 -50.9 6.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.488 -0.324 . . . . 74.540000000000006 111.422 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 153' ' ' ASN . 74.6 m-85 -64.99 -27.43 68.82 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.201 0.445 . . . . 74.299999999999997 112.201 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.2 p -69.36 -9.13 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.889 0.376 . . . . 71.450000000000003 111.558 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.37 -24.5 36.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.603 -0.271 . . . . 71.230000000000004 110.897 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.6 87.77 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.842 0.83 . . . . 74.129999999999995 109.647 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.75 ' H ' HG22 ' A' ' 20' ' ' THR . 3.7 t-20 -137.84 122.23 18.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.426 -0.806 . . . . 75.109999999999999 110.77 -174.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -134.35 133.83 41.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.639 -0.71 . . . . 74.430000000000007 109.407 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 157' ' ' ALA . 59.9 m -145.61 134.04 21.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.86 0.362 . . . . 70.510000000000005 110.471 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.04 -31.43 67.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.325 -0.398 . . . . 62.32 111.505 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.571 ' H ' HG22 ' A' ' 155' ' ' THR . . . -59.89 -40.73 89.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 71.549999999999997 111.9 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.792 ' HB3' ' HD2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -85.14 -17.75 36.29 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.035 -0.266 . . . . 74.340000000000003 111.361 -177.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 155' ' ' THR . 4.7 mmt180 -72.15 -24.62 61.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 72.329999999999998 110.927 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.68 -17.1 61.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 72.040000000000006 111.127 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.45 ' O ' HG13 ' A' ' 165' ' ' ILE . 25.0 mm-40 -92.66 -18.49 22.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 62.43 111.103 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.715 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 67.1 t -55.98 -56.99 24.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.594 0.59 . . . . 64.329999999999998 112.594 -174.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.715 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 32.2 Cg_exo -59.12 -30.12 92.34 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.135 1.89 . . . . 53.329999999999998 112.322 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.9 m -67.2 -46.3 74.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.949 -0.569 . . . . 52.340000000000003 110.555 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 161' ' ' GLU . 72.4 mt -70.02 -53.97 21.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.717 -0.674 . . . . 73.299999999999997 111.215 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.78 -57.94 9.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.383 0.512 . . . . 72.439999999999998 112.383 -172.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -62.88 -45.52 92.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.874 0.324 . . . . 61.539999999999999 111.874 -174.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -74.32 -32.02 62.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.798 0.295 . . . . 64.349999999999994 111.798 -173.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.29 -25.43 67.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.618 0.229 . . . . 65.120000000000005 111.618 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.23 74.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 73.310000000000002 111.289 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.4 -43.69 76.69 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.338 0.59 . . . . 61.530000000000001 110.766 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.7 -31.75 69.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.597 -0.729 . . . . 43.329999999999998 111.678 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.1 m -55.72 -43.09 76.19 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.776 0.322 . . . . 74.239999999999995 111.803 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.774 ' HG2' ' HB2' ' A' ' 55' ' ' LEU . 42.6 mt-10 -68.54 -28.65 67.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.754 0.311 . . . . 71.25 111.075 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.05 -25.77 65.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.352 -0.385 . . . . 75.430000000000007 111.051 -175.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.73 -37.81 88.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.188 0.518 . . . . 71.239999999999995 110.278 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -80.0 -39.9 20.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.678 -0.692 . . . . 72.209999999999994 110.091 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.49 -56.6 10.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.807 -0.633 . . . . 75.319999999999993 111.448 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -115.57 -77.09 0.57 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.079 -0.509 . . . . 75.340000000000003 110.208 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.32 -171.39 40.02 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.107 -0.797 . . . . 74.540000000000006 111.107 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.535 HD13 ' HA ' ' A' ' 107' ' ' LYS . 4.3 pp -91.13 -18.49 24.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.035 0.418 . . . . 73.219999999999999 110.32 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 33.5 mm-40 -58.63 -51.79 79.3 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.747 -0.66 . . . . 65.549999999999997 111.829 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 37.8 Cg_endo -69.01 -29.81 26.8 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.351 1.367 . . . . 61.520000000000003 112.027 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.15 -43.81 66.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 60.109999999999999 111.809 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 11.3 pt20 -58.8 -24.0 61.22 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.779 0.323 . . . . 53.200000000000003 111.303 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -77.65 -57.12 3.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.34 -0.391 . . . . 75.409999999999997 111.298 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -66.95 -31.01 71.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.383 -0.371 . . . . 73.230000000000004 111.876 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 8.1 p -71.42 -29.36 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.055 0.391 . . . . 75.430000000000007 112.055 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -94.03 0.06 55.74 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.46 -0.496 . . . . 55.240000000000002 110.636 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.49 -0.96 54.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 112.018 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 74.3 m95 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.697 -0.668 . . . . 74.349999999999994 110.64 -178.256 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 38.2 mt-10 . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.363 -0.236 . . . . 74.400000000000006 110.363 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 59' ' ' SER . 22.6 Cg_exo -64.71 106.4 0.74 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.598 2.199 . . . . 73.450000000000003 111.596 176.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.418 ' HG ' HG12 ' A' ' 60' ' ' VAL . 4.0 pp -89.94 153.77 20.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.304 -0.407 . . . . 55.409999999999997 111.021 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' HB3' HG12 ' A' ' 90' ' ' ILE . 62.9 tp -97.46 124.74 41.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.848 -0.615 . . . . 65.209999999999994 110.5 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.1 t -105.27 119.12 53.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.13 -0.486 . . . . 61.509999999999998 109.77 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.72 117.08 46.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.02 0.438 . . . . 74.329999999999998 110.801 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -127.9 128.72 6.13 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.371 -0.692 . . . . 64.209999999999994 111.371 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -72.56 118.94 16.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.759 -0.46 . . . . 73.450000000000003 109.759 -178.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.94 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -77.12 -158.4 9.21 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.206 -0.452 . . . . 73.549999999999997 113.069 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.47 91.36 9.95 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.619 0.723 . . . . 65.209999999999994 111.002 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 11' ' ' GLY . 2.0 Cg_endo -82.92 -8.95 10.96 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.215 2.61 . . . . 72.239999999999995 112.932 -176.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.19 160.92 29.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.826 -0.702 . . . . 70.430000000000007 112.229 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.42 -30.59 52.95 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.109 2.539 . . . . 75.140000000000001 112.482 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 p -73.24 -43.61 60.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.987 0.422 . . . . 53.420000000000002 111.2 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -59.89 -40.15 87.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.773 -0.648 . . . . 73.129999999999995 111.51 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.23 -3.71 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 65.510000000000005 111.771 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -111.45 8.29 21.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.352 -0.386 . . . . 72.310000000000002 110.424 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 153' ' ' ASN . 71.4 p -113.65 159.75 19.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 61.409999999999997 111.038 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -78.46 -20.16 51.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 62.340000000000003 111.672 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -76.73 -19.7 57.36 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.785 -0.366 . . . . 72.319999999999993 111.476 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 27' ' ' MET . 7.0 m120 -85.08 33.27 0.54 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.227 0.537 . . . . 73.310000000000002 111.042 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 1.3 pp -66.07 -17.26 64.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.552 -0.749 . . . . 74.239999999999995 111.521 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.424 ' N ' HD12 ' A' ' 24' ' ' LEU . . . -59.12 -34.24 78.55 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.195 -0.526 . . . . 61.43 111.962 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.94 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 54.6 t80 -90.11 -53.89 4.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.459 . . . . 75.219999999999999 109.841 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 85.7 mmm -56.89 -38.11 72.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.905 -1.043 . . . . 71.129999999999995 112.554 -169.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 166' ' ' VAL . 62.1 t -88.84 -41.9 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.798 0.332 . . . . 70.140000000000001 111.739 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.49 -22.42 47.49 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.189 0.44 . . . . 62.049999999999997 112.189 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -72.2 -39.28 68.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.732 0.301 . . . . 73.120000000000005 111.468 -175.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.41 -36.64 75.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 72.010000000000005 111.868 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.99 -27.08 62.52 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.771 0.319 . . . . 75.120000000000005 110.971 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.43 68.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.112 0.482 . . . . 54.030000000000001 110.309 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.16 -29.34 56.78 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.474 -0.869 . . . . 74.319999999999993 112.244 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -79.89 -21.87 43.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.342 0.497 . . . . 71.430000000000007 112.342 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.2 tp -78.15 -14.69 13.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.315 0.578 . . . . 71.450000000000003 110.335 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.31 41.03 2.87 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.121 -0.792 . . . . 54.530000000000001 111.121 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 62.8 m -135.3 150.08 49.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.229 -0.486 . . . . 65.549999999999997 110.684 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.97 136.24 52.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.687 0.279 . . . . 55.140000000000001 110.731 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.464 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 26.9 p90 -91.93 146.82 23.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.614 -0.513 . . . . 73.120000000000005 109.614 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 18.9 ptmt -155.39 166.87 32.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 74.010000000000005 111.155 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.22 128.31 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.469 -0.787 . . . . 72.400000000000006 111.314 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -101.9 106.13 17.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.234 -1.025 . . . . 64.209999999999994 108.234 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -57.91 154.26 12.64 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.502 0.556 . . . . 74.340000000000003 112.502 -166.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt 76.66 -47.55 0.54 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.387 1.075 . . . . 74.510000000000005 110.086 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 p -95.09 25.08 4.42 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.141 -0.936 . . . . 72.219999999999999 108.737 171.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.37 41.39 0.01 OUTLIER Glycine 0 CA--C 1.533 1.166 0 N-CA-C 119.238 2.455 . . . . 71.120000000000005 119.238 -159.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.02 140.1 29.84 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.847 -1.168 . . . . 74.140000000000001 107.847 163.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.51 120.12 19.63 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.723 -0.391 . . . . 71.230000000000004 110.553 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 63' ' ' ALA . 33.2 m -126.05 145.18 33.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.78 -0.646 . . . . 64.109999999999999 111.272 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 4.8 p -125.41 117.05 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.834 -0.621 . . . . 62.039999999999999 110.228 172.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.5 p -91.08 116.27 28.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.191 -0.459 . . . . 54.329999999999998 110.546 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.35 175.25 28.64 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.935 -0.65 . . . . 73.219999999999999 111.604 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 25.6 ptt85 -126.77 115.75 19.85 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.093 0.473 . . . . 74.219999999999999 110.922 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.9 mt -103.09 124.72 49.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.764 -0.653 . . . . 63.420000000000002 109.705 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 72.28 -53.01 0.7 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.823 0.702 . . . . 74.409999999999997 111.373 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.24 -52.13 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.115 -0.564 . . . . 71.329999999999998 111.986 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.696 ' HB ' HG22 ' A' ' 177' ' ' ILE . 17.8 m -72.62 138.67 46.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.857 0.36 . . . . 75.530000000000001 110.889 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.619 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 10.8 t -85.75 139.79 31.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.553 -0.536 . . . . 71.530000000000001 109.553 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.418 HG12 ' HG ' ' A' ' 5' ' ' LEU . 31.6 m -130.07 155.01 41.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.341 -0.391 . . . . 62.350000000000001 110.72 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.4 t -111.25 106.83 21.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.845 -0.616 . . . . 54.340000000000003 109.638 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 3.4 tm? -91.78 115.78 28.34 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.299 -0.63 . . . . 75.049999999999997 109.299 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 50' ' ' VAL . . . -119.27 142.24 48.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.239 -0.437 . . . . 44.450000000000003 111.385 -175.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HE2' ' CD2' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -139.14 127.25 13.52 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 75.430000000000007 110.387 175.445 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 13.0 Cg_exo -70.75 153.34 64.44 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.992 2.462 . . . . 73.420000000000002 112.023 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -93.96 -19.24 21.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.462 0.649 . . . . 74.310000000000002 110.0 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 60.4 m -101.94 159.26 15.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.217 -0.901 . . . . 45.340000000000003 109.463 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -78.05 -169.38 1.56 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.876 0.369 . . . . 65.219999999999999 111.522 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.831 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 18.9 ptp -52.75 -22.06 4.82 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.625 0.972 . . . . 70.150000000000006 113.625 -170.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -62.82 -49.62 74.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.791 0.329 . . . . 63.520000000000003 110.809 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.88 -0.11 21.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.011 0.375 . . . . 64.409999999999997 112.011 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 p -60.64 -42.77 97.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.927 0.394 . . . . 72.329999999999998 111.04 -176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.39 -21.17 78.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.945 -0.645 . . . . 71.030000000000001 112.769 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -80.63 -33.38 35.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.57 0.224 . . . . 71.129999999999995 111.391 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -74.9 -14.9 60.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.704 0.288 . . . . 75.319999999999993 111.617 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.21 -25.21 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.172 0.51 . . . . 65.519999999999996 110.304 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.69 -68.55 1.62 Allowed Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.881 -0.6 . . . . 63.32 112.865 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.82 -37.71 95.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.853 2.369 . . . . 64.329999999999998 112.462 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -55.87 -52.04 65.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 72.340000000000003 110.484 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.98 -44.75 83.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 65.400000000000006 112.012 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -72.77 -37.85 67.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.926 0.343 . . . . 72.099999999999994 111.926 -174.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -60.28 -47.49 85.76 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.75 0.309 . . . . 74.409999999999997 111.314 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -84.39 -15.14 47.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.934 -0.307 . . . . 74.329999999999998 110.791 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.2 m 59.78 47.61 10.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.863 -0.608 . . . . 71.430000000000007 110.693 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.441 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 29.4 m -94.42 148.8 35.61 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.642 -0.708 . . . . 73.510000000000005 110.321 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 11.2 Cg_exo -71.19 115.33 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.807 2.338 . . . . 70.400000000000006 111.969 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.523 ' HA ' HG13 ' A' ' 90' ' ' ILE . 28.8 Cg_exo -62.78 -19.53 68.73 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.006 2.471 . . . . 72.150000000000006 112.124 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -66.98 -21.7 65.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.86 -0.609 . . . . 74.319999999999993 110.684 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 89' ' ' GLN . 15.6 mm-40 -98.01 5.63 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.384 . . . . 73.430000000000007 111.413 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 87' ' ' PRO . 59.5 mt -69.22 130.92 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.109 0.48 . . . . 72.140000000000001 111.165 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 7.0 p -120.0 132.67 69.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 62.5 109.325 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.68 129.71 75.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.543 0.687 . . . . 74.319999999999993 111.649 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.13 113.1 29.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.167 -0.924 . . . . 73.439999999999998 109.174 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.455 ' HE1' ' H ' ' A' ' 114' ' ' GLY . 30.1 t-80 -135.26 154.28 51.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.277 0.561 . . . . 73.140000000000001 111.905 -174.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.87 129.53 34.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.628 -1.169 . . . . 73.549999999999997 110.899 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -129.47 138.45 51.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.016 0.436 . . . . 52.450000000000003 110.659 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.55 -0.03 44.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.88 -0.6 . . . . 50.439999999999998 110.919 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -58.67 -45.7 88.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.313 -0.858 . . . . 73.239999999999995 112.431 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.567 HD13 ' HG3' ' A' ' 105' ' ' ARG . 2.9 pt -122.22 174.92 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.307 0.575 . . . . 75.120000000000005 112.507 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.97 171.43 14.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.826 -1.079 . . . . 71.019999999999996 111.615 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -63.89 132.69 51.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.203 -0.908 . . . . 73.299999999999997 110.671 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.06 10.67 66.05 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.604 -0.808 . . . . 71.400000000000006 113.217 173.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.3 mmt-85 -123.0 153.56 39.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.103 0.452 . . . . 72.040000000000006 110.345 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.646 HD11 HG21 ' A' ' 188' ' ' VAL . 44.2 pt -138.81 149.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 74.420000000000002 110.874 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.567 ' HG3' HD13 ' A' ' 99' ' ' ILE . 99.0 mtt180 -127.15 128.06 45.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.936 -0.575 . . . . 74.319999999999993 109.903 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 185' ' ' GLN . 8.1 mp -109.75 110.19 21.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 61.329999999999998 110.953 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -157.68 148.4 21.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.053 -0.721 . . . . 74.219999999999999 109.053 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.72 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.3 pt? -73.66 125.12 27.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.776 -0.453 . . . . 72.25 109.776 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.76 -177.14 41.06 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.848 -0.692 . . . . 53.229999999999997 112.022 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.37 -164.73 39.28 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.962 -0.637 . . . . 51.439999999999998 112.628 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.35 152.36 22.07 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.381 -0.688 . . . . 55.229999999999997 111.381 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -113.32 7.53 17.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.776 0.288 . . . . 75.209999999999994 110.995 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -68.61 -86.77 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.701 -0.762 . . . . 62.329999999999998 111.855 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.455 ' H ' ' HE1' ' A' ' 94' ' ' HIS . . . -74.4 73.93 1.32 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.916 -0.659 . . . . 74.25 111.66 175.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.624 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -48.97 -66.43 0.4 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.488 0.715 . . . . 75.230000000000004 112.69 -174.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.564 ' HB2' ' SD ' ' A' ' 69' ' ' MET . 13.0 m120 -55.04 -43.63 73.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 62.039999999999999 111.527 -174.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.831 ' HA2' ' HB2' ' A' ' 69' ' ' MET . . . -62.9 -48.75 78.26 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.851 -0.613 . . . . 32.350000000000001 113.271 -176.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.74 -29.01 68.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.436 0.16 . . . . 74.310000000000002 111.291 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 115' ' ' HIS . 10.2 mmm180 -65.96 -42.27 90.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.657 0.265 . . . . 71.319999999999993 110.642 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -64.86 -47.79 76.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.387 -0.37 . . . . 62.030000000000001 110.549 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.28 -47.47 92.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 70.409999999999997 110.903 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.74 -31.28 72.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.891 -0.595 . . . . 54.130000000000003 111.844 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.2 t -80.34 -33.69 37.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.708 0.29 . . . . 55.520000000000003 110.918 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.21 -45.9 53.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 62.450000000000003 111.025 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.89 -38.53 45.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.479 . . . . 54.020000000000003 110.943 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.97 -12.52 63.78 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 121.116 -0.564 . . . . 53.240000000000002 113.168 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.504 ' C ' ' HD2' ' A' ' 128' ' ' LYS . 14.6 t -141.9 173.73 11.24 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.129 -0.323 . . . . 74.409999999999997 110.129 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.504 ' HD2' ' C ' ' A' ' 127' ' ' THR . 13.2 mptt -125.22 -115.25 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.436 -0.347 . . . . 72.299999999999997 110.224 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 61.93 21.77 12.55 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.94 0.496 . . . . 72.019999999999996 111.613 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -90.25 160.97 15.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.19 -0.459 . . . . 71.319999999999993 110.275 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 33.2 m80 -87.18 99.89 12.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.122 -0.696 . . . . 74.109999999999999 109.122 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.462 ' NH1' ' HG2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -111.75 136.31 51.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.975 0.416 . . . . 73.319999999999993 111.108 -174.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.03 127.11 59.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.016 -0.538 . . . . 74.340000000000003 109.782 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.462 ' HG2' ' NH1' ' A' ' 132' ' ' ARG . 5.2 mtm180 -93.36 96.83 10.19 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.685 -0.487 . . . . 71.409999999999997 109.685 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.526 ' HA ' HG22 ' A' ' 104' ' ' ILE . 51.4 mt -90.19 127.75 42.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.422 -0.354 . . . . 71.019999999999996 110.48 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.51 ' CA ' HG13 ' A' ' 99' ' ' ILE . . . -72.52 97.82 0.81 Allowed Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.987 -0.552 . . . . 75.519999999999996 112.545 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.8 p -88.65 -10.29 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.464 -0.569 . . . . 70.439999999999998 109.464 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.23 152.98 28.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.56 -0.745 . . . . 42.039999999999999 112.279 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 21.1 ptp180 -107.46 119.85 49.39 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.067 0.46 . . . . 72.019999999999996 110.235 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 32.5 Cg_exo -59.58 125.28 17.44 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.954 2.436 . . . . 54.049999999999997 112.746 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 1.9 Cg_endo -83.79 137.71 7.82 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.45 2.767 . . . . 73.409999999999997 112.374 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.09 -168.01 24.97 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.181 -0.767 . . . . 74.420000000000002 111.181 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -87.81 -24.38 23.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.631 -0.507 . . . . 72.150000000000006 109.631 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.446 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 42.4 mmtm -75.58 101.19 4.83 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.535 -0.913 . . . . 71.549999999999997 108.535 168.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.721 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 6.8 p-10 -73.1 168.49 24.43 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.916 -0.584 . . . . 73.329999999999998 110.41 -174.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.721 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 5.2 Cg_exo -35.99 -44.87 0.86 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.402 3.401 . . . . 64.109999999999999 114.274 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.42 68.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.236 0.458 . . . . 44.43 112.236 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.52 -43.77 11.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.847 0.356 . . . . 71.319999999999993 111.372 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 144' ' ' LYS . 2.6 m-85 -84.02 -19.43 34.49 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.869 0.692 . . . . 73.409999999999997 112.869 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.481 HG13 HD12 ' A' ' 151' ' ' LEU . 7.0 p -63.1 -25.56 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 112.201 0.445 . . . . 62.240000000000002 112.201 -173.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.481 HD12 HG13 ' A' ' 150' ' ' VAL . 6.0 mp -85.96 -10.24 55.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.659 0.266 . . . . 71.340000000000003 111.421 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.0 87.07 1.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.792 0.806 . . . . 74.209999999999994 109.438 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.559 ' H ' HG22 ' A' ' 20' ' ' THR . 23.8 t-20 -128.94 122.36 30.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.471 -0.786 . . . . 64.140000000000001 111.613 -170.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -155.31 134.86 12.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.386 -0.825 . . . . 74.209999999999994 109.199 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 157' ' ' ALA . 47.2 m -152.86 138.97 18.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.672 0.272 . . . . 72.230000000000004 110.605 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.91 -33.0 48.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 61.100000000000001 111.337 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.637 ' H ' HG22 ' A' ' 155' ' ' THR . . . -65.96 -49.24 68.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.903 -0.589 . . . . 64.109999999999999 111.568 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 155' ' ' THR . 3.0 pp20? -72.64 -22.04 61.0 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 120.849 -0.34 . . . . 74.040000000000006 111.252 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 155' ' ' THR . 16.4 mmt180 -56.59 -39.89 74.33 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.195 0.522 . . . . 65.019999999999996 110.34 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.45 -31.97 71.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.69 -0.686 . . . . 54.210000000000001 111.189 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.93 1.13 57.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.148 -0.478 . . . . 61.130000000000003 111.887 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.468 ' HB ' ' CD ' ' A' ' 163' ' ' PRO . 92.5 t -57.33 -57.87 21.96 Favored Pre-proline 0 C--O 1.233 0.229 0 C-N-CA 121.086 -0.245 . . . . 63.43 110.496 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' A' ' 162' ' ' VAL . 18.8 Cg_endo -61.07 -36.75 80.39 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.668 1.579 . . . . 72.109999999999999 111.476 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -56.18 -53.37 57.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.594 -0.73 . . . . 71.140000000000001 111.421 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.4 mt -64.3 -49.75 79.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.289 -0.414 . . . . 71.409999999999997 111.008 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 28' ' ' VAL . 97.6 t -57.22 -51.59 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.409 -0.359 . . . . 75.239999999999995 111.552 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.48 -49.87 73.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.503 -0.317 . . . . 75.430000000000007 111.754 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.547 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . 10.3 mm-40 -67.71 -36.78 81.25 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.027 -0.269 . . . . 65.140000000000001 111.498 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.24 75.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.61 0.243 . . . . 62.439999999999998 110.61 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.69 64.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.001 0.429 . . . . 61.219999999999999 111.301 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.42 -45.7 17.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.295 -0.411 . . . . 70.409999999999997 110.709 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.35 -33.96 70.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.068 -0.514 . . . . 73.340000000000003 111.979 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 176' ' ' LEU . 3.4 p -61.71 -27.4 68.68 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.865 0.32 . . . . 75.329999999999998 111.865 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -63.38 -44.76 93.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.701 0.286 . . . . 52.210000000000001 110.355 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 38.3 tp -74.65 -28.91 61.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 74.439999999999998 110.261 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.831 HD22 ' HA ' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -54.54 -49.02 71.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.366 -0.834 . . . . 70.409999999999997 109.306 174.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.696 HG22 ' HB ' ' A' ' 58' ' ' THR . 65.5 mt -79.7 -25.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.114 -0.948 . . . . 74.109999999999999 111.079 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.4 -43.68 72.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.008 -0.542 . . . . 73.109999999999999 112.158 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.22 -65.04 0.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.861 -0.336 . . . . 71.120000000000005 111.092 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -161.89 173.41 38.23 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.283 -0.96 . . . . 62.240000000000002 112.439 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.831 ' HA ' HD22 ' A' ' 176' ' ' LEU . 2.4 pt? -83.2 -30.6 27.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.723 0.297 . . . . 72.439999999999998 111.557 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 39.4 mt-10 -67.72 -49.31 39.64 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.098 0.407 . . . . 43.549999999999997 112.098 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 52.7 Cg_exo -55.76 -28.79 68.63 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.062 1.841 . . . . 73.209999999999994 112.228 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.69 -50.26 18.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 61.219999999999999 110.995 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.596 ' HG3' ' O ' ' A' ' 182' ' ' GLU . 1.4 pp0? -64.23 -32.9 74.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.766 0.317 . . . . 74.340000000000003 110.197 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -61.77 -23.08 65.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.905 -0.589 . . . . 74.310000000000002 111.099 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 26.4 m -87.15 -41.01 14.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.765 0.317 . . . . 55.240000000000002 111.605 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 104' ' ' ILE . 17.8 m -96.41 -12.77 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 114.35 1.241 . . . . 74.239999999999995 114.35 -171.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -69.45 -28.59 66.24 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.913 0.708 . . . . 71.230000000000004 112.913 -171.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -133.66 -10.73 2.75 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.122 0.416 . . . . 63.399999999999999 112.122 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 19.4 m0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 119.012 -0.518 . . . . 62.329999999999998 110.234 -176.835 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.343 0.592 . . . . 73.310000000000002 109.819 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HG2' HG12 ' A' ' 85' ' ' VAL . 6.7 Cg_endo -89.41 110.82 0.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.093 2.529 . . . . 75.530000000000001 113.191 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.634 HD12 HG23 ' A' ' 177' ' ' ILE . 91.7 mt -76.52 128.93 35.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 72.439999999999998 110.281 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.573 ' HA ' HG23 ' A' ' 61' ' ' VAL . 22.9 tp -96.72 114.55 26.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.041 0.448 . . . . 71.439999999999998 110.781 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.806 ' HB ' HD13 ' A' ' 62' ' ' LEU . 21.2 t -105.21 111.56 35.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.728 -0.669 . . . . 70.120000000000005 109.83 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.574 HG21 HG22 ' A' ' 76' ' ' VAL . 49.5 t -104.48 117.47 50.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.077 -0.511 . . . . 72.409999999999997 110.147 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.494 ' HA2' HG13 ' A' ' 93' ' ' ILE . . . -106.2 -142.91 11.15 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.448 -0.882 . . . . 73.209999999999994 112.622 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.553 ' H ' ' HA3' ' A' ' 25' ' ' GLY . 2.2 tt -117.47 122.57 44.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.448 -0.945 . . . . 73.430000000000007 108.448 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -76.31 169.9 54.86 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.945 -0.645 . . . . 73.230000000000004 113.424 -172.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.507 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 44.9 t-20 -109.28 109.26 60.46 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.234 -0.654 . . . . 75.299999999999997 109.234 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 6.3 Cg_exo -74.25 -61.8 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.231 2.62 . . . . 73.530000000000001 113.62 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.72 -168.09 11.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.202 -0.999 . . . . 75.450000000000003 113.362 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.02 -56.68 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.392 2.728 . . . . 61.020000000000003 113.378 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 m -61.78 -30.78 71.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.993 0.425 . . . . 72.519999999999996 111.518 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -83.59 -8.0 59.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.213 -0.448 . . . . 51.229999999999997 111.04 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HA ' HD21 ' A' ' 12' ' ' ASN . . . -81.28 -16.6 52.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 51.549999999999997 111.411 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.855 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 9.7 mmpt? -111.34 8.13 21.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.428 -0.351 . . . . 73.230000000000004 111.374 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.413 HG21 ' HA ' ' A' ' 152' ' ' GLU . 38.6 p -110.47 163.21 13.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.523 0.677 . . . . 73.310000000000002 112.173 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.899 HH21 ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -54.8 -33.47 61.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.428 -1.26 . . . . 75.219999999999999 113.465 -174.379 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -86.14 9.93 15.98 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.099 0.777 . . . . 73.450000000000003 113.099 -165.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.73 13.46 19.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.31 0.576 . . . . 65.209999999999994 110.556 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.899 ' HG ' HH21 ' A' ' 21' ' ' ARG . 0.0 OUTLIER -50.28 -31.35 14.0 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.182 0.808 . . . . 65.439999999999998 113.182 -173.443 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA3' ' H ' ' A' ' 10' ' ' LEU . . . -62.47 -42.64 99.69 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.823 -0.704 . . . . 65.129999999999995 112.536 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.481 ' CE2' ' HE3' ' A' ' 64' ' ' LYS . 56.3 t80 -67.13 -40.42 86.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.137 0.494 . . . . 73.349999999999994 110.439 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.497 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 4.8 mmt -65.36 -45.86 82.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.732 . . . . 74.209999999999994 111.381 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.752 HG12 HD23 ' A' ' 32' ' ' LEU . 57.9 t -68.15 -32.47 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.48 -0.327 . . . . 55.119999999999997 111.285 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.1 70.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.048 0.388 . . . . 53.509999999999998 112.048 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.27 -38.61 68.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.602 -0.272 . . . . 73.329999999999998 111.509 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.548 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 30.3 m -74.94 -33.38 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.091 0.404 . . . . 55.509999999999998 112.091 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.752 HD23 HG12 ' A' ' 28' ' ' VAL . 4.3 pp -70.93 -38.59 72.91 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 120.63 -0.428 . . . . 63.450000000000003 110.34 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -75.11 -36.89 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.231 0.539 . . . . 41.119999999999997 110.061 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.83 -18.28 45.87 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.497 -0.774 . . . . 51.310000000000002 113.067 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 15.3 mmt85 -68.67 -36.45 78.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.39 . . . . 73.120000000000005 111.17 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 36' ' ' ILE . 3.1 mp -88.17 -15.07 9.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.713 0.768 . . . . 74.319999999999993 109.703 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.35 24.9 9.8 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.616 -0.993 . . . . 71.129999999999995 110.616 -175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 70.5 m -99.24 123.23 43.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.845 -0.677 . . . . 62.450000000000003 111.021 -176.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.48 134.63 14.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.471 -0.331 . . . . 74.140000000000001 110.707 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 3.0 t80 -142.85 177.99 7.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.591 -0.522 . . . . 73.329999999999998 109.591 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 20.8 ptmt -123.39 174.14 7.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.702 -0.226 . . . . 74.219999999999999 110.446 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 6.3 p -49.8 128.29 6.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.262 0.553 . . . . 53.109999999999999 110.602 174.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -106.86 109.92 21.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.964 -0.562 . . . . 75.349999999999994 110.513 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -53.16 154.44 3.12 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.652 0.595 . . . . 54.25 111.993 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 45' ' ' LYS . 12.0 tptp 80.26 -41.73 0.21 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.362 1.065 . . . . 73.0 109.625 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.9 p -104.93 26.58 9.06 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.366 -1.288 . . . . 41.039999999999999 108.109 171.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.45 41.44 0.01 OUTLIER Glycine 0 N--CA 1.477 1.424 0 N-CA-C 119.72 2.648 . . . . 73.219999999999999 119.72 -154.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.02 168.63 9.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.14 -1.43 . . . . 64.120000000000005 107.14 160.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.815 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 46.0 mt-10 -77.64 124.18 27.6 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.065 -0.654 . . . . 73.25 109.737 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -133.54 138.85 50.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.928 -0.578 . . . . 55.329999999999998 109.995 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 62' ' ' LEU . 3.4 p -122.11 115.99 47.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.356 0.598 . . . . 71.310000000000002 110.241 173.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.0 m -99.47 136.06 39.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.529 -0.759 . . . . 74.530000000000001 110.183 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -175.09 -160.07 22.37 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.24 -0.744 . . . . 34.409999999999997 111.24 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -131.91 144.08 50.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.742 0.306 . . . . 74.349999999999994 110.195 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.76 ' HG ' HG21 ' A' ' 60' ' ' VAL . 79.9 mt -118.3 123.67 45.92 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.842 -0.799 . . . . 60.350000000000001 108.842 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.686 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . . . 70.18 -52.44 0.64 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.961 0.788 . . . . 61.020000000000003 111.274 -173.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.4 -40.82 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.327 -0.709 . . . . 35.420000000000002 111.327 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.675 ' HB ' HG22 ' A' ' 177' ' ' ILE . 20.6 m -65.54 144.57 56.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.42 -0.39 . . . . 73.239999999999995 110.724 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 20.3 m -76.18 142.72 41.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.312 -0.404 . . . . 72.430000000000007 110.499 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.76 HG21 ' HG ' ' A' ' 55' ' ' LEU . 29.4 m -138.33 150.81 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.255 0.55 . . . . 42.229999999999997 111.5 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 6' ' ' LEU . 3.6 m -129.76 112.14 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.526 -0.761 . . . . 44.439999999999998 109.904 173.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.806 HD13 ' HB ' ' A' ' 7' ' ' VAL . 4.1 mm? -92.49 128.07 38.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.797 -0.638 . . . . 73.510000000000005 109.992 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.14 122.25 46.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.173 0.511 . . . . 71.329999999999998 110.532 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HE3' ' CE2' ' A' ' 26' ' ' PHE . 6.9 ptmt -130.26 91.53 38.46 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.509 -0.769 . . . . 64.340000000000003 110.045 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.74 177.1 9.12 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.071 2.514 . . . . 64.019999999999996 112.812 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 20.3 mmt85 -109.35 13.3 24.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.46 -0.791 . . . . 65.510000000000005 109.044 175.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.556 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 61.2 m -102.26 178.91 4.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.947 -1.024 . . . . 60.439999999999998 109.923 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -85.36 -165.11 1.12 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.201 -0.454 . . . . 71.099999999999994 110.125 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -80.7 -19.62 44.69 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.705 0.261 . . . . 73.420000000000002 111.705 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -73.47 -61.71 1.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.222 0.534 . . . . 74.329999999999998 110.833 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 1.1 pm0 -82.69 6.6 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.987 -0.551 . . . . 71.310000000000002 111.792 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.6 p -67.54 -34.08 76.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.985 0.422 . . . . 71.109999999999999 110.069 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.96 -20.75 74.89 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.806 -0.634 . . . . 70.049999999999997 112.612 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 mmm180 -74.25 -19.62 60.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.997 0.427 . . . . 73.540000000000006 110.473 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -87.34 -8.01 57.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 71.209999999999994 110.789 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.574 HG22 HG21 ' A' ' 8' ' ' VAL . 74.0 t -66.67 -36.95 78.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 64.0 110.659 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.11 9.43 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.811 -0.632 . . . . 63.240000000000002 112.939 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.56 -18.73 56.19 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.834 2.356 . . . . 72.120000000000005 113.187 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.57 -51.29 7.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.01 0.433 . . . . 74.219999999999999 110.077 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.627 ' HA ' HG22 ' A' ' 85' ' ' VAL . . . -53.46 -63.48 1.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.55 -0.75 . . . . 74.329999999999998 113.018 -172.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -72.82 -22.88 60.74 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.353 0.501 . . . . 72.420000000000002 112.353 -170.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -77.76 -28.85 50.71 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.915 -0.314 . . . . 75.239999999999995 111.224 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -102.93 5.45 38.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.798 0.332 . . . . 74.030000000000001 110.938 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.7 t 65.58 28.7 11.28 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.522 -0.763 . . . . 44.509999999999998 111.976 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 80' ' ' ALA . 6.3 m -80.38 136.22 53.01 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.626 -0.43 . . . . 64.310000000000002 110.464 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.77 ' HD2' ' HG3' ' A' ' 89' ' ' GLN . 30.1 Cg_exo -63.29 155.11 63.77 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.651 2.234 . . . . 75.040000000000006 111.748 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.34 -56.77 2.42 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.011 2.474 . . . . 64.430000000000007 112.689 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.15 55.22 2.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.049 0.452 . . . . 62.539999999999999 111.827 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.77 ' HG3' ' HD2' ' A' ' 86' ' ' PRO . 22.9 mm-40 -129.36 16.13 6.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.795 -0.639 . . . . 73.310000000000002 109.422 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' HB ' HD22 ' A' ' 129' ' ' ASN . 49.6 mm -92.92 123.91 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.478 -0.783 . . . . 75.219999999999999 111.86 -172.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.43 114.76 29.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.701 -0.681 . . . . 61.32 109.512 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.67 HG21 HG11 ' A' ' 121' ' ' VAL . 61.3 t -109.52 123.24 65.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.131 -0.486 . . . . 64.209999999999994 111.313 -175.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.87 HG22 ' HB ' ' A' ' 133' ' ' VAL . 30.8 pt -107.72 117.33 53.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.952 -0.567 . . . . 54.109999999999999 110.271 177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -132.79 162.25 31.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.064 0.459 . . . . 74.349999999999994 111.375 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -84.76 121.75 28.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.327 -0.851 . . . . 52.140000000000001 109.53 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 114' ' ' GLY . 1.5 mm-40 -127.5 135.74 50.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.289 0.566 . . . . 73.530000000000001 111.998 -171.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.29 -7.02 59.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.579 -0.737 . . . . 62.439999999999998 110.218 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.48 -34.92 64.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.318 -0.855 . . . . 75.530000000000001 111.513 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.53 ' HB ' ' HA3' ' A' ' 136' ' ' GLY . 1.1 mp -111.02 141.37 26.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.096 -0.502 . . . . 74.519999999999996 109.716 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.654 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 41.9 m-20 -67.93 147.02 53.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.355 -0.609 . . . . 73.420000000000002 109.355 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.731 ' HE1' ' HB2' ' A' ' 161' ' ' GLU . 13.8 t80 -63.03 137.55 58.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.099 0.476 . . . . 73.439999999999998 111.323 -171.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.513 ' O ' ' HD3' ' A' ' 103' ' ' ARG . . . 133.51 -39.84 1.67 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.576 -0.738 . . . . 70.400000000000006 112.067 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 102' ' ' GLY . 62.1 mmt-85 -131.96 164.51 25.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.715 0.293 . . . . 63.25 110.305 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 135' ' ' ILE . 37.2 pt -117.62 160.85 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 71.450000000000003 110.618 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.476 ' HD2' HG13 ' A' ' 99' ' ' ILE . 92.6 mtt180 -123.23 129.52 51.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.994 0.426 . . . . 71.400000000000006 110.923 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.604 ' HG ' HG13 ' A' ' 133' ' ' VAL . 4.7 mp -114.53 129.77 56.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.906 -0.588 . . . . 72.319999999999993 109.823 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -155.52 153.47 30.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.701 0.286 . . . . 73.109999999999999 110.283 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.802 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.3 pt? -87.43 94.09 9.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.571 . . . . 71.329999999999998 110.11 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.527 ' O ' ' HD3' ' A' ' 132' ' ' ARG . . . 172.81 -150.55 12.62 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.795 -0.639 . . . . 41.32 111.797 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.87 -157.05 25.35 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.935 -0.65 . . . . 64.310000000000002 112.223 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.688 ' HA3' HD13 ' A' ' 118' ' ' LEU . . . -130.91 132.05 6.7 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.106 -0.569 . . . . 71.25 111.867 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -112.73 6.79 18.33 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.742 0.275 . . . . 72.310000000000002 111.742 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.41 -92.26 1.55 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.527 -0.845 . . . . 73.420000000000002 111.341 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.443 ' H ' ' CD ' ' A' ' 96' ' ' GLU . . . -69.11 -45.09 63.46 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.883 -0.887 . . . . 32.299999999999997 110.883 174.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.407 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 76.0 t60 70.52 -24.59 0.16 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.869 0.692 . . . . 73.349999999999994 112.869 172.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.409 ' H ' ' C ' ' A' ' 114' ' ' GLY . 28.5 t-20 -51.52 -66.35 0.4 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.694 0.627 . . . . 61.409999999999997 112.694 -173.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.93 -10.21 85.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.144 -1.027 . . . . 73.420000000000002 113.037 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.688 HD13 ' HA3' ' A' ' 111' ' ' GLY . 94.7 mt -84.36 -38.08 20.75 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.704 -0.292 . . . . 71.219999999999999 111.372 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 120' ' ' SER . 6.6 ptm180 -65.25 -37.16 86.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 75.310000000000002 110.845 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.439 ' N ' ' HG3' ' A' ' 119' ' ' ARG . 10.0 m -60.02 -41.4 92.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.994 -0.548 . . . . 71.409999999999997 110.774 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.67 HG11 HG21 ' A' ' 92' ' ' VAL . 59.9 t -69.63 -40.33 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 75.120000000000005 110.163 177.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.423 ' HA ' HH22 ' A' ' 132' ' ' ARG . . . -63.48 -46.66 85.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.836 -0.62 . . . . 43.439999999999998 111.045 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.1 m -72.23 -27.9 62.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.292 -0.413 . . . . 72.299999999999997 111.751 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.61 66.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.93 0.395 . . . . 72.310000000000002 111.033 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.6 mt -82.27 -32.21 29.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.897 -0.592 . . . . 41.229999999999997 110.793 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 108.12 -11.64 37.27 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.96 -0.564 . . . . 53.32 111.787 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.2 t -166.01 177.56 6.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.451 -0.574 . . . . 73.409999999999997 109.451 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.637 ' HD2' ' N ' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -60.21 -30.26 69.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.847 0.356 . . . . 74.120000000000005 110.408 174.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.637 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 9.2 t30 66.11 -13.88 0.15 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.213 1.005 . . . . 73.019999999999996 112.948 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 129' ' ' ASN . 3.4 t80 175.37 -84.5 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 122.464 0.306 . . . . 75.239999999999995 110.273 175.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -161.01 161.39 31.47 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.791 0.329 . . . . 71.310000000000002 111.737 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 109' ' ' GLY . 5.6 mpt_? -132.3 166.19 22.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.947 -0.57 . . . . 73.439999999999998 109.603 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.87 ' HB ' HG22 ' A' ' 93' ' ' ILE . 59.0 t -123.44 124.92 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.24 -0.436 . . . . 65.530000000000001 109.825 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.46 ' CB ' HD11 ' A' ' 99' ' ' ILE . 98.1 mtt180 -98.74 115.65 29.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.954 -0.566 . . . . 71.430000000000007 110.009 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.727 ' HA ' HG22 ' A' ' 104' ' ' ILE . 2.7 mp -87.89 117.59 32.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.341 -0.614 . . . . 72.230000000000004 109.341 176.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.53 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . -72.5 108.75 2.59 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.905 -0.664 . . . . 62.43 113.555 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.494 ' HA ' ' CD2' ' A' ' 101' ' ' PHE . 15.0 p -92.35 -16.21 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.562 0.696 . . . . 72.400000000000006 109.888 174.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 89.98 169.75 43.73 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.453 -0.794 . . . . 34.119999999999997 111.851 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.41 ' O ' ' HD3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -102.85 101.48 21.21 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 110.194 -0.298 . . . . 74.540000000000006 110.194 177.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 138' ' ' GLY . 2.9 Cg_exo -76.36 110.41 3.06 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.813 2.342 . . . . 71.040000000000006 111.388 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 139' ' ' ARG . 87.5 Cg_endo -80.25 143.96 16.1 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.554 2.169 . . . . 74.540000000000006 111.863 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 178.91 179.32 48.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.596 -0.811 . . . . 63.539999999999999 112.008 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -102.01 -4.13 26.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.64 0.733 . . . . 71.140000000000001 109.946 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.699 ' HE2' ' HA ' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -116.87 148.22 41.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.177 -1.416 . . . . 70.230000000000004 107.177 167.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -61.18 138.24 94.4 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.683 0.278 . . . . 61.450000000000003 110.777 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.647 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 18.5 Cg_endo -58.86 -9.59 7.92 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.246 2.631 . . . . 74.430000000000007 112.097 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.31 59.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.305 -0.861 . . . . 45.140000000000001 111.597 176.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.33 -23.5 24.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 51.329999999999998 111.606 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.647 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 92.7 m-85 -84.09 -34.36 24.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.872 0.368 . . . . 64.129999999999995 111.245 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.71 -18.35 22.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 60.43 111.726 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.43 HD12 ' HG2' ' A' ' 152' ' ' GLU . 4.5 pp -86.28 -8.85 57.43 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.808 -0.357 . . . . 74.129999999999995 111.395 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 10.6 pt-20 -156.97 102.64 2.0 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.252 0.549 . . . . 73.349999999999994 110.775 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -134.54 136.69 43.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.706 -0.398 . . . . 73.409999999999997 110.586 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -122.42 19.07 10.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.029 -0.532 . . . . 74.310000000000002 110.538 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.544 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 96.9 m -62.17 120.85 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.852 -0.613 . . . . 62.32 110.732 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.32 79.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 74.530000000000001 111.743 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.85 -53.78 53.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.11 -0.495 . . . . 70.430000000000007 111.524 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -67.85 -37.2 81.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.661 -0.245 . . . . 71.209999999999994 110.95 -176.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 159' ' ' ARG . 11.8 mmt180 -58.68 -29.17 66.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 72.219999999999999 111.312 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.02 -18.81 35.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.33 -0.395 . . . . 74.150000000000006 111.535 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.731 ' HB2' ' HE1' ' A' ' 101' ' ' PHE . 40.3 mt-10 -99.08 -6.7 27.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.68 0.276 . . . . 64.540000000000006 111.363 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 158' ' ' GLU . 89.8 t -69.75 -58.53 5.45 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.626 -0.261 . . . . 75.450000000000003 111.673 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 18.5 Cg_endo -59.58 -35.21 96.02 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.3 2.0 . . . . 72.439999999999998 112.878 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.6 p -62.1 -42.71 99.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 74.439999999999998 111.177 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.1 mt -65.62 -47.05 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 64.349999999999994 110.492 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.43 -50.84 78.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 44.219999999999999 111.48 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -60.79 -45.57 93.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 73.209999999999994 111.556 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -73.87 -26.23 60.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.696 0.284 . . . . 71.150000000000006 111.603 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.06 68.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.526 -0.306 . . . . 61.119999999999997 111.465 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.51 -51.42 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.511 -0.313 . . . . 71.129999999999995 111.33 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.59 -46.69 88.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.122 0.487 . . . . 65.420000000000002 110.488 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.89 -47.26 78.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.807 -0.633 . . . . 75.129999999999995 111.601 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.7 m -64.09 -39.87 94.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 64.25 110.917 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.686 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 21.8 tt0 -61.14 -47.31 86.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.602 -0.272 . . . . 31.309999999999999 110.41 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.9 tp -68.26 -31.31 70.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 74.439999999999998 111.242 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.685 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.9 tt -62.73 -46.16 89.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.377 0.608 . . . . 75.5 109.551 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.682 HD13 HG11 ' A' ' 60' ' ' VAL . 79.2 mt -73.52 -25.26 20.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.235 -0.893 . . . . 70.140000000000001 110.4 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.24 -68.19 0.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.76 -0.654 . . . . 71.120000000000005 111.815 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -144.24 -40.58 0.27 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.856 0.687 . . . . 75.519999999999996 112.856 -172.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 176' ' ' LEU . . . -106.38 114.4 4.42 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.759 -1.21 . . . . 73.310000000000002 113.663 -170.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.454 ' HA ' ' HG ' ' A' ' 176' ' ' LEU . 6.1 tt -91.22 -54.41 3.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.456 -0.572 . . . . 53.200000000000003 109.456 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -70.31 -40.73 12.37 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 74.439999999999998 111.741 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -48.28 -38.8 34.46 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.026 1.817 . . . . 61.299999999999997 112.27 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -65.81 -43.33 88.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.095 -0.502 . . . . 73.049999999999997 110.636 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -57.81 -45.71 85.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.957 0.408 . . . . 72.299999999999997 110.508 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -66.03 -49.73 66.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 71.450000000000003 111.617 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 184' ' ' ALA . 12.1 t -60.54 -38.02 83.09 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.093 -0.243 . . . . 74.129999999999995 111.509 -174.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.731 ' HA ' ' HD1' ' A' ' 191' ' ' TRP . 72.0 t -60.23 -28.45 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.987 0.423 . . . . 72.200000000000003 111.106 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -76.34 -10.47 59.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.376 -0.375 . . . . 73.400000000000006 111.035 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -115.73 13.29 16.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.126 0.417 . . . . 50.200000000000003 112.126 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.731 ' HD1' ' HA ' ' A' ' 188' ' ' VAL . 93.1 m95 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.652 -0.689 . . . . 75.230000000000004 110.077 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 13.5 mm-40 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.62 0.248 . . . . 64.329999999999998 110.695 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.483 ' HA ' ' HB2' ' A' ' 59' ' ' SER . 56.2 Cg_endo -92.55 107.26 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.187 2.591 . . . . 74.219999999999999 112.097 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.708 HD21 HG23 ' A' ' 177' ' ' ILE . 4.3 pp -89.21 157.71 18.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.307 -0.406 . . . . 75.140000000000001 110.647 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.419 ' HB2' HG11 ' A' ' 85' ' ' VAL . 47.5 tp -117.91 120.85 39.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.048 0.451 . . . . 74.150000000000006 111.281 -174.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.742 ' HB ' HD22 ' A' ' 62' ' ' LEU . 48.5 t -112.16 110.49 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.943 -0.571 . . . . 65.549999999999997 109.613 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.74 ' HB ' HG22 ' A' ' 92' ' ' VAL . 47.8 t -110.3 124.32 66.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 110.2 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.38 157.37 15.0 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.416 -0.897 . . . . 61.240000000000002 111.368 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.452 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -64.15 107.62 1.34 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.595 -0.891 . . . . 62.32 108.595 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -74.15 -176.89 35.76 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.673 -0.694 . . . . 61.420000000000002 113.523 -172.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -111.33 98.3 39.34 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.601 -0.518 . . . . 74.120000000000005 109.601 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.477 ' HB2' ' OH ' ' A' ' 17' ' ' TYR . 14.5 Cg_exo -67.8 -31.35 32.15 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.857 2.371 . . . . 71.439999999999998 112.445 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.78 -176.22 43.83 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.589 -0.815 . . . . 71.109999999999999 112.248 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.37 -159.43 0.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.907 2.405 . . . . 70.439999999999998 112.312 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m 70.64 -70.82 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.081 -0.509 . . . . 75.299999999999997 111.324 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 13' ' ' PRO . 28.7 p90 -88.63 3.51 50.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.965 0.412 . . . . 72.040000000000006 110.99 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.79 -1.57 4.04 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.879 -0.6 . . . . 35.509999999999998 112.371 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -100.62 18.5 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.33 . . . . 71.400000000000006 110.751 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.8 p -100.56 167.28 10.45 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.908 -0.405 . . . . 72.219999999999999 109.908 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 24' ' ' LEU . 22.4 ptt180 -84.38 -0.38 52.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.531 -0.304 . . . . 74.209999999999994 110.944 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.64 ' CD2' ' HA ' ' A' ' 150' ' ' VAL . 97.8 m-70 -86.21 -29.75 22.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.824 0.345 . . . . 65.040000000000006 110.944 -172.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -88.26 28.31 1.1 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.323 0.582 . . . . 61.5 109.88 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 2.4 pt? -67.28 -27.15 66.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.563 -0.744 . . . . 72.25 111.318 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.452 ' HA3' ' N ' ' A' ' 10' ' ' LEU . . . -59.23 -44.41 96.48 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.81 -0.709 . . . . 64.319999999999993 111.896 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.595 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 56.8 t80 -65.19 -35.8 82.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.743 0.306 . . . . 73.25 110.521 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 82.9 mmm -83.26 -47.27 11.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.704 -0.68 . . . . 62.310000000000002 111.989 -171.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.4 t -63.41 -42.12 95.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.14 0.495 . . . . 63.229999999999997 110.256 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . . . -67.18 -20.95 65.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.964 -0.562 . . . . 61.229999999999997 110.718 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 21.7 t70 -77.16 -43.17 34.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.978 -0.555 . . . . 71.030000000000001 111.031 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 36.0 m -71.23 -37.87 67.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.53 -0.305 . . . . 72.420000000000002 111.568 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.73 -24.83 62.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.042 0.449 . . . . 74.420000000000002 110.472 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 38' ' ' SER . . . -66.45 -46.74 75.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 64.319999999999993 110.158 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.76 -18.57 61.94 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.866 -0.607 . . . . 74.540000000000006 112.395 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 14.3 mmt85 -76.1 -58.15 3.45 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.766 0.284 . . . . 51.520000000000003 111.766 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.29 -15.4 14.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.873 0.368 . . . . 73.120000000000005 111.199 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.09 45.86 2.97 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.653 -0.979 . . . . 51.409999999999997 110.653 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.9 t -110.19 121.24 44.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.756 -0.722 . . . . 74.219999999999999 110.358 -173.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.83 126.62 55.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.347 -0.388 . . . . 72.25 110.242 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.463 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 48.4 p90 -106.0 137.81 43.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.044 0.45 . . . . 71.329999999999998 110.251 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -127.41 168.07 15.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.947 -0.57 . . . . 70.109999999999999 110.369 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.753 HG22 ' HG2' ' A' ' 49' ' ' GLU . 38.8 t -86.07 102.38 11.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.46 -0.57 . . . . 75.439999999999998 109.46 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.457 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 21.1 t-80 -79.58 85.03 5.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.921 -0.77 . . . . 75.230000000000004 108.921 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -66.55 96.8 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.559 0.695 . . . . 75.319999999999993 111.017 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 167.78 -55.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.47 -2.048 . . . . 73.120000000000005 105.47 -173.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.3 p -105.53 28.91 6.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.569 -2.105 . . . . 74.150000000000006 107.348 168.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 43' ' ' HIS . . . -49.92 43.27 0.01 OUTLIER Glycine 0 N--CA 1.476 1.356 0 N-CA-C 120.087 2.795 . . . . 71.450000000000003 120.087 -150.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.13 163.75 15.32 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.791 -1.189 . . . . 71.030000000000001 107.791 161.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.753 ' HG2' HG22 ' A' ' 42' ' ' VAL . 43.5 mt-10 -80.86 117.07 21.18 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.391 -0.524 . . . . 72.450000000000003 109.957 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.697 HG12 ' HA ' ' A' ' 63' ' ' ALA . 31.1 m -138.34 150.92 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 71.219999999999999 111.501 -173.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.28 137.71 56.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.774 -0.648 . . . . 73.120000000000005 109.961 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -111.3 125.64 54.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.688 0.28 . . . . 54.109999999999999 111.312 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.52 -167.75 24.46 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.007 -0.615 . . . . 74.230000000000004 111.621 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -136.96 104.38 5.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.084 0.442 . . . . 75.310000000000002 110.144 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.555 ' HG ' HG21 ' A' ' 60' ' ' VAL . 88.6 mt -89.78 131.19 35.86 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.619 -0.511 . . . . 63.420000000000002 109.619 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.85 9.01 4.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.228 -0.442 . . . . 73.340000000000003 111.564 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.75 -28.17 13.02 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.041 -0.599 . . . . 74.340000000000003 112.473 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.557 ' HB ' ' CG2' ' A' ' 177' ' ' ILE . 9.8 m -84.03 139.08 32.75 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.211 -0.292 . . . . 75.120000000000005 110.211 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 20.3 m -70.47 132.12 45.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.841 0.353 . . . . 45.530000000000001 110.601 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.576 HG12 HD11 ' A' ' 5' ' ' LEU . 34.1 m -126.44 136.47 60.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.124 0.488 . . . . 65.439999999999998 111.132 -176.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.2 112.71 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.829 -0.623 . . . . 61.409999999999997 109.629 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.742 HD22 ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -94.99 119.78 34.08 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.358 -0.608 . . . . 62.119999999999997 109.358 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.697 ' HA ' HG12 ' A' ' 50' ' ' VAL . . . -111.87 124.28 52.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.962 0.41 . . . . 72.140000000000001 111.587 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' HE2' ' HB3' ' A' ' 29' ' ' ALA . 91.5 mttt -119.88 107.28 40.34 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.051 -0.522 . . . . 63.450000000000003 110.242 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.455 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 4.7 Cg_exo -75.12 151.57 39.17 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.961 2.441 . . . . 73.510000000000005 112.405 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -110.44 16.53 21.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.288 0.566 . . . . 72.5 109.714 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 58.4 m -112.8 168.86 9.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.722 -0.672 . . . . 73.209999999999994 110.882 -174.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -72.23 173.84 8.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.054 -0.521 . . . . 75.340000000000003 110.73 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -19.24 65.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.379 -0.373 . . . . 70.409999999999997 111.699 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -87.91 -19.99 26.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.359 0.599 . . . . 72.420000000000002 110.163 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 36.6 mt-10 -100.46 -28.16 13.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.021 -0.536 . . . . 72.239999999999995 110.957 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 76' ' ' VAL . 14.0 p -57.73 -37.62 73.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 50.229999999999997 111.177 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.24 -32.38 76.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.181 -0.533 . . . . 65.439999999999998 112.412 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.637 HH11 ' HB2' ' A' ' 124' ' ' ALA . 26.8 mmt180 -76.73 -31.36 57.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.748 0.309 . . . . 72.230000000000004 110.698 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 78.8 mm-40 -69.66 -28.66 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 72.540000000000006 110.861 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 72' ' ' SER . 46.6 t -66.52 -30.27 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 74.140000000000001 110.773 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.62 -67.1 2.32 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 116.044 -0.525 . . . . 41.32 113.154 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.54 -43.46 39.33 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.442 2.095 . . . . 73.049999999999997 112.227 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -54.88 -51.59 65.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 110.755 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.49 84.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.119 -0.492 . . . . 44.43 111.547 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -77.49 -31.87 53.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 111.724 0.268 . . . . 51.43 111.724 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -65.86 -46.45 78.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.615 0.245 . . . . 54.43 111.262 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -90.8 -17.08 27.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.669 -0.241 . . . . 71.230000000000004 111.313 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.0 t 59.98 72.77 0.51 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.443 0.639 . . . . 75.519999999999996 110.47 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 27.8 m -98.15 139.73 21.43 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 61.219999999999999 111.188 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 13.1 Cg_exo -70.57 129.53 16.89 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.909 2.406 . . . . 71.349999999999994 111.797 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 18.3 Cg_exo -67.33 -4.4 11.73 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.133 2.555 . . . . 73.420000000000002 113.292 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -89.6 -12.18 40.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.876 0.37 . . . . 53.219999999999999 110.745 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.439 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 9.3 mm-40 -129.73 45.01 2.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.414 0.626 . . . . 75.450000000000003 110.566 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.584 HG23 ' HB3' ' A' ' 131' ' ' HIS . 10.4 tt -120.54 127.7 75.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.819 -0.628 . . . . 74.319999999999993 109.864 175.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.37 146.21 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.131 -0.486 . . . . 55.0 110.456 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.74 HG22 ' HB ' ' A' ' 8' ' ' VAL . 86.1 t -134.07 124.23 45.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.848 0.356 . . . . 73.109999999999999 110.744 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 mm -75.23 130.65 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.61 -0.723 . . . . 73.109999999999999 111.689 -175.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -143.42 141.9 31.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 74.310000000000002 110.166 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.63 ' HB2' HG21 ' A' ' 137' ' ' VAL . 4.6 p-10 -87.29 122.32 30.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.928 -0.767 . . . . 73.439999999999998 108.928 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' H ' ' A' ' 99' ' ' ILE . 10.5 tp10 -99.62 118.63 36.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.675 -0.693 . . . . 62.43 110.982 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 98' ' ' ASP . 3.3 pp -82.59 -20.7 35.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.474 -0.784 . . . . 70.049999999999997 111.253 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' HD12 ' A' ' 97' ' ' LEU . 38.6 t70 -78.63 -20.45 50.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.1 0.476 . . . . 64.129999999999995 110.742 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.496 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 66.0 mt -102.28 122.92 55.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 109.777 176.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.463 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 13.6 m-20 -62.13 149.87 40.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.281 -0.418 . . . . 63.409999999999997 110.839 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.877 ' HD2' ' HA ' ' A' ' 137' ' ' VAL . 29.4 t80 -65.61 133.76 51.85 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.18 -0.464 . . . . 75.120000000000005 110.918 -174.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.93 -62.29 0.32 Allowed Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.827 -0.624 . . . . 53.520000000000003 112.294 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -126.3 165.38 19.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.716 0.293 . . . . 60.350000000000001 110.263 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.708 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -118.57 159.18 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.194 -0.457 . . . . 60.450000000000003 110.173 -178.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -144.82 163.0 35.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.029 0.442 . . . . 73.310000000000002 110.94 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.0 mt -108.62 152.56 24.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.737 -0.665 . . . . 64.230000000000004 109.602 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -129.58 105.1 7.84 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.835 -0.346 . . . . 71.319999999999993 110.914 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 181' ' ' LEU . 85.6 mt -110.33 91.84 3.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 75.510000000000005 109.987 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.454 ' H ' ' NH2' ' A' ' 132' ' ' ARG . . . 162.65 -132.18 2.71 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.058 -0.817 . . . . 33.240000000000002 111.058 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.63 109.58 3.24 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.718 -0.953 . . . . 63.399999999999999 110.718 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.75 161.33 31.77 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.074 -1.06 . . . . 55.350000000000001 112.977 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.62 171.01 10.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.279 -0.461 . . . . 72.129999999999995 110.413 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.93 45.36 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.187 -0.765 . . . . 54.219999999999999 111.187 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.35 81.72 1.31 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.58 -1.008 . . . . 74.439999999999998 110.58 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -52.07 -50.56 61.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.444 0.535 . . . . 75.430000000000007 112.444 -170.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.55 -3.03 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.808 -0.357 . . . . 40.43 111.409 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.1 -33.59 7.65 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.954 -0.859 . . . . 72.299999999999997 110.954 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.8 -30.19 65.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.531 -0.544 . . . . 73.040000000000006 109.531 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -51.33 -50.28 59.75 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.153 -0.93 . . . . 73.019999999999996 111.683 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.2 p -72.81 -45.35 58.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.891 0.377 . . . . 75.439999999999998 111.326 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.612 HG11 ' HE1' ' A' ' 131' ' ' HIS . 59.3 t -65.79 -47.96 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.069 -0.514 . . . . 60.119999999999997 111.87 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.454 ' HA ' HD21 ' A' ' 129' ' ' ASN . . . -63.3 -38.48 91.31 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.987 0.366 . . . . 51.229999999999997 111.987 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.9 p -76.6 -29.21 56.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.631 -0.259 . . . . 53.32 111.193 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.637 ' HB2' HH11 ' A' ' 74' ' ' ARG . . . -79.35 -49.46 12.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 111.676 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -84.67 -41.78 15.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.352 -0.385 . . . . 64.049999999999997 111.536 -174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.95 -12.6 65.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.808 -0.711 . . . . 61.210000000000001 112.357 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.1 t -71.96 164.4 26.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.887 0.375 . . . . 52.020000000000003 110.793 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.86 -11.82 60.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 52.229999999999997 110.64 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.454 HD21 ' HA ' ' A' ' 122' ' ' ALA . 86.9 m-20 66.09 79.14 0.25 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.579 -0.737 . . . . 72.510000000000005 112.329 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.402 ' HB3' HD22 ' A' ' 108' ' ' LEU . 99.3 m-85 -83.56 -22.85 32.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.212 0.53 . . . . 71.010000000000005 110.032 174.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.612 ' HE1' HG11 ' A' ' 121' ' ' VAL . 13.1 p80 -68.63 87.61 0.34 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.445 -0.798 . . . . 70.310000000000002 112.347 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.454 ' NH2' ' H ' ' A' ' 109' ' ' GLY . 16.2 mtm180 -142.89 109.56 5.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.257 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.4 t -101.87 109.02 24.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.637 -0.875 . . . . 75.409999999999997 108.637 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.469 ' HD2' ' OE1' ' A' ' 96' ' ' GLU . 38.9 mtm180 -99.1 106.43 18.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.071 0.462 . . . . 75.530000000000001 110.93 -175.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 104' ' ' ILE . 3.0 mp -85.1 114.78 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.701 -0.681 . . . . 74.219999999999999 109.362 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.747 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -65.29 101.93 0.61 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.768 -0.729 . . . . 35.5 111.583 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.877 ' HA ' ' HD2' ' A' ' 101' ' ' PHE . 3.5 m -111.2 -7.37 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.255 0.465 . . . . 60.43 112.255 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 86.87 167.68 44.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 63.340000000000003 112.72 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.5 ptm180 -111.48 124.34 32.82 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.044 0.449 . . . . 72.549999999999997 110.984 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 9.5 Cg_endo -90.07 115.37 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.57 2.846 . . . . 74.209999999999994 112.259 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -93.23 155.9 2.58 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.962 2.441 . . . . 64.510000000000005 113.18 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.62 -161.78 29.97 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.258 -0.737 . . . . 53.340000000000003 111.258 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -78.12 -19.31 54.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.196 0.522 . . . . 71.219999999999999 110.161 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 32.5 mmtp -108.38 150.74 26.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.478 -0.783 . . . . 75.049999999999997 109.451 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.23 164.02 56.65 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.325 -0.398 . . . . 55.0 110.251 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' ' 149' ' ' PHE . 62.6 Cg_exo -53.58 -14.33 4.88 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.14 2.56 . . . . 71.239999999999995 113.292 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.94 -22.79 63.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 74.030000000000001 111.567 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.75 -26.87 22.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.394 0.616 . . . . 62.329999999999998 110.473 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 146' ' ' PRO . 68.5 m-85 -64.42 -15.95 61.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.044 -0.98 . . . . 72.129999999999995 112.038 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 33.6 m -55.48 -28.75 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 111.859 0.318 . . . . 62.32 111.859 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.543 ' HG ' HG23 ' A' ' 150' ' ' VAL . 86.6 mt -105.58 -27.15 11.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.921 0.391 . . . . 75.5 110.871 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -128.59 93.52 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.491 0.663 . . . . 72.319999999999993 110.272 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 149' ' ' PHE . 3.8 t30 -125.11 101.31 6.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.634 . . . . 74.5 110.491 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -132.13 102.13 5.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.286 0.565 . . . . 63.200000000000003 110.527 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.893 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 6.5 m -125.73 132.38 52.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.011 -0.541 . . . . 54.210000000000001 109.887 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.76 73.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.971 0.415 . . . . 72.049999999999997 110.868 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.65 -38.95 93.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.832 -0.622 . . . . 75.239999999999995 112.044 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.893 ' HG2' ' HB ' ' A' ' 155' ' ' THR . 10.5 pt-20 -72.58 -40.45 66.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.876 -0.33 . . . . 75.409999999999997 111.261 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.464 ' HA ' HG23 ' A' ' 162' ' ' VAL . 25.6 mmm180 -66.82 -34.34 77.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.85 0.357 . . . . 75.219999999999999 110.808 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.49 62.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.428 -0.805 . . . . 65.409999999999997 112.376 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.652 ' HB2' ' HE1' ' A' ' 101' ' ' PHE . 59.7 mm-40 -100.68 13.38 34.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.337 0.495 . . . . 73.340000000000003 112.337 -174.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.642 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 55.2 t -54.38 -52.47 68.96 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.035 -0.266 . . . . 74.310000000000002 110.798 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 53.9 Cg_exo -54.55 -25.89 43.0 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.142 1.895 . . . . 75.510000000000005 113.24 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.5 m -74.28 -48.21 29.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.057 0.456 . . . . 73.25 110.684 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.24 -33.59 64.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.962 -0.563 . . . . 72.120000000000005 111.34 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 162' ' ' VAL . 98.1 t -53.35 -39.1 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.835 0.35 . . . . 65.409999999999997 111.419 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -71.57 -50.07 34.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.46 -0.336 . . . . 60.409999999999997 111.29 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.531 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . 9.1 mm-40 -60.84 -42.78 98.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.783 0.325 . . . . 62.119999999999997 111.385 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.13 -22.98 67.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.237 -0.438 . . . . 54.140000000000001 111.641 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.39 -44.16 15.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.855 0.36 . . . . 45.340000000000003 111.742 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -85.05 -36.29 21.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.555 -0.293 . . . . 73.530000000000001 111.618 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.33 -43.67 73.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.843 0.312 . . . . 70.239999999999995 111.843 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.533 ' HA ' HD13 ' A' ' 176' ' ' LEU . 22.0 p -63.05 -31.49 72.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 65.519999999999996 111.69 -175.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.45 -26.4 66.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.278 -0.419 . . . . 73.109999999999999 110.821 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.72 -29.76 66.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.708 0.29 . . . . 71.140000000000001 110.593 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 173' ' ' THR . 8.3 mp -64.66 -36.5 84.47 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.482 0.658 . . . . 61.210000000000001 109.502 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.708 HG23 HD21 ' A' ' 5' ' ' LEU . 34.5 mt -76.99 -37.36 26.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.892 -1.049 . . . . 74.5 110.023 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.85 -48.84 67.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.57 -0.741 . . . . 54.450000000000003 111.364 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -133.22 -67.56 0.62 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.431 -0.35 . . . . 65.010000000000005 111.201 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.4 -178.32 46.09 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.749 -0.739 . . . . 70.340000000000003 111.886 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 108' ' ' LEU . 3.7 pp -89.87 -12.94 37.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.965 0.412 . . . . 74.019999999999996 110.584 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.71 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 6.5 tm-20 -53.68 -54.13 49.62 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.508 -0.769 . . . . 74.329999999999998 111.797 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.71 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 11.0 Cg_exo -71.19 -31.98 13.69 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 121.644 1.563 . . . . 62.200000000000003 112.176 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.59 -26.01 57.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 53.32 112.322 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 19.7 pt20 -62.29 -22.65 66.2 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.475 0.179 . . . . 74.150000000000006 111.444 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -85.98 -48.01 9.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.749 0.309 . . . . 72.140000000000001 110.657 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.6 m -53.22 -40.55 64.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.765 -0.652 . . . . 72.540000000000006 111.749 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.2 -12.75 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.62 0.6 . . . . 74.109999999999999 112.62 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -117.45 -28.58 6.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.614 0.245 . . . . 64.239999999999995 111.54 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.55 -17.15 39.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.586 -0.279 . . . . 72.319999999999993 111.607 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.3 m95 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.637 -0.697 . . . . 63.439999999999998 110.271 -179.535 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.0 mp0 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.632 0.253 . . . . 73.310000000000002 110.554 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 2.9 Cg_exo -76.21 117.85 4.77 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.137 2.558 . . . . 70.209999999999994 112.307 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.722 HD21 HG23 ' A' ' 177' ' ' ILE . 4.2 pp -121.89 149.25 43.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.291 -0.413 . . . . 73.040000000000006 110.246 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.473 ' HB3' HG12 ' A' ' 90' ' ' ILE . 64.8 tp -97.56 136.21 38.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.318 -0.401 . . . . 73.230000000000004 110.476 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.7 t -117.42 112.61 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.829 -0.434 . . . . 75.109999999999999 109.829 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.67 128.61 62.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 73.329999999999998 110.723 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.541 ' HA2' HG23 ' A' ' 93' ' ' ILE . . . -103.38 -177.06 26.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.198 -0.525 . . . . 72.519999999999996 112.095 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.568 HD13 ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -142.53 158.74 43.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.362 . . . . 73.099999999999994 110.926 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 22' ' ' HIS . . . 155.86 -158.28 28.43 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.449 -0.661 . . . . 60.399999999999999 111.449 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 61.0 t30 -163.08 105.32 1.01 Allowed Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.116 -0.328 . . . . 72.340000000000003 110.116 176.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 12' ' ' ASN . 56.2 Cg_endo -71.2 142.25 41.27 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.751 2.301 . . . . 53.140000000000001 112.271 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.62 177.92 39.9 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.754 -0.736 . . . . 42.439999999999998 111.849 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.4 -66.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.699 2.266 . . . . 62.109999999999999 112.083 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 m -76.7 -25.56 53.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.319 0.581 . . . . 65.239999999999995 110.113 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' HA ' HG23 ' A' ' 20' ' ' THR . 80.9 m-85 -70.71 -23.14 62.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.567 -0.742 . . . . 71.450000000000003 111.748 -175.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.4 -17.27 63.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 73.120000000000005 110.28 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -106.73 20.63 18.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.604 -0.725 . . . . 74.230000000000004 111.277 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.627 HG23 ' HA ' ' A' ' 17' ' ' TYR . 72.2 p -99.95 166.91 10.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.238 0.542 . . . . 74.439999999999998 110.385 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.544 ' HB3' HG23 ' A' ' 150' ' ' VAL . 17.5 tpt85 -93.76 1.56 56.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.912 -0.586 . . . . 74.299999999999997 111.1 -175.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.461 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 1.5 t-160 -106.81 11.04 30.56 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.909 -0.316 . . . . 65.319999999999993 111.549 -173.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -103.38 13.63 33.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 64.409999999999997 111.332 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.4 pt? -55.06 -39.96 69.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.837 -0.62 . . . . 74.319999999999993 112.144 -174.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 10' ' ' LEU . . . -61.2 -55.29 30.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.034 -0.603 . . . . 54.219999999999999 112.971 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.54 ' CE1' ' HD2' ' A' ' 65' ' ' PRO . 20.1 m-30 -61.4 -39.52 91.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.717 0.294 . . . . 44.420000000000002 111.315 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.527 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 16.3 mmt -68.83 -49.58 57.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.376 -0.374 . . . . 54.439999999999998 111.457 -176.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.27 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.359 . . . . 42.229999999999997 110.673 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -63.62 -34.93 78.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 73.099999999999994 111.446 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.38 -40.7 50.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.215 -0.448 . . . . 71.030000000000001 111.164 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.5 m -79.56 -21.13 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.547 0.573 . . . . 63.450000000000003 112.547 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.419 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -70.37 -26.05 63.54 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.326 -0.549 . . . . 62.219999999999999 110.712 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.419 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -71.54 -24.26 61.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.352 0.596 . . . . 33.509999999999998 110.158 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.64 -18.12 67.71 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.451 -0.795 . . . . 65.219999999999999 112.6 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -69.56 -32.44 71.22 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.046 0.45 . . . . 75.310000000000002 111.186 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 36' ' ' ILE . 4.2 mp -86.03 -15.57 10.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.989 -0.745 . . . . 71.25 108.989 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.76 41.04 15.97 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.711 -1.356 . . . . 73.299999999999997 109.711 -171.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 t -126.55 135.54 51.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.887 -0.656 . . . . 62.32 111.038 -169.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.04 128.31 9.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.045 -0.525 . . . . 75.25 110.215 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.537 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 7.3 t80 -107.86 -158.1 0.64 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.731 -0.47 . . . . 75.439999999999998 109.731 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -135.19 173.07 12.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 72.230000000000004 111.474 -171.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HB ' ' OE2' ' A' ' 49' ' ' GLU . 2.7 p -70.52 108.26 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.585 -0.734 . . . . 64.430000000000007 111.216 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -102.25 75.67 1.51 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.256 -1.016 . . . . 74.409999999999997 108.256 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -56.31 122.29 11.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.598 -0.728 . . . . 63.329999999999998 112.174 -168.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -134.76 -90.93 0.33 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.662 -0.699 . . . . 71.340000000000003 109.496 168.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.419 ' OG ' ' HB2' ' A' ' 78' ' ' PRO . 8.6 m -107.83 -41.25 5.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 118.898 -1.121 . . . . 73.239999999999995 111.556 171.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.79 1.68 4.73 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.369 -0.443 . . . . 73.540000000000006 112.573 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . -75.58 99.4 4.26 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 115.585 1.698 . . . . 64.049999999999997 115.585 -154.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.654 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 20.7 mt-10 -116.28 115.46 25.98 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.357 -1.72 . . . . 74.5 106.357 151.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 31.8 m -137.56 151.27 26.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.257 -0.577 . . . . 62.229999999999997 112.384 -167.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 62' ' ' LEU . 5.9 p -124.63 125.83 70.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.418 -0.956 . . . . 74.239999999999995 108.418 166.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.5 m -103.17 113.08 26.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.078 0.466 . . . . 73.019999999999996 111.169 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.29 -161.22 8.97 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.811 -0.916 . . . . 60.140000000000001 110.811 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -138.34 129.68 27.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.291 0.545 . . . . 75.420000000000002 110.953 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.9 mt -102.87 117.03 33.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.035 -0.728 . . . . 71.219999999999999 109.035 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.44 -46.46 0.62 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.98 0.8 . . . . 72.239999999999995 111.66 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.83 -37.79 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.206 -0.521 . . . . 64.239999999999995 111.881 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.28 133.68 46.24 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.878 0.37 . . . . 70.329999999999998 111.294 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.5 p -74.07 125.74 28.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 72.230000000000004 110.756 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.597 HG12 HD11 ' A' ' 5' ' ' LEU . 33.6 m -111.23 136.44 47.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.102 -0.499 . . . . 71.420000000000002 110.896 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 t -102.76 101.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.759 -0.83 . . . . 75.150000000000006 108.759 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.579 HD11 ' HB1' ' A' ' 29' ' ' ALA . 3.3 tm? -91.09 111.57 23.1 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.169 -0.678 . . . . 73.310000000000002 109.169 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 49' ' ' GLU . . . -109.33 123.58 49.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.981 -0.554 . . . . 64.540000000000006 111.297 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.654 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -122.99 90.2 50.42 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.677 0.751 . . . . 75.230000000000004 109.674 175.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.54 ' HD2' ' CE1' ' A' ' 26' ' ' PHE . 16.4 Cg_exo -68.95 166.67 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.704 2.269 . . . . 64.530000000000001 112.679 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -105.0 14.41 29.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.663 0.744 . . . . 75.329999999999998 109.06 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 63.3 m -102.16 138.51 39.01 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.73 -1.123 . . . . 33.140000000000001 108.866 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 70' ' ' ASN . 15.8 p90 -66.65 166.8 12.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.093 0.473 . . . . 73.329999999999998 111.545 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.4 ptp -46.68 -31.56 2.99 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.39 1.256 . . . . 55.130000000000003 114.39 -169.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.411 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 62.4 t30 -77.99 -50.44 12.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.872 0.368 . . . . 72.299999999999997 111.142 -176.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -78.56 -24.45 45.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.286 -0.416 . . . . 71.219999999999999 111.454 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.3 t -56.68 -39.4 73.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.388 -0.369 . . . . 74.540000000000006 110.433 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.07 -29.37 74.72 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.932 -0.576 . . . . 72.239999999999995 113.077 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -41.85 88.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.157 0.503 . . . . 74.219999999999999 110.914 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -84.22 -0.05 50.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.803 -0.635 . . . . 74.430000000000007 111.86 -171.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.2 t -70.74 -40.46 76.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.803 0.335 . . . . 61.409999999999997 110.444 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.97 -59.03 11.56 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 115.964 -0.562 . . . . 73.019999999999996 112.822 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HB2' ' OG ' ' A' ' 46' ' ' SER . 10.1 Cg_endo -56.2 -37.82 95.99 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.7 2.267 . . . . 71.450000000000003 112.749 175.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 48' ' ' ALA . 2.9 tm? -69.11 -44.61 72.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.647 -0.251 . . . . 74.349999999999994 111.255 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.52 86.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.0 0.37 . . . . 53.420000000000002 112.0 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -72.9 -20.43 61.08 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.822 0.304 . . . . 75.019999999999996 111.822 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -71.07 -28.7 64.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.854 0.359 . . . . 74.340000000000003 110.753 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.02 0.01 37.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 72.129999999999995 110.169 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t 62.24 24.29 14.44 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.443 -0.798 . . . . 34.299999999999997 111.426 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.483 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 18.5 m -88.04 131.85 41.67 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.887 0.375 . . . . 74.120000000000005 111.09 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 19.4 Cg_exo -67.38 127.94 17.45 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.832 2.354 . . . . 75.439999999999998 111.605 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.632 ' HA ' HD12 ' A' ' 90' ' ' ILE . 39.7 Cg_exo -57.63 -27.51 77.46 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.991 2.46 . . . . 71.25 113.055 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -64.46 -27.68 69.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.48 -0.327 . . . . 71.030000000000001 111.659 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -103.88 17.59 23.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.159 0.504 . . . . 72.329999999999998 110.761 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.721 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 58.9 mt -90.45 145.45 7.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.403 -0.591 . . . . 65.5 109.403 175.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 m -118.12 134.67 61.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.164 0.507 . . . . 73.530000000000001 110.254 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.79 115.92 47.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.086 -0.506 . . . . 75.420000000000002 110.543 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.541 HG23 ' HA2' ' A' ' 9' ' ' GLY . 6.8 tt -87.67 126.02 41.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.923 -0.58 . . . . 73.230000000000004 109.542 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.99 173.5 11.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.399 0.618 . . . . 73.439999999999998 110.649 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -85.55 152.61 23.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.176 -0.92 . . . . 72.530000000000001 110.521 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 22.5 tt0 -123.35 94.72 4.34 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.423 0.63 . . . . 75.120000000000005 110.169 174.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.847 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.9 pt? -83.57 -0.33 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.332 -0.849 . . . . 71.340000000000003 110.073 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.409 ' CG ' HH12 ' A' ' 134' ' ' ARG . 1.6 m-20 -68.42 -36.42 79.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.711 . . . . 71.510000000000005 109.678 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 mm -123.29 149.19 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.515 -0.766 . . . . 75.109999999999999 110.244 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.787 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 8.8 p-10 -75.42 155.03 36.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 61.0 110.973 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.639 ' HD2' ' HB2' ' A' ' 158' ' ' GLU . 6.0 t80 -68.03 138.73 56.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.718 -0.674 . . . . 73.530000000000001 111.577 -173.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 160.07 -35.62 0.45 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.342 -0.845 . . . . 45.43 111.081 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -148.55 164.89 32.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 70.340000000000003 110.455 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.618 HD11 HG21 ' A' ' 188' ' ' VAL . 2.4 pp -118.21 162.97 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.382 -0.599 . . . . 74.129999999999995 109.382 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.407 ' HE ' ' CD ' ' A' ' 96' ' ' GLU . 29.8 ptt180 -141.0 153.32 45.5 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.702 -0.399 . . . . 74.129999999999995 110.446 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 181' ' ' LEU . 60.3 tp -113.04 124.9 53.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.844 -0.616 . . . . 73.329999999999998 109.434 176.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -155.41 126.69 7.21 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.002 -0.74 . . . . 74.310000000000002 109.002 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 130' ' ' PHE . 88.0 mt -76.73 88.0 3.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.579 0.704 . . . . 74.310000000000002 109.638 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.6 147.72 5.16 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.31 -1.116 . . . . 63.340000000000003 110.31 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.462 ' HA3' ' HG2' ' A' ' 132' ' ' ARG . . . 178.86 112.44 0.34 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.692 -1.242 . . . . 54.219999999999999 113.061 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.57 76.06 0.17 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.308 -0.717 . . . . 73.200000000000003 111.308 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -171.77 149.73 2.57 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.201 -0.666 . . . . 44.030000000000001 109.201 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.22 -67.77 2.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.959 -0.639 . . . . 72.120000000000005 111.825 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.93 69.3 3.27 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.901 -0.88 . . . . 65.019999999999996 110.901 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -48.45 -54.86 12.59 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.661 0.784 . . . . 73.230000000000004 111.734 -173.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -85.6 -41.6 15.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.258 -0.428 . . . . 55.520000000000003 110.981 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.81 -37.26 90.07 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 116.13 -0.487 . . . . 74.0 113.703 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.3 -27.89 29.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.972 0.386 . . . . 64.439999999999998 111.347 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -79.43 -36.7 38.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.499 -0.318 . . . . 63.109999999999999 111.568 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.9 m -58.76 -38.21 77.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 72.310000000000002 111.138 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.02 -42.93 82.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.987 0.422 . . . . 50.420000000000002 110.477 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.61 82.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.022 -0.536 . . . . 72.230000000000004 110.766 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t -63.42 -41.77 98.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 44.439999999999998 110.768 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.3 -32.09 69.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.31 -0.405 . . . . 61.439999999999998 111.672 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.53 -7.71 40.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.789 0.328 . . . . 74.420000000000002 111.669 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.45 -11.77 69.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.851 -0.69 . . . . 72.420000000000002 113.408 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 129' ' ' ASN . 15.4 t -169.88 177.97 4.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.832 0.316 . . . . 52.219999999999999 110.184 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.872 ' H ' ' HD2' ' A' ' 128' ' ' LYS . 8.9 mptt -56.13 -57.3 12.78 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.088 -0.708 . . . . 70.099999999999994 109.088 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.441 ' HB2' HG23 ' A' ' 127' ' ' THR . 8.9 t-20 67.32 24.35 9.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.337 -0.847 . . . . 64.420000000000002 111.946 166.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.512 ' HB3' HD22 ' A' ' 108' ' ' LEU . 54.9 m-85 63.52 -130.72 0.44 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.074 -0.512 . . . . 75.230000000000004 111.817 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.721 ' HB3' ' O ' ' A' ' 90' ' ' ILE . 4.6 p80 34.44 85.95 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.456 1.28 . . . . 73.519999999999996 114.456 -173.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 131' ' ' HIS . 9.3 mpt_? -135.58 108.46 7.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.867 -0.606 . . . . 75.340000000000003 110.187 171.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 46.4 t -112.7 100.2 10.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.431 -0.952 . . . . 71.049999999999997 108.431 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.892 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 69.7 mtp180 -109.98 124.85 52.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 72.349999999999994 112.021 -169.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 135' ' ' ILE . 3.1 mp -97.0 107.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.293 -0.867 . . . . 74.109999999999999 109.282 174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -62.56 111.99 4.52 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 120.977 -0.63 . . . . 72.150000000000006 111.7 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.41 -10.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 111.968 0.359 . . . . 72.299999999999997 111.968 -175.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.787 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 151.89 130.08 1.58 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.063 -1.065 . . . . 65.230000000000004 112.433 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 28.5 ptt180 -86.03 159.69 53.73 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 110.238 -0.282 . . . . 74.340000000000003 110.238 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.554 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 51.6 Cg_exo -53.47 122.17 10.77 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.764 2.309 . . . . 73.230000000000004 112.799 -177.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.91 8.06 3.98 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.942 2.428 . . . . 71.349999999999994 112.24 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.0 -128.0 1.7 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.076 -0.583 . . . . 74.030000000000001 111.934 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -46.1 17.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.008 0.432 . . . . 73.439999999999998 110.543 -177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 17.3 mmtp -87.69 133.14 33.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.533 0.683 . . . . 73.129999999999995 110.531 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.608 ' HB2' HD12 ' A' ' 97' ' ' LEU . 2.6 p-10 -74.63 158.64 84.7 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 114.773 -1.103 . . . . 61.130000000000003 110.781 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.554 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 32.5 Cg_exo -58.69 -16.22 29.71 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.958 2.438 . . . . 72.409999999999997 113.26 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.512 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -68.39 -21.19 64.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 72.329999999999998 111.317 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.41 -34.55 18.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.9 0.381 . . . . 65.140000000000001 111.233 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -84.35 -19.16 34.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.078 0.466 . . . . 73.120000000000005 111.331 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 21' ' ' ARG . 5.2 p -72.17 5.15 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.596 -0.729 . . . . 73.340000000000003 112.391 -172.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.92 -5.86 37.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.013 0.375 . . . . 71.209999999999994 112.013 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -160.89 144.53 13.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.911 0.386 . . . . 64.219999999999999 111.492 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 67.31 -173.92 0.19 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.15 -0.932 . . . . 72.319999999999993 112.621 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -156.72 171.48 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 73.310000000000002 109.51 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.828 ' HB ' ' HG3' ' A' ' 158' ' ' GLU . 25.1 m -102.5 120.07 39.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.864 0.364 . . . . 65.25 110.944 -175.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.69 67.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 71.120000000000005 111.523 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.39 70.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 71.140000000000001 111.504 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.828 ' HG3' ' HB ' ' A' ' 155' ' ' THR . 1.5 pp20? -79.83 -20.83 45.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.692 0.282 . . . . 75.099999999999994 111.208 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.46 ' HA ' HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -61.4 -20.36 62.97 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.241 0.543 . . . . 75.530000000000001 110.199 177.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.61 81.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.62 -0.718 . . . . 42.539999999999999 111.318 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -85.66 -7.86 58.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.41 . . . . 73.340000000000003 111.501 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.802 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 93.8 t -57.74 -59.07 14.23 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 111.953 0.353 . . . . 74.010000000000005 111.953 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.802 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 44.6 Cg_exo -57.37 -36.0 98.87 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.047 1.831 . . . . 65.540000000000006 112.129 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.5 m -71.35 -44.78 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.85 -0.614 . . . . 64.019999999999996 111.291 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 162' ' ' VAL . 7.1 tp -67.52 -30.1 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 73.319999999999993 111.035 -175.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 162' ' ' VAL . 92.8 t -64.88 -48.82 82.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.318 . . . . 73.099999999999994 110.473 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -63.21 -44.25 95.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 72.310000000000002 110.332 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.47 -45.45 90.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 71.439999999999998 111.093 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.6 -30.91 69.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 70.510000000000005 111.432 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -56.82 -49.35 75.64 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.143 0.277 . . . . 45.009999999999998 111.61 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.69 -43.1 98.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 73.439999999999998 111.094 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.68 69.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.817 -0.629 . . . . 51.509999999999998 111.573 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.476 ' O ' HG12 ' A' ' 177' ' ' ILE . 18.2 p -69.0 -39.04 79.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.964 0.357 . . . . 71.450000000000003 111.964 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -66.17 -40.26 90.38 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.029 -0.268 . . . . 72.219999999999999 110.87 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.4 tp -73.19 -30.89 63.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.986 0.422 . . . . 75.209999999999994 110.158 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.6 -49.3 77.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.554 -0.748 . . . . 70.200000000000003 109.427 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.722 HG23 HD21 ' A' ' 5' ' ' LEU . 45.1 mm -64.67 -31.37 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.143 -0.935 . . . . 62.32 111.207 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.5 -68.71 0.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 111.804 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -158.06 -38.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.751 0.31 . . . . 71.239999999999995 111.388 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -115.37 116.32 3.67 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.284 -0.96 . . . . 63.130000000000003 113.303 -173.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.648 ' HB2' HD21 ' A' ' 106' ' ' LEU . 4.2 pp -89.59 -20.51 23.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.363 0.601 . . . . 74.430000000000007 109.894 174.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 41.0 mt-10 -63.99 -50.13 71.19 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.39 -0.823 . . . . 52.409999999999997 111.691 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 13.9 Cg_endo -58.28 -32.38 95.82 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.91 1.74 . . . . 73.409999999999997 111.924 174.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.529 ' HA ' HG22 ' A' ' 187' ' ' THR . . . -64.28 -41.88 96.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.022 -0.535 . . . . 74.450000000000003 110.464 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.569 ' HG2' ' HB3' ' A' ' 106' ' ' LEU . 90.9 mt-30 -57.76 -34.69 69.83 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.098 -0.501 . . . . 72.129999999999995 110.553 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.49 -53.32 6.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.715 -0.675 . . . . 60.5 111.23 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 184' ' ' ALA . 8.8 t -62.46 -48.18 80.78 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.011 0.375 . . . . 65.409999999999997 112.011 -173.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.618 HG21 HD11 ' A' ' 104' ' ' ILE . 5.1 p -68.7 -14.07 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.96 0.41 . . . . 61.310000000000002 111.56 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -86.59 -8.18 57.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.117 0.484 . . . . 62.130000000000003 109.98 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -102.58 -17.7 15.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 74.420000000000002 111.878 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.584 ' HD1' ' HA ' ' A' ' 188' ' ' VAL . 90.8 m95 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.654 -0.688 . . . . 74.549999999999997 110.738 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 110.132 -0.321 . . . . 52.420000000000002 110.132 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 59' ' ' SER . 9.5 Cg_endo -52.75 129.81 34.32 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.3 2.667 . . . . 65.540000000000006 113.228 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.33 143.16 30.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 72.239999999999995 110.329 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 HG22 ' A' ' 90' ' ' ILE . 59.3 tp -96.93 109.95 22.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.911 -0.403 . . . . 74.430000000000007 109.911 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.8 115.31 31.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.723 -0.473 . . . . 74.450000000000003 109.723 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.86 114.26 45.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.107 -0.497 . . . . 63.229999999999997 110.251 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.29 134.33 7.78 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.688 -0.768 . . . . 65.420000000000002 111.241 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 10' ' ' LEU . 4.3 mm? -63.14 115.81 4.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.919 0.39 . . . . 64.329999999999998 110.044 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.857 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -87.04 -145.65 9.63 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.581 -0.736 . . . . 75.340000000000003 112.82 -174.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -102.41 136.5 19.37 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 110.618 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -89.52 -153.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.883 2.389 . . . . 65.299999999999997 111.239 172.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.04 -174.03 33.34 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.842 -0.694 . . . . 62.039999999999999 112.54 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.25 160.21 20.17 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.005 2.47 . . . . 75.25 112.344 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.2 m 72.77 -58.22 0.61 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.155 -0.475 . . . . 71.409999999999997 111.821 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.87 -13.58 60.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.382 . . . . 75.230000000000004 111.509 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.12 0.6 31.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.212 0.529 . . . . 73.219999999999999 110.715 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -105.09 20.41 18.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.691 -0.686 . . . . 73.340000000000003 109.957 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.6 p -100.33 175.4 5.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.965 -0.561 . . . . 74.409999999999997 110.791 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.56 ' HD3' ' O ' ' A' ' 153' ' ' ASN . 0.7 OUTLIER -81.59 1.66 32.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.468 -0.333 . . . . 71.219999999999999 111.734 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -105.92 11.82 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.41 0.522 . . . . 71.400000000000006 112.41 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -96.2 14.17 24.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.087 0.47 . . . . 63.119999999999997 110.032 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.6 pt? -59.96 -33.08 71.44 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.61 -0.723 . . . . 70.230000000000004 111.987 -174.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.06 -48.5 85.77 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.666 -0.778 . . . . 73.109999999999999 111.691 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.857 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 85.9 t80 -60.67 -46.11 91.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.831 0.348 . . . . 62.219999999999999 110.904 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 96.2 mmm -59.23 -50.41 74.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.835 -0.621 . . . . 63.299999999999997 111.704 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.45 -40.12 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 73.430000000000007 111.025 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.59 ' HB1' HD21 ' A' ' 62' ' ' LEU . . . -66.07 -34.76 78.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.858 0.361 . . . . 53.420000000000002 111.362 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -71.69 -44.67 63.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.254 -0.43 . . . . 71.409999999999997 111.428 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.0 m -65.59 -34.25 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.159 0.429 . . . . 72.219999999999999 112.159 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -79.92 -29.03 39.72 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.539 -0.464 . . . . 54.130000000000003 110.73 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -67.77 -40.46 84.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.995 0.426 . . . . 60.340000000000003 110.035 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.33 -18.9 70.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.988 -0.625 . . . . 64.409999999999997 112.364 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -75.78 -54.32 7.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.723 0.297 . . . . 70.239999999999995 111.751 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 tp -67.13 -15.44 19.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.028 -0.533 . . . . 72.040000000000006 111.229 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.82 62.54 0.93 Allowed Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.592 -1.003 . . . . 73.349999999999994 110.592 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.553 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 32.1 m -151.86 156.17 39.62 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.087 0.47 . . . . 74.319999999999993 111.786 -169.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.4 144.49 31.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.623 -0.717 . . . . 50.0 109.089 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.7 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 40.4 p90 -108.01 149.43 28.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.108 0.48 . . . . 72.319999999999993 111.575 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -155.16 172.93 17.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.353 -0.84 . . . . 73.109999999999999 109.67 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.9 126.33 5.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.676 0.75 . . . . 63.450000000000003 112.125 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -137.18 158.95 43.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.364 -0.835 . . . . 73.540000000000006 110.715 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.686 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 1.6 tpmt? 63.22 -87.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 72.239999999999995 111.845 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.39 -87.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.745 1.387 . . . . 41.509999999999998 114.745 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 78' ' ' PRO . 51.8 p -91.45 -37.0 13.45 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.826 1.787 . . . . 53.119999999999997 115.826 -156.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.19 -7.49 4.46 Favored Glycine 0 CA--C 1.508 -0.372 0 C-N-CA 119.459 -1.353 . . . . 75.209999999999994 114.223 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.529 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -95.61 110.37 22.48 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.27 1.211 . . . . 74.019999999999996 114.27 -160.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.761 ' HG3' ' HD2' ' A' ' 66' ' ' ARG . 53.6 mt-10 -97.94 114.32 26.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.709 -1.589 . . . . 70.340000000000003 106.709 155.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.529 HG23 ' HB1' ' A' ' 48' ' ' ALA . 66.9 t -124.24 139.24 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.11 0.481 . . . . 63.310000000000002 111.823 -166.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.7 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 2.8 p -115.9 115.29 48.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.298 -1.001 . . . . 72.400000000000006 108.298 168.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -96.32 117.45 30.85 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.147 -0.479 . . . . 72.219999999999999 110.889 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.57 -169.96 22.64 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.032 -0.827 . . . . 63.130000000000003 111.032 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 54' ' ' ARG . 14.8 ptt180 -141.3 139.72 33.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.04 0.448 . . . . 74.409999999999997 110.61 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 57' ' ' GLY . 96.5 mt -118.42 136.98 53.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.198 -0.668 . . . . 63.140000000000001 109.198 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 72.1 -29.56 0.2 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.739 0.649 . . . . 70.120000000000005 112.212 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 145.15 -14.18 1.89 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.106 -0.568 . . . . 62.520000000000003 111.701 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.4 m -102.35 132.45 48.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.615 0.245 . . . . 74.109999999999999 110.492 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 17.4 m -69.85 145.15 52.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.255 -0.429 . . . . 53.32 110.656 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 177' ' ' ILE . 15.5 m -136.78 143.59 34.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.077 0.465 . . . . 71.5 110.919 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.07 101.98 13.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.741 -0.663 . . . . 65.439999999999998 109.673 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.59 HD21 ' HB1' ' A' ' 29' ' ' ALA . 53.0 tp -94.9 98.95 11.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.258 0.551 . . . . 74.319999999999993 110.996 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 50' ' ' VAL . . . -117.12 167.5 11.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.643 -0.708 . . . . 74.340000000000003 110.213 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -154.45 134.0 7.63 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.573 0.225 . . . . 65.420000000000002 110.653 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 26.4 Cg_exo -63.98 142.19 80.5 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.809 2.34 . . . . 75.349999999999994 111.502 173.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.761 ' HD2' ' HG3' ' A' ' 49' ' ' GLU . 42.8 mtp180 -110.34 16.67 21.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.797 0.808 . . . . 74.150000000000006 109.751 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 70.1 m -133.62 161.46 34.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.767 -1.106 . . . . 64.0 109.026 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -70.04 165.87 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.18 0.514 . . . . 71.239999999999995 112.163 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.615 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . 21.9 ptt? -46.47 -44.77 17.81 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.787 1.403 . . . . 73.549999999999997 114.787 -167.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -67.09 -33.07 74.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.099 0.409 . . . . 73.239999999999995 111.24 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -96.96 0.97 49.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 73.400000000000006 111.094 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.6 t -65.12 -22.45 66.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.376 -0.375 . . . . 75.420000000000002 111.151 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.14 -30.13 76.9 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.975 -0.631 . . . . 51.43 112.605 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -85.04 -3.17 58.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.955 0.407 . . . . 75.510000000000005 110.909 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.439 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 22.8 mm-40 -82.31 -52.36 7.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.23 -0.441 . . . . 64.549999999999997 110.298 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.43 -21.44 6.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.803 -0.635 . . . . 72.400000000000006 110.679 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.36 -73.29 0.38 Allowed Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.159 -0.473 . . . . 44.039999999999999 113.525 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.494 ' HB2' ' OG ' ' A' ' 46' ' ' SER . 50.6 Cg_exo -56.01 -35.63 94.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.63 2.22 . . . . 53.229999999999997 112.008 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.619 HD12 ' HG2' ' A' ' 44' ' ' LYS . 64.1 tp -57.94 -54.29 48.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.574 -0.739 . . . . 71.5 111.856 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.705 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . . . -62.81 -30.15 71.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.018 0.437 . . . . 71.340000000000003 111.892 -175.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.942 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 9.4 mmpt? -73.23 -24.21 60.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.248 -0.433 . . . . 72.319999999999993 111.677 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -72.39 -58.69 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.8 0.296 . . . . 73.109999999999999 111.8 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.705 ' CE1' ' HA ' ' A' ' 80' ' ' ALA . 1.5 p90 -77.74 -11.37 59.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.631 -0.428 . . . . 74.010000000000005 111.176 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.1 t 65.93 34.55 7.08 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.808 0.67 . . . . 63.32 112.808 166.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.584 HG22 ' CD1' ' A' ' 83' ' ' TYR . 18.4 m -101.65 136.0 19.67 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 120.043 -0.663 . . . . 70.040000000000006 110.024 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 20.0 Cg_exo -66.47 150.83 84.07 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.69 2.26 . . . . 75.319999999999993 111.976 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.94 41.35 0.64 Allowed 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.099 2.533 . . . . 72.340000000000003 112.57 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -95.47 -47.76 6.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.954 -0.566 . . . . 70.540000000000006 109.897 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -83.46 34.86 0.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.627 -0.715 . . . . 62.210000000000001 111.266 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 131' ' ' HIS . 46.3 pt -105.74 143.32 17.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 65.099999999999994 110.708 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.69 118.13 44.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.819 -0.628 . . . . 61.340000000000003 109.847 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.0 t -96.92 120.11 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 71.239999999999995 111.263 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 tt -98.54 111.42 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.534 0.683 . . . . 62.140000000000001 109.481 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -154.69 164.8 38.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 74.549999999999997 109.944 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.81 153.74 25.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.474 0.654 . . . . 74.129999999999995 111.444 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.492 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 30.0 tt0 -119.88 94.54 4.43 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.113 -1.069 . . . . 63.229999999999997 108.113 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.639 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 2.4 pt? -60.78 -27.99 68.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.244 -0.889 . . . . 53.43 112.552 -170.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.39 -10.76 60.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.134 0.492 . . . . 73.409999999999997 110.858 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.2 mm -107.92 135.51 46.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 73.450000000000003 109.841 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.449 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 14.8 m-20 -66.44 154.22 40.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.102 0.477 . . . . 71.349999999999994 111.686 -176.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.698 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 34.7 p90 -65.41 143.51 57.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.216 -0.902 . . . . 55.310000000000002 111.164 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.03 -67.57 0.51 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.408 -0.901 . . . . 75.129999999999995 112.689 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -116.74 155.67 28.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.795 0.331 . . . . 74.109999999999999 110.196 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.588 HG22 ' HA ' ' A' ' 135' ' ' ILE . 40.9 pt -116.75 165.4 12.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.134 -0.485 . . . . 75.420000000000002 110.692 -178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.466 ' HG3' ' HB2' ' A' ' 134' ' ' ARG . 38.4 ptt180 -142.52 170.21 16.13 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.077 -0.712 . . . . 73.120000000000005 109.077 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.731 HD22 ' HB2' ' A' ' 181' ' ' LEU . 5.7 mp -128.75 119.32 24.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.061 0.458 . . . . 74.299999999999997 110.8 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -143.05 127.03 17.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.778 -0.646 . . . . 72.109999999999999 109.912 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.779 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.0 pt? -72.48 121.75 20.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.798 -0.637 . . . . 53.310000000000002 109.936 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.68 -173.6 41.35 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.874 -0.679 . . . . 32.039999999999999 111.488 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.12 -154.32 16.17 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.437 -0.411 . . . . 75.310000000000002 112.789 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.492 ' HA3' HD12 ' A' ' 118' ' ' LEU . . . -110.78 81.49 0.29 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.764 -0.731 . . . . 71.329999999999998 112.221 177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -53.83 142.65 23.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.782 0.325 . . . . 74.430000000000007 110.434 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.34 -48.43 4.03 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.918 -0.658 . . . . 54.009999999999998 112.536 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.03 -59.46 3.65 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.994 -0.622 . . . . 61.43 111.816 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.4 m80 65.62 -74.49 0.06 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.378 0.671 . . . . 73.230000000000004 112.492 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -38.03 -56.89 1.11 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.242 1.017 . . . . 54.340000000000003 113.472 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.615 ' HA3' ' HB2' ' A' ' 69' ' ' MET . . . -62.45 -64.78 3.59 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.798 -0.715 . . . . 74.109999999999999 113.679 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.492 HD12 ' HA3' ' A' ' 111' ' ' GLY . 85.5 mt -68.09 -28.36 67.29 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.83 0.307 . . . . 75.400000000000006 111.83 -173.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -67.0 -39.92 87.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.31 -0.256 . . . . 61.350000000000001 110.31 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.2 t -64.13 -43.83 94.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.978 0.418 . . . . 40.420000000000002 110.08 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 t -67.18 -46.22 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 70.420000000000002 110.711 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -61.81 -41.48 97.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.743 -0.662 . . . . 61.229999999999997 111.754 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 m -66.26 -29.36 69.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.476 -0.329 . . . . 73.409999999999997 111.496 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.97 -46.94 17.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.903 0.382 . . . . 72.099999999999994 111.077 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.34 -35.81 54.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.516 . . . . 63.450000000000003 111.731 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.37 40.12 4.3 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.487 -0.863 . . . . 64.420000000000002 111.367 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.485 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 11.5 t -129.88 176.29 8.16 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.244 -0.28 . . . . 75.530000000000001 110.244 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -138.48 21.73 2.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.79 0.329 . . . . 74.340000000000003 110.148 177.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.42 78.93 0.27 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.446 -0.797 . . . . 74.340000000000003 110.233 -178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -71.83 -25.21 61.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.715 -0.675 . . . . 71.150000000000006 111.404 -176.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 85.4 m-70 -140.85 120.49 13.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.724 -0.473 . . . . 75.099999999999994 109.724 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -153.49 152.12 30.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.945 0.402 . . . . 73.400000000000006 110.767 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.0 t -94.22 143.46 11.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.785 -0.643 . . . . 62.210000000000001 109.744 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 12.0 mmt180 -103.82 93.5 4.93 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.412 -0.588 . . . . 64.340000000000003 109.412 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.588 ' HA ' HG22 ' A' ' 104' ' ' ILE . 65.1 mt -92.7 108.14 19.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.186 -0.461 . . . . 73.010000000000005 110.627 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.698 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -71.17 109.74 2.96 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.637 -0.792 . . . . 45.350000000000001 111.855 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.0 m -109.61 -6.95 11.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.013 0.435 . . . . 34.340000000000003 110.602 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 87.2 170.57 46.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.828 -0.701 . . . . 50.409999999999997 112.321 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.639 ' HD2' ' O ' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -141.49 131.67 12.93 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.592 -0.521 . . . . 72.319999999999993 109.592 176.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 28.9 Cg_endo -64.81 110.78 1.54 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.526 2.151 . . . . 64.200000000000003 111.93 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 6.1 Cg_exo -78.3 69.44 7.6 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.067 2.511 . . . . 60.32 111.82 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.03 -176.68 42.31 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.699 -0.682 . . . . 45.219999999999999 111.429 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.47 -15.25 29.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.006 0.432 . . . . 75.420000000000002 109.914 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -93.67 159.22 15.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.041 -0.527 . . . . 71.129999999999995 109.66 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.49 142.42 91.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.719 -0.475 . . . . 71.310000000000002 109.719 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.434 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 7.4 Cg_endo -52.08 -11.92 1.2 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.434 2.756 . . . . 63.420000000000002 113.744 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.14 -31.23 51.82 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.802 0.334 . . . . 63.43 111.403 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.73 -31.48 19.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.385 -0.37 . . . . 75.230000000000004 111.636 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.434 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 96.7 m-85 -84.16 -19.68 33.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.245 -0.434 . . . . 53.520000000000003 111.713 -175.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.01 -23.39 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.386 -0.37 . . . . 64.140000000000001 111.92 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.7 mt -94.15 -11.46 30.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.447 -0.342 . . . . 71.319999999999993 111.91 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.13 110.72 2.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.339 0.59 . . . . 71.010000000000005 111.015 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.56 ' O ' ' HD3' ' A' ' 21' ' ' ARG . 22.9 t-20 -160.28 121.97 3.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.801 -0.636 . . . . 70.25 110.562 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -164.76 100.28 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.835 0.71 . . . . 72.019999999999996 109.727 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.24 175.52 5.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.882 -0.599 . . . . 75.319999999999993 111.063 -174.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.65 -20.6 46.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 50.119999999999997 111.628 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.453 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -66.13 -50.26 64.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.176 -0.465 . . . . 51.119999999999997 111.477 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.55 ' O ' HG23 ' A' ' 162' ' ' VAL . 1.6 mp0 -60.54 -30.36 69.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 71.340000000000003 111.206 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -55.75 -28.76 57.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 112.078 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.22 60.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.674 0.273 . . . . 62.119999999999997 111.658 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -111.92 -7.86 14.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.351 0.5 . . . . 74.329999999999998 112.351 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 158' ' ' GLU . 92.3 t -56.46 -56.68 29.35 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 121.111 -0.235 . . . . 74.5 110.916 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 20.1 Cg_endo -61.47 -34.47 85.96 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.983 1.789 . . . . 51.329999999999998 111.844 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.5 m -59.49 -42.14 91.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.865 -0.607 . . . . 75.329999999999998 110.904 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.6 mt -77.32 -52.83 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 75.439999999999998 111.378 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 162' ' ' VAL . 96.1 t -53.9 -47.41 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.382 0.512 . . . . 53.530000000000001 112.382 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -56.89 -52.11 66.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.984 0.421 . . . . 73.340000000000003 110.478 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -74.26 -41.62 60.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.789 -0.641 . . . . 74.129999999999995 111.604 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.52 -56.48 21.63 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.957 0.355 . . . . 73.25 111.957 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.94 -31.37 66.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.035 0.445 . . . . 71.230000000000004 111.66 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -80.92 -45.85 16.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.939 -0.573 . . . . 72.319999999999993 111.144 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.81 -30.87 65.98 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.374 0.509 . . . . 65.439999999999998 112.374 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.635 ' HA ' HD13 ' A' ' 176' ' ' LEU . 86.2 m -54.02 -32.0 52.93 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.219 0.451 . . . . 62.310000000000002 112.219 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.98 -33.27 75.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 75.439999999999998 110.638 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.3 tp -73.14 -27.13 61.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 72.010000000000005 111.268 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 173' ' ' THR . 8.6 mp -66.93 -35.77 80.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.066 0.46 . . . . 73.409999999999997 110.112 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.555 HD13 HG11 ' A' ' 60' ' ' VAL . 50.0 mt -80.45 -25.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.604 -0.726 . . . . 55.399999999999999 109.899 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.16 -43.19 68.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.615 -0.72 . . . . 71.230000000000004 111.075 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -134.6 -73.17 0.47 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.371 -0.377 . . . . 71.140000000000001 110.405 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 176' ' ' LEU . . . -177.55 -157.97 19.59 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.248 -0.977 . . . . 74.439999999999998 112.789 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.764 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -89.83 -5.09 57.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.556 -0.322 . . . . 71.129999999999995 110.799 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.777 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 7.0 mm-40 -55.15 -56.97 22.52 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.853 -0.612 . . . . 64.340000000000003 111.859 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.777 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 2.9 Cg_exo -75.2 -26.58 10.47 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.744 1.629 . . . . 74.439999999999998 111.633 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 188' ' ' VAL . . . -65.15 -53.3 47.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.65 -0.705 . . . . 65.219999999999999 111.232 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -60.97 -21.12 63.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 64.340000000000003 111.157 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -78.35 -55.28 5.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.371 -0.377 . . . . 71.140000000000001 110.591 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.9 t -71.64 -30.18 65.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.323 0.49 . . . . 71.230000000000004 112.323 -173.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 184' ' ' ALA . 22.8 m -82.18 -12.55 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.117 -0.364 . . . . 72.129999999999995 111.56 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -109.42 -31.49 7.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.389 -0.368 . . . . 63.130000000000003 110.945 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.44 -24.24 46.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.379 . . . . 42.310000000000002 112.02 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 72.3 m95 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.469 -0.777 . . . . 74.239999999999995 110.175 179.425 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.405 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 42.9 mt-10 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 109.465 -0.568 . . . . 73.129999999999995 109.465 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 3' ' ' GLU . 71.3 Cg_exo -50.17 108.21 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.486 2.124 . . . . 65.010000000000005 112.295 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.72 152.69 18.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.007 -0.542 . . . . 63.219999999999999 111.157 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.3 tp -97.39 116.87 30.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.968 -0.56 . . . . 75.340000000000003 109.49 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.29 110.41 31.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 72.099999999999994 110.048 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.551 HG11 HG22 ' A' ' 76' ' ' VAL . 43.5 t -121.89 132.82 70.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.588 -0.278 . . . . 64.329999999999998 110.504 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 93' ' ' ILE . . . -122.13 130.78 8.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.936 -0.649 . . . . 31.41 111.8 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -72.63 144.19 47.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.238 0.542 . . . . 73.450000000000003 111.116 -176.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -156.94 -177.67 30.28 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.786 -0.721 . . . . 65.549999999999997 111.709 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 86.7 m-20 -127.37 83.25 66.53 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 110.248 -0.278 . . . . 73.519999999999996 110.248 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.9 93.62 0.1 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.8 2.334 . . . . 74.099999999999994 112.224 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.51 158.93 31.02 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.698 -0.683 . . . . 52.549999999999997 111.401 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.16 -68.1 0.07 OUTLIER 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 123.163 2.575 . . . . 75.310000000000002 113.106 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 p -75.66 -26.74 57.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.934 0.397 . . . . 74.319999999999993 111.523 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.427 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 18.4 m-85 -70.24 -24.19 63.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.981 -0.554 . . . . 73.549999999999997 111.282 -176.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.414 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . . . -73.61 -9.35 58.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.262 -0.426 . . . . 71.450000000000003 111.405 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -94.8 18.6 11.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.245 -0.434 . . . . 63.32 110.773 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.6 p -111.34 148.87 32.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.043 0.449 . . . . 63.009999999999998 111.016 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.567 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 30.5 ptt-85 -71.31 -5.73 34.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.066 -0.515 . . . . 74.420000000000002 110.557 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.534 ' CG ' HG23 ' A' ' 150' ' ' VAL . 30.6 t-80 -91.45 2.29 56.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.294 0.569 . . . . 70.25 109.949 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 18' ' ' ALA . 63.5 t30 -98.8 18.07 17.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.818 0.818 . . . . 73.129999999999995 109.206 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.4 -38.16 88.58 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.247 -0.888 . . . . 75.510000000000005 112.318 -173.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -62.51 -46.24 94.2 Favored Glycine 0 C--N 1.329 0.152 0 C-N-CA 120.529 -0.843 . . . . 60.149999999999999 112.426 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.604 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 82.5 t80 -65.08 -38.77 91.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.163 0.506 . . . . 75.319999999999993 110.706 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.4 mmt -81.92 -37.69 26.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.913 -0.585 . . . . 73.549999999999997 112.534 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 31' ' ' VAL . 53.3 t -62.23 -37.75 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.951 0.405 . . . . 61.25 110.34 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.54 78.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.023 -0.535 . . . . 63.409999999999997 110.696 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -75.61 -48.95 20.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.109 -0.496 . . . . 65.230000000000004 111.289 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 28' ' ' VAL . 35.1 m -63.15 -40.78 90.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.538 -0.301 . . . . 72.299999999999997 111.654 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 169' ' ' ALA . 66.8 mt -66.06 -41.34 90.92 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.695 0.283 . . . . 74.409999999999997 110.814 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.83 -47.5 85.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.062 -0.517 . . . . 44.210000000000001 110.468 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.89 -27.94 71.06 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.884 -0.674 . . . . 44.520000000000003 112.857 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 18.0 mmm180 -73.18 -42.83 62.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.006 0.373 . . . . 72.200000000000003 112.006 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.71 -14.89 13.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.441 0.639 . . . . 74.109999999999999 110.264 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.12 58.91 1.43 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 110.539 -1.024 . . . . 62.310000000000002 110.539 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.6 m -137.98 126.59 23.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.045 -0.577 . . . . 65.140000000000001 111.718 -171.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.88 143.03 24.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.591 -0.732 . . . . 73.040000000000006 109.429 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.608 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 2.7 t80 -141.8 -146.0 0.18 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.246 -0.279 . . . . 65.140000000000001 110.246 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -155.51 173.26 16.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.788 0.327 . . . . 73.140000000000001 111.579 -169.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 47' ' ' GLY . 2.6 p -54.09 132.2 16.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.509 -0.768 . . . . 71.019999999999996 110.079 169.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.408 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 34.7 t60 -137.23 133.98 35.72 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.713 -0.395 . . . . 63.210000000000001 111.676 -173.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 64.27 -172.79 0.17 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.565 -0.743 . . . . 72.019999999999996 112.195 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' C ' ' H ' ' A' ' 47' ' ' GLY . 33.5 ttpt -79.92 -15.01 58.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.802 0.81 . . . . 62.219999999999999 109.079 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 82' ' ' PHE . 9.7 p -81.75 25.4 0.55 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.638 -1.164 . . . . 74.310000000000002 109.238 170.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 45' ' ' LYS . . . -54.23 43.68 0.01 OUTLIER Glycine 0 C--N 1.34 0.769 0 N-CA-C 118.253 2.061 . . . . 73.530000000000001 118.253 -167.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.13 174.36 6.43 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 118.268 1.034 . . . . 63.240000000000002 108.212 165.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 58.0 mt-10 -72.1 116.52 12.61 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.065 -0.654 . . . . 74.140000000000001 109.866 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.608 ' O ' ' HB3' ' A' ' 40' ' ' PHE . 58.6 t -124.96 135.68 63.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 110.125 -0.324 . . . . 73.510000000000005 110.125 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 62' ' ' LEU . 3.1 p -125.71 110.97 25.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.339 0.59 . . . . 71.140000000000001 110.006 172.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 m -84.26 111.85 19.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.974 -0.557 . . . . 74.239999999999995 110.121 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -138.58 171.43 23.5 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.884 -0.675 . . . . 64.430000000000007 111.737 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -131.31 110.53 11.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.224 0.535 . . . . 75.140000000000001 111.137 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.526 ' HB3' ' HG2' ' A' ' 174' ' ' GLU . 6.9 mp -111.94 153.33 26.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.136 -0.69 . . . . 53.310000000000002 109.136 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.97 -73.36 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.844 0.715 . . . . 70.299999999999997 111.331 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.67 23.11 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.051 -0.595 . . . . 44.020000000000003 112.477 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.7 m -140.88 141.38 34.62 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.548 -0.383 . . . . 75.409999999999997 110.62 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.8 p -83.73 118.53 23.95 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.993 0.425 . . . . 54.0 110.008 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.52 155.72 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.168 -0.469 . . . . 55.039999999999999 110.975 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -97.03 100.54 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.907 -0.588 . . . . 62.310000000000002 109.731 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 51' ' ' VAL . 48.6 tp -95.05 115.28 27.22 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.339 -0.615 . . . . 75.329999999999998 109.339 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HB3' HG22 ' A' ' 8' ' ' VAL . . . -124.82 145.17 49.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.467 0.651 . . . . 73.439999999999998 112.295 -173.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -111.11 142.11 25.64 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.939 -1.028 . . . . 73.129999999999995 108.42 173.051 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 18.8 Cg_exo -65.95 152.59 81.0 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.368 2.045 . . . . 74.049999999999997 111.904 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -93.95 5.46 51.63 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.626 -0.879 . . . . 71.219999999999999 108.626 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.903 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 77.3 m -134.59 173.84 11.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.368 -1.287 . . . . 71.150000000000006 109.824 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.455 ' HD2' ' SD ' ' A' ' 69' ' ' MET . 17.3 p90 -85.35 -173.71 4.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 74.200000000000003 110.542 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 68' ' ' TYR . 1.7 pmm? -48.55 -46.24 38.69 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.388 0.885 . . . . 74.430000000000007 113.388 -170.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -66.16 -62.35 1.53 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 75.519999999999996 111.735 -173.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.903 ' HG3' ' HB3' ' A' ' 67' ' ' CYS . 6.2 pt-20 -87.48 18.91 3.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.469 . . . . 71.019999999999996 111.299 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.1 t -65.33 -39.2 92.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.342 -0.614 . . . . 73.230000000000004 109.342 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.51 -23.57 66.93 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.738 -0.665 . . . . 72.549999999999997 112.188 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -71.92 -17.27 62.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.74 0.305 . . . . 71.329999999999998 110.425 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -95.88 -42.62 8.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 64.519999999999996 110.537 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.551 HG22 HG11 ' A' ' 8' ' ' VAL . 25.7 t -62.23 -38.54 81.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.983 -0.553 . . . . 63.399999999999999 111.236 -177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.33 -64.56 4.27 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.879 -0.6 . . . . 65.209999999999994 113.257 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.05 -41.23 70.17 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.646 2.23 . . . . 74.109999999999999 112.31 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.1 tp -54.85 -48.65 72.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.28 -0.418 . . . . 54.43 111.113 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.83 88.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.167 -0.47 . . . . 51.039999999999999 111.334 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -75.98 -35.22 59.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.177 -0.465 . . . . 72.400000000000006 111.291 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' HD2' ' HB3' ' A' ' 46' ' ' SER . 21.5 m-85 -71.74 -20.14 61.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.78 0.324 . . . . 72.420000000000002 111.086 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -98.74 -1.37 40.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.292 -0.413 . . . . 75.430000000000007 110.871 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m 59.73 29.61 19.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.643 -0.708 . . . . 72.150000000000006 111.767 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.23 149.06 35.29 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 61.119999999999997 110.601 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 90' ' ' ILE . 14.1 Cg_exo -70.35 110.31 2.64 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.079 2.519 . . . . 71.329999999999998 112.046 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.523 ' HB3' HD22 ' A' ' 125' ' ' LEU . 23.1 Cg_exo -65.1 -11.92 32.21 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.158 2.572 . . . . 75.420000000000002 112.42 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -78.94 -43.29 24.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.261 -0.427 . . . . 63.439999999999998 110.174 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -96.63 0.71 50.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.12 -0.491 . . . . 71.420000000000002 112.155 -170.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 40.2 pt -75.47 174.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.806 -0.357 . . . . 54.520000000000003 110.425 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 p -119.88 125.26 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.331 0.586 . . . . 73.510000000000005 110.98 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 131' ' ' HIS . 98.1 t -119.32 123.8 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 53.219999999999999 110.448 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.522 ' HB ' ' HA2' ' A' ' 9' ' ' GLY . 48.8 mm -75.57 130.63 36.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.693 -0.685 . . . . 74.140000000000001 109.6 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.403 ' HE1' ' HA3' ' A' ' 114' ' ' GLY . 31.5 t-80 -136.6 157.58 46.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.118 0.485 . . . . 71.549999999999997 110.469 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -86.77 152.76 22.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.875 -0.602 . . . . 71.530000000000001 110.688 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.747 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 26.9 tt0 -128.07 93.78 3.76 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.915 -0.772 . . . . 65.230000000000004 108.915 168.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 139' ' ' ARG . 4.0 pp -84.02 0.09 49.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.027 -0.988 . . . . 60.219999999999999 112.04 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.438 ' HB2' ' HA2' ' A' ' 113' ' ' GLY . 27.9 t70 -87.08 -38.94 16.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.163 0.506 . . . . 74.219999999999999 110.351 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.44 152.06 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.462 -0.79 . . . . 53.219999999999999 109.852 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.503 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 5.1 p-10 -64.39 159.97 20.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.377 0.608 . . . . 70.519999999999996 111.61 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 0.8 OUTLIER -72.59 135.69 45.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.132 -0.94 . . . . 64.329999999999998 112.027 -176.66 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.02 -64.06 0.53 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.235 -0.983 . . . . 62.310000000000002 113.278 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -85.88 145.62 27.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.797 0.332 . . . . 72.409999999999997 110.839 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.568 HG12 HG21 ' A' ' 188' ' ' VAL . 30.7 pt -117.27 149.85 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.481 -0.562 . . . . 70.200000000000003 109.481 174.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -157.03 137.22 12.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.852 0.358 . . . . 70.219999999999999 110.949 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 4.0 pp -96.68 153.47 17.85 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.757 -0.46 . . . . 62.340000000000003 109.757 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -147.39 115.54 6.56 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.771 -0.455 . . . . 71.230000000000004 109.771 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 129' ' ' ASN . 0.7 OUTLIER -80.91 90.12 5.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.828 0.823 . . . . 73.519999999999996 110.326 177.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.28 -127.09 1.63 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.385 -0.825 . . . . 62.509999999999998 111.385 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.08 163.17 32.96 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.299 -0.721 . . . . 75.420000000000002 111.299 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.8 94.66 0.68 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.641 -0.79 . . . . 64.409999999999997 112.492 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.91 142.12 12.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.136 0.494 . . . . 72.299999999999997 111.334 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 98' ' ' ASP . . . 96.88 -76.12 0.7 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.041 -0.599 . . . . 63.25 112.972 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.403 ' HA3' ' HE1' ' A' ' 94' ' ' HIS . . . -80.28 63.78 4.09 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.046 -0.597 . . . . 71.099999999999994 112.93 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -62.67 -27.1 69.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.778 0.288 . . . . 74.140000000000001 111.778 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -65.51 -29.93 70.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.312 0.577 . . . . 73.319999999999993 110.786 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.43 20.56 29.97 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.59 -0.814 . . . . 64.420000000000002 112.308 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 118' ' ' LEU . 33.5 mt -84.5 -59.51 2.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.881 -0.328 . . . . 72.430000000000007 111.276 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HD2' ' N ' ' A' ' 119' ' ' ARG . 3.7 mpt_? -73.65 -35.78 65.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.35 -0.386 . . . . 74.540000000000006 110.58 -174.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 p -56.42 -43.96 79.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 54.43 111.233 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.461 ' HB ' HH22 ' A' ' 132' ' ' ARG . 48.9 t -85.33 -41.62 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 54.530000000000001 111.889 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.37 -47.16 71.2 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.051 0.389 . . . . 64.140000000000001 112.051 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.2 m -66.93 -24.53 66.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.659 0.266 . . . . 61.109999999999999 111.18 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.43 -45.6 37.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.758 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 87' ' ' PRO . 90.6 mt -72.58 -34.98 67.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 73.430000000000007 110.384 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.61 -12.56 20.86 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.907 -0.663 . . . . 73.239999999999995 113.15 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -169.56 177.57 4.53 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.167 0.508 . . . . 72.049999999999997 111.579 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 2.5 mptt -110.34 -110.97 0.33 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.587 -0.894 . . . . 75.439999999999998 108.587 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.477 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 64.3 t30 64.96 -9.89 0.18 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.708 0.803 . . . . 64.120000000000005 113.054 174.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.408 ' H ' ' C ' ' A' ' 128' ' ' LYS . 10.4 t80 -179.79 -157.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.659 -0.867 . . . . 71.140000000000001 108.659 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.593 ' O ' ' HD2' ' A' ' 132' ' ' ARG . 11.6 p-80 44.87 41.08 4.86 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.937 0.895 . . . . 65.319999999999993 113.067 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.593 ' HD2' ' O ' ' A' ' 131' ' ' HIS . 2.7 mpt_? -131.01 107.03 8.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.786 -0.643 . . . . 71.540000000000006 109.906 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 106' ' ' LEU . 58.8 t -119.18 109.95 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.943 -0.762 . . . . 64.230000000000004 108.943 174.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.747 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 90.2 mtm180 -92.14 122.64 34.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.088 0.471 . . . . 61.409999999999997 111.651 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 135' ' ' ILE . 2.1 mp -99.88 115.03 40.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.946 -0.761 . . . . 44.32 108.946 172.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -63.52 109.13 2.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.881 -0.676 . . . . 71.150000000000006 111.472 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.567 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 30.8 m -101.4 -18.7 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.562 0.22 . . . . 74.409999999999997 111.491 -176.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 107.92 139.66 9.08 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.424 -0.893 . . . . 75.219999999999999 112.664 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 6.1 ptp180 -80.88 133.5 54.86 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.032 0.444 . . . . 73.420000000000002 111.586 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 22.3 Cg_exo -65.23 128.99 21.66 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.303 2.669 . . . . 64.409999999999997 112.499 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 5.9 Cg_exo -78.86 45.67 1.97 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.191 2.594 . . . . 73.510000000000005 112.272 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.87 143.74 10.95 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.044 -0.823 . . . . 71.140000000000001 111.044 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 143' ' ' ARG . 18.1 mmt180 -89.58 58.39 4.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.513 0.673 . . . . 62.100000000000001 111.446 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -131.0 160.49 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.101 -0.954 . . . . 73.400000000000006 109.296 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -66.49 141.09 96.9 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.263 -0.643 . . . . 71.120000000000005 109.263 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.8 -14.37 1.22 Allowed 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.552 2.835 . . . . 71.230000000000004 113.915 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.32 28.62 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.588 0.355 . . . . 75.239999999999995 111.813 174.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.75 -41.63 13.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.146 0.498 . . . . 74.409999999999997 111.228 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -73.61 -19.81 60.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 61.25 111.76 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.534 HG23 ' CG ' ' A' ' 22' ' ' HIS . 14.5 p -65.21 -22.52 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.246 -0.434 . . . . 74.340000000000003 111.49 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.52 -27.76 13.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.62 -0.264 . . . . 72.140000000000001 111.36 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -165.43 109.7 0.86 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.259 0.552 . . . . 71.239999999999995 111.467 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -164.27 31.79 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.823 -0.626 . . . . 65.349999999999994 110.125 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -60.23 124.57 20.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.311 0.577 . . . . 74.150000000000006 111.142 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.17 176.32 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.459 -0.791 . . . . 64.319999999999993 110.289 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.65 -54.46 5.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.837 0.351 . . . . 74.439999999999998 111.741 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.39 -23.77 66.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.208 0.818 . . . . 54.340000000000003 113.208 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.71 -23.7 66.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.067 0.461 . . . . 74.310000000000002 110.698 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.452 ' HA ' HG23 ' A' ' 162' ' ' VAL . 22.7 mmm180 -69.41 -22.37 63.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.747 -0.661 . . . . 72.530000000000001 111.417 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.36 -33.21 73.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.281 -0.418 . . . . 61.0 111.711 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 165' ' ' ILE . 8.9 mm-40 -97.04 1.48 50.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.885 0.328 . . . . 62.509999999999998 111.885 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' A' ' 163' ' ' PRO . 95.1 t -60.82 -53.39 64.65 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.772 -0.194 . . . . 73.209999999999994 111.373 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 30.7 Cg_endo -64.64 -25.62 61.78 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.772 1.648 . . . . 74.439999999999998 111.794 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.1 m -63.32 -51.17 67.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.624 -0.716 . . . . 75.430000000000007 110.945 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 161' ' ' GLU . 78.9 mt -54.49 -38.17 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.938 -0.573 . . . . 64.239999999999995 111.727 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.25 -51.44 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 63.240000000000002 111.363 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -80.97 -30.44 35.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.406 -0.361 . . . . 74.319999999999993 111.563 -176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -67.12 -43.18 83.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 72.200000000000003 110.961 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.418 ' HB3' HD21 ' A' ' 32' ' ' LEU . . . -60.09 -37.9 81.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 73.310000000000002 111.29 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.78 92.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.896 0.379 . . . . 55.420000000000002 111.548 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.81 -41.61 78.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.85 0.357 . . . . 74.420000000000002 110.977 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.75 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.042 -0.527 . . . . 61.420000000000002 112.279 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 23.6 p -62.86 -48.63 78.19 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.218 0.451 . . . . 65.239999999999995 112.218 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.526 ' HG2' ' HB3' ' A' ' 55' ' ' LEU . 40.3 mt-10 -64.99 -29.66 70.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.742 -0.208 . . . . 75.129999999999995 111.347 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.522 HD23 ' HA ' ' A' ' 184' ' ' ALA . 22.0 tp -74.54 -31.77 62.23 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.749 -0.38 . . . . 53.420000000000002 110.38 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 181' ' ' LEU . 70.6 mt -62.18 -45.1 94.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.245 0.545 . . . . 65.239999999999995 110.121 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 59.8 mt -71.02 -28.63 33.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.367 -0.833 . . . . 62.43 110.274 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -59.06 5.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.556 -0.747 . . . . 62.350000000000001 111.186 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -178.1 -49.61 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.849 0.314 . . . . 70.329999999999998 111.849 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.14 116.82 5.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.637 -0.792 . . . . 55.229999999999997 113.71 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.682 ' HA ' HD23 ' A' ' 176' ' ' LEU . 10.2 mp -77.63 -44.24 28.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.01 0.433 . . . . 63.43 110.658 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.588 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 45.5 mt-10 -72.56 -44.07 9.34 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.195 -0.457 . . . . 73.150000000000006 111.697 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 74.8 Cg_exo -52.12 -35.89 64.03 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.532 1.488 . . . . 75.109999999999999 111.918 170.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.522 ' HA ' HD23 ' A' ' 175' ' ' LEU . . . -73.31 -38.01 65.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.38 -0.373 . . . . 70.209999999999994 111.682 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 12.6 pt20 -71.36 -27.49 63.39 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.535 -0.466 . . . . 71.510000000000005 109.906 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -86.34 -32.09 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 72.120000000000005 111.69 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 184' ' ' ALA . 13.1 t -61.87 -50.42 72.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.96 -0.296 . . . . 61.420000000000002 111.062 -176.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.568 HG21 HG12 ' A' ' 104' ' ' ILE . 9.4 p -67.39 -26.45 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 121.569 0.7 . . . . 55.399999999999999 110.299 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -69.69 -31.7 69.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.377 -0.829 . . . . 51.140000000000001 110.318 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -93.61 -6.58 46.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.886 -0.597 . . . . 23.329999999999998 111.75 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.9 m95 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.664 -0.684 . . . . 73.349999999999994 110.585 175.843 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 8.8 pt-20 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.239 0.542 . . . . 64.439999999999998 109.778 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.907 ' HB2' HG23 ' A' ' 61' ' ' VAL . 56.4 Cg_endo -92.27 117.28 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.987 2.458 . . . . 73.409999999999997 113.318 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.646 ' HB2' HG12 ' A' ' 60' ' ' VAL . 70.9 mt -67.67 145.17 55.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 71.340000000000003 109.935 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.581 HD23 HG12 ' A' ' 90' ' ' ILE . 57.3 tp -93.32 109.36 20.91 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.107 -0.331 . . . . 72.420000000000002 110.107 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.58 113.12 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.496 . . . . 63.530000000000001 110.366 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.02 164.1 22.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.232 -0.44 . . . . 74.239999999999995 110.602 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.29 -178.66 39.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.601 -0.809 . . . . 51.039999999999999 112.25 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.476 HD21 ' CE1' ' A' ' 94' ' ' HIS . 86.3 mt -67.55 126.48 29.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.69 0.281 . . . . 73.540000000000006 110.966 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.98 177.73 52.09 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.934 -0.651 . . . . 30.109999999999999 113.149 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 30.0 t-20 -124.63 108.06 28.94 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 110.048 -0.353 . . . . 64.439999999999998 110.048 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 4.6 Cg_exo -76.75 -33.26 3.05 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.41 2.74 . . . . 43.340000000000003 114.117 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.92 147.81 15.01 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.889 -1.148 . . . . 44.530000000000001 113.104 -174.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.02 -31.83 94.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.553 2.835 . . . . 73.349999999999994 113.34 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 m -61.05 -39.14 88.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.293 0.568 . . . . 72.420000000000002 110.879 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.573 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 91.0 m-85 -97.17 2.5 51.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.53 -0.759 . . . . 74.109999999999999 110.52 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.426 ' CB ' HD21 ' A' ' 12' ' ' ASN . . . -71.28 -18.46 62.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.763 0.653 . . . . 72.040000000000006 112.763 -171.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -92.53 18.84 7.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.697 0.284 . . . . 73.430000000000007 111.228 -175.151 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.636 HG21 ' O ' ' A' ' 151' ' ' LEU . 59.8 p -113.95 -174.08 2.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.277 0.56 . . . . 71.549999999999997 111.904 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.601 ' HD2' ' HB ' ' A' ' 137' ' ' VAL . 5.0 ptt180 -94.47 1.53 55.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.513 -0.767 . . . . 73.200000000000003 112.85 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.617 ' HB3' HG22 ' A' ' 150' ' ' VAL . 3.6 p-80 -94.74 10.8 33.68 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.414 -0.515 . . . . 74.329999999999998 111.496 -176.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -139.15 35.04 2.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.075 0.464 . . . . 74.540000000000006 110.757 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.9 mt -56.04 -46.56 78.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.427 -0.806 . . . . 73.519999999999996 111.796 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.94 -51.19 60.67 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.999 -0.546 . . . . 70.030000000000001 113.013 -174.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -57.82 -38.3 75.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 73.310000000000002 111.289 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 90.1 mtp -73.01 -54.43 8.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.56 -0.291 . . . . 74.299999999999997 111.388 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.468 HG12 HD23 ' A' ' 32' ' ' LEU . 57.7 t -61.21 -44.2 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 71.519999999999996 111.558 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.516 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -58.78 -53.24 60.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 51.109999999999999 112.138 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.73 -37.12 81.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.169 0.433 . . . . 60.039999999999999 112.169 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.63 -32.02 34.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.603 -0.439 . . . . 53.130000000000003 112.117 -175.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.6 pp -76.41 -33.27 58.82 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.462 -0.495 . . . . 71.329999999999998 110.577 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -70.0 -34.04 72.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.263 0.554 . . . . 51.009999999999998 110.279 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.88 -18.68 57.51 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.508 -0.769 . . . . 63.509999999999998 113.088 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -64.02 -39.38 93.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.026 0.413 . . . . 73.319999999999993 111.651 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 36' ' ' ILE . 3.9 mp -83.11 -14.47 11.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.702 0.763 . . . . 74.439999999999998 109.553 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.98 13.69 54.04 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.87 -1.292 . . . . 71.010000000000005 109.87 -171.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.2 m -87.71 113.19 23.16 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.307 -0.946 . . . . 75.439999999999998 111.197 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.91 128.32 9.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.282 -0.417 . . . . 73.319999999999993 110.782 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.534 ' CD1' HG23 ' A' ' 51' ' ' VAL . 4.5 m-85 -102.76 -157.36 0.61 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.973 -0.558 . . . . 65.319999999999993 109.721 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -140.91 172.36 12.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.818 -0.353 . . . . 74.239999999999995 110.961 -173.12 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.797 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 3.3 p -55.83 105.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.748 0.785 . . . . 74.340000000000003 110.464 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.49 ' H ' ' HA ' ' A' ' 49' ' ' GLU . 39.8 t-80 -104.76 145.05 30.91 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.501 -0.772 . . . . 74.120000000000005 109.433 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -65.97 -77.11 0.07 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.176 -0.466 . . . . 54.210000000000001 111.277 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.587 ' HE3' ' HD2' ' A' ' 82' ' ' PHE . 28.8 mmmt 47.26 -133.27 1.18 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.501 -0.555 . . . . 54.350000000000001 109.501 -172.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 p -105.97 -39.46 6.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.389 -0.925 . . . . 65.409999999999997 112.725 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.726 ' HA3' ' HB3' ' A' ' 75' ' ' GLN . . . -133.01 -24.18 0.73 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 118.4 -1.857 . . . . 53.240000000000002 117.055 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.72 162.01 36.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.678 1.362 . . . . 51.520000000000003 114.678 -160.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.797 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 23.0 mt-10 -74.94 135.98 41.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.182 -1.372 . . . . 73.540000000000006 108.75 170.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.61 140.11 49.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.002 0.43 . . . . 72.299999999999997 111.654 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.779 HG13 ' HB3' ' A' ' 62' ' ' LEU . 2.4 p -124.41 114.76 42.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.717 -0.674 . . . . 75.409999999999997 109.953 171.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 m -95.65 131.22 42.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 74.430000000000007 110.505 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.23 -161.16 29.38 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.374 -0.69 . . . . 74.140000000000001 111.374 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -131.41 132.69 44.55 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.896 0.379 . . . . 73.310000000000002 110.458 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.1 mt -102.93 126.56 50.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.983 -0.553 . . . . 64.420000000000002 109.593 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 178' ' ' ALA . . . 68.97 -47.92 0.58 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.009 0.818 . . . . 65.420000000000002 111.778 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.11 -41.62 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.079 -0.581 . . . . 62.32 112.397 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.685 ' HB ' HG22 ' A' ' 177' ' ' ILE . 6.8 m -84.46 141.52 30.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.781 0.324 . . . . 44.329999999999998 110.965 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 3.7 p -70.22 143.3 52.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 74.109999999999999 111.353 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 177' ' ' ILE . 20.5 m -143.67 158.14 16.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.081 0.467 . . . . 52.039999999999999 111.297 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.907 HG23 ' HB2' ' A' ' 4' ' ' PRO . 85.0 t -112.07 104.93 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.675 -0.693 . . . . 65.340000000000003 109.186 172.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.779 ' HB3' HG13 ' A' ' 51' ' ' VAL . 3.0 tm? -95.84 118.72 33.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.552 -0.536 . . . . 71.25 109.552 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -134.64 131.15 37.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.733 -0.667 . . . . 71.209999999999994 109.96 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -127.59 135.23 27.15 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.942 0.401 . . . . 64.239999999999995 110.882 -178.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 1.4 Cg_endo -83.8 164.45 13.86 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.104 2.536 . . . . 61.119999999999997 111.918 176.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 68.3 mtt180 -112.19 17.1 19.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.37 0.605 . . . . 72.099999999999994 109.82 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 52.9 m -112.03 164.2 13.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.477 -0.783 . . . . 62.310000000000002 110.146 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -66.18 167.95 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.282 -0.417 . . . . 63.409999999999997 110.998 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 19.3 ptp -55.23 -32.44 62.28 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.855 0.687 . . . . 74.340000000000003 112.855 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -72.1 -24.33 61.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.11 0.481 . . . . 75.519999999999996 110.585 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 12.5 mm-40 -102.91 -10.3 19.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.923 -0.581 . . . . 72.019999999999996 110.996 -175.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.5 m -61.56 -51.8 67.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 73.030000000000001 111.676 -173.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.872 ' HA3' ' HA ' ' A' ' 121' ' ' VAL . . . -62.03 -23.83 64.25 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.193 -0.527 . . . . 53.0 113.276 -174.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -61.97 -37.9 86.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.039 0.447 . . . . 73.540000000000006 110.974 -176.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.726 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 12.9 mm100 -92.19 -20.43 21.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.931 -0.577 . . . . 74.319999999999993 110.996 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 72' ' ' SER . 95.7 t -73.69 -36.27 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 72.030000000000001 111.015 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.716 ' HA2' ' HB3' ' A' ' 125' ' ' LEU . . . -52.12 -68.45 1.56 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.991 -0.549 . . . . 74.019999999999996 112.973 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -58.11 -28.85 85.21 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.629 2.22 . . . . 74.310000000000002 112.495 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.94 -48.78 77.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 73.519999999999996 110.24 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.55 90.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.004 -0.544 . . . . 63.530000000000001 111.491 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.66 -20.19 59.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.288 -0.415 . . . . 45.229999999999997 111.564 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HD2' ' HE3' ' A' ' 45' ' ' LYS . 4.8 m-30 -74.21 -20.19 60.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.497 -0.32 . . . . 74.230000000000004 110.728 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -106.99 -11.74 15.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.51 -0.314 . . . . 70.099999999999994 110.833 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.0 t 61.74 36.3 16.41 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.627 -0.715 . . . . 64.420000000000002 110.529 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.4 m -74.11 142.76 79.53 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 110.619 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.89 128.32 25.12 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.869 2.38 . . . . 54.43 112.079 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.55 -9.39 18.0 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.02 2.48 . . . . 65.340000000000003 112.633 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.68 -12.75 55.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.113 -0.494 . . . . 73.450000000000003 110.903 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -105.31 24.79 11.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 75.230000000000004 111.186 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.581 HG12 HD23 ' A' ' 6' ' ' LEU . 62.6 mt -89.07 109.84 20.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.412 . . . . 70.319999999999993 111.196 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.785 HG12 ' HB3' ' A' ' 131' ' ' HIS . 32.6 m -113.42 141.7 28.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.468 -0.568 . . . . 61.100000000000001 109.468 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.01 130.16 51.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.318 0.58 . . . . 63.030000000000001 111.989 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.1 mm -85.28 118.0 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.55 -0.75 . . . . 74.329999999999998 109.291 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.476 ' CE1' HD21 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -137.61 170.26 16.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.411 0.624 . . . . 73.219999999999999 111.482 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -90.35 145.71 24.74 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.703 -1.135 . . . . 65.019999999999996 111.973 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 7.2 mm-40 -140.43 119.42 12.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.624 -0.716 . . . . 73.310000000000002 109.778 169.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.541 ' HB2' ' HG2' ' A' ' 139' ' ' ARG . 1.7 pp -83.77 -0.15 49.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.523 -0.762 . . . . 55.229999999999997 112.529 -174.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.416 ' OD2' HG13 ' A' ' 99' ' ' ILE . 3.4 p-10 -77.29 -10.85 59.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 71.209999999999994 111.383 -174.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.416 HG13 ' OD2' ' A' ' 98' ' ' ASP . 61.3 mt -135.17 149.72 29.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.956 -0.757 . . . . 64.299999999999997 108.956 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.05 179.1 7.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.453 -0.573 . . . . 75.349999999999994 109.453 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -66.17 123.79 20.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.091 0.472 . . . . 73.150000000000006 110.382 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.18 -118.13 0.78 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.789 -0.925 . . . . 74.299999999999997 110.789 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -83.4 132.99 34.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.265 0.533 . . . . 73.530000000000001 110.064 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.3 pt -97.69 166.16 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.995 -0.548 . . . . 63.509999999999998 110.703 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -126.6 127.85 45.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.235 0.54 . . . . 75.010000000000005 110.785 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.692 HD13 HG21 ' A' ' 188' ' ' VAL . 10.0 mp -104.71 111.88 24.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.979 -0.555 . . . . 62.0 110.947 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -143.58 135.77 26.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.581 -0.736 . . . . 65.25 109.201 176.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.5 pp -85.75 125.73 33.45 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 61.200000000000003 110.015 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.58 179.26 38.56 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.654 -0.703 . . . . 61.149999999999999 111.544 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.1 -156.95 6.8 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.011 -0.614 . . . . 74.549999999999997 112.594 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.62 ' HA3' HD13 ' A' ' 118' ' ' LEU . . . -78.8 130.98 10.34 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.021 -0.609 . . . . 75.099999999999994 112.141 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -105.91 -30.92 9.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.77 0.319 . . . . 64.019999999999996 110.467 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.79 -4.86 63.26 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.843 -0.694 . . . . 75.010000000000005 112.862 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.2 103.58 0.09 OUTLIER Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.019 -0.61 . . . . 61.210000000000001 112.525 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.652 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 32.0 m-70 -138.83 142.42 38.66 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.04 -0.356 . . . . 74.099999999999994 110.04 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -66.89 -44.84 79.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 72.530000000000001 111.243 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.34 11.91 3.69 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.056 -0.592 . . . . 74.510000000000005 113.664 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.652 ' HG ' ' HB2' ' A' ' 115' ' ' HIS . 95.9 mt -84.28 -51.35 7.07 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.606 -0.35 . . . . 75.310000000000002 110.599 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -79.02 -28.78 43.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.928 -0.578 . . . . 70.209999999999994 110.821 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.6 m -61.86 -32.72 73.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.081 0.467 . . . . 74.239999999999995 110.777 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.872 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 68.3 t -84.4 -47.26 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.445 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' HA ' ' CG2' ' A' ' 127' ' ' THR . . . -57.5 -55.79 30.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.759 -0.655 . . . . 73.129999999999995 112.45 -174.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.6 m -66.52 -21.64 66.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.024 0.379 . . . . 75.510000000000005 112.024 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.82 -52.09 64.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.803 0.297 . . . . 73.120000000000005 111.803 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.716 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 1.4 pt? -110.17 3.75 20.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.786 -0.366 . . . . 72.310000000000002 111.385 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.92 20.04 61.98 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.68 -0.772 . . . . 64.099999999999994 112.852 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.465 ' CG2' ' HA ' ' A' ' 122' ' ' ALA . 13.0 t -85.91 167.47 15.08 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.927 -0.397 . . . . 74.019999999999996 109.927 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 12.0 mptt -119.82 8.21 11.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.438 -0.346 . . . . 70.120000000000005 110.16 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 59.58 62.99 1.61 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.756 -0.656 . . . . 70.340000000000003 109.67 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -57.91 -70.58 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.282 -0.872 . . . . 64.299999999999997 111.718 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.785 ' HB3' HG12 ' A' ' 91' ' ' VAL . 34.8 t60 -99.55 86.71 3.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.115 0.483 . . . . 60.350000000000001 109.964 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -96.16 121.94 38.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.833 -0.621 . . . . 70.5 110.402 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -83.24 126.96 40.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.158 -0.682 . . . . 52.140000000000001 109.158 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -106.64 103.03 12.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.111 -0.495 . . . . 64.109999999999999 110.833 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 66.8 mt -96.53 128.06 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.879 -0.6 . . . . 64.420000000000002 109.857 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.95 115.3 7.11 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.818 -0.706 . . . . 74.200000000000003 111.81 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.601 ' HB ' ' HD2' ' A' ' 21' ' ' ARG . 35.0 m -100.88 -20.38 5.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.703 0.287 . . . . 74.439999999999998 111.061 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.31 151.4 1.73 Allowed Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.067 -0.515 . . . . 74.109999999999999 112.857 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.541 ' HG2' ' HB2' ' A' ' 97' ' ' LEU . 1.6 ppt_? -158.52 138.06 8.47 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.635 -0.332 . . . . 74.519999999999996 110.174 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 22.9 Cg_endo -93.54 134.14 0.97 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.218 2.612 . . . . 73.239999999999995 112.036 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.33 132.12 24.99 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.224 1.95 . . . . 73.140000000000001 111.718 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -159.04 179.17 34.86 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.562 -0.828 . . . . 74.109999999999999 111.858 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 143' ' ' ARG . 2.9 mpt_? -87.62 9.89 19.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.494 0.664 . . . . 74.150000000000006 110.106 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -124.73 131.59 53.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.873 -1.058 . . . . 74.329999999999998 108.431 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.9 149.95 62.61 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.944 0.402 . . . . 74.519999999999996 110.82 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.712 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 41.4 Cg_endo -66.92 4.6 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.345 2.697 . . . . 64.030000000000001 114.093 -172.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . -61.24 -39.22 89.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 53.030000000000001 110.636 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.72 -36.17 62.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.166 0.508 . . . . 72.239999999999995 110.543 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.712 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 95.8 m-85 -71.29 -24.61 62.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 73.439999999999998 111.513 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 22' ' ' HIS . 9.0 p -85.31 -15.21 10.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.887 0.375 . . . . 73.230000000000004 110.872 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.636 ' O ' HG21 ' A' ' 20' ' ' THR . 87.4 mt -84.01 -37.83 21.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.415 -0.357 . . . . 64.120000000000005 111.766 -177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -162.96 101.28 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.401 0.619 . . . . 73.530000000000001 111.482 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -160.06 115.21 2.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.714 -0.675 . . . . 73.219999999999999 110.196 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -134.19 145.04 48.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.727 -0.669 . . . . 54.100000000000001 109.612 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 0.2 OUTLIER -137.68 -160.01 1.01 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.226 -0.287 . . . . 74.530000000000001 110.226 -175.65 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.463 ' H ' HG22 ' A' ' 155' ' ' THR . . . -82.45 -29.0 30.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.835 0.35 . . . . 63.140000000000001 111.31 176.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.15 -60.54 2.19 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.095 0.776 . . . . 65.319999999999993 113.095 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -34.7 69.1 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.966 0.358 . . . . 70.099999999999994 111.966 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 155' ' ' THR . 7.2 mmp_? -60.79 -31.31 70.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.906 0.384 . . . . 74.340000000000003 110.678 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.38 -28.03 65.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 64.129999999999995 111.391 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -87.87 -19.05 27.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.011 -0.54 . . . . 61.43 111.102 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.658 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 88.7 t -50.63 -55.37 27.08 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 112.821 0.675 . . . . 73.010000000000005 112.821 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 77.5 Cg_exo -51.48 -33.8 48.87 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.364 2.043 . . . . 72.540000000000006 112.992 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.0 m -80.21 -46.7 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.458 . . . . 73.439999999999998 110.787 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.482 ' HA ' ' HB3' ' A' ' 168' ' ' GLN . 1.6 mp -59.51 -34.57 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 70.5 111.906 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 162' ' ' VAL . 85.6 t -55.37 -46.54 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.902 0.382 . . . . 52.549999999999997 111.152 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -79.11 -37.56 38.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.073 0.463 . . . . 73.030000000000001 110.221 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 165' ' ' ILE . 7.7 tt0 -61.3 -46.86 88.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.478 -0.783 . . . . 74.540000000000006 111.462 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.47 90.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 65.450000000000003 110.623 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.45 90.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.6 . . . . 63.450000000000003 110.729 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.52 -36.08 79.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.229 0.538 . . . . 75.010000000000005 110.605 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 176' ' ' LEU . . . -68.21 -47.74 67.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.717 -0.674 . . . . 72.209999999999994 111.026 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 21.5 p -66.77 -42.69 85.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.577 -0.283 . . . . 74.219999999999999 111.407 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -57.1 -56.42 21.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 73.239999999999995 111.202 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.35 -29.16 67.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.596 -0.274 . . . . 74.340000000000003 111.428 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.566 HD22 ' HA ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -60.48 -46.63 89.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.305 0.574 . . . . 74.430000000000007 109.576 178.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.705 HD13 HG11 ' A' ' 60' ' ' VAL . 62.9 mt -80.09 -30.34 12.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.356 -0.838 . . . . 74.040000000000006 110.809 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.469 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . . . -71.66 -47.39 54.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 61.130000000000003 111.838 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.15 -75.14 0.6 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.3 -0.409 . . . . 63.100000000000001 110.638 -174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.58 -172.78 38.63 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.42 -0.895 . . . . 53.310000000000002 112.385 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 181' ' ' LEU . 1.1 pt? -94.31 -26.25 16.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.606 0.241 . . . . 50.420000000000002 111.184 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 39.8 mt-10 -66.91 -47.29 54.0 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 111.981 0.363 . . . . 74.140000000000001 111.981 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 32.9 Cg_endo -65.94 -29.51 49.35 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.373 1.382 . . . . 72.219999999999999 111.877 174.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.66 -48.93 62.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.862 -0.608 . . . . 50.439999999999998 111.304 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.568 ' HA ' HG22 ' A' ' 188' ' ' VAL . 8.2 pt20 -60.99 -33.08 72.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.831 0.348 . . . . 63.409999999999997 111.062 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -69.97 -26.17 63.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.933 0.397 . . . . 73.420000000000002 110.628 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 31.4 m -86.28 -41.82 14.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.094 -0.503 . . . . 75.299999999999997 111.203 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.692 HG21 HD13 ' A' ' 106' ' ' LEU . 33.2 m -71.0 -20.24 21.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.871 0.367 . . . . 62.100000000000001 111.47 -178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -97.23 16.03 21.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.453 0.644 . . . . 62.020000000000003 109.79 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -105.59 17.03 24.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.909 -0.587 . . . . 72.129999999999995 110.286 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 87.3 m95 . . . . . 0 C--O 1.247 0.948 0 CA-C-N 115.681 -0.69 . . . . 73.5 109.962 179.719 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 6.6 pt-20 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.412 0.149 . . . . 73.219999999999999 110.68 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 59' ' ' SER . 21.5 Cg_exo -64.69 108.82 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.901 2.401 . . . . 72.219999999999999 112.862 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.676 HD12 HG22 ' A' ' 177' ' ' ILE . 87.8 mt -95.24 156.64 16.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.92 -0.582 . . . . 70.530000000000001 109.652 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.594 HD23 HD12 ' A' ' 90' ' ' ILE . 34.1 tp -108.25 120.75 43.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.941 0.4 . . . . 74.140000000000001 110.75 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 t -118.53 116.97 53.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.862 -0.608 . . . . 72.420000000000002 109.883 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.741 ' HB ' HG22 ' A' ' 92' ' ' VAL . 35.3 t -114.81 143.7 23.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.474 -0.33 . . . . 75.450000000000003 110.473 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.58 157.11 20.25 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.824 -0.703 . . . . 62.43 111.553 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.492 ' H ' ' HA3' ' A' ' 25' ' ' GLY . 61.9 mt -66.43 115.78 6.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 73.409999999999997 109.688 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -83.96 -179.07 51.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.029 -0.605 . . . . 71.129999999999995 113.565 -171.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -94.16 124.16 56.79 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.963 0.411 . . . . 74.25 110.456 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.495 ' HG2' ' HB2' ' A' ' 17' ' ' TYR . 74.2 Cg_endo -88.54 -6.28 6.05 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.759 2.306 . . . . 72.319999999999993 113.469 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.5 171.21 28.39 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.722 -0.751 . . . . 75.439999999999998 112.131 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.4 -52.18 3.51 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.167 2.578 . . . . 74.230000000000004 113.034 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.7 m -61.31 -34.84 75.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 70.099999999999994 111.561 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.535 ' HE1' ' HB3' ' A' ' 151' ' ' LEU . 98.1 m-85 -89.22 -9.39 50.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.316 -0.402 . . . . 73.239999999999995 111.634 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.98 -6.87 45.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.342 . . . . 70.409999999999997 110.954 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.5 11.42 36.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 63.420000000000002 111.101 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -101.88 147.66 26.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.72 -0.845 . . . . 64.430000000000007 108.72 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -0.44 37.71 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.502 -0.479 . . . . 75.120000000000005 111.449 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -76.91 -6.33 52.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.101 0.477 . . . . 61.229999999999997 111.021 -174.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -118.45 34.38 5.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.375 0.607 . . . . 75.219999999999999 110.005 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pp -63.81 -12.67 37.79 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.6 -0.727 . . . . 62.240000000000002 111.451 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.492 ' HA3' ' H ' ' A' ' 10' ' ' LEU . . . -61.09 -47.23 92.22 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.124 -0.79 . . . . 54.350000000000001 111.124 175.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.637 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 83.4 t80 -65.26 -39.65 92.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.825 -0.435 . . . . 75.219999999999999 109.825 175.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 65.2 mtt -59.87 -56.8 17.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.672 -0.694 . . . . 63.210000000000001 110.96 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.442 ' HA ' HG22 ' A' ' 31' ' ' VAL . 94.7 t -59.03 -44.0 90.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.474 -0.33 . . . . 54.399999999999999 110.946 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.656 ' HB1' HD21 ' A' ' 62' ' ' LEU . . . -58.91 -45.24 90.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.948 0.404 . . . . 72.239999999999995 111.023 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.22 -44.6 68.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 63.530000000000001 111.559 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 32.8 m -69.17 -31.73 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.956 -0.298 . . . . 71.230000000000004 111.581 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 60.1 mt -71.8 -58.73 3.22 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.939 -0.304 . . . . 71.409999999999997 110.609 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.49 -46.72 88.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 52.340000000000003 110.728 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.14 -20.76 69.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.081 -0.58 . . . . 73.140000000000001 113.179 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 40.1 ttp180 -84.44 -33.4 23.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.068 0.434 . . . . 73.430000000000007 110.645 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.51 -36.09 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.191 0.52 . . . . 43.25 110.04 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.47 68.75 0.29 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.629 -0.989 . . . . 71.150000000000006 110.629 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 57.8 m -152.46 119.91 5.99 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.502 -0.349 . . . . 54.420000000000002 110.793 -170.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.82 127.95 16.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.52 -0.309 . . . . 60.399999999999999 110.404 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.632 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 14.3 m-85 -141.63 172.85 12.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 72.519999999999996 110.123 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -142.84 176.31 9.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 75.439999999999998 111.123 -171.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.8 t -48.06 130.94 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.795 0.665 . . . . 75.239999999999995 112.795 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.518 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 72.1 t60 -109.28 115.46 30.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.49 -0.777 . . . . 53.32 109.658 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 2.5 tmtp? -68.89 99.92 1.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.944 0.35 . . . . 70.319999999999993 111.944 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 80.2 tttt 160.2 -51.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.1 -1.444 . . . . 73.439999999999998 107.1 173.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 48' ' ' ALA . 13.8 p -102.91 28.6 6.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.218 -1.81 . . . . 65.510000000000005 108.076 173.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 43' ' ' HIS . . . -48.85 44.08 0.01 OUTLIER Glycine 0 N--CA 1.474 1.18 0 N-CA-C 119.81 2.684 . . . . 41.420000000000002 119.81 -150.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 46' ' ' SER . . . -96.47 179.76 4.9 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.333 -1.358 . . . . 64.439999999999998 107.333 159.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.895 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 32.3 mt-10 -80.34 118.0 21.59 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 119.998 -0.681 . . . . 71.510000000000005 109.565 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.5 m -121.11 137.73 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.978 0.418 . . . . 73.129999999999995 110.768 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.874 HG13 ' HB3' ' A' ' 62' ' ' LEU . 1.6 p -124.35 110.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.253 0.549 . . . . 72.510000000000005 110.265 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.4 HG22 HG22 ' A' ' 61' ' ' VAL . 24.7 p -92.52 107.93 19.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.733 -0.667 . . . . 73.239999999999995 110.202 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.02 165.01 28.57 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.35 -0.7 . . . . 52.240000000000002 111.35 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 54' ' ' ARG . 15.5 ptt-85 -104.91 103.85 13.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.537 0.684 . . . . 61.140000000000001 110.611 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.43 135.57 38.12 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.676 -0.861 . . . . 72.049999999999997 108.676 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 62.53 10.74 4.24 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.463 0.477 . . . . 53.340000000000003 111.149 -174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.56 -22.91 34.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.989 -0.624 . . . . 73.439999999999998 112.623 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 m -89.59 122.52 32.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 64.099999999999994 110.845 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 19.3 m -68.49 116.47 9.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.441 -0.345 . . . . 74.0 110.414 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.422 HG11 HG21 ' A' ' 177' ' ' ILE . 31.0 m -127.68 164.05 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.957 0.408 . . . . 72.430000000000007 110.689 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.4 HG22 HG22 ' A' ' 52' ' ' THR . 41.3 t -110.01 111.05 34.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.93 -0.577 . . . . 55.450000000000003 109.808 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.874 ' HB3' HG13 ' A' ' 51' ' ' VAL . 64.4 tp -96.82 129.83 44.19 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.534 -0.543 . . . . 74.129999999999995 109.534 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 65' ' ' PRO . . . -108.91 129.27 55.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.217 0.532 . . . . 60.049999999999997 112.049 -175.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.895 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 45.3 mtpt -110.92 92.05 14.05 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.2 -0.909 . . . . 71.209999999999994 109.691 175.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.563 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.7 Cg_endo -83.54 173.03 9.86 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.992 2.461 . . . . 74.5 112.143 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -110.82 12.98 22.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.428 0.633 . . . . 64.219999999999999 109.48 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 60.0 m -130.08 175.15 9.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.558 -0.746 . . . . 75.420000000000002 110.633 -175.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.483 ' CE2' ' HG3' ' A' ' 13' ' ' PRO . 45.9 m-85 -100.25 -169.82 1.78 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.109 -0.496 . . . . 71.099999999999994 110.96 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.607 ' HA ' ' HB2' ' A' ' 72' ' ' SER . 24.9 ptt? -66.8 -20.16 65.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.876 -0.602 . . . . 43.409999999999997 111.537 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.4 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 14.2 t30 -71.87 -25.22 61.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.211 0.529 . . . . 74.129999999999995 109.897 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 18.0 mp0 -105.89 2.42 27.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.717 -0.674 . . . . 75.310000000000002 110.525 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 69' ' ' MET . 27.0 t -60.24 -38.57 83.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.438 -0.346 . . . . 65.230000000000004 110.681 -175.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.82 -20.34 64.14 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.005 -0.617 . . . . 72.239999999999995 112.393 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -85.05 -31.4 23.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.863 0.363 . . . . 60.420000000000002 110.609 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -89.6 -40.65 12.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 62.240000000000002 111.42 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.97 -32.33 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.33 -0.395 . . . . 61.509999999999998 111.102 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.8 -67.83 1.75 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.908 -0.587 . . . . 61.32 113.261 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.07 -39.26 32.55 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.531 2.154 . . . . 63.030000000000001 112.409 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.9 tp -55.32 -58.47 7.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 74.129999999999995 111.731 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.48 68.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.957 0.408 . . . . 75.239999999999995 111.153 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -73.04 -32.7 65.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.817 -0.629 . . . . 72.019999999999996 111.638 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -81.96 -41.78 20.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.873 0.323 . . . . 64.319999999999993 111.873 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -85.45 -17.13 37.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.13 0.418 . . . . 72.540000000000006 112.13 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 t 62.72 71.8 0.51 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.237 0.541 . . . . 52.229999999999997 110.863 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 6' ' ' LEU . 28.0 m -118.17 158.24 46.86 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.798 -0.637 . . . . 72.030000000000001 109.821 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.425 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 35.6 Cg_exo -61.11 111.52 1.11 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.515 2.143 . . . . 71.140000000000001 112.001 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.38 -6.77 19.38 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.707 2.272 . . . . 75.349999999999994 112.267 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -98.27 -12.43 21.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.993 -0.549 . . . . 70.230000000000004 110.457 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 86' ' ' PRO . 79.0 mm-40 -114.49 20.14 15.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 71.219999999999999 110.8 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.594 HD12 HD23 ' A' ' 6' ' ' LEU . 5.8 tt -83.31 134.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.185 -0.461 . . . . 65.430000000000007 110.224 177.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 131' ' ' HIS . 21.6 m -120.9 141.35 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.835 0.35 . . . . 71.299999999999997 110.68 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.741 HG22 ' HB ' ' A' ' 8' ' ' VAL . 45.9 t -132.78 127.34 55.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.316 -0.402 . . . . 73.299999999999997 110.465 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 mm -75.15 139.23 19.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.887 -0.597 . . . . 75.310000000000002 110.708 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -142.45 152.89 43.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.506 -0.316 . . . . 75.430000000000007 110.521 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.97 135.55 42.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.479 -0.934 . . . . 65.430000000000007 108.479 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 99' ' ' ILE . 10.1 tp10 -104.37 127.68 52.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.377 0.608 . . . . 71.0 111.001 -174.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.568 HD22 ' HG3' ' A' ' 146' ' ' PRO . 3.2 pp -84.26 -13.83 51.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.05 -0.977 . . . . 75.109999999999999 110.775 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.94 -47.67 20.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 52.210000000000001 111.157 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.49 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 56.7 mt -89.74 142.13 13.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.089 -0.505 . . . . 52.200000000000003 110.789 -176.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.89 166.46 18.9 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.509 . . . . 72.530000000000001 110.607 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.652 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 15.4 p90 -64.45 128.72 36.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.247 0.546 . . . . 75.299999999999997 112.164 -174.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.62 -22.94 3.84 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.726 -0.75 . . . . 74.310000000000002 112.958 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 17.0 mmt180 -132.35 128.34 37.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.265 0.555 . . . . 75.209999999999994 112.451 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.558 HG22 HG23 ' A' ' 135' ' ' ILE . 47.3 pt -107.79 146.77 13.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.334 -0.848 . . . . 73.530000000000001 109.414 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -157.73 125.2 5.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.908 0.385 . . . . 74.540000000000006 110.46 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.83 HD23 ' H ' ' A' ' 106' ' ' LEU . 1.9 pt? -97.91 144.62 27.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.442 -0.344 . . . . 73.129999999999995 110.092 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 104.44 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.179 -0.674 . . . . 53.520000000000003 109.179 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.845 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.6 pt? -93.37 97.47 10.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.396 0.617 . . . . 71.439999999999998 110.758 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.94 -155.21 26.33 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.271 -0.732 . . . . 64.409999999999997 111.271 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.38 123.91 7.95 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.012 -0.613 . . . . 72.319999999999993 112.378 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.31 -176.61 44.64 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.55 -0.62 . . . . 52.439999999999998 111.55 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.609 ' HG2' ' H ' ' A' ' 113' ' ' GLY . 16.7 tt0 -142.76 -152.41 0.41 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.878 -0.415 . . . . 63.240000000000002 109.878 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.609 ' H ' ' HG2' ' A' ' 112' ' ' GLU . . . 139.75 -74.18 0.38 Allowed Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.299 -0.72 . . . . 25.050000000000001 111.299 -175.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.08 -6.57 87.54 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.971 -0.633 . . . . 60.229999999999997 111.829 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.8 t60 62.74 -87.3 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.774 0.829 . . . . 73.230000000000004 112.595 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -67.08 -46.55 73.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.792 0.329 . . . . 74.409999999999997 111.481 -168.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -60.99 -29.19 70.19 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 120.835 -0.698 . . . . 74.230000000000004 112.464 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.501 ' HB3' HH21 ' A' ' 132' ' ' ARG . 89.6 mt -82.88 -23.77 33.49 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.815 -0.227 . . . . 55.0 111.099 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -79.11 -39.7 32.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.235 -0.439 . . . . 74.200000000000003 110.634 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.5 t -61.59 -54.31 44.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.802 -0.635 . . . . 61.229999999999997 110.795 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 117' ' ' GLY . 48.4 t -59.5 -41.69 85.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.433 -0.349 . . . . 65.329999999999998 111.101 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.46 -52.09 67.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 64.519999999999996 111.209 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.8 m -71.46 -34.02 69.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.853 -0.612 . . . . 62.340000000000003 111.553 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.08 -36.84 78.04 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.833 0.349 . . . . 65.030000000000001 111.286 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.7 mt -87.31 -31.27 20.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.47 -0.332 . . . . 75.310000000000002 111.138 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.64 40.33 5.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.517 -0.849 . . . . 41.439999999999998 111.951 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 129' ' ' ASN . 9.7 t -148.06 176.61 10.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.948 -0.39 . . . . 72.409999999999997 109.948 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 1.1 mptm? -77.62 -5.87 51.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.72 0.295 . . . . 54.310000000000002 110.462 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.408 ' H ' HG23 ' A' ' 127' ' ' THR . 56.7 t30 72.01 81.31 0.15 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.327 -0.851 . . . . 73.430000000000007 111.896 172.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -71.2 -148.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.798 -0.637 . . . . 75.340000000000003 110.118 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.589 ' HB3' ' O ' ' A' ' 90' ' ' ILE . 32.1 p80 45.13 40.02 4.46 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.86 0.689 . . . . 62.109999999999999 112.86 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.501 HH21 ' HB3' ' A' ' 118' ' ' LEU . 50.3 mtt85 -91.65 107.97 19.58 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.433 -0.58 . . . . 71.25 109.433 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.04 109.43 28.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.628 -0.714 . . . . 62.210000000000001 109.88 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.408 ' HG2' ' OE1' ' A' ' 96' ' ' GLU . 95.4 mtt180 -88.71 100.75 13.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.019 -0.537 . . . . 74.409999999999997 110.889 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.558 HG23 HG22 ' A' ' 104' ' ' ILE . 55.7 mt -93.74 108.64 20.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.035 -0.529 . . . . 73.519999999999996 110.046 175.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -73.33 98.0 0.89 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.032 -0.604 . . . . 65.239999999999995 112.322 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 135' ' ' ILE . 3.5 m -110.95 0.97 9.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.702 0.287 . . . . 61.420000000000002 111.484 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 131.88 140.1 4.47 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.264 -0.969 . . . . 50.450000000000003 112.843 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.472 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 7.8 ptp85 -99.46 139.49 20.94 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.656 0.265 . . . . 74.430000000000007 110.506 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 3.0 Cg_exo -75.29 141.36 25.74 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.803 2.336 . . . . 64.409999999999997 111.88 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.38 149.1 88.52 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.575 2.183 . . . . 64.530000000000001 111.58 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.19 44.42 2.15 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.323 -0.465 . . . . 51.140000000000001 113.626 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -82.27 -67.73 0.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.673 -1.232 . . . . 73.230000000000004 107.673 175.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 22.5 mmtm -131.36 147.97 52.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.621 -1.172 . . . . 73.239999999999995 108.289 166.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.581 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 1.7 p-10 -58.91 157.45 20.35 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 123.335 0.397 . . . . 52.409999999999997 110.699 -175.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 4.8 Cg_endo -46.1 -28.76 5.66 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 124.192 3.261 . . . . 72.109999999999999 114.149 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.69 -32.11 28.63 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.186 0.439 . . . . 61.140000000000001 112.186 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.57 -57.97 2.75 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.355 0.502 . . . . 65.239999999999995 112.355 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 144' ' ' LYS . 67.6 m-85 -84.03 -19.99 33.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.654 0.983 . . . . 73.200000000000003 113.654 -168.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.0 p -71.63 -5.97 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.169 0.433 . . . . 73.319999999999993 112.169 -171.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.535 ' HB3' ' HE1' ' A' ' 17' ' ' TYR . 87.9 mt -91.12 -1.91 57.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 61.210000000000001 111.424 -176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -138.91 103.06 4.7 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.752 -0.833 . . . . 74.310000000000002 108.752 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -129.34 119.33 23.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.613 -0.722 . . . . 61.509999999999998 112.024 -164.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -169.1 103.08 0.37 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.642 0.734 . . . . 64.230000000000004 110.12 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.538 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 3.1 m -134.99 131.77 37.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.515 . . . . 73.349999999999994 109.928 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.87 -38.02 86.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.758 0.313 . . . . 72.239999999999995 111.085 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.2 92.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.764 -0.653 . . . . 71.409999999999997 112.31 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.538 ' HG2' ' HB ' ' A' ' 155' ' ' THR . 15.2 pt-20 -82.21 -32.85 29.62 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.968 -0.293 . . . . 72.109999999999999 111.155 -175.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.592 ' HA ' HG23 ' A' ' 162' ' ' VAL . 49.5 mtm180 -71.6 -20.09 62.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.754 0.312 . . . . 74.310000000000002 110.694 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.86 -38.71 76.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.933 -0.576 . . . . 63.240000000000002 112.041 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -103.02 7.58 39.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.197 0.443 . . . . 72.519999999999996 112.197 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 159' ' ' ARG . 77.3 t -58.19 -51.64 80.35 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 121.058 -0.257 . . . . 72.109999999999999 111.34 177.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 12.5 Cg_endo -56.71 -27.61 71.69 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.326 2.018 . . . . 61.020000000000003 112.354 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 168' ' ' GLN . 9.4 m -68.32 -55.47 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.36 -0.382 . . . . 54.210000000000001 110.121 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.456 HG13 HG23 ' A' ' 104' ' ' ILE . 1.7 mp -56.06 -43.17 74.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.524 -0.762 . . . . 75.310000000000002 111.503 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 162' ' ' VAL . 92.4 t -58.04 -49.94 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.618 0.247 . . . . 75.400000000000006 111.369 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.69 -33.15 70.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.563 -0.289 . . . . 73.530000000000001 111.318 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 164' ' ' THR . 98.7 mt-30 -62.52 -48.13 80.87 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.099 0.476 . . . . 64.439999999999998 109.89 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.14 -41.13 97.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.656 -0.702 . . . . 74.209999999999994 111.194 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.09 87.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.401 -0.363 . . . . 74.340000000000003 111.102 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.09 -36.52 83.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 73.230000000000004 110.784 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.29 -45.93 44.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 70.109999999999999 111.335 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.839 ' HA ' HD12 ' A' ' 176' ' ' LEU . 80.1 m -58.3 -40.57 82.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.228 -0.442 . . . . 64.340000000000003 111.541 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -53.71 -45.31 70.37 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.263 -0.426 . . . . 60.119999999999997 111.249 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 183' ' ' PRO . 30.7 tp -81.88 -28.33 33.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.059 -0.257 . . . . 74.230000000000004 111.534 -174.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.839 HD12 ' HA ' ' A' ' 173' ' ' THR . 74.0 mt -52.2 -55.95 17.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.26 0.552 . . . . 74.349999999999994 110.665 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.676 HG22 HD12 ' A' ' 5' ' ' LEU . 6.9 pt -80.97 -23.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.376 -0.829 . . . . 73.439999999999998 111.78 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 175' ' ' LEU . . . -65.77 -45.69 81.56 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 111.748 0.277 . . . . 53.32 111.748 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -136.65 -61.63 0.67 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.83 0.348 . . . . 73.420000000000002 111.277 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -168.59 170.31 42.17 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.541 -0.838 . . . . 53.329999999999998 112.307 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.757 ' HA ' HD23 ' A' ' 176' ' ' LEU . 3.3 pp -82.71 -31.54 28.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.225 0.454 . . . . 73.430000000000007 112.225 -175.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 14.6 mm-40 -60.66 -54.26 56.43 Favored Pre-proline 0 N--CA 1.468 0.439 0 N-CA-C 112.559 0.577 . . . . 74.120000000000005 112.559 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.462 ' HB2' HD21 ' A' ' 175' ' ' LEU . 19.6 Cg_endo -60.75 -31.19 91.61 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.426 1.417 . . . . 63.119999999999997 111.856 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -72.15 -45.77 59.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.539 . . . . 50.009999999999998 111.266 -178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 182' ' ' GLU . 1.2 pp0? -67.77 -20.92 65.27 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.145 0.498 . . . . 51.149999999999999 110.542 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.416 ' HA ' ' NE2' ' A' ' 189' ' ' HIS . 5.6 m-20 -67.48 -46.94 71.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 71.349999999999994 109.873 171.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 56.2 m -62.35 -33.52 74.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 63.439999999999998 111.143 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 184' ' ' ALA . 94.6 t -54.45 -38.47 41.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 74.120000000000005 111.426 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.416 ' NE2' ' HA ' ' A' ' 186' ' ' ASN . 31.5 p80 -100.22 9.04 43.35 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.554 -0.459 . . . . 74.540000000000006 110.947 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.51 -34.17 18.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.302 -0.408 . . . . 64.019999999999996 109.946 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 38.7 m95 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.554 -0.748 . . . . 60.100000000000001 110.309 174.923 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.065 -0.346 . . . . 71.230000000000004 110.065 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.28 77.23 0.33 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.663 -0.698 . . . . 55.149999999999999 111.907 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.7 pm0 -91.72 140.91 25.19 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.002 -0.544 . . . . 64.120000000000005 109.961 173.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 15.7 Cg_exo -68.39 111.01 2.4 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.816 2.344 . . . . 72.0 112.246 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.21 153.0 42.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.175 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.29 115.37 27.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.049 0.452 . . . . 64.200000000000003 110.881 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.46 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 50.3 t -105.53 116.44 49.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.258 -0.645 . . . . 61.340000000000003 109.258 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.823 ' HB ' HG22 ' A' ' 92' ' ' VAL . 45.8 t -102.19 122.5 54.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.877 0.37 . . . . 61.119999999999997 110.81 -176.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.603 ' O ' ' HD2' ' A' ' 65' ' ' PRO . . . -103.63 122.1 7.31 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.537 -0.839 . . . . 75.519999999999996 111.698 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.18 116.69 19.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.948 0.404 . . . . 65.109999999999999 110.44 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 23' ' ' ASN . . . -129.94 145.67 16.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.168 -0.773 . . . . 72.540000000000006 111.168 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 22' ' ' HIS . 13.8 m-20 -124.58 73.75 61.93 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.915 0.357 . . . . 73.049999999999997 110.914 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.76 109.45 1.07 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.601 2.201 . . . . 65.129999999999995 112.471 176.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' A' ' 17' ' ' TYR . . . -146.9 172.28 27.42 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.399 -0.68 . . . . 64.409999999999997 111.399 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.48 -53.25 7.33 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.257 2.638 . . . . 72.310000000000002 112.304 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 m -112.03 -10.41 13.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.601 0.715 . . . . 43.210000000000001 109.67 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.727 ' HE1' ' HB3' ' A' ' 151' ' ' LEU . 93.0 m-85 -81.37 -17.12 50.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.389 -0.823 . . . . 73.540000000000006 111.458 -174.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.54 1.38 26.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.042 0.449 . . . . 70.400000000000006 110.711 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -118.58 18.23 13.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.663 -0.699 . . . . 65.349999999999994 109.955 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -103.44 -169.85 1.7 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.277 0.561 . . . . 62.119999999999997 111.137 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -86.81 -0.23 56.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.743 -0.662 . . . . 65.230000000000004 110.208 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 2.8 m170 -89.6 11.37 19.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 111.928 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 26.6 m-80 -109.87 20.1 18.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.806 -0.179 . . . . 54.130000000000003 111.124 -175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.607 ' H ' HD12 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -50.0 -48.91 52.24 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.487 0.492 . . . . 62.43 111.933 -173.501 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.05 -58.74 8.28 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.665 -0.698 . . . . 63.310000000000002 114.39 -171.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 23' ' ' ASN . 49.2 p90 -86.23 -22.6 26.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.336 0.568 . . . . 72.010000000000005 111.863 -174.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 23.1 mmt -71.25 -42.18 69.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.8 0.333 . . . . 73.310000000000002 111.121 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.3 t -80.04 -41.52 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.733 0.301 . . . . 72.140000000000001 111.026 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.58 -28.02 69.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.378 -0.374 . . . . 74.310000000000002 111.521 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 17.0 t70 -56.52 -50.17 72.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 60.229999999999997 111.312 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 m -75.97 -33.18 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.333 0.494 . . . . 75.230000000000004 112.333 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.4 pp -78.67 -35.9 44.53 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.512 -0.475 . . . . 72.510000000000005 111.095 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -71.3 -36.68 71.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 64.200000000000003 110.247 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.52 -30.43 74.47 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.847 -0.692 . . . . 72.430000000000007 112.845 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -83.96 -37.38 22.34 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.422 0.527 . . . . 74.409999999999997 112.422 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.2 tp -72.7 -15.22 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.256 0.55 . . . . 74.25 110.581 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.51 59.98 0.96 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.661 -0.975 . . . . 53.450000000000003 110.661 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.9 m -142.55 128.81 19.89 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.118 0.485 . . . . 51.409999999999997 111.349 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.14 150.72 26.85 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.808 -0.633 . . . . 43.200000000000003 109.971 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 30' ' ' ASP . 89.1 m-85 -89.44 139.56 30.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.703 0.287 . . . . 74.530000000000001 110.613 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 41' ' ' LYS . 11.6 mptt -110.57 135.82 50.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.274 -0.421 . . . . 65.519999999999996 110.004 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 56.2 t -100.19 106.39 19.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.923 -0.58 . . . . 53.210000000000001 110.407 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -116.95 77.1 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.26 -0.644 . . . . 75.200000000000003 109.26 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 96.6 mttt -55.56 105.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.334 -0.848 . . . . 73.400000000000006 112.638 -171.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 32.1 ttmt 168.29 -88.99 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 124.471 1.107 . . . . 73.519999999999996 108.694 174.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 m -106.05 -14.98 15.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.409 0.623 . . . . 72.439999999999998 109.985 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.85 43.01 1.6 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.29 -0.868 . . . . 52.32 112.193 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 42' ' ' VAL . . . -51.45 -45.44 62.7 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.708 0.262 . . . . 71.439999999999998 111.708 -171.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.696 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 40.2 mt-10 -130.09 116.44 18.52 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.755 -0.461 . . . . 74.239999999999995 109.755 171.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.55 135.64 46.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.084 0.468 . . . . 73.040000000000006 111.154 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 8.3 p -128.59 133.39 66.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.959 -0.564 . . . . 61.409999999999997 110.334 172.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.589 HG22 HG22 ' A' ' 61' ' ' VAL . 68.4 p -105.0 107.57 18.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.036 0.446 . . . . 53.310000000000002 110.361 174.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -128.11 158.48 21.53 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.074 -0.81 . . . . 31.120000000000001 111.074 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.1 ptt180 -120.66 104.98 10.35 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.42 0.628 . . . . 73.450000000000003 111.614 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.834 HD13 ' HA ' ' A' ' 174' ' ' GLU . 1.6 pp -104.22 146.72 28.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.524 -0.762 . . . . 72.319999999999993 109.241 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 71.05 -32.44 0.25 Allowed 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.608 0.567 . . . . 63.409999999999997 111.991 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 154.5 -40.89 0.63 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.166 -0.54 . . . . 60.329999999999998 112.191 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.7 m -89.4 137.17 32.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.831 0.348 . . . . 63.420000000000002 111.098 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 23.0 t -81.79 129.83 34.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.347 -0.388 . . . . 54.530000000000001 110.23 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.15 163.88 18.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.226 -0.443 . . . . 74.409999999999997 110.375 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 52' ' ' THR . 57.9 t -107.54 112.4 39.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.367 -0.379 . . . . 73.409999999999997 110.296 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.464 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . 5.6 mp -95.36 111.95 23.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.645 -0.502 . . . . 72.030000000000001 109.645 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.7 135.67 50.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.945 -0.57 . . . . 42.009999999999998 110.609 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.696 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -123.71 117.37 27.54 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.047 -0.524 . . . . 74.040000000000006 110.073 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 9' ' ' GLY . 29.0 Cg_endo -65.8 122.77 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.922 1.748 . . . . 73.310000000000002 110.795 171.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -95.67 9.2 41.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.029 0.919 . . . . 71.439999999999998 108.528 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.46 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . 43.2 m -100.84 179.82 4.28 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.093 -1.412 . . . . 64.120000000000005 109.006 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -74.13 162.02 29.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.441 -0.345 . . . . 70.310000000000002 110.47 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.444 ' HG3' ' OD1' ' A' ' 116' ' ' ASN . 26.8 ptt? -59.57 -24.8 64.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.357 -0.383 . . . . 74.420000000000002 111.298 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.53 -35.15 73.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.225 0.536 . . . . 72.040000000000006 110.56 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.46 ' OE1' ' HB3' ' A' ' 67' ' ' CYS . 29.2 mt-10 -98.07 -2.46 40.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.615 -0.72 . . . . 72.140000000000001 111.189 -173.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.7 t -60.12 -43.08 95.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.435 -0.348 . . . . 70.549999999999997 111.496 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' HA2' HG22 ' A' ' 121' ' ' VAL . . . -63.02 -20.69 62.81 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.947 -0.644 . . . . 74.519999999999996 112.846 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.502 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 3.1 mpt_? -86.29 -12.22 50.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.795 0.331 . . . . 73.519999999999996 110.837 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.812 HE21 ' HA ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -86.69 -47.32 9.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.245 -0.434 . . . . 71.310000000000002 110.936 -178.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.69 -42.69 97.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.792 -0.64 . . . . 72.219999999999999 111.942 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.73 -67.3 1.98 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.982 -0.554 . . . . 42.100000000000001 114.097 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.01 -36.98 79.94 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.604 2.203 . . . . 75.420000000000002 112.838 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.38 -43.73 98.13 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.272 -0.422 . . . . 72.319999999999993 110.471 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.31 75.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 43.109999999999999 111.309 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.83 -34.09 74.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 64.530000000000001 111.523 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -62.2 -41.85 98.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.827 0.346 . . . . 53.140000000000001 111.291 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -98.17 3.89 49.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.488 -0.324 . . . . 73.140000000000001 111.5 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t 58.34 39.47 25.41 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.017 -0.538 . . . . 53.350000000000001 110.82 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.478 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 18.3 m -108.69 134.64 20.23 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.101 -0.5 . . . . 53.329999999999998 110.579 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 13.0 Cg_exo -69.93 122.5 9.13 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.74 2.294 . . . . 44.43 111.939 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -78.49 18.32 0.97 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.965 2.443 . . . . 73.230000000000004 112.5 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -81.59 -61.89 1.8 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.314 0.578 . . . . 50.25 110.145 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -87.71 68.95 9.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.616 -0.72 . . . . 54.030000000000001 110.085 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 pt -115.2 150.56 17.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.904 -0.589 . . . . 60.210000000000001 110.958 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 m -112.6 127.99 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 62.439999999999998 110.387 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.823 HG22 ' HB ' ' A' ' 8' ' ' VAL . 47.4 t -124.53 121.49 61.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 110.377 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.474 ' CG2' ' HA2' ' A' ' 9' ' ' GLY . 7.2 tt -84.31 123.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.751 0.31 . . . . 64.230000000000004 110.207 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -153.76 150.08 28.13 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.892 0.377 . . . . 71.040000000000006 111.009 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.461 ' HB3' HD21 ' A' ' 24' ' ' LEU . 9.9 p-10 -84.68 141.29 30.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.72 -0.673 . . . . 70.030000000000001 110.592 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 112' ' ' GLU . 53.3 mm-40 -148.7 155.8 41.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.197 0.523 . . . . 75.409999999999997 111.63 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.29 2.12 37.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.232 -0.894 . . . . 65.219999999999999 111.881 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -49.35 -44.84 45.02 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.556 0.535 . . . . 64.430000000000007 111.355 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.81 HD12 ' HG2' ' A' ' 103' ' ' ARG . 7.6 pt -139.13 173.85 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 74.439999999999998 110.847 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.411 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 0.8 OUTLIER -75.78 163.22 27.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.182 -0.463 . . . . 54.149999999999999 111.08 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.669 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 4.3 t80 -70.79 126.64 30.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.054 -0.521 . . . . 75.329999999999998 110.521 -176.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 161' ' ' GLU . . . 145.72 -45.37 0.82 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.572 -0.611 . . . . 72.219999999999999 111.572 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.81 ' HG2' HD12 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -119.98 160.49 22.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.512 -0.551 . . . . 74.310000000000002 109.512 178.243 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 135' ' ' ILE . 39.8 pt -127.67 157.29 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.809 0.338 . . . . 74.120000000000005 111.189 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -130.71 125.1 33.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.048 -0.523 . . . . 75.409999999999997 110.591 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -101.24 111.51 23.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.424 -0.584 . . . . 71.329999999999998 109.424 175.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.678 ' HD3' ' HD2' ' A' ' 134' ' ' ARG . 16.0 ptmt -143.61 153.57 42.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.472 -0.786 . . . . 74.25 110.445 -169.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -100.24 114.06 27.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.595 0.712 . . . . 75.109999999999999 110.825 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.53 178.86 38.9 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.861 -0.895 . . . . 75.239999999999995 110.861 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.548 ' HA2' HD13 ' A' ' 118' ' ' LEU . . . -166.81 86.56 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.047 -1.073 . . . . 71.140000000000001 113.593 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.4 74.94 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.934 -0.65 . . . . 42.030000000000001 111.942 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.527 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 3.3 mp0 -143.53 -82.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.554 0.216 . . . . 74.400000000000006 111.027 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -104.73 -69.67 0.77 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.706 -0.759 . . . . 42.219999999999999 113.046 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.21 69.14 3.32 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.026 -0.607 . . . . 70.200000000000003 112.054 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -55.72 -48.04 75.85 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.746 0.276 . . . . 75.329999999999998 111.746 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.444 ' OD1' ' HG3' ' A' ' 69' ' ' MET . 24.8 t-20 -61.58 -45.01 95.94 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.729 0.27 . . . . 71.120000000000005 111.729 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.54 -23.73 72.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.733 -0.746 . . . . 44.539999999999999 112.405 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.548 HD13 ' HA2' ' A' ' 110' ' ' GLY . 46.1 mt -83.23 -45.87 13.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.211 0.529 . . . . 73.319999999999993 109.693 174.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -65.35 -44.77 86.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.207 -0.906 . . . . 63.439999999999998 111.821 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.5 t -52.41 -47.21 66.43 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.938 0.399 . . . . 75.299999999999997 111.098 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.668 ' HB ' HH22 ' A' ' 132' ' ' ARG . 36.5 t -78.18 -44.28 27.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.262 -0.426 . . . . 75.099999999999994 110.928 -177.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.58 98.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.293 -0.412 . . . . 74.129999999999995 111.539 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.5 t -73.61 -30.28 62.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.261 -0.427 . . . . 70.439999999999998 110.711 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.47 -42.27 68.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 74.329999999999998 110.519 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.2 mt -76.68 -21.36 55.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 74.219999999999999 110.258 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.72 13.52 82.27 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.902 -0.59 . . . . 64.430000000000007 112.043 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.8 t -165.0 169.53 16.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.858 -0.423 . . . . 73.340000000000003 109.858 -176.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -96.72 -106.51 0.16 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.733 -0.469 . . . . 75.340000000000003 109.733 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.6 t30 67.56 -10.33 0.38 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.119 0.785 . . . . 72.129999999999995 113.119 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -76.57 129.27 36.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.361 0.6 . . . . 75.340000000000003 111.464 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -98.96 87.0 3.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.881 -0.599 . . . . 61.409999999999997 109.734 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.668 HH22 ' HB ' ' A' ' 121' ' ' VAL . 93.5 mtt180 -90.48 156.06 18.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 71.310000000000002 111.389 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 106' ' ' LEU . 46.1 t -99.79 112.14 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.729 -0.668 . . . . 64.030000000000001 109.581 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.678 ' HD2' ' HD3' ' A' ' 107' ' ' LYS . 70.3 mtt85 -94.15 114.2 26.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.033 -0.531 . . . . 60.299999999999997 110.925 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.673 ' HA ' HG22 ' A' ' 104' ' ' ILE . 2.0 mp -83.26 118.22 30.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 108.708 -0.849 . . . . 65.5 108.708 173.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.669 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -66.87 118.65 10.75 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.626 -0.797 . . . . 74.239999999999995 111.627 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.577 ' HA ' ' HD2' ' A' ' 101' ' ' PHE . 35.0 m -109.9 1.13 9.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.145 0.497 . . . . 71.120000000000005 110.556 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 86.48 175.16 49.58 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.827 -0.701 . . . . 74.25 111.972 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.06 104.3 54.63 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.168 -0.308 . . . . 75.420000000000002 110.168 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 72.0 Cg_exo -50.05 114.61 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.068 2.512 . . . . 63.439999999999998 112.085 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 12.0 Cg_exo -70.34 127.96 14.85 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.869 2.379 . . . . 74.310000000000002 112.16 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 172.05 175.79 40.46 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.127 -0.789 . . . . 73.140000000000001 111.127 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -94.92 -6.69 42.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.441 0.639 . . . . 75.420000000000002 109.781 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -101.03 159.82 14.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.575 -0.739 . . . . 75.230000000000004 109.265 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.42 139.56 94.55 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.012 -0.366 . . . . 75.219999999999999 110.012 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.526 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 92.7 Cg_exo -47.65 -19.39 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.664 2.909 . . . . 64.109999999999999 113.722 177.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -47.19 -40.42 16.02 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.024 0.53 . . . . 55.439999999999998 112.029 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.64 -31.37 41.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.41 -0.359 . . . . 72.420000000000002 111.674 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.526 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 77.2 m-85 -84.07 -31.94 25.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.274 -0.421 . . . . 71.5 111.624 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.04 -4.81 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.049 0.452 . . . . 74.310000000000002 111.805 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.727 ' HB3' ' HE1' ' A' ' 17' ' ' TYR . 90.5 mt -86.91 -12.5 47.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.453 -0.34 . . . . 61.5 111.266 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -160.89 107.64 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.203 0.525 . . . . 75.329999999999998 110.068 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -131.81 148.96 52.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.077 -0.511 . . . . 74.319999999999993 110.378 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -146.47 35.88 0.97 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.402 0.62 . . . . 73.140000000000001 109.999 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.646 ' O ' ' HG2' ' A' ' 158' ' ' GLU . 84.8 m -86.23 115.25 23.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.701 -0.682 . . . . 62.229999999999997 110.418 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.96 -20.85 59.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 111.89 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.43 ' H ' HG22 ' A' ' 155' ' ' THR . . . -66.04 -30.24 70.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 44.420000000000002 111.813 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 155' ' ' THR . 15.2 pt-20 -71.4 -21.95 61.93 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.263 0.554 . . . . 65.409999999999997 110.446 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.512 ' HA ' HG23 ' A' ' 162' ' ' VAL . 16.3 mmm-85 -78.18 -25.19 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.653 -0.703 . . . . 63.409999999999997 110.655 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.36 80.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.691 . . . . 72.219999999999999 112.102 -174.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.639 ' HB2' ' HD1' ' A' ' 101' ' ' PHE . 6.0 mm-40 -105.38 7.78 33.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.072 0.397 . . . . 65.120000000000005 112.072 -175.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.522 ' N ' ' HD2' ' A' ' 163' ' ' PRO . 70.3 t -57.35 -52.38 74.66 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.669 -0.205 . . . . 73.120000000000005 111.084 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 13.7 Cg_endo -57.28 -33.62 96.4 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.108 1.872 . . . . 70.219999999999999 112.187 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.5 m -64.96 -43.42 92.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.937 -0.574 . . . . 75.319999999999993 110.61 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.3 -38.59 82.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.42 . . . . 74.209999999999994 110.763 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 162' ' ' VAL . 91.7 t -57.31 -54.04 35.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.553 -0.294 . . . . 73.340000000000003 111.205 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -61.19 -42.09 97.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.369 -0.378 . . . . 75.219999999999999 111.517 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' ' 191' ' ' TRP . 13.8 mm-40 -66.26 -49.52 66.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.482 -0.326 . . . . 74.230000000000004 111.314 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.0 96.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.448 -0.342 . . . . 74.219999999999999 111.593 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.5 -34.93 79.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.798 0.332 . . . . 62.009999999999998 111.553 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -80.63 -43.85 19.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.946 0.403 . . . . 75.239999999999995 110.794 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.27 -39.21 92.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 61.539999999999999 111.894 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.8 p -65.01 -38.86 92.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.744 0.307 . . . . 72.019999999999996 111.45 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.834 ' HA ' HD13 ' A' ' 55' ' ' LEU . 41.6 tt0 -73.55 -44.21 57.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.39 -0.368 . . . . 73.239999999999995 110.629 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 178' ' ' ALA . 44.5 tp -64.73 -27.93 69.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.492 -0.322 . . . . 53.210000000000001 111.023 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.0 tp -57.24 -45.63 83.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 73.450000000000003 110.766 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.58 -32.4 14.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.012 -0.54 . . . . 74.120000000000005 110.305 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 175' ' ' LEU . . . -61.52 -48.04 82.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.722 -0.672 . . . . 51.310000000000002 111.82 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -129.11 -67.72 0.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.077 -0.249 . . . . 74.239999999999995 111.381 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.64 -170.01 37.99 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.379 -0.915 . . . . 43.119999999999997 112.41 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.772 HD23 ' H ' ' A' ' 181' ' ' LEU . 1.8 pt? -81.82 -35.71 29.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.312 0.066 . . . . 73.510000000000005 110.98 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.587 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 4.9 mm-40 -54.46 -56.67 24.29 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 112.278 0.473 . . . . 61.200000000000003 112.278 -178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 50.1 Cg_exo -56.26 -34.48 93.75 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.807 1.671 . . . . 73.420000000000002 112.138 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.96 -55.01 9.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.996 -0.547 . . . . 71.299999999999997 111.453 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 181' ' ' LEU . 11.6 pt20 -69.38 -21.41 63.8 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 111.718 0.266 . . . . 51.310000000000002 111.718 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.51 -38.22 68.17 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.705 -0.398 . . . . 73.049999999999997 110.662 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 85.0 m -66.96 -44.27 80.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 55.310000000000002 111.489 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 185' ' ' GLN . 32.6 m -70.4 -16.82 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.43 . . . . 74.310000000000002 111.249 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -94.17 -13.5 26.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 61.32 110.034 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -93.27 -33.33 13.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 71.540000000000006 110.848 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.598 ' HB2' ' NE2' ' A' ' 168' ' ' GLN . 76.6 m95 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.526 -0.75 . . . . 73.310000000000002 109.552 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.006 -0.368 . . . . 72.340000000000003 110.006 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.46 80.11 0.24 Allowed 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.787 0.68 . . . . 72.25 110.54 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.24 145.78 41.04 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.609 -0.723 . . . . 75.120000000000005 109.746 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.531 ' HB3' HG23 ' A' ' 61' ' ' VAL . 51.4 Cg_exo -54.88 123.64 14.26 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.118 2.546 . . . . 75.120000000000005 112.927 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.863 HD12 ' HG2' ' A' ' 89' ' ' GLN . 2.1 mm? -84.44 133.02 34.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.45 -0.574 . . . . 62.25 109.45 177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.53 HD23 HD13 ' A' ' 90' ' ' ILE . 59.2 tp -93.6 117.53 30.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.015 0.436 . . . . 72.150000000000006 111.156 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.98 118.78 59.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.536 -0.756 . . . . 75.099999999999994 109.589 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.615 HG12 ' HB3' ' A' ' 63' ' ' ALA . 29.4 m -122.01 155.82 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.986 0.422 . . . . 52.229999999999997 111.022 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.97 163.95 30.27 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.797 -0.716 . . . . 61.539999999999999 111.983 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.718 HD21 ' HA ' ' A' ' 69' ' ' MET . 2.5 mt -68.92 106.4 2.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.914 0.388 . . . . 65.150000000000006 110.898 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.684 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -77.75 -141.57 1.61 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.823 -0.626 . . . . 63.140000000000001 112.253 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -97.78 99.71 7.19 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.067 0.46 . . . . 73.420000000000002 110.671 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.763 ' HB3' ' HA ' ' A' ' 68' ' ' TYR . 5.5 Cg_exo -78.77 -8.19 15.7 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.359 2.706 . . . . 51.420000000000002 112.887 -176.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.95 173.3 23.58 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.694 -0.765 . . . . 74.239999999999995 112.131 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.93 -54.8 2.4 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.032 2.488 . . . . 72.200000000000003 112.419 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 m -59.75 -35.62 74.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 73.140000000000001 111.601 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -74.89 -17.18 60.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.426 . . . . 71.239999999999995 111.296 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.42 -7.49 51.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.004 0.431 . . . . 43.100000000000001 110.861 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.41 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 3.8 mptp? -92.96 -10.22 37.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 63.399999999999999 110.263 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.75 HG22 ' H ' ' A' ' 153' ' ' ASN . 36.5 p -102.71 -169.38 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 63.340000000000003 110.741 -175.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.74 ' HG3' HD23 ' A' ' 24' ' ' LEU . 1.3 tpp180 -92.12 1.78 56.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.035 0.445 . . . . 75.239999999999995 110.123 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -76.8 11.36 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.26 0.467 . . . . 54.520000000000003 112.26 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -123.43 20.23 9.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.953 0.406 . . . . 55.350000000000001 110.144 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.753 HD13 HG12 ' A' ' 93' ' ' ILE . 1.1 pp -61.54 -24.26 66.51 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.982 -0.554 . . . . 74.319999999999993 111.968 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.606 ' N ' HD12 ' A' ' 24' ' ' LEU . . . -69.47 -47.96 47.3 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.995 -0.842 . . . . 73.549999999999997 110.995 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.684 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 88.8 t80 -61.05 -36.02 78.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.838 0.351 . . . . 61.130000000000003 110.217 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 61.8 mtt -61.34 -49.6 76.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 74.430000000000007 111.668 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.11 -47.67 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.056 0.391 . . . . 73.200000000000003 112.056 -174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.769 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -63.09 -38.87 92.91 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.405 0.521 . . . . 72.549999999999997 112.405 -171.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.65 -41.86 75.0 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.994 0.426 . . . . 75.430000000000007 111.125 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 22.9 m -79.65 -26.61 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.602 0.593 . . . . 73.409999999999997 112.602 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -67.66 -28.28 67.57 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.892 -0.323 . . . . 72.5 111.214 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 38' ' ' SER . . . -69.46 -41.96 75.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.143 0.496 . . . . 51.229999999999997 110.699 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.7 -18.13 71.83 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.003 -0.618 . . . . 63.420000000000002 112.86 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 8.2 mmt180 -61.17 -46.46 90.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.125 0.417 . . . . 73.239999999999995 112.125 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 36' ' ' ILE . 4.2 mp -73.23 -15.76 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.455 0.645 . . . . 73.530000000000001 110.407 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.99 12.92 26.53 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 110.765 -0.934 . . . . 43.039999999999999 110.765 -173.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 66.3 m -86.23 147.67 26.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.002 -0.599 . . . . 63.200000000000003 110.434 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.77 127.99 52.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.298 -0.41 . . . . 73.099999999999994 110.305 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -85.66 151.45 23.87 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.331 -0.618 . . . . 74.409999999999997 109.331 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -155.15 168.24 27.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.096 0.474 . . . . 73.349999999999994 110.914 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 5.1 p -84.16 117.77 30.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.71 -0.677 . . . . 75.530000000000001 109.766 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 5.8 t-80 -103.37 110.68 22.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.569 -0.9 . . . . 63.140000000000001 108.569 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -68.83 83.56 0.3 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 65.340000000000003 110.181 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.823 ' HE3' ' HB3' ' A' ' 82' ' ' PHE . 28.2 tptt -105.19 -95.13 0.34 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.909 -0.587 . . . . 74.010000000000005 109.513 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.534 ' HB3' ' CE2' ' A' ' 82' ' ' PHE . 9.6 p -108.16 -42.06 4.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 118.661 -1.216 . . . . 53.030000000000001 113.233 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.23 -25.62 0.46 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 118.544 -1.788 . . . . 42.399999999999999 117.025 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -139.76 -176.75 4.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 114.829 1.418 . . . . 72.5 114.829 -156.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 34.4 mt-10 -76.18 143.05 41.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.413 -1.267 . . . . 65.340000000000003 109.407 173.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 43' ' ' HIS . 93.8 t -142.8 133.19 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.993 -0.373 . . . . 74.409999999999997 109.993 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 62' ' ' LEU . 3.2 p -125.08 125.3 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.507 -0.553 . . . . 72.010000000000005 109.507 172.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -103.24 121.1 42.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.244 0.545 . . . . 62.509999999999998 110.035 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.01 157.58 23.47 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.215 -0.754 . . . . 70.219999999999999 111.215 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 7.0 ptt180 -109.98 103.42 12.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.511 0.672 . . . . 75.230000000000004 110.915 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.774 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 3.1 pp -113.06 151.81 30.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.091 -0.959 . . . . 61.439999999999998 109.153 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.28 -57.85 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.831 0.707 . . . . 73.430000000000007 110.993 -172.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.84 -38.67 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.146 -0.549 . . . . 60.420000000000002 112.273 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -93.45 140.66 29.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.76 0.314 . . . . 61.140000000000001 110.867 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 25.9 m -77.64 121.63 24.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.352 -0.385 . . . . 72.019999999999996 110.066 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.3 171.7 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.899 0.38 . . . . 44.25 111.408 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 4' ' ' PRO . 77.6 t -117.82 111.57 35.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 72.530000000000001 110.137 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.769 HD11 ' HB1' ' A' ' 29' ' ' ALA . 3.0 tm? -98.68 119.88 38.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.18 -0.674 . . . . 71.019999999999996 109.18 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.615 ' HB3' HG12 ' A' ' 8' ' ' VAL . . . -108.85 137.87 46.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.347 -0.388 . . . . 64.439999999999998 110.922 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 54.6 mtpt -114.0 92.61 26.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.998 -0.546 . . . . 75.319999999999993 110.957 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.4 138.79 51.91 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.863 2.376 . . . . 54.140000000000001 112.184 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -109.73 16.81 21.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.506 0.669 . . . . 64.200000000000003 109.351 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 59.7 m -114.8 179.99 3.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.333 -0.848 . . . . 74.299999999999997 111.231 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.763 ' HA ' ' HB3' ' A' ' 13' ' ' PRO . 97.7 m-85 -70.25 175.54 4.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.609 . . . . 71.040000000000006 112.031 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.718 ' HA ' HD21 ' A' ' 10' ' ' LEU . 27.3 ptt? -67.46 -31.06 70.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.752 -0.658 . . . . 62.140000000000001 112.344 -173.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -72.2 -30.76 65.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.44 0.638 . . . . 44.310000000000002 109.96 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 51.2 mm-40 -80.2 -22.27 42.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.528 -0.76 . . . . 71.319999999999993 111.355 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.0 p -56.3 -45.23 80.33 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.216 0.322 . . . . 72.030000000000001 111.467 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 121' ' ' VAL . . . -73.88 -28.15 65.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.665 -0.779 . . . . 74.299999999999997 112.257 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -78.73 -11.32 59.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.859 0.362 . . . . 73.340000000000003 110.612 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 31.0 mm-40 -65.5 -30.27 71.02 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.101 0.477 . . . . 63.25 110.021 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.5 t -67.47 -21.73 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.467 -0.788 . . . . 75.430000000000007 110.897 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.54 -72.28 0.55 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 116.018 -0.537 . . . . 55.240000000000002 112.879 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.95 -30.2 48.59 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.442 2.095 . . . . 54.32 112.037 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.493 HD12 HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -59.28 -40.36 85.87 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.748 -0.66 . . . . 62.240000000000002 110.689 -176.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.97 -30.89 70.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 64.010000000000005 112.108 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.26 -41.21 34.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 55.299999999999997 111.131 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.823 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 55.2 m-85 -71.63 -43.08 66.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.491 0.552 . . . . 74.040000000000006 112.491 -172.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.609 ' CE1' ' HG2' ' A' ' 45' ' ' LYS . 95.3 m-85 -97.68 -16.88 19.76 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.739 -0.384 . . . . 74.540000000000006 111.201 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 t 63.96 33.46 12.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.199 0.523 . . . . 75.510000000000005 110.382 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.511 HG21 HD22 ' A' ' 6' ' ' LEU . 25.7 m -69.0 149.7 97.77 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.472 -0.786 . . . . 75.430000000000007 111.362 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.84 117.01 4.28 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.745 2.296 . . . . 53.32 112.402 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.91 -1.87 10.11 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.032 2.488 . . . . 50.130000000000003 112.633 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -95.32 -25.47 16.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.127 -0.488 . . . . 55.43 110.342 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.863 ' HG2' HD12 ' A' ' 5' ' ' LEU . 7.5 tp60 -92.57 -11.05 35.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.635 . . . . 72.420000000000002 111.106 -174.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.53 HD13 HD23 ' A' ' 6' ' ' LEU . 5.3 tp -52.62 113.73 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.729 0.776 . . . . 70.510000000000005 111.776 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 9.3 p -116.76 138.79 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.301 -0.863 . . . . 63.100000000000001 110.147 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 7.7 p -132.6 134.06 59.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.151 -0.477 . . . . 74.299999999999997 110.67 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.753 HG12 HD13 ' A' ' 24' ' ' LEU . 7.7 tt -89.9 124.53 42.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.827 -0.624 . . . . 65.239999999999995 109.967 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -140.53 162.12 36.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.889 0.376 . . . . 71.040000000000006 110.767 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.53 153.01 23.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.719 -0.673 . . . . 74.310000000000002 110.252 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.937 ' HG3' ' HD2' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -140.84 121.35 14.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.938 0.399 . . . . 65.310000000000002 111.41 -178.506 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.803 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.8 pt? -84.91 -12.24 53.83 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.67 -0.696 . . . . 71.129999999999995 110.765 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.64 -39.17 93.0 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.151 0.501 . . . . 65.310000000000002 110.108 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.631 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.8 pt -104.81 154.11 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 74.439999999999998 110.052 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.597 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 6.9 p-10 -88.37 -170.09 2.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.102 0.477 . . . . 75.219999999999999 112.018 -171.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.792 ' HD2' ' HB3' ' A' ' 158' ' ' GLU . 68.1 m-85 -62.97 119.65 9.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.363 -0.835 . . . . 72.230000000000004 112.526 -168.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.69 -0.16 82.39 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.813 -0.708 . . . . 65.510000000000005 113.363 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.512 ' O ' HD12 ' A' ' 99' ' ' ILE . 33.0 mmt180 -88.94 96.09 10.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 117.069 0.434 . . . . 74.25 110.192 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.716 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -103.34 137.35 32.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.92 0.39 . . . . 62.130000000000003 110.666 -179.269 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 105' ' ' ARG . 52.0 mtt180 -145.61 125.74 13.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.997 -0.547 . . . . 74.329999999999998 110.062 176.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -100.21 130.22 46.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.342 -0.614 . . . . 75.409999999999997 109.342 172.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.535 ' HA ' HD13 ' A' ' 181' ' ' LEU . 1.5 tmtm? -155.41 154.2 31.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.266 0.555 . . . . 70.540000000000006 111.637 -171.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.474 HD23 HD11 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -83.95 92.95 7.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.343 0.592 . . . . 75.150000000000006 109.561 171.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.04 176.58 37.46 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.623 -0.717 . . . . 55.130000000000003 111.435 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.79 170.41 27.91 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.615 -0.802 . . . . 75.150000000000006 112.673 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.2 -169.19 34.68 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.447 -0.661 . . . . 51.049999999999997 111.447 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -134.26 -11.73 2.49 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.754 -0.379 . . . . 70.120000000000005 110.781 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -108.31 138.91 14.91 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.72 -0.752 . . . . 74.340000000000003 111.354 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.13 56.32 18.83 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.578 -0.82 . . . . 72.430000000000007 111.773 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -53.74 -38.93 64.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.06 0.393 . . . . 70.420000000000002 112.06 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -58.24 -53.72 55.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.724 0.297 . . . . 43.219999999999999 111.274 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.65 -28.81 73.95 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.007 -0.616 . . . . 35.009999999999998 112.831 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.1 mt -82.48 -46.12 13.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.654 0.264 . . . . 61.149999999999999 111.488 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -77.56 -21.48 52.45 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.879 -0.328 . . . . 63.329999999999998 110.879 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 t -63.27 -37.85 88.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.513 -0.551 . . . . 75.400000000000006 109.513 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 45.2 t -66.79 -31.01 51.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.801 -0.636 . . . . 63.0 110.202 176.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.6 -52.33 10.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.852 -0.613 . . . . 62.399999999999999 111.001 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 62.7 m -66.78 -22.75 66.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 64.409999999999997 111.772 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.32 -54.91 29.57 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 111.872 0.323 . . . . 44.130000000000003 111.872 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.73 ' H ' HD23 ' A' ' 125' ' ' LEU . 2.2 pt? -106.71 -17.73 14.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 75.340000000000003 111.369 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.54 40.24 2.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.242 -0.98 . . . . 64.200000000000003 112.936 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -110.26 171.82 7.23 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.505 -0.554 . . . . 73.230000000000004 109.505 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -114.22 38.88 2.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.488 0.185 . . . . 53.439999999999998 111.127 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 63.38 34.89 12.64 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.373 -0.376 . . . . 61.539999999999999 111.117 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -64.67 -13.11 52.7 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.132 -0.486 . . . . 42.130000000000003 112.303 -173.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 48.1 m80 -146.86 99.29 3.17 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.232 -0.293 . . . . 65.219999999999999 110.366 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 143.82 49.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.815 0.341 . . . . 75.140000000000001 110.822 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 34.3 t -116.94 120.59 65.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.812 -0.44 . . . . 72.310000000000002 109.812 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.937 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 44.0 mtm180 -107.32 117.58 34.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.676 0.274 . . . . 64.439999999999998 111.027 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.444 HD13 HG13 ' A' ' 93' ' ' ILE . 1.9 mp -103.51 115.11 44.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.762 -0.459 . . . . 74.519999999999996 109.762 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.631 ' HA2' HG13 ' A' ' 99' ' ' ILE . . . -62.13 113.63 5.98 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.872 -0.604 . . . . 40.450000000000003 112.879 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 p -101.66 -17.22 6.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.226 0.536 . . . . 71.230000000000004 109.648 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 88.49 -171.99 40.57 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.718 -0.753 . . . . 62.149999999999999 111.4 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -135.06 111.96 11.14 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 120.901 0.382 . . . . 73.430000000000007 110.197 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 146' ' ' PRO . 23.8 Cg_exo -63.67 114.99 2.79 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.108 2.539 . . . . 71.239999999999995 112.441 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 2.1 Cg_endo -85.16 139.32 7.08 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.319 2.679 . . . . 63.310000000000002 112.347 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -173.32 -151.91 8.44 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.43 -0.668 . . . . 53.130000000000003 111.43 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.13 -8.17 49.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.449 0.642 . . . . 74.420000000000002 109.688 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.421 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 71.6 mmtt -116.89 156.11 27.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.198 -0.91 . . . . 63.539999999999999 109.795 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.34 143.29 97.27 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.885 -0.598 . . . . 72.209999999999994 110.03 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.703 ' HB3' ' HD2' ' A' ' 140' ' ' PRO . 82.9 Cg_exo -47.0 -26.06 4.57 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.364 2.71 . . . . 62.310000000000002 113.016 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.05 -31.16 39.96 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.956 -0.565 . . . . 71.400000000000006 111.916 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.13 -50.9 6.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.488 -0.324 . . . . 74.540000000000006 111.422 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 153' ' ' ASN . 74.6 m-85 -64.99 -27.43 68.82 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.201 0.445 . . . . 74.299999999999997 112.201 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.2 p -69.36 -9.13 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.889 0.376 . . . . 71.450000000000003 111.558 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.37 -24.5 36.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.603 -0.271 . . . . 71.230000000000004 110.897 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.6 87.77 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.842 0.83 . . . . 74.129999999999995 109.647 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.75 ' H ' HG22 ' A' ' 20' ' ' THR . 3.7 t-20 -137.84 122.23 18.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.426 -0.806 . . . . 75.109999999999999 110.77 -174.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -134.35 133.83 41.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.639 -0.71 . . . . 74.430000000000007 109.407 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 157' ' ' ALA . 59.9 m -145.61 134.04 21.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.86 0.362 . . . . 70.510000000000005 110.471 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.04 -31.43 67.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.325 -0.398 . . . . 62.32 111.505 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.571 ' H ' HG22 ' A' ' 155' ' ' THR . . . -59.89 -40.73 89.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 71.549999999999997 111.9 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.792 ' HB3' ' HD2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -85.14 -17.75 36.29 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.035 -0.266 . . . . 74.340000000000003 111.361 -177.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 155' ' ' THR . 4.7 mmt180 -72.15 -24.62 61.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 72.329999999999998 110.927 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.68 -17.1 61.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 72.040000000000006 111.127 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.45 ' O ' HG13 ' A' ' 165' ' ' ILE . 25.0 mm-40 -92.66 -18.49 22.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 62.43 111.103 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.715 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 67.1 t -55.98 -56.99 24.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.594 0.59 . . . . 64.329999999999998 112.594 -174.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.715 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 32.2 Cg_exo -59.12 -30.12 92.34 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.135 1.89 . . . . 53.329999999999998 112.322 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.9 m -67.2 -46.3 74.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.949 -0.569 . . . . 52.340000000000003 110.555 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 161' ' ' GLU . 72.4 mt -70.02 -53.97 21.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.717 -0.674 . . . . 73.299999999999997 111.215 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.78 -57.94 9.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.383 0.512 . . . . 72.439999999999998 112.383 -172.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -62.88 -45.52 92.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.874 0.324 . . . . 61.539999999999999 111.874 -174.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -74.32 -32.02 62.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.798 0.295 . . . . 64.349999999999994 111.798 -173.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.29 -25.43 67.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.618 0.229 . . . . 65.120000000000005 111.618 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.23 74.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 73.310000000000002 111.289 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.4 -43.69 76.69 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.338 0.59 . . . . 61.530000000000001 110.766 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.7 -31.75 69.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.597 -0.729 . . . . 43.329999999999998 111.678 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.1 m -55.72 -43.09 76.19 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.776 0.322 . . . . 74.239999999999995 111.803 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.774 ' HG2' ' HB2' ' A' ' 55' ' ' LEU . 42.6 mt-10 -68.54 -28.65 67.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.754 0.311 . . . . 71.25 111.075 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.05 -25.77 65.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.352 -0.385 . . . . 75.430000000000007 111.051 -175.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.73 -37.81 88.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.188 0.518 . . . . 71.239999999999995 110.278 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -80.0 -39.9 20.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.678 -0.692 . . . . 72.209999999999994 110.091 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.49 -56.6 10.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.807 -0.633 . . . . 75.319999999999993 111.448 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -115.57 -77.09 0.57 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.079 -0.509 . . . . 75.340000000000003 110.208 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.32 -171.39 40.02 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.107 -0.797 . . . . 74.540000000000006 111.107 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.535 HD13 ' HA ' ' A' ' 107' ' ' LYS . 4.3 pp -91.13 -18.49 24.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.035 0.418 . . . . 73.219999999999999 110.32 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 33.5 mm-40 -58.63 -51.79 79.3 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.747 -0.66 . . . . 65.549999999999997 111.829 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 37.8 Cg_endo -69.01 -29.81 26.8 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.351 1.367 . . . . 61.520000000000003 112.027 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.15 -43.81 66.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 60.109999999999999 111.809 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 11.3 pt20 -58.8 -24.0 61.22 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.779 0.323 . . . . 53.200000000000003 111.303 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -77.65 -57.12 3.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.34 -0.391 . . . . 75.409999999999997 111.298 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -66.95 -31.01 71.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.383 -0.371 . . . . 73.230000000000004 111.876 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 8.1 p -71.42 -29.36 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.055 0.391 . . . . 75.430000000000007 112.055 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -94.03 0.06 55.74 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.46 -0.496 . . . . 55.240000000000002 110.636 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.49 -0.96 54.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 112.018 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 74.3 m95 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.697 -0.668 . . . . 74.349999999999994 110.64 -178.256 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.102 -0.333 . . . . 72.319999999999993 110.102 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.54 178.92 4.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.007 -0.368 . . . . 50.140000000000001 110.007 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 38.2 mt-10 -92.77 142.84 26.11 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.609 -0.269 . . . . 74.400000000000006 110.363 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 59' ' ' SER . 22.6 Cg_exo -64.71 106.4 0.74 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.598 2.199 . . . . 73.450000000000003 111.596 176.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.418 ' HG ' HG12 ' A' ' 60' ' ' VAL . 4.0 pp -89.94 153.77 20.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.304 -0.407 . . . . 55.409999999999997 111.021 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' HB3' HG12 ' A' ' 90' ' ' ILE . 62.9 tp -97.46 124.74 41.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.848 -0.615 . . . . 65.209999999999994 110.5 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.1 t -105.27 119.12 53.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.13 -0.486 . . . . 61.509999999999998 109.77 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.72 117.08 46.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.02 0.438 . . . . 74.329999999999998 110.801 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -127.9 128.72 6.13 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.371 -0.692 . . . . 64.209999999999994 111.371 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -72.56 118.94 16.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.759 -0.46 . . . . 73.450000000000003 109.759 -178.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.94 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -77.12 -158.4 9.21 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.206 -0.452 . . . . 73.549999999999997 113.069 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.47 91.36 9.95 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.619 0.723 . . . . 65.209999999999994 111.002 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 11' ' ' GLY . 2.0 Cg_endo -82.92 -8.95 10.96 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.215 2.61 . . . . 72.239999999999995 112.932 -176.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.19 160.92 29.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.826 -0.702 . . . . 70.430000000000007 112.229 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.42 -30.59 52.95 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.109 2.539 . . . . 75.140000000000001 112.482 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 p -73.24 -43.61 60.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.987 0.422 . . . . 53.420000000000002 111.2 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -59.89 -40.15 87.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.773 -0.648 . . . . 73.129999999999995 111.51 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.23 -3.71 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 65.510000000000005 111.771 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -111.45 8.29 21.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.352 -0.386 . . . . 72.310000000000002 110.424 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 153' ' ' ASN . 71.4 p -113.65 159.75 19.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 61.409999999999997 111.038 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -78.46 -20.16 51.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 62.340000000000003 111.672 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -76.73 -19.7 57.36 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.785 -0.366 . . . . 72.319999999999993 111.476 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 27' ' ' MET . 7.0 m120 -85.08 33.27 0.54 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.227 0.537 . . . . 73.310000000000002 111.042 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 1.3 pp -66.07 -17.26 64.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.552 -0.749 . . . . 74.239999999999995 111.521 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.424 ' N ' HD12 ' A' ' 24' ' ' LEU . . . -59.12 -34.24 78.55 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.195 -0.526 . . . . 61.43 111.962 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.94 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 54.6 t80 -90.11 -53.89 4.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.459 . . . . 75.219999999999999 109.841 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 85.7 mmm -56.89 -38.11 72.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.905 -1.043 . . . . 71.129999999999995 112.554 -169.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 166' ' ' VAL . 62.1 t -88.84 -41.9 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.798 0.332 . . . . 70.140000000000001 111.739 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.49 -22.42 47.49 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.189 0.44 . . . . 62.049999999999997 112.189 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -72.2 -39.28 68.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.732 0.301 . . . . 73.120000000000005 111.468 -175.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.41 -36.64 75.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 72.010000000000005 111.868 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.99 -27.08 62.52 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.771 0.319 . . . . 75.120000000000005 110.971 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.43 68.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.112 0.482 . . . . 54.030000000000001 110.309 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.16 -29.34 56.78 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.474 -0.869 . . . . 74.319999999999993 112.244 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -79.89 -21.87 43.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.342 0.497 . . . . 71.430000000000007 112.342 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.2 tp -78.15 -14.69 13.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.315 0.578 . . . . 71.450000000000003 110.335 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.31 41.03 2.87 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.121 -0.792 . . . . 54.530000000000001 111.121 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 62.8 m -135.3 150.08 49.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.229 -0.486 . . . . 65.549999999999997 110.684 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.97 136.24 52.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.687 0.279 . . . . 55.140000000000001 110.731 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.464 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 26.9 p90 -91.93 146.82 23.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.614 -0.513 . . . . 73.120000000000005 109.614 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 18.9 ptmt -155.39 166.87 32.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 74.010000000000005 111.155 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.22 128.31 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.469 -0.787 . . . . 72.400000000000006 111.314 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -101.9 106.13 17.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.234 -1.025 . . . . 64.209999999999994 108.234 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -57.91 154.26 12.64 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.502 0.556 . . . . 74.340000000000003 112.502 -166.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt 76.66 -47.55 0.54 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.387 1.075 . . . . 74.510000000000005 110.086 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 p -95.09 25.08 4.42 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.141 -0.936 . . . . 72.219999999999999 108.737 171.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.37 41.39 0.01 OUTLIER Glycine 0 CA--C 1.533 1.166 0 N-CA-C 119.238 2.455 . . . . 71.120000000000005 119.238 -159.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.02 140.1 29.84 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.847 -1.168 . . . . 74.140000000000001 107.847 163.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.51 120.12 19.63 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.723 -0.391 . . . . 71.230000000000004 110.553 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 63' ' ' ALA . 33.2 m -126.05 145.18 33.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.78 -0.646 . . . . 64.109999999999999 111.272 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 4.8 p -125.41 117.05 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.834 -0.621 . . . . 62.039999999999999 110.228 172.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.5 p -91.08 116.27 28.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.191 -0.459 . . . . 54.329999999999998 110.546 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.35 175.25 28.64 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.935 -0.65 . . . . 73.219999999999999 111.604 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 25.6 ptt85 -126.77 115.75 19.85 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.093 0.473 . . . . 74.219999999999999 110.922 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.9 mt -103.09 124.72 49.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.764 -0.653 . . . . 63.420000000000002 109.705 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 72.28 -53.01 0.7 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.823 0.702 . . . . 74.409999999999997 111.373 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.24 -52.13 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.115 -0.564 . . . . 71.329999999999998 111.986 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.696 ' HB ' HG22 ' A' ' 177' ' ' ILE . 17.8 m -72.62 138.67 46.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.857 0.36 . . . . 75.530000000000001 110.889 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.619 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 10.8 t -85.75 139.79 31.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.553 -0.536 . . . . 71.530000000000001 109.553 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.418 HG12 ' HG ' ' A' ' 5' ' ' LEU . 31.6 m -130.07 155.01 41.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.341 -0.391 . . . . 62.350000000000001 110.72 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.4 t -111.25 106.83 21.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.845 -0.616 . . . . 54.340000000000003 109.638 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 3.4 tm? -91.78 115.78 28.34 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.299 -0.63 . . . . 75.049999999999997 109.299 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 50' ' ' VAL . . . -119.27 142.24 48.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.239 -0.437 . . . . 44.450000000000003 111.385 -175.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HE2' ' CD2' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -139.14 127.25 13.52 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 75.430000000000007 110.387 175.445 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 13.0 Cg_exo -70.75 153.34 64.44 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.992 2.462 . . . . 73.420000000000002 112.023 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -93.96 -19.24 21.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.462 0.649 . . . . 74.310000000000002 110.0 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 60.4 m -101.94 159.26 15.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.217 -0.901 . . . . 45.340000000000003 109.463 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -78.05 -169.38 1.56 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.876 0.369 . . . . 65.219999999999999 111.522 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.831 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 18.9 ptp -52.75 -22.06 4.82 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.625 0.972 . . . . 70.150000000000006 113.625 -170.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -62.82 -49.62 74.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.791 0.329 . . . . 63.520000000000003 110.809 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.88 -0.11 21.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.011 0.375 . . . . 64.409999999999997 112.011 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 p -60.64 -42.77 97.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.927 0.394 . . . . 72.329999999999998 111.04 -176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.39 -21.17 78.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.945 -0.645 . . . . 71.030000000000001 112.769 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -80.63 -33.38 35.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.57 0.224 . . . . 71.129999999999995 111.391 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -74.9 -14.9 60.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.704 0.288 . . . . 75.319999999999993 111.617 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.21 -25.21 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.172 0.51 . . . . 65.519999999999996 110.304 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.69 -68.55 1.62 Allowed Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.881 -0.6 . . . . 63.32 112.865 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.82 -37.71 95.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.853 2.369 . . . . 64.329999999999998 112.462 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -55.87 -52.04 65.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 72.340000000000003 110.484 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.98 -44.75 83.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 65.400000000000006 112.012 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -72.77 -37.85 67.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.926 0.343 . . . . 72.099999999999994 111.926 -174.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -60.28 -47.49 85.76 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.75 0.309 . . . . 74.409999999999997 111.314 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -84.39 -15.14 47.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.934 -0.307 . . . . 74.329999999999998 110.791 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.2 m 59.78 47.61 10.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.863 -0.608 . . . . 71.430000000000007 110.693 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.441 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 29.4 m -94.42 148.8 35.61 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.642 -0.708 . . . . 73.510000000000005 110.321 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 11.2 Cg_exo -71.19 115.33 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.807 2.338 . . . . 70.400000000000006 111.969 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.523 ' HA ' HG13 ' A' ' 90' ' ' ILE . 28.8 Cg_exo -62.78 -19.53 68.73 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.006 2.471 . . . . 72.150000000000006 112.124 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -66.98 -21.7 65.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.86 -0.609 . . . . 74.319999999999993 110.684 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 89' ' ' GLN . 15.6 mm-40 -98.01 5.63 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.384 . . . . 73.430000000000007 111.413 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 87' ' ' PRO . 59.5 mt -69.22 130.92 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.109 0.48 . . . . 72.140000000000001 111.165 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 7.0 p -120.0 132.67 69.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 62.5 109.325 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.68 129.71 75.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.543 0.687 . . . . 74.319999999999993 111.649 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.13 113.1 29.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.167 -0.924 . . . . 73.439999999999998 109.174 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.455 ' HE1' ' H ' ' A' ' 114' ' ' GLY . 30.1 t-80 -135.26 154.28 51.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.277 0.561 . . . . 73.140000000000001 111.905 -174.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.87 129.53 34.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.628 -1.169 . . . . 73.549999999999997 110.899 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -129.47 138.45 51.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.016 0.436 . . . . 52.450000000000003 110.659 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.55 -0.03 44.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.88 -0.6 . . . . 50.439999999999998 110.919 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -58.67 -45.7 88.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.313 -0.858 . . . . 73.239999999999995 112.431 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.567 HD13 ' HG3' ' A' ' 105' ' ' ARG . 2.9 pt -122.22 174.92 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.307 0.575 . . . . 75.120000000000005 112.507 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.97 171.43 14.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.826 -1.079 . . . . 71.019999999999996 111.615 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -63.89 132.69 51.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.203 -0.908 . . . . 73.299999999999997 110.671 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.06 10.67 66.05 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.604 -0.808 . . . . 71.400000000000006 113.217 173.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.3 mmt-85 -123.0 153.56 39.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.103 0.452 . . . . 72.040000000000006 110.345 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.646 HD11 HG21 ' A' ' 188' ' ' VAL . 44.2 pt -138.81 149.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 74.420000000000002 110.874 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.567 ' HG3' HD13 ' A' ' 99' ' ' ILE . 99.0 mtt180 -127.15 128.06 45.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.936 -0.575 . . . . 74.319999999999993 109.903 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 185' ' ' GLN . 8.1 mp -109.75 110.19 21.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 61.329999999999998 110.953 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -157.68 148.4 21.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.053 -0.721 . . . . 74.219999999999999 109.053 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.72 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.3 pt? -73.66 125.12 27.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.776 -0.453 . . . . 72.25 109.776 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.76 -177.14 41.06 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.848 -0.692 . . . . 53.229999999999997 112.022 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.37 -164.73 39.28 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.962 -0.637 . . . . 51.439999999999998 112.628 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.35 152.36 22.07 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.381 -0.688 . . . . 55.229999999999997 111.381 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -113.32 7.53 17.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.776 0.288 . . . . 75.209999999999994 110.995 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -68.61 -86.77 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.701 -0.762 . . . . 62.329999999999998 111.855 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.455 ' H ' ' HE1' ' A' ' 94' ' ' HIS . . . -74.4 73.93 1.32 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.916 -0.659 . . . . 74.25 111.66 175.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.624 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -48.97 -66.43 0.4 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.488 0.715 . . . . 75.230000000000004 112.69 -174.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.564 ' HB2' ' SD ' ' A' ' 69' ' ' MET . 13.0 m120 -55.04 -43.63 73.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 62.039999999999999 111.527 -174.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.831 ' HA2' ' HB2' ' A' ' 69' ' ' MET . . . -62.9 -48.75 78.26 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.851 -0.613 . . . . 32.350000000000001 113.271 -176.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.74 -29.01 68.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.436 0.16 . . . . 74.310000000000002 111.291 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 115' ' ' HIS . 10.2 mmm180 -65.96 -42.27 90.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.657 0.265 . . . . 71.319999999999993 110.642 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -64.86 -47.79 76.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.387 -0.37 . . . . 62.030000000000001 110.549 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.28 -47.47 92.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 70.409999999999997 110.903 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.74 -31.28 72.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.891 -0.595 . . . . 54.130000000000003 111.844 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.2 t -80.34 -33.69 37.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.708 0.29 . . . . 55.520000000000003 110.918 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.21 -45.9 53.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 62.450000000000003 111.025 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.89 -38.53 45.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.479 . . . . 54.020000000000003 110.943 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.97 -12.52 63.78 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 121.116 -0.564 . . . . 53.240000000000002 113.168 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.504 ' C ' ' HD2' ' A' ' 128' ' ' LYS . 14.6 t -141.9 173.73 11.24 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.129 -0.323 . . . . 74.409999999999997 110.129 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.504 ' HD2' ' C ' ' A' ' 127' ' ' THR . 13.2 mptt -125.22 -115.25 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.436 -0.347 . . . . 72.299999999999997 110.224 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 61.93 21.77 12.55 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.94 0.496 . . . . 72.019999999999996 111.613 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -90.25 160.97 15.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.19 -0.459 . . . . 71.319999999999993 110.275 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 33.2 m80 -87.18 99.89 12.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.122 -0.696 . . . . 74.109999999999999 109.122 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.462 ' NH1' ' HG2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -111.75 136.31 51.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.975 0.416 . . . . 73.319999999999993 111.108 -174.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.03 127.11 59.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.016 -0.538 . . . . 74.340000000000003 109.782 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.462 ' HG2' ' NH1' ' A' ' 132' ' ' ARG . 5.2 mtm180 -93.36 96.83 10.19 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.685 -0.487 . . . . 71.409999999999997 109.685 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.526 ' HA ' HG22 ' A' ' 104' ' ' ILE . 51.4 mt -90.19 127.75 42.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.422 -0.354 . . . . 71.019999999999996 110.48 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.51 ' CA ' HG13 ' A' ' 99' ' ' ILE . . . -72.52 97.82 0.81 Allowed Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.987 -0.552 . . . . 75.519999999999996 112.545 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.8 p -88.65 -10.29 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.464 -0.569 . . . . 70.439999999999998 109.464 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.23 152.98 28.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.56 -0.745 . . . . 42.039999999999999 112.279 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 21.1 ptp180 -107.46 119.85 49.39 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.067 0.46 . . . . 72.019999999999996 110.235 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 32.5 Cg_exo -59.58 125.28 17.44 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.954 2.436 . . . . 54.049999999999997 112.746 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 1.9 Cg_endo -83.79 137.71 7.82 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.45 2.767 . . . . 73.409999999999997 112.374 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.09 -168.01 24.97 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.181 -0.767 . . . . 74.420000000000002 111.181 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -87.81 -24.38 23.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.631 -0.507 . . . . 72.150000000000006 109.631 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.446 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 42.4 mmtm -75.58 101.19 4.83 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.535 -0.913 . . . . 71.549999999999997 108.535 168.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.721 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 6.8 p-10 -73.1 168.49 24.43 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.916 -0.584 . . . . 73.329999999999998 110.41 -174.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.721 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 5.2 Cg_exo -35.99 -44.87 0.86 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.402 3.401 . . . . 64.109999999999999 114.274 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.42 68.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.236 0.458 . . . . 44.43 112.236 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.52 -43.77 11.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.847 0.356 . . . . 71.319999999999993 111.372 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 144' ' ' LYS . 2.6 m-85 -84.02 -19.43 34.49 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.869 0.692 . . . . 73.409999999999997 112.869 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.481 HG13 HD12 ' A' ' 151' ' ' LEU . 7.0 p -63.1 -25.56 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 112.201 0.445 . . . . 62.240000000000002 112.201 -173.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.481 HD12 HG13 ' A' ' 150' ' ' VAL . 6.0 mp -85.96 -10.24 55.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.659 0.266 . . . . 71.340000000000003 111.421 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.0 87.07 1.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.792 0.806 . . . . 74.209999999999994 109.438 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.559 ' H ' HG22 ' A' ' 20' ' ' THR . 23.8 t-20 -128.94 122.36 30.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.471 -0.786 . . . . 64.140000000000001 111.613 -170.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -155.31 134.86 12.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.386 -0.825 . . . . 74.209999999999994 109.199 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 157' ' ' ALA . 47.2 m -152.86 138.97 18.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.672 0.272 . . . . 72.230000000000004 110.605 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.91 -33.0 48.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 61.100000000000001 111.337 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.637 ' H ' HG22 ' A' ' 155' ' ' THR . . . -65.96 -49.24 68.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.903 -0.589 . . . . 64.109999999999999 111.568 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 155' ' ' THR . 3.0 pp20? -72.64 -22.04 61.0 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 120.849 -0.34 . . . . 74.040000000000006 111.252 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 155' ' ' THR . 16.4 mmt180 -56.59 -39.89 74.33 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.195 0.522 . . . . 65.019999999999996 110.34 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.45 -31.97 71.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.69 -0.686 . . . . 54.210000000000001 111.189 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.93 1.13 57.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.148 -0.478 . . . . 61.130000000000003 111.887 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.468 ' HB ' ' CD ' ' A' ' 163' ' ' PRO . 92.5 t -57.33 -57.87 21.96 Favored Pre-proline 0 C--O 1.233 0.229 0 C-N-CA 121.086 -0.245 . . . . 63.43 110.496 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' A' ' 162' ' ' VAL . 18.8 Cg_endo -61.07 -36.75 80.39 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.668 1.579 . . . . 72.109999999999999 111.476 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -56.18 -53.37 57.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.594 -0.73 . . . . 71.140000000000001 111.421 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.4 mt -64.3 -49.75 79.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.289 -0.414 . . . . 71.409999999999997 111.008 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 28' ' ' VAL . 97.6 t -57.22 -51.59 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.409 -0.359 . . . . 75.239999999999995 111.552 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.48 -49.87 73.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.503 -0.317 . . . . 75.430000000000007 111.754 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.547 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . 10.3 mm-40 -67.71 -36.78 81.25 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.027 -0.269 . . . . 65.140000000000001 111.498 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.24 75.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.61 0.243 . . . . 62.439999999999998 110.61 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.69 64.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.001 0.429 . . . . 61.219999999999999 111.301 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.42 -45.7 17.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.295 -0.411 . . . . 70.409999999999997 110.709 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.35 -33.96 70.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.068 -0.514 . . . . 73.340000000000003 111.979 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 176' ' ' LEU . 3.4 p -61.71 -27.4 68.68 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.865 0.32 . . . . 75.329999999999998 111.865 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -63.38 -44.76 93.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.701 0.286 . . . . 52.210000000000001 110.355 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 38.3 tp -74.65 -28.91 61.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 74.439999999999998 110.261 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.831 HD22 ' HA ' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -54.54 -49.02 71.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.366 -0.834 . . . . 70.409999999999997 109.306 174.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.696 HG22 ' HB ' ' A' ' 58' ' ' THR . 65.5 mt -79.7 -25.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.114 -0.948 . . . . 74.109999999999999 111.079 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.4 -43.68 72.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.008 -0.542 . . . . 73.109999999999999 112.158 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.22 -65.04 0.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.861 -0.336 . . . . 71.120000000000005 111.092 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -161.89 173.41 38.23 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.283 -0.96 . . . . 62.240000000000002 112.439 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.831 ' HA ' HD22 ' A' ' 176' ' ' LEU . 2.4 pt? -83.2 -30.6 27.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.723 0.297 . . . . 72.439999999999998 111.557 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 39.4 mt-10 -67.72 -49.31 39.64 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.098 0.407 . . . . 43.549999999999997 112.098 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 52.7 Cg_exo -55.76 -28.79 68.63 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.062 1.841 . . . . 73.209999999999994 112.228 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.69 -50.26 18.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 61.219999999999999 110.995 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.596 ' HG3' ' O ' ' A' ' 182' ' ' GLU . 1.4 pp0? -64.23 -32.9 74.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.766 0.317 . . . . 74.340000000000003 110.197 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -61.77 -23.08 65.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.905 -0.589 . . . . 74.310000000000002 111.099 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 26.4 m -87.15 -41.01 14.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.765 0.317 . . . . 55.240000000000002 111.605 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 104' ' ' ILE . 17.8 m -96.41 -12.77 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 114.35 1.241 . . . . 74.239999999999995 114.35 -171.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -69.45 -28.59 66.24 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.913 0.708 . . . . 71.230000000000004 112.913 -171.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -133.66 -10.73 2.75 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.122 0.416 . . . . 63.399999999999999 112.122 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 19.4 m0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 119.012 -0.518 . . . . 62.329999999999998 110.234 -176.835 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 109.976 -0.379 . . . . 74.150000000000006 109.976 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -106.02 102.98 12.37 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.212 -0.292 . . . . 71.019999999999996 110.212 173.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 0.4 OUTLIER -106.4 97.57 16.89 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.343 0.592 . . . . 73.310000000000002 109.819 176.007 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HG2' HG12 ' A' ' 85' ' ' VAL . 6.7 Cg_endo -89.41 110.82 0.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.093 2.529 . . . . 75.530000000000001 113.191 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.634 HD12 HG23 ' A' ' 177' ' ' ILE . 91.7 mt -76.52 128.93 35.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 72.439999999999998 110.281 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.573 ' HA ' HG23 ' A' ' 61' ' ' VAL . 22.9 tp -96.72 114.55 26.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.041 0.448 . . . . 71.439999999999998 110.781 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.806 ' HB ' HD13 ' A' ' 62' ' ' LEU . 21.2 t -105.21 111.56 35.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.728 -0.669 . . . . 70.120000000000005 109.83 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.574 HG21 HG22 ' A' ' 76' ' ' VAL . 49.5 t -104.48 117.47 50.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.077 -0.511 . . . . 72.409999999999997 110.147 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.494 ' HA2' HG13 ' A' ' 93' ' ' ILE . . . -106.2 -142.91 11.15 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.448 -0.882 . . . . 73.209999999999994 112.622 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.553 ' H ' ' HA3' ' A' ' 25' ' ' GLY . 2.2 tt -117.47 122.57 44.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.448 -0.945 . . . . 73.430000000000007 108.448 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -76.31 169.9 54.86 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.945 -0.645 . . . . 73.230000000000004 113.424 -172.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.507 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 44.9 t-20 -109.28 109.26 60.46 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.234 -0.654 . . . . 75.299999999999997 109.234 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 6.3 Cg_exo -74.25 -61.8 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.231 2.62 . . . . 73.530000000000001 113.62 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.72 -168.09 11.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.202 -0.999 . . . . 75.450000000000003 113.362 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.02 -56.68 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.392 2.728 . . . . 61.020000000000003 113.378 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 m -61.78 -30.78 71.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.993 0.425 . . . . 72.519999999999996 111.518 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -83.59 -8.0 59.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.213 -0.448 . . . . 51.229999999999997 111.04 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HA ' HD21 ' A' ' 12' ' ' ASN . . . -81.28 -16.6 52.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 51.549999999999997 111.411 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.855 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 9.7 mmpt? -111.34 8.13 21.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.428 -0.351 . . . . 73.230000000000004 111.374 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.413 HG21 ' HA ' ' A' ' 152' ' ' GLU . 38.6 p -110.47 163.21 13.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.523 0.677 . . . . 73.310000000000002 112.173 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.899 HH21 ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -54.8 -33.47 61.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.428 -1.26 . . . . 75.219999999999999 113.465 -174.379 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -86.14 9.93 15.98 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.099 0.777 . . . . 73.450000000000003 113.099 -165.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.73 13.46 19.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.31 0.576 . . . . 65.209999999999994 110.556 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.899 ' HG ' HH21 ' A' ' 21' ' ' ARG . 0.0 OUTLIER -50.28 -31.35 14.0 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.182 0.808 . . . . 65.439999999999998 113.182 -173.443 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA3' ' H ' ' A' ' 10' ' ' LEU . . . -62.47 -42.64 99.69 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.823 -0.704 . . . . 65.129999999999995 112.536 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.481 ' CE2' ' HE3' ' A' ' 64' ' ' LYS . 56.3 t80 -67.13 -40.42 86.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.137 0.494 . . . . 73.349999999999994 110.439 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.497 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 4.8 mmt -65.36 -45.86 82.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.732 . . . . 74.209999999999994 111.381 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.752 HG12 HD23 ' A' ' 32' ' ' LEU . 57.9 t -68.15 -32.47 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.48 -0.327 . . . . 55.119999999999997 111.285 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.1 70.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.048 0.388 . . . . 53.509999999999998 112.048 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.27 -38.61 68.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.602 -0.272 . . . . 73.329999999999998 111.509 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.548 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 30.3 m -74.94 -33.38 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.091 0.404 . . . . 55.509999999999998 112.091 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.752 HD23 HG12 ' A' ' 28' ' ' VAL . 4.3 pp -70.93 -38.59 72.91 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 120.63 -0.428 . . . . 63.450000000000003 110.34 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -75.11 -36.89 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.231 0.539 . . . . 41.119999999999997 110.061 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.83 -18.28 45.87 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.497 -0.774 . . . . 51.310000000000002 113.067 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 15.3 mmt85 -68.67 -36.45 78.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.39 . . . . 73.120000000000005 111.17 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 36' ' ' ILE . 3.1 mp -88.17 -15.07 9.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.713 0.768 . . . . 74.319999999999993 109.703 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.35 24.9 9.8 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.616 -0.993 . . . . 71.129999999999995 110.616 -175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 70.5 m -99.24 123.23 43.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.845 -0.677 . . . . 62.450000000000003 111.021 -176.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.48 134.63 14.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.471 -0.331 . . . . 74.140000000000001 110.707 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 3.0 t80 -142.85 177.99 7.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.591 -0.522 . . . . 73.329999999999998 109.591 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 20.8 ptmt -123.39 174.14 7.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.702 -0.226 . . . . 74.219999999999999 110.446 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 6.3 p -49.8 128.29 6.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.262 0.553 . . . . 53.109999999999999 110.602 174.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -106.86 109.92 21.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.964 -0.562 . . . . 75.349999999999994 110.513 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -53.16 154.44 3.12 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.652 0.595 . . . . 54.25 111.993 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 45' ' ' LYS . 12.0 tptp 80.26 -41.73 0.21 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.362 1.065 . . . . 73.0 109.625 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.9 p -104.93 26.58 9.06 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.366 -1.288 . . . . 41.039999999999999 108.109 171.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.45 41.44 0.01 OUTLIER Glycine 0 N--CA 1.477 1.424 0 N-CA-C 119.72 2.648 . . . . 73.219999999999999 119.72 -154.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.02 168.63 9.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.14 -1.43 . . . . 64.120000000000005 107.14 160.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.815 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 46.0 mt-10 -77.64 124.18 27.6 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.065 -0.654 . . . . 73.25 109.737 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -133.54 138.85 50.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.928 -0.578 . . . . 55.329999999999998 109.995 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 62' ' ' LEU . 3.4 p -122.11 115.99 47.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.356 0.598 . . . . 71.310000000000002 110.241 173.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.0 m -99.47 136.06 39.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.529 -0.759 . . . . 74.530000000000001 110.183 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -175.09 -160.07 22.37 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.24 -0.744 . . . . 34.409999999999997 111.24 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -131.91 144.08 50.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.742 0.306 . . . . 74.349999999999994 110.195 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.76 ' HG ' HG21 ' A' ' 60' ' ' VAL . 79.9 mt -118.3 123.67 45.92 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.842 -0.799 . . . . 60.350000000000001 108.842 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.686 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . . . 70.18 -52.44 0.64 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.961 0.788 . . . . 61.020000000000003 111.274 -173.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.4 -40.82 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.327 -0.709 . . . . 35.420000000000002 111.327 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.675 ' HB ' HG22 ' A' ' 177' ' ' ILE . 20.6 m -65.54 144.57 56.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.42 -0.39 . . . . 73.239999999999995 110.724 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 20.3 m -76.18 142.72 41.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.312 -0.404 . . . . 72.430000000000007 110.499 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.76 HG21 ' HG ' ' A' ' 55' ' ' LEU . 29.4 m -138.33 150.81 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.255 0.55 . . . . 42.229999999999997 111.5 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 6' ' ' LEU . 3.6 m -129.76 112.14 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.526 -0.761 . . . . 44.439999999999998 109.904 173.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.806 HD13 ' HB ' ' A' ' 7' ' ' VAL . 4.1 mm? -92.49 128.07 38.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.797 -0.638 . . . . 73.510000000000005 109.992 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.14 122.25 46.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.173 0.511 . . . . 71.329999999999998 110.532 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HE3' ' CE2' ' A' ' 26' ' ' PHE . 6.9 ptmt -130.26 91.53 38.46 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.509 -0.769 . . . . 64.340000000000003 110.045 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.74 177.1 9.12 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.071 2.514 . . . . 64.019999999999996 112.812 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 20.3 mmt85 -109.35 13.3 24.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.46 -0.791 . . . . 65.510000000000005 109.044 175.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.556 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 61.2 m -102.26 178.91 4.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.947 -1.024 . . . . 60.439999999999998 109.923 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -85.36 -165.11 1.12 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.201 -0.454 . . . . 71.099999999999994 110.125 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -80.7 -19.62 44.69 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.705 0.261 . . . . 73.420000000000002 111.705 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -73.47 -61.71 1.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.222 0.534 . . . . 74.329999999999998 110.833 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 1.1 pm0 -82.69 6.6 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.987 -0.551 . . . . 71.310000000000002 111.792 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.6 p -67.54 -34.08 76.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.985 0.422 . . . . 71.109999999999999 110.069 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.96 -20.75 74.89 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.806 -0.634 . . . . 70.049999999999997 112.612 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 mmm180 -74.25 -19.62 60.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.997 0.427 . . . . 73.540000000000006 110.473 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -87.34 -8.01 57.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 71.209999999999994 110.789 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.574 HG22 HG21 ' A' ' 8' ' ' VAL . 74.0 t -66.67 -36.95 78.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 64.0 110.659 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.11 9.43 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.811 -0.632 . . . . 63.240000000000002 112.939 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.56 -18.73 56.19 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.834 2.356 . . . . 72.120000000000005 113.187 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.57 -51.29 7.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.01 0.433 . . . . 74.219999999999999 110.077 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.627 ' HA ' HG22 ' A' ' 85' ' ' VAL . . . -53.46 -63.48 1.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.55 -0.75 . . . . 74.329999999999998 113.018 -172.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -72.82 -22.88 60.74 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.353 0.501 . . . . 72.420000000000002 112.353 -170.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -77.76 -28.85 50.71 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.915 -0.314 . . . . 75.239999999999995 111.224 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -102.93 5.45 38.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.798 0.332 . . . . 74.030000000000001 110.938 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.7 t 65.58 28.7 11.28 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.522 -0.763 . . . . 44.509999999999998 111.976 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 80' ' ' ALA . 6.3 m -80.38 136.22 53.01 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.626 -0.43 . . . . 64.310000000000002 110.464 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.77 ' HD2' ' HG3' ' A' ' 89' ' ' GLN . 30.1 Cg_exo -63.29 155.11 63.77 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.651 2.234 . . . . 75.040000000000006 111.748 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.34 -56.77 2.42 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.011 2.474 . . . . 64.430000000000007 112.689 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.15 55.22 2.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.049 0.452 . . . . 62.539999999999999 111.827 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.77 ' HG3' ' HD2' ' A' ' 86' ' ' PRO . 22.9 mm-40 -129.36 16.13 6.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.795 -0.639 . . . . 73.310000000000002 109.422 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' HB ' HD22 ' A' ' 129' ' ' ASN . 49.6 mm -92.92 123.91 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.478 -0.783 . . . . 75.219999999999999 111.86 -172.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.43 114.76 29.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.701 -0.681 . . . . 61.32 109.512 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.67 HG21 HG11 ' A' ' 121' ' ' VAL . 61.3 t -109.52 123.24 65.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.131 -0.486 . . . . 64.209999999999994 111.313 -175.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.87 HG22 ' HB ' ' A' ' 133' ' ' VAL . 30.8 pt -107.72 117.33 53.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.952 -0.567 . . . . 54.109999999999999 110.271 177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -132.79 162.25 31.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.064 0.459 . . . . 74.349999999999994 111.375 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -84.76 121.75 28.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.327 -0.851 . . . . 52.140000000000001 109.53 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 114' ' ' GLY . 1.5 mm-40 -127.5 135.74 50.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.289 0.566 . . . . 73.530000000000001 111.998 -171.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.29 -7.02 59.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.579 -0.737 . . . . 62.439999999999998 110.218 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.48 -34.92 64.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.318 -0.855 . . . . 75.530000000000001 111.513 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.53 ' HB ' ' HA3' ' A' ' 136' ' ' GLY . 1.1 mp -111.02 141.37 26.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.096 -0.502 . . . . 74.519999999999996 109.716 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.654 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 41.9 m-20 -67.93 147.02 53.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.355 -0.609 . . . . 73.420000000000002 109.355 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.731 ' HE1' ' HB2' ' A' ' 161' ' ' GLU . 13.8 t80 -63.03 137.55 58.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.099 0.476 . . . . 73.439999999999998 111.323 -171.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' O ' ' HD3' ' A' ' 103' ' ' ARG . . . 133.51 -39.84 1.67 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.576 -0.738 . . . . 70.400000000000006 112.067 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 102' ' ' GLY . 62.1 mmt-85 -131.96 164.51 25.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.715 0.293 . . . . 63.25 110.305 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 135' ' ' ILE . 37.2 pt -117.62 160.85 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 71.450000000000003 110.618 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.476 ' HD2' HG13 ' A' ' 99' ' ' ILE . 92.6 mtt180 -123.23 129.52 51.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.994 0.426 . . . . 71.400000000000006 110.923 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.604 ' HG ' HG13 ' A' ' 133' ' ' VAL . 4.7 mp -114.53 129.77 56.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.906 -0.588 . . . . 72.319999999999993 109.823 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -155.52 153.47 30.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.701 0.286 . . . . 73.109999999999999 110.283 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.802 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.3 pt? -87.43 94.09 9.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.571 . . . . 71.329999999999998 110.11 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.527 ' O ' ' HD3' ' A' ' 132' ' ' ARG . . . 172.81 -150.55 12.62 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.795 -0.639 . . . . 41.32 111.797 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.87 -157.05 25.35 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.935 -0.65 . . . . 64.310000000000002 112.223 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.688 ' HA3' HD13 ' A' ' 118' ' ' LEU . . . -130.91 132.05 6.7 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.106 -0.569 . . . . 71.25 111.867 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -112.73 6.79 18.33 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.742 0.275 . . . . 72.310000000000002 111.742 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.41 -92.26 1.55 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.527 -0.845 . . . . 73.420000000000002 111.341 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.443 ' H ' ' CD ' ' A' ' 96' ' ' GLU . . . -69.11 -45.09 63.46 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.883 -0.887 . . . . 32.299999999999997 110.883 174.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.407 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 76.0 t60 70.52 -24.59 0.16 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.869 0.692 . . . . 73.349999999999994 112.869 172.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.409 ' H ' ' C ' ' A' ' 114' ' ' GLY . 28.5 t-20 -51.52 -66.35 0.4 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.694 0.627 . . . . 61.409999999999997 112.694 -173.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.93 -10.21 85.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.144 -1.027 . . . . 73.420000000000002 113.037 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.688 HD13 ' HA3' ' A' ' 111' ' ' GLY . 94.7 mt -84.36 -38.08 20.75 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.704 -0.292 . . . . 71.219999999999999 111.372 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 120' ' ' SER . 6.6 ptm180 -65.25 -37.16 86.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 75.310000000000002 110.845 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.439 ' N ' ' HG3' ' A' ' 119' ' ' ARG . 10.0 m -60.02 -41.4 92.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.994 -0.548 . . . . 71.409999999999997 110.774 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.67 HG11 HG21 ' A' ' 92' ' ' VAL . 59.9 t -69.63 -40.33 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 75.120000000000005 110.163 177.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.423 ' HA ' HH22 ' A' ' 132' ' ' ARG . . . -63.48 -46.66 85.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.836 -0.62 . . . . 43.439999999999998 111.045 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.1 m -72.23 -27.9 62.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.292 -0.413 . . . . 72.299999999999997 111.751 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.61 66.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.93 0.395 . . . . 72.310000000000002 111.033 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.6 mt -82.27 -32.21 29.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.897 -0.592 . . . . 41.229999999999997 110.793 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 108.12 -11.64 37.27 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.96 -0.564 . . . . 53.32 111.787 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.2 t -166.01 177.56 6.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.451 -0.574 . . . . 73.409999999999997 109.451 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.637 ' HD2' ' N ' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -60.21 -30.26 69.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.847 0.356 . . . . 74.120000000000005 110.408 174.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.637 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 9.2 t30 66.11 -13.88 0.15 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.213 1.005 . . . . 73.019999999999996 112.948 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 129' ' ' ASN . 3.4 t80 175.37 -84.5 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 122.464 0.306 . . . . 75.239999999999995 110.273 175.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -161.01 161.39 31.47 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.791 0.329 . . . . 71.310000000000002 111.737 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 109' ' ' GLY . 5.6 mpt_? -132.3 166.19 22.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.947 -0.57 . . . . 73.439999999999998 109.603 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.87 ' HB ' HG22 ' A' ' 93' ' ' ILE . 59.0 t -123.44 124.92 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.24 -0.436 . . . . 65.530000000000001 109.825 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.46 ' CB ' HD11 ' A' ' 99' ' ' ILE . 98.1 mtt180 -98.74 115.65 29.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.954 -0.566 . . . . 71.430000000000007 110.009 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.727 ' HA ' HG22 ' A' ' 104' ' ' ILE . 2.7 mp -87.89 117.59 32.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.341 -0.614 . . . . 72.230000000000004 109.341 176.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.53 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . -72.5 108.75 2.59 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.905 -0.664 . . . . 62.43 113.555 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.494 ' HA ' ' CD2' ' A' ' 101' ' ' PHE . 15.0 p -92.35 -16.21 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.562 0.696 . . . . 72.400000000000006 109.888 174.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 89.98 169.75 43.73 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.453 -0.794 . . . . 34.119999999999997 111.851 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.41 ' O ' ' HD3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -102.85 101.48 21.21 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 110.194 -0.298 . . . . 74.540000000000006 110.194 177.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 138' ' ' GLY . 2.9 Cg_exo -76.36 110.41 3.06 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.813 2.342 . . . . 71.040000000000006 111.388 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 139' ' ' ARG . 87.5 Cg_endo -80.25 143.96 16.1 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.554 2.169 . . . . 74.540000000000006 111.863 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 178.91 179.32 48.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.596 -0.811 . . . . 63.539999999999999 112.008 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -102.01 -4.13 26.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.64 0.733 . . . . 71.140000000000001 109.946 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.699 ' HE2' ' HA ' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -116.87 148.22 41.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.177 -1.416 . . . . 70.230000000000004 107.177 167.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -61.18 138.24 94.4 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.683 0.278 . . . . 61.450000000000003 110.777 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.647 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 18.5 Cg_endo -58.86 -9.59 7.92 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.246 2.631 . . . . 74.430000000000007 112.097 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.31 59.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.305 -0.861 . . . . 45.140000000000001 111.597 176.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.33 -23.5 24.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 51.329999999999998 111.606 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.647 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 92.7 m-85 -84.09 -34.36 24.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.872 0.368 . . . . 64.129999999999995 111.245 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.71 -18.35 22.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 60.43 111.726 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.43 HD12 ' HG2' ' A' ' 152' ' ' GLU . 4.5 pp -86.28 -8.85 57.43 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.808 -0.357 . . . . 74.129999999999995 111.395 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 10.6 pt-20 -156.97 102.64 2.0 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.252 0.549 . . . . 73.349999999999994 110.775 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -134.54 136.69 43.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.706 -0.398 . . . . 73.409999999999997 110.586 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -122.42 19.07 10.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.029 -0.532 . . . . 74.310000000000002 110.538 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.544 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 96.9 m -62.17 120.85 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.852 -0.613 . . . . 62.32 110.732 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.32 79.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 74.530000000000001 111.743 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.85 -53.78 53.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.11 -0.495 . . . . 70.430000000000007 111.524 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -67.85 -37.2 81.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.661 -0.245 . . . . 71.209999999999994 110.95 -176.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 159' ' ' ARG . 11.8 mmt180 -58.68 -29.17 66.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 72.219999999999999 111.312 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.02 -18.81 35.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.33 -0.395 . . . . 74.150000000000006 111.535 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.731 ' HB2' ' HE1' ' A' ' 101' ' ' PHE . 40.3 mt-10 -99.08 -6.7 27.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.68 0.276 . . . . 64.540000000000006 111.363 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 158' ' ' GLU . 89.8 t -69.75 -58.53 5.45 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.626 -0.261 . . . . 75.450000000000003 111.673 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 18.5 Cg_endo -59.58 -35.21 96.02 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.3 2.0 . . . . 72.439999999999998 112.878 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.6 p -62.1 -42.71 99.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 74.439999999999998 111.177 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.1 mt -65.62 -47.05 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 64.349999999999994 110.492 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.43 -50.84 78.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 44.219999999999999 111.48 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -60.79 -45.57 93.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 73.209999999999994 111.556 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -73.87 -26.23 60.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.696 0.284 . . . . 71.150000000000006 111.603 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.06 68.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.526 -0.306 . . . . 61.119999999999997 111.465 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.51 -51.42 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.511 -0.313 . . . . 71.129999999999995 111.33 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.59 -46.69 88.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.122 0.487 . . . . 65.420000000000002 110.488 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.89 -47.26 78.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.807 -0.633 . . . . 75.129999999999995 111.601 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.7 m -64.09 -39.87 94.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 64.25 110.917 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.686 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 21.8 tt0 -61.14 -47.31 86.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.602 -0.272 . . . . 31.309999999999999 110.41 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.9 tp -68.26 -31.31 70.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 74.439999999999998 111.242 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.685 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.9 tt -62.73 -46.16 89.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.377 0.608 . . . . 75.5 109.551 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.682 HD13 HG11 ' A' ' 60' ' ' VAL . 79.2 mt -73.52 -25.26 20.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.235 -0.893 . . . . 70.140000000000001 110.4 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.24 -68.19 0.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.76 -0.654 . . . . 71.120000000000005 111.815 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -144.24 -40.58 0.27 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.856 0.687 . . . . 75.519999999999996 112.856 -172.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 176' ' ' LEU . . . -106.38 114.4 4.42 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.759 -1.21 . . . . 73.310000000000002 113.663 -170.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.454 ' HA ' ' HG ' ' A' ' 176' ' ' LEU . 6.1 tt -91.22 -54.41 3.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.456 -0.572 . . . . 53.200000000000003 109.456 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -70.31 -40.73 12.37 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 74.439999999999998 111.741 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -48.28 -38.8 34.46 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.026 1.817 . . . . 61.299999999999997 112.27 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -65.81 -43.33 88.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.095 -0.502 . . . . 73.049999999999997 110.636 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -57.81 -45.71 85.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.957 0.408 . . . . 72.299999999999997 110.508 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -66.03 -49.73 66.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 71.450000000000003 111.617 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 184' ' ' ALA . 12.1 t -60.54 -38.02 83.09 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.093 -0.243 . . . . 74.129999999999995 111.509 -174.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.731 ' HA ' ' HD1' ' A' ' 191' ' ' TRP . 72.0 t -60.23 -28.45 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.987 0.423 . . . . 72.200000000000003 111.106 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -76.34 -10.47 59.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.376 -0.375 . . . . 73.400000000000006 111.035 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -115.73 13.29 16.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.126 0.417 . . . . 50.200000000000003 112.126 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.731 ' HD1' ' HA ' ' A' ' 188' ' ' VAL . 93.1 m95 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.652 -0.689 . . . . 75.230000000000004 110.077 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 120.872 0.368 . . . . 54.219999999999999 110.275 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.9 126.99 48.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 73.120000000000005 110.483 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 13.5 mm-40 -86.5 126.12 65.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.184 -0.462 . . . . 64.329999999999998 110.695 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.483 ' HA ' ' HB2' ' A' ' 59' ' ' SER . 56.2 Cg_endo -92.55 107.26 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.187 2.591 . . . . 74.219999999999999 112.097 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.708 HD21 HG23 ' A' ' 177' ' ' ILE . 4.3 pp -89.21 157.71 18.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.307 -0.406 . . . . 75.140000000000001 110.647 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.419 ' HB2' HG11 ' A' ' 85' ' ' VAL . 47.5 tp -117.91 120.85 39.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.048 0.451 . . . . 74.150000000000006 111.281 -174.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.742 ' HB ' HD22 ' A' ' 62' ' ' LEU . 48.5 t -112.16 110.49 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.943 -0.571 . . . . 65.549999999999997 109.613 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.74 ' HB ' HG22 ' A' ' 92' ' ' VAL . 47.8 t -110.3 124.32 66.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 110.2 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.38 157.37 15.0 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.416 -0.897 . . . . 61.240000000000002 111.368 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.452 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -64.15 107.62 1.34 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.595 -0.891 . . . . 62.32 108.595 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -74.15 -176.89 35.76 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.673 -0.694 . . . . 61.420000000000002 113.523 -172.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -111.33 98.3 39.34 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.601 -0.518 . . . . 74.120000000000005 109.601 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.477 ' HB2' ' OH ' ' A' ' 17' ' ' TYR . 14.5 Cg_exo -67.8 -31.35 32.15 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.857 2.371 . . . . 71.439999999999998 112.445 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.78 -176.22 43.83 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.589 -0.815 . . . . 71.109999999999999 112.248 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.37 -159.43 0.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.907 2.405 . . . . 70.439999999999998 112.312 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m 70.64 -70.82 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.081 -0.509 . . . . 75.299999999999997 111.324 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 13' ' ' PRO . 28.7 p90 -88.63 3.51 50.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.965 0.412 . . . . 72.040000000000006 110.99 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.79 -1.57 4.04 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.879 -0.6 . . . . 35.509999999999998 112.371 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -100.62 18.5 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.33 . . . . 71.400000000000006 110.751 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.8 p -100.56 167.28 10.45 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.908 -0.405 . . . . 72.219999999999999 109.908 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 24' ' ' LEU . 22.4 ptt180 -84.38 -0.38 52.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.531 -0.304 . . . . 74.209999999999994 110.944 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.64 ' CD2' ' HA ' ' A' ' 150' ' ' VAL . 97.8 m-70 -86.21 -29.75 22.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.824 0.345 . . . . 65.040000000000006 110.944 -172.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -88.26 28.31 1.1 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.323 0.582 . . . . 61.5 109.88 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 2.4 pt? -67.28 -27.15 66.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.563 -0.744 . . . . 72.25 111.318 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.452 ' HA3' ' N ' ' A' ' 10' ' ' LEU . . . -59.23 -44.41 96.48 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.81 -0.709 . . . . 64.319999999999993 111.896 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.595 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 56.8 t80 -65.19 -35.8 82.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.743 0.306 . . . . 73.25 110.521 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 82.9 mmm -83.26 -47.27 11.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.704 -0.68 . . . . 62.310000000000002 111.989 -171.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.4 t -63.41 -42.12 95.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.14 0.495 . . . . 63.229999999999997 110.256 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . . . -67.18 -20.95 65.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.964 -0.562 . . . . 61.229999999999997 110.718 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 21.7 t70 -77.16 -43.17 34.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.978 -0.555 . . . . 71.030000000000001 111.031 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 36.0 m -71.23 -37.87 67.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.53 -0.305 . . . . 72.420000000000002 111.568 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.73 -24.83 62.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.042 0.449 . . . . 74.420000000000002 110.472 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 38' ' ' SER . . . -66.45 -46.74 75.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 64.319999999999993 110.158 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.76 -18.57 61.94 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.866 -0.607 . . . . 74.540000000000006 112.395 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 14.3 mmt85 -76.1 -58.15 3.45 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.766 0.284 . . . . 51.520000000000003 111.766 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.29 -15.4 14.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.873 0.368 . . . . 73.120000000000005 111.199 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.09 45.86 2.97 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.653 -0.979 . . . . 51.409999999999997 110.653 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.9 t -110.19 121.24 44.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.756 -0.722 . . . . 74.219999999999999 110.358 -173.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.83 126.62 55.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.347 -0.388 . . . . 72.25 110.242 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.463 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 48.4 p90 -106.0 137.81 43.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.044 0.45 . . . . 71.329999999999998 110.251 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -127.41 168.07 15.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.947 -0.57 . . . . 70.109999999999999 110.369 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.753 HG22 ' HG2' ' A' ' 49' ' ' GLU . 38.8 t -86.07 102.38 11.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.46 -0.57 . . . . 75.439999999999998 109.46 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.457 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 21.1 t-80 -79.58 85.03 5.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.921 -0.77 . . . . 75.230000000000004 108.921 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -66.55 96.8 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.559 0.695 . . . . 75.319999999999993 111.017 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 167.78 -55.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.47 -2.048 . . . . 73.120000000000005 105.47 -173.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.3 p -105.53 28.91 6.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.569 -2.105 . . . . 74.150000000000006 107.348 168.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 43' ' ' HIS . . . -49.92 43.27 0.01 OUTLIER Glycine 0 N--CA 1.476 1.356 0 N-CA-C 120.087 2.795 . . . . 71.450000000000003 120.087 -150.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.13 163.75 15.32 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.791 -1.189 . . . . 71.030000000000001 107.791 161.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.753 ' HG2' HG22 ' A' ' 42' ' ' VAL . 43.5 mt-10 -80.86 117.07 21.18 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.391 -0.524 . . . . 72.450000000000003 109.957 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.697 HG12 ' HA ' ' A' ' 63' ' ' ALA . 31.1 m -138.34 150.92 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 71.219999999999999 111.501 -173.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.28 137.71 56.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.774 -0.648 . . . . 73.120000000000005 109.961 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -111.3 125.64 54.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.688 0.28 . . . . 54.109999999999999 111.312 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.52 -167.75 24.46 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.007 -0.615 . . . . 74.230000000000004 111.621 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -136.96 104.38 5.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.084 0.442 . . . . 75.310000000000002 110.144 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.555 ' HG ' HG21 ' A' ' 60' ' ' VAL . 88.6 mt -89.78 131.19 35.86 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.619 -0.511 . . . . 63.420000000000002 109.619 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.85 9.01 4.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.228 -0.442 . . . . 73.340000000000003 111.564 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.75 -28.17 13.02 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.041 -0.599 . . . . 74.340000000000003 112.473 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.557 ' HB ' ' CG2' ' A' ' 177' ' ' ILE . 9.8 m -84.03 139.08 32.75 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.211 -0.292 . . . . 75.120000000000005 110.211 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 20.3 m -70.47 132.12 45.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.841 0.353 . . . . 45.530000000000001 110.601 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.576 HG12 HD11 ' A' ' 5' ' ' LEU . 34.1 m -126.44 136.47 60.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.124 0.488 . . . . 65.439999999999998 111.132 -176.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.2 112.71 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.829 -0.623 . . . . 61.409999999999997 109.629 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.742 HD22 ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -94.99 119.78 34.08 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.358 -0.608 . . . . 62.119999999999997 109.358 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.697 ' HA ' HG12 ' A' ' 50' ' ' VAL . . . -111.87 124.28 52.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.962 0.41 . . . . 72.140000000000001 111.587 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' HE2' ' HB3' ' A' ' 29' ' ' ALA . 91.5 mttt -119.88 107.28 40.34 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.051 -0.522 . . . . 63.450000000000003 110.242 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.455 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 4.7 Cg_exo -75.12 151.57 39.17 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.961 2.441 . . . . 73.510000000000005 112.405 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -110.44 16.53 21.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.288 0.566 . . . . 72.5 109.714 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 58.4 m -112.8 168.86 9.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.722 -0.672 . . . . 73.209999999999994 110.882 -174.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -72.23 173.84 8.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.054 -0.521 . . . . 75.340000000000003 110.73 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -19.24 65.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.379 -0.373 . . . . 70.409999999999997 111.699 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -87.91 -19.99 26.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.359 0.599 . . . . 72.420000000000002 110.163 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 36.6 mt-10 -100.46 -28.16 13.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.021 -0.536 . . . . 72.239999999999995 110.957 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 76' ' ' VAL . 14.0 p -57.73 -37.62 73.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 50.229999999999997 111.177 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.24 -32.38 76.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.181 -0.533 . . . . 65.439999999999998 112.412 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.637 HH11 ' HB2' ' A' ' 124' ' ' ALA . 26.8 mmt180 -76.73 -31.36 57.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.748 0.309 . . . . 72.230000000000004 110.698 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 78.8 mm-40 -69.66 -28.66 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 72.540000000000006 110.861 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 72' ' ' SER . 46.6 t -66.52 -30.27 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 74.140000000000001 110.773 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.62 -67.1 2.32 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 116.044 -0.525 . . . . 41.32 113.154 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.54 -43.46 39.33 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.442 2.095 . . . . 73.049999999999997 112.227 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -54.88 -51.59 65.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 110.755 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.49 84.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.119 -0.492 . . . . 44.43 111.547 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -77.49 -31.87 53.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 111.724 0.268 . . . . 51.43 111.724 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -65.86 -46.45 78.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.615 0.245 . . . . 54.43 111.262 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -90.8 -17.08 27.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.669 -0.241 . . . . 71.230000000000004 111.313 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.0 t 59.98 72.77 0.51 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.443 0.639 . . . . 75.519999999999996 110.47 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 27.8 m -98.15 139.73 21.43 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 61.219999999999999 111.188 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 13.1 Cg_exo -70.57 129.53 16.89 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.909 2.406 . . . . 71.349999999999994 111.797 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 18.3 Cg_exo -67.33 -4.4 11.73 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.133 2.555 . . . . 73.420000000000002 113.292 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -89.6 -12.18 40.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.876 0.37 . . . . 53.219999999999999 110.745 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.439 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 9.3 mm-40 -129.73 45.01 2.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.414 0.626 . . . . 75.450000000000003 110.566 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.584 HG23 ' HB3' ' A' ' 131' ' ' HIS . 10.4 tt -120.54 127.7 75.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.819 -0.628 . . . . 74.319999999999993 109.864 175.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.37 146.21 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.131 -0.486 . . . . 55.0 110.456 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.74 HG22 ' HB ' ' A' ' 8' ' ' VAL . 86.1 t -134.07 124.23 45.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.848 0.356 . . . . 73.109999999999999 110.744 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 mm -75.23 130.65 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.61 -0.723 . . . . 73.109999999999999 111.689 -175.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -143.42 141.9 31.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 74.310000000000002 110.166 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.63 ' HB2' HG21 ' A' ' 137' ' ' VAL . 4.6 p-10 -87.29 122.32 30.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.928 -0.767 . . . . 73.439999999999998 108.928 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' H ' ' A' ' 99' ' ' ILE . 10.5 tp10 -99.62 118.63 36.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.675 -0.693 . . . . 62.43 110.982 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 98' ' ' ASP . 3.3 pp -82.59 -20.7 35.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.474 -0.784 . . . . 70.049999999999997 111.253 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' HD12 ' A' ' 97' ' ' LEU . 38.6 t70 -78.63 -20.45 50.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.1 0.476 . . . . 64.129999999999995 110.742 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.496 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 66.0 mt -102.28 122.92 55.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 109.777 176.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.463 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 13.6 m-20 -62.13 149.87 40.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.281 -0.418 . . . . 63.409999999999997 110.839 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.877 ' HD2' ' HA ' ' A' ' 137' ' ' VAL . 29.4 t80 -65.61 133.76 51.85 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.18 -0.464 . . . . 75.120000000000005 110.918 -174.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.93 -62.29 0.32 Allowed Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.827 -0.624 . . . . 53.520000000000003 112.294 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -126.3 165.38 19.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.716 0.293 . . . . 60.350000000000001 110.263 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.708 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -118.57 159.18 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.194 -0.457 . . . . 60.450000000000003 110.173 -178.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -144.82 163.0 35.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.029 0.442 . . . . 73.310000000000002 110.94 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.0 mt -108.62 152.56 24.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.737 -0.665 . . . . 64.230000000000004 109.602 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -129.58 105.1 7.84 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.835 -0.346 . . . . 71.319999999999993 110.914 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 181' ' ' LEU . 85.6 mt -110.33 91.84 3.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 75.510000000000005 109.987 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.454 ' H ' ' NH2' ' A' ' 132' ' ' ARG . . . 162.65 -132.18 2.71 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.058 -0.817 . . . . 33.240000000000002 111.058 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.63 109.58 3.24 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.718 -0.953 . . . . 63.399999999999999 110.718 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.75 161.33 31.77 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.074 -1.06 . . . . 55.350000000000001 112.977 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.62 171.01 10.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.279 -0.461 . . . . 72.129999999999995 110.413 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.93 45.36 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.187 -0.765 . . . . 54.219999999999999 111.187 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.35 81.72 1.31 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.58 -1.008 . . . . 74.439999999999998 110.58 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -52.07 -50.56 61.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.444 0.535 . . . . 75.430000000000007 112.444 -170.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.55 -3.03 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.808 -0.357 . . . . 40.43 111.409 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.1 -33.59 7.65 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.954 -0.859 . . . . 72.299999999999997 110.954 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.8 -30.19 65.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.531 -0.544 . . . . 73.040000000000006 109.531 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -51.33 -50.28 59.75 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.153 -0.93 . . . . 73.019999999999996 111.683 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.2 p -72.81 -45.35 58.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.891 0.377 . . . . 75.439999999999998 111.326 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.612 HG11 ' HE1' ' A' ' 131' ' ' HIS . 59.3 t -65.79 -47.96 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.069 -0.514 . . . . 60.119999999999997 111.87 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.454 ' HA ' HD21 ' A' ' 129' ' ' ASN . . . -63.3 -38.48 91.31 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.987 0.366 . . . . 51.229999999999997 111.987 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.9 p -76.6 -29.21 56.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.631 -0.259 . . . . 53.32 111.193 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.637 ' HB2' HH11 ' A' ' 74' ' ' ARG . . . -79.35 -49.46 12.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 111.676 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -84.67 -41.78 15.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.352 -0.385 . . . . 64.049999999999997 111.536 -174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.95 -12.6 65.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.808 -0.711 . . . . 61.210000000000001 112.357 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.1 t -71.96 164.4 26.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.887 0.375 . . . . 52.020000000000003 110.793 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.86 -11.82 60.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 52.229999999999997 110.64 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.454 HD21 ' HA ' ' A' ' 122' ' ' ALA . 86.9 m-20 66.09 79.14 0.25 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.579 -0.737 . . . . 72.510000000000005 112.329 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.402 ' HB3' HD22 ' A' ' 108' ' ' LEU . 99.3 m-85 -83.56 -22.85 32.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.212 0.53 . . . . 71.010000000000005 110.032 174.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.612 ' HE1' HG11 ' A' ' 121' ' ' VAL . 13.1 p80 -68.63 87.61 0.34 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.445 -0.798 . . . . 70.310000000000002 112.347 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.454 ' NH2' ' H ' ' A' ' 109' ' ' GLY . 16.2 mtm180 -142.89 109.56 5.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.257 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.4 t -101.87 109.02 24.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.637 -0.875 . . . . 75.409999999999997 108.637 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.469 ' HD2' ' OE1' ' A' ' 96' ' ' GLU . 38.9 mtm180 -99.1 106.43 18.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.071 0.462 . . . . 75.530000000000001 110.93 -175.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 104' ' ' ILE . 3.0 mp -85.1 114.78 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.701 -0.681 . . . . 74.219999999999999 109.362 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.747 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -65.29 101.93 0.61 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.768 -0.729 . . . . 35.5 111.583 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.877 ' HA ' ' HD2' ' A' ' 101' ' ' PHE . 3.5 m -111.2 -7.37 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.255 0.465 . . . . 60.43 112.255 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 86.87 167.68 44.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 63.340000000000003 112.72 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.5 ptm180 -111.48 124.34 32.82 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.044 0.449 . . . . 72.549999999999997 110.984 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 9.5 Cg_endo -90.07 115.37 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.57 2.846 . . . . 74.209999999999994 112.259 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -93.23 155.9 2.58 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.962 2.441 . . . . 64.510000000000005 113.18 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.62 -161.78 29.97 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.258 -0.737 . . . . 53.340000000000003 111.258 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -78.12 -19.31 54.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.196 0.522 . . . . 71.219999999999999 110.161 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 32.5 mmtp -108.38 150.74 26.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.478 -0.783 . . . . 75.049999999999997 109.451 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.23 164.02 56.65 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.325 -0.398 . . . . 55.0 110.251 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' ' 149' ' ' PHE . 62.6 Cg_exo -53.58 -14.33 4.88 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.14 2.56 . . . . 71.239999999999995 113.292 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.94 -22.79 63.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 74.030000000000001 111.567 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.75 -26.87 22.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.394 0.616 . . . . 62.329999999999998 110.473 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 146' ' ' PRO . 68.5 m-85 -64.42 -15.95 61.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.044 -0.98 . . . . 72.129999999999995 112.038 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 33.6 m -55.48 -28.75 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 111.859 0.318 . . . . 62.32 111.859 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.543 ' HG ' HG23 ' A' ' 150' ' ' VAL . 86.6 mt -105.58 -27.15 11.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.921 0.391 . . . . 75.5 110.871 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -128.59 93.52 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.491 0.663 . . . . 72.319999999999993 110.272 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 149' ' ' PHE . 3.8 t30 -125.11 101.31 6.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.634 . . . . 74.5 110.491 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -132.13 102.13 5.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.286 0.565 . . . . 63.200000000000003 110.527 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.893 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 6.5 m -125.73 132.38 52.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.011 -0.541 . . . . 54.210000000000001 109.887 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.76 73.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.971 0.415 . . . . 72.049999999999997 110.868 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.65 -38.95 93.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.832 -0.622 . . . . 75.239999999999995 112.044 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.893 ' HG2' ' HB ' ' A' ' 155' ' ' THR . 10.5 pt-20 -72.58 -40.45 66.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.876 -0.33 . . . . 75.409999999999997 111.261 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.464 ' HA ' HG23 ' A' ' 162' ' ' VAL . 25.6 mmm180 -66.82 -34.34 77.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.85 0.357 . . . . 75.219999999999999 110.808 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.49 62.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.428 -0.805 . . . . 65.409999999999997 112.376 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.652 ' HB2' ' HE1' ' A' ' 101' ' ' PHE . 59.7 mm-40 -100.68 13.38 34.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.337 0.495 . . . . 73.340000000000003 112.337 -174.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.642 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 55.2 t -54.38 -52.47 68.96 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.035 -0.266 . . . . 74.310000000000002 110.798 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 53.9 Cg_exo -54.55 -25.89 43.0 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.142 1.895 . . . . 75.510000000000005 113.24 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.5 m -74.28 -48.21 29.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.057 0.456 . . . . 73.25 110.684 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.24 -33.59 64.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.962 -0.563 . . . . 72.120000000000005 111.34 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 162' ' ' VAL . 98.1 t -53.35 -39.1 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.835 0.35 . . . . 65.409999999999997 111.419 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -71.57 -50.07 34.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.46 -0.336 . . . . 60.409999999999997 111.29 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.531 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . 9.1 mm-40 -60.84 -42.78 98.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.783 0.325 . . . . 62.119999999999997 111.385 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.13 -22.98 67.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.237 -0.438 . . . . 54.140000000000001 111.641 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.39 -44.16 15.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.855 0.36 . . . . 45.340000000000003 111.742 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -85.05 -36.29 21.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.555 -0.293 . . . . 73.530000000000001 111.618 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.33 -43.67 73.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.843 0.312 . . . . 70.239999999999995 111.843 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.533 ' HA ' HD13 ' A' ' 176' ' ' LEU . 22.0 p -63.05 -31.49 72.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 65.519999999999996 111.69 -175.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.45 -26.4 66.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.278 -0.419 . . . . 73.109999999999999 110.821 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.72 -29.76 66.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.708 0.29 . . . . 71.140000000000001 110.593 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 173' ' ' THR . 8.3 mp -64.66 -36.5 84.47 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.482 0.658 . . . . 61.210000000000001 109.502 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.708 HG23 HD21 ' A' ' 5' ' ' LEU . 34.5 mt -76.99 -37.36 26.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.892 -1.049 . . . . 74.5 110.023 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.85 -48.84 67.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.57 -0.741 . . . . 54.450000000000003 111.364 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -133.22 -67.56 0.62 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.431 -0.35 . . . . 65.010000000000005 111.201 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.4 -178.32 46.09 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.749 -0.739 . . . . 70.340000000000003 111.886 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 108' ' ' LEU . 3.7 pp -89.87 -12.94 37.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.965 0.412 . . . . 74.019999999999996 110.584 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.71 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 6.5 tm-20 -53.68 -54.13 49.62 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.508 -0.769 . . . . 74.329999999999998 111.797 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.71 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 11.0 Cg_exo -71.19 -31.98 13.69 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 121.644 1.563 . . . . 62.200000000000003 112.176 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.59 -26.01 57.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 53.32 112.322 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 19.7 pt20 -62.29 -22.65 66.2 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.475 0.179 . . . . 74.150000000000006 111.444 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -85.98 -48.01 9.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.749 0.309 . . . . 72.140000000000001 110.657 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.6 m -53.22 -40.55 64.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.765 -0.652 . . . . 72.540000000000006 111.749 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.2 -12.75 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.62 0.6 . . . . 74.109999999999999 112.62 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -117.45 -28.58 6.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.614 0.245 . . . . 64.239999999999995 111.54 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.55 -17.15 39.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.586 -0.279 . . . . 72.319999999999993 111.607 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.3 m95 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.637 -0.697 . . . . 63.439999999999998 110.271 -179.535 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.242 0.544 . . . . 74.400000000000006 110.269 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -158.41 42.22 0.27 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.689 -0.687 . . . . 71.239999999999995 109.569 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.0 mp0 -84.44 142.93 40.82 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.611 -0.722 . . . . 73.310000000000002 110.554 -172.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 2.9 Cg_exo -76.21 117.85 4.77 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.137 2.558 . . . . 70.209999999999994 112.307 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.722 HD21 HG23 ' A' ' 177' ' ' ILE . 4.2 pp -121.89 149.25 43.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.291 -0.413 . . . . 73.040000000000006 110.246 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.473 ' HB3' HG12 ' A' ' 90' ' ' ILE . 64.8 tp -97.56 136.21 38.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.318 -0.401 . . . . 73.230000000000004 110.476 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.7 t -117.42 112.61 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.829 -0.434 . . . . 75.109999999999999 109.829 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.67 128.61 62.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 73.329999999999998 110.723 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.541 ' HA2' HG23 ' A' ' 93' ' ' ILE . . . -103.38 -177.06 26.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.198 -0.525 . . . . 72.519999999999996 112.095 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.568 HD13 ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -142.53 158.74 43.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.362 . . . . 73.099999999999994 110.926 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 22' ' ' HIS . . . 155.86 -158.28 28.43 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.449 -0.661 . . . . 60.399999999999999 111.449 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 61.0 t30 -163.08 105.32 1.01 Allowed Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.116 -0.328 . . . . 72.340000000000003 110.116 176.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 12' ' ' ASN . 56.2 Cg_endo -71.2 142.25 41.27 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.751 2.301 . . . . 53.140000000000001 112.271 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.62 177.92 39.9 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.754 -0.736 . . . . 42.439999999999998 111.849 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.4 -66.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.699 2.266 . . . . 62.109999999999999 112.083 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 m -76.7 -25.56 53.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.319 0.581 . . . . 65.239999999999995 110.113 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' HA ' HG23 ' A' ' 20' ' ' THR . 80.9 m-85 -70.71 -23.14 62.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.567 -0.742 . . . . 71.450000000000003 111.748 -175.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.4 -17.27 63.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 73.120000000000005 110.28 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -106.73 20.63 18.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.604 -0.725 . . . . 74.230000000000004 111.277 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.627 HG23 ' HA ' ' A' ' 17' ' ' TYR . 72.2 p -99.95 166.91 10.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.238 0.542 . . . . 74.439999999999998 110.385 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.544 ' HB3' HG23 ' A' ' 150' ' ' VAL . 17.5 tpt85 -93.76 1.56 56.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.912 -0.586 . . . . 74.299999999999997 111.1 -175.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.461 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 1.5 t-160 -106.81 11.04 30.56 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.909 -0.316 . . . . 65.319999999999993 111.549 -173.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -103.38 13.63 33.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 64.409999999999997 111.332 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.4 pt? -55.06 -39.96 69.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.837 -0.62 . . . . 74.319999999999993 112.144 -174.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 10' ' ' LEU . . . -61.2 -55.29 30.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.034 -0.603 . . . . 54.219999999999999 112.971 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.54 ' CE1' ' HD2' ' A' ' 65' ' ' PRO . 20.1 m-30 -61.4 -39.52 91.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.717 0.294 . . . . 44.420000000000002 111.315 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.527 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 16.3 mmt -68.83 -49.58 57.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.376 -0.374 . . . . 54.439999999999998 111.457 -176.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.27 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.359 . . . . 42.229999999999997 110.673 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -63.62 -34.93 78.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 73.099999999999994 111.446 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.38 -40.7 50.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.215 -0.448 . . . . 71.030000000000001 111.164 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.5 m -79.56 -21.13 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.547 0.573 . . . . 63.450000000000003 112.547 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.419 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -70.37 -26.05 63.54 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.326 -0.549 . . . . 62.219999999999999 110.712 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.419 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -71.54 -24.26 61.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.352 0.596 . . . . 33.509999999999998 110.158 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.64 -18.12 67.71 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.451 -0.795 . . . . 65.219999999999999 112.6 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -69.56 -32.44 71.22 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.046 0.45 . . . . 75.310000000000002 111.186 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 36' ' ' ILE . 4.2 mp -86.03 -15.57 10.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.989 -0.745 . . . . 71.25 108.989 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.76 41.04 15.97 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.711 -1.356 . . . . 73.299999999999997 109.711 -171.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 t -126.55 135.54 51.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.887 -0.656 . . . . 62.32 111.038 -169.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.04 128.31 9.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.045 -0.525 . . . . 75.25 110.215 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.537 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 7.3 t80 -107.86 -158.1 0.64 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.731 -0.47 . . . . 75.439999999999998 109.731 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -135.19 173.07 12.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 72.230000000000004 111.474 -171.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HB ' ' OE2' ' A' ' 49' ' ' GLU . 2.7 p -70.52 108.26 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.585 -0.734 . . . . 64.430000000000007 111.216 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -102.25 75.67 1.51 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.256 -1.016 . . . . 74.409999999999997 108.256 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -56.31 122.29 11.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.598 -0.728 . . . . 63.329999999999998 112.174 -168.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -134.76 -90.93 0.33 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.662 -0.699 . . . . 71.340000000000003 109.496 168.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.419 ' OG ' ' HB2' ' A' ' 78' ' ' PRO . 8.6 m -107.83 -41.25 5.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 118.898 -1.121 . . . . 73.239999999999995 111.556 171.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.79 1.68 4.73 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.369 -0.443 . . . . 73.540000000000006 112.573 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . -75.58 99.4 4.26 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 115.585 1.698 . . . . 64.049999999999997 115.585 -154.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.654 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 20.7 mt-10 -116.28 115.46 25.98 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.357 -1.72 . . . . 74.5 106.357 151.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 31.8 m -137.56 151.27 26.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.257 -0.577 . . . . 62.229999999999997 112.384 -167.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 62' ' ' LEU . 5.9 p -124.63 125.83 70.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.418 -0.956 . . . . 74.239999999999995 108.418 166.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.5 m -103.17 113.08 26.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.078 0.466 . . . . 73.019999999999996 111.169 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.29 -161.22 8.97 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.811 -0.916 . . . . 60.140000000000001 110.811 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -138.34 129.68 27.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.291 0.545 . . . . 75.420000000000002 110.953 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.9 mt -102.87 117.03 33.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.035 -0.728 . . . . 71.219999999999999 109.035 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.44 -46.46 0.62 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.98 0.8 . . . . 72.239999999999995 111.66 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.83 -37.79 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.206 -0.521 . . . . 64.239999999999995 111.881 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -71.28 133.68 46.24 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.878 0.37 . . . . 70.329999999999998 111.294 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.5 p -74.07 125.74 28.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 72.230000000000004 110.756 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.597 HG12 HD11 ' A' ' 5' ' ' LEU . 33.6 m -111.23 136.44 47.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.102 -0.499 . . . . 71.420000000000002 110.896 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 t -102.76 101.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.759 -0.83 . . . . 75.150000000000006 108.759 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.579 HD11 ' HB1' ' A' ' 29' ' ' ALA . 3.3 tm? -91.09 111.57 23.1 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.169 -0.678 . . . . 73.310000000000002 109.169 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 49' ' ' GLU . . . -109.33 123.58 49.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.981 -0.554 . . . . 64.540000000000006 111.297 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.654 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -122.99 90.2 50.42 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.677 0.751 . . . . 75.230000000000004 109.674 175.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.54 ' HD2' ' CE1' ' A' ' 26' ' ' PHE . 16.4 Cg_exo -68.95 166.67 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.704 2.269 . . . . 64.530000000000001 112.679 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -105.0 14.41 29.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.663 0.744 . . . . 75.329999999999998 109.06 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 63.3 m -102.16 138.51 39.01 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.73 -1.123 . . . . 33.140000000000001 108.866 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 70' ' ' ASN . 15.8 p90 -66.65 166.8 12.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.093 0.473 . . . . 73.329999999999998 111.545 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.4 ptp -46.68 -31.56 2.99 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.39 1.256 . . . . 55.130000000000003 114.39 -169.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.411 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 62.4 t30 -77.99 -50.44 12.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.872 0.368 . . . . 72.299999999999997 111.142 -176.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -78.56 -24.45 45.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.286 -0.416 . . . . 71.219999999999999 111.454 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.3 t -56.68 -39.4 73.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.388 -0.369 . . . . 74.540000000000006 110.433 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.07 -29.37 74.72 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.932 -0.576 . . . . 72.239999999999995 113.077 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -41.85 88.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.157 0.503 . . . . 74.219999999999999 110.914 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -84.22 -0.05 50.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.803 -0.635 . . . . 74.430000000000007 111.86 -171.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.2 t -70.74 -40.46 76.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.803 0.335 . . . . 61.409999999999997 110.444 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.97 -59.03 11.56 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 115.964 -0.562 . . . . 73.019999999999996 112.822 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HB2' ' OG ' ' A' ' 46' ' ' SER . 10.1 Cg_endo -56.2 -37.82 95.99 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.7 2.267 . . . . 71.450000000000003 112.749 175.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 48' ' ' ALA . 2.9 tm? -69.11 -44.61 72.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.647 -0.251 . . . . 74.349999999999994 111.255 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.52 86.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.0 0.37 . . . . 53.420000000000002 112.0 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -72.9 -20.43 61.08 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.822 0.304 . . . . 75.019999999999996 111.822 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -71.07 -28.7 64.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.854 0.359 . . . . 74.340000000000003 110.753 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.02 0.01 37.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 72.129999999999995 110.169 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t 62.24 24.29 14.44 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.443 -0.798 . . . . 34.299999999999997 111.426 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.483 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 18.5 m -88.04 131.85 41.67 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.887 0.375 . . . . 74.120000000000005 111.09 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 19.4 Cg_exo -67.38 127.94 17.45 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.832 2.354 . . . . 75.439999999999998 111.605 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.632 ' HA ' HD12 ' A' ' 90' ' ' ILE . 39.7 Cg_exo -57.63 -27.51 77.46 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.991 2.46 . . . . 71.25 113.055 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -64.46 -27.68 69.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.48 -0.327 . . . . 71.030000000000001 111.659 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -103.88 17.59 23.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.159 0.504 . . . . 72.329999999999998 110.761 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.721 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 58.9 mt -90.45 145.45 7.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.403 -0.591 . . . . 65.5 109.403 175.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 m -118.12 134.67 61.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.164 0.507 . . . . 73.530000000000001 110.254 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.79 115.92 47.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.086 -0.506 . . . . 75.420000000000002 110.543 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.541 HG23 ' HA2' ' A' ' 9' ' ' GLY . 6.8 tt -87.67 126.02 41.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.923 -0.58 . . . . 73.230000000000004 109.542 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.99 173.5 11.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.399 0.618 . . . . 73.439999999999998 110.649 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -85.55 152.61 23.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.176 -0.92 . . . . 72.530000000000001 110.521 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 22.5 tt0 -123.35 94.72 4.34 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.423 0.63 . . . . 75.120000000000005 110.169 174.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.847 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.9 pt? -83.57 -0.33 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.332 -0.849 . . . . 71.340000000000003 110.073 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.409 ' CG ' HH12 ' A' ' 134' ' ' ARG . 1.6 m-20 -68.42 -36.42 79.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.711 . . . . 71.510000000000005 109.678 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 mm -123.29 149.19 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.515 -0.766 . . . . 75.109999999999999 110.244 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.787 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 8.8 p-10 -75.42 155.03 36.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 61.0 110.973 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.639 ' HD2' ' HB2' ' A' ' 158' ' ' GLU . 6.0 t80 -68.03 138.73 56.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.718 -0.674 . . . . 73.530000000000001 111.577 -173.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 160.07 -35.62 0.45 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.342 -0.845 . . . . 45.43 111.081 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -148.55 164.89 32.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 70.340000000000003 110.455 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.618 HD11 HG21 ' A' ' 188' ' ' VAL . 2.4 pp -118.21 162.97 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.382 -0.599 . . . . 74.129999999999995 109.382 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.407 ' HE ' ' CD ' ' A' ' 96' ' ' GLU . 29.8 ptt180 -141.0 153.32 45.5 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.702 -0.399 . . . . 74.129999999999995 110.446 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 181' ' ' LEU . 60.3 tp -113.04 124.9 53.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.844 -0.616 . . . . 73.329999999999998 109.434 176.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -155.41 126.69 7.21 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.002 -0.74 . . . . 74.310000000000002 109.002 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 130' ' ' PHE . 88.0 mt -76.73 88.0 3.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.579 0.704 . . . . 74.310000000000002 109.638 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.6 147.72 5.16 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.31 -1.116 . . . . 63.340000000000003 110.31 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.462 ' HA3' ' HG2' ' A' ' 132' ' ' ARG . . . 178.86 112.44 0.34 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.692 -1.242 . . . . 54.219999999999999 113.061 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.57 76.06 0.17 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.308 -0.717 . . . . 73.200000000000003 111.308 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -171.77 149.73 2.57 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.201 -0.666 . . . . 44.030000000000001 109.201 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.22 -67.77 2.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.959 -0.639 . . . . 72.120000000000005 111.825 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.93 69.3 3.27 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.901 -0.88 . . . . 65.019999999999996 110.901 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -48.45 -54.86 12.59 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.661 0.784 . . . . 73.230000000000004 111.734 -173.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -85.6 -41.6 15.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.258 -0.428 . . . . 55.520000000000003 110.981 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.81 -37.26 90.07 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 116.13 -0.487 . . . . 74.0 113.703 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.3 -27.89 29.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.972 0.386 . . . . 64.439999999999998 111.347 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -79.43 -36.7 38.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.499 -0.318 . . . . 63.109999999999999 111.568 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.9 m -58.76 -38.21 77.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 72.310000000000002 111.138 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.02 -42.93 82.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.987 0.422 . . . . 50.420000000000002 110.477 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.61 82.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.022 -0.536 . . . . 72.230000000000004 110.766 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t -63.42 -41.77 98.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 44.439999999999998 110.768 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.3 -32.09 69.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.31 -0.405 . . . . 61.439999999999998 111.672 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.53 -7.71 40.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.789 0.328 . . . . 74.420000000000002 111.669 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.45 -11.77 69.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.851 -0.69 . . . . 72.420000000000002 113.408 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 129' ' ' ASN . 15.4 t -169.88 177.97 4.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.832 0.316 . . . . 52.219999999999999 110.184 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.872 ' H ' ' HD2' ' A' ' 128' ' ' LYS . 8.9 mptt -56.13 -57.3 12.78 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.088 -0.708 . . . . 70.099999999999994 109.088 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.441 ' HB2' HG23 ' A' ' 127' ' ' THR . 8.9 t-20 67.32 24.35 9.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.337 -0.847 . . . . 64.420000000000002 111.946 166.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.512 ' HB3' HD22 ' A' ' 108' ' ' LEU . 54.9 m-85 63.52 -130.72 0.44 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.074 -0.512 . . . . 75.230000000000004 111.817 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.721 ' HB3' ' O ' ' A' ' 90' ' ' ILE . 4.6 p80 34.44 85.95 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.456 1.28 . . . . 73.519999999999996 114.456 -173.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 131' ' ' HIS . 9.3 mpt_? -135.58 108.46 7.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.867 -0.606 . . . . 75.340000000000003 110.187 171.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 46.4 t -112.7 100.2 10.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.431 -0.952 . . . . 71.049999999999997 108.431 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.892 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 69.7 mtp180 -109.98 124.85 52.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 72.349999999999994 112.021 -169.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 135' ' ' ILE . 3.1 mp -97.0 107.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.293 -0.867 . . . . 74.109999999999999 109.282 174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -62.56 111.99 4.52 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 120.977 -0.63 . . . . 72.150000000000006 111.7 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.41 -10.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 111.968 0.359 . . . . 72.299999999999997 111.968 -175.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.787 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 151.89 130.08 1.58 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.063 -1.065 . . . . 65.230000000000004 112.433 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 28.5 ptt180 -86.03 159.69 53.73 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 110.238 -0.282 . . . . 74.340000000000003 110.238 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.554 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 51.6 Cg_exo -53.47 122.17 10.77 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.764 2.309 . . . . 73.230000000000004 112.799 -177.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.91 8.06 3.98 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.942 2.428 . . . . 71.349999999999994 112.24 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.0 -128.0 1.7 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.076 -0.583 . . . . 74.030000000000001 111.934 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -46.1 17.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.008 0.432 . . . . 73.439999999999998 110.543 -177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 17.3 mmtp -87.69 133.14 33.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.533 0.683 . . . . 73.129999999999995 110.531 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.608 ' HB2' HD12 ' A' ' 97' ' ' LEU . 2.6 p-10 -74.63 158.64 84.7 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 114.773 -1.103 . . . . 61.130000000000003 110.781 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.554 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 32.5 Cg_exo -58.69 -16.22 29.71 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.958 2.438 . . . . 72.409999999999997 113.26 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.512 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -68.39 -21.19 64.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 72.329999999999998 111.317 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.41 -34.55 18.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.9 0.381 . . . . 65.140000000000001 111.233 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -84.35 -19.16 34.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.078 0.466 . . . . 73.120000000000005 111.331 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 21' ' ' ARG . 5.2 p -72.17 5.15 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.596 -0.729 . . . . 73.340000000000003 112.391 -172.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.92 -5.86 37.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.013 0.375 . . . . 71.209999999999994 112.013 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -160.89 144.53 13.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.911 0.386 . . . . 64.219999999999999 111.492 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 67.31 -173.92 0.19 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.15 -0.932 . . . . 72.319999999999993 112.621 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -156.72 171.48 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 73.310000000000002 109.51 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.828 ' HB ' ' HG3' ' A' ' 158' ' ' GLU . 25.1 m -102.5 120.07 39.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.864 0.364 . . . . 65.25 110.944 -175.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.69 67.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 71.120000000000005 111.523 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.39 70.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 71.140000000000001 111.504 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.828 ' HG3' ' HB ' ' A' ' 155' ' ' THR . 1.5 pp20? -79.83 -20.83 45.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.692 0.282 . . . . 75.099999999999994 111.208 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.46 ' HA ' HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -61.4 -20.36 62.97 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.241 0.543 . . . . 75.530000000000001 110.199 177.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.61 81.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.62 -0.718 . . . . 42.539999999999999 111.318 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -85.66 -7.86 58.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.41 . . . . 73.340000000000003 111.501 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.802 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 93.8 t -57.74 -59.07 14.23 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 111.953 0.353 . . . . 74.010000000000005 111.953 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.802 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 44.6 Cg_exo -57.37 -36.0 98.87 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.047 1.831 . . . . 65.540000000000006 112.129 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.5 m -71.35 -44.78 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.85 -0.614 . . . . 64.019999999999996 111.291 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 162' ' ' VAL . 7.1 tp -67.52 -30.1 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 73.319999999999993 111.035 -175.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 162' ' ' VAL . 92.8 t -64.88 -48.82 82.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.318 . . . . 73.099999999999994 110.473 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -63.21 -44.25 95.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 72.310000000000002 110.332 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.47 -45.45 90.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 71.439999999999998 111.093 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.6 -30.91 69.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 70.510000000000005 111.432 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -56.82 -49.35 75.64 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.143 0.277 . . . . 45.009999999999998 111.61 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.69 -43.1 98.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 73.439999999999998 111.094 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.68 69.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.817 -0.629 . . . . 51.509999999999998 111.573 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.476 ' O ' HG12 ' A' ' 177' ' ' ILE . 18.2 p -69.0 -39.04 79.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.964 0.357 . . . . 71.450000000000003 111.964 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -66.17 -40.26 90.38 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.029 -0.268 . . . . 72.219999999999999 110.87 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.4 tp -73.19 -30.89 63.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.986 0.422 . . . . 75.209999999999994 110.158 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.6 -49.3 77.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.554 -0.748 . . . . 70.200000000000003 109.427 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.722 HG23 HD21 ' A' ' 5' ' ' LEU . 45.1 mm -64.67 -31.37 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.143 -0.935 . . . . 62.32 111.207 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.5 -68.71 0.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 111.804 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -158.06 -38.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.751 0.31 . . . . 71.239999999999995 111.388 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -115.37 116.32 3.67 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.284 -0.96 . . . . 63.130000000000003 113.303 -173.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.648 ' HB2' HD21 ' A' ' 106' ' ' LEU . 4.2 pp -89.59 -20.51 23.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.363 0.601 . . . . 74.430000000000007 109.894 174.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 41.0 mt-10 -63.99 -50.13 71.19 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.39 -0.823 . . . . 52.409999999999997 111.691 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 13.9 Cg_endo -58.28 -32.38 95.82 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.91 1.74 . . . . 73.409999999999997 111.924 174.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.529 ' HA ' HG22 ' A' ' 187' ' ' THR . . . -64.28 -41.88 96.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.022 -0.535 . . . . 74.450000000000003 110.464 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.569 ' HG2' ' HB3' ' A' ' 106' ' ' LEU . 90.9 mt-30 -57.76 -34.69 69.83 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.098 -0.501 . . . . 72.129999999999995 110.553 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.49 -53.32 6.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.715 -0.675 . . . . 60.5 111.23 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 184' ' ' ALA . 8.8 t -62.46 -48.18 80.78 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.011 0.375 . . . . 65.409999999999997 112.011 -173.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.618 HG21 HD11 ' A' ' 104' ' ' ILE . 5.1 p -68.7 -14.07 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.96 0.41 . . . . 61.310000000000002 111.56 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -86.59 -8.18 57.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.117 0.484 . . . . 62.130000000000003 109.98 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -102.58 -17.7 15.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 74.420000000000002 111.878 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.584 ' HD1' ' HA ' ' A' ' 188' ' ' VAL . 90.8 m95 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.654 -0.688 . . . . 74.549999999999997 110.738 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptp . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.884 0.373 . . . . 62.119999999999997 110.709 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.45 147.83 49.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.091 -0.504 . . . . 63.109999999999999 110.468 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.2 pm0 -91.72 153.66 43.85 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.975 -0.557 . . . . 52.420000000000002 110.132 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 59' ' ' SER . 9.5 Cg_endo -52.75 129.81 34.32 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.3 2.667 . . . . 65.540000000000006 113.228 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.33 143.16 30.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 72.239999999999995 110.329 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 HG22 ' A' ' 90' ' ' ILE . 59.3 tp -96.93 109.95 22.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.911 -0.403 . . . . 74.430000000000007 109.911 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.8 115.31 31.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.723 -0.473 . . . . 74.450000000000003 109.723 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.86 114.26 45.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.107 -0.497 . . . . 63.229999999999997 110.251 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.29 134.33 7.78 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.688 -0.768 . . . . 65.420000000000002 111.241 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 10' ' ' LEU . 4.3 mm? -63.14 115.81 4.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.919 0.39 . . . . 64.329999999999998 110.044 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.857 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -87.04 -145.65 9.63 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.581 -0.736 . . . . 75.340000000000003 112.82 -174.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -102.41 136.5 19.37 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 110.618 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -89.52 -153.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.883 2.389 . . . . 65.299999999999997 111.239 172.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.04 -174.03 33.34 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.842 -0.694 . . . . 62.039999999999999 112.54 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.25 160.21 20.17 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.005 2.47 . . . . 75.25 112.344 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.2 m 72.77 -58.22 0.61 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.155 -0.475 . . . . 71.409999999999997 111.821 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.87 -13.58 60.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.382 . . . . 75.230000000000004 111.509 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.12 0.6 31.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.212 0.529 . . . . 73.219999999999999 110.715 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -105.09 20.41 18.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.691 -0.686 . . . . 73.340000000000003 109.957 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.6 p -100.33 175.4 5.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.965 -0.561 . . . . 74.409999999999997 110.791 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.56 ' HD3' ' O ' ' A' ' 153' ' ' ASN . 0.7 OUTLIER -81.59 1.66 32.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.468 -0.333 . . . . 71.219999999999999 111.734 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -105.92 11.82 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.41 0.522 . . . . 71.400000000000006 112.41 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -96.2 14.17 24.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.087 0.47 . . . . 63.119999999999997 110.032 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.6 pt? -59.96 -33.08 71.44 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.61 -0.723 . . . . 70.230000000000004 111.987 -174.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.06 -48.5 85.77 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.666 -0.778 . . . . 73.109999999999999 111.691 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.857 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 85.9 t80 -60.67 -46.11 91.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.831 0.348 . . . . 62.219999999999999 110.904 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 96.2 mmm -59.23 -50.41 74.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.835 -0.621 . . . . 63.299999999999997 111.704 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.45 -40.12 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 73.430000000000007 111.025 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.59 ' HB1' HD21 ' A' ' 62' ' ' LEU . . . -66.07 -34.76 78.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.858 0.361 . . . . 53.420000000000002 111.362 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -71.69 -44.67 63.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.254 -0.43 . . . . 71.409999999999997 111.428 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.0 m -65.59 -34.25 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.159 0.429 . . . . 72.219999999999999 112.159 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -79.92 -29.03 39.72 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.539 -0.464 . . . . 54.130000000000003 110.73 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -67.77 -40.46 84.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.995 0.426 . . . . 60.340000000000003 110.035 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.33 -18.9 70.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.988 -0.625 . . . . 64.409999999999997 112.364 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -75.78 -54.32 7.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.723 0.297 . . . . 70.239999999999995 111.751 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 tp -67.13 -15.44 19.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.028 -0.533 . . . . 72.040000000000006 111.229 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.82 62.54 0.93 Allowed Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.592 -1.003 . . . . 73.349999999999994 110.592 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.553 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 32.1 m -151.86 156.17 39.62 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.087 0.47 . . . . 74.319999999999993 111.786 -169.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.4 144.49 31.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.623 -0.717 . . . . 50.0 109.089 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.7 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 40.4 p90 -108.01 149.43 28.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.108 0.48 . . . . 72.319999999999993 111.575 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -155.16 172.93 17.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.353 -0.84 . . . . 73.109999999999999 109.67 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.9 126.33 5.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.676 0.75 . . . . 63.450000000000003 112.125 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -137.18 158.95 43.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.364 -0.835 . . . . 73.540000000000006 110.715 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.686 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 1.6 tpmt? 63.22 -87.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 72.239999999999995 111.845 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.39 -87.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.745 1.387 . . . . 41.509999999999998 114.745 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 78' ' ' PRO . 51.8 p -91.45 -37.0 13.45 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.826 1.787 . . . . 53.119999999999997 115.826 -156.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.19 -7.49 4.46 Favored Glycine 0 CA--C 1.508 -0.372 0 C-N-CA 119.459 -1.353 . . . . 75.209999999999994 114.223 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.529 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -95.61 110.37 22.48 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.27 1.211 . . . . 74.019999999999996 114.27 -160.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.761 ' HG3' ' HD2' ' A' ' 66' ' ' ARG . 53.6 mt-10 -97.94 114.32 26.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.709 -1.589 . . . . 70.340000000000003 106.709 155.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.529 HG23 ' HB1' ' A' ' 48' ' ' ALA . 66.9 t -124.24 139.24 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.11 0.481 . . . . 63.310000000000002 111.823 -166.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.7 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 2.8 p -115.9 115.29 48.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.298 -1.001 . . . . 72.400000000000006 108.298 168.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -96.32 117.45 30.85 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.147 -0.479 . . . . 72.219999999999999 110.889 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.57 -169.96 22.64 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.032 -0.827 . . . . 63.130000000000003 111.032 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 54' ' ' ARG . 14.8 ptt180 -141.3 139.72 33.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.04 0.448 . . . . 74.409999999999997 110.61 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 57' ' ' GLY . 96.5 mt -118.42 136.98 53.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.198 -0.668 . . . . 63.140000000000001 109.198 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 72.1 -29.56 0.2 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.739 0.649 . . . . 70.120000000000005 112.212 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 145.15 -14.18 1.89 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.106 -0.568 . . . . 62.520000000000003 111.701 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.4 m -102.35 132.45 48.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.615 0.245 . . . . 74.109999999999999 110.492 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 17.4 m -69.85 145.15 52.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.255 -0.429 . . . . 53.32 110.656 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 177' ' ' ILE . 15.5 m -136.78 143.59 34.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.077 0.465 . . . . 71.5 110.919 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.07 101.98 13.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.741 -0.663 . . . . 65.439999999999998 109.673 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.59 HD21 ' HB1' ' A' ' 29' ' ' ALA . 53.0 tp -94.9 98.95 11.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.258 0.551 . . . . 74.319999999999993 110.996 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 50' ' ' VAL . . . -117.12 167.5 11.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.643 -0.708 . . . . 74.340000000000003 110.213 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -154.45 134.0 7.63 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.573 0.225 . . . . 65.420000000000002 110.653 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 26.4 Cg_exo -63.98 142.19 80.5 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.809 2.34 . . . . 75.349999999999994 111.502 173.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.761 ' HD2' ' HG3' ' A' ' 49' ' ' GLU . 42.8 mtp180 -110.34 16.67 21.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.797 0.808 . . . . 74.150000000000006 109.751 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 70.1 m -133.62 161.46 34.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.767 -1.106 . . . . 64.0 109.026 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -70.04 165.87 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.18 0.514 . . . . 71.239999999999995 112.163 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.615 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . 21.9 ptt? -46.47 -44.77 17.81 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.787 1.403 . . . . 73.549999999999997 114.787 -167.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -67.09 -33.07 74.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.099 0.409 . . . . 73.239999999999995 111.24 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -96.96 0.97 49.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 73.400000000000006 111.094 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.6 t -65.12 -22.45 66.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.376 -0.375 . . . . 75.420000000000002 111.151 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.14 -30.13 76.9 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.975 -0.631 . . . . 51.43 112.605 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -85.04 -3.17 58.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.955 0.407 . . . . 75.510000000000005 110.909 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.439 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 22.8 mm-40 -82.31 -52.36 7.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.23 -0.441 . . . . 64.549999999999997 110.298 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.43 -21.44 6.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.803 -0.635 . . . . 72.400000000000006 110.679 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.36 -73.29 0.38 Allowed Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.159 -0.473 . . . . 44.039999999999999 113.525 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.494 ' HB2' ' OG ' ' A' ' 46' ' ' SER . 50.6 Cg_exo -56.01 -35.63 94.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.63 2.22 . . . . 53.229999999999997 112.008 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.619 HD12 ' HG2' ' A' ' 44' ' ' LYS . 64.1 tp -57.94 -54.29 48.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.574 -0.739 . . . . 71.5 111.856 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.705 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . . . -62.81 -30.15 71.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.018 0.437 . . . . 71.340000000000003 111.892 -175.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.942 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 9.4 mmpt? -73.23 -24.21 60.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.248 -0.433 . . . . 72.319999999999993 111.677 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -72.39 -58.69 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.8 0.296 . . . . 73.109999999999999 111.8 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.705 ' CE1' ' HA ' ' A' ' 80' ' ' ALA . 1.5 p90 -77.74 -11.37 59.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.631 -0.428 . . . . 74.010000000000005 111.176 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.1 t 65.93 34.55 7.08 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.808 0.67 . . . . 63.32 112.808 166.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.584 HG22 ' CD1' ' A' ' 83' ' ' TYR . 18.4 m -101.65 136.0 19.67 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 120.043 -0.663 . . . . 70.040000000000006 110.024 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 20.0 Cg_exo -66.47 150.83 84.07 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.69 2.26 . . . . 75.319999999999993 111.976 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.94 41.35 0.64 Allowed 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.099 2.533 . . . . 72.340000000000003 112.57 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -95.47 -47.76 6.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.954 -0.566 . . . . 70.540000000000006 109.897 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -83.46 34.86 0.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.627 -0.715 . . . . 62.210000000000001 111.266 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 131' ' ' HIS . 46.3 pt -105.74 143.32 17.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 65.099999999999994 110.708 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.69 118.13 44.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.819 -0.628 . . . . 61.340000000000003 109.847 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.0 t -96.92 120.11 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 71.239999999999995 111.263 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 tt -98.54 111.42 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.534 0.683 . . . . 62.140000000000001 109.481 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -154.69 164.8 38.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 74.549999999999997 109.944 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.81 153.74 25.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.474 0.654 . . . . 74.129999999999995 111.444 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.492 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 30.0 tt0 -119.88 94.54 4.43 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.113 -1.069 . . . . 63.229999999999997 108.113 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.639 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 2.4 pt? -60.78 -27.99 68.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.244 -0.889 . . . . 53.43 112.552 -170.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.39 -10.76 60.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.134 0.492 . . . . 73.409999999999997 110.858 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.2 mm -107.92 135.51 46.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 73.450000000000003 109.841 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.449 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 14.8 m-20 -66.44 154.22 40.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.102 0.477 . . . . 71.349999999999994 111.686 -176.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.698 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 34.7 p90 -65.41 143.51 57.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.216 -0.902 . . . . 55.310000000000002 111.164 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.03 -67.57 0.51 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.408 -0.901 . . . . 75.129999999999995 112.689 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -116.74 155.67 28.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.795 0.331 . . . . 74.109999999999999 110.196 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.588 HG22 ' HA ' ' A' ' 135' ' ' ILE . 40.9 pt -116.75 165.4 12.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.134 -0.485 . . . . 75.420000000000002 110.692 -178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.466 ' HG3' ' HB2' ' A' ' 134' ' ' ARG . 38.4 ptt180 -142.52 170.21 16.13 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.077 -0.712 . . . . 73.120000000000005 109.077 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.731 HD22 ' HB2' ' A' ' 181' ' ' LEU . 5.7 mp -128.75 119.32 24.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.061 0.458 . . . . 74.299999999999997 110.8 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -143.05 127.03 17.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.778 -0.646 . . . . 72.109999999999999 109.912 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.779 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.0 pt? -72.48 121.75 20.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.798 -0.637 . . . . 53.310000000000002 109.936 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.68 -173.6 41.35 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.874 -0.679 . . . . 32.039999999999999 111.488 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.12 -154.32 16.17 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.437 -0.411 . . . . 75.310000000000002 112.789 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.492 ' HA3' HD12 ' A' ' 118' ' ' LEU . . . -110.78 81.49 0.29 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.764 -0.731 . . . . 71.329999999999998 112.221 177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -53.83 142.65 23.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.782 0.325 . . . . 74.430000000000007 110.434 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.34 -48.43 4.03 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.918 -0.658 . . . . 54.009999999999998 112.536 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.03 -59.46 3.65 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.994 -0.622 . . . . 61.43 111.816 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.4 m80 65.62 -74.49 0.06 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.378 0.671 . . . . 73.230000000000004 112.492 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -38.03 -56.89 1.11 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.242 1.017 . . . . 54.340000000000003 113.472 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.615 ' HA3' ' HB2' ' A' ' 69' ' ' MET . . . -62.45 -64.78 3.59 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.798 -0.715 . . . . 74.109999999999999 113.679 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.492 HD12 ' HA3' ' A' ' 111' ' ' GLY . 85.5 mt -68.09 -28.36 67.29 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.83 0.307 . . . . 75.400000000000006 111.83 -173.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -67.0 -39.92 87.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.31 -0.256 . . . . 61.350000000000001 110.31 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.2 t -64.13 -43.83 94.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.978 0.418 . . . . 40.420000000000002 110.08 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 t -67.18 -46.22 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 70.420000000000002 110.711 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -61.81 -41.48 97.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.743 -0.662 . . . . 61.229999999999997 111.754 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 m -66.26 -29.36 69.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.476 -0.329 . . . . 73.409999999999997 111.496 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.97 -46.94 17.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.903 0.382 . . . . 72.099999999999994 111.077 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.34 -35.81 54.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.516 . . . . 63.450000000000003 111.731 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.37 40.12 4.3 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.487 -0.863 . . . . 64.420000000000002 111.367 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.485 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 11.5 t -129.88 176.29 8.16 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.244 -0.28 . . . . 75.530000000000001 110.244 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -138.48 21.73 2.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.79 0.329 . . . . 74.340000000000003 110.148 177.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 63.42 78.93 0.27 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.446 -0.797 . . . . 74.340000000000003 110.233 -178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -71.83 -25.21 61.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.715 -0.675 . . . . 71.150000000000006 111.404 -176.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 85.4 m-70 -140.85 120.49 13.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.724 -0.473 . . . . 75.099999999999994 109.724 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -153.49 152.12 30.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.945 0.402 . . . . 73.400000000000006 110.767 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.0 t -94.22 143.46 11.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.785 -0.643 . . . . 62.210000000000001 109.744 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 12.0 mmt180 -103.82 93.5 4.93 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.412 -0.588 . . . . 64.340000000000003 109.412 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.588 ' HA ' HG22 ' A' ' 104' ' ' ILE . 65.1 mt -92.7 108.14 19.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.186 -0.461 . . . . 73.010000000000005 110.627 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.698 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -71.17 109.74 2.96 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.637 -0.792 . . . . 45.350000000000001 111.855 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.0 m -109.61 -6.95 11.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.013 0.435 . . . . 34.340000000000003 110.602 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 87.2 170.57 46.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.828 -0.701 . . . . 50.409999999999997 112.321 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.639 ' HD2' ' O ' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -141.49 131.67 12.93 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.592 -0.521 . . . . 72.319999999999993 109.592 176.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 28.9 Cg_endo -64.81 110.78 1.54 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.526 2.151 . . . . 64.200000000000003 111.93 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 6.1 Cg_exo -78.3 69.44 7.6 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.067 2.511 . . . . 60.32 111.82 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.03 -176.68 42.31 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.699 -0.682 . . . . 45.219999999999999 111.429 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.47 -15.25 29.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.006 0.432 . . . . 75.420000000000002 109.914 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -93.67 159.22 15.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.041 -0.527 . . . . 71.129999999999995 109.66 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.49 142.42 91.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.719 -0.475 . . . . 71.310000000000002 109.719 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.434 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 7.4 Cg_endo -52.08 -11.92 1.2 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.434 2.756 . . . . 63.420000000000002 113.744 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.14 -31.23 51.82 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.802 0.334 . . . . 63.43 111.403 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.73 -31.48 19.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.385 -0.37 . . . . 75.230000000000004 111.636 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.434 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 96.7 m-85 -84.16 -19.68 33.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.245 -0.434 . . . . 53.520000000000003 111.713 -175.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.01 -23.39 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.386 -0.37 . . . . 64.140000000000001 111.92 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.7 mt -94.15 -11.46 30.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.447 -0.342 . . . . 71.319999999999993 111.91 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.13 110.72 2.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.339 0.59 . . . . 71.010000000000005 111.015 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.56 ' O ' ' HD3' ' A' ' 21' ' ' ARG . 22.9 t-20 -160.28 121.97 3.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.801 -0.636 . . . . 70.25 110.562 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -164.76 100.28 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.835 0.71 . . . . 72.019999999999996 109.727 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.24 175.52 5.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.882 -0.599 . . . . 75.319999999999993 111.063 -174.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.65 -20.6 46.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 50.119999999999997 111.628 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.453 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -66.13 -50.26 64.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.176 -0.465 . . . . 51.119999999999997 111.477 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.55 ' O ' HG23 ' A' ' 162' ' ' VAL . 1.6 mp0 -60.54 -30.36 69.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 71.340000000000003 111.206 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -55.75 -28.76 57.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 112.078 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.22 60.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.674 0.273 . . . . 62.119999999999997 111.658 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -111.92 -7.86 14.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.351 0.5 . . . . 74.329999999999998 112.351 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 158' ' ' GLU . 92.3 t -56.46 -56.68 29.35 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 121.111 -0.235 . . . . 74.5 110.916 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 20.1 Cg_endo -61.47 -34.47 85.96 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.983 1.789 . . . . 51.329999999999998 111.844 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.5 m -59.49 -42.14 91.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.865 -0.607 . . . . 75.329999999999998 110.904 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.6 mt -77.32 -52.83 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 75.439999999999998 111.378 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 162' ' ' VAL . 96.1 t -53.9 -47.41 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.382 0.512 . . . . 53.530000000000001 112.382 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -56.89 -52.11 66.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.984 0.421 . . . . 73.340000000000003 110.478 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -74.26 -41.62 60.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.789 -0.641 . . . . 74.129999999999995 111.604 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.52 -56.48 21.63 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.957 0.355 . . . . 73.25 111.957 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.94 -31.37 66.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.035 0.445 . . . . 71.230000000000004 111.66 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -80.92 -45.85 16.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.939 -0.573 . . . . 72.319999999999993 111.144 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.81 -30.87 65.98 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.374 0.509 . . . . 65.439999999999998 112.374 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.635 ' HA ' HD13 ' A' ' 176' ' ' LEU . 86.2 m -54.02 -32.0 52.93 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.219 0.451 . . . . 62.310000000000002 112.219 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.98 -33.27 75.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 75.439999999999998 110.638 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.3 tp -73.14 -27.13 61.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 72.010000000000005 111.268 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 173' ' ' THR . 8.6 mp -66.93 -35.77 80.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.066 0.46 . . . . 73.409999999999997 110.112 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.555 HD13 HG11 ' A' ' 60' ' ' VAL . 50.0 mt -80.45 -25.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.604 -0.726 . . . . 55.399999999999999 109.899 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.16 -43.19 68.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.615 -0.72 . . . . 71.230000000000004 111.075 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -134.6 -73.17 0.47 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.371 -0.377 . . . . 71.140000000000001 110.405 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 176' ' ' LEU . . . -177.55 -157.97 19.59 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.248 -0.977 . . . . 74.439999999999998 112.789 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.764 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -89.83 -5.09 57.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.556 -0.322 . . . . 71.129999999999995 110.799 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.777 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 7.0 mm-40 -55.15 -56.97 22.52 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.853 -0.612 . . . . 64.340000000000003 111.859 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.777 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 2.9 Cg_exo -75.2 -26.58 10.47 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.744 1.629 . . . . 74.439999999999998 111.633 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 188' ' ' VAL . . . -65.15 -53.3 47.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.65 -0.705 . . . . 65.219999999999999 111.232 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -60.97 -21.12 63.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 64.340000000000003 111.157 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -78.35 -55.28 5.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.371 -0.377 . . . . 71.140000000000001 110.591 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.9 t -71.64 -30.18 65.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.323 0.49 . . . . 71.230000000000004 112.323 -173.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 184' ' ' ALA . 22.8 m -82.18 -12.55 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.117 -0.364 . . . . 72.129999999999995 111.56 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -109.42 -31.49 7.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.389 -0.368 . . . . 63.130000000000003 110.945 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.44 -24.24 46.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.379 . . . . 42.310000000000002 112.02 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 72.3 m95 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.469 -0.777 . . . . 74.239999999999995 110.175 179.425 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.84 0.352 . . . . 74.120000000000005 110.502 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.88 -165.58 1.24 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.237 -0.438 . . . . 54.509999999999998 110.197 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.405 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 42.9 mt-10 -89.47 165.3 26.28 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.465 -0.568 . . . . 73.129999999999995 109.465 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 3' ' ' GLU . 71.3 Cg_exo -50.17 108.21 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.486 2.124 . . . . 65.010000000000005 112.295 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.72 152.69 18.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.007 -0.542 . . . . 63.219999999999999 111.157 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.3 tp -97.39 116.87 30.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.968 -0.56 . . . . 75.340000000000003 109.49 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.29 110.41 31.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 72.099999999999994 110.048 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.551 HG11 HG22 ' A' ' 76' ' ' VAL . 43.5 t -121.89 132.82 70.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.588 -0.278 . . . . 64.329999999999998 110.504 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 93' ' ' ILE . . . -122.13 130.78 8.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.936 -0.649 . . . . 31.41 111.8 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -72.63 144.19 47.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.238 0.542 . . . . 73.450000000000003 111.116 -176.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -156.94 -177.67 30.28 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.786 -0.721 . . . . 65.549999999999997 111.709 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 86.7 m-20 -127.37 83.25 66.53 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 110.248 -0.278 . . . . 73.519999999999996 110.248 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.9 93.62 0.1 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.8 2.334 . . . . 74.099999999999994 112.224 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.51 158.93 31.02 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.698 -0.683 . . . . 52.549999999999997 111.401 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.16 -68.1 0.07 OUTLIER 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 123.163 2.575 . . . . 75.310000000000002 113.106 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 p -75.66 -26.74 57.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.934 0.397 . . . . 74.319999999999993 111.523 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.427 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 18.4 m-85 -70.24 -24.19 63.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.981 -0.554 . . . . 73.549999999999997 111.282 -176.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.414 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . . . -73.61 -9.35 58.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.262 -0.426 . . . . 71.450000000000003 111.405 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -94.8 18.6 11.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.245 -0.434 . . . . 63.32 110.773 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.6 p -111.34 148.87 32.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.043 0.449 . . . . 63.009999999999998 111.016 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.567 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 30.5 ptt-85 -71.31 -5.73 34.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.066 -0.515 . . . . 74.420000000000002 110.557 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.534 ' CG ' HG23 ' A' ' 150' ' ' VAL . 30.6 t-80 -91.45 2.29 56.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.294 0.569 . . . . 70.25 109.949 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 18' ' ' ALA . 63.5 t30 -98.8 18.07 17.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.818 0.818 . . . . 73.129999999999995 109.206 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.4 -38.16 88.58 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.247 -0.888 . . . . 75.510000000000005 112.318 -173.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -62.51 -46.24 94.2 Favored Glycine 0 C--N 1.329 0.152 0 C-N-CA 120.529 -0.843 . . . . 60.149999999999999 112.426 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.604 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 82.5 t80 -65.08 -38.77 91.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.163 0.506 . . . . 75.319999999999993 110.706 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.4 mmt -81.92 -37.69 26.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.913 -0.585 . . . . 73.549999999999997 112.534 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 31' ' ' VAL . 53.3 t -62.23 -37.75 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.951 0.405 . . . . 61.25 110.34 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.54 78.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.023 -0.535 . . . . 63.409999999999997 110.696 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -75.61 -48.95 20.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.109 -0.496 . . . . 65.230000000000004 111.289 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 28' ' ' VAL . 35.1 m -63.15 -40.78 90.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.538 -0.301 . . . . 72.299999999999997 111.654 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 169' ' ' ALA . 66.8 mt -66.06 -41.34 90.92 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.695 0.283 . . . . 74.409999999999997 110.814 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.83 -47.5 85.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.062 -0.517 . . . . 44.210000000000001 110.468 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.89 -27.94 71.06 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.884 -0.674 . . . . 44.520000000000003 112.857 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 18.0 mmm180 -73.18 -42.83 62.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.006 0.373 . . . . 72.200000000000003 112.006 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.71 -14.89 13.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.441 0.639 . . . . 74.109999999999999 110.264 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.12 58.91 1.43 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 110.539 -1.024 . . . . 62.310000000000002 110.539 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.6 m -137.98 126.59 23.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.045 -0.577 . . . . 65.140000000000001 111.718 -171.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.88 143.03 24.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.591 -0.732 . . . . 73.040000000000006 109.429 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.608 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 2.7 t80 -141.8 -146.0 0.18 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.246 -0.279 . . . . 65.140000000000001 110.246 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -155.51 173.26 16.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.788 0.327 . . . . 73.140000000000001 111.579 -169.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 47' ' ' GLY . 2.6 p -54.09 132.2 16.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.509 -0.768 . . . . 71.019999999999996 110.079 169.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.408 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 34.7 t60 -137.23 133.98 35.72 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.713 -0.395 . . . . 63.210000000000001 111.676 -173.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 64.27 -172.79 0.17 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.565 -0.743 . . . . 72.019999999999996 112.195 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' C ' ' H ' ' A' ' 47' ' ' GLY . 33.5 ttpt -79.92 -15.01 58.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.802 0.81 . . . . 62.219999999999999 109.079 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 82' ' ' PHE . 9.7 p -81.75 25.4 0.55 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.638 -1.164 . . . . 74.310000000000002 109.238 170.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 45' ' ' LYS . . . -54.23 43.68 0.01 OUTLIER Glycine 0 C--N 1.34 0.769 0 N-CA-C 118.253 2.061 . . . . 73.530000000000001 118.253 -167.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.13 174.36 6.43 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 118.268 1.034 . . . . 63.240000000000002 108.212 165.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 58.0 mt-10 -72.1 116.52 12.61 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.065 -0.654 . . . . 74.140000000000001 109.866 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.608 ' O ' ' HB3' ' A' ' 40' ' ' PHE . 58.6 t -124.96 135.68 63.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 110.125 -0.324 . . . . 73.510000000000005 110.125 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 62' ' ' LEU . 3.1 p -125.71 110.97 25.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.339 0.59 . . . . 71.140000000000001 110.006 172.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 m -84.26 111.85 19.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.974 -0.557 . . . . 74.239999999999995 110.121 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -138.58 171.43 23.5 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.884 -0.675 . . . . 64.430000000000007 111.737 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -131.31 110.53 11.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.224 0.535 . . . . 75.140000000000001 111.137 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.526 ' HB3' ' HG2' ' A' ' 174' ' ' GLU . 6.9 mp -111.94 153.33 26.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.136 -0.69 . . . . 53.310000000000002 109.136 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.97 -73.36 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.844 0.715 . . . . 70.299999999999997 111.331 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.67 23.11 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.051 -0.595 . . . . 44.020000000000003 112.477 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.7 m -140.88 141.38 34.62 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.548 -0.383 . . . . 75.409999999999997 110.62 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.8 p -83.73 118.53 23.95 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.993 0.425 . . . . 54.0 110.008 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.52 155.72 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.168 -0.469 . . . . 55.039999999999999 110.975 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -97.03 100.54 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.907 -0.588 . . . . 62.310000000000002 109.731 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 51' ' ' VAL . 48.6 tp -95.05 115.28 27.22 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.339 -0.615 . . . . 75.329999999999998 109.339 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HB3' HG22 ' A' ' 8' ' ' VAL . . . -124.82 145.17 49.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.467 0.651 . . . . 73.439999999999998 112.295 -173.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -111.11 142.11 25.64 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.939 -1.028 . . . . 73.129999999999995 108.42 173.051 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 18.8 Cg_exo -65.95 152.59 81.0 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.368 2.045 . . . . 74.049999999999997 111.904 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -93.95 5.46 51.63 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.626 -0.879 . . . . 71.219999999999999 108.626 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.903 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 77.3 m -134.59 173.84 11.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.368 -1.287 . . . . 71.150000000000006 109.824 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.455 ' HD2' ' SD ' ' A' ' 69' ' ' MET . 17.3 p90 -85.35 -173.71 4.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 74.200000000000003 110.542 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 68' ' ' TYR . 1.7 pmm? -48.55 -46.24 38.69 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.388 0.885 . . . . 74.430000000000007 113.388 -170.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -66.16 -62.35 1.53 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 75.519999999999996 111.735 -173.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.903 ' HG3' ' HB3' ' A' ' 67' ' ' CYS . 6.2 pt-20 -87.48 18.91 3.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.469 . . . . 71.019999999999996 111.299 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.1 t -65.33 -39.2 92.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.342 -0.614 . . . . 73.230000000000004 109.342 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.51 -23.57 66.93 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.738 -0.665 . . . . 72.549999999999997 112.188 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -71.92 -17.27 62.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.74 0.305 . . . . 71.329999999999998 110.425 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -95.88 -42.62 8.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 64.519999999999996 110.537 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.551 HG22 HG11 ' A' ' 8' ' ' VAL . 25.7 t -62.23 -38.54 81.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.983 -0.553 . . . . 63.399999999999999 111.236 -177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.33 -64.56 4.27 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.879 -0.6 . . . . 65.209999999999994 113.257 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.05 -41.23 70.17 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.646 2.23 . . . . 74.109999999999999 112.31 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.1 tp -54.85 -48.65 72.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.28 -0.418 . . . . 54.43 111.113 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.83 88.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.167 -0.47 . . . . 51.039999999999999 111.334 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -75.98 -35.22 59.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.177 -0.465 . . . . 72.400000000000006 111.291 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' HD2' ' HB3' ' A' ' 46' ' ' SER . 21.5 m-85 -71.74 -20.14 61.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.78 0.324 . . . . 72.420000000000002 111.086 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -98.74 -1.37 40.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.292 -0.413 . . . . 75.430000000000007 110.871 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m 59.73 29.61 19.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.643 -0.708 . . . . 72.150000000000006 111.767 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.23 149.06 35.29 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 61.119999999999997 110.601 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 90' ' ' ILE . 14.1 Cg_exo -70.35 110.31 2.64 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.079 2.519 . . . . 71.329999999999998 112.046 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.523 ' HB3' HD22 ' A' ' 125' ' ' LEU . 23.1 Cg_exo -65.1 -11.92 32.21 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.158 2.572 . . . . 75.420000000000002 112.42 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -78.94 -43.29 24.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.261 -0.427 . . . . 63.439999999999998 110.174 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -96.63 0.71 50.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.12 -0.491 . . . . 71.420000000000002 112.155 -170.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 40.2 pt -75.47 174.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.806 -0.357 . . . . 54.520000000000003 110.425 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 p -119.88 125.26 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.331 0.586 . . . . 73.510000000000005 110.98 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 131' ' ' HIS . 98.1 t -119.32 123.8 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 53.219999999999999 110.448 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.522 ' HB ' ' HA2' ' A' ' 9' ' ' GLY . 48.8 mm -75.57 130.63 36.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.693 -0.685 . . . . 74.140000000000001 109.6 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.403 ' HE1' ' HA3' ' A' ' 114' ' ' GLY . 31.5 t-80 -136.6 157.58 46.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.118 0.485 . . . . 71.549999999999997 110.469 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -86.77 152.76 22.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.875 -0.602 . . . . 71.530000000000001 110.688 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.747 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 26.9 tt0 -128.07 93.78 3.76 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.915 -0.772 . . . . 65.230000000000004 108.915 168.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 139' ' ' ARG . 4.0 pp -84.02 0.09 49.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.027 -0.988 . . . . 60.219999999999999 112.04 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.438 ' HB2' ' HA2' ' A' ' 113' ' ' GLY . 27.9 t70 -87.08 -38.94 16.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.163 0.506 . . . . 74.219999999999999 110.351 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.44 152.06 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.462 -0.79 . . . . 53.219999999999999 109.852 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.503 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 5.1 p-10 -64.39 159.97 20.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.377 0.608 . . . . 70.519999999999996 111.61 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 0.8 OUTLIER -72.59 135.69 45.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.132 -0.94 . . . . 64.329999999999998 112.027 -176.66 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.02 -64.06 0.53 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.235 -0.983 . . . . 62.310000000000002 113.278 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -85.88 145.62 27.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.797 0.332 . . . . 72.409999999999997 110.839 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.568 HG12 HG21 ' A' ' 188' ' ' VAL . 30.7 pt -117.27 149.85 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.481 -0.562 . . . . 70.200000000000003 109.481 174.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -157.03 137.22 12.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.852 0.358 . . . . 70.219999999999999 110.949 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 4.0 pp -96.68 153.47 17.85 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.757 -0.46 . . . . 62.340000000000003 109.757 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -147.39 115.54 6.56 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.771 -0.455 . . . . 71.230000000000004 109.771 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 129' ' ' ASN . 0.7 OUTLIER -80.91 90.12 5.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.828 0.823 . . . . 73.519999999999996 110.326 177.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.28 -127.09 1.63 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.385 -0.825 . . . . 62.509999999999998 111.385 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.08 163.17 32.96 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.299 -0.721 . . . . 75.420000000000002 111.299 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.8 94.66 0.68 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.641 -0.79 . . . . 64.409999999999997 112.492 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.91 142.12 12.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.136 0.494 . . . . 72.299999999999997 111.334 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 98' ' ' ASP . . . 96.88 -76.12 0.7 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.041 -0.599 . . . . 63.25 112.972 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.403 ' HA3' ' HE1' ' A' ' 94' ' ' HIS . . . -80.28 63.78 4.09 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.046 -0.597 . . . . 71.099999999999994 112.93 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -62.67 -27.1 69.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.778 0.288 . . . . 74.140000000000001 111.778 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -65.51 -29.93 70.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.312 0.577 . . . . 73.319999999999993 110.786 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.43 20.56 29.97 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.59 -0.814 . . . . 64.420000000000002 112.308 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 118' ' ' LEU . 33.5 mt -84.5 -59.51 2.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.881 -0.328 . . . . 72.430000000000007 111.276 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HD2' ' N ' ' A' ' 119' ' ' ARG . 3.7 mpt_? -73.65 -35.78 65.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.35 -0.386 . . . . 74.540000000000006 110.58 -174.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 p -56.42 -43.96 79.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 54.43 111.233 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.461 ' HB ' HH22 ' A' ' 132' ' ' ARG . 48.9 t -85.33 -41.62 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 54.530000000000001 111.889 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.37 -47.16 71.2 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.051 0.389 . . . . 64.140000000000001 112.051 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.2 m -66.93 -24.53 66.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.659 0.266 . . . . 61.109999999999999 111.18 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.43 -45.6 37.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.758 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 87' ' ' PRO . 90.6 mt -72.58 -34.98 67.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 73.430000000000007 110.384 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.61 -12.56 20.86 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.907 -0.663 . . . . 73.239999999999995 113.15 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -169.56 177.57 4.53 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.167 0.508 . . . . 72.049999999999997 111.579 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 2.5 mptt -110.34 -110.97 0.33 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.587 -0.894 . . . . 75.439999999999998 108.587 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.477 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 64.3 t30 64.96 -9.89 0.18 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.708 0.803 . . . . 64.120000000000005 113.054 174.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.408 ' H ' ' C ' ' A' ' 128' ' ' LYS . 10.4 t80 -179.79 -157.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.659 -0.867 . . . . 71.140000000000001 108.659 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.593 ' O ' ' HD2' ' A' ' 132' ' ' ARG . 11.6 p-80 44.87 41.08 4.86 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.937 0.895 . . . . 65.319999999999993 113.067 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.593 ' HD2' ' O ' ' A' ' 131' ' ' HIS . 2.7 mpt_? -131.01 107.03 8.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.786 -0.643 . . . . 71.540000000000006 109.906 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 106' ' ' LEU . 58.8 t -119.18 109.95 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.943 -0.762 . . . . 64.230000000000004 108.943 174.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.747 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 90.2 mtm180 -92.14 122.64 34.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.088 0.471 . . . . 61.409999999999997 111.651 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 135' ' ' ILE . 2.1 mp -99.88 115.03 40.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.946 -0.761 . . . . 44.32 108.946 172.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -63.52 109.13 2.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.881 -0.676 . . . . 71.150000000000006 111.472 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.567 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 30.8 m -101.4 -18.7 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.562 0.22 . . . . 74.409999999999997 111.491 -176.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 107.92 139.66 9.08 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.424 -0.893 . . . . 75.219999999999999 112.664 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 6.1 ptp180 -80.88 133.5 54.86 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.032 0.444 . . . . 73.420000000000002 111.586 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 22.3 Cg_exo -65.23 128.99 21.66 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.303 2.669 . . . . 64.409999999999997 112.499 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 5.9 Cg_exo -78.86 45.67 1.97 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.191 2.594 . . . . 73.510000000000005 112.272 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.87 143.74 10.95 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.044 -0.823 . . . . 71.140000000000001 111.044 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 143' ' ' ARG . 18.1 mmt180 -89.58 58.39 4.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.513 0.673 . . . . 62.100000000000001 111.446 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -131.0 160.49 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.101 -0.954 . . . . 73.400000000000006 109.296 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -66.49 141.09 96.9 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.263 -0.643 . . . . 71.120000000000005 109.263 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.8 -14.37 1.22 Allowed 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.552 2.835 . . . . 71.230000000000004 113.915 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.32 28.62 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.588 0.355 . . . . 75.239999999999995 111.813 174.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.75 -41.63 13.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.146 0.498 . . . . 74.409999999999997 111.228 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -73.61 -19.81 60.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 61.25 111.76 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.534 HG23 ' CG ' ' A' ' 22' ' ' HIS . 14.5 p -65.21 -22.52 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.246 -0.434 . . . . 74.340000000000003 111.49 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.52 -27.76 13.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.62 -0.264 . . . . 72.140000000000001 111.36 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -165.43 109.7 0.86 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.259 0.552 . . . . 71.239999999999995 111.467 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -164.27 31.79 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.823 -0.626 . . . . 65.349999999999994 110.125 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -60.23 124.57 20.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.311 0.577 . . . . 74.150000000000006 111.142 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.17 176.32 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.459 -0.791 . . . . 64.319999999999993 110.289 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.65 -54.46 5.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.837 0.351 . . . . 74.439999999999998 111.741 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.39 -23.77 66.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.208 0.818 . . . . 54.340000000000003 113.208 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.71 -23.7 66.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.067 0.461 . . . . 74.310000000000002 110.698 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.452 ' HA ' HG23 ' A' ' 162' ' ' VAL . 22.7 mmm180 -69.41 -22.37 63.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.747 -0.661 . . . . 72.530000000000001 111.417 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.36 -33.21 73.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.281 -0.418 . . . . 61.0 111.711 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 165' ' ' ILE . 8.9 mm-40 -97.04 1.48 50.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.885 0.328 . . . . 62.509999999999998 111.885 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' A' ' 163' ' ' PRO . 95.1 t -60.82 -53.39 64.65 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.772 -0.194 . . . . 73.209999999999994 111.373 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 30.7 Cg_endo -64.64 -25.62 61.78 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.772 1.648 . . . . 74.439999999999998 111.794 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.1 m -63.32 -51.17 67.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.624 -0.716 . . . . 75.430000000000007 110.945 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 161' ' ' GLU . 78.9 mt -54.49 -38.17 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.938 -0.573 . . . . 64.239999999999995 111.727 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.25 -51.44 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 63.240000000000002 111.363 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -80.97 -30.44 35.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.406 -0.361 . . . . 74.319999999999993 111.563 -176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -67.12 -43.18 83.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 72.200000000000003 110.961 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.418 ' HB3' HD21 ' A' ' 32' ' ' LEU . . . -60.09 -37.9 81.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 73.310000000000002 111.29 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.78 92.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.896 0.379 . . . . 55.420000000000002 111.548 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.81 -41.61 78.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.85 0.357 . . . . 74.420000000000002 110.977 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.75 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.042 -0.527 . . . . 61.420000000000002 112.279 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 23.6 p -62.86 -48.63 78.19 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.218 0.451 . . . . 65.239999999999995 112.218 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.526 ' HG2' ' HB3' ' A' ' 55' ' ' LEU . 40.3 mt-10 -64.99 -29.66 70.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.742 -0.208 . . . . 75.129999999999995 111.347 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.522 HD23 ' HA ' ' A' ' 184' ' ' ALA . 22.0 tp -74.54 -31.77 62.23 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.749 -0.38 . . . . 53.420000000000002 110.38 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 181' ' ' LEU . 70.6 mt -62.18 -45.1 94.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.245 0.545 . . . . 65.239999999999995 110.121 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 59.8 mt -71.02 -28.63 33.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.367 -0.833 . . . . 62.43 110.274 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -59.06 5.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.556 -0.747 . . . . 62.350000000000001 111.186 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -178.1 -49.61 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.849 0.314 . . . . 70.329999999999998 111.849 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.14 116.82 5.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.637 -0.792 . . . . 55.229999999999997 113.71 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.682 ' HA ' HD23 ' A' ' 176' ' ' LEU . 10.2 mp -77.63 -44.24 28.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.01 0.433 . . . . 63.43 110.658 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.588 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 45.5 mt-10 -72.56 -44.07 9.34 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.195 -0.457 . . . . 73.150000000000006 111.697 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 74.8 Cg_exo -52.12 -35.89 64.03 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.532 1.488 . . . . 75.109999999999999 111.918 170.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.522 ' HA ' HD23 ' A' ' 175' ' ' LEU . . . -73.31 -38.01 65.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.38 -0.373 . . . . 70.209999999999994 111.682 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 12.6 pt20 -71.36 -27.49 63.39 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.535 -0.466 . . . . 71.510000000000005 109.906 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -86.34 -32.09 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 72.120000000000005 111.69 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 184' ' ' ALA . 13.1 t -61.87 -50.42 72.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.96 -0.296 . . . . 61.420000000000002 111.062 -176.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.568 HG21 HG12 ' A' ' 104' ' ' ILE . 9.4 p -67.39 -26.45 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 121.569 0.7 . . . . 55.399999999999999 110.299 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -69.69 -31.7 69.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.377 -0.829 . . . . 51.140000000000001 110.318 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -93.61 -6.58 46.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.886 -0.597 . . . . 23.329999999999998 111.75 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.9 m95 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.664 -0.684 . . . . 73.349999999999994 110.585 175.843 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.747 -0.464 . . . . 75.219999999999999 109.747 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.52 88.04 7.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.942 0.401 . . . . 64.329999999999998 110.558 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 8.8 pt-20 -101.81 105.59 42.24 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.755 -0.657 . . . . 64.439999999999998 109.778 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.907 ' HB2' HG23 ' A' ' 61' ' ' VAL . 56.4 Cg_endo -92.27 117.28 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.987 2.458 . . . . 73.409999999999997 113.318 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.646 ' HB2' HG12 ' A' ' 60' ' ' VAL . 70.9 mt -67.67 145.17 55.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 71.340000000000003 109.935 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.581 HD23 HG12 ' A' ' 90' ' ' ILE . 57.3 tp -93.32 109.36 20.91 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.107 -0.331 . . . . 72.420000000000002 110.107 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.58 113.12 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.496 . . . . 63.530000000000001 110.366 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.02 164.1 22.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.232 -0.44 . . . . 74.239999999999995 110.602 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.29 -178.66 39.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.601 -0.809 . . . . 51.039999999999999 112.25 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.476 HD21 ' CE1' ' A' ' 94' ' ' HIS . 86.3 mt -67.55 126.48 29.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.69 0.281 . . . . 73.540000000000006 110.966 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.98 177.73 52.09 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.934 -0.651 . . . . 30.109999999999999 113.149 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 30.0 t-20 -124.63 108.06 28.94 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 110.048 -0.353 . . . . 64.439999999999998 110.048 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 4.6 Cg_exo -76.75 -33.26 3.05 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.41 2.74 . . . . 43.340000000000003 114.117 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.92 147.81 15.01 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.889 -1.148 . . . . 44.530000000000001 113.104 -174.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.02 -31.83 94.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.553 2.835 . . . . 73.349999999999994 113.34 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 m -61.05 -39.14 88.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.293 0.568 . . . . 72.420000000000002 110.879 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.573 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 91.0 m-85 -97.17 2.5 51.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.53 -0.759 . . . . 74.109999999999999 110.52 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.426 ' CB ' HD21 ' A' ' 12' ' ' ASN . . . -71.28 -18.46 62.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.763 0.653 . . . . 72.040000000000006 112.763 -171.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -92.53 18.84 7.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.697 0.284 . . . . 73.430000000000007 111.228 -175.151 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.636 HG21 ' O ' ' A' ' 151' ' ' LEU . 59.8 p -113.95 -174.08 2.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.277 0.56 . . . . 71.549999999999997 111.904 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.601 ' HD2' ' HB ' ' A' ' 137' ' ' VAL . 5.0 ptt180 -94.47 1.53 55.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.513 -0.767 . . . . 73.200000000000003 112.85 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.617 ' HB3' HG22 ' A' ' 150' ' ' VAL . 3.6 p-80 -94.74 10.8 33.68 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.414 -0.515 . . . . 74.329999999999998 111.496 -176.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -139.15 35.04 2.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.075 0.464 . . . . 74.540000000000006 110.757 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.9 mt -56.04 -46.56 78.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.427 -0.806 . . . . 73.519999999999996 111.796 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.94 -51.19 60.67 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.999 -0.546 . . . . 70.030000000000001 113.013 -174.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -57.82 -38.3 75.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 73.310000000000002 111.289 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 90.1 mtp -73.01 -54.43 8.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.56 -0.291 . . . . 74.299999999999997 111.388 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.468 HG12 HD23 ' A' ' 32' ' ' LEU . 57.7 t -61.21 -44.2 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 71.519999999999996 111.558 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.516 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -58.78 -53.24 60.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 51.109999999999999 112.138 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.73 -37.12 81.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.169 0.433 . . . . 60.039999999999999 112.169 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.63 -32.02 34.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.603 -0.439 . . . . 53.130000000000003 112.117 -175.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.6 pp -76.41 -33.27 58.82 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.462 -0.495 . . . . 71.329999999999998 110.577 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -70.0 -34.04 72.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.263 0.554 . . . . 51.009999999999998 110.279 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.88 -18.68 57.51 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.508 -0.769 . . . . 63.509999999999998 113.088 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -64.02 -39.38 93.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.026 0.413 . . . . 73.319999999999993 111.651 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 36' ' ' ILE . 3.9 mp -83.11 -14.47 11.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.702 0.763 . . . . 74.439999999999998 109.553 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.98 13.69 54.04 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.87 -1.292 . . . . 71.010000000000005 109.87 -171.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.2 m -87.71 113.19 23.16 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.307 -0.946 . . . . 75.439999999999998 111.197 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.91 128.32 9.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.282 -0.417 . . . . 73.319999999999993 110.782 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.534 ' CD1' HG23 ' A' ' 51' ' ' VAL . 4.5 m-85 -102.76 -157.36 0.61 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.973 -0.558 . . . . 65.319999999999993 109.721 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -140.91 172.36 12.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.818 -0.353 . . . . 74.239999999999995 110.961 -173.12 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.797 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 3.3 p -55.83 105.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.748 0.785 . . . . 74.340000000000003 110.464 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.49 ' H ' ' HA ' ' A' ' 49' ' ' GLU . 39.8 t-80 -104.76 145.05 30.91 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.501 -0.772 . . . . 74.120000000000005 109.433 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -65.97 -77.11 0.07 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.176 -0.466 . . . . 54.210000000000001 111.277 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.587 ' HE3' ' HD2' ' A' ' 82' ' ' PHE . 28.8 mmmt 47.26 -133.27 1.18 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.501 -0.555 . . . . 54.350000000000001 109.501 -172.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 p -105.97 -39.46 6.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.389 -0.925 . . . . 65.409999999999997 112.725 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.726 ' HA3' ' HB3' ' A' ' 75' ' ' GLN . . . -133.01 -24.18 0.73 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 118.4 -1.857 . . . . 53.240000000000002 117.055 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.72 162.01 36.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.678 1.362 . . . . 51.520000000000003 114.678 -160.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.797 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 23.0 mt-10 -74.94 135.98 41.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.182 -1.372 . . . . 73.540000000000006 108.75 170.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.61 140.11 49.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.002 0.43 . . . . 72.299999999999997 111.654 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.779 HG13 ' HB3' ' A' ' 62' ' ' LEU . 2.4 p -124.41 114.76 42.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.717 -0.674 . . . . 75.409999999999997 109.953 171.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 m -95.65 131.22 42.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 74.430000000000007 110.505 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.23 -161.16 29.38 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.374 -0.69 . . . . 74.140000000000001 111.374 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -131.41 132.69 44.55 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.896 0.379 . . . . 73.310000000000002 110.458 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.1 mt -102.93 126.56 50.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.983 -0.553 . . . . 64.420000000000002 109.593 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 178' ' ' ALA . . . 68.97 -47.92 0.58 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.009 0.818 . . . . 65.420000000000002 111.778 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.11 -41.62 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.079 -0.581 . . . . 62.32 112.397 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.685 ' HB ' HG22 ' A' ' 177' ' ' ILE . 6.8 m -84.46 141.52 30.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.781 0.324 . . . . 44.329999999999998 110.965 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 3.7 p -70.22 143.3 52.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 74.109999999999999 111.353 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 177' ' ' ILE . 20.5 m -143.67 158.14 16.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.081 0.467 . . . . 52.039999999999999 111.297 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.907 HG23 ' HB2' ' A' ' 4' ' ' PRO . 85.0 t -112.07 104.93 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.675 -0.693 . . . . 65.340000000000003 109.186 172.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.779 ' HB3' HG13 ' A' ' 51' ' ' VAL . 3.0 tm? -95.84 118.72 33.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.552 -0.536 . . . . 71.25 109.552 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -134.64 131.15 37.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.733 -0.667 . . . . 71.209999999999994 109.96 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -127.59 135.23 27.15 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.942 0.401 . . . . 64.239999999999995 110.882 -178.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 1.4 Cg_endo -83.8 164.45 13.86 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.104 2.536 . . . . 61.119999999999997 111.918 176.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 68.3 mtt180 -112.19 17.1 19.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.37 0.605 . . . . 72.099999999999994 109.82 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 52.9 m -112.03 164.2 13.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.477 -0.783 . . . . 62.310000000000002 110.146 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -66.18 167.95 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.282 -0.417 . . . . 63.409999999999997 110.998 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 19.3 ptp -55.23 -32.44 62.28 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.855 0.687 . . . . 74.340000000000003 112.855 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -72.1 -24.33 61.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.11 0.481 . . . . 75.519999999999996 110.585 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 12.5 mm-40 -102.91 -10.3 19.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.923 -0.581 . . . . 72.019999999999996 110.996 -175.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.5 m -61.56 -51.8 67.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 73.030000000000001 111.676 -173.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.872 ' HA3' ' HA ' ' A' ' 121' ' ' VAL . . . -62.03 -23.83 64.25 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.193 -0.527 . . . . 53.0 113.276 -174.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -61.97 -37.9 86.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.039 0.447 . . . . 73.540000000000006 110.974 -176.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.726 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 12.9 mm100 -92.19 -20.43 21.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.931 -0.577 . . . . 74.319999999999993 110.996 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 72' ' ' SER . 95.7 t -73.69 -36.27 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 72.030000000000001 111.015 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.716 ' HA2' ' HB3' ' A' ' 125' ' ' LEU . . . -52.12 -68.45 1.56 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.991 -0.549 . . . . 74.019999999999996 112.973 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -58.11 -28.85 85.21 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.629 2.22 . . . . 74.310000000000002 112.495 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.94 -48.78 77.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 73.519999999999996 110.24 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.55 90.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.004 -0.544 . . . . 63.530000000000001 111.491 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.66 -20.19 59.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.288 -0.415 . . . . 45.229999999999997 111.564 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HD2' ' HE3' ' A' ' 45' ' ' LYS . 4.8 m-30 -74.21 -20.19 60.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.497 -0.32 . . . . 74.230000000000004 110.728 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -106.99 -11.74 15.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.51 -0.314 . . . . 70.099999999999994 110.833 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.0 t 61.74 36.3 16.41 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.627 -0.715 . . . . 64.420000000000002 110.529 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.4 m -74.11 142.76 79.53 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 110.619 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.89 128.32 25.12 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.869 2.38 . . . . 54.43 112.079 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.55 -9.39 18.0 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.02 2.48 . . . . 65.340000000000003 112.633 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.68 -12.75 55.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.113 -0.494 . . . . 73.450000000000003 110.903 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -105.31 24.79 11.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 75.230000000000004 111.186 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.581 HG12 HD23 ' A' ' 6' ' ' LEU . 62.6 mt -89.07 109.84 20.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.412 . . . . 70.319999999999993 111.196 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.785 HG12 ' HB3' ' A' ' 131' ' ' HIS . 32.6 m -113.42 141.7 28.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.468 -0.568 . . . . 61.100000000000001 109.468 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.01 130.16 51.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.318 0.58 . . . . 63.030000000000001 111.989 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.1 mm -85.28 118.0 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.55 -0.75 . . . . 74.329999999999998 109.291 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.476 ' CE1' HD21 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -137.61 170.26 16.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.411 0.624 . . . . 73.219999999999999 111.482 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -90.35 145.71 24.74 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.703 -1.135 . . . . 65.019999999999996 111.973 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 7.2 mm-40 -140.43 119.42 12.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.624 -0.716 . . . . 73.310000000000002 109.778 169.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.541 ' HB2' ' HG2' ' A' ' 139' ' ' ARG . 1.7 pp -83.77 -0.15 49.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.523 -0.762 . . . . 55.229999999999997 112.529 -174.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.416 ' OD2' HG13 ' A' ' 99' ' ' ILE . 3.4 p-10 -77.29 -10.85 59.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 71.209999999999994 111.383 -174.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.416 HG13 ' OD2' ' A' ' 98' ' ' ASP . 61.3 mt -135.17 149.72 29.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.956 -0.757 . . . . 64.299999999999997 108.956 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.05 179.1 7.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.453 -0.573 . . . . 75.349999999999994 109.453 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -66.17 123.79 20.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.091 0.472 . . . . 73.150000000000006 110.382 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.18 -118.13 0.78 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.789 -0.925 . . . . 74.299999999999997 110.789 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -83.4 132.99 34.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.265 0.533 . . . . 73.530000000000001 110.064 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.3 pt -97.69 166.16 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.995 -0.548 . . . . 63.509999999999998 110.703 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -126.6 127.85 45.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.235 0.54 . . . . 75.010000000000005 110.785 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.692 HD13 HG21 ' A' ' 188' ' ' VAL . 10.0 mp -104.71 111.88 24.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.979 -0.555 . . . . 62.0 110.947 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -143.58 135.77 26.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.581 -0.736 . . . . 65.25 109.201 176.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.5 pp -85.75 125.73 33.45 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 61.200000000000003 110.015 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.58 179.26 38.56 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.654 -0.703 . . . . 61.149999999999999 111.544 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.1 -156.95 6.8 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.011 -0.614 . . . . 74.549999999999997 112.594 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.62 ' HA3' HD13 ' A' ' 118' ' ' LEU . . . -78.8 130.98 10.34 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.021 -0.609 . . . . 75.099999999999994 112.141 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -105.91 -30.92 9.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.77 0.319 . . . . 64.019999999999996 110.467 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.79 -4.86 63.26 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.843 -0.694 . . . . 75.010000000000005 112.862 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.2 103.58 0.09 OUTLIER Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.019 -0.61 . . . . 61.210000000000001 112.525 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.652 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 32.0 m-70 -138.83 142.42 38.66 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.04 -0.356 . . . . 74.099999999999994 110.04 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -66.89 -44.84 79.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 72.530000000000001 111.243 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.34 11.91 3.69 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.056 -0.592 . . . . 74.510000000000005 113.664 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.652 ' HG ' ' HB2' ' A' ' 115' ' ' HIS . 95.9 mt -84.28 -51.35 7.07 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.606 -0.35 . . . . 75.310000000000002 110.599 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -79.02 -28.78 43.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.928 -0.578 . . . . 70.209999999999994 110.821 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.6 m -61.86 -32.72 73.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.081 0.467 . . . . 74.239999999999995 110.777 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.872 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 68.3 t -84.4 -47.26 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.445 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' HA ' ' CG2' ' A' ' 127' ' ' THR . . . -57.5 -55.79 30.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.759 -0.655 . . . . 73.129999999999995 112.45 -174.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.6 m -66.52 -21.64 66.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.024 0.379 . . . . 75.510000000000005 112.024 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.82 -52.09 64.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.803 0.297 . . . . 73.120000000000005 111.803 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.716 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 1.4 pt? -110.17 3.75 20.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.786 -0.366 . . . . 72.310000000000002 111.385 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.92 20.04 61.98 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.68 -0.772 . . . . 64.099999999999994 112.852 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.465 ' CG2' ' HA ' ' A' ' 122' ' ' ALA . 13.0 t -85.91 167.47 15.08 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.927 -0.397 . . . . 74.019999999999996 109.927 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 12.0 mptt -119.82 8.21 11.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.438 -0.346 . . . . 70.120000000000005 110.16 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 59.58 62.99 1.61 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.756 -0.656 . . . . 70.340000000000003 109.67 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -57.91 -70.58 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.282 -0.872 . . . . 64.299999999999997 111.718 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.785 ' HB3' HG12 ' A' ' 91' ' ' VAL . 34.8 t60 -99.55 86.71 3.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.115 0.483 . . . . 60.350000000000001 109.964 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -96.16 121.94 38.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.833 -0.621 . . . . 70.5 110.402 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -83.24 126.96 40.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.158 -0.682 . . . . 52.140000000000001 109.158 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -106.64 103.03 12.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.111 -0.495 . . . . 64.109999999999999 110.833 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 66.8 mt -96.53 128.06 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.879 -0.6 . . . . 64.420000000000002 109.857 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.95 115.3 7.11 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.818 -0.706 . . . . 74.200000000000003 111.81 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.601 ' HB ' ' HD2' ' A' ' 21' ' ' ARG . 35.0 m -100.88 -20.38 5.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.703 0.287 . . . . 74.439999999999998 111.061 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.31 151.4 1.73 Allowed Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.067 -0.515 . . . . 74.109999999999999 112.857 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.541 ' HG2' ' HB2' ' A' ' 97' ' ' LEU . 1.6 ppt_? -158.52 138.06 8.47 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.635 -0.332 . . . . 74.519999999999996 110.174 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 22.9 Cg_endo -93.54 134.14 0.97 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.218 2.612 . . . . 73.239999999999995 112.036 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.33 132.12 24.99 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.224 1.95 . . . . 73.140000000000001 111.718 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -159.04 179.17 34.86 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.562 -0.828 . . . . 74.109999999999999 111.858 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 143' ' ' ARG . 2.9 mpt_? -87.62 9.89 19.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.494 0.664 . . . . 74.150000000000006 110.106 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -124.73 131.59 53.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.873 -1.058 . . . . 74.329999999999998 108.431 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.9 149.95 62.61 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.944 0.402 . . . . 74.519999999999996 110.82 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.712 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 41.4 Cg_endo -66.92 4.6 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.345 2.697 . . . . 64.030000000000001 114.093 -172.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . -61.24 -39.22 89.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 53.030000000000001 110.636 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.72 -36.17 62.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.166 0.508 . . . . 72.239999999999995 110.543 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.712 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 95.8 m-85 -71.29 -24.61 62.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 73.439999999999998 111.513 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 22' ' ' HIS . 9.0 p -85.31 -15.21 10.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.887 0.375 . . . . 73.230000000000004 110.872 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.636 ' O ' HG21 ' A' ' 20' ' ' THR . 87.4 mt -84.01 -37.83 21.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.415 -0.357 . . . . 64.120000000000005 111.766 -177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -162.96 101.28 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.401 0.619 . . . . 73.530000000000001 111.482 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -160.06 115.21 2.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.714 -0.675 . . . . 73.219999999999999 110.196 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -134.19 145.04 48.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.727 -0.669 . . . . 54.100000000000001 109.612 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 0.2 OUTLIER -137.68 -160.01 1.01 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.226 -0.287 . . . . 74.530000000000001 110.226 -175.65 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.463 ' H ' HG22 ' A' ' 155' ' ' THR . . . -82.45 -29.0 30.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.835 0.35 . . . . 63.140000000000001 111.31 176.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.15 -60.54 2.19 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.095 0.776 . . . . 65.319999999999993 113.095 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -34.7 69.1 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.966 0.358 . . . . 70.099999999999994 111.966 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 155' ' ' THR . 7.2 mmp_? -60.79 -31.31 70.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.906 0.384 . . . . 74.340000000000003 110.678 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.38 -28.03 65.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 64.129999999999995 111.391 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -87.87 -19.05 27.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.011 -0.54 . . . . 61.43 111.102 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.658 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 88.7 t -50.63 -55.37 27.08 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 112.821 0.675 . . . . 73.010000000000005 112.821 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 77.5 Cg_exo -51.48 -33.8 48.87 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.364 2.043 . . . . 72.540000000000006 112.992 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.0 m -80.21 -46.7 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.458 . . . . 73.439999999999998 110.787 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.482 ' HA ' ' HB3' ' A' ' 168' ' ' GLN . 1.6 mp -59.51 -34.57 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 70.5 111.906 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 162' ' ' VAL . 85.6 t -55.37 -46.54 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.902 0.382 . . . . 52.549999999999997 111.152 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -79.11 -37.56 38.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.073 0.463 . . . . 73.030000000000001 110.221 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 165' ' ' ILE . 7.7 tt0 -61.3 -46.86 88.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.478 -0.783 . . . . 74.540000000000006 111.462 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.47 90.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 65.450000000000003 110.623 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.45 90.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.6 . . . . 63.450000000000003 110.729 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.52 -36.08 79.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.229 0.538 . . . . 75.010000000000005 110.605 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 176' ' ' LEU . . . -68.21 -47.74 67.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.717 -0.674 . . . . 72.209999999999994 111.026 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 21.5 p -66.77 -42.69 85.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.577 -0.283 . . . . 74.219999999999999 111.407 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -57.1 -56.42 21.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 73.239999999999995 111.202 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.35 -29.16 67.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.596 -0.274 . . . . 74.340000000000003 111.428 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.566 HD22 ' HA ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -60.48 -46.63 89.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.305 0.574 . . . . 74.430000000000007 109.576 178.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.705 HD13 HG11 ' A' ' 60' ' ' VAL . 62.9 mt -80.09 -30.34 12.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.356 -0.838 . . . . 74.040000000000006 110.809 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.469 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . . . -71.66 -47.39 54.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 61.130000000000003 111.838 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.15 -75.14 0.6 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.3 -0.409 . . . . 63.100000000000001 110.638 -174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.58 -172.78 38.63 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.42 -0.895 . . . . 53.310000000000002 112.385 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 181' ' ' LEU . 1.1 pt? -94.31 -26.25 16.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.606 0.241 . . . . 50.420000000000002 111.184 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 39.8 mt-10 -66.91 -47.29 54.0 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 111.981 0.363 . . . . 74.140000000000001 111.981 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 32.9 Cg_endo -65.94 -29.51 49.35 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.373 1.382 . . . . 72.219999999999999 111.877 174.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.66 -48.93 62.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.862 -0.608 . . . . 50.439999999999998 111.304 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.568 ' HA ' HG22 ' A' ' 188' ' ' VAL . 8.2 pt20 -60.99 -33.08 72.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.831 0.348 . . . . 63.409999999999997 111.062 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -69.97 -26.17 63.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.933 0.397 . . . . 73.420000000000002 110.628 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 31.4 m -86.28 -41.82 14.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.094 -0.503 . . . . 75.299999999999997 111.203 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.692 HG21 HD13 ' A' ' 106' ' ' LEU . 33.2 m -71.0 -20.24 21.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.871 0.367 . . . . 62.100000000000001 111.47 -178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -97.23 16.03 21.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.453 0.644 . . . . 62.020000000000003 109.79 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -105.59 17.03 24.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.909 -0.587 . . . . 72.129999999999995 110.286 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 87.3 m95 . . . . . 0 C--O 1.247 0.948 0 CA-C-N 115.681 -0.69 . . . . 73.5 109.962 179.719 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 121.138 0.494 . . . . 75.140000000000001 110.689 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.09 90.62 2.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.638 -0.71 . . . . 74.099999999999994 109.505 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 6.6 pt-20 -116.69 151.54 47.31 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.678 -0.692 . . . . 73.219999999999999 110.68 -173.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 59' ' ' SER . 21.5 Cg_exo -64.69 108.82 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.901 2.401 . . . . 72.219999999999999 112.862 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.676 HD12 HG22 ' A' ' 177' ' ' ILE . 87.8 mt -95.24 156.64 16.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.92 -0.582 . . . . 70.530000000000001 109.652 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.594 HD23 HD12 ' A' ' 90' ' ' ILE . 34.1 tp -108.25 120.75 43.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.941 0.4 . . . . 74.140000000000001 110.75 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 t -118.53 116.97 53.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.862 -0.608 . . . . 72.420000000000002 109.883 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.741 ' HB ' HG22 ' A' ' 92' ' ' VAL . 35.3 t -114.81 143.7 23.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.474 -0.33 . . . . 75.450000000000003 110.473 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.58 157.11 20.25 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.824 -0.703 . . . . 62.43 111.553 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.492 ' H ' ' HA3' ' A' ' 25' ' ' GLY . 61.9 mt -66.43 115.78 6.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 73.409999999999997 109.688 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -83.96 -179.07 51.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.029 -0.605 . . . . 71.129999999999995 113.565 -171.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -94.16 124.16 56.79 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.963 0.411 . . . . 74.25 110.456 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.495 ' HG2' ' HB2' ' A' ' 17' ' ' TYR . 74.2 Cg_endo -88.54 -6.28 6.05 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.759 2.306 . . . . 72.319999999999993 113.469 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.5 171.21 28.39 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.722 -0.751 . . . . 75.439999999999998 112.131 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.4 -52.18 3.51 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.167 2.578 . . . . 74.230000000000004 113.034 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.7 m -61.31 -34.84 75.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 70.099999999999994 111.561 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.535 ' HE1' ' HB3' ' A' ' 151' ' ' LEU . 98.1 m-85 -89.22 -9.39 50.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.316 -0.402 . . . . 73.239999999999995 111.634 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.98 -6.87 45.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.342 . . . . 70.409999999999997 110.954 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.5 11.42 36.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 63.420000000000002 111.101 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -101.88 147.66 26.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.72 -0.845 . . . . 64.430000000000007 108.72 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -0.44 37.71 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.502 -0.479 . . . . 75.120000000000005 111.449 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -76.91 -6.33 52.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.101 0.477 . . . . 61.229999999999997 111.021 -174.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -118.45 34.38 5.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.375 0.607 . . . . 75.219999999999999 110.005 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pp -63.81 -12.67 37.79 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.6 -0.727 . . . . 62.240000000000002 111.451 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.492 ' HA3' ' H ' ' A' ' 10' ' ' LEU . . . -61.09 -47.23 92.22 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.124 -0.79 . . . . 54.350000000000001 111.124 175.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.637 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 83.4 t80 -65.26 -39.65 92.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.825 -0.435 . . . . 75.219999999999999 109.825 175.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 65.2 mtt -59.87 -56.8 17.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.672 -0.694 . . . . 63.210000000000001 110.96 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.442 ' HA ' HG22 ' A' ' 31' ' ' VAL . 94.7 t -59.03 -44.0 90.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.474 -0.33 . . . . 54.399999999999999 110.946 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.656 ' HB1' HD21 ' A' ' 62' ' ' LEU . . . -58.91 -45.24 90.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.948 0.404 . . . . 72.239999999999995 111.023 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.22 -44.6 68.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 63.530000000000001 111.559 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 32.8 m -69.17 -31.73 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.956 -0.298 . . . . 71.230000000000004 111.581 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 60.1 mt -71.8 -58.73 3.22 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.939 -0.304 . . . . 71.409999999999997 110.609 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.49 -46.72 88.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 52.340000000000003 110.728 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.14 -20.76 69.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.081 -0.58 . . . . 73.140000000000001 113.179 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 40.1 ttp180 -84.44 -33.4 23.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.068 0.434 . . . . 73.430000000000007 110.645 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.51 -36.09 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.191 0.52 . . . . 43.25 110.04 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.47 68.75 0.29 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.629 -0.989 . . . . 71.150000000000006 110.629 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 57.8 m -152.46 119.91 5.99 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.502 -0.349 . . . . 54.420000000000002 110.793 -170.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.82 127.95 16.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.52 -0.309 . . . . 60.399999999999999 110.404 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.632 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 14.3 m-85 -141.63 172.85 12.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 72.519999999999996 110.123 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -142.84 176.31 9.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 75.439999999999998 111.123 -171.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.8 t -48.06 130.94 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.795 0.665 . . . . 75.239999999999995 112.795 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.518 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 72.1 t60 -109.28 115.46 30.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.49 -0.777 . . . . 53.32 109.658 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 2.5 tmtp? -68.89 99.92 1.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.944 0.35 . . . . 70.319999999999993 111.944 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 80.2 tttt 160.2 -51.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.1 -1.444 . . . . 73.439999999999998 107.1 173.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 48' ' ' ALA . 13.8 p -102.91 28.6 6.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.218 -1.81 . . . . 65.510000000000005 108.076 173.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 43' ' ' HIS . . . -48.85 44.08 0.01 OUTLIER Glycine 0 N--CA 1.474 1.18 0 N-CA-C 119.81 2.684 . . . . 41.420000000000002 119.81 -150.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 46' ' ' SER . . . -96.47 179.76 4.9 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.333 -1.358 . . . . 64.439999999999998 107.333 159.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.895 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 32.3 mt-10 -80.34 118.0 21.59 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 119.998 -0.681 . . . . 71.510000000000005 109.565 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.5 m -121.11 137.73 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.978 0.418 . . . . 73.129999999999995 110.768 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.874 HG13 ' HB3' ' A' ' 62' ' ' LEU . 1.6 p -124.35 110.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.253 0.549 . . . . 72.510000000000005 110.265 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.4 HG22 HG22 ' A' ' 61' ' ' VAL . 24.7 p -92.52 107.93 19.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.733 -0.667 . . . . 73.239999999999995 110.202 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.02 165.01 28.57 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.35 -0.7 . . . . 52.240000000000002 111.35 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 54' ' ' ARG . 15.5 ptt-85 -104.91 103.85 13.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.537 0.684 . . . . 61.140000000000001 110.611 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.43 135.57 38.12 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.676 -0.861 . . . . 72.049999999999997 108.676 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 62.53 10.74 4.24 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.463 0.477 . . . . 53.340000000000003 111.149 -174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.56 -22.91 34.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.989 -0.624 . . . . 73.439999999999998 112.623 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 m -89.59 122.52 32.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 64.099999999999994 110.845 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 19.3 m -68.49 116.47 9.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.441 -0.345 . . . . 74.0 110.414 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.422 HG11 HG21 ' A' ' 177' ' ' ILE . 31.0 m -127.68 164.05 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.957 0.408 . . . . 72.430000000000007 110.689 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.4 HG22 HG22 ' A' ' 52' ' ' THR . 41.3 t -110.01 111.05 34.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.93 -0.577 . . . . 55.450000000000003 109.808 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.874 ' HB3' HG13 ' A' ' 51' ' ' VAL . 64.4 tp -96.82 129.83 44.19 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.534 -0.543 . . . . 74.129999999999995 109.534 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 65' ' ' PRO . . . -108.91 129.27 55.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.217 0.532 . . . . 60.049999999999997 112.049 -175.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.895 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 45.3 mtpt -110.92 92.05 14.05 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.2 -0.909 . . . . 71.209999999999994 109.691 175.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.563 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.7 Cg_endo -83.54 173.03 9.86 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.992 2.461 . . . . 74.5 112.143 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -110.82 12.98 22.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.428 0.633 . . . . 64.219999999999999 109.48 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 60.0 m -130.08 175.15 9.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.558 -0.746 . . . . 75.420000000000002 110.633 -175.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.483 ' CE2' ' HG3' ' A' ' 13' ' ' PRO . 45.9 m-85 -100.25 -169.82 1.78 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.109 -0.496 . . . . 71.099999999999994 110.96 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.607 ' HA ' ' HB2' ' A' ' 72' ' ' SER . 24.9 ptt? -66.8 -20.16 65.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.876 -0.602 . . . . 43.409999999999997 111.537 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.4 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 14.2 t30 -71.87 -25.22 61.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.211 0.529 . . . . 74.129999999999995 109.897 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 18.0 mp0 -105.89 2.42 27.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.717 -0.674 . . . . 75.310000000000002 110.525 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 69' ' ' MET . 27.0 t -60.24 -38.57 83.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.438 -0.346 . . . . 65.230000000000004 110.681 -175.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.82 -20.34 64.14 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.005 -0.617 . . . . 72.239999999999995 112.393 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -85.05 -31.4 23.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.863 0.363 . . . . 60.420000000000002 110.609 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -89.6 -40.65 12.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 62.240000000000002 111.42 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.97 -32.33 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.33 -0.395 . . . . 61.509999999999998 111.102 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.8 -67.83 1.75 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.908 -0.587 . . . . 61.32 113.261 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.07 -39.26 32.55 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.531 2.154 . . . . 63.030000000000001 112.409 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.9 tp -55.32 -58.47 7.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 74.129999999999995 111.731 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.48 68.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.957 0.408 . . . . 75.239999999999995 111.153 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -73.04 -32.7 65.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.817 -0.629 . . . . 72.019999999999996 111.638 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -81.96 -41.78 20.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.873 0.323 . . . . 64.319999999999993 111.873 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -85.45 -17.13 37.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.13 0.418 . . . . 72.540000000000006 112.13 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 t 62.72 71.8 0.51 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.237 0.541 . . . . 52.229999999999997 110.863 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 6' ' ' LEU . 28.0 m -118.17 158.24 46.86 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.798 -0.637 . . . . 72.030000000000001 109.821 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.425 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 35.6 Cg_exo -61.11 111.52 1.11 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.515 2.143 . . . . 71.140000000000001 112.001 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.38 -6.77 19.38 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.707 2.272 . . . . 75.349999999999994 112.267 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -98.27 -12.43 21.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.993 -0.549 . . . . 70.230000000000004 110.457 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 86' ' ' PRO . 79.0 mm-40 -114.49 20.14 15.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 71.219999999999999 110.8 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.594 HD12 HD23 ' A' ' 6' ' ' LEU . 5.8 tt -83.31 134.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.185 -0.461 . . . . 65.430000000000007 110.224 177.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 131' ' ' HIS . 21.6 m -120.9 141.35 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.835 0.35 . . . . 71.299999999999997 110.68 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.741 HG22 ' HB ' ' A' ' 8' ' ' VAL . 45.9 t -132.78 127.34 55.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.316 -0.402 . . . . 73.299999999999997 110.465 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 mm -75.15 139.23 19.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.887 -0.597 . . . . 75.310000000000002 110.708 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -142.45 152.89 43.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.506 -0.316 . . . . 75.430000000000007 110.521 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.97 135.55 42.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.479 -0.934 . . . . 65.430000000000007 108.479 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 99' ' ' ILE . 10.1 tp10 -104.37 127.68 52.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.377 0.608 . . . . 71.0 111.001 -174.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.568 HD22 ' HG3' ' A' ' 146' ' ' PRO . 3.2 pp -84.26 -13.83 51.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.05 -0.977 . . . . 75.109999999999999 110.775 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.94 -47.67 20.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 52.210000000000001 111.157 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.49 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 56.7 mt -89.74 142.13 13.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.089 -0.505 . . . . 52.200000000000003 110.789 -176.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.89 166.46 18.9 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.509 . . . . 72.530000000000001 110.607 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.652 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 15.4 p90 -64.45 128.72 36.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.247 0.546 . . . . 75.299999999999997 112.164 -174.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.62 -22.94 3.84 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.726 -0.75 . . . . 74.310000000000002 112.958 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 17.0 mmt180 -132.35 128.34 37.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.265 0.555 . . . . 75.209999999999994 112.451 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.558 HG22 HG23 ' A' ' 135' ' ' ILE . 47.3 pt -107.79 146.77 13.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.334 -0.848 . . . . 73.530000000000001 109.414 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -157.73 125.2 5.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.908 0.385 . . . . 74.540000000000006 110.46 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.83 HD23 ' H ' ' A' ' 106' ' ' LEU . 1.9 pt? -97.91 144.62 27.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.442 -0.344 . . . . 73.129999999999995 110.092 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 104.44 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.179 -0.674 . . . . 53.520000000000003 109.179 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.845 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.6 pt? -93.37 97.47 10.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.396 0.617 . . . . 71.439999999999998 110.758 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.94 -155.21 26.33 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.271 -0.732 . . . . 64.409999999999997 111.271 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.38 123.91 7.95 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.012 -0.613 . . . . 72.319999999999993 112.378 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.31 -176.61 44.64 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.55 -0.62 . . . . 52.439999999999998 111.55 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.609 ' HG2' ' H ' ' A' ' 113' ' ' GLY . 16.7 tt0 -142.76 -152.41 0.41 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.878 -0.415 . . . . 63.240000000000002 109.878 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.609 ' H ' ' HG2' ' A' ' 112' ' ' GLU . . . 139.75 -74.18 0.38 Allowed Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.299 -0.72 . . . . 25.050000000000001 111.299 -175.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.08 -6.57 87.54 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.971 -0.633 . . . . 60.229999999999997 111.829 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.8 t60 62.74 -87.3 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.774 0.829 . . . . 73.230000000000004 112.595 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -67.08 -46.55 73.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.792 0.329 . . . . 74.409999999999997 111.481 -168.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -60.99 -29.19 70.19 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 120.835 -0.698 . . . . 74.230000000000004 112.464 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.501 ' HB3' HH21 ' A' ' 132' ' ' ARG . 89.6 mt -82.88 -23.77 33.49 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.815 -0.227 . . . . 55.0 111.099 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -79.11 -39.7 32.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.235 -0.439 . . . . 74.200000000000003 110.634 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.5 t -61.59 -54.31 44.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.802 -0.635 . . . . 61.229999999999997 110.795 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 117' ' ' GLY . 48.4 t -59.5 -41.69 85.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.433 -0.349 . . . . 65.329999999999998 111.101 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.46 -52.09 67.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 64.519999999999996 111.209 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.8 m -71.46 -34.02 69.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.853 -0.612 . . . . 62.340000000000003 111.553 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.08 -36.84 78.04 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.833 0.349 . . . . 65.030000000000001 111.286 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.7 mt -87.31 -31.27 20.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.47 -0.332 . . . . 75.310000000000002 111.138 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.64 40.33 5.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.517 -0.849 . . . . 41.439999999999998 111.951 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 129' ' ' ASN . 9.7 t -148.06 176.61 10.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.948 -0.39 . . . . 72.409999999999997 109.948 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 1.1 mptm? -77.62 -5.87 51.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.72 0.295 . . . . 54.310000000000002 110.462 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.408 ' H ' HG23 ' A' ' 127' ' ' THR . 56.7 t30 72.01 81.31 0.15 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.327 -0.851 . . . . 73.430000000000007 111.896 172.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -71.2 -148.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.798 -0.637 . . . . 75.340000000000003 110.118 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.589 ' HB3' ' O ' ' A' ' 90' ' ' ILE . 32.1 p80 45.13 40.02 4.46 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.86 0.689 . . . . 62.109999999999999 112.86 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.501 HH21 ' HB3' ' A' ' 118' ' ' LEU . 50.3 mtt85 -91.65 107.97 19.58 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.433 -0.58 . . . . 71.25 109.433 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.04 109.43 28.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.628 -0.714 . . . . 62.210000000000001 109.88 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.408 ' HG2' ' OE1' ' A' ' 96' ' ' GLU . 95.4 mtt180 -88.71 100.75 13.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.019 -0.537 . . . . 74.409999999999997 110.889 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.558 HG23 HG22 ' A' ' 104' ' ' ILE . 55.7 mt -93.74 108.64 20.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.035 -0.529 . . . . 73.519999999999996 110.046 175.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -73.33 98.0 0.89 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.032 -0.604 . . . . 65.239999999999995 112.322 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 135' ' ' ILE . 3.5 m -110.95 0.97 9.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.702 0.287 . . . . 61.420000000000002 111.484 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 131.88 140.1 4.47 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.264 -0.969 . . . . 50.450000000000003 112.843 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.472 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 7.8 ptp85 -99.46 139.49 20.94 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.656 0.265 . . . . 74.430000000000007 110.506 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 3.0 Cg_exo -75.29 141.36 25.74 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.803 2.336 . . . . 64.409999999999997 111.88 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.38 149.1 88.52 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.575 2.183 . . . . 64.530000000000001 111.58 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.19 44.42 2.15 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.323 -0.465 . . . . 51.140000000000001 113.626 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -82.27 -67.73 0.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.673 -1.232 . . . . 73.230000000000004 107.673 175.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 22.5 mmtm -131.36 147.97 52.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.621 -1.172 . . . . 73.239999999999995 108.289 166.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.581 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 1.7 p-10 -58.91 157.45 20.35 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 123.335 0.397 . . . . 52.409999999999997 110.699 -175.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 4.8 Cg_endo -46.1 -28.76 5.66 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 124.192 3.261 . . . . 72.109999999999999 114.149 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.69 -32.11 28.63 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.186 0.439 . . . . 61.140000000000001 112.186 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.57 -57.97 2.75 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.355 0.502 . . . . 65.239999999999995 112.355 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 144' ' ' LYS . 67.6 m-85 -84.03 -19.99 33.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.654 0.983 . . . . 73.200000000000003 113.654 -168.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.0 p -71.63 -5.97 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.169 0.433 . . . . 73.319999999999993 112.169 -171.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.535 ' HB3' ' HE1' ' A' ' 17' ' ' TYR . 87.9 mt -91.12 -1.91 57.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 61.210000000000001 111.424 -176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -138.91 103.06 4.7 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.752 -0.833 . . . . 74.310000000000002 108.752 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -129.34 119.33 23.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.613 -0.722 . . . . 61.509999999999998 112.024 -164.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -169.1 103.08 0.37 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.642 0.734 . . . . 64.230000000000004 110.12 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.538 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 3.1 m -134.99 131.77 37.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.515 . . . . 73.349999999999994 109.928 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.87 -38.02 86.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.758 0.313 . . . . 72.239999999999995 111.085 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.2 92.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.764 -0.653 . . . . 71.409999999999997 112.31 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.538 ' HG2' ' HB ' ' A' ' 155' ' ' THR . 15.2 pt-20 -82.21 -32.85 29.62 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.968 -0.293 . . . . 72.109999999999999 111.155 -175.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.592 ' HA ' HG23 ' A' ' 162' ' ' VAL . 49.5 mtm180 -71.6 -20.09 62.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.754 0.312 . . . . 74.310000000000002 110.694 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.86 -38.71 76.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.933 -0.576 . . . . 63.240000000000002 112.041 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -103.02 7.58 39.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.197 0.443 . . . . 72.519999999999996 112.197 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 159' ' ' ARG . 77.3 t -58.19 -51.64 80.35 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 121.058 -0.257 . . . . 72.109999999999999 111.34 177.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 12.5 Cg_endo -56.71 -27.61 71.69 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.326 2.018 . . . . 61.020000000000003 112.354 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 168' ' ' GLN . 9.4 m -68.32 -55.47 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.36 -0.382 . . . . 54.210000000000001 110.121 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.456 HG13 HG23 ' A' ' 104' ' ' ILE . 1.7 mp -56.06 -43.17 74.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.524 -0.762 . . . . 75.310000000000002 111.503 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 162' ' ' VAL . 92.4 t -58.04 -49.94 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.618 0.247 . . . . 75.400000000000006 111.369 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.69 -33.15 70.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.563 -0.289 . . . . 73.530000000000001 111.318 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 164' ' ' THR . 98.7 mt-30 -62.52 -48.13 80.87 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.099 0.476 . . . . 64.439999999999998 109.89 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.14 -41.13 97.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.656 -0.702 . . . . 74.209999999999994 111.194 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.09 87.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.401 -0.363 . . . . 74.340000000000003 111.102 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.09 -36.52 83.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 73.230000000000004 110.784 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.29 -45.93 44.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 70.109999999999999 111.335 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.839 ' HA ' HD12 ' A' ' 176' ' ' LEU . 80.1 m -58.3 -40.57 82.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.228 -0.442 . . . . 64.340000000000003 111.541 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -53.71 -45.31 70.37 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.263 -0.426 . . . . 60.119999999999997 111.249 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 183' ' ' PRO . 30.7 tp -81.88 -28.33 33.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.059 -0.257 . . . . 74.230000000000004 111.534 -174.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.839 HD12 ' HA ' ' A' ' 173' ' ' THR . 74.0 mt -52.2 -55.95 17.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.26 0.552 . . . . 74.349999999999994 110.665 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.676 HG22 HD12 ' A' ' 5' ' ' LEU . 6.9 pt -80.97 -23.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.376 -0.829 . . . . 73.439999999999998 111.78 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 175' ' ' LEU . . . -65.77 -45.69 81.56 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 111.748 0.277 . . . . 53.32 111.748 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -136.65 -61.63 0.67 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.83 0.348 . . . . 73.420000000000002 111.277 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -168.59 170.31 42.17 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.541 -0.838 . . . . 53.329999999999998 112.307 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.757 ' HA ' HD23 ' A' ' 176' ' ' LEU . 3.3 pp -82.71 -31.54 28.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.225 0.454 . . . . 73.430000000000007 112.225 -175.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 14.6 mm-40 -60.66 -54.26 56.43 Favored Pre-proline 0 N--CA 1.468 0.439 0 N-CA-C 112.559 0.577 . . . . 74.120000000000005 112.559 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.462 ' HB2' HD21 ' A' ' 175' ' ' LEU . 19.6 Cg_endo -60.75 -31.19 91.61 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.426 1.417 . . . . 63.119999999999997 111.856 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -72.15 -45.77 59.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.539 . . . . 50.009999999999998 111.266 -178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 182' ' ' GLU . 1.2 pp0? -67.77 -20.92 65.27 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.145 0.498 . . . . 51.149999999999999 110.542 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.416 ' HA ' ' NE2' ' A' ' 189' ' ' HIS . 5.6 m-20 -67.48 -46.94 71.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 71.349999999999994 109.873 171.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 56.2 m -62.35 -33.52 74.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 63.439999999999998 111.143 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 184' ' ' ALA . 94.6 t -54.45 -38.47 41.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 74.120000000000005 111.426 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.416 ' NE2' ' HA ' ' A' ' 186' ' ' ASN . 31.5 p80 -100.22 9.04 43.35 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.554 -0.459 . . . . 74.540000000000006 110.947 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.51 -34.17 18.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.302 -0.408 . . . . 64.019999999999996 109.946 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 38.7 m95 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.554 -0.748 . . . . 60.100000000000001 110.309 174.923 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.7 pm0 . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.961 -0.385 . . . . 64.120000000000005 109.961 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 15.7 Cg_exo -68.39 111.01 2.4 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.816 2.344 . . . . 72.0 112.246 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.21 153.0 42.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.175 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.29 115.37 27.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.049 0.452 . . . . 64.200000000000003 110.881 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.46 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 50.3 t -105.53 116.44 49.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.258 -0.645 . . . . 61.340000000000003 109.258 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.823 ' HB ' HG22 ' A' ' 92' ' ' VAL . 45.8 t -102.19 122.5 54.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.877 0.37 . . . . 61.119999999999997 110.81 -176.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.603 ' O ' ' HD2' ' A' ' 65' ' ' PRO . . . -103.63 122.1 7.31 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.537 -0.839 . . . . 75.519999999999996 111.698 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.18 116.69 19.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.948 0.404 . . . . 65.109999999999999 110.44 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.459 ' C ' HD22 ' A' ' 12' ' ' ASN . . . -129.94 145.67 16.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.168 -0.773 . . . . 72.540000000000006 111.168 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.459 HD22 ' C ' ' A' ' 11' ' ' GLY . 1.2 m120 -124.58 73.75 61.93 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.915 0.357 . . . . 73.049999999999997 110.914 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.76 109.45 1.07 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.601 2.201 . . . . 65.129999999999995 112.471 176.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' A' ' 17' ' ' TYR . . . -146.9 172.28 27.42 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.399 -0.68 . . . . 64.409999999999997 111.399 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.48 -53.25 7.33 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.257 2.638 . . . . 72.310000000000002 112.304 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 m -112.03 -10.41 13.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.601 0.715 . . . . 43.210000000000001 109.67 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.727 ' HE1' ' HB3' ' A' ' 151' ' ' LEU . 93.0 m-85 -81.37 -17.12 50.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.389 -0.823 . . . . 73.540000000000006 111.458 -174.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.659 ' HA ' HD21 ' A' ' 23' ' ' ASN . . . -79.54 1.38 26.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.042 0.449 . . . . 70.400000000000006 110.711 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -118.58 18.23 13.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.663 -0.699 . . . . 65.349999999999994 109.955 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -103.44 -169.85 1.7 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.277 0.561 . . . . 62.119999999999997 111.137 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -86.81 -0.23 56.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.743 -0.662 . . . . 65.230000000000004 110.208 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 2.8 m170 -89.6 11.37 19.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 111.928 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.659 HD21 ' HA ' ' A' ' 18' ' ' ALA . 13.5 m120 -109.87 20.1 18.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.806 -0.179 . . . . 54.130000000000003 111.124 -175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.607 ' H ' HD12 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -50.0 -48.91 52.24 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.487 0.492 . . . . 62.43 111.933 -173.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.05 -58.74 8.28 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.665 -0.698 . . . . 63.310000000000002 114.39 -171.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 23' ' ' ASN . 49.2 p90 -86.23 -22.6 26.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.336 0.568 . . . . 72.010000000000005 111.863 -174.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 23.1 mmt -71.25 -42.18 69.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.8 0.333 . . . . 73.310000000000002 111.121 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.3 t -80.04 -41.52 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.733 0.301 . . . . 72.140000000000001 111.026 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.58 -28.02 69.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.378 -0.374 . . . . 74.310000000000002 111.521 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 17.0 t70 -56.52 -50.17 72.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 60.229999999999997 111.312 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 m -75.97 -33.18 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.333 0.494 . . . . 75.230000000000004 112.333 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.4 pp -78.67 -35.9 44.53 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.512 -0.475 . . . . 72.510000000000005 111.095 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -71.3 -36.68 71.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 64.200000000000003 110.247 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.52 -30.43 74.47 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.847 -0.692 . . . . 72.430000000000007 112.845 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -83.96 -37.38 22.34 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.422 0.527 . . . . 74.409999999999997 112.422 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.2 tp -72.7 -15.22 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.256 0.55 . . . . 74.25 110.581 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.51 59.98 0.96 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.661 -0.975 . . . . 53.450000000000003 110.661 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.9 m -142.55 128.81 19.89 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.118 0.485 . . . . 51.409999999999997 111.349 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.14 150.72 26.85 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.808 -0.633 . . . . 43.200000000000003 109.971 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 30' ' ' ASP . 89.1 m-85 -89.44 139.56 30.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.703 0.287 . . . . 74.530000000000001 110.613 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 41' ' ' LYS . 11.6 mptt -110.57 135.82 50.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.274 -0.421 . . . . 65.519999999999996 110.004 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 56.2 t -100.19 106.39 19.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.923 -0.58 . . . . 53.210000000000001 110.407 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -116.95 77.1 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.26 -0.644 . . . . 75.200000000000003 109.26 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 96.6 mttt -55.56 105.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.334 -0.848 . . . . 73.400000000000006 112.638 -171.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 32.1 ttmt 168.29 -88.99 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 124.471 1.107 . . . . 73.519999999999996 108.694 174.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 m -106.05 -14.98 15.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.409 0.623 . . . . 72.439999999999998 109.985 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.85 43.01 1.6 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.29 -0.868 . . . . 52.32 112.193 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 42' ' ' VAL . . . -51.45 -45.44 62.7 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.708 0.262 . . . . 71.439999999999998 111.708 -171.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.696 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 40.2 mt-10 -130.09 116.44 18.52 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.755 -0.461 . . . . 74.239999999999995 109.755 171.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.55 135.64 46.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.084 0.468 . . . . 73.040000000000006 111.154 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 8.3 p -128.59 133.39 66.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.959 -0.564 . . . . 61.409999999999997 110.334 172.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.589 HG22 HG22 ' A' ' 61' ' ' VAL . 68.4 p -105.0 107.57 18.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.036 0.446 . . . . 53.310000000000002 110.361 174.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -128.11 158.48 21.53 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.074 -0.81 . . . . 31.120000000000001 111.074 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.1 ptt180 -120.66 104.98 10.35 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.42 0.628 . . . . 73.450000000000003 111.614 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.834 HD13 ' HA ' ' A' ' 174' ' ' GLU . 1.6 pp -104.22 146.72 28.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.524 -0.762 . . . . 72.319999999999993 109.241 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 71.05 -32.44 0.25 Allowed 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.608 0.567 . . . . 63.409999999999997 111.991 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 154.5 -40.89 0.63 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.166 -0.54 . . . . 60.329999999999998 112.191 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.7 m -89.4 137.17 32.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.831 0.348 . . . . 63.420000000000002 111.098 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 23.0 t -81.79 129.83 34.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.347 -0.388 . . . . 54.530000000000001 110.23 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.15 163.88 18.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.226 -0.443 . . . . 74.409999999999997 110.375 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 52' ' ' THR . 57.9 t -107.54 112.4 39.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.367 -0.379 . . . . 73.409999999999997 110.296 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.464 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . 5.6 mp -95.36 111.95 23.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.645 -0.502 . . . . 72.030000000000001 109.645 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.7 135.67 50.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.945 -0.57 . . . . 42.009999999999998 110.609 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.696 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -123.71 117.37 27.54 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.047 -0.524 . . . . 74.040000000000006 110.073 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 9' ' ' GLY . 29.0 Cg_endo -65.8 122.77 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.922 1.748 . . . . 73.310000000000002 110.795 171.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -95.67 9.2 41.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.029 0.919 . . . . 71.439999999999998 108.528 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.46 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . 43.2 m -100.84 179.82 4.28 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.093 -1.412 . . . . 64.120000000000005 109.006 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -74.13 162.02 29.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.441 -0.345 . . . . 70.310000000000002 110.47 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.444 ' HG3' ' OD1' ' A' ' 116' ' ' ASN . 26.8 ptt? -59.57 -24.8 64.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.357 -0.383 . . . . 74.420000000000002 111.298 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.53 -35.15 73.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.225 0.536 . . . . 72.040000000000006 110.56 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.46 ' OE1' ' HB3' ' A' ' 67' ' ' CYS . 29.2 mt-10 -98.07 -2.46 40.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.615 -0.72 . . . . 72.140000000000001 111.189 -173.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.7 t -60.12 -43.08 95.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.435 -0.348 . . . . 70.549999999999997 111.496 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' HA2' HG22 ' A' ' 121' ' ' VAL . . . -63.02 -20.69 62.81 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.947 -0.644 . . . . 74.519999999999996 112.846 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.502 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 3.1 mpt_? -86.29 -12.22 50.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.795 0.331 . . . . 73.519999999999996 110.837 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.812 HE21 ' HA ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -86.69 -47.32 9.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.245 -0.434 . . . . 71.310000000000002 110.936 -178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.69 -42.69 97.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.792 -0.64 . . . . 72.219999999999999 111.942 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.73 -67.3 1.98 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.982 -0.554 . . . . 42.100000000000001 114.097 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.01 -36.98 79.94 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.604 2.203 . . . . 75.420000000000002 112.838 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.38 -43.73 98.13 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.272 -0.422 . . . . 72.319999999999993 110.471 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.31 75.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 43.109999999999999 111.309 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.83 -34.09 74.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 64.530000000000001 111.523 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -62.2 -41.85 98.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.827 0.346 . . . . 53.140000000000001 111.291 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -98.17 3.89 49.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.488 -0.324 . . . . 73.140000000000001 111.5 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t 58.34 39.47 25.41 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.017 -0.538 . . . . 53.350000000000001 110.82 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.478 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 18.3 m -108.69 134.64 20.23 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.101 -0.5 . . . . 53.329999999999998 110.579 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 13.0 Cg_exo -69.93 122.5 9.13 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.74 2.294 . . . . 44.43 111.939 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -78.49 18.32 0.97 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.965 2.443 . . . . 73.230000000000004 112.5 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -81.59 -61.89 1.8 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.314 0.578 . . . . 50.25 110.145 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -87.71 68.95 9.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.616 -0.72 . . . . 54.030000000000001 110.085 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 pt -115.2 150.56 17.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.904 -0.589 . . . . 60.210000000000001 110.958 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 m -112.6 127.99 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 62.439999999999998 110.387 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.823 HG22 ' HB ' ' A' ' 8' ' ' VAL . 47.4 t -124.53 121.49 61.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 110.377 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.474 ' CG2' ' HA2' ' A' ' 9' ' ' GLY . 7.2 tt -84.31 123.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.751 0.31 . . . . 64.230000000000004 110.207 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -153.76 150.08 28.13 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.892 0.377 . . . . 71.040000000000006 111.009 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.461 ' HB3' HD21 ' A' ' 24' ' ' LEU . 9.9 p-10 -84.68 141.29 30.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.72 -0.673 . . . . 70.030000000000001 110.592 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 112' ' ' GLU . 53.3 mm-40 -148.7 155.8 41.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.197 0.523 . . . . 75.409999999999997 111.63 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.29 2.12 37.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.232 -0.894 . . . . 65.219999999999999 111.881 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -49.35 -44.84 45.02 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.556 0.535 . . . . 64.430000000000007 111.355 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.81 HD12 ' HG2' ' A' ' 103' ' ' ARG . 7.6 pt -139.13 173.85 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 74.439999999999998 110.847 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.411 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 0.8 OUTLIER -75.78 163.22 27.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.182 -0.463 . . . . 54.149999999999999 111.08 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.669 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 4.3 t80 -70.79 126.64 30.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.054 -0.521 . . . . 75.329999999999998 110.521 -176.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 161' ' ' GLU . . . 145.72 -45.37 0.82 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.572 -0.611 . . . . 72.219999999999999 111.572 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.81 ' HG2' HD12 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -119.98 160.49 22.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.512 -0.551 . . . . 74.310000000000002 109.512 178.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 135' ' ' ILE . 39.8 pt -127.67 157.29 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.809 0.338 . . . . 74.120000000000005 111.189 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -130.71 125.1 33.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.048 -0.523 . . . . 75.409999999999997 110.591 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.676 HD12 ' HE1' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -101.24 111.51 23.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.424 -0.584 . . . . 71.329999999999998 109.424 175.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.678 ' HD3' ' HD2' ' A' ' 134' ' ' ARG . 16.0 ptmt -143.61 153.57 42.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.472 -0.786 . . . . 74.25 110.445 -169.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -100.24 114.06 27.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.595 0.712 . . . . 75.109999999999999 110.825 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.53 178.86 38.9 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.861 -0.895 . . . . 75.239999999999995 110.861 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.548 ' HA2' HD13 ' A' ' 118' ' ' LEU . . . -166.81 86.56 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.047 -1.073 . . . . 71.140000000000001 113.593 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.4 74.94 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.934 -0.65 . . . . 42.030000000000001 111.942 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.527 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 3.3 mp0 -143.53 -82.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.554 0.216 . . . . 74.400000000000006 111.027 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -104.73 -69.67 0.77 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.706 -0.759 . . . . 42.219999999999999 113.046 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.21 69.14 3.32 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.026 -0.607 . . . . 70.200000000000003 112.054 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -55.72 -48.04 75.85 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.746 0.276 . . . . 75.329999999999998 111.746 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.444 ' OD1' ' HG3' ' A' ' 69' ' ' MET . 24.8 t-20 -61.58 -45.01 95.94 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.729 0.27 . . . . 71.120000000000005 111.729 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.54 -23.73 72.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.733 -0.746 . . . . 44.539999999999999 112.405 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.548 HD13 ' HA2' ' A' ' 110' ' ' GLY . 46.1 mt -83.23 -45.87 13.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.211 0.529 . . . . 73.319999999999993 109.693 174.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -65.35 -44.77 86.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.207 -0.906 . . . . 63.439999999999998 111.821 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.5 t -52.41 -47.21 66.43 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.938 0.399 . . . . 75.299999999999997 111.098 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.668 ' HB ' HH22 ' A' ' 132' ' ' ARG . 36.5 t -78.18 -44.28 27.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.262 -0.426 . . . . 75.099999999999994 110.928 -177.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.58 98.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.293 -0.412 . . . . 74.129999999999995 111.539 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.5 t -73.61 -30.28 62.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.261 -0.427 . . . . 70.439999999999998 110.711 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.47 -42.27 68.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 74.329999999999998 110.519 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.2 mt -76.68 -21.36 55.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 74.219999999999999 110.258 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.72 13.52 82.27 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.902 -0.59 . . . . 64.430000000000007 112.043 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.8 t -165.0 169.53 16.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.858 -0.423 . . . . 73.340000000000003 109.858 -176.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -96.72 -106.51 0.16 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.733 -0.469 . . . . 75.340000000000003 109.733 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 67.56 -10.33 0.38 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.119 0.785 . . . . 72.129999999999995 113.119 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -76.57 129.27 36.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.361 0.6 . . . . 75.340000000000003 111.464 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.676 ' HE1' HD12 ' A' ' 106' ' ' LEU . 51.2 t-80 -98.96 87.0 3.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.881 -0.599 . . . . 61.409999999999997 109.734 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.668 HH22 ' HB ' ' A' ' 121' ' ' VAL . 93.5 mtt180 -90.48 156.06 18.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 71.310000000000002 111.389 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 106' ' ' LEU . 46.1 t -99.79 112.14 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.729 -0.668 . . . . 64.030000000000001 109.581 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.678 ' HD2' ' HD3' ' A' ' 107' ' ' LYS . 70.3 mtt85 -94.15 114.2 26.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.033 -0.531 . . . . 60.299999999999997 110.925 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.673 ' HA ' HG22 ' A' ' 104' ' ' ILE . 2.0 mp -83.26 118.22 30.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 108.708 -0.849 . . . . 65.5 108.708 173.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.669 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -66.87 118.65 10.75 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.626 -0.797 . . . . 74.239999999999995 111.627 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.577 ' HA ' ' HD2' ' A' ' 101' ' ' PHE . 35.0 m -109.9 1.13 9.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.145 0.497 . . . . 71.120000000000005 110.556 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 86.48 175.16 49.58 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.827 -0.701 . . . . 74.25 111.972 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.06 104.3 54.63 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.168 -0.308 . . . . 75.420000000000002 110.168 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 72.0 Cg_exo -50.05 114.61 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.068 2.512 . . . . 63.439999999999998 112.085 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 12.0 Cg_exo -70.34 127.96 14.85 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.869 2.379 . . . . 74.310000000000002 112.16 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 172.05 175.79 40.46 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.127 -0.789 . . . . 73.140000000000001 111.127 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -94.92 -6.69 42.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.441 0.639 . . . . 75.420000000000002 109.781 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -101.03 159.82 14.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.575 -0.739 . . . . 75.230000000000004 109.265 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.42 139.56 94.55 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.012 -0.366 . . . . 75.219999999999999 110.012 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.526 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 92.7 Cg_exo -47.65 -19.39 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.664 2.909 . . . . 64.109999999999999 113.722 177.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -47.19 -40.42 16.02 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.024 0.53 . . . . 55.439999999999998 112.029 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.64 -31.37 41.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.41 -0.359 . . . . 72.420000000000002 111.674 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.526 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 77.2 m-85 -84.07 -31.94 25.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.274 -0.421 . . . . 71.5 111.624 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.04 -4.81 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.049 0.452 . . . . 74.310000000000002 111.805 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.727 ' HB3' ' HE1' ' A' ' 17' ' ' TYR . 90.5 mt -86.91 -12.5 47.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.453 -0.34 . . . . 61.5 111.266 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -160.89 107.64 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.203 0.525 . . . . 75.329999999999998 110.068 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -131.81 148.96 52.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.077 -0.511 . . . . 74.319999999999993 110.378 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -146.47 35.88 0.97 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.402 0.62 . . . . 73.140000000000001 109.999 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.646 ' O ' ' HG2' ' A' ' 158' ' ' GLU . 84.8 m -86.23 115.25 23.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.701 -0.682 . . . . 62.229999999999997 110.418 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.96 -20.85 59.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 111.89 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.43 ' H ' HG22 ' A' ' 155' ' ' THR . . . -66.04 -30.24 70.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 44.420000000000002 111.813 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 155' ' ' THR . 15.2 pt-20 -71.4 -21.95 61.93 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.263 0.554 . . . . 65.409999999999997 110.446 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.512 ' HA ' HG23 ' A' ' 162' ' ' VAL . 16.3 mmm-85 -78.18 -25.19 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.653 -0.703 . . . . 63.409999999999997 110.655 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.36 80.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.691 . . . . 72.219999999999999 112.102 -174.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.639 ' HB2' ' HD1' ' A' ' 101' ' ' PHE . 6.0 mm-40 -105.38 7.78 33.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.072 0.397 . . . . 65.120000000000005 112.072 -175.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.522 ' N ' ' HD2' ' A' ' 163' ' ' PRO . 70.3 t -57.35 -52.38 74.66 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.669 -0.205 . . . . 73.120000000000005 111.084 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 13.7 Cg_endo -57.28 -33.62 96.4 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.108 1.872 . . . . 70.219999999999999 112.187 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.5 m -64.96 -43.42 92.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.937 -0.574 . . . . 75.319999999999993 110.61 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.3 -38.59 82.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.42 . . . . 74.209999999999994 110.763 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 162' ' ' VAL . 91.7 t -57.31 -54.04 35.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.553 -0.294 . . . . 73.340000000000003 111.205 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -61.19 -42.09 97.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.369 -0.378 . . . . 75.219999999999999 111.517 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' ' 191' ' ' TRP . 13.8 mm-40 -66.26 -49.52 66.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.482 -0.326 . . . . 74.230000000000004 111.314 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.0 96.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.448 -0.342 . . . . 74.219999999999999 111.593 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.5 -34.93 79.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.798 0.332 . . . . 62.009999999999998 111.553 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -80.63 -43.85 19.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.946 0.403 . . . . 75.239999999999995 110.794 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.27 -39.21 92.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 61.539999999999999 111.894 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.8 p -65.01 -38.86 92.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.744 0.307 . . . . 72.019999999999996 111.45 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.834 ' HA ' HD13 ' A' ' 55' ' ' LEU . 41.6 tt0 -73.55 -44.21 57.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.39 -0.368 . . . . 73.239999999999995 110.629 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 178' ' ' ALA . 44.5 tp -64.73 -27.93 69.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.492 -0.322 . . . . 53.210000000000001 111.023 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.0 tp -57.24 -45.63 83.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 73.450000000000003 110.766 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.58 -32.4 14.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.012 -0.54 . . . . 74.120000000000005 110.305 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 175' ' ' LEU . . . -61.52 -48.04 82.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.722 -0.672 . . . . 51.310000000000002 111.82 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -129.11 -67.72 0.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.077 -0.249 . . . . 74.239999999999995 111.381 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.64 -170.01 37.99 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.379 -0.915 . . . . 43.119999999999997 112.41 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.772 HD23 ' H ' ' A' ' 181' ' ' LEU . 1.8 pt? -81.82 -35.71 29.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.312 0.066 . . . . 73.510000000000005 110.98 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.587 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 4.9 mm-40 -54.46 -56.67 24.29 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 112.278 0.473 . . . . 61.200000000000003 112.278 -178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 50.1 Cg_exo -56.26 -34.48 93.75 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.807 1.671 . . . . 73.420000000000002 112.138 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.96 -55.01 9.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.996 -0.547 . . . . 71.299999999999997 111.453 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 181' ' ' LEU . 11.6 pt20 -69.38 -21.41 63.8 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 111.718 0.266 . . . . 51.310000000000002 111.718 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.51 -38.22 68.17 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.705 -0.398 . . . . 73.049999999999997 110.662 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 85.0 m -66.96 -44.27 80.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 55.310000000000002 111.489 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 185' ' ' GLN . 32.6 m -70.4 -16.82 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.43 . . . . 74.310000000000002 111.249 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -94.17 -13.5 26.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 61.32 110.034 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -93.27 -33.33 13.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 71.540000000000006 110.848 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.598 ' HB2' ' NE2' ' A' ' 168' ' ' GLN . 76.6 m95 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.526 -0.75 . . . . 73.310000000000002 109.552 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.746 -0.464 . . . . 75.120000000000005 109.746 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.531 ' HB3' HG23 ' A' ' 61' ' ' VAL . 51.4 Cg_exo -54.88 123.64 14.26 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.118 2.546 . . . . 75.120000000000005 112.927 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.863 HD12 ' HG2' ' A' ' 89' ' ' GLN . 2.1 mm? -84.44 133.02 34.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.45 -0.574 . . . . 62.25 109.45 177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.53 HD23 HD13 ' A' ' 90' ' ' ILE . 59.2 tp -93.6 117.53 30.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.015 0.436 . . . . 72.150000000000006 111.156 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.98 118.78 59.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.536 -0.756 . . . . 75.099999999999994 109.589 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.615 HG12 ' HB3' ' A' ' 63' ' ' ALA . 29.4 m -122.01 155.82 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.986 0.422 . . . . 52.229999999999997 111.022 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.97 163.95 30.27 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.797 -0.716 . . . . 61.539999999999999 111.983 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.718 HD21 ' HA ' ' A' ' 69' ' ' MET . 2.5 mt -68.92 106.4 2.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.914 0.388 . . . . 65.150000000000006 110.898 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.684 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -77.75 -141.57 1.61 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.823 -0.626 . . . . 63.140000000000001 112.253 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -97.78 99.71 7.19 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.067 0.46 . . . . 73.420000000000002 110.671 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.763 ' HB3' ' HA ' ' A' ' 68' ' ' TYR . 5.5 Cg_exo -78.77 -8.19 15.7 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.359 2.706 . . . . 51.420000000000002 112.887 -176.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.95 173.3 23.58 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.694 -0.765 . . . . 74.239999999999995 112.131 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.93 -54.8 2.4 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.032 2.488 . . . . 72.200000000000003 112.419 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 m -59.75 -35.62 74.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 73.140000000000001 111.601 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -74.89 -17.18 60.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.426 . . . . 71.239999999999995 111.296 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.42 -7.49 51.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.004 0.431 . . . . 43.100000000000001 110.861 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.41 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 3.8 mptp? -92.96 -10.22 37.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 63.399999999999999 110.263 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.75 HG22 ' H ' ' A' ' 153' ' ' ASN . 36.5 p -102.71 -169.38 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 63.340000000000003 110.741 -175.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.74 ' HG3' HD23 ' A' ' 24' ' ' LEU . 1.3 tpp180 -92.12 1.78 56.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.035 0.445 . . . . 75.239999999999995 110.123 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.461 ' CE1' HG22 ' A' ' 150' ' ' VAL . 30.8 m80 -76.8 11.36 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.26 0.467 . . . . 54.520000000000003 112.26 -174.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -123.43 20.23 9.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.953 0.406 . . . . 55.350000000000001 110.144 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.753 HD13 HG12 ' A' ' 93' ' ' ILE . 1.1 pp -61.54 -24.26 66.51 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.982 -0.554 . . . . 74.319999999999993 111.968 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.606 ' N ' HD12 ' A' ' 24' ' ' LEU . . . -69.47 -47.96 47.3 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.995 -0.842 . . . . 73.549999999999997 110.995 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.684 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 88.8 t80 -61.05 -36.02 78.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.838 0.351 . . . . 61.130000000000003 110.217 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 61.8 mtt -61.34 -49.6 76.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 74.430000000000007 111.668 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.11 -47.67 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.056 0.391 . . . . 73.200000000000003 112.056 -174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.769 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -63.09 -38.87 92.91 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.405 0.521 . . . . 72.549999999999997 112.405 -171.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.65 -41.86 75.0 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.994 0.426 . . . . 75.430000000000007 111.125 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 22.9 m -79.65 -26.61 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.602 0.593 . . . . 73.409999999999997 112.602 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -67.66 -28.28 67.57 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.892 -0.323 . . . . 72.5 111.214 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 38' ' ' SER . . . -69.46 -41.96 75.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.143 0.496 . . . . 51.229999999999997 110.699 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.7 -18.13 71.83 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.003 -0.618 . . . . 63.420000000000002 112.86 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 8.2 mmt180 -61.17 -46.46 90.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.125 0.417 . . . . 73.239999999999995 112.125 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 36' ' ' ILE . 4.2 mp -73.23 -15.76 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.455 0.645 . . . . 73.530000000000001 110.407 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.99 12.92 26.53 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 110.765 -0.934 . . . . 43.039999999999999 110.765 -173.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 66.3 m -86.23 147.67 26.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.002 -0.599 . . . . 63.200000000000003 110.434 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.77 127.99 52.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.298 -0.41 . . . . 73.099999999999994 110.305 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -85.66 151.45 23.87 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.331 -0.618 . . . . 74.409999999999997 109.331 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -155.15 168.24 27.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.096 0.474 . . . . 73.349999999999994 110.914 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 5.1 p -84.16 117.77 30.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.71 -0.677 . . . . 75.530000000000001 109.766 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 5.8 t-80 -103.37 110.68 22.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.569 -0.9 . . . . 63.140000000000001 108.569 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -68.83 83.56 0.3 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 65.340000000000003 110.181 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.823 ' HE3' ' HB3' ' A' ' 82' ' ' PHE . 28.2 tptt -105.19 -95.13 0.34 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.909 -0.587 . . . . 74.010000000000005 109.513 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.534 ' HB3' ' CE2' ' A' ' 82' ' ' PHE . 9.6 p -108.16 -42.06 4.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 118.661 -1.216 . . . . 53.030000000000001 113.233 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.23 -25.62 0.46 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 118.544 -1.788 . . . . 42.399999999999999 117.025 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -139.76 -176.75 4.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 114.829 1.418 . . . . 72.5 114.829 -156.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 34.4 mt-10 -76.18 143.05 41.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.413 -1.267 . . . . 65.340000000000003 109.407 173.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 43' ' ' HIS . 93.8 t -142.8 133.19 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.993 -0.373 . . . . 74.409999999999997 109.993 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 62' ' ' LEU . 3.2 p -125.08 125.3 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.507 -0.553 . . . . 72.010000000000005 109.507 172.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -103.24 121.1 42.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.244 0.545 . . . . 62.509999999999998 110.035 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.01 157.58 23.47 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.215 -0.754 . . . . 70.219999999999999 111.215 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 7.0 ptt180 -109.98 103.42 12.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.511 0.672 . . . . 75.230000000000004 110.915 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.774 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 3.1 pp -113.06 151.81 30.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.091 -0.959 . . . . 61.439999999999998 109.153 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.28 -57.85 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.831 0.707 . . . . 73.430000000000007 110.993 -172.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.84 -38.67 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.146 -0.549 . . . . 60.420000000000002 112.273 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -93.45 140.66 29.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.76 0.314 . . . . 61.140000000000001 110.867 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 25.9 m -77.64 121.63 24.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.352 -0.385 . . . . 72.019999999999996 110.066 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.3 171.7 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.899 0.38 . . . . 44.25 111.408 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 4' ' ' PRO . 77.6 t -117.82 111.57 35.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 72.530000000000001 110.137 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.769 HD11 ' HB1' ' A' ' 29' ' ' ALA . 3.0 tm? -98.68 119.88 38.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.18 -0.674 . . . . 71.019999999999996 109.18 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.615 ' HB3' HG12 ' A' ' 8' ' ' VAL . . . -108.85 137.87 46.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.347 -0.388 . . . . 64.439999999999998 110.922 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 54.6 mtpt -114.0 92.61 26.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.998 -0.546 . . . . 75.319999999999993 110.957 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.4 138.79 51.91 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.863 2.376 . . . . 54.140000000000001 112.184 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -109.73 16.81 21.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.506 0.669 . . . . 64.200000000000003 109.351 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 59.7 m -114.8 179.99 3.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.333 -0.848 . . . . 74.299999999999997 111.231 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.763 ' HA ' ' HB3' ' A' ' 13' ' ' PRO . 97.7 m-85 -70.25 175.54 4.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.609 . . . . 71.040000000000006 112.031 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.718 ' HA ' HD21 ' A' ' 10' ' ' LEU . 27.3 ptt? -67.46 -31.06 70.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.752 -0.658 . . . . 62.140000000000001 112.344 -173.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -72.2 -30.76 65.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.44 0.638 . . . . 44.310000000000002 109.96 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 51.2 mm-40 -80.2 -22.27 42.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.528 -0.76 . . . . 71.319999999999993 111.355 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.0 p -56.3 -45.23 80.33 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.216 0.322 . . . . 72.030000000000001 111.467 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 121' ' ' VAL . . . -73.88 -28.15 65.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.665 -0.779 . . . . 74.299999999999997 112.257 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -78.73 -11.32 59.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.859 0.362 . . . . 73.340000000000003 110.612 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 31.0 mm-40 -65.5 -30.27 71.02 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.101 0.477 . . . . 63.25 110.021 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.5 t -67.47 -21.73 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.467 -0.788 . . . . 75.430000000000007 110.897 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.54 -72.28 0.55 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 116.018 -0.537 . . . . 55.240000000000002 112.879 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.95 -30.2 48.59 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.442 2.095 . . . . 54.32 112.037 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.493 HD12 HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -59.28 -40.36 85.87 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.748 -0.66 . . . . 62.240000000000002 110.689 -176.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.97 -30.89 70.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 64.010000000000005 112.108 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.26 -41.21 34.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 55.299999999999997 111.131 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.823 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 55.2 m-85 -71.63 -43.08 66.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.491 0.552 . . . . 74.040000000000006 112.491 -172.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.609 ' CE1' ' HG2' ' A' ' 45' ' ' LYS . 95.3 m-85 -97.68 -16.88 19.76 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.739 -0.384 . . . . 74.540000000000006 111.201 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 t 63.96 33.46 12.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.199 0.523 . . . . 75.510000000000005 110.382 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.511 HG21 HD22 ' A' ' 6' ' ' LEU . 25.7 m -69.0 149.7 97.77 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.472 -0.786 . . . . 75.430000000000007 111.362 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.84 117.01 4.28 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.745 2.296 . . . . 53.32 112.402 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.91 -1.87 10.11 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.032 2.488 . . . . 50.130000000000003 112.633 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -95.32 -25.47 16.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.127 -0.488 . . . . 55.43 110.342 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.863 ' HG2' HD12 ' A' ' 5' ' ' LEU . 7.5 tp60 -92.57 -11.05 35.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.635 . . . . 72.420000000000002 111.106 -174.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.53 HD13 HD23 ' A' ' 6' ' ' LEU . 5.3 tp -52.62 113.73 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.729 0.776 . . . . 70.510000000000005 111.776 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 9.3 p -116.76 138.79 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.301 -0.863 . . . . 63.100000000000001 110.147 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 7.7 p -132.6 134.06 59.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.151 -0.477 . . . . 74.299999999999997 110.67 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.753 HG12 HD13 ' A' ' 24' ' ' LEU . 7.7 tt -89.9 124.53 42.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.827 -0.624 . . . . 65.239999999999995 109.967 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -140.53 162.12 36.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.889 0.376 . . . . 71.040000000000006 110.767 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.53 153.01 23.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.719 -0.673 . . . . 74.310000000000002 110.252 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.937 ' HG3' ' HD2' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -140.84 121.35 14.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.938 0.399 . . . . 65.310000000000002 111.41 -178.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.803 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.8 pt? -84.91 -12.24 53.83 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.67 -0.696 . . . . 71.129999999999995 110.765 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.64 -39.17 93.0 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.151 0.501 . . . . 65.310000000000002 110.108 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.631 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.8 pt -104.81 154.11 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 74.439999999999998 110.052 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.597 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 6.9 p-10 -88.37 -170.09 2.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.102 0.477 . . . . 75.219999999999999 112.018 -171.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.792 ' HD2' ' HB3' ' A' ' 158' ' ' GLU . 68.1 m-85 -62.97 119.65 9.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.363 -0.835 . . . . 72.230000000000004 112.526 -168.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.69 -0.16 82.39 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.813 -0.708 . . . . 65.510000000000005 113.363 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.512 ' O ' HD12 ' A' ' 99' ' ' ILE . 33.0 mmt180 -88.94 96.09 10.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 117.069 0.434 . . . . 74.25 110.192 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.716 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -103.34 137.35 32.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.92 0.39 . . . . 62.130000000000003 110.666 -179.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 105' ' ' ARG . 52.0 mtt180 -145.61 125.74 13.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.997 -0.547 . . . . 74.329999999999998 110.062 176.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -100.21 130.22 46.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.342 -0.614 . . . . 75.409999999999997 109.342 172.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.535 ' HA ' HD13 ' A' ' 181' ' ' LEU . 1.5 tmtm? -155.41 154.2 31.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.266 0.555 . . . . 70.540000000000006 111.637 -171.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.474 HD23 HD11 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -83.95 92.95 7.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.343 0.592 . . . . 75.150000000000006 109.561 171.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.04 176.58 37.46 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.623 -0.717 . . . . 55.130000000000003 111.435 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.79 170.41 27.91 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.615 -0.802 . . . . 75.150000000000006 112.673 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.2 -169.19 34.68 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.447 -0.661 . . . . 51.049999999999997 111.447 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -134.26 -11.73 2.49 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.754 -0.379 . . . . 70.120000000000005 110.781 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -108.31 138.91 14.91 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.72 -0.752 . . . . 74.340000000000003 111.354 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.13 56.32 18.83 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.578 -0.82 . . . . 72.430000000000007 111.773 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -53.74 -38.93 64.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.06 0.393 . . . . 70.420000000000002 112.06 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -58.24 -53.72 55.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.724 0.297 . . . . 43.219999999999999 111.274 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.65 -28.81 73.95 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.007 -0.616 . . . . 35.009999999999998 112.831 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.1 mt -82.48 -46.12 13.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.654 0.264 . . . . 61.149999999999999 111.488 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -77.56 -21.48 52.45 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.879 -0.328 . . . . 63.329999999999998 110.879 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 t -63.27 -37.85 88.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.513 -0.551 . . . . 75.400000000000006 109.513 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 45.2 t -66.79 -31.01 51.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.801 -0.636 . . . . 63.0 110.202 176.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.6 -52.33 10.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.852 -0.613 . . . . 62.399999999999999 111.001 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 62.7 m -66.78 -22.75 66.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 64.409999999999997 111.772 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.32 -54.91 29.57 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 111.872 0.323 . . . . 44.130000000000003 111.872 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.73 ' H ' HD23 ' A' ' 125' ' ' LEU . 2.2 pt? -106.71 -17.73 14.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 75.340000000000003 111.369 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.54 40.24 2.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.242 -0.98 . . . . 64.200000000000003 112.936 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -110.26 171.82 7.23 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.505 -0.554 . . . . 73.230000000000004 109.505 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -114.22 38.88 2.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.488 0.185 . . . . 53.439999999999998 111.127 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 63.38 34.89 12.64 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.373 -0.376 . . . . 61.539999999999999 111.117 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -64.67 -13.11 52.7 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.132 -0.486 . . . . 42.130000000000003 112.303 -173.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 48.1 m80 -146.86 99.29 3.17 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.232 -0.293 . . . . 65.219999999999999 110.366 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 143.82 49.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.815 0.341 . . . . 75.140000000000001 110.822 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 34.3 t -116.94 120.59 65.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.812 -0.44 . . . . 72.310000000000002 109.812 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.937 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 44.0 mtm180 -107.32 117.58 34.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.676 0.274 . . . . 64.439999999999998 111.027 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.444 HD13 HG13 ' A' ' 93' ' ' ILE . 1.9 mp -103.51 115.11 44.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.762 -0.459 . . . . 74.519999999999996 109.762 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.631 ' HA2' HG13 ' A' ' 99' ' ' ILE . . . -62.13 113.63 5.98 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.872 -0.604 . . . . 40.450000000000003 112.879 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 p -101.66 -17.22 6.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.226 0.536 . . . . 71.230000000000004 109.648 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 88.49 -171.99 40.57 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.718 -0.753 . . . . 62.149999999999999 111.4 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -135.06 111.96 11.14 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 120.901 0.382 . . . . 73.430000000000007 110.197 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 146' ' ' PRO . 23.8 Cg_exo -63.67 114.99 2.79 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.108 2.539 . . . . 71.239999999999995 112.441 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 2.1 Cg_endo -85.16 139.32 7.08 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.319 2.679 . . . . 63.310000000000002 112.347 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -173.32 -151.91 8.44 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.43 -0.668 . . . . 53.130000000000003 111.43 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.13 -8.17 49.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.449 0.642 . . . . 74.420000000000002 109.688 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.421 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 71.6 mmtt -116.89 156.11 27.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.198 -0.91 . . . . 63.539999999999999 109.795 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.34 143.29 97.27 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.885 -0.598 . . . . 72.209999999999994 110.03 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.703 ' HB3' ' HD2' ' A' ' 140' ' ' PRO . 82.9 Cg_exo -47.0 -26.06 4.57 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.364 2.71 . . . . 62.310000000000002 113.016 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.05 -31.16 39.96 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.956 -0.565 . . . . 71.400000000000006 111.916 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.13 -50.9 6.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.488 -0.324 . . . . 74.540000000000006 111.422 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 153' ' ' ASN . 74.6 m-85 -64.99 -27.43 68.82 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.201 0.445 . . . . 74.299999999999997 112.201 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.461 HG22 ' CE1' ' A' ' 22' ' ' HIS . 6.2 p -69.36 -9.13 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.889 0.376 . . . . 71.450000000000003 111.558 -174.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.37 -24.5 36.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.603 -0.271 . . . . 71.230000000000004 110.897 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.6 87.77 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.842 0.83 . . . . 74.129999999999995 109.647 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.75 ' H ' HG22 ' A' ' 20' ' ' THR . 3.7 t-20 -137.84 122.23 18.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.426 -0.806 . . . . 75.109999999999999 110.77 -174.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -134.35 133.83 41.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.639 -0.71 . . . . 74.430000000000007 109.407 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 157' ' ' ALA . 59.9 m -145.61 134.04 21.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.86 0.362 . . . . 70.510000000000005 110.471 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.04 -31.43 67.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.325 -0.398 . . . . 62.32 111.505 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.571 ' H ' HG22 ' A' ' 155' ' ' THR . . . -59.89 -40.73 89.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 71.549999999999997 111.9 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.792 ' HB3' ' HD2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -85.14 -17.75 36.29 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.035 -0.266 . . . . 74.340000000000003 111.361 -177.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 155' ' ' THR . 4.7 mmt180 -72.15 -24.62 61.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 72.329999999999998 110.927 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.68 -17.1 61.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 72.040000000000006 111.127 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.45 ' O ' HG13 ' A' ' 165' ' ' ILE . 25.0 mm-40 -92.66 -18.49 22.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 62.43 111.103 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.715 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 67.1 t -55.98 -56.99 24.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.594 0.59 . . . . 64.329999999999998 112.594 -174.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.715 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 32.2 Cg_exo -59.12 -30.12 92.34 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.135 1.89 . . . . 53.329999999999998 112.322 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.9 m -67.2 -46.3 74.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.949 -0.569 . . . . 52.340000000000003 110.555 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 161' ' ' GLU . 72.4 mt -70.02 -53.97 21.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.717 -0.674 . . . . 73.299999999999997 111.215 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.78 -57.94 9.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.383 0.512 . . . . 72.439999999999998 112.383 -172.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -62.88 -45.52 92.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.874 0.324 . . . . 61.539999999999999 111.874 -174.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -74.32 -32.02 62.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.798 0.295 . . . . 64.349999999999994 111.798 -173.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.29 -25.43 67.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.618 0.229 . . . . 65.120000000000005 111.618 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.23 74.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 73.310000000000002 111.289 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.4 -43.69 76.69 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.338 0.59 . . . . 61.530000000000001 110.766 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.7 -31.75 69.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.597 -0.729 . . . . 43.329999999999998 111.678 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.1 m -55.72 -43.09 76.19 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.776 0.322 . . . . 74.239999999999995 111.803 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.774 ' HG2' ' HB2' ' A' ' 55' ' ' LEU . 42.6 mt-10 -68.54 -28.65 67.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.754 0.311 . . . . 71.25 111.075 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.05 -25.77 65.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.352 -0.385 . . . . 75.430000000000007 111.051 -175.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.73 -37.81 88.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.188 0.518 . . . . 71.239999999999995 110.278 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -80.0 -39.9 20.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.678 -0.692 . . . . 72.209999999999994 110.091 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.49 -56.6 10.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.807 -0.633 . . . . 75.319999999999993 111.448 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -115.57 -77.09 0.57 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.079 -0.509 . . . . 75.340000000000003 110.208 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.32 -171.39 40.02 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.107 -0.797 . . . . 74.540000000000006 111.107 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.535 HD13 ' HA ' ' A' ' 107' ' ' LYS . 4.3 pp -91.13 -18.49 24.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.035 0.418 . . . . 73.219999999999999 110.32 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 33.5 mm-40 -58.63 -51.79 79.3 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.747 -0.66 . . . . 65.549999999999997 111.829 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 37.8 Cg_endo -69.01 -29.81 26.8 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.351 1.367 . . . . 61.520000000000003 112.027 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.15 -43.81 66.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 60.109999999999999 111.809 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 11.3 pt20 -58.8 -24.0 61.22 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.779 0.323 . . . . 53.200000000000003 111.303 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -77.65 -57.12 3.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.34 -0.391 . . . . 75.409999999999997 111.298 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -66.95 -31.01 71.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.383 -0.371 . . . . 73.230000000000004 111.876 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 8.1 p -71.42 -29.36 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.055 0.391 . . . . 75.430000000000007 112.055 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -94.03 0.06 55.74 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.46 -0.496 . . . . 55.240000000000002 110.636 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.49 -0.96 54.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 112.018 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 74.3 m95 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.697 -0.668 . . . . 74.349999999999994 110.64 -178.256 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 38.2 mt-10 . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.363 -0.236 . . . . 74.400000000000006 110.363 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 59' ' ' SER . 22.6 Cg_exo -64.71 106.4 0.74 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.598 2.199 . . . . 73.450000000000003 111.596 176.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.418 ' HG ' HG12 ' A' ' 60' ' ' VAL . 4.0 pp -89.94 153.77 20.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.304 -0.407 . . . . 55.409999999999997 111.021 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' HB3' HG12 ' A' ' 90' ' ' ILE . 62.9 tp -97.46 124.74 41.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.848 -0.615 . . . . 65.209999999999994 110.5 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.1 t -105.27 119.12 53.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.13 -0.486 . . . . 61.509999999999998 109.77 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.72 117.08 46.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.02 0.438 . . . . 74.329999999999998 110.801 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -127.9 128.72 6.13 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.371 -0.692 . . . . 64.209999999999994 111.371 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -72.56 118.94 16.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.759 -0.46 . . . . 73.450000000000003 109.759 -178.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.94 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -77.12 -158.4 9.21 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.206 -0.452 . . . . 73.549999999999997 113.069 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.47 91.36 9.95 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.619 0.723 . . . . 65.209999999999994 111.002 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 11' ' ' GLY . 2.0 Cg_endo -82.92 -8.95 10.96 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.215 2.61 . . . . 72.239999999999995 112.932 -176.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.19 160.92 29.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.826 -0.702 . . . . 70.430000000000007 112.229 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.42 -30.59 52.95 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.109 2.539 . . . . 75.140000000000001 112.482 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 p -73.24 -43.61 60.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.987 0.422 . . . . 53.420000000000002 111.2 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -59.89 -40.15 87.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.773 -0.648 . . . . 73.129999999999995 111.51 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.23 -3.71 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 65.510000000000005 111.771 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -111.45 8.29 21.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.352 -0.386 . . . . 72.310000000000002 110.424 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 153' ' ' ASN . 71.4 p -113.65 159.75 19.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 61.409999999999997 111.038 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -78.46 -20.16 51.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 62.340000000000003 111.672 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -76.73 -19.7 57.36 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.785 -0.366 . . . . 72.319999999999993 111.476 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 27' ' ' MET . 7.0 m120 -85.08 33.27 0.54 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.227 0.537 . . . . 73.310000000000002 111.042 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 1.3 pp -66.07 -17.26 64.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.552 -0.749 . . . . 74.239999999999995 111.521 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.424 ' N ' HD12 ' A' ' 24' ' ' LEU . . . -59.12 -34.24 78.55 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.195 -0.526 . . . . 61.43 111.962 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.94 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 54.6 t80 -90.11 -53.89 4.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.459 . . . . 75.219999999999999 109.841 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 85.7 mmm -56.89 -38.11 72.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.905 -1.043 . . . . 71.129999999999995 112.554 -169.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 166' ' ' VAL . 62.1 t -88.84 -41.9 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.798 0.332 . . . . 70.140000000000001 111.739 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.49 -22.42 47.49 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.189 0.44 . . . . 62.049999999999997 112.189 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -72.2 -39.28 68.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.732 0.301 . . . . 73.120000000000005 111.468 -175.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.41 -36.64 75.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 72.010000000000005 111.868 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.99 -27.08 62.52 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.771 0.319 . . . . 75.120000000000005 110.971 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.43 68.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.112 0.482 . . . . 54.030000000000001 110.309 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.16 -29.34 56.78 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.474 -0.869 . . . . 74.319999999999993 112.244 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -79.89 -21.87 43.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.342 0.497 . . . . 71.430000000000007 112.342 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.2 tp -78.15 -14.69 13.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.315 0.578 . . . . 71.450000000000003 110.335 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.31 41.03 2.87 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.121 -0.792 . . . . 54.530000000000001 111.121 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 62.8 m -135.3 150.08 49.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.229 -0.486 . . . . 65.549999999999997 110.684 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.97 136.24 52.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.687 0.279 . . . . 55.140000000000001 110.731 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.464 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 26.9 p90 -91.93 146.82 23.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.614 -0.513 . . . . 73.120000000000005 109.614 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 18.9 ptmt -155.39 166.87 32.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 74.010000000000005 111.155 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.22 128.31 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.469 -0.787 . . . . 72.400000000000006 111.314 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -101.9 106.13 17.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.234 -1.025 . . . . 64.209999999999994 108.234 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -57.91 154.26 12.64 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.502 0.556 . . . . 74.340000000000003 112.502 -166.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt 76.66 -47.55 0.54 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.387 1.075 . . . . 74.510000000000005 110.086 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 p -95.09 25.08 4.42 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.141 -0.936 . . . . 72.219999999999999 108.737 171.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.37 41.39 0.01 OUTLIER Glycine 0 CA--C 1.533 1.166 0 N-CA-C 119.238 2.455 . . . . 71.120000000000005 119.238 -159.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.02 140.1 29.84 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.847 -1.168 . . . . 74.140000000000001 107.847 163.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.51 120.12 19.63 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.723 -0.391 . . . . 71.230000000000004 110.553 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 63' ' ' ALA . 33.2 m -126.05 145.18 33.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.78 -0.646 . . . . 64.109999999999999 111.272 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 4.8 p -125.41 117.05 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.834 -0.621 . . . . 62.039999999999999 110.228 172.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.5 p -91.08 116.27 28.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.191 -0.459 . . . . 54.329999999999998 110.546 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.35 175.25 28.64 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.935 -0.65 . . . . 73.219999999999999 111.604 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 25.6 ptt85 -126.77 115.75 19.85 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.093 0.473 . . . . 74.219999999999999 110.922 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.9 mt -103.09 124.72 49.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.764 -0.653 . . . . 63.420000000000002 109.705 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 72.28 -53.01 0.7 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.823 0.702 . . . . 74.409999999999997 111.373 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.24 -52.13 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.115 -0.564 . . . . 71.329999999999998 111.986 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.696 ' HB ' HG22 ' A' ' 177' ' ' ILE . 17.8 m -72.62 138.67 46.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.857 0.36 . . . . 75.530000000000001 110.889 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.619 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 10.8 t -85.75 139.79 31.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.553 -0.536 . . . . 71.530000000000001 109.553 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.418 HG12 ' HG ' ' A' ' 5' ' ' LEU . 31.6 m -130.07 155.01 41.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.341 -0.391 . . . . 62.350000000000001 110.72 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.4 t -111.25 106.83 21.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.845 -0.616 . . . . 54.340000000000003 109.638 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 3.4 tm? -91.78 115.78 28.34 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.299 -0.63 . . . . 75.049999999999997 109.299 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 50' ' ' VAL . . . -119.27 142.24 48.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.239 -0.437 . . . . 44.450000000000003 111.385 -175.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HE2' ' CD2' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -139.14 127.25 13.52 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 75.430000000000007 110.387 175.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 13.0 Cg_exo -70.75 153.34 64.44 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.992 2.462 . . . . 73.420000000000002 112.023 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -93.96 -19.24 21.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.462 0.649 . . . . 74.310000000000002 110.0 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 60.4 m -101.94 159.26 15.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.217 -0.901 . . . . 45.340000000000003 109.463 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -78.05 -169.38 1.56 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.876 0.369 . . . . 65.219999999999999 111.522 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.831 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 18.9 ptp -52.75 -22.06 4.82 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.625 0.972 . . . . 70.150000000000006 113.625 -170.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -62.82 -49.62 74.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.791 0.329 . . . . 63.520000000000003 110.809 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.88 -0.11 21.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.011 0.375 . . . . 64.409999999999997 112.011 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 p -60.64 -42.77 97.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.927 0.394 . . . . 72.329999999999998 111.04 -176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.39 -21.17 78.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.945 -0.645 . . . . 71.030000000000001 112.769 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -80.63 -33.38 35.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.57 0.224 . . . . 71.129999999999995 111.391 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -74.9 -14.9 60.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.704 0.288 . . . . 75.319999999999993 111.617 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.21 -25.21 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.172 0.51 . . . . 65.519999999999996 110.304 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.69 -68.55 1.62 Allowed Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.881 -0.6 . . . . 63.32 112.865 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.82 -37.71 95.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.853 2.369 . . . . 64.329999999999998 112.462 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -55.87 -52.04 65.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 72.340000000000003 110.484 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.98 -44.75 83.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 65.400000000000006 112.012 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -72.77 -37.85 67.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.926 0.343 . . . . 72.099999999999994 111.926 -174.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -60.28 -47.49 85.76 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.75 0.309 . . . . 74.409999999999997 111.314 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -84.39 -15.14 47.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.934 -0.307 . . . . 74.329999999999998 110.791 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.2 m 59.78 47.61 10.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.863 -0.608 . . . . 71.430000000000007 110.693 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.441 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 29.4 m -94.42 148.8 35.61 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.642 -0.708 . . . . 73.510000000000005 110.321 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 11.2 Cg_exo -71.19 115.33 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.807 2.338 . . . . 70.400000000000006 111.969 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.523 ' HA ' HG13 ' A' ' 90' ' ' ILE . 28.8 Cg_exo -62.78 -19.53 68.73 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.006 2.471 . . . . 72.150000000000006 112.124 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -66.98 -21.7 65.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.86 -0.609 . . . . 74.319999999999993 110.684 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 89' ' ' GLN . 15.6 mm-40 -98.01 5.63 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.384 . . . . 73.430000000000007 111.413 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 87' ' ' PRO . 59.5 mt -69.22 130.92 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.109 0.48 . . . . 72.140000000000001 111.165 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 7.0 p -120.0 132.67 69.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 62.5 109.325 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.68 129.71 75.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.543 0.687 . . . . 74.319999999999993 111.649 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.13 113.1 29.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.167 -0.924 . . . . 73.439999999999998 109.174 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.455 ' HE1' ' H ' ' A' ' 114' ' ' GLY . 30.1 t-80 -135.26 154.28 51.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.277 0.561 . . . . 73.140000000000001 111.905 -174.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.87 129.53 34.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.628 -1.169 . . . . 73.549999999999997 110.899 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -129.47 138.45 51.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.016 0.436 . . . . 52.450000000000003 110.659 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.55 -0.03 44.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.88 -0.6 . . . . 50.439999999999998 110.919 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -58.67 -45.7 88.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.313 -0.858 . . . . 73.239999999999995 112.431 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.567 HD13 ' HG3' ' A' ' 105' ' ' ARG . 2.9 pt -122.22 174.92 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.307 0.575 . . . . 75.120000000000005 112.507 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.97 171.43 14.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.826 -1.079 . . . . 71.019999999999996 111.615 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -63.89 132.69 51.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.203 -0.908 . . . . 73.299999999999997 110.671 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.06 10.67 66.05 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.604 -0.808 . . . . 71.400000000000006 113.217 173.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.3 mmt-85 -123.0 153.56 39.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.103 0.452 . . . . 72.040000000000006 110.345 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.646 HD11 HG21 ' A' ' 188' ' ' VAL . 44.2 pt -138.81 149.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 74.420000000000002 110.874 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.567 ' HG3' HD13 ' A' ' 99' ' ' ILE . 99.0 mtt180 -127.15 128.06 45.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.936 -0.575 . . . . 74.319999999999993 109.903 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 185' ' ' GLN . 8.1 mp -109.75 110.19 21.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 61.329999999999998 110.953 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -157.68 148.4 21.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.053 -0.721 . . . . 74.219999999999999 109.053 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.72 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.3 pt? -73.66 125.12 27.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.776 -0.453 . . . . 72.25 109.776 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.76 -177.14 41.06 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.848 -0.692 . . . . 53.229999999999997 112.022 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.37 -164.73 39.28 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.962 -0.637 . . . . 51.439999999999998 112.628 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.35 152.36 22.07 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.381 -0.688 . . . . 55.229999999999997 111.381 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -113.32 7.53 17.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.776 0.288 . . . . 75.209999999999994 110.995 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -68.61 -86.77 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.701 -0.762 . . . . 62.329999999999998 111.855 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.455 ' H ' ' HE1' ' A' ' 94' ' ' HIS . . . -74.4 73.93 1.32 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.916 -0.659 . . . . 74.25 111.66 175.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.624 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -48.97 -66.43 0.4 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.488 0.715 . . . . 75.230000000000004 112.69 -174.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.564 ' HB2' ' SD ' ' A' ' 69' ' ' MET . 13.0 m120 -55.04 -43.63 73.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 62.039999999999999 111.527 -174.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.831 ' HA2' ' HB2' ' A' ' 69' ' ' MET . . . -62.9 -48.75 78.26 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.851 -0.613 . . . . 32.350000000000001 113.271 -176.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.74 -29.01 68.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.436 0.16 . . . . 74.310000000000002 111.291 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 115' ' ' HIS . 10.2 mmm180 -65.96 -42.27 90.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.657 0.265 . . . . 71.319999999999993 110.642 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -64.86 -47.79 76.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.387 -0.37 . . . . 62.030000000000001 110.549 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.28 -47.47 92.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 70.409999999999997 110.903 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.74 -31.28 72.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.891 -0.595 . . . . 54.130000000000003 111.844 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.2 t -80.34 -33.69 37.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.708 0.29 . . . . 55.520000000000003 110.918 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.21 -45.9 53.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 62.450000000000003 111.025 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.89 -38.53 45.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.479 . . . . 54.020000000000003 110.943 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.97 -12.52 63.78 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 121.116 -0.564 . . . . 53.240000000000002 113.168 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.504 ' C ' ' HD2' ' A' ' 128' ' ' LYS . 14.6 t -141.9 173.73 11.24 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.129 -0.323 . . . . 74.409999999999997 110.129 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.504 ' HD2' ' C ' ' A' ' 127' ' ' THR . 13.2 mptt -125.22 -115.25 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.436 -0.347 . . . . 72.299999999999997 110.224 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 61.93 21.77 12.55 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.94 0.496 . . . . 72.019999999999996 111.613 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -90.25 160.97 15.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.19 -0.459 . . . . 71.319999999999993 110.275 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 33.2 m80 -87.18 99.89 12.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.122 -0.696 . . . . 74.109999999999999 109.122 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.462 ' NH1' ' HG2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -111.75 136.31 51.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.975 0.416 . . . . 73.319999999999993 111.108 -174.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.03 127.11 59.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.016 -0.538 . . . . 74.340000000000003 109.782 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.462 ' HG2' ' NH1' ' A' ' 132' ' ' ARG . 5.2 mtm180 -93.36 96.83 10.19 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.685 -0.487 . . . . 71.409999999999997 109.685 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.526 ' HA ' HG22 ' A' ' 104' ' ' ILE . 51.4 mt -90.19 127.75 42.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.422 -0.354 . . . . 71.019999999999996 110.48 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.51 ' CA ' HG13 ' A' ' 99' ' ' ILE . . . -72.52 97.82 0.81 Allowed Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.987 -0.552 . . . . 75.519999999999996 112.545 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.8 p -88.65 -10.29 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.464 -0.569 . . . . 70.439999999999998 109.464 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.23 152.98 28.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.56 -0.745 . . . . 42.039999999999999 112.279 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 21.1 ptp180 -107.46 119.85 49.39 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.067 0.46 . . . . 72.019999999999996 110.235 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 32.5 Cg_exo -59.58 125.28 17.44 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.954 2.436 . . . . 54.049999999999997 112.746 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 1.9 Cg_endo -83.79 137.71 7.82 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.45 2.767 . . . . 73.409999999999997 112.374 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.09 -168.01 24.97 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.181 -0.767 . . . . 74.420000000000002 111.181 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -87.81 -24.38 23.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.631 -0.507 . . . . 72.150000000000006 109.631 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.446 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 42.4 mmtm -75.58 101.19 4.83 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.535 -0.913 . . . . 71.549999999999997 108.535 168.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.721 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 6.8 p-10 -73.1 168.49 24.43 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.916 -0.584 . . . . 73.329999999999998 110.41 -174.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.721 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 5.2 Cg_exo -35.99 -44.87 0.86 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.402 3.401 . . . . 64.109999999999999 114.274 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.42 68.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.236 0.458 . . . . 44.43 112.236 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.52 -43.77 11.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.847 0.356 . . . . 71.319999999999993 111.372 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 144' ' ' LYS . 2.6 m-85 -84.02 -19.43 34.49 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.869 0.692 . . . . 73.409999999999997 112.869 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.481 HG13 HD12 ' A' ' 151' ' ' LEU . 7.0 p -63.1 -25.56 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 112.201 0.445 . . . . 62.240000000000002 112.201 -173.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.481 HD12 HG13 ' A' ' 150' ' ' VAL . 6.0 mp -85.96 -10.24 55.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.659 0.266 . . . . 71.340000000000003 111.421 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.0 87.07 1.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.792 0.806 . . . . 74.209999999999994 109.438 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.559 ' H ' HG22 ' A' ' 20' ' ' THR . 23.8 t-20 -128.94 122.36 30.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.471 -0.786 . . . . 64.140000000000001 111.613 -170.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -155.31 134.86 12.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.386 -0.825 . . . . 74.209999999999994 109.199 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 157' ' ' ALA . 47.2 m -152.86 138.97 18.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.672 0.272 . . . . 72.230000000000004 110.605 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.91 -33.0 48.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 61.100000000000001 111.337 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.637 ' H ' HG22 ' A' ' 155' ' ' THR . . . -65.96 -49.24 68.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.903 -0.589 . . . . 64.109999999999999 111.568 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 155' ' ' THR . 3.0 pp20? -72.64 -22.04 61.0 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 120.849 -0.34 . . . . 74.040000000000006 111.252 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 155' ' ' THR . 16.4 mmt180 -56.59 -39.89 74.33 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.195 0.522 . . . . 65.019999999999996 110.34 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.45 -31.97 71.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.69 -0.686 . . . . 54.210000000000001 111.189 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.93 1.13 57.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.148 -0.478 . . . . 61.130000000000003 111.887 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.468 ' HB ' ' CD ' ' A' ' 163' ' ' PRO . 92.5 t -57.33 -57.87 21.96 Favored Pre-proline 0 C--O 1.233 0.229 0 C-N-CA 121.086 -0.245 . . . . 63.43 110.496 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' A' ' 162' ' ' VAL . 18.8 Cg_endo -61.07 -36.75 80.39 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.668 1.579 . . . . 72.109999999999999 111.476 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -56.18 -53.37 57.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.594 -0.73 . . . . 71.140000000000001 111.421 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.4 mt -64.3 -49.75 79.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.289 -0.414 . . . . 71.409999999999997 111.008 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 28' ' ' VAL . 97.6 t -57.22 -51.59 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.409 -0.359 . . . . 75.239999999999995 111.552 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.48 -49.87 73.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.503 -0.317 . . . . 75.430000000000007 111.754 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.547 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . 10.3 mm-40 -67.71 -36.78 81.25 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.027 -0.269 . . . . 65.140000000000001 111.498 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.24 75.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.61 0.243 . . . . 62.439999999999998 110.61 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.69 64.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.001 0.429 . . . . 61.219999999999999 111.301 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.42 -45.7 17.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.295 -0.411 . . . . 70.409999999999997 110.709 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.35 -33.96 70.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.068 -0.514 . . . . 73.340000000000003 111.979 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 176' ' ' LEU . 3.4 p -61.71 -27.4 68.68 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.865 0.32 . . . . 75.329999999999998 111.865 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -63.38 -44.76 93.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.701 0.286 . . . . 52.210000000000001 110.355 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 38.3 tp -74.65 -28.91 61.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 74.439999999999998 110.261 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.831 HD22 ' HA ' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -54.54 -49.02 71.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.366 -0.834 . . . . 70.409999999999997 109.306 174.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.696 HG22 ' HB ' ' A' ' 58' ' ' THR . 65.5 mt -79.7 -25.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.114 -0.948 . . . . 74.109999999999999 111.079 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.4 -43.68 72.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.008 -0.542 . . . . 73.109999999999999 112.158 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.22 -65.04 0.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.861 -0.336 . . . . 71.120000000000005 111.092 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -161.89 173.41 38.23 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.283 -0.96 . . . . 62.240000000000002 112.439 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.831 ' HA ' HD22 ' A' ' 176' ' ' LEU . 2.4 pt? -83.2 -30.6 27.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.723 0.297 . . . . 72.439999999999998 111.557 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 39.4 mt-10 -67.72 -49.31 39.64 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.098 0.407 . . . . 43.549999999999997 112.098 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 52.7 Cg_exo -55.76 -28.79 68.63 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.062 1.841 . . . . 73.209999999999994 112.228 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.69 -50.26 18.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 61.219999999999999 110.995 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.596 ' HG3' ' O ' ' A' ' 182' ' ' GLU . 1.4 pp0? -64.23 -32.9 74.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.766 0.317 . . . . 74.340000000000003 110.197 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -61.77 -23.08 65.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.905 -0.589 . . . . 74.310000000000002 111.099 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 26.4 m -87.15 -41.01 14.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.765 0.317 . . . . 55.240000000000002 111.605 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 104' ' ' ILE . 17.8 m -96.41 -12.77 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 114.35 1.241 . . . . 74.239999999999995 114.35 -171.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -69.45 -28.59 66.24 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.913 0.708 . . . . 71.230000000000004 112.913 -171.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -133.66 -10.73 2.75 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.122 0.416 . . . . 63.399999999999999 112.122 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 19.4 m0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 119.012 -0.518 . . . . 62.329999999999998 110.234 -176.835 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.343 0.592 . . . . 73.310000000000002 109.819 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HG2' HG12 ' A' ' 85' ' ' VAL . 6.7 Cg_endo -89.41 110.82 0.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.093 2.529 . . . . 75.530000000000001 113.191 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.634 HD12 HG23 ' A' ' 177' ' ' ILE . 91.7 mt -76.52 128.93 35.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 72.439999999999998 110.281 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.573 ' HA ' HG23 ' A' ' 61' ' ' VAL . 22.9 tp -96.72 114.55 26.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.041 0.448 . . . . 71.439999999999998 110.781 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.806 ' HB ' HD13 ' A' ' 62' ' ' LEU . 21.2 t -105.21 111.56 35.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.728 -0.669 . . . . 70.120000000000005 109.83 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.574 HG21 HG22 ' A' ' 76' ' ' VAL . 49.5 t -104.48 117.47 50.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.077 -0.511 . . . . 72.409999999999997 110.147 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.494 ' HA2' HG13 ' A' ' 93' ' ' ILE . . . -106.2 -142.91 11.15 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.448 -0.882 . . . . 73.209999999999994 112.622 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.553 ' H ' ' HA3' ' A' ' 25' ' ' GLY . 2.2 tt -117.47 122.57 44.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.448 -0.945 . . . . 73.430000000000007 108.448 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -76.31 169.9 54.86 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.945 -0.645 . . . . 73.230000000000004 113.424 -172.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.507 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 44.9 t-20 -109.28 109.26 60.46 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.234 -0.654 . . . . 75.299999999999997 109.234 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 6.3 Cg_exo -74.25 -61.8 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.231 2.62 . . . . 73.530000000000001 113.62 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.72 -168.09 11.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.202 -0.999 . . . . 75.450000000000003 113.362 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.02 -56.68 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.392 2.728 . . . . 61.020000000000003 113.378 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 m -61.78 -30.78 71.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.993 0.425 . . . . 72.519999999999996 111.518 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -83.59 -8.0 59.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.213 -0.448 . . . . 51.229999999999997 111.04 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HA ' HD21 ' A' ' 12' ' ' ASN . . . -81.28 -16.6 52.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 51.549999999999997 111.411 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.855 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 9.7 mmpt? -111.34 8.13 21.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.428 -0.351 . . . . 73.230000000000004 111.374 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.413 HG21 ' HA ' ' A' ' 152' ' ' GLU . 38.6 p -110.47 163.21 13.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.523 0.677 . . . . 73.310000000000002 112.173 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.899 HH21 ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -54.8 -33.47 61.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.428 -1.26 . . . . 75.219999999999999 113.465 -174.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -86.14 9.93 15.98 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.099 0.777 . . . . 73.450000000000003 113.099 -165.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.73 13.46 19.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.31 0.576 . . . . 65.209999999999994 110.556 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.899 ' HG ' HH21 ' A' ' 21' ' ' ARG . 0.0 OUTLIER -50.28 -31.35 14.0 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.182 0.808 . . . . 65.439999999999998 113.182 -173.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA3' ' H ' ' A' ' 10' ' ' LEU . . . -62.47 -42.64 99.69 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.823 -0.704 . . . . 65.129999999999995 112.536 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.481 ' CE2' ' HE3' ' A' ' 64' ' ' LYS . 56.3 t80 -67.13 -40.42 86.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.137 0.494 . . . . 73.349999999999994 110.439 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.497 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 4.8 mmt -65.36 -45.86 82.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.732 . . . . 74.209999999999994 111.381 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.752 HG12 HD23 ' A' ' 32' ' ' LEU . 57.9 t -68.15 -32.47 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.48 -0.327 . . . . 55.119999999999997 111.285 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.1 70.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.048 0.388 . . . . 53.509999999999998 112.048 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.27 -38.61 68.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.602 -0.272 . . . . 73.329999999999998 111.509 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.548 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 30.3 m -74.94 -33.38 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.091 0.404 . . . . 55.509999999999998 112.091 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.752 HD23 HG12 ' A' ' 28' ' ' VAL . 4.3 pp -70.93 -38.59 72.91 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 120.63 -0.428 . . . . 63.450000000000003 110.34 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -75.11 -36.89 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.231 0.539 . . . . 41.119999999999997 110.061 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.83 -18.28 45.87 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.497 -0.774 . . . . 51.310000000000002 113.067 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 15.3 mmt85 -68.67 -36.45 78.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.39 . . . . 73.120000000000005 111.17 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 36' ' ' ILE . 3.1 mp -88.17 -15.07 9.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.713 0.768 . . . . 74.319999999999993 109.703 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.35 24.9 9.8 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.616 -0.993 . . . . 71.129999999999995 110.616 -175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 70.5 m -99.24 123.23 43.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.845 -0.677 . . . . 62.450000000000003 111.021 -176.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.48 134.63 14.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.471 -0.331 . . . . 74.140000000000001 110.707 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 3.0 t80 -142.85 177.99 7.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.591 -0.522 . . . . 73.329999999999998 109.591 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 20.8 ptmt -123.39 174.14 7.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.702 -0.226 . . . . 74.219999999999999 110.446 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 6.3 p -49.8 128.29 6.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.262 0.553 . . . . 53.109999999999999 110.602 174.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -106.86 109.92 21.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.964 -0.562 . . . . 75.349999999999994 110.513 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -53.16 154.44 3.12 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.652 0.595 . . . . 54.25 111.993 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 45' ' ' LYS . 12.0 tptp 80.26 -41.73 0.21 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.362 1.065 . . . . 73.0 109.625 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.9 p -104.93 26.58 9.06 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.366 -1.288 . . . . 41.039999999999999 108.109 171.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.45 41.44 0.01 OUTLIER Glycine 0 N--CA 1.477 1.424 0 N-CA-C 119.72 2.648 . . . . 73.219999999999999 119.72 -154.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.02 168.63 9.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.14 -1.43 . . . . 64.120000000000005 107.14 160.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.815 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 46.0 mt-10 -77.64 124.18 27.6 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.065 -0.654 . . . . 73.25 109.737 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -133.54 138.85 50.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.928 -0.578 . . . . 55.329999999999998 109.995 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 62' ' ' LEU . 3.4 p -122.11 115.99 47.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.356 0.598 . . . . 71.310000000000002 110.241 173.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.0 m -99.47 136.06 39.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.529 -0.759 . . . . 74.530000000000001 110.183 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -175.09 -160.07 22.37 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.24 -0.744 . . . . 34.409999999999997 111.24 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -131.91 144.08 50.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.742 0.306 . . . . 74.349999999999994 110.195 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.76 ' HG ' HG21 ' A' ' 60' ' ' VAL . 79.9 mt -118.3 123.67 45.92 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.842 -0.799 . . . . 60.350000000000001 108.842 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.686 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . . . 70.18 -52.44 0.64 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.961 0.788 . . . . 61.020000000000003 111.274 -173.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.4 -40.82 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.327 -0.709 . . . . 35.420000000000002 111.327 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.675 ' HB ' HG22 ' A' ' 177' ' ' ILE . 20.6 m -65.54 144.57 56.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.42 -0.39 . . . . 73.239999999999995 110.724 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 20.3 m -76.18 142.72 41.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.312 -0.404 . . . . 72.430000000000007 110.499 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.76 HG21 ' HG ' ' A' ' 55' ' ' LEU . 29.4 m -138.33 150.81 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.255 0.55 . . . . 42.229999999999997 111.5 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 6' ' ' LEU . 3.6 m -129.76 112.14 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.526 -0.761 . . . . 44.439999999999998 109.904 173.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.806 HD13 ' HB ' ' A' ' 7' ' ' VAL . 4.1 mm? -92.49 128.07 38.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.797 -0.638 . . . . 73.510000000000005 109.992 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.14 122.25 46.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.173 0.511 . . . . 71.329999999999998 110.532 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HE3' ' CE2' ' A' ' 26' ' ' PHE . 6.9 ptmt -130.26 91.53 38.46 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.509 -0.769 . . . . 64.340000000000003 110.045 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.74 177.1 9.12 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.071 2.514 . . . . 64.019999999999996 112.812 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 20.3 mmt85 -109.35 13.3 24.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.46 -0.791 . . . . 65.510000000000005 109.044 175.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.556 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 61.2 m -102.26 178.91 4.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.947 -1.024 . . . . 60.439999999999998 109.923 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -85.36 -165.11 1.12 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.201 -0.454 . . . . 71.099999999999994 110.125 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -80.7 -19.62 44.69 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.705 0.261 . . . . 73.420000000000002 111.705 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -73.47 -61.71 1.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.222 0.534 . . . . 74.329999999999998 110.833 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 1.1 pm0 -82.69 6.6 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.987 -0.551 . . . . 71.310000000000002 111.792 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.6 p -67.54 -34.08 76.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.985 0.422 . . . . 71.109999999999999 110.069 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.96 -20.75 74.89 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.806 -0.634 . . . . 70.049999999999997 112.612 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 mmm180 -74.25 -19.62 60.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.997 0.427 . . . . 73.540000000000006 110.473 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -87.34 -8.01 57.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 71.209999999999994 110.789 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.574 HG22 HG21 ' A' ' 8' ' ' VAL . 74.0 t -66.67 -36.95 78.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 64.0 110.659 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.11 9.43 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.811 -0.632 . . . . 63.240000000000002 112.939 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.56 -18.73 56.19 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.834 2.356 . . . . 72.120000000000005 113.187 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.57 -51.29 7.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.01 0.433 . . . . 74.219999999999999 110.077 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.627 ' HA ' HG22 ' A' ' 85' ' ' VAL . . . -53.46 -63.48 1.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.55 -0.75 . . . . 74.329999999999998 113.018 -172.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -72.82 -22.88 60.74 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.353 0.501 . . . . 72.420000000000002 112.353 -170.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -77.76 -28.85 50.71 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.915 -0.314 . . . . 75.239999999999995 111.224 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -102.93 5.45 38.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.798 0.332 . . . . 74.030000000000001 110.938 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.7 t 65.58 28.7 11.28 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.522 -0.763 . . . . 44.509999999999998 111.976 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 80' ' ' ALA . 6.3 m -80.38 136.22 53.01 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.626 -0.43 . . . . 64.310000000000002 110.464 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.77 ' HD2' ' HG3' ' A' ' 89' ' ' GLN . 30.1 Cg_exo -63.29 155.11 63.77 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.651 2.234 . . . . 75.040000000000006 111.748 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.34 -56.77 2.42 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.011 2.474 . . . . 64.430000000000007 112.689 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.15 55.22 2.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.049 0.452 . . . . 62.539999999999999 111.827 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.77 ' HG3' ' HD2' ' A' ' 86' ' ' PRO . 22.9 mm-40 -129.36 16.13 6.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.795 -0.639 . . . . 73.310000000000002 109.422 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' HB ' HD22 ' A' ' 129' ' ' ASN . 49.6 mm -92.92 123.91 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.478 -0.783 . . . . 75.219999999999999 111.86 -172.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.43 114.76 29.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.701 -0.681 . . . . 61.32 109.512 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.67 HG21 HG11 ' A' ' 121' ' ' VAL . 61.3 t -109.52 123.24 65.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.131 -0.486 . . . . 64.209999999999994 111.313 -175.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.87 HG22 ' HB ' ' A' ' 133' ' ' VAL . 30.8 pt -107.72 117.33 53.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.952 -0.567 . . . . 54.109999999999999 110.271 177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -132.79 162.25 31.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.064 0.459 . . . . 74.349999999999994 111.375 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -84.76 121.75 28.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.327 -0.851 . . . . 52.140000000000001 109.53 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 114' ' ' GLY . 1.5 mm-40 -127.5 135.74 50.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.289 0.566 . . . . 73.530000000000001 111.998 -171.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.29 -7.02 59.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.579 -0.737 . . . . 62.439999999999998 110.218 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.48 -34.92 64.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.318 -0.855 . . . . 75.530000000000001 111.513 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.53 ' HB ' ' HA3' ' A' ' 136' ' ' GLY . 1.1 mp -111.02 141.37 26.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.096 -0.502 . . . . 74.519999999999996 109.716 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.654 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 41.9 m-20 -67.93 147.02 53.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.355 -0.609 . . . . 73.420000000000002 109.355 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.731 ' HE1' ' HB2' ' A' ' 161' ' ' GLU . 13.8 t80 -63.03 137.55 58.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.099 0.476 . . . . 73.439999999999998 111.323 -171.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.513 ' O ' ' HD3' ' A' ' 103' ' ' ARG . . . 133.51 -39.84 1.67 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.576 -0.738 . . . . 70.400000000000006 112.067 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 102' ' ' GLY . 62.1 mmt-85 -131.96 164.51 25.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.715 0.293 . . . . 63.25 110.305 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 135' ' ' ILE . 37.2 pt -117.62 160.85 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 71.450000000000003 110.618 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.476 ' HD2' HG13 ' A' ' 99' ' ' ILE . 92.6 mtt180 -123.23 129.52 51.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.994 0.426 . . . . 71.400000000000006 110.923 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.604 ' HG ' HG13 ' A' ' 133' ' ' VAL . 4.7 mp -114.53 129.77 56.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.906 -0.588 . . . . 72.319999999999993 109.823 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -155.52 153.47 30.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.701 0.286 . . . . 73.109999999999999 110.283 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.802 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.3 pt? -87.43 94.09 9.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.571 . . . . 71.329999999999998 110.11 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.527 ' O ' ' HD3' ' A' ' 132' ' ' ARG . . . 172.81 -150.55 12.62 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.795 -0.639 . . . . 41.32 111.797 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.87 -157.05 25.35 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.935 -0.65 . . . . 64.310000000000002 112.223 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.688 ' HA3' HD13 ' A' ' 118' ' ' LEU . . . -130.91 132.05 6.7 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.106 -0.569 . . . . 71.25 111.867 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -112.73 6.79 18.33 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.742 0.275 . . . . 72.310000000000002 111.742 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.41 -92.26 1.55 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.527 -0.845 . . . . 73.420000000000002 111.341 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.443 ' H ' ' CD ' ' A' ' 96' ' ' GLU . . . -69.11 -45.09 63.46 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.883 -0.887 . . . . 32.299999999999997 110.883 174.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.407 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 76.0 t60 70.52 -24.59 0.16 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.869 0.692 . . . . 73.349999999999994 112.869 172.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.409 ' H ' ' C ' ' A' ' 114' ' ' GLY . 28.5 t-20 -51.52 -66.35 0.4 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.694 0.627 . . . . 61.409999999999997 112.694 -173.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.93 -10.21 85.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.144 -1.027 . . . . 73.420000000000002 113.037 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.688 HD13 ' HA3' ' A' ' 111' ' ' GLY . 94.7 mt -84.36 -38.08 20.75 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.704 -0.292 . . . . 71.219999999999999 111.372 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 120' ' ' SER . 6.6 ptm180 -65.25 -37.16 86.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 75.310000000000002 110.845 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.439 ' N ' ' HG3' ' A' ' 119' ' ' ARG . 10.0 m -60.02 -41.4 92.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.994 -0.548 . . . . 71.409999999999997 110.774 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.67 HG11 HG21 ' A' ' 92' ' ' VAL . 59.9 t -69.63 -40.33 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 75.120000000000005 110.163 177.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.423 ' HA ' HH22 ' A' ' 132' ' ' ARG . . . -63.48 -46.66 85.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.836 -0.62 . . . . 43.439999999999998 111.045 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.1 m -72.23 -27.9 62.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.292 -0.413 . . . . 72.299999999999997 111.751 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.61 66.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.93 0.395 . . . . 72.310000000000002 111.033 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.6 mt -82.27 -32.21 29.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.897 -0.592 . . . . 41.229999999999997 110.793 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 108.12 -11.64 37.27 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.96 -0.564 . . . . 53.32 111.787 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.2 t -166.01 177.56 6.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.451 -0.574 . . . . 73.409999999999997 109.451 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.637 ' HD2' ' N ' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -60.21 -30.26 69.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.847 0.356 . . . . 74.120000000000005 110.408 174.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.637 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 9.2 t30 66.11 -13.88 0.15 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.213 1.005 . . . . 73.019999999999996 112.948 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 129' ' ' ASN . 3.4 t80 175.37 -84.5 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 122.464 0.306 . . . . 75.239999999999995 110.273 175.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -161.01 161.39 31.47 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.791 0.329 . . . . 71.310000000000002 111.737 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 109' ' ' GLY . 5.6 mpt_? -132.3 166.19 22.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.947 -0.57 . . . . 73.439999999999998 109.603 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.87 ' HB ' HG22 ' A' ' 93' ' ' ILE . 59.0 t -123.44 124.92 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.24 -0.436 . . . . 65.530000000000001 109.825 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.46 ' CB ' HD11 ' A' ' 99' ' ' ILE . 98.1 mtt180 -98.74 115.65 29.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.954 -0.566 . . . . 71.430000000000007 110.009 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.727 ' HA ' HG22 ' A' ' 104' ' ' ILE . 2.7 mp -87.89 117.59 32.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.341 -0.614 . . . . 72.230000000000004 109.341 176.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.53 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . -72.5 108.75 2.59 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.905 -0.664 . . . . 62.43 113.555 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.494 ' HA ' ' CD2' ' A' ' 101' ' ' PHE . 15.0 p -92.35 -16.21 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.562 0.696 . . . . 72.400000000000006 109.888 174.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 89.98 169.75 43.73 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.453 -0.794 . . . . 34.119999999999997 111.851 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.41 ' O ' ' HD3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -102.85 101.48 21.21 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 110.194 -0.298 . . . . 74.540000000000006 110.194 177.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 138' ' ' GLY . 2.9 Cg_exo -76.36 110.41 3.06 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.813 2.342 . . . . 71.040000000000006 111.388 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 139' ' ' ARG . 87.5 Cg_endo -80.25 143.96 16.1 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.554 2.169 . . . . 74.540000000000006 111.863 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 178.91 179.32 48.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.596 -0.811 . . . . 63.539999999999999 112.008 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -102.01 -4.13 26.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.64 0.733 . . . . 71.140000000000001 109.946 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.699 ' HE2' ' HA ' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -116.87 148.22 41.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.177 -1.416 . . . . 70.230000000000004 107.177 167.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -61.18 138.24 94.4 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.683 0.278 . . . . 61.450000000000003 110.777 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.647 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 18.5 Cg_endo -58.86 -9.59 7.92 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.246 2.631 . . . . 74.430000000000007 112.097 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.31 59.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.305 -0.861 . . . . 45.140000000000001 111.597 176.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.33 -23.5 24.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 51.329999999999998 111.606 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.647 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 92.7 m-85 -84.09 -34.36 24.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.872 0.368 . . . . 64.129999999999995 111.245 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.71 -18.35 22.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 60.43 111.726 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.43 HD12 ' HG2' ' A' ' 152' ' ' GLU . 4.5 pp -86.28 -8.85 57.43 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.808 -0.357 . . . . 74.129999999999995 111.395 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 10.6 pt-20 -156.97 102.64 2.0 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.252 0.549 . . . . 73.349999999999994 110.775 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -134.54 136.69 43.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.706 -0.398 . . . . 73.409999999999997 110.586 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -122.42 19.07 10.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.029 -0.532 . . . . 74.310000000000002 110.538 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.544 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 96.9 m -62.17 120.85 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.852 -0.613 . . . . 62.32 110.732 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.32 79.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 74.530000000000001 111.743 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.85 -53.78 53.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.11 -0.495 . . . . 70.430000000000007 111.524 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -67.85 -37.2 81.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.661 -0.245 . . . . 71.209999999999994 110.95 -176.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 159' ' ' ARG . 11.8 mmt180 -58.68 -29.17 66.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 72.219999999999999 111.312 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.02 -18.81 35.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.33 -0.395 . . . . 74.150000000000006 111.535 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.731 ' HB2' ' HE1' ' A' ' 101' ' ' PHE . 40.3 mt-10 -99.08 -6.7 27.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.68 0.276 . . . . 64.540000000000006 111.363 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 158' ' ' GLU . 89.8 t -69.75 -58.53 5.45 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.626 -0.261 . . . . 75.450000000000003 111.673 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 18.5 Cg_endo -59.58 -35.21 96.02 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.3 2.0 . . . . 72.439999999999998 112.878 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.6 p -62.1 -42.71 99.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 74.439999999999998 111.177 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.1 mt -65.62 -47.05 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 64.349999999999994 110.492 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.43 -50.84 78.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 44.219999999999999 111.48 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -60.79 -45.57 93.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 73.209999999999994 111.556 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -73.87 -26.23 60.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.696 0.284 . . . . 71.150000000000006 111.603 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.06 68.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.526 -0.306 . . . . 61.119999999999997 111.465 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.51 -51.42 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.511 -0.313 . . . . 71.129999999999995 111.33 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.59 -46.69 88.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.122 0.487 . . . . 65.420000000000002 110.488 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.89 -47.26 78.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.807 -0.633 . . . . 75.129999999999995 111.601 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.7 m -64.09 -39.87 94.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 64.25 110.917 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.686 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 21.8 tt0 -61.14 -47.31 86.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.602 -0.272 . . . . 31.309999999999999 110.41 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.9 tp -68.26 -31.31 70.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 74.439999999999998 111.242 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.685 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.9 tt -62.73 -46.16 89.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.377 0.608 . . . . 75.5 109.551 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.682 HD13 HG11 ' A' ' 60' ' ' VAL . 79.2 mt -73.52 -25.26 20.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.235 -0.893 . . . . 70.140000000000001 110.4 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.24 -68.19 0.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.76 -0.654 . . . . 71.120000000000005 111.815 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -144.24 -40.58 0.27 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.856 0.687 . . . . 75.519999999999996 112.856 -172.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 176' ' ' LEU . . . -106.38 114.4 4.42 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.759 -1.21 . . . . 73.310000000000002 113.663 -170.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.454 ' HA ' ' HG ' ' A' ' 176' ' ' LEU . 6.1 tt -91.22 -54.41 3.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.456 -0.572 . . . . 53.200000000000003 109.456 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -70.31 -40.73 12.37 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 74.439999999999998 111.741 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -48.28 -38.8 34.46 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.026 1.817 . . . . 61.299999999999997 112.27 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -65.81 -43.33 88.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.095 -0.502 . . . . 73.049999999999997 110.636 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -57.81 -45.71 85.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.957 0.408 . . . . 72.299999999999997 110.508 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -66.03 -49.73 66.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 71.450000000000003 111.617 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 184' ' ' ALA . 12.1 t -60.54 -38.02 83.09 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.093 -0.243 . . . . 74.129999999999995 111.509 -174.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.731 ' HA ' ' HD1' ' A' ' 191' ' ' TRP . 72.0 t -60.23 -28.45 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.987 0.423 . . . . 72.200000000000003 111.106 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -76.34 -10.47 59.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.376 -0.375 . . . . 73.400000000000006 111.035 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -115.73 13.29 16.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.126 0.417 . . . . 50.200000000000003 112.126 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.731 ' HD1' ' HA ' ' A' ' 188' ' ' VAL . 93.1 m95 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.652 -0.689 . . . . 75.230000000000004 110.077 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 13.5 mm-40 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.62 0.248 . . . . 64.329999999999998 110.695 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.483 ' HA ' ' HB2' ' A' ' 59' ' ' SER . 56.2 Cg_endo -92.55 107.26 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.187 2.591 . . . . 74.219999999999999 112.097 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.708 HD21 HG23 ' A' ' 177' ' ' ILE . 4.3 pp -89.21 157.71 18.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.307 -0.406 . . . . 75.140000000000001 110.647 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.419 ' HB2' HG11 ' A' ' 85' ' ' VAL . 47.5 tp -117.91 120.85 39.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.048 0.451 . . . . 74.150000000000006 111.281 -174.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.742 ' HB ' HD22 ' A' ' 62' ' ' LEU . 48.5 t -112.16 110.49 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.943 -0.571 . . . . 65.549999999999997 109.613 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.74 ' HB ' HG22 ' A' ' 92' ' ' VAL . 47.8 t -110.3 124.32 66.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 110.2 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.38 157.37 15.0 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.416 -0.897 . . . . 61.240000000000002 111.368 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.452 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -64.15 107.62 1.34 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.595 -0.891 . . . . 62.32 108.595 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -74.15 -176.89 35.76 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.673 -0.694 . . . . 61.420000000000002 113.523 -172.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -111.33 98.3 39.34 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.601 -0.518 . . . . 74.120000000000005 109.601 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.477 ' HB2' ' OH ' ' A' ' 17' ' ' TYR . 14.5 Cg_exo -67.8 -31.35 32.15 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.857 2.371 . . . . 71.439999999999998 112.445 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.78 -176.22 43.83 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.589 -0.815 . . . . 71.109999999999999 112.248 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.37 -159.43 0.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.907 2.405 . . . . 70.439999999999998 112.312 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m 70.64 -70.82 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.081 -0.509 . . . . 75.299999999999997 111.324 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 13' ' ' PRO . 28.7 p90 -88.63 3.51 50.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.965 0.412 . . . . 72.040000000000006 110.99 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.79 -1.57 4.04 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.879 -0.6 . . . . 35.509999999999998 112.371 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -100.62 18.5 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.33 . . . . 71.400000000000006 110.751 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.8 p -100.56 167.28 10.45 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.908 -0.405 . . . . 72.219999999999999 109.908 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 24' ' ' LEU . 22.4 ptt180 -84.38 -0.38 52.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.531 -0.304 . . . . 74.209999999999994 110.944 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.64 ' CD2' ' HA ' ' A' ' 150' ' ' VAL . 97.8 m-70 -86.21 -29.75 22.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.824 0.345 . . . . 65.040000000000006 110.944 -172.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -88.26 28.31 1.1 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.323 0.582 . . . . 61.5 109.88 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 2.4 pt? -67.28 -27.15 66.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.563 -0.744 . . . . 72.25 111.318 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.452 ' HA3' ' N ' ' A' ' 10' ' ' LEU . . . -59.23 -44.41 96.48 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.81 -0.709 . . . . 64.319999999999993 111.896 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.595 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 56.8 t80 -65.19 -35.8 82.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.743 0.306 . . . . 73.25 110.521 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 82.9 mmm -83.26 -47.27 11.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.704 -0.68 . . . . 62.310000000000002 111.989 -171.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.4 t -63.41 -42.12 95.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.14 0.495 . . . . 63.229999999999997 110.256 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . . . -67.18 -20.95 65.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.964 -0.562 . . . . 61.229999999999997 110.718 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 21.7 t70 -77.16 -43.17 34.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.978 -0.555 . . . . 71.030000000000001 111.031 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 36.0 m -71.23 -37.87 67.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.53 -0.305 . . . . 72.420000000000002 111.568 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.73 -24.83 62.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.042 0.449 . . . . 74.420000000000002 110.472 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 38' ' ' SER . . . -66.45 -46.74 75.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 64.319999999999993 110.158 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.76 -18.57 61.94 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.866 -0.607 . . . . 74.540000000000006 112.395 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 14.3 mmt85 -76.1 -58.15 3.45 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.766 0.284 . . . . 51.520000000000003 111.766 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.29 -15.4 14.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.873 0.368 . . . . 73.120000000000005 111.199 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.09 45.86 2.97 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.653 -0.979 . . . . 51.409999999999997 110.653 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.9 t -110.19 121.24 44.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.756 -0.722 . . . . 74.219999999999999 110.358 -173.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.83 126.62 55.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.347 -0.388 . . . . 72.25 110.242 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.463 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 48.4 p90 -106.0 137.81 43.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.044 0.45 . . . . 71.329999999999998 110.251 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -127.41 168.07 15.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.947 -0.57 . . . . 70.109999999999999 110.369 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.753 HG22 ' HG2' ' A' ' 49' ' ' GLU . 38.8 t -86.07 102.38 11.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.46 -0.57 . . . . 75.439999999999998 109.46 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.457 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 21.1 t-80 -79.58 85.03 5.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.921 -0.77 . . . . 75.230000000000004 108.921 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -66.55 96.8 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.559 0.695 . . . . 75.319999999999993 111.017 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 167.78 -55.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.47 -2.048 . . . . 73.120000000000005 105.47 -173.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.3 p -105.53 28.91 6.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.569 -2.105 . . . . 74.150000000000006 107.348 168.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 43' ' ' HIS . . . -49.92 43.27 0.01 OUTLIER Glycine 0 N--CA 1.476 1.356 0 N-CA-C 120.087 2.795 . . . . 71.450000000000003 120.087 -150.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.13 163.75 15.32 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.791 -1.189 . . . . 71.030000000000001 107.791 161.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.753 ' HG2' HG22 ' A' ' 42' ' ' VAL . 43.5 mt-10 -80.86 117.07 21.18 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.391 -0.524 . . . . 72.450000000000003 109.957 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.697 HG12 ' HA ' ' A' ' 63' ' ' ALA . 31.1 m -138.34 150.92 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 71.219999999999999 111.501 -173.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.28 137.71 56.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.774 -0.648 . . . . 73.120000000000005 109.961 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -111.3 125.64 54.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.688 0.28 . . . . 54.109999999999999 111.312 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.52 -167.75 24.46 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.007 -0.615 . . . . 74.230000000000004 111.621 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -136.96 104.38 5.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.084 0.442 . . . . 75.310000000000002 110.144 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.555 ' HG ' HG21 ' A' ' 60' ' ' VAL . 88.6 mt -89.78 131.19 35.86 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.619 -0.511 . . . . 63.420000000000002 109.619 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.85 9.01 4.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.228 -0.442 . . . . 73.340000000000003 111.564 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.75 -28.17 13.02 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.041 -0.599 . . . . 74.340000000000003 112.473 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.557 ' HB ' ' CG2' ' A' ' 177' ' ' ILE . 9.8 m -84.03 139.08 32.75 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.211 -0.292 . . . . 75.120000000000005 110.211 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 20.3 m -70.47 132.12 45.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.841 0.353 . . . . 45.530000000000001 110.601 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.576 HG12 HD11 ' A' ' 5' ' ' LEU . 34.1 m -126.44 136.47 60.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.124 0.488 . . . . 65.439999999999998 111.132 -176.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.2 112.71 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.829 -0.623 . . . . 61.409999999999997 109.629 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.742 HD22 ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -94.99 119.78 34.08 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.358 -0.608 . . . . 62.119999999999997 109.358 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.697 ' HA ' HG12 ' A' ' 50' ' ' VAL . . . -111.87 124.28 52.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.962 0.41 . . . . 72.140000000000001 111.587 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' HE2' ' HB3' ' A' ' 29' ' ' ALA . 91.5 mttt -119.88 107.28 40.34 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.051 -0.522 . . . . 63.450000000000003 110.242 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.455 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 4.7 Cg_exo -75.12 151.57 39.17 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.961 2.441 . . . . 73.510000000000005 112.405 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -110.44 16.53 21.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.288 0.566 . . . . 72.5 109.714 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 58.4 m -112.8 168.86 9.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.722 -0.672 . . . . 73.209999999999994 110.882 -174.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -72.23 173.84 8.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.054 -0.521 . . . . 75.340000000000003 110.73 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -19.24 65.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.379 -0.373 . . . . 70.409999999999997 111.699 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -87.91 -19.99 26.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.359 0.599 . . . . 72.420000000000002 110.163 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 36.6 mt-10 -100.46 -28.16 13.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.021 -0.536 . . . . 72.239999999999995 110.957 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 76' ' ' VAL . 14.0 p -57.73 -37.62 73.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 50.229999999999997 111.177 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.24 -32.38 76.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.181 -0.533 . . . . 65.439999999999998 112.412 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.637 HH11 ' HB2' ' A' ' 124' ' ' ALA . 26.8 mmt180 -76.73 -31.36 57.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.748 0.309 . . . . 72.230000000000004 110.698 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 78.8 mm-40 -69.66 -28.66 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 72.540000000000006 110.861 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 72' ' ' SER . 46.6 t -66.52 -30.27 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 74.140000000000001 110.773 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.62 -67.1 2.32 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 116.044 -0.525 . . . . 41.32 113.154 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.54 -43.46 39.33 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.442 2.095 . . . . 73.049999999999997 112.227 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -54.88 -51.59 65.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 110.755 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.49 84.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.119 -0.492 . . . . 44.43 111.547 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -77.49 -31.87 53.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 111.724 0.268 . . . . 51.43 111.724 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -65.86 -46.45 78.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.615 0.245 . . . . 54.43 111.262 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -90.8 -17.08 27.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.669 -0.241 . . . . 71.230000000000004 111.313 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.0 t 59.98 72.77 0.51 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.443 0.639 . . . . 75.519999999999996 110.47 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 27.8 m -98.15 139.73 21.43 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 61.219999999999999 111.188 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 13.1 Cg_exo -70.57 129.53 16.89 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.909 2.406 . . . . 71.349999999999994 111.797 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 18.3 Cg_exo -67.33 -4.4 11.73 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.133 2.555 . . . . 73.420000000000002 113.292 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -89.6 -12.18 40.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.876 0.37 . . . . 53.219999999999999 110.745 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.439 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 9.3 mm-40 -129.73 45.01 2.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.414 0.626 . . . . 75.450000000000003 110.566 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.584 HG23 ' HB3' ' A' ' 131' ' ' HIS . 10.4 tt -120.54 127.7 75.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.819 -0.628 . . . . 74.319999999999993 109.864 175.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.37 146.21 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.131 -0.486 . . . . 55.0 110.456 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.74 HG22 ' HB ' ' A' ' 8' ' ' VAL . 86.1 t -134.07 124.23 45.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.848 0.356 . . . . 73.109999999999999 110.744 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 mm -75.23 130.65 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.61 -0.723 . . . . 73.109999999999999 111.689 -175.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -143.42 141.9 31.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 74.310000000000002 110.166 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.63 ' HB2' HG21 ' A' ' 137' ' ' VAL . 4.6 p-10 -87.29 122.32 30.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.928 -0.767 . . . . 73.439999999999998 108.928 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' H ' ' A' ' 99' ' ' ILE . 10.5 tp10 -99.62 118.63 36.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.675 -0.693 . . . . 62.43 110.982 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 98' ' ' ASP . 3.3 pp -82.59 -20.7 35.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.474 -0.784 . . . . 70.049999999999997 111.253 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' HD12 ' A' ' 97' ' ' LEU . 38.6 t70 -78.63 -20.45 50.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.1 0.476 . . . . 64.129999999999995 110.742 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.496 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 66.0 mt -102.28 122.92 55.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 109.777 176.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.463 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 13.6 m-20 -62.13 149.87 40.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.281 -0.418 . . . . 63.409999999999997 110.839 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.877 ' HD2' ' HA ' ' A' ' 137' ' ' VAL . 29.4 t80 -65.61 133.76 51.85 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.18 -0.464 . . . . 75.120000000000005 110.918 -174.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.93 -62.29 0.32 Allowed Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.827 -0.624 . . . . 53.520000000000003 112.294 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -126.3 165.38 19.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.716 0.293 . . . . 60.350000000000001 110.263 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.708 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -118.57 159.18 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.194 -0.457 . . . . 60.450000000000003 110.173 -178.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -144.82 163.0 35.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.029 0.442 . . . . 73.310000000000002 110.94 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.0 mt -108.62 152.56 24.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.737 -0.665 . . . . 64.230000000000004 109.602 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -129.58 105.1 7.84 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.835 -0.346 . . . . 71.319999999999993 110.914 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 181' ' ' LEU . 85.6 mt -110.33 91.84 3.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 75.510000000000005 109.987 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.454 ' H ' ' NH2' ' A' ' 132' ' ' ARG . . . 162.65 -132.18 2.71 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.058 -0.817 . . . . 33.240000000000002 111.058 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.63 109.58 3.24 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.718 -0.953 . . . . 63.399999999999999 110.718 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.75 161.33 31.77 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.074 -1.06 . . . . 55.350000000000001 112.977 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.62 171.01 10.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.279 -0.461 . . . . 72.129999999999995 110.413 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.93 45.36 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.187 -0.765 . . . . 54.219999999999999 111.187 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.35 81.72 1.31 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.58 -1.008 . . . . 74.439999999999998 110.58 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -52.07 -50.56 61.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.444 0.535 . . . . 75.430000000000007 112.444 -170.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.55 -3.03 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.808 -0.357 . . . . 40.43 111.409 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.1 -33.59 7.65 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.954 -0.859 . . . . 72.299999999999997 110.954 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.8 -30.19 65.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.531 -0.544 . . . . 73.040000000000006 109.531 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -51.33 -50.28 59.75 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.153 -0.93 . . . . 73.019999999999996 111.683 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.2 p -72.81 -45.35 58.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.891 0.377 . . . . 75.439999999999998 111.326 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.612 HG11 ' HE1' ' A' ' 131' ' ' HIS . 59.3 t -65.79 -47.96 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.069 -0.514 . . . . 60.119999999999997 111.87 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.454 ' HA ' HD21 ' A' ' 129' ' ' ASN . . . -63.3 -38.48 91.31 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.987 0.366 . . . . 51.229999999999997 111.987 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.9 p -76.6 -29.21 56.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.631 -0.259 . . . . 53.32 111.193 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.637 ' HB2' HH11 ' A' ' 74' ' ' ARG . . . -79.35 -49.46 12.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 111.676 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -84.67 -41.78 15.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.352 -0.385 . . . . 64.049999999999997 111.536 -174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.95 -12.6 65.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.808 -0.711 . . . . 61.210000000000001 112.357 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.1 t -71.96 164.4 26.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.887 0.375 . . . . 52.020000000000003 110.793 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.86 -11.82 60.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 52.229999999999997 110.64 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.454 HD21 ' HA ' ' A' ' 122' ' ' ALA . 86.9 m-20 66.09 79.14 0.25 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.579 -0.737 . . . . 72.510000000000005 112.329 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.402 ' HB3' HD22 ' A' ' 108' ' ' LEU . 99.3 m-85 -83.56 -22.85 32.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.212 0.53 . . . . 71.010000000000005 110.032 174.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.612 ' HE1' HG11 ' A' ' 121' ' ' VAL . 13.1 p80 -68.63 87.61 0.34 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.445 -0.798 . . . . 70.310000000000002 112.347 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.454 ' NH2' ' H ' ' A' ' 109' ' ' GLY . 16.2 mtm180 -142.89 109.56 5.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.257 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.4 t -101.87 109.02 24.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.637 -0.875 . . . . 75.409999999999997 108.637 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.469 ' HD2' ' OE1' ' A' ' 96' ' ' GLU . 38.9 mtm180 -99.1 106.43 18.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.071 0.462 . . . . 75.530000000000001 110.93 -175.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 104' ' ' ILE . 3.0 mp -85.1 114.78 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.701 -0.681 . . . . 74.219999999999999 109.362 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.747 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -65.29 101.93 0.61 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.768 -0.729 . . . . 35.5 111.583 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.877 ' HA ' ' HD2' ' A' ' 101' ' ' PHE . 3.5 m -111.2 -7.37 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.255 0.465 . . . . 60.43 112.255 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 86.87 167.68 44.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 63.340000000000003 112.72 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.5 ptm180 -111.48 124.34 32.82 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.044 0.449 . . . . 72.549999999999997 110.984 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 9.5 Cg_endo -90.07 115.37 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.57 2.846 . . . . 74.209999999999994 112.259 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -93.23 155.9 2.58 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.962 2.441 . . . . 64.510000000000005 113.18 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.62 -161.78 29.97 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.258 -0.737 . . . . 53.340000000000003 111.258 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -78.12 -19.31 54.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.196 0.522 . . . . 71.219999999999999 110.161 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 32.5 mmtp -108.38 150.74 26.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.478 -0.783 . . . . 75.049999999999997 109.451 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.23 164.02 56.65 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.325 -0.398 . . . . 55.0 110.251 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' ' 149' ' ' PHE . 62.6 Cg_exo -53.58 -14.33 4.88 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.14 2.56 . . . . 71.239999999999995 113.292 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.94 -22.79 63.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 74.030000000000001 111.567 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.75 -26.87 22.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.394 0.616 . . . . 62.329999999999998 110.473 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 146' ' ' PRO . 68.5 m-85 -64.42 -15.95 61.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.044 -0.98 . . . . 72.129999999999995 112.038 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 33.6 m -55.48 -28.75 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 111.859 0.318 . . . . 62.32 111.859 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.543 ' HG ' HG23 ' A' ' 150' ' ' VAL . 86.6 mt -105.58 -27.15 11.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.921 0.391 . . . . 75.5 110.871 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -128.59 93.52 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.491 0.663 . . . . 72.319999999999993 110.272 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 149' ' ' PHE . 3.8 t30 -125.11 101.31 6.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.634 . . . . 74.5 110.491 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -132.13 102.13 5.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.286 0.565 . . . . 63.200000000000003 110.527 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.893 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 6.5 m -125.73 132.38 52.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.011 -0.541 . . . . 54.210000000000001 109.887 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.76 73.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.971 0.415 . . . . 72.049999999999997 110.868 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.65 -38.95 93.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.832 -0.622 . . . . 75.239999999999995 112.044 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.893 ' HG2' ' HB ' ' A' ' 155' ' ' THR . 10.5 pt-20 -72.58 -40.45 66.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.876 -0.33 . . . . 75.409999999999997 111.261 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.464 ' HA ' HG23 ' A' ' 162' ' ' VAL . 25.6 mmm180 -66.82 -34.34 77.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.85 0.357 . . . . 75.219999999999999 110.808 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.49 62.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.428 -0.805 . . . . 65.409999999999997 112.376 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.652 ' HB2' ' HE1' ' A' ' 101' ' ' PHE . 59.7 mm-40 -100.68 13.38 34.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.337 0.495 . . . . 73.340000000000003 112.337 -174.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.642 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 55.2 t -54.38 -52.47 68.96 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.035 -0.266 . . . . 74.310000000000002 110.798 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 53.9 Cg_exo -54.55 -25.89 43.0 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.142 1.895 . . . . 75.510000000000005 113.24 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.5 m -74.28 -48.21 29.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.057 0.456 . . . . 73.25 110.684 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.24 -33.59 64.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.962 -0.563 . . . . 72.120000000000005 111.34 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 162' ' ' VAL . 98.1 t -53.35 -39.1 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.835 0.35 . . . . 65.409999999999997 111.419 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -71.57 -50.07 34.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.46 -0.336 . . . . 60.409999999999997 111.29 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.531 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . 9.1 mm-40 -60.84 -42.78 98.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.783 0.325 . . . . 62.119999999999997 111.385 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.13 -22.98 67.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.237 -0.438 . . . . 54.140000000000001 111.641 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.39 -44.16 15.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.855 0.36 . . . . 45.340000000000003 111.742 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -85.05 -36.29 21.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.555 -0.293 . . . . 73.530000000000001 111.618 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.33 -43.67 73.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.843 0.312 . . . . 70.239999999999995 111.843 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.533 ' HA ' HD13 ' A' ' 176' ' ' LEU . 22.0 p -63.05 -31.49 72.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 65.519999999999996 111.69 -175.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.45 -26.4 66.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.278 -0.419 . . . . 73.109999999999999 110.821 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.72 -29.76 66.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.708 0.29 . . . . 71.140000000000001 110.593 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 173' ' ' THR . 8.3 mp -64.66 -36.5 84.47 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.482 0.658 . . . . 61.210000000000001 109.502 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.708 HG23 HD21 ' A' ' 5' ' ' LEU . 34.5 mt -76.99 -37.36 26.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.892 -1.049 . . . . 74.5 110.023 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.85 -48.84 67.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.57 -0.741 . . . . 54.450000000000003 111.364 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -133.22 -67.56 0.62 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.431 -0.35 . . . . 65.010000000000005 111.201 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.4 -178.32 46.09 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.749 -0.739 . . . . 70.340000000000003 111.886 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 108' ' ' LEU . 3.7 pp -89.87 -12.94 37.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.965 0.412 . . . . 74.019999999999996 110.584 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.71 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 6.5 tm-20 -53.68 -54.13 49.62 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.508 -0.769 . . . . 74.329999999999998 111.797 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.71 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 11.0 Cg_exo -71.19 -31.98 13.69 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 121.644 1.563 . . . . 62.200000000000003 112.176 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.59 -26.01 57.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 53.32 112.322 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 19.7 pt20 -62.29 -22.65 66.2 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.475 0.179 . . . . 74.150000000000006 111.444 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -85.98 -48.01 9.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.749 0.309 . . . . 72.140000000000001 110.657 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.6 m -53.22 -40.55 64.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.765 -0.652 . . . . 72.540000000000006 111.749 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.2 -12.75 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.62 0.6 . . . . 74.109999999999999 112.62 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -117.45 -28.58 6.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.614 0.245 . . . . 64.239999999999995 111.54 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.55 -17.15 39.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.586 -0.279 . . . . 72.319999999999993 111.607 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.3 m95 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.637 -0.697 . . . . 63.439999999999998 110.271 -179.535 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.0 mp0 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.632 0.253 . . . . 73.310000000000002 110.554 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 2.9 Cg_exo -76.21 117.85 4.77 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.137 2.558 . . . . 70.209999999999994 112.307 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.722 HD21 HG23 ' A' ' 177' ' ' ILE . 4.2 pp -121.89 149.25 43.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.291 -0.413 . . . . 73.040000000000006 110.246 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.473 ' HB3' HG12 ' A' ' 90' ' ' ILE . 64.8 tp -97.56 136.21 38.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.318 -0.401 . . . . 73.230000000000004 110.476 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.7 t -117.42 112.61 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.829 -0.434 . . . . 75.109999999999999 109.829 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.67 128.61 62.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 73.329999999999998 110.723 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.541 ' HA2' HG23 ' A' ' 93' ' ' ILE . . . -103.38 -177.06 26.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.198 -0.525 . . . . 72.519999999999996 112.095 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.568 HD13 ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -142.53 158.74 43.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.362 . . . . 73.099999999999994 110.926 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 22' ' ' HIS . . . 155.86 -158.28 28.43 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.449 -0.661 . . . . 60.399999999999999 111.449 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 61.0 t30 -163.08 105.32 1.01 Allowed Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.116 -0.328 . . . . 72.340000000000003 110.116 176.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 12' ' ' ASN . 56.2 Cg_endo -71.2 142.25 41.27 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.751 2.301 . . . . 53.140000000000001 112.271 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.62 177.92 39.9 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.754 -0.736 . . . . 42.439999999999998 111.849 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.4 -66.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.699 2.266 . . . . 62.109999999999999 112.083 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 m -76.7 -25.56 53.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.319 0.581 . . . . 65.239999999999995 110.113 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' HA ' HG23 ' A' ' 20' ' ' THR . 80.9 m-85 -70.71 -23.14 62.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.567 -0.742 . . . . 71.450000000000003 111.748 -175.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.4 -17.27 63.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 73.120000000000005 110.28 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -106.73 20.63 18.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.604 -0.725 . . . . 74.230000000000004 111.277 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.627 HG23 ' HA ' ' A' ' 17' ' ' TYR . 72.2 p -99.95 166.91 10.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.238 0.542 . . . . 74.439999999999998 110.385 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.544 ' HB3' HG23 ' A' ' 150' ' ' VAL . 17.5 tpt85 -93.76 1.56 56.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.912 -0.586 . . . . 74.299999999999997 111.1 -175.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.461 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 1.5 t-160 -106.81 11.04 30.56 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.909 -0.316 . . . . 65.319999999999993 111.549 -173.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -103.38 13.63 33.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 64.409999999999997 111.332 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.4 pt? -55.06 -39.96 69.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.837 -0.62 . . . . 74.319999999999993 112.144 -174.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 10' ' ' LEU . . . -61.2 -55.29 30.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.034 -0.603 . . . . 54.219999999999999 112.971 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.54 ' CE1' ' HD2' ' A' ' 65' ' ' PRO . 20.1 m-30 -61.4 -39.52 91.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.717 0.294 . . . . 44.420000000000002 111.315 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.527 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 16.3 mmt -68.83 -49.58 57.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.376 -0.374 . . . . 54.439999999999998 111.457 -176.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.27 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.359 . . . . 42.229999999999997 110.673 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -63.62 -34.93 78.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 73.099999999999994 111.446 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.38 -40.7 50.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.215 -0.448 . . . . 71.030000000000001 111.164 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.5 m -79.56 -21.13 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.547 0.573 . . . . 63.450000000000003 112.547 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.419 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -70.37 -26.05 63.54 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.326 -0.549 . . . . 62.219999999999999 110.712 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.419 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -71.54 -24.26 61.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.352 0.596 . . . . 33.509999999999998 110.158 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.64 -18.12 67.71 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.451 -0.795 . . . . 65.219999999999999 112.6 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -69.56 -32.44 71.22 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.046 0.45 . . . . 75.310000000000002 111.186 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 36' ' ' ILE . 4.2 mp -86.03 -15.57 10.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.989 -0.745 . . . . 71.25 108.989 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.76 41.04 15.97 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.711 -1.356 . . . . 73.299999999999997 109.711 -171.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 t -126.55 135.54 51.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.887 -0.656 . . . . 62.32 111.038 -169.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.04 128.31 9.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.045 -0.525 . . . . 75.25 110.215 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.537 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 7.3 t80 -107.86 -158.1 0.64 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.731 -0.47 . . . . 75.439999999999998 109.731 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -135.19 173.07 12.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 72.230000000000004 111.474 -171.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HB ' ' OE2' ' A' ' 49' ' ' GLU . 2.7 p -70.52 108.26 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.585 -0.734 . . . . 64.430000000000007 111.216 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -102.25 75.67 1.51 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.256 -1.016 . . . . 74.409999999999997 108.256 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -56.31 122.29 11.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.598 -0.728 . . . . 63.329999999999998 112.174 -168.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -134.76 -90.93 0.33 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.662 -0.699 . . . . 71.340000000000003 109.496 168.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.419 ' OG ' ' HB2' ' A' ' 78' ' ' PRO . 8.6 m -107.83 -41.25 5.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 118.898 -1.121 . . . . 73.239999999999995 111.556 171.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.79 1.68 4.73 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.369 -0.443 . . . . 73.540000000000006 112.573 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . -75.58 99.4 4.26 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 115.585 1.698 . . . . 64.049999999999997 115.585 -154.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.654 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 20.7 mt-10 -116.28 115.46 25.98 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.357 -1.72 . . . . 74.5 106.357 151.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 31.8 m -137.56 151.27 26.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.257 -0.577 . . . . 62.229999999999997 112.384 -167.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 62' ' ' LEU . 5.9 p -124.63 125.83 70.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.418 -0.956 . . . . 74.239999999999995 108.418 166.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.5 m -103.17 113.08 26.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.078 0.466 . . . . 73.019999999999996 111.169 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.29 -161.22 8.97 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.811 -0.916 . . . . 60.140000000000001 110.811 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -138.34 129.68 27.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.291 0.545 . . . . 75.420000000000002 110.953 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.9 mt -102.87 117.03 33.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.035 -0.728 . . . . 71.219999999999999 109.035 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.44 -46.46 0.62 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.98 0.8 . . . . 72.239999999999995 111.66 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.83 -37.79 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.206 -0.521 . . . . 64.239999999999995 111.881 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.28 133.68 46.24 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.878 0.37 . . . . 70.329999999999998 111.294 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.5 p -74.07 125.74 28.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 72.230000000000004 110.756 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.597 HG12 HD11 ' A' ' 5' ' ' LEU . 33.6 m -111.23 136.44 47.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.102 -0.499 . . . . 71.420000000000002 110.896 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 t -102.76 101.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.759 -0.83 . . . . 75.150000000000006 108.759 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.579 HD11 ' HB1' ' A' ' 29' ' ' ALA . 3.3 tm? -91.09 111.57 23.1 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.169 -0.678 . . . . 73.310000000000002 109.169 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 49' ' ' GLU . . . -109.33 123.58 49.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.981 -0.554 . . . . 64.540000000000006 111.297 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.654 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -122.99 90.2 50.42 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.677 0.751 . . . . 75.230000000000004 109.674 175.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.54 ' HD2' ' CE1' ' A' ' 26' ' ' PHE . 16.4 Cg_exo -68.95 166.67 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.704 2.269 . . . . 64.530000000000001 112.679 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -105.0 14.41 29.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.663 0.744 . . . . 75.329999999999998 109.06 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 63.3 m -102.16 138.51 39.01 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.73 -1.123 . . . . 33.140000000000001 108.866 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 70' ' ' ASN . 15.8 p90 -66.65 166.8 12.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.093 0.473 . . . . 73.329999999999998 111.545 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.4 ptp -46.68 -31.56 2.99 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.39 1.256 . . . . 55.130000000000003 114.39 -169.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.411 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 62.4 t30 -77.99 -50.44 12.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.872 0.368 . . . . 72.299999999999997 111.142 -176.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -78.56 -24.45 45.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.286 -0.416 . . . . 71.219999999999999 111.454 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.3 t -56.68 -39.4 73.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.388 -0.369 . . . . 74.540000000000006 110.433 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.07 -29.37 74.72 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.932 -0.576 . . . . 72.239999999999995 113.077 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -41.85 88.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.157 0.503 . . . . 74.219999999999999 110.914 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -84.22 -0.05 50.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.803 -0.635 . . . . 74.430000000000007 111.86 -171.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.2 t -70.74 -40.46 76.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.803 0.335 . . . . 61.409999999999997 110.444 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.97 -59.03 11.56 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 115.964 -0.562 . . . . 73.019999999999996 112.822 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HB2' ' OG ' ' A' ' 46' ' ' SER . 10.1 Cg_endo -56.2 -37.82 95.99 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.7 2.267 . . . . 71.450000000000003 112.749 175.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 48' ' ' ALA . 2.9 tm? -69.11 -44.61 72.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.647 -0.251 . . . . 74.349999999999994 111.255 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.52 86.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.0 0.37 . . . . 53.420000000000002 112.0 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -72.9 -20.43 61.08 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.822 0.304 . . . . 75.019999999999996 111.822 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -71.07 -28.7 64.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.854 0.359 . . . . 74.340000000000003 110.753 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.02 0.01 37.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 72.129999999999995 110.169 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t 62.24 24.29 14.44 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.443 -0.798 . . . . 34.299999999999997 111.426 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.483 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 18.5 m -88.04 131.85 41.67 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.887 0.375 . . . . 74.120000000000005 111.09 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 19.4 Cg_exo -67.38 127.94 17.45 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.832 2.354 . . . . 75.439999999999998 111.605 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.632 ' HA ' HD12 ' A' ' 90' ' ' ILE . 39.7 Cg_exo -57.63 -27.51 77.46 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.991 2.46 . . . . 71.25 113.055 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -64.46 -27.68 69.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.48 -0.327 . . . . 71.030000000000001 111.659 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -103.88 17.59 23.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.159 0.504 . . . . 72.329999999999998 110.761 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.721 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 58.9 mt -90.45 145.45 7.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.403 -0.591 . . . . 65.5 109.403 175.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 m -118.12 134.67 61.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.164 0.507 . . . . 73.530000000000001 110.254 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.79 115.92 47.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.086 -0.506 . . . . 75.420000000000002 110.543 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.541 HG23 ' HA2' ' A' ' 9' ' ' GLY . 6.8 tt -87.67 126.02 41.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.923 -0.58 . . . . 73.230000000000004 109.542 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.99 173.5 11.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.399 0.618 . . . . 73.439999999999998 110.649 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -85.55 152.61 23.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.176 -0.92 . . . . 72.530000000000001 110.521 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 22.5 tt0 -123.35 94.72 4.34 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.423 0.63 . . . . 75.120000000000005 110.169 174.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.847 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.9 pt? -83.57 -0.33 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.332 -0.849 . . . . 71.340000000000003 110.073 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.409 ' CG ' HH12 ' A' ' 134' ' ' ARG . 1.6 m-20 -68.42 -36.42 79.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.711 . . . . 71.510000000000005 109.678 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 mm -123.29 149.19 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.515 -0.766 . . . . 75.109999999999999 110.244 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.787 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 8.8 p-10 -75.42 155.03 36.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 61.0 110.973 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.639 ' HD2' ' HB2' ' A' ' 158' ' ' GLU . 6.0 t80 -68.03 138.73 56.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.718 -0.674 . . . . 73.530000000000001 111.577 -173.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 160.07 -35.62 0.45 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.342 -0.845 . . . . 45.43 111.081 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -148.55 164.89 32.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 70.340000000000003 110.455 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.618 HD11 HG21 ' A' ' 188' ' ' VAL . 2.4 pp -118.21 162.97 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.382 -0.599 . . . . 74.129999999999995 109.382 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.407 ' HE ' ' CD ' ' A' ' 96' ' ' GLU . 29.8 ptt180 -141.0 153.32 45.5 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.702 -0.399 . . . . 74.129999999999995 110.446 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 181' ' ' LEU . 60.3 tp -113.04 124.9 53.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.844 -0.616 . . . . 73.329999999999998 109.434 176.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -155.41 126.69 7.21 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.002 -0.74 . . . . 74.310000000000002 109.002 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 130' ' ' PHE . 88.0 mt -76.73 88.0 3.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.579 0.704 . . . . 74.310000000000002 109.638 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.6 147.72 5.16 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.31 -1.116 . . . . 63.340000000000003 110.31 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.462 ' HA3' ' HG2' ' A' ' 132' ' ' ARG . . . 178.86 112.44 0.34 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.692 -1.242 . . . . 54.219999999999999 113.061 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.57 76.06 0.17 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.308 -0.717 . . . . 73.200000000000003 111.308 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -171.77 149.73 2.57 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.201 -0.666 . . . . 44.030000000000001 109.201 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.22 -67.77 2.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.959 -0.639 . . . . 72.120000000000005 111.825 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.93 69.3 3.27 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.901 -0.88 . . . . 65.019999999999996 110.901 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -48.45 -54.86 12.59 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.661 0.784 . . . . 73.230000000000004 111.734 -173.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -85.6 -41.6 15.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.258 -0.428 . . . . 55.520000000000003 110.981 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.81 -37.26 90.07 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 116.13 -0.487 . . . . 74.0 113.703 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.3 -27.89 29.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.972 0.386 . . . . 64.439999999999998 111.347 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -79.43 -36.7 38.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.499 -0.318 . . . . 63.109999999999999 111.568 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.9 m -58.76 -38.21 77.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 72.310000000000002 111.138 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.02 -42.93 82.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.987 0.422 . . . . 50.420000000000002 110.477 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.61 82.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.022 -0.536 . . . . 72.230000000000004 110.766 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t -63.42 -41.77 98.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 44.439999999999998 110.768 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.3 -32.09 69.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.31 -0.405 . . . . 61.439999999999998 111.672 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.53 -7.71 40.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.789 0.328 . . . . 74.420000000000002 111.669 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.45 -11.77 69.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.851 -0.69 . . . . 72.420000000000002 113.408 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 129' ' ' ASN . 15.4 t -169.88 177.97 4.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.832 0.316 . . . . 52.219999999999999 110.184 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.872 ' H ' ' HD2' ' A' ' 128' ' ' LYS . 8.9 mptt -56.13 -57.3 12.78 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.088 -0.708 . . . . 70.099999999999994 109.088 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.441 ' HB2' HG23 ' A' ' 127' ' ' THR . 8.9 t-20 67.32 24.35 9.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.337 -0.847 . . . . 64.420000000000002 111.946 166.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.512 ' HB3' HD22 ' A' ' 108' ' ' LEU . 54.9 m-85 63.52 -130.72 0.44 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.074 -0.512 . . . . 75.230000000000004 111.817 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.721 ' HB3' ' O ' ' A' ' 90' ' ' ILE . 4.6 p80 34.44 85.95 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.456 1.28 . . . . 73.519999999999996 114.456 -173.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 131' ' ' HIS . 9.3 mpt_? -135.58 108.46 7.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.867 -0.606 . . . . 75.340000000000003 110.187 171.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 46.4 t -112.7 100.2 10.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.431 -0.952 . . . . 71.049999999999997 108.431 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.892 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 69.7 mtp180 -109.98 124.85 52.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 72.349999999999994 112.021 -169.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 135' ' ' ILE . 3.1 mp -97.0 107.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.293 -0.867 . . . . 74.109999999999999 109.282 174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -62.56 111.99 4.52 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 120.977 -0.63 . . . . 72.150000000000006 111.7 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.41 -10.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 111.968 0.359 . . . . 72.299999999999997 111.968 -175.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.787 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 151.89 130.08 1.58 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.063 -1.065 . . . . 65.230000000000004 112.433 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 28.5 ptt180 -86.03 159.69 53.73 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 110.238 -0.282 . . . . 74.340000000000003 110.238 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.554 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 51.6 Cg_exo -53.47 122.17 10.77 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.764 2.309 . . . . 73.230000000000004 112.799 -177.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.91 8.06 3.98 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.942 2.428 . . . . 71.349999999999994 112.24 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.0 -128.0 1.7 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.076 -0.583 . . . . 74.030000000000001 111.934 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -46.1 17.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.008 0.432 . . . . 73.439999999999998 110.543 -177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 17.3 mmtp -87.69 133.14 33.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.533 0.683 . . . . 73.129999999999995 110.531 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.608 ' HB2' HD12 ' A' ' 97' ' ' LEU . 2.6 p-10 -74.63 158.64 84.7 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 114.773 -1.103 . . . . 61.130000000000003 110.781 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.554 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 32.5 Cg_exo -58.69 -16.22 29.71 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.958 2.438 . . . . 72.409999999999997 113.26 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.512 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -68.39 -21.19 64.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 72.329999999999998 111.317 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.41 -34.55 18.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.9 0.381 . . . . 65.140000000000001 111.233 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -84.35 -19.16 34.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.078 0.466 . . . . 73.120000000000005 111.331 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 21' ' ' ARG . 5.2 p -72.17 5.15 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.596 -0.729 . . . . 73.340000000000003 112.391 -172.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.92 -5.86 37.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.013 0.375 . . . . 71.209999999999994 112.013 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -160.89 144.53 13.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.911 0.386 . . . . 64.219999999999999 111.492 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 67.31 -173.92 0.19 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.15 -0.932 . . . . 72.319999999999993 112.621 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -156.72 171.48 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 73.310000000000002 109.51 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.828 ' HB ' ' HG3' ' A' ' 158' ' ' GLU . 25.1 m -102.5 120.07 39.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.864 0.364 . . . . 65.25 110.944 -175.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.69 67.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 71.120000000000005 111.523 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.39 70.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 71.140000000000001 111.504 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.828 ' HG3' ' HB ' ' A' ' 155' ' ' THR . 1.5 pp20? -79.83 -20.83 45.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.692 0.282 . . . . 75.099999999999994 111.208 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.46 ' HA ' HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -61.4 -20.36 62.97 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.241 0.543 . . . . 75.530000000000001 110.199 177.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.61 81.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.62 -0.718 . . . . 42.539999999999999 111.318 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -85.66 -7.86 58.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.41 . . . . 73.340000000000003 111.501 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.802 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 93.8 t -57.74 -59.07 14.23 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 111.953 0.353 . . . . 74.010000000000005 111.953 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.802 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 44.6 Cg_exo -57.37 -36.0 98.87 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.047 1.831 . . . . 65.540000000000006 112.129 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.5 m -71.35 -44.78 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.85 -0.614 . . . . 64.019999999999996 111.291 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 162' ' ' VAL . 7.1 tp -67.52 -30.1 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 73.319999999999993 111.035 -175.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 162' ' ' VAL . 92.8 t -64.88 -48.82 82.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.318 . . . . 73.099999999999994 110.473 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -63.21 -44.25 95.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 72.310000000000002 110.332 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.47 -45.45 90.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 71.439999999999998 111.093 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.6 -30.91 69.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 70.510000000000005 111.432 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -56.82 -49.35 75.64 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.143 0.277 . . . . 45.009999999999998 111.61 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.69 -43.1 98.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 73.439999999999998 111.094 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.68 69.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.817 -0.629 . . . . 51.509999999999998 111.573 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.476 ' O ' HG12 ' A' ' 177' ' ' ILE . 18.2 p -69.0 -39.04 79.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.964 0.357 . . . . 71.450000000000003 111.964 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -66.17 -40.26 90.38 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.029 -0.268 . . . . 72.219999999999999 110.87 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.4 tp -73.19 -30.89 63.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.986 0.422 . . . . 75.209999999999994 110.158 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.6 -49.3 77.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.554 -0.748 . . . . 70.200000000000003 109.427 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.722 HG23 HD21 ' A' ' 5' ' ' LEU . 45.1 mm -64.67 -31.37 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.143 -0.935 . . . . 62.32 111.207 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.5 -68.71 0.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 111.804 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -158.06 -38.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.751 0.31 . . . . 71.239999999999995 111.388 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -115.37 116.32 3.67 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.284 -0.96 . . . . 63.130000000000003 113.303 -173.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.648 ' HB2' HD21 ' A' ' 106' ' ' LEU . 4.2 pp -89.59 -20.51 23.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.363 0.601 . . . . 74.430000000000007 109.894 174.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 41.0 mt-10 -63.99 -50.13 71.19 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.39 -0.823 . . . . 52.409999999999997 111.691 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 13.9 Cg_endo -58.28 -32.38 95.82 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.91 1.74 . . . . 73.409999999999997 111.924 174.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.529 ' HA ' HG22 ' A' ' 187' ' ' THR . . . -64.28 -41.88 96.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.022 -0.535 . . . . 74.450000000000003 110.464 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.569 ' HG2' ' HB3' ' A' ' 106' ' ' LEU . 25.3 mt-30 -57.76 -34.69 69.83 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.098 -0.501 . . . . 72.129999999999995 110.553 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.49 -53.32 6.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.715 -0.675 . . . . 60.5 111.23 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 184' ' ' ALA . 8.8 t -62.46 -48.18 80.78 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.011 0.375 . . . . 65.409999999999997 112.011 -173.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.618 HG21 HD11 ' A' ' 104' ' ' ILE . 5.1 p -68.7 -14.07 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.96 0.41 . . . . 61.310000000000002 111.56 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -86.59 -8.18 57.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.117 0.484 . . . . 62.130000000000003 109.98 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -102.58 -17.7 15.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 74.420000000000002 111.878 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.584 ' HD1' ' HA ' ' A' ' 188' ' ' VAL . 90.8 m95 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.654 -0.688 . . . . 74.549999999999997 110.738 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 110.132 -0.321 . . . . 52.420000000000002 110.132 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 59' ' ' SER . 9.5 Cg_endo -52.75 129.81 34.32 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.3 2.667 . . . . 65.540000000000006 113.228 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.33 143.16 30.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 72.239999999999995 110.329 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 HG22 ' A' ' 90' ' ' ILE . 59.3 tp -96.93 109.95 22.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.911 -0.403 . . . . 74.430000000000007 109.911 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.8 115.31 31.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.723 -0.473 . . . . 74.450000000000003 109.723 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.86 114.26 45.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.107 -0.497 . . . . 63.229999999999997 110.251 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.29 134.33 7.78 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.688 -0.768 . . . . 65.420000000000002 111.241 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 10' ' ' LEU . 4.3 mm? -63.14 115.81 4.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.919 0.39 . . . . 64.329999999999998 110.044 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.857 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -87.04 -145.65 9.63 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.581 -0.736 . . . . 75.340000000000003 112.82 -174.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -102.41 136.5 19.37 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 110.618 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -89.52 -153.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.883 2.389 . . . . 65.299999999999997 111.239 172.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.04 -174.03 33.34 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.842 -0.694 . . . . 62.039999999999999 112.54 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.25 160.21 20.17 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.005 2.47 . . . . 75.25 112.344 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.2 m 72.77 -58.22 0.61 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.155 -0.475 . . . . 71.409999999999997 111.821 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.87 -13.58 60.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.382 . . . . 75.230000000000004 111.509 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.12 0.6 31.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.212 0.529 . . . . 73.219999999999999 110.715 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -105.09 20.41 18.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.691 -0.686 . . . . 73.340000000000003 109.957 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.6 p -100.33 175.4 5.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.965 -0.561 . . . . 74.409999999999997 110.791 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.56 ' HD3' ' O ' ' A' ' 153' ' ' ASN . 0.7 OUTLIER -81.59 1.66 32.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.468 -0.333 . . . . 71.219999999999999 111.734 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -105.92 11.82 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.41 0.522 . . . . 71.400000000000006 112.41 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -96.2 14.17 24.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.087 0.47 . . . . 63.119999999999997 110.032 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.6 pt? -59.96 -33.08 71.44 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.61 -0.723 . . . . 70.230000000000004 111.987 -174.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.06 -48.5 85.77 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.666 -0.778 . . . . 73.109999999999999 111.691 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.857 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 85.9 t80 -60.67 -46.11 91.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.831 0.348 . . . . 62.219999999999999 110.904 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 96.2 mmm -59.23 -50.41 74.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.835 -0.621 . . . . 63.299999999999997 111.704 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.45 -40.12 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 73.430000000000007 111.025 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.59 ' HB1' HD21 ' A' ' 62' ' ' LEU . . . -66.07 -34.76 78.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.858 0.361 . . . . 53.420000000000002 111.362 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -71.69 -44.67 63.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.254 -0.43 . . . . 71.409999999999997 111.428 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.0 m -65.59 -34.25 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.159 0.429 . . . . 72.219999999999999 112.159 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -79.92 -29.03 39.72 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.539 -0.464 . . . . 54.130000000000003 110.73 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -67.77 -40.46 84.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.995 0.426 . . . . 60.340000000000003 110.035 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.33 -18.9 70.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.988 -0.625 . . . . 64.409999999999997 112.364 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -75.78 -54.32 7.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.723 0.297 . . . . 70.239999999999995 111.751 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 tp -67.13 -15.44 19.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.028 -0.533 . . . . 72.040000000000006 111.229 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.82 62.54 0.93 Allowed Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.592 -1.003 . . . . 73.349999999999994 110.592 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.553 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 32.1 m -151.86 156.17 39.62 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.087 0.47 . . . . 74.319999999999993 111.786 -169.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.4 144.49 31.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.623 -0.717 . . . . 50.0 109.089 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.7 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 40.4 p90 -108.01 149.43 28.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.108 0.48 . . . . 72.319999999999993 111.575 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -155.16 172.93 17.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.353 -0.84 . . . . 73.109999999999999 109.67 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.9 126.33 5.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.676 0.75 . . . . 63.450000000000003 112.125 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -137.18 158.95 43.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.364 -0.835 . . . . 73.540000000000006 110.715 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.686 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 1.6 tpmt? 63.22 -87.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 72.239999999999995 111.845 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.39 -87.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.745 1.387 . . . . 41.509999999999998 114.745 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 78' ' ' PRO . 51.8 p -91.45 -37.0 13.45 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.826 1.787 . . . . 53.119999999999997 115.826 -156.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.19 -7.49 4.46 Favored Glycine 0 CA--C 1.508 -0.372 0 C-N-CA 119.459 -1.353 . . . . 75.209999999999994 114.223 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.529 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -95.61 110.37 22.48 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.27 1.211 . . . . 74.019999999999996 114.27 -160.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.761 ' HG3' ' HD2' ' A' ' 66' ' ' ARG . 53.6 mt-10 -97.94 114.32 26.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.709 -1.589 . . . . 70.340000000000003 106.709 155.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.529 HG23 ' HB1' ' A' ' 48' ' ' ALA . 66.9 t -124.24 139.24 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.11 0.481 . . . . 63.310000000000002 111.823 -166.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.7 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 2.8 p -115.9 115.29 48.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.298 -1.001 . . . . 72.400000000000006 108.298 168.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -96.32 117.45 30.85 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.147 -0.479 . . . . 72.219999999999999 110.889 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.57 -169.96 22.64 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.032 -0.827 . . . . 63.130000000000003 111.032 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 54' ' ' ARG . 14.8 ptt180 -141.3 139.72 33.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.04 0.448 . . . . 74.409999999999997 110.61 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 57' ' ' GLY . 96.5 mt -118.42 136.98 53.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.198 -0.668 . . . . 63.140000000000001 109.198 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 72.1 -29.56 0.2 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.739 0.649 . . . . 70.120000000000005 112.212 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 145.15 -14.18 1.89 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.106 -0.568 . . . . 62.520000000000003 111.701 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.4 m -102.35 132.45 48.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.615 0.245 . . . . 74.109999999999999 110.492 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 17.4 m -69.85 145.15 52.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.255 -0.429 . . . . 53.32 110.656 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 177' ' ' ILE . 15.5 m -136.78 143.59 34.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.077 0.465 . . . . 71.5 110.919 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.07 101.98 13.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.741 -0.663 . . . . 65.439999999999998 109.673 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.59 HD21 ' HB1' ' A' ' 29' ' ' ALA . 53.0 tp -94.9 98.95 11.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.258 0.551 . . . . 74.319999999999993 110.996 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 50' ' ' VAL . . . -117.12 167.5 11.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.643 -0.708 . . . . 74.340000000000003 110.213 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -154.45 134.0 7.63 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.573 0.225 . . . . 65.420000000000002 110.653 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 26.4 Cg_exo -63.98 142.19 80.5 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.809 2.34 . . . . 75.349999999999994 111.502 173.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.761 ' HD2' ' HG3' ' A' ' 49' ' ' GLU . 42.8 mtp180 -110.34 16.67 21.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.797 0.808 . . . . 74.150000000000006 109.751 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 70.1 m -133.62 161.46 34.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.767 -1.106 . . . . 64.0 109.026 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -70.04 165.87 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.18 0.514 . . . . 71.239999999999995 112.163 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.615 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . 21.9 ptt? -46.47 -44.77 17.81 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.787 1.403 . . . . 73.549999999999997 114.787 -167.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -67.09 -33.07 74.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.099 0.409 . . . . 73.239999999999995 111.24 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -96.96 0.97 49.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 73.400000000000006 111.094 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.6 t -65.12 -22.45 66.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.376 -0.375 . . . . 75.420000000000002 111.151 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.14 -30.13 76.9 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.975 -0.631 . . . . 51.43 112.605 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -85.04 -3.17 58.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.955 0.407 . . . . 75.510000000000005 110.909 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.439 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 22.8 mm-40 -82.31 -52.36 7.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.23 -0.441 . . . . 64.549999999999997 110.298 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.43 -21.44 6.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.803 -0.635 . . . . 72.400000000000006 110.679 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.36 -73.29 0.38 Allowed Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.159 -0.473 . . . . 44.039999999999999 113.525 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.494 ' HB2' ' OG ' ' A' ' 46' ' ' SER . 50.6 Cg_exo -56.01 -35.63 94.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.63 2.22 . . . . 53.229999999999997 112.008 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.619 HD12 ' HG2' ' A' ' 44' ' ' LYS . 64.1 tp -57.94 -54.29 48.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.574 -0.739 . . . . 71.5 111.856 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.705 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . . . -62.81 -30.15 71.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.018 0.437 . . . . 71.340000000000003 111.892 -175.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.942 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 9.4 mmpt? -73.23 -24.21 60.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.248 -0.433 . . . . 72.319999999999993 111.677 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -72.39 -58.69 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.8 0.296 . . . . 73.109999999999999 111.8 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.705 ' CE1' ' HA ' ' A' ' 80' ' ' ALA . 1.5 p90 -77.74 -11.37 59.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.631 -0.428 . . . . 74.010000000000005 111.176 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.1 t 65.93 34.55 7.08 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.808 0.67 . . . . 63.32 112.808 166.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.584 HG22 ' CD1' ' A' ' 83' ' ' TYR . 18.4 m -101.65 136.0 19.67 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 120.043 -0.663 . . . . 70.040000000000006 110.024 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 20.0 Cg_exo -66.47 150.83 84.07 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.69 2.26 . . . . 75.319999999999993 111.976 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.94 41.35 0.64 Allowed 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.099 2.533 . . . . 72.340000000000003 112.57 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -95.47 -47.76 6.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.954 -0.566 . . . . 70.540000000000006 109.897 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -83.46 34.86 0.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.627 -0.715 . . . . 62.210000000000001 111.266 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 131' ' ' HIS . 46.3 pt -105.74 143.32 17.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 65.099999999999994 110.708 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.69 118.13 44.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.819 -0.628 . . . . 61.340000000000003 109.847 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.0 t -96.92 120.11 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 71.239999999999995 111.263 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 tt -98.54 111.42 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.534 0.683 . . . . 62.140000000000001 109.481 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -154.69 164.8 38.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 74.549999999999997 109.944 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.81 153.74 25.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.474 0.654 . . . . 74.129999999999995 111.444 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.492 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 30.0 tt0 -119.88 94.54 4.43 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.113 -1.069 . . . . 63.229999999999997 108.113 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.639 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 2.4 pt? -60.78 -27.99 68.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.244 -0.889 . . . . 53.43 112.552 -170.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.39 -10.76 60.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.134 0.492 . . . . 73.409999999999997 110.858 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.2 mm -107.92 135.51 46.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 73.450000000000003 109.841 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.449 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 14.8 m-20 -66.44 154.22 40.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.102 0.477 . . . . 71.349999999999994 111.686 -176.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.698 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 34.7 p90 -65.41 143.51 57.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.216 -0.902 . . . . 55.310000000000002 111.164 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.03 -67.57 0.51 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.408 -0.901 . . . . 75.129999999999995 112.689 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -116.74 155.67 28.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.795 0.331 . . . . 74.109999999999999 110.196 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.588 HG22 ' HA ' ' A' ' 135' ' ' ILE . 40.9 pt -116.75 165.4 12.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.134 -0.485 . . . . 75.420000000000002 110.692 -178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.466 ' HG3' ' HB2' ' A' ' 134' ' ' ARG . 38.4 ptt180 -142.52 170.21 16.13 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.077 -0.712 . . . . 73.120000000000005 109.077 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.731 HD22 ' HB2' ' A' ' 181' ' ' LEU . 5.7 mp -128.75 119.32 24.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.061 0.458 . . . . 74.299999999999997 110.8 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -143.05 127.03 17.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.778 -0.646 . . . . 72.109999999999999 109.912 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.779 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.0 pt? -72.48 121.75 20.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.798 -0.637 . . . . 53.310000000000002 109.936 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.68 -173.6 41.35 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.874 -0.679 . . . . 32.039999999999999 111.488 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.12 -154.32 16.17 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.437 -0.411 . . . . 75.310000000000002 112.789 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.492 ' HA3' HD12 ' A' ' 118' ' ' LEU . . . -110.78 81.49 0.29 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.764 -0.731 . . . . 71.329999999999998 112.221 177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -53.83 142.65 23.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.782 0.325 . . . . 74.430000000000007 110.434 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.34 -48.43 4.03 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.918 -0.658 . . . . 54.009999999999998 112.536 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.03 -59.46 3.65 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.994 -0.622 . . . . 61.43 111.816 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.4 m80 65.62 -74.49 0.06 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.378 0.671 . . . . 73.230000000000004 112.492 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -38.03 -56.89 1.11 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.242 1.017 . . . . 54.340000000000003 113.472 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.615 ' HA3' ' HB2' ' A' ' 69' ' ' MET . . . -62.45 -64.78 3.59 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.798 -0.715 . . . . 74.109999999999999 113.679 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.492 HD12 ' HA3' ' A' ' 111' ' ' GLY . 85.5 mt -68.09 -28.36 67.29 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.83 0.307 . . . . 75.400000000000006 111.83 -173.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -67.0 -39.92 87.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.31 -0.256 . . . . 61.350000000000001 110.31 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.2 t -64.13 -43.83 94.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.978 0.418 . . . . 40.420000000000002 110.08 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 t -67.18 -46.22 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 70.420000000000002 110.711 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -61.81 -41.48 97.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.743 -0.662 . . . . 61.229999999999997 111.754 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 m -66.26 -29.36 69.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.476 -0.329 . . . . 73.409999999999997 111.496 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.97 -46.94 17.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.903 0.382 . . . . 72.099999999999994 111.077 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.34 -35.81 54.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.516 . . . . 63.450000000000003 111.731 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.37 40.12 4.3 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.487 -0.863 . . . . 64.420000000000002 111.367 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.485 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 11.5 t -129.88 176.29 8.16 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.244 -0.28 . . . . 75.530000000000001 110.244 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -138.48 21.73 2.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.79 0.329 . . . . 74.340000000000003 110.148 177.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.402 ' N ' HD22 ' A' ' 129' ' ' ASN . 0.9 OUTLIER 63.42 78.93 0.27 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.446 -0.797 . . . . 74.340000000000003 110.233 -178.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -71.83 -25.21 61.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.715 -0.675 . . . . 71.150000000000006 111.404 -176.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 85.4 m-70 -140.85 120.49 13.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.724 -0.473 . . . . 75.099999999999994 109.724 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -153.49 152.12 30.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.945 0.402 . . . . 73.400000000000006 110.767 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.0 t -94.22 143.46 11.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.785 -0.643 . . . . 62.210000000000001 109.744 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 12.0 mmt180 -103.82 93.5 4.93 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.412 -0.588 . . . . 64.340000000000003 109.412 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.588 ' HA ' HG22 ' A' ' 104' ' ' ILE . 65.1 mt -92.7 108.14 19.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.186 -0.461 . . . . 73.010000000000005 110.627 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.698 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -71.17 109.74 2.96 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.637 -0.792 . . . . 45.350000000000001 111.855 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.0 m -109.61 -6.95 11.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.013 0.435 . . . . 34.340000000000003 110.602 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 87.2 170.57 46.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.828 -0.701 . . . . 50.409999999999997 112.321 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.639 ' HD2' ' O ' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -141.49 131.67 12.93 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.592 -0.521 . . . . 72.319999999999993 109.592 176.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 28.9 Cg_endo -64.81 110.78 1.54 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.526 2.151 . . . . 64.200000000000003 111.93 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 6.1 Cg_exo -78.3 69.44 7.6 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.067 2.511 . . . . 60.32 111.82 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.03 -176.68 42.31 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.699 -0.682 . . . . 45.219999999999999 111.429 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.47 -15.25 29.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.006 0.432 . . . . 75.420000000000002 109.914 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -93.67 159.22 15.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.041 -0.527 . . . . 71.129999999999995 109.66 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.49 142.42 91.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.719 -0.475 . . . . 71.310000000000002 109.719 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.434 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 7.4 Cg_endo -52.08 -11.92 1.2 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.434 2.756 . . . . 63.420000000000002 113.744 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.14 -31.23 51.82 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.802 0.334 . . . . 63.43 111.403 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.73 -31.48 19.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.385 -0.37 . . . . 75.230000000000004 111.636 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.434 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 96.7 m-85 -84.16 -19.68 33.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.245 -0.434 . . . . 53.520000000000003 111.713 -175.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.01 -23.39 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.386 -0.37 . . . . 64.140000000000001 111.92 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.7 mt -94.15 -11.46 30.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.447 -0.342 . . . . 71.319999999999993 111.91 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.13 110.72 2.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.339 0.59 . . . . 71.010000000000005 111.015 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.56 ' O ' ' HD3' ' A' ' 21' ' ' ARG . 22.9 t-20 -160.28 121.97 3.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.801 -0.636 . . . . 70.25 110.562 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -164.76 100.28 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.835 0.71 . . . . 72.019999999999996 109.727 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.24 175.52 5.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.882 -0.599 . . . . 75.319999999999993 111.063 -174.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.65 -20.6 46.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 50.119999999999997 111.628 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.453 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -66.13 -50.26 64.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.176 -0.465 . . . . 51.119999999999997 111.477 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.55 ' O ' HG23 ' A' ' 162' ' ' VAL . 1.6 mp0 -60.54 -30.36 69.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 71.340000000000003 111.206 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -55.75 -28.76 57.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 112.078 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.22 60.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.674 0.273 . . . . 62.119999999999997 111.658 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -111.92 -7.86 14.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.351 0.5 . . . . 74.329999999999998 112.351 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 158' ' ' GLU . 92.3 t -56.46 -56.68 29.35 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 121.111 -0.235 . . . . 74.5 110.916 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 20.1 Cg_endo -61.47 -34.47 85.96 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.983 1.789 . . . . 51.329999999999998 111.844 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.5 m -59.49 -42.14 91.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.865 -0.607 . . . . 75.329999999999998 110.904 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.6 mt -77.32 -52.83 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 75.439999999999998 111.378 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 162' ' ' VAL . 96.1 t -53.9 -47.41 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.382 0.512 . . . . 53.530000000000001 112.382 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -56.89 -52.11 66.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.984 0.421 . . . . 73.340000000000003 110.478 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -74.26 -41.62 60.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.789 -0.641 . . . . 74.129999999999995 111.604 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.52 -56.48 21.63 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.957 0.355 . . . . 73.25 111.957 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.94 -31.37 66.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.035 0.445 . . . . 71.230000000000004 111.66 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -80.92 -45.85 16.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.939 -0.573 . . . . 72.319999999999993 111.144 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.81 -30.87 65.98 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.374 0.509 . . . . 65.439999999999998 112.374 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.635 ' HA ' HD13 ' A' ' 176' ' ' LEU . 86.2 m -54.02 -32.0 52.93 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.219 0.451 . . . . 62.310000000000002 112.219 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.98 -33.27 75.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 75.439999999999998 110.638 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.3 tp -73.14 -27.13 61.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 72.010000000000005 111.268 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 173' ' ' THR . 8.6 mp -66.93 -35.77 80.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.066 0.46 . . . . 73.409999999999997 110.112 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.555 HD13 HG11 ' A' ' 60' ' ' VAL . 50.0 mt -80.45 -25.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.604 -0.726 . . . . 55.399999999999999 109.899 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.16 -43.19 68.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.615 -0.72 . . . . 71.230000000000004 111.075 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -134.6 -73.17 0.47 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.371 -0.377 . . . . 71.140000000000001 110.405 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 176' ' ' LEU . . . -177.55 -157.97 19.59 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.248 -0.977 . . . . 74.439999999999998 112.789 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.764 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -89.83 -5.09 57.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.556 -0.322 . . . . 71.129999999999995 110.799 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.777 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 7.0 mm-40 -55.15 -56.97 22.52 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.853 -0.612 . . . . 64.340000000000003 111.859 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.777 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 2.9 Cg_exo -75.2 -26.58 10.47 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.744 1.629 . . . . 74.439999999999998 111.633 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 188' ' ' VAL . . . -65.15 -53.3 47.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.65 -0.705 . . . . 65.219999999999999 111.232 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -60.97 -21.12 63.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 64.340000000000003 111.157 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -78.35 -55.28 5.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.371 -0.377 . . . . 71.140000000000001 110.591 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.9 t -71.64 -30.18 65.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.323 0.49 . . . . 71.230000000000004 112.323 -173.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 184' ' ' ALA . 22.8 m -82.18 -12.55 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.117 -0.364 . . . . 72.129999999999995 111.56 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -109.42 -31.49 7.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.389 -0.368 . . . . 63.130000000000003 110.945 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.44 -24.24 46.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.379 . . . . 42.310000000000002 112.02 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 72.3 m95 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.469 -0.777 . . . . 74.239999999999995 110.175 179.425 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.405 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 42.9 mt-10 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 109.465 -0.568 . . . . 73.129999999999995 109.465 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 3' ' ' GLU . 71.3 Cg_exo -50.17 108.21 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.486 2.124 . . . . 65.010000000000005 112.295 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.72 152.69 18.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.007 -0.542 . . . . 63.219999999999999 111.157 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.3 tp -97.39 116.87 30.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.968 -0.56 . . . . 75.340000000000003 109.49 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.29 110.41 31.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 72.099999999999994 110.048 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.551 HG11 HG22 ' A' ' 76' ' ' VAL . 43.5 t -121.89 132.82 70.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.588 -0.278 . . . . 64.329999999999998 110.504 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 93' ' ' ILE . . . -122.13 130.78 8.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.936 -0.649 . . . . 31.41 111.8 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -72.63 144.19 47.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.238 0.542 . . . . 73.450000000000003 111.116 -176.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -156.94 -177.67 30.28 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.786 -0.721 . . . . 65.549999999999997 111.709 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 86.7 m-20 -127.37 83.25 66.53 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 110.248 -0.278 . . . . 73.519999999999996 110.248 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.9 93.62 0.1 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.8 2.334 . . . . 74.099999999999994 112.224 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.51 158.93 31.02 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.698 -0.683 . . . . 52.549999999999997 111.401 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.16 -68.1 0.07 OUTLIER 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 123.163 2.575 . . . . 75.310000000000002 113.106 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 p -75.66 -26.74 57.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.934 0.397 . . . . 74.319999999999993 111.523 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.427 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 18.4 m-85 -70.24 -24.19 63.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.981 -0.554 . . . . 73.549999999999997 111.282 -176.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.414 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . . . -73.61 -9.35 58.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.262 -0.426 . . . . 71.450000000000003 111.405 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -94.8 18.6 11.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.245 -0.434 . . . . 63.32 110.773 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.6 p -111.34 148.87 32.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.043 0.449 . . . . 63.009999999999998 111.016 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.567 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 30.5 ptt-85 -71.31 -5.73 34.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.066 -0.515 . . . . 74.420000000000002 110.557 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.534 ' CG ' HG23 ' A' ' 150' ' ' VAL . 30.6 t-80 -91.45 2.29 56.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.294 0.569 . . . . 70.25 109.949 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 18' ' ' ALA . 63.5 t30 -98.8 18.07 17.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.818 0.818 . . . . 73.129999999999995 109.206 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.4 -38.16 88.58 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.247 -0.888 . . . . 75.510000000000005 112.318 -173.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -62.51 -46.24 94.2 Favored Glycine 0 C--N 1.329 0.152 0 C-N-CA 120.529 -0.843 . . . . 60.149999999999999 112.426 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.604 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 82.5 t80 -65.08 -38.77 91.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.163 0.506 . . . . 75.319999999999993 110.706 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.4 mmt -81.92 -37.69 26.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.913 -0.585 . . . . 73.549999999999997 112.534 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 31' ' ' VAL . 53.3 t -62.23 -37.75 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.951 0.405 . . . . 61.25 110.34 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.54 78.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.023 -0.535 . . . . 63.409999999999997 110.696 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -75.61 -48.95 20.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.109 -0.496 . . . . 65.230000000000004 111.289 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 28' ' ' VAL . 35.1 m -63.15 -40.78 90.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.538 -0.301 . . . . 72.299999999999997 111.654 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 169' ' ' ALA . 66.8 mt -66.06 -41.34 90.92 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.695 0.283 . . . . 74.409999999999997 110.814 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.83 -47.5 85.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.062 -0.517 . . . . 44.210000000000001 110.468 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.89 -27.94 71.06 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.884 -0.674 . . . . 44.520000000000003 112.857 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 18.0 mmm180 -73.18 -42.83 62.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.006 0.373 . . . . 72.200000000000003 112.006 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.71 -14.89 13.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.441 0.639 . . . . 74.109999999999999 110.264 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.12 58.91 1.43 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 110.539 -1.024 . . . . 62.310000000000002 110.539 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.6 m -137.98 126.59 23.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.045 -0.577 . . . . 65.140000000000001 111.718 -171.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.88 143.03 24.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.591 -0.732 . . . . 73.040000000000006 109.429 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.608 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 2.7 t80 -141.8 -146.0 0.18 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.246 -0.279 . . . . 65.140000000000001 110.246 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -155.51 173.26 16.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.788 0.327 . . . . 73.140000000000001 111.579 -169.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 47' ' ' GLY . 2.6 p -54.09 132.2 16.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.509 -0.768 . . . . 71.019999999999996 110.079 169.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.408 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 34.7 t60 -137.23 133.98 35.72 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.713 -0.395 . . . . 63.210000000000001 111.676 -173.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 64.27 -172.79 0.17 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.565 -0.743 . . . . 72.019999999999996 112.195 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' C ' ' H ' ' A' ' 47' ' ' GLY . 33.5 ttpt -79.92 -15.01 58.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.802 0.81 . . . . 62.219999999999999 109.079 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 82' ' ' PHE . 9.7 p -81.75 25.4 0.55 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.638 -1.164 . . . . 74.310000000000002 109.238 170.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 45' ' ' LYS . . . -54.23 43.68 0.01 OUTLIER Glycine 0 C--N 1.34 0.769 0 N-CA-C 118.253 2.061 . . . . 73.530000000000001 118.253 -167.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.13 174.36 6.43 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 118.268 1.034 . . . . 63.240000000000002 108.212 165.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 58.0 mt-10 -72.1 116.52 12.61 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.065 -0.654 . . . . 74.140000000000001 109.866 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.608 ' O ' ' HB3' ' A' ' 40' ' ' PHE . 58.6 t -124.96 135.68 63.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 110.125 -0.324 . . . . 73.510000000000005 110.125 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 62' ' ' LEU . 3.1 p -125.71 110.97 25.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.339 0.59 . . . . 71.140000000000001 110.006 172.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 m -84.26 111.85 19.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.974 -0.557 . . . . 74.239999999999995 110.121 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -138.58 171.43 23.5 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.884 -0.675 . . . . 64.430000000000007 111.737 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -131.31 110.53 11.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.224 0.535 . . . . 75.140000000000001 111.137 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.526 ' HB3' ' HG2' ' A' ' 174' ' ' GLU . 6.9 mp -111.94 153.33 26.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.136 -0.69 . . . . 53.310000000000002 109.136 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.97 -73.36 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.844 0.715 . . . . 70.299999999999997 111.331 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.67 23.11 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.051 -0.595 . . . . 44.020000000000003 112.477 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.7 m -140.88 141.38 34.62 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.548 -0.383 . . . . 75.409999999999997 110.62 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.8 p -83.73 118.53 23.95 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.993 0.425 . . . . 54.0 110.008 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.52 155.72 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.168 -0.469 . . . . 55.039999999999999 110.975 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -97.03 100.54 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.907 -0.588 . . . . 62.310000000000002 109.731 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 51' ' ' VAL . 48.6 tp -95.05 115.28 27.22 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.339 -0.615 . . . . 75.329999999999998 109.339 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HB3' HG22 ' A' ' 8' ' ' VAL . . . -124.82 145.17 49.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.467 0.651 . . . . 73.439999999999998 112.295 -173.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -111.11 142.11 25.64 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.939 -1.028 . . . . 73.129999999999995 108.42 173.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 18.8 Cg_exo -65.95 152.59 81.0 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.368 2.045 . . . . 74.049999999999997 111.904 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -93.95 5.46 51.63 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.626 -0.879 . . . . 71.219999999999999 108.626 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.903 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 77.3 m -134.59 173.84 11.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.368 -1.287 . . . . 71.150000000000006 109.824 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.455 ' HD2' ' SD ' ' A' ' 69' ' ' MET . 17.3 p90 -85.35 -173.71 4.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 74.200000000000003 110.542 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 68' ' ' TYR . 1.7 pmm? -48.55 -46.24 38.69 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.388 0.885 . . . . 74.430000000000007 113.388 -170.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -66.16 -62.35 1.53 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 75.519999999999996 111.735 -173.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.903 ' HG3' ' HB3' ' A' ' 67' ' ' CYS . 6.2 pt-20 -87.48 18.91 3.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.469 . . . . 71.019999999999996 111.299 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.1 t -65.33 -39.2 92.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.342 -0.614 . . . . 73.230000000000004 109.342 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.51 -23.57 66.93 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.738 -0.665 . . . . 72.549999999999997 112.188 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -71.92 -17.27 62.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.74 0.305 . . . . 71.329999999999998 110.425 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -95.88 -42.62 8.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 64.519999999999996 110.537 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.551 HG22 HG11 ' A' ' 8' ' ' VAL . 25.7 t -62.23 -38.54 81.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.983 -0.553 . . . . 63.399999999999999 111.236 -177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.33 -64.56 4.27 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.879 -0.6 . . . . 65.209999999999994 113.257 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.05 -41.23 70.17 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.646 2.23 . . . . 74.109999999999999 112.31 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.1 tp -54.85 -48.65 72.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.28 -0.418 . . . . 54.43 111.113 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.83 88.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.167 -0.47 . . . . 51.039999999999999 111.334 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -75.98 -35.22 59.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.177 -0.465 . . . . 72.400000000000006 111.291 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' HD2' ' HB3' ' A' ' 46' ' ' SER . 21.5 m-85 -71.74 -20.14 61.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.78 0.324 . . . . 72.420000000000002 111.086 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -98.74 -1.37 40.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.292 -0.413 . . . . 75.430000000000007 110.871 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m 59.73 29.61 19.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.643 -0.708 . . . . 72.150000000000006 111.767 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.23 149.06 35.29 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 61.119999999999997 110.601 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 90' ' ' ILE . 14.1 Cg_exo -70.35 110.31 2.64 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.079 2.519 . . . . 71.329999999999998 112.046 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.523 ' HB3' HD22 ' A' ' 125' ' ' LEU . 23.1 Cg_exo -65.1 -11.92 32.21 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.158 2.572 . . . . 75.420000000000002 112.42 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -78.94 -43.29 24.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.261 -0.427 . . . . 63.439999999999998 110.174 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -96.63 0.71 50.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.12 -0.491 . . . . 71.420000000000002 112.155 -170.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 40.2 pt -75.47 174.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.806 -0.357 . . . . 54.520000000000003 110.425 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 p -119.88 125.26 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.331 0.586 . . . . 73.510000000000005 110.98 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 131' ' ' HIS . 98.1 t -119.32 123.8 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 53.219999999999999 110.448 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.522 ' HB ' ' HA2' ' A' ' 9' ' ' GLY . 48.8 mm -75.57 130.63 36.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.693 -0.685 . . . . 74.140000000000001 109.6 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.403 ' HE1' ' HA3' ' A' ' 114' ' ' GLY . 31.5 t-80 -136.6 157.58 46.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.118 0.485 . . . . 71.549999999999997 110.469 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -86.77 152.76 22.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.875 -0.602 . . . . 71.530000000000001 110.688 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.747 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 26.9 tt0 -128.07 93.78 3.76 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.915 -0.772 . . . . 65.230000000000004 108.915 168.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 139' ' ' ARG . 4.0 pp -84.02 0.09 49.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.027 -0.988 . . . . 60.219999999999999 112.04 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.438 ' HB2' ' HA2' ' A' ' 113' ' ' GLY . 27.9 t70 -87.08 -38.94 16.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.163 0.506 . . . . 74.219999999999999 110.351 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.44 152.06 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.462 -0.79 . . . . 53.219999999999999 109.852 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.503 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 5.1 p-10 -64.39 159.97 20.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.377 0.608 . . . . 70.519999999999996 111.61 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 0.8 OUTLIER -72.59 135.69 45.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.132 -0.94 . . . . 64.329999999999998 112.027 -176.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.02 -64.06 0.53 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.235 -0.983 . . . . 62.310000000000002 113.278 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -85.88 145.62 27.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.797 0.332 . . . . 72.409999999999997 110.839 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.568 HG12 HG21 ' A' ' 188' ' ' VAL . 30.7 pt -117.27 149.85 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.481 -0.562 . . . . 70.200000000000003 109.481 174.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -157.03 137.22 12.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.852 0.358 . . . . 70.219999999999999 110.949 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 4.0 pp -96.68 153.47 17.85 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.757 -0.46 . . . . 62.340000000000003 109.757 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -147.39 115.54 6.56 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.771 -0.455 . . . . 71.230000000000004 109.771 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 129' ' ' ASN . 0.7 OUTLIER -80.91 90.12 5.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.828 0.823 . . . . 73.519999999999996 110.326 177.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.28 -127.09 1.63 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.385 -0.825 . . . . 62.509999999999998 111.385 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.08 163.17 32.96 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.299 -0.721 . . . . 75.420000000000002 111.299 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.8 94.66 0.68 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.641 -0.79 . . . . 64.409999999999997 112.492 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.91 142.12 12.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.136 0.494 . . . . 72.299999999999997 111.334 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 98' ' ' ASP . . . 96.88 -76.12 0.7 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.041 -0.599 . . . . 63.25 112.972 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.403 ' HA3' ' HE1' ' A' ' 94' ' ' HIS . . . -80.28 63.78 4.09 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.046 -0.597 . . . . 71.099999999999994 112.93 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -62.67 -27.1 69.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.778 0.288 . . . . 74.140000000000001 111.778 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -65.51 -29.93 70.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.312 0.577 . . . . 73.319999999999993 110.786 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.43 20.56 29.97 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.59 -0.814 . . . . 64.420000000000002 112.308 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 118' ' ' LEU . 33.5 mt -84.5 -59.51 2.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.881 -0.328 . . . . 72.430000000000007 111.276 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HD2' ' N ' ' A' ' 119' ' ' ARG . 3.7 mpt_? -73.65 -35.78 65.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.35 -0.386 . . . . 74.540000000000006 110.58 -174.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 p -56.42 -43.96 79.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 54.43 111.233 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.461 ' HB ' HH22 ' A' ' 132' ' ' ARG . 48.9 t -85.33 -41.62 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 54.530000000000001 111.889 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.37 -47.16 71.2 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.051 0.389 . . . . 64.140000000000001 112.051 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.2 m -66.93 -24.53 66.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.659 0.266 . . . . 61.109999999999999 111.18 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.43 -45.6 37.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.758 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 87' ' ' PRO . 90.6 mt -72.58 -34.98 67.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 73.430000000000007 110.384 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.61 -12.56 20.86 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.907 -0.663 . . . . 73.239999999999995 113.15 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -169.56 177.57 4.53 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.167 0.508 . . . . 72.049999999999997 111.579 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 2.5 mptt -110.34 -110.97 0.33 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.587 -0.894 . . . . 75.439999999999998 108.587 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.477 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 4.3 t-20 64.96 -9.89 0.18 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.708 0.803 . . . . 64.120000000000005 113.054 174.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.408 ' H ' ' C ' ' A' ' 128' ' ' LYS . 10.4 t80 -179.79 -157.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.659 -0.867 . . . . 71.140000000000001 108.659 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.593 ' O ' ' HD2' ' A' ' 132' ' ' ARG . 11.6 p-80 44.87 41.08 4.86 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.937 0.895 . . . . 65.319999999999993 113.067 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.593 ' HD2' ' O ' ' A' ' 131' ' ' HIS . 2.7 mpt_? -131.01 107.03 8.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.786 -0.643 . . . . 71.540000000000006 109.906 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 106' ' ' LEU . 58.8 t -119.18 109.95 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.943 -0.762 . . . . 64.230000000000004 108.943 174.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.747 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 90.2 mtm180 -92.14 122.64 34.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.088 0.471 . . . . 61.409999999999997 111.651 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 135' ' ' ILE . 2.1 mp -99.88 115.03 40.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.946 -0.761 . . . . 44.32 108.946 172.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -63.52 109.13 2.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.881 -0.676 . . . . 71.150000000000006 111.472 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.567 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 30.8 m -101.4 -18.7 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.562 0.22 . . . . 74.409999999999997 111.491 -176.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 107.92 139.66 9.08 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.424 -0.893 . . . . 75.219999999999999 112.664 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 6.1 ptp180 -80.88 133.5 54.86 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.032 0.444 . . . . 73.420000000000002 111.586 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 22.3 Cg_exo -65.23 128.99 21.66 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.303 2.669 . . . . 64.409999999999997 112.499 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 5.9 Cg_exo -78.86 45.67 1.97 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.191 2.594 . . . . 73.510000000000005 112.272 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.87 143.74 10.95 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.044 -0.823 . . . . 71.140000000000001 111.044 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 143' ' ' ARG . 18.1 mmt180 -89.58 58.39 4.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.513 0.673 . . . . 62.100000000000001 111.446 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -131.0 160.49 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.101 -0.954 . . . . 73.400000000000006 109.296 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -66.49 141.09 96.9 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.263 -0.643 . . . . 71.120000000000005 109.263 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.8 -14.37 1.22 Allowed 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.552 2.835 . . . . 71.230000000000004 113.915 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.32 28.62 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.588 0.355 . . . . 75.239999999999995 111.813 174.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.75 -41.63 13.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.146 0.498 . . . . 74.409999999999997 111.228 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -73.61 -19.81 60.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 61.25 111.76 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.534 HG23 ' CG ' ' A' ' 22' ' ' HIS . 14.5 p -65.21 -22.52 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.246 -0.434 . . . . 74.340000000000003 111.49 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.52 -27.76 13.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.62 -0.264 . . . . 72.140000000000001 111.36 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -165.43 109.7 0.86 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.259 0.552 . . . . 71.239999999999995 111.467 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -164.27 31.79 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.823 -0.626 . . . . 65.349999999999994 110.125 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -60.23 124.57 20.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.311 0.577 . . . . 74.150000000000006 111.142 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.17 176.32 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.459 -0.791 . . . . 64.319999999999993 110.289 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.65 -54.46 5.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.837 0.351 . . . . 74.439999999999998 111.741 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.39 -23.77 66.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.208 0.818 . . . . 54.340000000000003 113.208 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.71 -23.7 66.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.067 0.461 . . . . 74.310000000000002 110.698 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.452 ' HA ' HG23 ' A' ' 162' ' ' VAL . 22.7 mmm180 -69.41 -22.37 63.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.747 -0.661 . . . . 72.530000000000001 111.417 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.36 -33.21 73.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.281 -0.418 . . . . 61.0 111.711 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 165' ' ' ILE . 8.9 mm-40 -97.04 1.48 50.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.885 0.328 . . . . 62.509999999999998 111.885 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' A' ' 163' ' ' PRO . 95.1 t -60.82 -53.39 64.65 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.772 -0.194 . . . . 73.209999999999994 111.373 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 30.7 Cg_endo -64.64 -25.62 61.78 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.772 1.648 . . . . 74.439999999999998 111.794 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.1 m -63.32 -51.17 67.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.624 -0.716 . . . . 75.430000000000007 110.945 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 161' ' ' GLU . 78.9 mt -54.49 -38.17 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.938 -0.573 . . . . 64.239999999999995 111.727 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.25 -51.44 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 63.240000000000002 111.363 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -80.97 -30.44 35.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.406 -0.361 . . . . 74.319999999999993 111.563 -176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -67.12 -43.18 83.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 72.200000000000003 110.961 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.418 ' HB3' HD21 ' A' ' 32' ' ' LEU . . . -60.09 -37.9 81.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 73.310000000000002 111.29 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.78 92.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.896 0.379 . . . . 55.420000000000002 111.548 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.81 -41.61 78.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.85 0.357 . . . . 74.420000000000002 110.977 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.75 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.042 -0.527 . . . . 61.420000000000002 112.279 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 23.6 p -62.86 -48.63 78.19 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.218 0.451 . . . . 65.239999999999995 112.218 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.526 ' HG2' ' HB3' ' A' ' 55' ' ' LEU . 40.3 mt-10 -64.99 -29.66 70.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.742 -0.208 . . . . 75.129999999999995 111.347 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.522 HD23 ' HA ' ' A' ' 184' ' ' ALA . 22.0 tp -74.54 -31.77 62.23 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.749 -0.38 . . . . 53.420000000000002 110.38 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 181' ' ' LEU . 70.6 mt -62.18 -45.1 94.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.245 0.545 . . . . 65.239999999999995 110.121 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 59.8 mt -71.02 -28.63 33.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.367 -0.833 . . . . 62.43 110.274 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -59.06 5.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.556 -0.747 . . . . 62.350000000000001 111.186 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -178.1 -49.61 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.849 0.314 . . . . 70.329999999999998 111.849 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.14 116.82 5.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.637 -0.792 . . . . 55.229999999999997 113.71 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.682 ' HA ' HD23 ' A' ' 176' ' ' LEU . 10.2 mp -77.63 -44.24 28.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.01 0.433 . . . . 63.43 110.658 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.588 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 45.5 mt-10 -72.56 -44.07 9.34 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.195 -0.457 . . . . 73.150000000000006 111.697 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 74.8 Cg_exo -52.12 -35.89 64.03 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.532 1.488 . . . . 75.109999999999999 111.918 170.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.522 ' HA ' HD23 ' A' ' 175' ' ' LEU . . . -73.31 -38.01 65.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.38 -0.373 . . . . 70.209999999999994 111.682 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 3.4 pt20 -71.36 -27.49 63.39 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.535 -0.466 . . . . 71.510000000000005 109.906 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -86.34 -32.09 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 72.120000000000005 111.69 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 184' ' ' ALA . 13.1 t -61.87 -50.42 72.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.96 -0.296 . . . . 61.420000000000002 111.062 -176.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.568 HG21 HG12 ' A' ' 104' ' ' ILE . 9.4 p -67.39 -26.45 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 121.569 0.7 . . . . 55.399999999999999 110.299 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -69.69 -31.7 69.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.377 -0.829 . . . . 51.140000000000001 110.318 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -93.61 -6.58 46.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.886 -0.597 . . . . 23.329999999999998 111.75 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.9 m95 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.664 -0.684 . . . . 73.349999999999994 110.585 175.843 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 8.8 pt-20 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.239 0.542 . . . . 64.439999999999998 109.778 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.907 ' HB2' HG23 ' A' ' 61' ' ' VAL . 56.4 Cg_endo -92.27 117.28 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.987 2.458 . . . . 73.409999999999997 113.318 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.646 ' HB2' HG12 ' A' ' 60' ' ' VAL . 70.9 mt -67.67 145.17 55.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 71.340000000000003 109.935 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.581 HD23 HG12 ' A' ' 90' ' ' ILE . 57.3 tp -93.32 109.36 20.91 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.107 -0.331 . . . . 72.420000000000002 110.107 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.58 113.12 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.496 . . . . 63.530000000000001 110.366 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.02 164.1 22.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.232 -0.44 . . . . 74.239999999999995 110.602 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.29 -178.66 39.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.601 -0.809 . . . . 51.039999999999999 112.25 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.476 HD21 ' CE1' ' A' ' 94' ' ' HIS . 86.3 mt -67.55 126.48 29.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.69 0.281 . . . . 73.540000000000006 110.966 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.98 177.73 52.09 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.934 -0.651 . . . . 30.109999999999999 113.149 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 30.0 t-20 -124.63 108.06 28.94 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 110.048 -0.353 . . . . 64.439999999999998 110.048 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 4.6 Cg_exo -76.75 -33.26 3.05 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.41 2.74 . . . . 43.340000000000003 114.117 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.92 147.81 15.01 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.889 -1.148 . . . . 44.530000000000001 113.104 -174.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.02 -31.83 94.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.553 2.835 . . . . 73.349999999999994 113.34 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 m -61.05 -39.14 88.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.293 0.568 . . . . 72.420000000000002 110.879 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.573 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 91.0 m-85 -97.17 2.5 51.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.53 -0.759 . . . . 74.109999999999999 110.52 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.426 ' CB ' HD21 ' A' ' 12' ' ' ASN . . . -71.28 -18.46 62.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.763 0.653 . . . . 72.040000000000006 112.763 -171.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -92.53 18.84 7.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.697 0.284 . . . . 73.430000000000007 111.228 -175.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.636 HG21 ' O ' ' A' ' 151' ' ' LEU . 59.8 p -113.95 -174.08 2.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.277 0.56 . . . . 71.549999999999997 111.904 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.601 ' HD2' ' HB ' ' A' ' 137' ' ' VAL . 5.0 ptt180 -94.47 1.53 55.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.513 -0.767 . . . . 73.200000000000003 112.85 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.617 ' HB3' HG22 ' A' ' 150' ' ' VAL . 3.6 p-80 -94.74 10.8 33.68 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.414 -0.515 . . . . 74.329999999999998 111.496 -176.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -139.15 35.04 2.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.075 0.464 . . . . 74.540000000000006 110.757 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.9 mt -56.04 -46.56 78.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.427 -0.806 . . . . 73.519999999999996 111.796 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.94 -51.19 60.67 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.999 -0.546 . . . . 70.030000000000001 113.013 -174.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -57.82 -38.3 75.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 73.310000000000002 111.289 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 90.1 mtp -73.01 -54.43 8.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.56 -0.291 . . . . 74.299999999999997 111.388 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.468 HG12 HD23 ' A' ' 32' ' ' LEU . 57.7 t -61.21 -44.2 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 71.519999999999996 111.558 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.516 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -58.78 -53.24 60.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 51.109999999999999 112.138 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.73 -37.12 81.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.169 0.433 . . . . 60.039999999999999 112.169 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.63 -32.02 34.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.603 -0.439 . . . . 53.130000000000003 112.117 -175.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.6 pp -76.41 -33.27 58.82 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.462 -0.495 . . . . 71.329999999999998 110.577 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -70.0 -34.04 72.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.263 0.554 . . . . 51.009999999999998 110.279 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.88 -18.68 57.51 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.508 -0.769 . . . . 63.509999999999998 113.088 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -64.02 -39.38 93.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.026 0.413 . . . . 73.319999999999993 111.651 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 36' ' ' ILE . 3.9 mp -83.11 -14.47 11.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.702 0.763 . . . . 74.439999999999998 109.553 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.98 13.69 54.04 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.87 -1.292 . . . . 71.010000000000005 109.87 -171.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.2 m -87.71 113.19 23.16 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.307 -0.946 . . . . 75.439999999999998 111.197 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.91 128.32 9.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.282 -0.417 . . . . 73.319999999999993 110.782 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.534 ' CD1' HG23 ' A' ' 51' ' ' VAL . 4.5 m-85 -102.76 -157.36 0.61 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.973 -0.558 . . . . 65.319999999999993 109.721 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -140.91 172.36 12.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.818 -0.353 . . . . 74.239999999999995 110.961 -173.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.797 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 3.3 p -55.83 105.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.748 0.785 . . . . 74.340000000000003 110.464 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.571 ' HD2' ' HG2' ' A' ' 45' ' ' LYS . 8.0 t60 -104.76 145.05 30.91 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.501 -0.772 . . . . 74.120000000000005 109.433 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -65.97 -77.11 0.07 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.176 -0.466 . . . . 54.210000000000001 111.277 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.587 ' HE3' ' HD2' ' A' ' 82' ' ' PHE . 28.8 mmmt 47.26 -133.27 1.18 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.501 -0.555 . . . . 54.350000000000001 109.501 -172.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 p -105.97 -39.46 6.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.389 -0.925 . . . . 65.409999999999997 112.725 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.726 ' HA3' ' HB3' ' A' ' 75' ' ' GLN . . . -133.01 -24.18 0.73 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 118.4 -1.857 . . . . 53.240000000000002 117.055 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.72 162.01 36.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.678 1.362 . . . . 51.520000000000003 114.678 -160.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.797 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 23.0 mt-10 -74.94 135.98 41.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.182 -1.372 . . . . 73.540000000000006 108.75 170.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.61 140.11 49.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.002 0.43 . . . . 72.299999999999997 111.654 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.779 HG13 ' HB3' ' A' ' 62' ' ' LEU . 2.4 p -124.41 114.76 42.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.717 -0.674 . . . . 75.409999999999997 109.953 171.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 m -95.65 131.22 42.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 74.430000000000007 110.505 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.23 -161.16 29.38 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.374 -0.69 . . . . 74.140000000000001 111.374 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -131.41 132.69 44.55 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.896 0.379 . . . . 73.310000000000002 110.458 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.1 mt -102.93 126.56 50.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.983 -0.553 . . . . 64.420000000000002 109.593 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 178' ' ' ALA . . . 68.97 -47.92 0.58 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.009 0.818 . . . . 65.420000000000002 111.778 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.11 -41.62 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.079 -0.581 . . . . 62.32 112.397 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.685 ' HB ' HG22 ' A' ' 177' ' ' ILE . 6.8 m -84.46 141.52 30.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.781 0.324 . . . . 44.329999999999998 110.965 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 3.7 p -70.22 143.3 52.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 74.109999999999999 111.353 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 177' ' ' ILE . 20.5 m -143.67 158.14 16.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.081 0.467 . . . . 52.039999999999999 111.297 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.907 HG23 ' HB2' ' A' ' 4' ' ' PRO . 85.0 t -112.07 104.93 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.675 -0.693 . . . . 65.340000000000003 109.186 172.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.779 ' HB3' HG13 ' A' ' 51' ' ' VAL . 3.0 tm? -95.84 118.72 33.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.552 -0.536 . . . . 71.25 109.552 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -134.64 131.15 37.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.733 -0.667 . . . . 71.209999999999994 109.96 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -127.59 135.23 27.15 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.942 0.401 . . . . 64.239999999999995 110.882 -178.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 1.4 Cg_endo -83.8 164.45 13.86 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.104 2.536 . . . . 61.119999999999997 111.918 176.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 68.3 mtt180 -112.19 17.1 19.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.37 0.605 . . . . 72.099999999999994 109.82 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 52.9 m -112.03 164.2 13.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.477 -0.783 . . . . 62.310000000000002 110.146 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -66.18 167.95 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.282 -0.417 . . . . 63.409999999999997 110.998 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 19.3 ptp -55.23 -32.44 62.28 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.855 0.687 . . . . 74.340000000000003 112.855 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -72.1 -24.33 61.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.11 0.481 . . . . 75.519999999999996 110.585 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 12.5 mm-40 -102.91 -10.3 19.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.923 -0.581 . . . . 72.019999999999996 110.996 -175.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.5 m -61.56 -51.8 67.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 73.030000000000001 111.676 -173.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.872 ' HA3' ' HA ' ' A' ' 121' ' ' VAL . . . -62.03 -23.83 64.25 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.193 -0.527 . . . . 53.0 113.276 -174.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -61.97 -37.9 86.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.039 0.447 . . . . 73.540000000000006 110.974 -176.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.726 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 12.9 mm100 -92.19 -20.43 21.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.931 -0.577 . . . . 74.319999999999993 110.996 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 72' ' ' SER . 95.7 t -73.69 -36.27 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 72.030000000000001 111.015 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.716 ' HA2' ' HB3' ' A' ' 125' ' ' LEU . . . -52.12 -68.45 1.56 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.991 -0.549 . . . . 74.019999999999996 112.973 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -58.11 -28.85 85.21 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.629 2.22 . . . . 74.310000000000002 112.495 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.94 -48.78 77.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 73.519999999999996 110.24 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.55 90.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.004 -0.544 . . . . 63.530000000000001 111.491 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.66 -20.19 59.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.288 -0.415 . . . . 45.229999999999997 111.564 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HD2' ' HE3' ' A' ' 45' ' ' LYS . 4.8 m-30 -74.21 -20.19 60.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.497 -0.32 . . . . 74.230000000000004 110.728 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -106.99 -11.74 15.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.51 -0.314 . . . . 70.099999999999994 110.833 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.0 t 61.74 36.3 16.41 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.627 -0.715 . . . . 64.420000000000002 110.529 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.4 m -74.11 142.76 79.53 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 110.619 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.89 128.32 25.12 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.869 2.38 . . . . 54.43 112.079 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.55 -9.39 18.0 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.02 2.48 . . . . 65.340000000000003 112.633 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -83.68 -12.75 55.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.113 -0.494 . . . . 73.450000000000003 110.903 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -105.31 24.79 11.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 75.230000000000004 111.186 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.581 HG12 HD23 ' A' ' 6' ' ' LEU . 62.6 mt -89.07 109.84 20.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.412 . . . . 70.319999999999993 111.196 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.785 HG12 ' HB3' ' A' ' 131' ' ' HIS . 32.6 m -113.42 141.7 28.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.468 -0.568 . . . . 61.100000000000001 109.468 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.01 130.16 51.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.318 0.58 . . . . 63.030000000000001 111.989 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.1 mm -85.28 118.0 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.55 -0.75 . . . . 74.329999999999998 109.291 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.476 ' CE1' HD21 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -137.61 170.26 16.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.411 0.624 . . . . 73.219999999999999 111.482 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -90.35 145.71 24.74 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.703 -1.135 . . . . 65.019999999999996 111.973 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 7.2 mm-40 -140.43 119.42 12.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.624 -0.716 . . . . 73.310000000000002 109.778 169.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.541 ' HB2' ' HG2' ' A' ' 139' ' ' ARG . 1.7 pp -83.77 -0.15 49.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.523 -0.762 . . . . 55.229999999999997 112.529 -174.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.416 ' OD2' HG13 ' A' ' 99' ' ' ILE . 3.4 p-10 -77.29 -10.85 59.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 71.209999999999994 111.383 -174.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.416 HG13 ' OD2' ' A' ' 98' ' ' ASP . 61.3 mt -135.17 149.72 29.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.956 -0.757 . . . . 64.299999999999997 108.956 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.05 179.1 7.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.453 -0.573 . . . . 75.349999999999994 109.453 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -66.17 123.79 20.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.091 0.472 . . . . 73.150000000000006 110.382 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.18 -118.13 0.78 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.789 -0.925 . . . . 74.299999999999997 110.789 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.568 ' HA ' HE22 ' A' ' 168' ' ' GLN . 7.8 ppt_? -83.4 132.99 34.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.265 0.533 . . . . 73.530000000000001 110.064 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.3 pt -97.69 166.16 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.995 -0.548 . . . . 63.509999999999998 110.703 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -126.6 127.85 45.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.235 0.54 . . . . 75.010000000000005 110.785 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.692 HD13 HG21 ' A' ' 188' ' ' VAL . 10.0 mp -104.71 111.88 24.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.979 -0.555 . . . . 62.0 110.947 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -143.58 135.77 26.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.581 -0.736 . . . . 65.25 109.201 176.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.5 pp -85.75 125.73 33.45 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 61.200000000000003 110.015 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.58 179.26 38.56 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.654 -0.703 . . . . 61.149999999999999 111.544 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.1 -156.95 6.8 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.011 -0.614 . . . . 74.549999999999997 112.594 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.62 ' HA3' HD13 ' A' ' 118' ' ' LEU . . . -78.8 130.98 10.34 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.021 -0.609 . . . . 75.099999999999994 112.141 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -105.91 -30.92 9.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.77 0.319 . . . . 64.019999999999996 110.467 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.79 -4.86 63.26 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.843 -0.694 . . . . 75.010000000000005 112.862 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.2 103.58 0.09 OUTLIER Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.019 -0.61 . . . . 61.210000000000001 112.525 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.652 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 32.0 m-70 -138.83 142.42 38.66 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.04 -0.356 . . . . 74.099999999999994 110.04 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -66.89 -44.84 79.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 72.530000000000001 111.243 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.34 11.91 3.69 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.056 -0.592 . . . . 74.510000000000005 113.664 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.652 ' HG ' ' HB2' ' A' ' 115' ' ' HIS . 95.9 mt -84.28 -51.35 7.07 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.606 -0.35 . . . . 75.310000000000002 110.599 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -79.02 -28.78 43.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.928 -0.578 . . . . 70.209999999999994 110.821 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.6 m -61.86 -32.72 73.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.081 0.467 . . . . 74.239999999999995 110.777 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.872 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 68.3 t -84.4 -47.26 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.445 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' HA ' ' CG2' ' A' ' 127' ' ' THR . . . -57.5 -55.79 30.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.759 -0.655 . . . . 73.129999999999995 112.45 -174.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.6 m -66.52 -21.64 66.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.024 0.379 . . . . 75.510000000000005 112.024 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.82 -52.09 64.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.803 0.297 . . . . 73.120000000000005 111.803 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.716 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 1.4 pt? -110.17 3.75 20.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.786 -0.366 . . . . 72.310000000000002 111.385 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.92 20.04 61.98 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.68 -0.772 . . . . 64.099999999999994 112.852 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.465 ' CG2' ' HA ' ' A' ' 122' ' ' ALA . 13.0 t -85.91 167.47 15.08 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.927 -0.397 . . . . 74.019999999999996 109.927 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 12.0 mptt -119.82 8.21 11.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.438 -0.346 . . . . 70.120000000000005 110.16 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 59.58 62.99 1.61 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.756 -0.656 . . . . 70.340000000000003 109.67 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -57.91 -70.58 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.282 -0.872 . . . . 64.299999999999997 111.718 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.785 ' HB3' HG12 ' A' ' 91' ' ' VAL . 34.8 t60 -99.55 86.71 3.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.115 0.483 . . . . 60.350000000000001 109.964 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -96.16 121.94 38.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.833 -0.621 . . . . 70.5 110.402 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -83.24 126.96 40.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.158 -0.682 . . . . 52.140000000000001 109.158 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -106.64 103.03 12.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.111 -0.495 . . . . 64.109999999999999 110.833 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 66.8 mt -96.53 128.06 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.879 -0.6 . . . . 64.420000000000002 109.857 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.95 115.3 7.11 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.818 -0.706 . . . . 74.200000000000003 111.81 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.601 ' HB ' ' HD2' ' A' ' 21' ' ' ARG . 35.0 m -100.88 -20.38 5.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.703 0.287 . . . . 74.439999999999998 111.061 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.31 151.4 1.73 Allowed Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.067 -0.515 . . . . 74.109999999999999 112.857 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.541 ' HG2' ' HB2' ' A' ' 97' ' ' LEU . 1.6 ppt_? -158.52 138.06 8.47 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.635 -0.332 . . . . 74.519999999999996 110.174 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 22.9 Cg_endo -93.54 134.14 0.97 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.218 2.612 . . . . 73.239999999999995 112.036 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.33 132.12 24.99 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.224 1.95 . . . . 73.140000000000001 111.718 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -159.04 179.17 34.86 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.562 -0.828 . . . . 74.109999999999999 111.858 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 143' ' ' ARG . 2.9 mpt_? -87.62 9.89 19.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.494 0.664 . . . . 74.150000000000006 110.106 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -124.73 131.59 53.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.873 -1.058 . . . . 74.329999999999998 108.431 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.9 149.95 62.61 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.944 0.402 . . . . 74.519999999999996 110.82 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.712 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 41.4 Cg_endo -66.92 4.6 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.345 2.697 . . . . 64.030000000000001 114.093 -172.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . -61.24 -39.22 89.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 53.030000000000001 110.636 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.72 -36.17 62.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.166 0.508 . . . . 72.239999999999995 110.543 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.712 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 95.8 m-85 -71.29 -24.61 62.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 73.439999999999998 111.513 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 22' ' ' HIS . 9.0 p -85.31 -15.21 10.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.887 0.375 . . . . 73.230000000000004 110.872 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.636 ' O ' HG21 ' A' ' 20' ' ' THR . 87.4 mt -84.01 -37.83 21.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.415 -0.357 . . . . 64.120000000000005 111.766 -177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -162.96 101.28 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.401 0.619 . . . . 73.530000000000001 111.482 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -160.06 115.21 2.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.714 -0.675 . . . . 73.219999999999999 110.196 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -134.19 145.04 48.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.727 -0.669 . . . . 54.100000000000001 109.612 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 0.2 OUTLIER -137.68 -160.01 1.01 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.226 -0.287 . . . . 74.530000000000001 110.226 -175.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.463 ' H ' HG22 ' A' ' 155' ' ' THR . . . -82.45 -29.0 30.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.835 0.35 . . . . 63.140000000000001 111.31 176.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.15 -60.54 2.19 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.095 0.776 . . . . 65.319999999999993 113.095 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -34.7 69.1 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.966 0.358 . . . . 70.099999999999994 111.966 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 155' ' ' THR . 7.2 mmp_? -60.79 -31.31 70.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.906 0.384 . . . . 74.340000000000003 110.678 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.38 -28.03 65.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 64.129999999999995 111.391 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -87.87 -19.05 27.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.011 -0.54 . . . . 61.43 111.102 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.658 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 88.7 t -50.63 -55.37 27.08 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 112.821 0.675 . . . . 73.010000000000005 112.821 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 77.5 Cg_exo -51.48 -33.8 48.87 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.364 2.043 . . . . 72.540000000000006 112.992 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.0 m -80.21 -46.7 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.458 . . . . 73.439999999999998 110.787 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.482 ' HA ' ' HB3' ' A' ' 168' ' ' GLN . 1.6 mp -59.51 -34.57 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 70.5 111.906 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 162' ' ' VAL . 85.6 t -55.37 -46.54 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.902 0.382 . . . . 52.549999999999997 111.152 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -79.11 -37.56 38.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.073 0.463 . . . . 73.030000000000001 110.221 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.568 HE22 ' HA ' ' A' ' 103' ' ' ARG . 47.3 tt0 -61.3 -46.86 88.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.478 -0.783 . . . . 74.540000000000006 111.462 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.47 90.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 65.450000000000003 110.623 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.45 90.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.6 . . . . 63.450000000000003 110.729 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.52 -36.08 79.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.229 0.538 . . . . 75.010000000000005 110.605 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 176' ' ' LEU . . . -68.21 -47.74 67.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.717 -0.674 . . . . 72.209999999999994 111.026 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 21.5 p -66.77 -42.69 85.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.577 -0.283 . . . . 74.219999999999999 111.407 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -57.1 -56.42 21.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 73.239999999999995 111.202 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.35 -29.16 67.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.596 -0.274 . . . . 74.340000000000003 111.428 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.566 HD22 ' HA ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -60.48 -46.63 89.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.305 0.574 . . . . 74.430000000000007 109.576 178.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.705 HD13 HG11 ' A' ' 60' ' ' VAL . 62.9 mt -80.09 -30.34 12.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.356 -0.838 . . . . 74.040000000000006 110.809 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.469 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . . . -71.66 -47.39 54.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 61.130000000000003 111.838 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.15 -75.14 0.6 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.3 -0.409 . . . . 63.100000000000001 110.638 -174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.58 -172.78 38.63 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.42 -0.895 . . . . 53.310000000000002 112.385 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 181' ' ' LEU . 1.1 pt? -94.31 -26.25 16.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.606 0.241 . . . . 50.420000000000002 111.184 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 39.8 mt-10 -66.91 -47.29 54.0 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 111.981 0.363 . . . . 74.140000000000001 111.981 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 32.9 Cg_endo -65.94 -29.51 49.35 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.373 1.382 . . . . 72.219999999999999 111.877 174.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.66 -48.93 62.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.862 -0.608 . . . . 50.439999999999998 111.304 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.568 ' HA ' HG22 ' A' ' 188' ' ' VAL . 8.2 pt20 -60.99 -33.08 72.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.831 0.348 . . . . 63.409999999999997 111.062 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -69.97 -26.17 63.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.933 0.397 . . . . 73.420000000000002 110.628 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 31.4 m -86.28 -41.82 14.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.094 -0.503 . . . . 75.299999999999997 111.203 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.692 HG21 HD13 ' A' ' 106' ' ' LEU . 33.2 m -71.0 -20.24 21.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.871 0.367 . . . . 62.100000000000001 111.47 -178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -97.23 16.03 21.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.453 0.644 . . . . 62.020000000000003 109.79 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -105.59 17.03 24.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.909 -0.587 . . . . 72.129999999999995 110.286 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 87.3 m95 . . . . . 0 C--O 1.247 0.948 0 CA-C-N 115.681 -0.69 . . . . 73.5 109.962 179.719 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 6.6 pt-20 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.412 0.149 . . . . 73.219999999999999 110.68 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 59' ' ' SER . 21.5 Cg_exo -64.69 108.82 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.901 2.401 . . . . 72.219999999999999 112.862 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.676 HD12 HG22 ' A' ' 177' ' ' ILE . 87.8 mt -95.24 156.64 16.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.92 -0.582 . . . . 70.530000000000001 109.652 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.594 HD23 HD12 ' A' ' 90' ' ' ILE . 34.1 tp -108.25 120.75 43.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.941 0.4 . . . . 74.140000000000001 110.75 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 t -118.53 116.97 53.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.862 -0.608 . . . . 72.420000000000002 109.883 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.741 ' HB ' HG22 ' A' ' 92' ' ' VAL . 35.3 t -114.81 143.7 23.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.474 -0.33 . . . . 75.450000000000003 110.473 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.58 157.11 20.25 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.824 -0.703 . . . . 62.43 111.553 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.492 ' H ' ' HA3' ' A' ' 25' ' ' GLY . 61.9 mt -66.43 115.78 6.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 73.409999999999997 109.688 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -83.96 -179.07 51.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.029 -0.605 . . . . 71.129999999999995 113.565 -171.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -94.16 124.16 56.79 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.963 0.411 . . . . 74.25 110.456 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.495 ' HG2' ' HB2' ' A' ' 17' ' ' TYR . 74.2 Cg_endo -88.54 -6.28 6.05 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.759 2.306 . . . . 72.319999999999993 113.469 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.5 171.21 28.39 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.722 -0.751 . . . . 75.439999999999998 112.131 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.4 -52.18 3.51 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.167 2.578 . . . . 74.230000000000004 113.034 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.7 m -61.31 -34.84 75.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 70.099999999999994 111.561 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.535 ' HE1' ' HB3' ' A' ' 151' ' ' LEU . 98.1 m-85 -89.22 -9.39 50.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.316 -0.402 . . . . 73.239999999999995 111.634 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.98 -6.87 45.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.342 . . . . 70.409999999999997 110.954 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.5 11.42 36.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 63.420000000000002 111.101 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -101.88 147.66 26.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.72 -0.845 . . . . 64.430000000000007 108.72 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -0.44 37.71 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.502 -0.479 . . . . 75.120000000000005 111.449 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -76.91 -6.33 52.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.101 0.477 . . . . 61.229999999999997 111.021 -174.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -118.45 34.38 5.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.375 0.607 . . . . 75.219999999999999 110.005 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pp -63.81 -12.67 37.79 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.6 -0.727 . . . . 62.240000000000002 111.451 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.492 ' HA3' ' H ' ' A' ' 10' ' ' LEU . . . -61.09 -47.23 92.22 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.124 -0.79 . . . . 54.350000000000001 111.124 175.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.637 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 83.4 t80 -65.26 -39.65 92.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.825 -0.435 . . . . 75.219999999999999 109.825 175.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 65.2 mtt -59.87 -56.8 17.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.672 -0.694 . . . . 63.210000000000001 110.96 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.442 ' HA ' HG22 ' A' ' 31' ' ' VAL . 94.7 t -59.03 -44.0 90.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.474 -0.33 . . . . 54.399999999999999 110.946 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.656 ' HB1' HD21 ' A' ' 62' ' ' LEU . . . -58.91 -45.24 90.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.948 0.404 . . . . 72.239999999999995 111.023 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.22 -44.6 68.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 63.530000000000001 111.559 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 32.8 m -69.17 -31.73 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.956 -0.298 . . . . 71.230000000000004 111.581 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 60.1 mt -71.8 -58.73 3.22 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.939 -0.304 . . . . 71.409999999999997 110.609 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.49 -46.72 88.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 52.340000000000003 110.728 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.14 -20.76 69.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.081 -0.58 . . . . 73.140000000000001 113.179 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 40.1 ttp180 -84.44 -33.4 23.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.068 0.434 . . . . 73.430000000000007 110.645 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.51 -36.09 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.191 0.52 . . . . 43.25 110.04 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.47 68.75 0.29 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.629 -0.989 . . . . 71.150000000000006 110.629 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 57.8 m -152.46 119.91 5.99 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.502 -0.349 . . . . 54.420000000000002 110.793 -170.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.82 127.95 16.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.52 -0.309 . . . . 60.399999999999999 110.404 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.632 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 14.3 m-85 -141.63 172.85 12.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 72.519999999999996 110.123 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -142.84 176.31 9.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 75.439999999999998 111.123 -171.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.8 t -48.06 130.94 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.795 0.665 . . . . 75.239999999999995 112.795 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.518 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 72.1 t60 -109.28 115.46 30.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.49 -0.777 . . . . 53.32 109.658 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 2.5 tmtp? -68.89 99.92 1.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.944 0.35 . . . . 70.319999999999993 111.944 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 80.2 tttt 160.2 -51.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.1 -1.444 . . . . 73.439999999999998 107.1 173.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 48' ' ' ALA . 13.8 p -102.91 28.6 6.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.218 -1.81 . . . . 65.510000000000005 108.076 173.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 43' ' ' HIS . . . -48.85 44.08 0.01 OUTLIER Glycine 0 N--CA 1.474 1.18 0 N-CA-C 119.81 2.684 . . . . 41.420000000000002 119.81 -150.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 46' ' ' SER . . . -96.47 179.76 4.9 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.333 -1.358 . . . . 64.439999999999998 107.333 159.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.895 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 32.3 mt-10 -80.34 118.0 21.59 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 119.998 -0.681 . . . . 71.510000000000005 109.565 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.5 m -121.11 137.73 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.978 0.418 . . . . 73.129999999999995 110.768 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.874 HG13 ' HB3' ' A' ' 62' ' ' LEU . 1.6 p -124.35 110.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.253 0.549 . . . . 72.510000000000005 110.265 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.4 HG22 HG22 ' A' ' 61' ' ' VAL . 24.7 p -92.52 107.93 19.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.733 -0.667 . . . . 73.239999999999995 110.202 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.02 165.01 28.57 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.35 -0.7 . . . . 52.240000000000002 111.35 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 54' ' ' ARG . 15.5 ptt-85 -104.91 103.85 13.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.537 0.684 . . . . 61.140000000000001 110.611 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.43 135.57 38.12 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.676 -0.861 . . . . 72.049999999999997 108.676 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 62.53 10.74 4.24 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.463 0.477 . . . . 53.340000000000003 111.149 -174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.56 -22.91 34.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.989 -0.624 . . . . 73.439999999999998 112.623 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 m -89.59 122.52 32.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 64.099999999999994 110.845 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 19.3 m -68.49 116.47 9.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.441 -0.345 . . . . 74.0 110.414 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.422 HG11 HG21 ' A' ' 177' ' ' ILE . 31.0 m -127.68 164.05 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.957 0.408 . . . . 72.430000000000007 110.689 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.4 HG22 HG22 ' A' ' 52' ' ' THR . 41.3 t -110.01 111.05 34.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.93 -0.577 . . . . 55.450000000000003 109.808 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.874 ' HB3' HG13 ' A' ' 51' ' ' VAL . 64.4 tp -96.82 129.83 44.19 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.534 -0.543 . . . . 74.129999999999995 109.534 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 65' ' ' PRO . . . -108.91 129.27 55.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.217 0.532 . . . . 60.049999999999997 112.049 -175.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.895 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 45.3 mtpt -110.92 92.05 14.05 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.2 -0.909 . . . . 71.209999999999994 109.691 175.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.563 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.7 Cg_endo -83.54 173.03 9.86 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.992 2.461 . . . . 74.5 112.143 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -110.82 12.98 22.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.428 0.633 . . . . 64.219999999999999 109.48 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 60.0 m -130.08 175.15 9.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.558 -0.746 . . . . 75.420000000000002 110.633 -175.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.483 ' CE2' ' HG3' ' A' ' 13' ' ' PRO . 45.9 m-85 -100.25 -169.82 1.78 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.109 -0.496 . . . . 71.099999999999994 110.96 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.607 ' HA ' ' HB2' ' A' ' 72' ' ' SER . 24.9 ptt? -66.8 -20.16 65.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.876 -0.602 . . . . 43.409999999999997 111.537 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.4 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 14.2 t30 -71.87 -25.22 61.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.211 0.529 . . . . 74.129999999999995 109.897 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 18.0 mp0 -105.89 2.42 27.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.717 -0.674 . . . . 75.310000000000002 110.525 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 69' ' ' MET . 27.0 t -60.24 -38.57 83.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.438 -0.346 . . . . 65.230000000000004 110.681 -175.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.82 -20.34 64.14 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.005 -0.617 . . . . 72.239999999999995 112.393 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -85.05 -31.4 23.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.863 0.363 . . . . 60.420000000000002 110.609 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -89.6 -40.65 12.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 62.240000000000002 111.42 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.97 -32.33 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.33 -0.395 . . . . 61.509999999999998 111.102 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.8 -67.83 1.75 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.908 -0.587 . . . . 61.32 113.261 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.07 -39.26 32.55 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.531 2.154 . . . . 63.030000000000001 112.409 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.9 tp -55.32 -58.47 7.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 74.129999999999995 111.731 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.48 68.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.957 0.408 . . . . 75.239999999999995 111.153 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -73.04 -32.7 65.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.817 -0.629 . . . . 72.019999999999996 111.638 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -81.96 -41.78 20.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.873 0.323 . . . . 64.319999999999993 111.873 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -85.45 -17.13 37.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.13 0.418 . . . . 72.540000000000006 112.13 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 t 62.72 71.8 0.51 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.237 0.541 . . . . 52.229999999999997 110.863 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 6' ' ' LEU . 28.0 m -118.17 158.24 46.86 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.798 -0.637 . . . . 72.030000000000001 109.821 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.425 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 35.6 Cg_exo -61.11 111.52 1.11 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.515 2.143 . . . . 71.140000000000001 112.001 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.38 -6.77 19.38 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.707 2.272 . . . . 75.349999999999994 112.267 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -98.27 -12.43 21.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.993 -0.549 . . . . 70.230000000000004 110.457 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 86' ' ' PRO . 79.0 mm-40 -114.49 20.14 15.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 71.219999999999999 110.8 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.594 HD12 HD23 ' A' ' 6' ' ' LEU . 5.8 tt -83.31 134.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.185 -0.461 . . . . 65.430000000000007 110.224 177.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 131' ' ' HIS . 21.6 m -120.9 141.35 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.835 0.35 . . . . 71.299999999999997 110.68 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.741 HG22 ' HB ' ' A' ' 8' ' ' VAL . 45.9 t -132.78 127.34 55.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.316 -0.402 . . . . 73.299999999999997 110.465 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 mm -75.15 139.23 19.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.887 -0.597 . . . . 75.310000000000002 110.708 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -142.45 152.89 43.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.506 -0.316 . . . . 75.430000000000007 110.521 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.97 135.55 42.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.479 -0.934 . . . . 65.430000000000007 108.479 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 99' ' ' ILE . 10.1 tp10 -104.37 127.68 52.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.377 0.608 . . . . 71.0 111.001 -174.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.568 HD22 ' HG3' ' A' ' 146' ' ' PRO . 3.2 pp -84.26 -13.83 51.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.05 -0.977 . . . . 75.109999999999999 110.775 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.94 -47.67 20.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 52.210000000000001 111.157 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.49 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 56.7 mt -89.74 142.13 13.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.089 -0.505 . . . . 52.200000000000003 110.789 -176.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.89 166.46 18.9 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.509 . . . . 72.530000000000001 110.607 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.652 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 15.4 p90 -64.45 128.72 36.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.247 0.546 . . . . 75.299999999999997 112.164 -174.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.62 -22.94 3.84 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.726 -0.75 . . . . 74.310000000000002 112.958 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 17.0 mmt180 -132.35 128.34 37.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.265 0.555 . . . . 75.209999999999994 112.451 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.558 HG22 HG23 ' A' ' 135' ' ' ILE . 47.3 pt -107.79 146.77 13.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.334 -0.848 . . . . 73.530000000000001 109.414 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -157.73 125.2 5.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.908 0.385 . . . . 74.540000000000006 110.46 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.83 HD23 ' H ' ' A' ' 106' ' ' LEU . 1.9 pt? -97.91 144.62 27.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.442 -0.344 . . . . 73.129999999999995 110.092 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 104.44 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.179 -0.674 . . . . 53.520000000000003 109.179 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.845 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.6 pt? -93.37 97.47 10.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.396 0.617 . . . . 71.439999999999998 110.758 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.94 -155.21 26.33 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.271 -0.732 . . . . 64.409999999999997 111.271 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.38 123.91 7.95 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.012 -0.613 . . . . 72.319999999999993 112.378 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.31 -176.61 44.64 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.55 -0.62 . . . . 52.439999999999998 111.55 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.609 ' HG2' ' H ' ' A' ' 113' ' ' GLY . 16.7 tt0 -142.76 -152.41 0.41 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.878 -0.415 . . . . 63.240000000000002 109.878 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.609 ' H ' ' HG2' ' A' ' 112' ' ' GLU . . . 139.75 -74.18 0.38 Allowed Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.299 -0.72 . . . . 25.050000000000001 111.299 -175.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.08 -6.57 87.54 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.971 -0.633 . . . . 60.229999999999997 111.829 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.8 t60 62.74 -87.3 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.774 0.829 . . . . 73.230000000000004 112.595 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -67.08 -46.55 73.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.792 0.329 . . . . 74.409999999999997 111.481 -168.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -60.99 -29.19 70.19 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 120.835 -0.698 . . . . 74.230000000000004 112.464 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.501 ' HB3' HH21 ' A' ' 132' ' ' ARG . 89.6 mt -82.88 -23.77 33.49 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.815 -0.227 . . . . 55.0 111.099 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -79.11 -39.7 32.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.235 -0.439 . . . . 74.200000000000003 110.634 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.5 t -61.59 -54.31 44.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.802 -0.635 . . . . 61.229999999999997 110.795 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 117' ' ' GLY . 48.4 t -59.5 -41.69 85.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.433 -0.349 . . . . 65.329999999999998 111.101 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.46 -52.09 67.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 64.519999999999996 111.209 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.8 m -71.46 -34.02 69.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.853 -0.612 . . . . 62.340000000000003 111.553 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.08 -36.84 78.04 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.833 0.349 . . . . 65.030000000000001 111.286 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.7 mt -87.31 -31.27 20.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.47 -0.332 . . . . 75.310000000000002 111.138 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.64 40.33 5.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.517 -0.849 . . . . 41.439999999999998 111.951 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 129' ' ' ASN . 9.7 t -148.06 176.61 10.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.948 -0.39 . . . . 72.409999999999997 109.948 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 1.1 mptm? -77.62 -5.87 51.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.72 0.295 . . . . 54.310000000000002 110.462 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.408 ' H ' HG23 ' A' ' 127' ' ' THR . 56.7 t30 72.01 81.31 0.15 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.327 -0.851 . . . . 73.430000000000007 111.896 172.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -71.2 -148.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.798 -0.637 . . . . 75.340000000000003 110.118 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.589 ' HB3' ' O ' ' A' ' 90' ' ' ILE . 32.1 p80 45.13 40.02 4.46 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.86 0.689 . . . . 62.109999999999999 112.86 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.501 HH21 ' HB3' ' A' ' 118' ' ' LEU . 50.3 mtt85 -91.65 107.97 19.58 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.433 -0.58 . . . . 71.25 109.433 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.04 109.43 28.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.628 -0.714 . . . . 62.210000000000001 109.88 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.408 ' HG2' ' OE1' ' A' ' 96' ' ' GLU . 95.4 mtt180 -88.71 100.75 13.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.019 -0.537 . . . . 74.409999999999997 110.889 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.558 HG23 HG22 ' A' ' 104' ' ' ILE . 55.7 mt -93.74 108.64 20.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.035 -0.529 . . . . 73.519999999999996 110.046 175.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -73.33 98.0 0.89 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.032 -0.604 . . . . 65.239999999999995 112.322 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 135' ' ' ILE . 3.5 m -110.95 0.97 9.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.702 0.287 . . . . 61.420000000000002 111.484 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 131.88 140.1 4.47 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.264 -0.969 . . . . 50.450000000000003 112.843 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.472 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 7.8 ptp85 -99.46 139.49 20.94 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.656 0.265 . . . . 74.430000000000007 110.506 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 3.0 Cg_exo -75.29 141.36 25.74 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.803 2.336 . . . . 64.409999999999997 111.88 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.38 149.1 88.52 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.575 2.183 . . . . 64.530000000000001 111.58 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.19 44.42 2.15 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.323 -0.465 . . . . 51.140000000000001 113.626 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -82.27 -67.73 0.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.673 -1.232 . . . . 73.230000000000004 107.673 175.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 22.5 mmtm -131.36 147.97 52.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.621 -1.172 . . . . 73.239999999999995 108.289 166.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.581 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 1.7 p-10 -58.91 157.45 20.35 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 123.335 0.397 . . . . 52.409999999999997 110.699 -175.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 4.8 Cg_endo -46.1 -28.76 5.66 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 124.192 3.261 . . . . 72.109999999999999 114.149 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.69 -32.11 28.63 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.186 0.439 . . . . 61.140000000000001 112.186 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.57 -57.97 2.75 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.355 0.502 . . . . 65.239999999999995 112.355 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 144' ' ' LYS . 67.6 m-85 -84.03 -19.99 33.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.654 0.983 . . . . 73.200000000000003 113.654 -168.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.0 p -71.63 -5.97 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.169 0.433 . . . . 73.319999999999993 112.169 -171.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.535 ' HB3' ' HE1' ' A' ' 17' ' ' TYR . 87.9 mt -91.12 -1.91 57.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 61.210000000000001 111.424 -176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -138.91 103.06 4.7 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.752 -0.833 . . . . 74.310000000000002 108.752 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -129.34 119.33 23.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.613 -0.722 . . . . 61.509999999999998 112.024 -164.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -169.1 103.08 0.37 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.642 0.734 . . . . 64.230000000000004 110.12 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.538 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 3.1 m -134.99 131.77 37.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.515 . . . . 73.349999999999994 109.928 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.87 -38.02 86.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.758 0.313 . . . . 72.239999999999995 111.085 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.2 92.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.764 -0.653 . . . . 71.409999999999997 112.31 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.538 ' HG2' ' HB ' ' A' ' 155' ' ' THR . 15.2 pt-20 -82.21 -32.85 29.62 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.968 -0.293 . . . . 72.109999999999999 111.155 -175.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.592 ' HA ' HG23 ' A' ' 162' ' ' VAL . 49.5 mtm180 -71.6 -20.09 62.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.754 0.312 . . . . 74.310000000000002 110.694 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.86 -38.71 76.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.933 -0.576 . . . . 63.240000000000002 112.041 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -103.02 7.58 39.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.197 0.443 . . . . 72.519999999999996 112.197 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 159' ' ' ARG . 77.3 t -58.19 -51.64 80.35 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 121.058 -0.257 . . . . 72.109999999999999 111.34 177.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 12.5 Cg_endo -56.71 -27.61 71.69 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.326 2.018 . . . . 61.020000000000003 112.354 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 168' ' ' GLN . 9.4 m -68.32 -55.47 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.36 -0.382 . . . . 54.210000000000001 110.121 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.456 HG13 HG23 ' A' ' 104' ' ' ILE . 1.7 mp -56.06 -43.17 74.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.524 -0.762 . . . . 75.310000000000002 111.503 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 162' ' ' VAL . 92.4 t -58.04 -49.94 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.618 0.247 . . . . 75.400000000000006 111.369 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.69 -33.15 70.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.563 -0.289 . . . . 73.530000000000001 111.318 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 164' ' ' THR . 98.7 mt-30 -62.52 -48.13 80.87 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.099 0.476 . . . . 64.439999999999998 109.89 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.14 -41.13 97.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.656 -0.702 . . . . 74.209999999999994 111.194 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.09 87.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.401 -0.363 . . . . 74.340000000000003 111.102 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.09 -36.52 83.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 73.230000000000004 110.784 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.29 -45.93 44.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 70.109999999999999 111.335 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.839 ' HA ' HD12 ' A' ' 176' ' ' LEU . 80.1 m -58.3 -40.57 82.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.228 -0.442 . . . . 64.340000000000003 111.541 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -53.71 -45.31 70.37 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.263 -0.426 . . . . 60.119999999999997 111.249 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 183' ' ' PRO . 30.7 tp -81.88 -28.33 33.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.059 -0.257 . . . . 74.230000000000004 111.534 -174.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.839 HD12 ' HA ' ' A' ' 173' ' ' THR . 74.0 mt -52.2 -55.95 17.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.26 0.552 . . . . 74.349999999999994 110.665 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.676 HG22 HD12 ' A' ' 5' ' ' LEU . 6.9 pt -80.97 -23.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.376 -0.829 . . . . 73.439999999999998 111.78 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 175' ' ' LEU . . . -65.77 -45.69 81.56 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 111.748 0.277 . . . . 53.32 111.748 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -136.65 -61.63 0.67 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.83 0.348 . . . . 73.420000000000002 111.277 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -168.59 170.31 42.17 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.541 -0.838 . . . . 53.329999999999998 112.307 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.757 ' HA ' HD23 ' A' ' 176' ' ' LEU . 3.3 pp -82.71 -31.54 28.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.225 0.454 . . . . 73.430000000000007 112.225 -175.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 14.6 mm-40 -60.66 -54.26 56.43 Favored Pre-proline 0 N--CA 1.468 0.439 0 N-CA-C 112.559 0.577 . . . . 74.120000000000005 112.559 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.462 ' HB2' HD21 ' A' ' 175' ' ' LEU . 19.6 Cg_endo -60.75 -31.19 91.61 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.426 1.417 . . . . 63.119999999999997 111.856 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -72.15 -45.77 59.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.539 . . . . 50.009999999999998 111.266 -178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 182' ' ' GLU . 1.2 pp0? -67.77 -20.92 65.27 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.145 0.498 . . . . 51.149999999999999 110.542 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.616 ' HA ' ' CE1' ' A' ' 189' ' ' HIS . 0.9 OUTLIER -67.48 -46.94 71.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 71.349999999999994 109.873 171.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 56.2 m -62.35 -33.52 74.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 63.439999999999998 111.143 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 184' ' ' ALA . 94.6 t -54.45 -38.47 41.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 74.120000000000005 111.426 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.616 ' CE1' ' HA ' ' A' ' 186' ' ' ASN . 10.2 p-80 -100.22 9.04 43.35 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.554 -0.459 . . . . 74.540000000000006 110.947 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.51 -34.17 18.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.302 -0.408 . . . . 64.019999999999996 109.946 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 38.7 m95 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.554 -0.748 . . . . 60.100000000000001 110.309 174.923 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.065 -0.346 . . . . 71.230000000000004 110.065 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.28 77.23 0.33 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.663 -0.698 . . . . 55.149999999999999 111.907 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.7 pm0 -91.72 140.91 25.19 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.002 -0.544 . . . . 64.120000000000005 109.961 173.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 15.7 Cg_exo -68.39 111.01 2.4 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.816 2.344 . . . . 72.0 112.246 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.21 153.0 42.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.175 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.29 115.37 27.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.049 0.452 . . . . 64.200000000000003 110.881 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.46 ' HB ' ' HG ' ' A' ' 62' ' ' LEU . 50.3 t -105.53 116.44 49.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.258 -0.645 . . . . 61.340000000000003 109.258 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.823 ' HB ' HG22 ' A' ' 92' ' ' VAL . 45.8 t -102.19 122.5 54.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.877 0.37 . . . . 61.119999999999997 110.81 -176.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.603 ' O ' ' HD2' ' A' ' 65' ' ' PRO . . . -103.63 122.1 7.31 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.537 -0.839 . . . . 75.519999999999996 111.698 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.18 116.69 19.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.948 0.404 . . . . 65.109999999999999 110.44 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.459 ' C ' HD22 ' A' ' 12' ' ' ASN . . . -129.94 145.67 16.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.168 -0.773 . . . . 72.540000000000006 111.168 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.459 HD22 ' C ' ' A' ' 11' ' ' GLY . 1.2 m120 -124.58 73.75 61.93 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.915 0.357 . . . . 73.049999999999997 110.914 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.76 109.45 1.07 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.601 2.201 . . . . 65.129999999999995 112.471 176.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.43 ' HA3' ' HB2' ' A' ' 17' ' ' TYR . . . -146.9 172.28 27.42 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.399 -0.68 . . . . 64.409999999999997 111.399 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.48 -53.25 7.33 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.257 2.638 . . . . 72.310000000000002 112.304 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 m -112.03 -10.41 13.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.601 0.715 . . . . 43.210000000000001 109.67 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.727 ' HE1' ' HB3' ' A' ' 151' ' ' LEU . 93.0 m-85 -81.37 -17.12 50.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.389 -0.823 . . . . 73.540000000000006 111.458 -174.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.659 ' HA ' HD21 ' A' ' 23' ' ' ASN . . . -79.54 1.38 26.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.042 0.449 . . . . 70.400000000000006 110.711 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -118.58 18.23 13.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.663 -0.699 . . . . 65.349999999999994 109.955 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -103.44 -169.85 1.7 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.277 0.561 . . . . 62.119999999999997 111.137 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -86.81 -0.23 56.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.743 -0.662 . . . . 65.230000000000004 110.208 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . 2.8 m170 -89.6 11.37 19.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 111.928 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.659 HD21 ' HA ' ' A' ' 18' ' ' ALA . 13.5 m120 -109.87 20.1 18.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.806 -0.179 . . . . 54.130000000000003 111.124 -175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.607 ' H ' HD12 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -50.0 -48.91 52.24 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.487 0.492 . . . . 62.43 111.933 -173.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.05 -58.74 8.28 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.665 -0.698 . . . . 63.310000000000002 114.39 -171.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 23' ' ' ASN . 49.2 p90 -86.23 -22.6 26.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.336 0.568 . . . . 72.010000000000005 111.863 -174.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 23.1 mmt -71.25 -42.18 69.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.8 0.333 . . . . 73.310000000000002 111.121 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.3 t -80.04 -41.52 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.733 0.301 . . . . 72.140000000000001 111.026 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.58 -28.02 69.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.378 -0.374 . . . . 74.310000000000002 111.521 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 40' ' ' PHE . 17.0 t70 -56.52 -50.17 72.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 60.229999999999997 111.312 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 m -75.97 -33.18 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 112.333 0.494 . . . . 75.230000000000004 112.333 -173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.4 pp -78.67 -35.9 44.53 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.512 -0.475 . . . . 72.510000000000005 111.095 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -71.3 -36.68 71.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 64.200000000000003 110.247 178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.52 -30.43 74.47 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.847 -0.692 . . . . 72.430000000000007 112.845 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -83.96 -37.38 22.34 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.422 0.527 . . . . 74.409999999999997 112.422 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.2 tp -72.7 -15.22 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.256 0.55 . . . . 74.25 110.581 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.51 59.98 0.96 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.661 -0.975 . . . . 53.450000000000003 110.661 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.9 m -142.55 128.81 19.89 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.118 0.485 . . . . 51.409999999999997 111.349 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -108.14 150.72 26.85 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.808 -0.633 . . . . 43.200000000000003 109.971 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 30' ' ' ASP . 89.1 m-85 -89.44 139.56 30.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.703 0.287 . . . . 74.530000000000001 110.613 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 41' ' ' LYS . 11.6 mptt -110.57 135.82 50.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.274 -0.421 . . . . 65.519999999999996 110.004 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 48' ' ' ALA . 56.2 t -100.19 106.39 19.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.923 -0.58 . . . . 53.210000000000001 110.407 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -116.95 77.1 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.26 -0.644 . . . . 75.200000000000003 109.26 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 96.6 mttt -55.56 105.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.334 -0.848 . . . . 73.400000000000006 112.638 -171.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 32.1 ttmt 168.29 -88.99 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 124.471 1.107 . . . . 73.519999999999996 108.694 174.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 m -106.05 -14.98 15.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.409 0.623 . . . . 72.439999999999998 109.985 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.85 43.01 1.6 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.29 -0.868 . . . . 52.32 112.193 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 42' ' ' VAL . . . -51.45 -45.44 62.7 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.708 0.262 . . . . 71.439999999999998 111.708 -171.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.696 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 40.2 mt-10 -130.09 116.44 18.52 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.755 -0.461 . . . . 74.239999999999995 109.755 171.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.55 135.64 46.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.084 0.468 . . . . 73.040000000000006 111.154 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 62' ' ' LEU . 8.3 p -128.59 133.39 66.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.959 -0.564 . . . . 61.409999999999997 110.334 172.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.589 HG22 HG22 ' A' ' 61' ' ' VAL . 68.4 p -105.0 107.57 18.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.036 0.446 . . . . 53.310000000000002 110.361 174.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -128.11 158.48 21.53 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.074 -0.81 . . . . 31.120000000000001 111.074 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 29.1 ptt180 -120.66 104.98 10.35 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.42 0.628 . . . . 73.450000000000003 111.614 -177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.834 HD13 ' HA ' ' A' ' 174' ' ' GLU . 1.6 pp -104.22 146.72 28.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.524 -0.762 . . . . 72.319999999999993 109.241 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 71.05 -32.44 0.25 Allowed 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.608 0.567 . . . . 63.409999999999997 111.991 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 154.5 -40.89 0.63 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.166 -0.54 . . . . 60.329999999999998 112.191 178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.7 m -89.4 137.17 32.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.831 0.348 . . . . 63.420000000000002 111.098 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 23.0 t -81.79 129.83 34.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.347 -0.388 . . . . 54.530000000000001 110.23 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.15 163.88 18.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.226 -0.443 . . . . 74.409999999999997 110.375 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 52' ' ' THR . 57.9 t -107.54 112.4 39.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.367 -0.379 . . . . 73.409999999999997 110.296 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.464 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . 5.6 mp -95.36 111.95 23.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.645 -0.502 . . . . 72.030000000000001 109.645 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.7 135.67 50.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.945 -0.57 . . . . 42.009999999999998 110.609 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.696 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -123.71 117.37 27.54 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.047 -0.524 . . . . 74.040000000000006 110.073 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' A' ' 9' ' ' GLY . 29.0 Cg_endo -65.8 122.77 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.922 1.748 . . . . 73.310000000000002 110.795 171.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -95.67 9.2 41.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.029 0.919 . . . . 71.439999999999998 108.528 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.46 ' HB3' ' OE1' ' A' ' 71' ' ' GLU . 43.2 m -100.84 179.82 4.28 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.093 -1.412 . . . . 64.120000000000005 109.006 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -74.13 162.02 29.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.441 -0.345 . . . . 70.310000000000002 110.47 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.444 ' HG3' ' OD1' ' A' ' 116' ' ' ASN . 26.8 ptt? -59.57 -24.8 64.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.357 -0.383 . . . . 74.420000000000002 111.298 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.53 -35.15 73.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.225 0.536 . . . . 72.040000000000006 110.56 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.46 ' OE1' ' HB3' ' A' ' 67' ' ' CYS . 29.2 mt-10 -98.07 -2.46 40.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.615 -0.72 . . . . 72.140000000000001 111.189 -173.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.7 t -60.12 -43.08 95.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.435 -0.348 . . . . 70.549999999999997 111.496 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' HA2' HG22 ' A' ' 121' ' ' VAL . . . -63.02 -20.69 62.81 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.947 -0.644 . . . . 74.519999999999996 112.846 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.502 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 3.1 mpt_? -86.29 -12.22 50.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.795 0.331 . . . . 73.519999999999996 110.837 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.812 HE21 ' HA ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -86.69 -47.32 9.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.245 -0.434 . . . . 71.310000000000002 110.936 -178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.69 -42.69 97.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.792 -0.64 . . . . 72.219999999999999 111.942 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.73 -67.3 1.98 Allowed Glycine 0 CA--C 1.523 0.544 0 CA-C-N 115.982 -0.554 . . . . 42.100000000000001 114.097 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.01 -36.98 79.94 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.604 2.203 . . . . 75.420000000000002 112.838 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.38 -43.73 98.13 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.272 -0.422 . . . . 72.319999999999993 110.471 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.52 -37.31 75.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 43.109999999999999 111.309 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.83 -34.09 74.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 64.530000000000001 111.523 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -62.2 -41.85 98.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.827 0.346 . . . . 53.140000000000001 111.291 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -98.17 3.89 49.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.488 -0.324 . . . . 73.140000000000001 111.5 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t 58.34 39.47 25.41 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.017 -0.538 . . . . 53.350000000000001 110.82 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.478 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 18.3 m -108.69 134.64 20.23 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.101 -0.5 . . . . 53.329999999999998 110.579 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 13.0 Cg_exo -69.93 122.5 9.13 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.74 2.294 . . . . 44.43 111.939 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -78.49 18.32 0.97 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.965 2.443 . . . . 73.230000000000004 112.5 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -81.59 -61.89 1.8 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.314 0.578 . . . . 50.25 110.145 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -87.71 68.95 9.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.616 -0.72 . . . . 54.030000000000001 110.085 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.5 pt -115.2 150.56 17.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.904 -0.589 . . . . 60.210000000000001 110.958 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 m -112.6 127.99 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 62.439999999999998 110.387 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.823 HG22 ' HB ' ' A' ' 8' ' ' VAL . 47.4 t -124.53 121.49 61.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 110.377 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.474 ' CG2' ' HA2' ' A' ' 9' ' ' GLY . 7.2 tt -84.31 123.13 38.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.751 0.31 . . . . 64.230000000000004 110.207 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -153.76 150.08 28.13 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.892 0.377 . . . . 71.040000000000006 111.009 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.461 ' HB3' HD21 ' A' ' 24' ' ' LEU . 9.9 p-10 -84.68 141.29 30.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.72 -0.673 . . . . 70.030000000000001 110.592 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 112' ' ' GLU . 53.3 mm-40 -148.7 155.8 41.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.197 0.523 . . . . 75.409999999999997 111.63 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.29 2.12 37.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.232 -0.894 . . . . 65.219999999999999 111.881 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -49.35 -44.84 45.02 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.556 0.535 . . . . 64.430000000000007 111.355 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.81 HD12 ' HG2' ' A' ' 103' ' ' ARG . 7.6 pt -139.13 173.85 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.31 -0.405 . . . . 74.439999999999998 110.847 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.411 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 0.8 OUTLIER -75.78 163.22 27.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.182 -0.463 . . . . 54.149999999999999 111.08 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.669 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 4.3 t80 -70.79 126.64 30.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.054 -0.521 . . . . 75.329999999999998 110.521 -176.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 161' ' ' GLU . . . 145.72 -45.37 0.82 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.572 -0.611 . . . . 72.219999999999999 111.572 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.81 ' HG2' HD12 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -119.98 160.49 22.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.512 -0.551 . . . . 74.310000000000002 109.512 178.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 135' ' ' ILE . 39.8 pt -127.67 157.29 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.809 0.338 . . . . 74.120000000000005 111.189 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -130.71 125.1 33.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.048 -0.523 . . . . 75.409999999999997 110.591 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.676 HD12 ' HE1' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -101.24 111.51 23.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.424 -0.584 . . . . 71.329999999999998 109.424 175.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.678 ' HD3' ' HD2' ' A' ' 134' ' ' ARG . 16.0 ptmt -143.61 153.57 42.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.472 -0.786 . . . . 74.25 110.445 -169.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -100.24 114.06 27.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.595 0.712 . . . . 75.109999999999999 110.825 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.53 178.86 38.9 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.861 -0.895 . . . . 75.239999999999995 110.861 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.548 ' HA2' HD13 ' A' ' 118' ' ' LEU . . . -166.81 86.56 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.047 -1.073 . . . . 71.140000000000001 113.593 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.4 74.94 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.934 -0.65 . . . . 42.030000000000001 111.942 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.527 ' HB2' ' OE1' ' A' ' 96' ' ' GLU . 3.3 mp0 -143.53 -82.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.554 0.216 . . . . 74.400000000000006 111.027 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -104.73 -69.67 0.77 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.706 -0.759 . . . . 42.219999999999999 113.046 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.21 69.14 3.32 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.026 -0.607 . . . . 70.200000000000003 112.054 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -55.72 -48.04 75.85 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.746 0.276 . . . . 75.329999999999998 111.746 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.444 ' OD1' ' HG3' ' A' ' 69' ' ' MET . 24.8 t-20 -61.58 -45.01 95.94 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.729 0.27 . . . . 71.120000000000005 111.729 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.54 -23.73 72.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.733 -0.746 . . . . 44.539999999999999 112.405 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.548 HD13 ' HA2' ' A' ' 110' ' ' GLY . 46.1 mt -83.23 -45.87 13.34 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.211 0.529 . . . . 73.319999999999993 109.693 174.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -65.35 -44.77 86.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.207 -0.906 . . . . 63.439999999999998 111.821 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.5 t -52.41 -47.21 66.43 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.938 0.399 . . . . 75.299999999999997 111.098 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.668 ' HB ' HH22 ' A' ' 132' ' ' ARG . 36.5 t -78.18 -44.28 27.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.262 -0.426 . . . . 75.099999999999994 110.928 -177.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.58 98.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.293 -0.412 . . . . 74.129999999999995 111.539 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.5 t -73.61 -30.28 62.89 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.261 -0.427 . . . . 70.439999999999998 110.711 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.47 -42.27 68.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 74.329999999999998 110.519 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.2 mt -76.68 -21.36 55.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 74.219999999999999 110.258 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 79.72 13.52 82.27 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.902 -0.59 . . . . 64.430000000000007 112.043 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.8 t -165.0 169.53 16.27 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.858 -0.423 . . . . 73.340000000000003 109.858 -176.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -96.72 -106.51 0.16 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.733 -0.469 . . . . 75.340000000000003 109.733 177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 67.56 -10.33 0.38 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.119 0.785 . . . . 72.129999999999995 113.119 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -76.57 129.27 36.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.361 0.6 . . . . 75.340000000000003 111.464 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.676 ' HE1' HD12 ' A' ' 106' ' ' LEU . 51.2 t-80 -98.96 87.0 3.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.881 -0.599 . . . . 61.409999999999997 109.734 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.668 HH22 ' HB ' ' A' ' 121' ' ' VAL . 93.5 mtt180 -90.48 156.06 18.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.986 -0.552 . . . . 71.310000000000002 111.389 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 106' ' ' LEU . 46.1 t -99.79 112.14 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.729 -0.668 . . . . 64.030000000000001 109.581 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.678 ' HD2' ' HD3' ' A' ' 107' ' ' LYS . 70.3 mtt85 -94.15 114.2 26.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.033 -0.531 . . . . 60.299999999999997 110.925 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.673 ' HA ' HG22 ' A' ' 104' ' ' ILE . 2.0 mp -83.26 118.22 30.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 108.708 -0.849 . . . . 65.5 108.708 173.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.669 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -66.87 118.65 10.75 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.626 -0.797 . . . . 74.239999999999995 111.627 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.577 ' HA ' ' HD2' ' A' ' 101' ' ' PHE . 35.0 m -109.9 1.13 9.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.145 0.497 . . . . 71.120000000000005 110.556 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 86.48 175.16 49.58 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.827 -0.701 . . . . 74.25 111.972 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.06 104.3 54.63 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.168 -0.308 . . . . 75.420000000000002 110.168 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 72.0 Cg_exo -50.05 114.61 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.068 2.512 . . . . 63.439999999999998 112.085 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 12.0 Cg_exo -70.34 127.96 14.85 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.869 2.379 . . . . 74.310000000000002 112.16 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 172.05 175.79 40.46 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.127 -0.789 . . . . 73.140000000000001 111.127 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -94.92 -6.69 42.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.441 0.639 . . . . 75.420000000000002 109.781 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -101.03 159.82 14.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.575 -0.739 . . . . 75.230000000000004 109.265 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.42 139.56 94.55 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.012 -0.366 . . . . 75.219999999999999 110.012 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.526 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 92.7 Cg_exo -47.65 -19.39 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.664 2.909 . . . . 64.109999999999999 113.722 177.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -47.19 -40.42 16.02 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.024 0.53 . . . . 55.439999999999998 112.029 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.64 -31.37 41.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.41 -0.359 . . . . 72.420000000000002 111.674 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.526 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 77.2 m-85 -84.07 -31.94 25.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.274 -0.421 . . . . 71.5 111.624 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.04 -4.81 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.049 0.452 . . . . 74.310000000000002 111.805 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.727 ' HB3' ' HE1' ' A' ' 17' ' ' TYR . 90.5 mt -86.91 -12.5 47.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.453 -0.34 . . . . 61.5 111.266 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -160.89 107.64 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.203 0.525 . . . . 75.329999999999998 110.068 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -131.81 148.96 52.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.077 -0.511 . . . . 74.319999999999993 110.378 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -146.47 35.88 0.97 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.402 0.62 . . . . 73.140000000000001 109.999 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.646 ' O ' ' HG2' ' A' ' 158' ' ' GLU . 84.8 m -86.23 115.25 23.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.701 -0.682 . . . . 62.229999999999997 110.418 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.96 -20.85 59.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 111.89 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.43 ' H ' HG22 ' A' ' 155' ' ' THR . . . -66.04 -30.24 70.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 44.420000000000002 111.813 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.646 ' HG2' ' O ' ' A' ' 155' ' ' THR . 15.2 pt-20 -71.4 -21.95 61.93 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.263 0.554 . . . . 65.409999999999997 110.446 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.512 ' HA ' HG23 ' A' ' 162' ' ' VAL . 16.3 mmm-85 -78.18 -25.19 47.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.653 -0.703 . . . . 63.409999999999997 110.655 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -63.54 -35.36 80.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.691 . . . . 72.219999999999999 112.102 -174.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.639 ' HB2' ' HD1' ' A' ' 101' ' ' PHE . 6.0 mm-40 -105.38 7.78 33.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.072 0.397 . . . . 65.120000000000005 112.072 -175.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.522 ' N ' ' HD2' ' A' ' 163' ' ' PRO . 70.3 t -57.35 -52.38 74.66 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.669 -0.205 . . . . 73.120000000000005 111.084 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 13.7 Cg_endo -57.28 -33.62 96.4 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.108 1.872 . . . . 70.219999999999999 112.187 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.5 m -64.96 -43.42 92.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.937 -0.574 . . . . 75.319999999999993 110.61 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.3 -38.59 82.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.42 . . . . 74.209999999999994 110.763 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 162' ' ' VAL . 91.7 t -57.31 -54.04 35.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.553 -0.294 . . . . 73.340000000000003 111.205 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -61.19 -42.09 97.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.369 -0.378 . . . . 75.219999999999999 111.517 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.598 ' NE2' ' HB2' ' A' ' 191' ' ' TRP . 13.8 mm-40 -66.26 -49.52 66.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.482 -0.326 . . . . 74.230000000000004 111.314 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.0 96.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.448 -0.342 . . . . 74.219999999999999 111.593 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.5 -34.93 79.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.798 0.332 . . . . 62.009999999999998 111.553 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -80.63 -43.85 19.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.946 0.403 . . . . 75.239999999999995 110.794 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.27 -39.21 92.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.995 -0.548 . . . . 61.539999999999999 111.894 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.8 p -65.01 -38.86 92.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.744 0.307 . . . . 72.019999999999996 111.45 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.834 ' HA ' HD13 ' A' ' 55' ' ' LEU . 41.6 tt0 -73.55 -44.21 57.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.39 -0.368 . . . . 73.239999999999995 110.629 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 178' ' ' ALA . 44.5 tp -64.73 -27.93 69.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.492 -0.322 . . . . 53.210000000000001 111.023 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.0 tp -57.24 -45.63 83.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.867 -0.606 . . . . 73.450000000000003 110.766 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.58 -32.4 14.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.012 -0.54 . . . . 74.120000000000005 110.305 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 175' ' ' LEU . . . -61.52 -48.04 82.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.722 -0.672 . . . . 51.310000000000002 111.82 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -129.11 -67.72 0.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.077 -0.249 . . . . 74.239999999999995 111.381 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.64 -170.01 37.99 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.379 -0.915 . . . . 43.119999999999997 112.41 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.772 HD23 ' H ' ' A' ' 181' ' ' LEU . 1.8 pt? -81.82 -35.71 29.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.312 0.066 . . . . 73.510000000000005 110.98 -177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.587 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 4.9 mm-40 -54.46 -56.67 24.29 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 112.278 0.473 . . . . 61.200000000000003 112.278 -178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 50.1 Cg_exo -56.26 -34.48 93.75 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.807 1.671 . . . . 73.420000000000002 112.138 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.96 -55.01 9.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.996 -0.547 . . . . 71.299999999999997 111.453 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 181' ' ' LEU . 11.6 pt20 -69.38 -21.41 63.8 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 111.718 0.266 . . . . 51.310000000000002 111.718 -177.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.51 -38.22 68.17 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.705 -0.398 . . . . 73.049999999999997 110.662 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 85.0 m -66.96 -44.27 80.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 55.310000000000002 111.489 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 185' ' ' GLN . 32.6 m -70.4 -16.82 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.43 . . . . 74.310000000000002 111.249 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -94.17 -13.5 26.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 61.32 110.034 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -93.27 -33.33 13.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.54 . . . . 71.540000000000006 110.848 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.598 ' HB2' ' NE2' ' A' ' 168' ' ' GLN . 76.6 m95 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.526 -0.75 . . . . 73.310000000000002 109.552 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.006 -0.368 . . . . 72.340000000000003 110.006 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.46 80.11 0.24 Allowed 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.787 0.68 . . . . 72.25 110.54 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.24 145.78 41.04 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.609 -0.723 . . . . 75.120000000000005 109.746 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.531 ' HB3' HG23 ' A' ' 61' ' ' VAL . 51.4 Cg_exo -54.88 123.64 14.26 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.118 2.546 . . . . 75.120000000000005 112.927 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.863 HD12 ' HG2' ' A' ' 89' ' ' GLN . 2.1 mm? -84.44 133.02 34.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.45 -0.574 . . . . 62.25 109.45 177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.53 HD23 HD13 ' A' ' 90' ' ' ILE . 59.2 tp -93.6 117.53 30.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.015 0.436 . . . . 72.150000000000006 111.156 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.98 118.78 59.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.536 -0.756 . . . . 75.099999999999994 109.589 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.615 HG12 ' HB3' ' A' ' 63' ' ' ALA . 29.4 m -122.01 155.82 26.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.986 0.422 . . . . 52.229999999999997 111.022 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.97 163.95 30.27 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.797 -0.716 . . . . 61.539999999999999 111.983 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.718 HD21 ' HA ' ' A' ' 69' ' ' MET . 2.5 mt -68.92 106.4 2.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.914 0.388 . . . . 65.150000000000006 110.898 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.684 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -77.75 -141.57 1.61 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.823 -0.626 . . . . 63.140000000000001 112.253 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -97.78 99.71 7.19 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.067 0.46 . . . . 73.420000000000002 110.671 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.763 ' HB3' ' HA ' ' A' ' 68' ' ' TYR . 5.5 Cg_exo -78.77 -8.19 15.7 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.359 2.706 . . . . 51.420000000000002 112.887 -176.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.95 173.3 23.58 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.694 -0.765 . . . . 74.239999999999995 112.131 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.93 -54.8 2.4 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.032 2.488 . . . . 72.200000000000003 112.419 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 m -59.75 -35.62 74.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 73.140000000000001 111.601 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -74.89 -17.18 60.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.264 -0.426 . . . . 71.239999999999995 111.296 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.42 -7.49 51.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.004 0.431 . . . . 43.100000000000001 110.861 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.41 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 3.8 mptp? -92.96 -10.22 37.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 63.399999999999999 110.263 177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.75 HG22 ' H ' ' A' ' 153' ' ' ASN . 36.5 p -102.71 -169.38 1.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 63.340000000000003 110.741 -175.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.74 ' HG3' HD23 ' A' ' 24' ' ' LEU . 1.3 tpp180 -92.12 1.78 56.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.035 0.445 . . . . 75.239999999999995 110.123 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.461 ' CE1' HG22 ' A' ' 150' ' ' VAL . 30.8 m80 -76.8 11.36 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.26 0.467 . . . . 54.520000000000003 112.26 -174.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -123.43 20.23 9.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.953 0.406 . . . . 55.350000000000001 110.144 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.753 HD13 HG12 ' A' ' 93' ' ' ILE . 1.1 pp -61.54 -24.26 66.51 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.982 -0.554 . . . . 74.319999999999993 111.968 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.606 ' N ' HD12 ' A' ' 24' ' ' LEU . . . -69.47 -47.96 47.3 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.995 -0.842 . . . . 73.549999999999997 110.995 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.684 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 88.8 t80 -61.05 -36.02 78.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.838 0.351 . . . . 61.130000000000003 110.217 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 61.8 mtt -61.34 -49.6 76.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.882 -0.599 . . . . 74.430000000000007 111.668 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.11 -47.67 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.056 0.391 . . . . 73.200000000000003 112.056 -174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.769 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -63.09 -38.87 92.91 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.405 0.521 . . . . 72.549999999999997 112.405 -171.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -69.65 -41.86 75.0 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.994 0.426 . . . . 75.430000000000007 111.125 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 22.9 m -79.65 -26.61 12.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.602 0.593 . . . . 73.409999999999997 112.602 -172.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -67.66 -28.28 67.57 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.892 -0.323 . . . . 72.5 111.214 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 38' ' ' SER . . . -69.46 -41.96 75.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.143 0.496 . . . . 51.229999999999997 110.699 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.7 -18.13 71.83 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.003 -0.618 . . . . 63.420000000000002 112.86 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 8.2 mmt180 -61.17 -46.46 90.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.125 0.417 . . . . 73.239999999999995 112.125 -175.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 36' ' ' ILE . 4.2 mp -73.23 -15.76 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.455 0.645 . . . . 73.530000000000001 110.407 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.99 12.92 26.53 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 110.765 -0.934 . . . . 43.039999999999999 110.765 -173.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 66.3 m -86.23 147.67 26.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.002 -0.599 . . . . 63.200000000000003 110.434 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.77 127.99 52.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.298 -0.41 . . . . 73.099999999999994 110.305 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -85.66 151.45 23.87 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.331 -0.618 . . . . 74.409999999999997 109.331 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -155.15 168.24 27.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.096 0.474 . . . . 73.349999999999994 110.914 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 5.1 p -84.16 117.77 30.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.71 -0.677 . . . . 75.530000000000001 109.766 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 5.8 t-80 -103.37 110.68 22.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.569 -0.9 . . . . 63.140000000000001 108.569 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -68.83 83.56 0.3 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.051 -0.522 . . . . 65.340000000000003 110.181 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.823 ' HE3' ' HB3' ' A' ' 82' ' ' PHE . 28.2 tptt -105.19 -95.13 0.34 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.909 -0.587 . . . . 74.010000000000005 109.513 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.534 ' HB3' ' CE2' ' A' ' 82' ' ' PHE . 9.6 p -108.16 -42.06 4.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 118.661 -1.216 . . . . 53.030000000000001 113.233 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.23 -25.62 0.46 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 118.544 -1.788 . . . . 42.399999999999999 117.025 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 64' ' ' LYS . . . -139.76 -176.75 4.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 114.829 1.418 . . . . 72.5 114.829 -156.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 34.4 mt-10 -76.18 143.05 41.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.413 -1.267 . . . . 65.340000000000003 109.407 173.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 43' ' ' HIS . 93.8 t -142.8 133.19 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.993 -0.373 . . . . 74.409999999999997 109.993 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 62' ' ' LEU . 3.2 p -125.08 125.3 69.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.507 -0.553 . . . . 72.010000000000005 109.507 172.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -103.24 121.1 42.01 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.244 0.545 . . . . 62.509999999999998 110.035 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.01 157.58 23.47 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.215 -0.754 . . . . 70.219999999999999 111.215 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 7.0 ptt180 -109.98 103.42 12.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.511 0.672 . . . . 75.230000000000004 110.915 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.774 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 3.1 pp -113.06 151.81 30.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.091 -0.959 . . . . 61.439999999999998 109.153 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 67.28 -57.85 0.43 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.831 0.707 . . . . 73.430000000000007 110.993 -172.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.84 -38.67 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.146 -0.549 . . . . 60.420000000000002 112.273 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.6 m -93.45 140.66 29.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.76 0.314 . . . . 61.140000000000001 110.867 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 25.9 m -77.64 121.63 24.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.352 -0.385 . . . . 72.019999999999996 110.066 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.3 171.7 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.899 0.38 . . . . 44.25 111.408 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 4' ' ' PRO . 77.6 t -117.82 111.57 35.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.828 -0.624 . . . . 72.530000000000001 110.137 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.769 HD11 ' HB1' ' A' ' 29' ' ' ALA . 3.0 tm? -98.68 119.88 38.16 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.18 -0.674 . . . . 71.019999999999996 109.18 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.615 ' HB3' HG12 ' A' ' 8' ' ' VAL . . . -108.85 137.87 46.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.347 -0.388 . . . . 64.439999999999998 110.922 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 54.6 mtpt -114.0 92.61 26.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.998 -0.546 . . . . 75.319999999999993 110.957 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.4 138.79 51.91 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.863 2.376 . . . . 54.140000000000001 112.184 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -109.73 16.81 21.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.506 0.669 . . . . 64.200000000000003 109.351 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 59.7 m -114.8 179.99 3.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.333 -0.848 . . . . 74.299999999999997 111.231 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.763 ' HA ' ' HB3' ' A' ' 13' ' ' PRO . 97.7 m-85 -70.25 175.54 4.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.609 . . . . 71.040000000000006 112.031 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.718 ' HA ' HD21 ' A' ' 10' ' ' LEU . 27.3 ptt? -67.46 -31.06 70.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.752 -0.658 . . . . 62.140000000000001 112.344 -173.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -72.2 -30.76 65.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.44 0.638 . . . . 44.310000000000002 109.96 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 51.2 mm-40 -80.2 -22.27 42.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.528 -0.76 . . . . 71.319999999999993 111.355 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.0 p -56.3 -45.23 80.33 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.216 0.322 . . . . 72.030000000000001 111.467 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 121' ' ' VAL . . . -73.88 -28.15 65.4 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.665 -0.779 . . . . 74.299999999999997 112.257 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -78.73 -11.32 59.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.859 0.362 . . . . 73.340000000000003 110.612 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 31.0 mm-40 -65.5 -30.27 71.02 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.101 0.477 . . . . 63.25 110.021 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.5 t -67.47 -21.73 27.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.467 -0.788 . . . . 75.430000000000007 110.897 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.54 -72.28 0.55 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 116.018 -0.537 . . . . 55.240000000000002 112.879 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.95 -30.2 48.59 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.442 2.095 . . . . 54.32 112.037 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.493 HD12 HD22 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -59.28 -40.36 85.87 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.748 -0.66 . . . . 62.240000000000002 110.689 -176.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.97 -30.89 70.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 64.010000000000005 112.108 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.26 -41.21 34.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 55.299999999999997 111.131 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.823 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 55.2 m-85 -71.63 -43.08 66.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.491 0.552 . . . . 74.040000000000006 112.491 -172.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.609 ' CE1' ' HG2' ' A' ' 45' ' ' LYS . 95.3 m-85 -97.68 -16.88 19.76 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.739 -0.384 . . . . 74.540000000000006 111.201 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 t 63.96 33.46 12.34 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.199 0.523 . . . . 75.510000000000005 110.382 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.511 HG21 HD22 ' A' ' 6' ' ' LEU . 25.7 m -69.0 149.7 97.77 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.472 -0.786 . . . . 75.430000000000007 111.362 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.84 117.01 4.28 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.745 2.296 . . . . 53.32 112.402 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.91 -1.87 10.11 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.032 2.488 . . . . 50.130000000000003 112.633 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -95.32 -25.47 16.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.127 -0.488 . . . . 55.43 110.342 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.863 ' HG2' HD12 ' A' ' 5' ' ' LEU . 7.5 tp60 -92.57 -11.05 35.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.804 -0.635 . . . . 72.420000000000002 111.106 -174.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.53 HD13 HD23 ' A' ' 6' ' ' LEU . 5.3 tp -52.62 113.73 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.729 0.776 . . . . 70.510000000000005 111.776 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 9.3 p -116.76 138.79 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.301 -0.863 . . . . 63.100000000000001 110.147 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 7.7 p -132.6 134.06 59.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.151 -0.477 . . . . 74.299999999999997 110.67 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.753 HG12 HD13 ' A' ' 24' ' ' LEU . 7.7 tt -89.9 124.53 42.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.827 -0.624 . . . . 65.239999999999995 109.967 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -140.53 162.12 36.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.889 0.376 . . . . 71.040000000000006 110.767 -175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.53 153.01 23.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.719 -0.673 . . . . 74.310000000000002 110.252 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.937 ' HG3' ' HD2' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -140.84 121.35 14.14 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.938 0.399 . . . . 65.310000000000002 111.41 -178.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.803 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.8 pt? -84.91 -12.24 53.83 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.67 -0.696 . . . . 71.129999999999995 110.765 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.64 -39.17 93.0 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.151 0.501 . . . . 65.310000000000002 110.108 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.631 HG13 ' HA2' ' A' ' 136' ' ' GLY . 2.8 pt -104.81 154.11 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.634 -0.712 . . . . 74.439999999999998 110.052 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.597 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 6.9 p-10 -88.37 -170.09 2.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.102 0.477 . . . . 75.219999999999999 112.018 -171.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.792 ' HD2' ' HB3' ' A' ' 158' ' ' GLU . 68.1 m-85 -62.97 119.65 9.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.363 -0.835 . . . . 72.230000000000004 112.526 -168.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.69 -0.16 82.39 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.813 -0.708 . . . . 65.510000000000005 113.363 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.512 ' O ' HD12 ' A' ' 99' ' ' ILE . 33.0 mmt180 -88.94 96.09 10.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 117.069 0.434 . . . . 74.25 110.192 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.716 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -103.34 137.35 32.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.92 0.39 . . . . 62.130000000000003 110.666 -179.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 105' ' ' ARG . 52.0 mtt180 -145.61 125.74 13.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.997 -0.547 . . . . 74.329999999999998 110.062 176.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -100.21 130.22 46.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.342 -0.614 . . . . 75.409999999999997 109.342 172.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.535 ' HA ' HD13 ' A' ' 181' ' ' LEU . 1.5 tmtm? -155.41 154.2 31.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.266 0.555 . . . . 70.540000000000006 111.637 -171.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.474 HD23 HD11 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -83.95 92.95 7.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.343 0.592 . . . . 75.150000000000006 109.561 171.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 166.04 176.58 37.46 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.623 -0.717 . . . . 55.130000000000003 111.435 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.79 170.41 27.91 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.615 -0.802 . . . . 75.150000000000006 112.673 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.2 -169.19 34.68 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.447 -0.661 . . . . 51.049999999999997 111.447 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -134.26 -11.73 2.49 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.754 -0.379 . . . . 70.120000000000005 110.781 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -108.31 138.91 14.91 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.72 -0.752 . . . . 74.340000000000003 111.354 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.13 56.32 18.83 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.578 -0.82 . . . . 72.430000000000007 111.773 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -53.74 -38.93 64.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.06 0.393 . . . . 70.420000000000002 112.06 -174.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -58.24 -53.72 55.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.724 0.297 . . . . 43.219999999999999 111.274 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.65 -28.81 73.95 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.007 -0.616 . . . . 35.009999999999998 112.831 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.1 mt -82.48 -46.12 13.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.654 0.264 . . . . 61.149999999999999 111.488 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -77.56 -21.48 52.45 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.879 -0.328 . . . . 63.329999999999998 110.879 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.1 t -63.27 -37.85 88.87 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.513 -0.551 . . . . 75.400000000000006 109.513 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.498 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 45.2 t -66.79 -31.01 51.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.801 -0.636 . . . . 63.0 110.202 176.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.6 -52.33 10.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.852 -0.613 . . . . 62.399999999999999 111.001 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 62.7 m -66.78 -22.75 66.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 64.409999999999997 111.772 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.32 -54.91 29.57 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 111.872 0.323 . . . . 44.130000000000003 111.872 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.73 ' H ' HD23 ' A' ' 125' ' ' LEU . 2.2 pt? -106.71 -17.73 14.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 75.340000000000003 111.369 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.54 40.24 2.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.242 -0.98 . . . . 64.200000000000003 112.936 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -110.26 171.82 7.23 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.505 -0.554 . . . . 73.230000000000004 109.505 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -114.22 38.88 2.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.488 0.185 . . . . 53.439999999999998 111.127 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 63.38 34.89 12.64 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.373 -0.376 . . . . 61.539999999999999 111.117 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -64.67 -13.11 52.7 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.132 -0.486 . . . . 42.130000000000003 112.303 -173.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 48.1 m80 -146.86 99.29 3.17 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.232 -0.293 . . . . 65.219999999999999 110.366 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.12 143.82 49.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.815 0.341 . . . . 75.140000000000001 110.822 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 34.3 t -116.94 120.59 65.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.812 -0.44 . . . . 72.310000000000002 109.812 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.937 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 44.0 mtm180 -107.32 117.58 34.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.676 0.274 . . . . 64.439999999999998 111.027 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.444 HD13 HG13 ' A' ' 93' ' ' ILE . 1.9 mp -103.51 115.11 44.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.762 -0.459 . . . . 74.519999999999996 109.762 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.631 ' HA2' HG13 ' A' ' 99' ' ' ILE . . . -62.13 113.63 5.98 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.872 -0.604 . . . . 40.450000000000003 112.879 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 p -101.66 -17.22 6.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.226 0.536 . . . . 71.230000000000004 109.648 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 88.49 -171.99 40.57 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.718 -0.753 . . . . 62.149999999999999 111.4 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -135.06 111.96 11.14 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 120.901 0.382 . . . . 73.430000000000007 110.197 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.703 ' HD2' ' HB3' ' A' ' 146' ' ' PRO . 23.8 Cg_exo -63.67 114.99 2.79 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.108 2.539 . . . . 71.239999999999995 112.441 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 2.1 Cg_endo -85.16 139.32 7.08 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.319 2.679 . . . . 63.310000000000002 112.347 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -173.32 -151.91 8.44 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.43 -0.668 . . . . 53.130000000000003 111.43 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.13 -8.17 49.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.449 0.642 . . . . 74.420000000000002 109.688 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.421 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 71.6 mmtt -116.89 156.11 27.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.198 -0.91 . . . . 63.539999999999999 109.795 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.34 143.29 97.27 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.885 -0.598 . . . . 72.209999999999994 110.03 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.703 ' HB3' ' HD2' ' A' ' 140' ' ' PRO . 82.9 Cg_exo -47.0 -26.06 4.57 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.364 2.71 . . . . 62.310000000000002 113.016 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.05 -31.16 39.96 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.956 -0.565 . . . . 71.400000000000006 111.916 176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.13 -50.9 6.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.488 -0.324 . . . . 74.540000000000006 111.422 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 153' ' ' ASN . 74.6 m-85 -64.99 -27.43 68.82 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.201 0.445 . . . . 74.299999999999997 112.201 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.461 HG22 ' CE1' ' A' ' 22' ' ' HIS . 6.2 p -69.36 -9.13 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.889 0.376 . . . . 71.450000000000003 111.558 -174.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.37 -24.5 36.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.603 -0.271 . . . . 71.230000000000004 110.897 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -148.6 87.77 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.842 0.83 . . . . 74.129999999999995 109.647 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.75 ' H ' HG22 ' A' ' 20' ' ' THR . 3.7 t-20 -137.84 122.23 18.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.426 -0.806 . . . . 75.109999999999999 110.77 -174.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -134.35 133.83 41.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.639 -0.71 . . . . 74.430000000000007 109.407 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 157' ' ' ALA . 59.9 m -145.61 134.04 21.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.86 0.362 . . . . 70.510000000000005 110.471 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.04 -31.43 67.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.325 -0.398 . . . . 62.32 111.505 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.571 ' H ' HG22 ' A' ' 155' ' ' THR . . . -59.89 -40.73 89.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 71.549999999999997 111.9 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.792 ' HB3' ' HD2' ' A' ' 101' ' ' PHE . 1.0 OUTLIER -85.14 -17.75 36.29 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.035 -0.266 . . . . 74.340000000000003 111.361 -177.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 155' ' ' THR . 4.7 mmt180 -72.15 -24.62 61.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 72.329999999999998 110.927 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.68 -17.1 61.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 72.040000000000006 111.127 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.45 ' O ' HG13 ' A' ' 165' ' ' ILE . 25.0 mm-40 -92.66 -18.49 22.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 62.43 111.103 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.715 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 67.1 t -55.98 -56.99 24.67 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.594 0.59 . . . . 64.329999999999998 112.594 -174.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.715 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 32.2 Cg_exo -59.12 -30.12 92.34 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.135 1.89 . . . . 53.329999999999998 112.322 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.9 m -67.2 -46.3 74.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.949 -0.569 . . . . 52.340000000000003 110.555 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 161' ' ' GLU . 72.4 mt -70.02 -53.97 21.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.717 -0.674 . . . . 73.299999999999997 111.215 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.78 -57.94 9.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.383 0.512 . . . . 72.439999999999998 112.383 -172.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -62.88 -45.52 92.17 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.874 0.324 . . . . 61.539999999999999 111.874 -174.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -74.32 -32.02 62.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.798 0.295 . . . . 64.349999999999994 111.798 -173.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.29 -25.43 67.86 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.618 0.229 . . . . 65.120000000000005 111.618 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.23 74.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 73.310000000000002 111.289 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -68.4 -43.69 76.69 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.338 0.59 . . . . 61.530000000000001 110.766 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.7 -31.75 69.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.597 -0.729 . . . . 43.329999999999998 111.678 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.1 m -55.72 -43.09 76.19 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.776 0.322 . . . . 74.239999999999995 111.803 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.774 ' HG2' ' HB2' ' A' ' 55' ' ' LEU . 42.6 mt-10 -68.54 -28.65 67.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.754 0.311 . . . . 71.25 111.075 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.05 -25.77 65.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.352 -0.385 . . . . 75.430000000000007 111.051 -175.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.73 -37.81 88.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.188 0.518 . . . . 71.239999999999995 110.278 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.5 mm -80.0 -39.9 20.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.678 -0.692 . . . . 72.209999999999994 110.091 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.49 -56.6 10.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.807 -0.633 . . . . 75.319999999999993 111.448 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -115.57 -77.09 0.57 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.079 -0.509 . . . . 75.340000000000003 110.208 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.32 -171.39 40.02 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.107 -0.797 . . . . 74.540000000000006 111.107 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.535 HD13 ' HA ' ' A' ' 107' ' ' LYS . 4.3 pp -91.13 -18.49 24.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.035 0.418 . . . . 73.219999999999999 110.32 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 33.5 mm-40 -58.63 -51.79 79.3 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.747 -0.66 . . . . 65.549999999999997 111.829 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 37.8 Cg_endo -69.01 -29.81 26.8 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.351 1.367 . . . . 61.520000000000003 112.027 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -71.15 -43.81 66.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 60.109999999999999 111.809 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 11.3 pt20 -58.8 -24.0 61.22 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.779 0.323 . . . . 53.200000000000003 111.303 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -77.65 -57.12 3.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.34 -0.391 . . . . 75.409999999999997 111.298 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -66.95 -31.01 71.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.383 -0.371 . . . . 73.230000000000004 111.876 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 8.1 p -71.42 -29.36 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.055 0.391 . . . . 75.430000000000007 112.055 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -94.03 0.06 55.74 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.46 -0.496 . . . . 55.240000000000002 110.636 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.49 -0.96 54.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 112.018 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 74.3 m95 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.697 -0.668 . . . . 74.349999999999994 110.64 -178.256 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.102 -0.333 . . . . 72.319999999999993 110.102 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.54 178.92 4.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.007 -0.368 . . . . 50.140000000000001 110.007 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 38.2 mt-10 -92.77 142.84 26.11 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.609 -0.269 . . . . 74.400000000000006 110.363 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 59' ' ' SER . 22.6 Cg_exo -64.71 106.4 0.74 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.598 2.199 . . . . 73.450000000000003 111.596 176.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.418 ' HG ' HG12 ' A' ' 60' ' ' VAL . 4.0 pp -89.94 153.77 20.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.304 -0.407 . . . . 55.409999999999997 111.021 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' HB3' HG12 ' A' ' 90' ' ' ILE . 62.9 tp -97.46 124.74 41.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.848 -0.615 . . . . 65.209999999999994 110.5 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.1 t -105.27 119.12 53.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.13 -0.486 . . . . 61.509999999999998 109.77 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.72 117.08 46.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.02 0.438 . . . . 74.329999999999998 110.801 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -127.9 128.72 6.13 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.371 -0.692 . . . . 64.209999999999994 111.371 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -72.56 118.94 16.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.759 -0.46 . . . . 73.450000000000003 109.759 -178.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.94 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -77.12 -158.4 9.21 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.206 -0.452 . . . . 73.549999999999997 113.069 -177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.47 91.36 9.95 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.619 0.723 . . . . 65.209999999999994 111.002 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 11' ' ' GLY . 2.0 Cg_endo -82.92 -8.95 10.96 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.215 2.61 . . . . 72.239999999999995 112.932 -176.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.19 160.92 29.15 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.826 -0.702 . . . . 70.430000000000007 112.229 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.42 -30.59 52.95 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.109 2.539 . . . . 75.140000000000001 112.482 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 p -73.24 -43.61 60.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.987 0.422 . . . . 53.420000000000002 111.2 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -59.89 -40.15 87.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.773 -0.648 . . . . 73.129999999999995 111.51 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.23 -3.71 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 65.510000000000005 111.771 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -111.45 8.29 21.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.352 -0.386 . . . . 72.310000000000002 110.424 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 153' ' ' ASN . 71.4 p -113.65 159.75 19.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.959 0.409 . . . . 61.409999999999997 111.038 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -78.46 -20.16 51.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 62.340000000000003 111.672 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -76.73 -19.7 57.36 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.785 -0.366 . . . . 72.319999999999993 111.476 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 27' ' ' MET . 7.0 m120 -85.08 33.27 0.54 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.227 0.537 . . . . 73.310000000000002 111.042 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 1.3 pp -66.07 -17.26 64.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.552 -0.749 . . . . 74.239999999999995 111.521 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.424 ' N ' HD12 ' A' ' 24' ' ' LEU . . . -59.12 -34.24 78.55 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.195 -0.526 . . . . 61.43 111.962 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.94 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 54.6 t80 -90.11 -53.89 4.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.459 . . . . 75.219999999999999 109.841 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 85.7 mmm -56.89 -38.11 72.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.905 -1.043 . . . . 71.129999999999995 112.554 -169.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 166' ' ' VAL . 62.1 t -88.84 -41.9 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.798 0.332 . . . . 70.140000000000001 111.739 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.49 -22.42 47.49 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.189 0.44 . . . . 62.049999999999997 112.189 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -72.2 -39.28 68.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.732 0.301 . . . . 73.120000000000005 111.468 -175.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.41 -36.64 75.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 72.010000000000005 111.868 -175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.99 -27.08 62.52 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.771 0.319 . . . . 75.120000000000005 110.971 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.43 68.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.112 0.482 . . . . 54.030000000000001 110.309 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.16 -29.34 56.78 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.474 -0.869 . . . . 74.319999999999993 112.244 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -79.89 -21.87 43.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.342 0.497 . . . . 71.430000000000007 112.342 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.2 tp -78.15 -14.69 13.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.315 0.578 . . . . 71.450000000000003 110.335 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.31 41.03 2.87 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.121 -0.792 . . . . 54.530000000000001 111.121 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 62.8 m -135.3 150.08 49.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.229 -0.486 . . . . 65.549999999999997 110.684 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.97 136.24 52.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.687 0.279 . . . . 55.140000000000001 110.731 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.464 ' HA ' ' HB ' ' A' ' 51' ' ' VAL . 26.9 p90 -91.93 146.82 23.44 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.614 -0.513 . . . . 73.120000000000005 109.614 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 18.9 ptmt -155.39 166.87 32.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 74.010000000000005 111.155 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.22 128.31 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.469 -0.787 . . . . 72.400000000000006 111.314 -177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -101.9 106.13 17.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.234 -1.025 . . . . 64.209999999999994 108.234 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -57.91 154.26 12.64 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.502 0.556 . . . . 74.340000000000003 112.502 -166.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt 76.66 -47.55 0.54 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.387 1.075 . . . . 74.510000000000005 110.086 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 p -95.09 25.08 4.42 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.141 -0.936 . . . . 72.219999999999999 108.737 171.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.37 41.39 0.01 OUTLIER Glycine 0 CA--C 1.533 1.166 0 N-CA-C 119.238 2.455 . . . . 71.120000000000005 119.238 -159.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.02 140.1 29.84 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.847 -1.168 . . . . 74.140000000000001 107.847 163.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.51 120.12 19.63 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.723 -0.391 . . . . 71.230000000000004 110.553 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 63' ' ' ALA . 33.2 m -126.05 145.18 33.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.78 -0.646 . . . . 64.109999999999999 111.272 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' A' ' 40' ' ' PHE . 4.8 p -125.41 117.05 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.834 -0.621 . . . . 62.039999999999999 110.228 172.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.5 p -91.08 116.27 28.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.191 -0.459 . . . . 54.329999999999998 110.546 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.35 175.25 28.64 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.935 -0.65 . . . . 73.219999999999999 111.604 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 59' ' ' SER . 25.6 ptt85 -126.77 115.75 19.85 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.093 0.473 . . . . 74.219999999999999 110.922 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.9 mt -103.09 124.72 49.08 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.764 -0.653 . . . . 63.420000000000002 109.705 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 72.28 -53.01 0.7 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.823 0.702 . . . . 74.409999999999997 111.373 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.24 -52.13 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.115 -0.564 . . . . 71.329999999999998 111.986 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.696 ' HB ' HG22 ' A' ' 177' ' ' ILE . 17.8 m -72.62 138.67 46.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.857 0.36 . . . . 75.530000000000001 110.889 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.619 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 10.8 t -85.75 139.79 31.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.553 -0.536 . . . . 71.530000000000001 109.553 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.418 HG12 ' HG ' ' A' ' 5' ' ' LEU . 31.6 m -130.07 155.01 41.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.341 -0.391 . . . . 62.350000000000001 110.72 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 37.4 t -111.25 106.83 21.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.845 -0.616 . . . . 54.340000000000003 109.638 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . 3.4 tm? -91.78 115.78 28.34 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.299 -0.63 . . . . 75.049999999999997 109.299 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 50' ' ' VAL . . . -119.27 142.24 48.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.239 -0.437 . . . . 44.450000000000003 111.385 -175.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.563 ' HE2' ' CD2' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -139.14 127.25 13.52 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 75.430000000000007 110.387 175.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 13.0 Cg_exo -70.75 153.34 64.44 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.992 2.462 . . . . 73.420000000000002 112.023 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -93.96 -19.24 21.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.462 0.649 . . . . 74.310000000000002 110.0 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 60.4 m -101.94 159.26 15.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.217 -0.901 . . . . 45.340000000000003 109.463 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -78.05 -169.38 1.56 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.876 0.369 . . . . 65.219999999999999 111.522 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.831 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 18.9 ptp -52.75 -22.06 4.82 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.625 0.972 . . . . 70.150000000000006 113.625 -170.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -62.82 -49.62 74.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.791 0.329 . . . . 63.520000000000003 110.809 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.88 -0.11 21.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.011 0.375 . . . . 64.409999999999997 112.011 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.6 p -60.64 -42.77 97.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.927 0.394 . . . . 72.329999999999998 111.04 -176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.39 -21.17 78.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.945 -0.645 . . . . 71.030000000000001 112.769 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -80.63 -33.38 35.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.57 0.224 . . . . 71.129999999999995 111.391 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -74.9 -14.9 60.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.704 0.288 . . . . 75.319999999999993 111.617 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.21 -25.21 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.172 0.51 . . . . 65.519999999999996 110.304 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.69 -68.55 1.62 Allowed Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.881 -0.6 . . . . 63.32 112.865 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.82 -37.71 95.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.853 2.369 . . . . 64.329999999999998 112.462 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -55.87 -52.04 65.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 72.340000000000003 110.484 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.98 -44.75 83.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 65.400000000000006 112.012 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -72.77 -37.85 67.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.926 0.343 . . . . 72.099999999999994 111.926 -174.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -60.28 -47.49 85.76 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.75 0.309 . . . . 74.409999999999997 111.314 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -84.39 -15.14 47.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.934 -0.307 . . . . 74.329999999999998 110.791 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.2 m 59.78 47.61 10.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.863 -0.608 . . . . 71.430000000000007 110.693 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.441 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 29.4 m -94.42 148.8 35.61 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.642 -0.708 . . . . 73.510000000000005 110.321 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 11.2 Cg_exo -71.19 115.33 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.807 2.338 . . . . 70.400000000000006 111.969 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.523 ' HA ' HG13 ' A' ' 90' ' ' ILE . 28.8 Cg_exo -62.78 -19.53 68.73 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.006 2.471 . . . . 72.150000000000006 112.124 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -66.98 -21.7 65.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.86 -0.609 . . . . 74.319999999999993 110.684 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 89' ' ' GLN . 15.6 mm-40 -98.01 5.63 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.384 . . . . 73.430000000000007 111.413 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 87' ' ' PRO . 59.5 mt -69.22 130.92 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.109 0.48 . . . . 72.140000000000001 111.165 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 131' ' ' HIS . 7.0 p -120.0 132.67 69.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 62.5 109.325 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.68 129.71 75.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.543 0.687 . . . . 74.319999999999993 111.649 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.13 113.1 29.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.167 -0.924 . . . . 73.439999999999998 109.174 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.455 ' HE1' ' H ' ' A' ' 114' ' ' GLY . 30.1 t-80 -135.26 154.28 51.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.277 0.561 . . . . 73.140000000000001 111.905 -174.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.87 129.53 34.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.628 -1.169 . . . . 73.549999999999997 110.899 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -129.47 138.45 51.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.016 0.436 . . . . 52.450000000000003 110.659 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.55 -0.03 44.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.88 -0.6 . . . . 50.439999999999998 110.919 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -58.67 -45.7 88.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.313 -0.858 . . . . 73.239999999999995 112.431 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.567 HD13 ' HG3' ' A' ' 105' ' ' ARG . 2.9 pt -122.22 174.92 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.307 0.575 . . . . 75.120000000000005 112.507 -174.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.97 171.43 14.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.826 -1.079 . . . . 71.019999999999996 111.615 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -63.89 132.69 51.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.203 -0.908 . . . . 73.299999999999997 110.671 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.06 10.67 66.05 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.604 -0.808 . . . . 71.400000000000006 113.217 173.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.3 mmt-85 -123.0 153.56 39.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.103 0.452 . . . . 72.040000000000006 110.345 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.646 HD11 HG21 ' A' ' 188' ' ' VAL . 44.2 pt -138.81 149.25 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.781 0.324 . . . . 74.420000000000002 110.874 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.567 ' HG3' HD13 ' A' ' 99' ' ' ILE . 99.0 mtt180 -127.15 128.06 45.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.936 -0.575 . . . . 74.319999999999993 109.903 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 185' ' ' GLN . 8.1 mp -109.75 110.19 21.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 61.329999999999998 110.953 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -157.68 148.4 21.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.053 -0.721 . . . . 74.219999999999999 109.053 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.72 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.3 pt? -73.66 125.12 27.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.776 -0.453 . . . . 72.25 109.776 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.76 -177.14 41.06 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.848 -0.692 . . . . 53.229999999999997 112.022 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.37 -164.73 39.28 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.962 -0.637 . . . . 51.439999999999998 112.628 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.35 152.36 22.07 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.381 -0.688 . . . . 55.229999999999997 111.381 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -113.32 7.53 17.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.776 0.288 . . . . 75.209999999999994 110.995 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -68.61 -86.77 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.701 -0.762 . . . . 62.329999999999998 111.855 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.455 ' H ' ' HE1' ' A' ' 94' ' ' HIS . . . -74.4 73.93 1.32 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.916 -0.659 . . . . 74.25 111.66 175.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.624 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 0.2 OUTLIER -48.97 -66.43 0.4 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.488 0.715 . . . . 75.230000000000004 112.69 -174.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.564 ' HB2' ' SD ' ' A' ' 69' ' ' MET . 13.0 m120 -55.04 -43.63 73.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 62.039999999999999 111.527 -174.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.831 ' HA2' ' HB2' ' A' ' 69' ' ' MET . . . -62.9 -48.75 78.26 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.851 -0.613 . . . . 32.350000000000001 113.271 -176.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.74 -29.01 68.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.436 0.16 . . . . 74.310000000000002 111.291 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 115' ' ' HIS . 10.2 mmm180 -65.96 -42.27 90.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.657 0.265 . . . . 71.319999999999993 110.642 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -64.86 -47.79 76.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.387 -0.37 . . . . 62.030000000000001 110.549 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.28 -47.47 92.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.115 -0.493 . . . . 70.409999999999997 110.903 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.74 -31.28 72.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.891 -0.595 . . . . 54.130000000000003 111.844 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.2 t -80.34 -33.69 37.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.708 0.29 . . . . 55.520000000000003 110.918 -177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.21 -45.9 53.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.936 0.398 . . . . 62.450000000000003 111.025 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.89 -38.53 45.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.479 . . . . 54.020000000000003 110.943 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 87.97 -12.52 63.78 Favored Glycine 0 C--O 1.228 -0.274 0 C-N-CA 121.116 -0.564 . . . . 53.240000000000002 113.168 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.504 ' C ' ' HD2' ' A' ' 128' ' ' LYS . 14.6 t -141.9 173.73 11.24 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.129 -0.323 . . . . 74.409999999999997 110.129 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.504 ' HD2' ' C ' ' A' ' 127' ' ' THR . 13.2 mptt -125.22 -115.25 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.436 -0.347 . . . . 72.299999999999997 110.224 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 61.93 21.77 12.55 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.94 0.496 . . . . 72.019999999999996 111.613 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -90.25 160.97 15.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.19 -0.459 . . . . 71.319999999999993 110.275 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 33.2 m80 -87.18 99.89 12.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.122 -0.696 . . . . 74.109999999999999 109.122 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.462 ' NH1' ' HG2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -111.75 136.31 51.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.975 0.416 . . . . 73.319999999999993 111.108 -174.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.03 127.11 59.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.016 -0.538 . . . . 74.340000000000003 109.782 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.462 ' HG2' ' NH1' ' A' ' 132' ' ' ARG . 5.2 mtm180 -93.36 96.83 10.19 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.685 -0.487 . . . . 71.409999999999997 109.685 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.526 ' HA ' HG22 ' A' ' 104' ' ' ILE . 51.4 mt -90.19 127.75 42.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.422 -0.354 . . . . 71.019999999999996 110.48 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.51 ' CA ' HG13 ' A' ' 99' ' ' ILE . . . -72.52 97.82 0.81 Allowed Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.987 -0.552 . . . . 75.519999999999996 112.545 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.8 p -88.65 -10.29 10.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.464 -0.569 . . . . 70.439999999999998 109.464 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.23 152.98 28.01 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.56 -0.745 . . . . 42.039999999999999 112.279 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 21.1 ptp180 -107.46 119.85 49.39 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.067 0.46 . . . . 72.019999999999996 110.235 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 32.5 Cg_exo -59.58 125.28 17.44 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.954 2.436 . . . . 54.049999999999997 112.746 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 1.9 Cg_endo -83.79 137.71 7.82 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.45 2.767 . . . . 73.409999999999997 112.374 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.09 -168.01 24.97 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.181 -0.767 . . . . 74.420000000000002 111.181 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -87.81 -24.38 23.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.631 -0.507 . . . . 72.150000000000006 109.631 175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.446 ' HB2' ' CE2' ' A' ' 149' ' ' PHE . 42.4 mmtm -75.58 101.19 4.83 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.535 -0.913 . . . . 71.549999999999997 108.535 168.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.721 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 6.8 p-10 -73.1 168.49 24.43 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.916 -0.584 . . . . 73.329999999999998 110.41 -174.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.721 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 5.2 Cg_exo -35.99 -44.87 0.86 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.402 3.401 . . . . 64.109999999999999 114.274 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 -29.42 68.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.236 0.458 . . . . 44.43 112.236 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.52 -43.77 11.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.847 0.356 . . . . 71.319999999999993 111.372 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 144' ' ' LYS . 2.6 m-85 -84.02 -19.43 34.49 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.869 0.692 . . . . 73.409999999999997 112.869 -175.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.481 HG13 HD12 ' A' ' 151' ' ' LEU . 7.0 p -63.1 -25.56 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 112.201 0.445 . . . . 62.240000000000002 112.201 -173.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.481 HD12 HG13 ' A' ' 150' ' ' VAL . 6.0 mp -85.96 -10.24 55.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.659 0.266 . . . . 71.340000000000003 111.421 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.0 87.07 1.73 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.792 0.806 . . . . 74.209999999999994 109.438 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.559 ' H ' HG22 ' A' ' 20' ' ' THR . 23.8 t-20 -128.94 122.36 30.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.471 -0.786 . . . . 64.140000000000001 111.613 -170.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -155.31 134.86 12.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.386 -0.825 . . . . 74.209999999999994 109.199 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.637 HG22 ' H ' ' A' ' 157' ' ' ALA . 47.2 m -152.86 138.97 18.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.672 0.272 . . . . 72.230000000000004 110.605 -178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.91 -33.0 48.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 61.100000000000001 111.337 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.637 ' H ' HG22 ' A' ' 155' ' ' THR . . . -65.96 -49.24 68.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.903 -0.589 . . . . 64.109999999999999 111.568 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.461 ' HG3' ' HB ' ' A' ' 155' ' ' THR . 3.0 pp20? -72.64 -22.04 61.0 Favored 'General case' 0 CA--C 1.523 -0.058 0 C-N-CA 120.849 -0.34 . . . . 74.040000000000006 111.252 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 155' ' ' THR . 16.4 mmt180 -56.59 -39.89 74.33 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.195 0.522 . . . . 65.019999999999996 110.34 175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.45 -31.97 71.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.69 -0.686 . . . . 54.210000000000001 111.189 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.93 1.13 57.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.148 -0.478 . . . . 61.130000000000003 111.887 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.468 ' HB ' ' CD ' ' A' ' 163' ' ' PRO . 92.5 t -57.33 -57.87 21.96 Favored Pre-proline 0 C--O 1.233 0.229 0 C-N-CA 121.086 -0.245 . . . . 63.43 110.496 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' A' ' 162' ' ' VAL . 18.8 Cg_endo -61.07 -36.75 80.39 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.668 1.579 . . . . 72.109999999999999 111.476 176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.3 m -56.18 -53.37 57.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.594 -0.73 . . . . 71.140000000000001 111.421 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 84.4 mt -64.3 -49.75 79.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.289 -0.414 . . . . 71.409999999999997 111.008 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 28' ' ' VAL . 97.6 t -57.22 -51.59 67.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.409 -0.359 . . . . 75.239999999999995 111.552 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -62.48 -49.87 73.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.503 -0.317 . . . . 75.430000000000007 111.754 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.547 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . 10.3 mm-40 -67.71 -36.78 81.25 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.027 -0.269 . . . . 65.140000000000001 111.498 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.24 75.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.61 0.243 . . . . 62.439999999999998 110.61 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.69 64.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.001 0.429 . . . . 61.219999999999999 111.301 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -80.42 -45.7 17.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.295 -0.411 . . . . 70.409999999999997 110.709 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.35 -33.96 70.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.068 -0.514 . . . . 73.340000000000003 111.979 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 176' ' ' LEU . 3.4 p -61.71 -27.4 68.68 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.865 0.32 . . . . 75.329999999999998 111.865 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -63.38 -44.76 93.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.701 0.286 . . . . 52.210000000000001 110.355 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 38.3 tp -74.65 -28.91 61.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 74.439999999999998 110.261 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.831 HD22 ' HA ' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -54.54 -49.02 71.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.366 -0.834 . . . . 70.409999999999997 109.306 174.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.696 HG22 ' HB ' ' A' ' 58' ' ' THR . 65.5 mt -79.7 -25.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.114 -0.948 . . . . 74.109999999999999 111.079 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.4 -43.68 72.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.008 -0.542 . . . . 73.109999999999999 112.158 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.22 -65.04 0.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.861 -0.336 . . . . 71.120000000000005 111.092 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -161.89 173.41 38.23 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.283 -0.96 . . . . 62.240000000000002 112.439 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.831 ' HA ' HD22 ' A' ' 176' ' ' LEU . 2.4 pt? -83.2 -30.6 27.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.723 0.297 . . . . 72.439999999999998 111.557 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 39.4 mt-10 -67.72 -49.31 39.64 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.098 0.407 . . . . 43.549999999999997 112.098 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 52.7 Cg_exo -55.76 -28.79 68.63 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.062 1.841 . . . . 73.209999999999994 112.228 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -74.69 -50.26 18.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 61.219999999999999 110.995 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.596 ' HG3' ' O ' ' A' ' 182' ' ' GLU . 1.4 pp0? -64.23 -32.9 74.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.766 0.317 . . . . 74.340000000000003 110.197 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -61.77 -23.08 65.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.905 -0.589 . . . . 74.310000000000002 111.099 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 26.4 m -87.15 -41.01 14.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.765 0.317 . . . . 55.240000000000002 111.605 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 104' ' ' ILE . 17.8 m -96.41 -12.77 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 114.35 1.241 . . . . 74.239999999999995 114.35 -171.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -69.45 -28.59 66.24 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.913 0.708 . . . . 71.230000000000004 112.913 -171.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -133.66 -10.73 2.75 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.122 0.416 . . . . 63.399999999999999 112.122 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 19.4 m0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 119.012 -0.518 . . . . 62.329999999999998 110.234 -176.835 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 109.976 -0.379 . . . . 74.150000000000006 109.976 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 4' ' ' PRO . . . -106.02 102.98 12.37 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.212 -0.292 . . . . 71.019999999999996 110.212 173.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 0.4 OUTLIER -106.4 97.57 16.89 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.343 0.592 . . . . 73.310000000000002 109.819 176.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HG2' HG12 ' A' ' 85' ' ' VAL . 6.7 Cg_endo -89.41 110.82 0.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.093 2.529 . . . . 75.530000000000001 113.191 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.634 HD12 HG23 ' A' ' 177' ' ' ILE . 91.7 mt -76.52 128.93 35.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 72.439999999999998 110.281 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.573 ' HA ' HG23 ' A' ' 61' ' ' VAL . 22.9 tp -96.72 114.55 26.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.041 0.448 . . . . 71.439999999999998 110.781 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.806 ' HB ' HD13 ' A' ' 62' ' ' LEU . 21.2 t -105.21 111.56 35.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.728 -0.669 . . . . 70.120000000000005 109.83 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.574 HG21 HG22 ' A' ' 76' ' ' VAL . 49.5 t -104.48 117.47 50.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.077 -0.511 . . . . 72.409999999999997 110.147 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.494 ' HA2' HG13 ' A' ' 93' ' ' ILE . . . -106.2 -142.91 11.15 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.448 -0.882 . . . . 73.209999999999994 112.622 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.553 ' H ' ' HA3' ' A' ' 25' ' ' GLY . 2.2 tt -117.47 122.57 44.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.448 -0.945 . . . . 73.430000000000007 108.448 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -76.31 169.9 54.86 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.945 -0.645 . . . . 73.230000000000004 113.424 -172.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.507 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 44.9 t-20 -109.28 109.26 60.46 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.234 -0.654 . . . . 75.299999999999997 109.234 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 6.3 Cg_exo -74.25 -61.8 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 123.231 2.62 . . . . 73.530000000000001 113.62 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.72 -168.09 11.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.202 -0.999 . . . . 75.450000000000003 113.362 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.02 -56.68 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.392 2.728 . . . . 61.020000000000003 113.378 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 m -61.78 -30.78 71.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.993 0.425 . . . . 72.519999999999996 111.518 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -83.59 -8.0 59.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.213 -0.448 . . . . 51.229999999999997 111.04 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HA ' HD21 ' A' ' 12' ' ' ASN . . . -81.28 -16.6 52.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 51.549999999999997 111.411 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.855 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 9.7 mmpt? -111.34 8.13 21.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.428 -0.351 . . . . 73.230000000000004 111.374 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.413 HG21 ' HA ' ' A' ' 152' ' ' GLU . 38.6 p -110.47 163.21 13.92 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.523 0.677 . . . . 73.310000000000002 112.173 -176.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.899 HH21 ' HG ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -54.8 -33.47 61.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.428 -1.26 . . . . 75.219999999999999 113.465 -174.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -86.14 9.93 15.98 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.099 0.777 . . . . 73.450000000000003 113.099 -165.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.73 13.46 19.83 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.31 0.576 . . . . 65.209999999999994 110.556 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.899 ' HG ' HH21 ' A' ' 21' ' ' ARG . 0.0 OUTLIER -50.28 -31.35 14.0 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.182 0.808 . . . . 65.439999999999998 113.182 -173.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA3' ' H ' ' A' ' 10' ' ' LEU . . . -62.47 -42.64 99.69 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.823 -0.704 . . . . 65.129999999999995 112.536 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.481 ' CE2' ' HE3' ' A' ' 64' ' ' LYS . 56.3 t80 -67.13 -40.42 86.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.137 0.494 . . . . 73.349999999999994 110.439 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.497 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 4.8 mmt -65.36 -45.86 82.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.732 . . . . 74.209999999999994 111.381 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.752 HG12 HD23 ' A' ' 32' ' ' LEU . 57.9 t -68.15 -32.47 56.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.48 -0.327 . . . . 55.119999999999997 111.285 -177.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.1 70.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.048 0.388 . . . . 53.509999999999998 112.048 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.27 -38.61 68.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.602 -0.272 . . . . 73.329999999999998 111.509 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.548 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 30.3 m -74.94 -33.38 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.091 0.404 . . . . 55.509999999999998 112.091 -173.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.752 HD23 HG12 ' A' ' 28' ' ' VAL . 4.3 pp -70.93 -38.59 72.91 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 120.63 -0.428 . . . . 63.450000000000003 110.34 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 38' ' ' SER . . . -75.11 -36.89 61.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.231 0.539 . . . . 41.119999999999997 110.061 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.83 -18.28 45.87 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.497 -0.774 . . . . 51.310000000000002 113.067 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 15.3 mmt85 -68.67 -36.45 78.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.39 . . . . 73.120000000000005 111.17 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 36' ' ' ILE . 3.1 mp -88.17 -15.07 9.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.713 0.768 . . . . 74.319999999999993 109.703 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.35 24.9 9.8 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.616 -0.993 . . . . 71.129999999999995 110.616 -175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB2' ' HB1' ' A' ' 33' ' ' ALA . 70.5 m -99.24 123.23 43.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.845 -0.677 . . . . 62.450000000000003 111.021 -176.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -152.48 134.63 14.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.471 -0.331 . . . . 74.140000000000001 110.707 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 3.0 t80 -142.85 177.99 7.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.591 -0.522 . . . . 73.329999999999998 109.591 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 41' ' ' LYS . 20.8 ptmt -123.39 174.14 7.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.702 -0.226 . . . . 74.219999999999999 110.446 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.815 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 6.3 p -49.8 128.29 6.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.262 0.553 . . . . 53.109999999999999 110.602 174.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -106.86 109.92 21.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.964 -0.562 . . . . 75.349999999999994 110.513 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -53.16 154.44 3.12 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.652 0.595 . . . . 54.25 111.993 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 45' ' ' LYS . 12.0 tptp 80.26 -41.73 0.21 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.362 1.065 . . . . 73.0 109.625 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.9 p -104.93 26.58 9.06 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.366 -1.288 . . . . 41.039999999999999 108.109 171.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.45 41.44 0.01 OUTLIER Glycine 0 N--CA 1.477 1.424 0 N-CA-C 119.72 2.648 . . . . 73.219999999999999 119.72 -154.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.02 168.63 9.48 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.14 -1.43 . . . . 64.120000000000005 107.14 160.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.815 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 46.0 mt-10 -77.64 124.18 27.6 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.065 -0.654 . . . . 73.25 109.737 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -133.54 138.85 50.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.928 -0.578 . . . . 55.329999999999998 109.995 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 62' ' ' LEU . 3.4 p -122.11 115.99 47.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.356 0.598 . . . . 71.310000000000002 110.241 173.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.0 m -99.47 136.06 39.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.529 -0.759 . . . . 74.530000000000001 110.183 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -175.09 -160.07 22.37 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.24 -0.744 . . . . 34.409999999999997 111.24 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -131.91 144.08 50.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.742 0.306 . . . . 74.349999999999994 110.195 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.76 ' HG ' HG21 ' A' ' 60' ' ' VAL . 79.9 mt -118.3 123.67 45.92 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.842 -0.799 . . . . 60.350000000000001 108.842 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.686 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . . . 70.18 -52.44 0.64 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.961 0.788 . . . . 61.020000000000003 111.274 -173.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.4 -40.82 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.327 -0.709 . . . . 35.420000000000002 111.327 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.675 ' HB ' HG22 ' A' ' 177' ' ' ILE . 20.6 m -65.54 144.57 56.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.42 -0.39 . . . . 73.239999999999995 110.724 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 20.3 m -76.18 142.72 41.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.312 -0.404 . . . . 72.430000000000007 110.499 -178.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.76 HG21 ' HG ' ' A' ' 55' ' ' LEU . 29.4 m -138.33 150.81 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.255 0.55 . . . . 42.229999999999997 111.5 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 6' ' ' LEU . 3.6 m -129.76 112.14 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.526 -0.761 . . . . 44.439999999999998 109.904 173.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.806 HD13 ' HB ' ' A' ' 7' ' ' VAL . 4.1 mm? -92.49 128.07 38.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.797 -0.638 . . . . 73.510000000000005 109.992 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.14 122.25 46.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.173 0.511 . . . . 71.329999999999998 110.532 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HE3' ' CE2' ' A' ' 26' ' ' PHE . 6.9 ptmt -130.26 91.53 38.46 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.509 -0.769 . . . . 64.340000000000003 110.045 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.74 177.1 9.12 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.071 2.514 . . . . 64.019999999999996 112.812 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 20.3 mmt85 -109.35 13.3 24.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.46 -0.791 . . . . 65.510000000000005 109.044 175.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.556 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 61.2 m -102.26 178.91 4.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.947 -1.024 . . . . 60.439999999999998 109.923 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -85.36 -165.11 1.12 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.201 -0.454 . . . . 71.099999999999994 110.125 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -80.7 -19.62 44.69 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.705 0.261 . . . . 73.420000000000002 111.705 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -73.47 -61.71 1.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.222 0.534 . . . . 74.329999999999998 110.833 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 67' ' ' CYS . 1.1 pm0 -82.69 6.6 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.987 -0.551 . . . . 71.310000000000002 111.792 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.6 p -67.54 -34.08 76.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.985 0.422 . . . . 71.109999999999999 110.069 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.96 -20.75 74.89 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.806 -0.634 . . . . 70.049999999999997 112.612 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 mmm180 -74.25 -19.62 60.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.997 0.427 . . . . 73.540000000000006 110.473 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -87.34 -8.01 57.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 71.209999999999994 110.789 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.574 HG22 HG21 ' A' ' 8' ' ' VAL . 74.0 t -66.67 -36.95 78.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 64.0 110.659 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.11 9.43 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.811 -0.632 . . . . 63.240000000000002 112.939 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.56 -18.73 56.19 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.834 2.356 . . . . 72.120000000000005 113.187 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.57 -51.29 7.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.01 0.433 . . . . 74.219999999999999 110.077 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.627 ' HA ' HG22 ' A' ' 85' ' ' VAL . . . -53.46 -63.48 1.13 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.55 -0.75 . . . . 74.329999999999998 113.018 -172.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -72.82 -22.88 60.74 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.353 0.501 . . . . 72.420000000000002 112.353 -170.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -77.76 -28.85 50.71 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.915 -0.314 . . . . 75.239999999999995 111.224 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -102.93 5.45 38.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.798 0.332 . . . . 74.030000000000001 110.938 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.7 t 65.58 28.7 11.28 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.522 -0.763 . . . . 44.509999999999998 111.976 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 80' ' ' ALA . 6.3 m -80.38 136.22 53.01 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.626 -0.43 . . . . 64.310000000000002 110.464 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.77 ' HD2' ' HG3' ' A' ' 89' ' ' GLN . 30.1 Cg_exo -63.29 155.11 63.77 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.651 2.234 . . . . 75.040000000000006 111.748 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.34 -56.77 2.42 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.011 2.474 . . . . 64.430000000000007 112.689 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -80.15 55.22 2.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.049 0.452 . . . . 62.539999999999999 111.827 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.77 ' HG3' ' HD2' ' A' ' 86' ' ' PRO . 22.9 mm-40 -129.36 16.13 6.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.795 -0.639 . . . . 73.310000000000002 109.422 174.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' HB ' HD22 ' A' ' 129' ' ' ASN . 49.6 mm -92.92 123.91 45.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.478 -0.783 . . . . 75.219999999999999 111.86 -172.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.43 114.76 29.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.701 -0.681 . . . . 61.32 109.512 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.67 HG21 HG11 ' A' ' 121' ' ' VAL . 61.3 t -109.52 123.24 65.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.131 -0.486 . . . . 64.209999999999994 111.313 -175.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.87 HG22 ' HB ' ' A' ' 133' ' ' VAL . 30.8 pt -107.72 117.33 53.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.952 -0.567 . . . . 54.109999999999999 110.271 177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -132.79 162.25 31.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.064 0.459 . . . . 74.349999999999994 111.375 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -84.76 121.75 28.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.327 -0.851 . . . . 52.140000000000001 109.53 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 114' ' ' GLY . 1.5 mm-40 -127.5 135.74 50.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.289 0.566 . . . . 73.530000000000001 111.998 -171.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.29 -7.02 59.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.579 -0.737 . . . . 62.439999999999998 110.218 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.48 -34.92 64.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.318 -0.855 . . . . 75.530000000000001 111.513 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.53 ' HB ' ' HA3' ' A' ' 136' ' ' GLY . 1.1 mp -111.02 141.37 26.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.096 -0.502 . . . . 74.519999999999996 109.716 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.654 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 41.9 m-20 -67.93 147.02 53.04 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.355 -0.609 . . . . 73.420000000000002 109.355 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.731 ' HE1' ' HB2' ' A' ' 161' ' ' GLU . 13.8 t80 -63.03 137.55 58.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.099 0.476 . . . . 73.439999999999998 111.323 -171.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' O ' ' HD3' ' A' ' 103' ' ' ARG . . . 133.51 -39.84 1.67 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.576 -0.738 . . . . 70.400000000000006 112.067 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 102' ' ' GLY . 62.1 mmt-85 -131.96 164.51 25.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.715 0.293 . . . . 63.25 110.305 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 135' ' ' ILE . 37.2 pt -117.62 160.85 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 71.450000000000003 110.618 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.476 ' HD2' HG13 ' A' ' 99' ' ' ILE . 92.6 mtt180 -123.23 129.52 51.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.994 0.426 . . . . 71.400000000000006 110.923 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.604 ' HG ' HG13 ' A' ' 133' ' ' VAL . 4.7 mp -114.53 129.77 56.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.906 -0.588 . . . . 72.319999999999993 109.823 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -155.52 153.47 30.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.701 0.286 . . . . 73.109999999999999 110.283 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.802 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.3 pt? -87.43 94.09 9.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.571 . . . . 71.329999999999998 110.11 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.527 ' O ' ' HD3' ' A' ' 132' ' ' ARG . . . 172.81 -150.55 12.62 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.795 -0.639 . . . . 41.32 111.797 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.87 -157.05 25.35 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.935 -0.65 . . . . 64.310000000000002 112.223 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.688 ' HA3' HD13 ' A' ' 118' ' ' LEU . . . -130.91 132.05 6.7 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.106 -0.569 . . . . 71.25 111.867 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -112.73 6.79 18.33 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.742 0.275 . . . . 72.310000000000002 111.742 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.41 -92.26 1.55 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.527 -0.845 . . . . 73.420000000000002 111.341 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.443 ' H ' ' CD ' ' A' ' 96' ' ' GLU . . . -69.11 -45.09 63.46 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.883 -0.887 . . . . 32.299999999999997 110.883 174.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.407 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 76.0 t60 70.52 -24.59 0.16 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.869 0.692 . . . . 73.349999999999994 112.869 172.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.409 ' H ' ' C ' ' A' ' 114' ' ' GLY . 28.5 t-20 -51.52 -66.35 0.4 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.694 0.627 . . . . 61.409999999999997 112.694 -173.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.93 -10.21 85.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.144 -1.027 . . . . 73.420000000000002 113.037 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.688 HD13 ' HA3' ' A' ' 111' ' ' GLY . 94.7 mt -84.36 -38.08 20.75 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.704 -0.292 . . . . 71.219999999999999 111.372 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 120' ' ' SER . 6.6 ptm180 -65.25 -37.16 86.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 75.310000000000002 110.845 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.439 ' N ' ' HG3' ' A' ' 119' ' ' ARG . 10.0 m -60.02 -41.4 92.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.994 -0.548 . . . . 71.409999999999997 110.774 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.67 HG11 HG21 ' A' ' 92' ' ' VAL . 59.9 t -69.63 -40.33 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 75.120000000000005 110.163 177.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.423 ' HA ' HH22 ' A' ' 132' ' ' ARG . . . -63.48 -46.66 85.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.836 -0.62 . . . . 43.439999999999998 111.045 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.1 m -72.23 -27.9 62.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.292 -0.413 . . . . 72.299999999999997 111.751 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.24 -45.61 66.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.93 0.395 . . . . 72.310000000000002 111.033 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.6 mt -82.27 -32.21 29.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.897 -0.592 . . . . 41.229999999999997 110.793 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 108.12 -11.64 37.27 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.96 -0.564 . . . . 53.32 111.787 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.2 t -166.01 177.56 6.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.451 -0.574 . . . . 73.409999999999997 109.451 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.637 ' HD2' ' N ' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -60.21 -30.26 69.27 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.847 0.356 . . . . 74.120000000000005 110.408 174.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.637 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 9.2 t30 66.11 -13.88 0.15 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.213 1.005 . . . . 73.019999999999996 112.948 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 129' ' ' ASN . 3.4 t80 175.37 -84.5 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 122.464 0.306 . . . . 75.239999999999995 110.273 175.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -161.01 161.39 31.47 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.791 0.329 . . . . 71.310000000000002 111.737 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.527 ' HD3' ' O ' ' A' ' 109' ' ' GLY . 5.6 mpt_? -132.3 166.19 22.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.947 -0.57 . . . . 73.439999999999998 109.603 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.87 ' HB ' HG22 ' A' ' 93' ' ' ILE . 59.0 t -123.44 124.92 70.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.24 -0.436 . . . . 65.530000000000001 109.825 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.46 ' CB ' HD11 ' A' ' 99' ' ' ILE . 98.1 mtt180 -98.74 115.65 29.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.954 -0.566 . . . . 71.430000000000007 110.009 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.727 ' HA ' HG22 ' A' ' 104' ' ' ILE . 2.7 mp -87.89 117.59 32.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.341 -0.614 . . . . 72.230000000000004 109.341 176.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.53 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . -72.5 108.75 2.59 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.905 -0.664 . . . . 62.43 113.555 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.494 ' HA ' ' CD2' ' A' ' 101' ' ' PHE . 15.0 p -92.35 -16.21 7.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.562 0.696 . . . . 72.400000000000006 109.888 174.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 89.98 169.75 43.73 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.453 -0.794 . . . . 34.119999999999997 111.851 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.41 ' O ' ' HD3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -102.85 101.48 21.21 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 110.194 -0.298 . . . . 74.540000000000006 110.194 177.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 138' ' ' GLY . 2.9 Cg_exo -76.36 110.41 3.06 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.813 2.342 . . . . 71.040000000000006 111.388 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 139' ' ' ARG . 87.5 Cg_endo -80.25 143.96 16.1 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.554 2.169 . . . . 74.540000000000006 111.863 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 178.91 179.32 48.62 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.596 -0.811 . . . . 63.539999999999999 112.008 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -102.01 -4.13 26.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.64 0.733 . . . . 71.140000000000001 109.946 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.699 ' HE2' ' HA ' ' A' ' 144' ' ' LYS . 0.1 OUTLIER -116.87 148.22 41.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.177 -1.416 . . . . 70.230000000000004 107.177 167.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -61.18 138.24 94.4 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.683 0.278 . . . . 61.450000000000003 110.777 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.647 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 18.5 Cg_endo -58.86 -9.59 7.92 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.246 2.631 . . . . 74.430000000000007 112.097 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.79 -37.31 59.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.305 -0.861 . . . . 45.140000000000001 111.597 176.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.33 -23.5 24.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 51.329999999999998 111.606 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.647 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 92.7 m-85 -84.09 -34.36 24.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.872 0.368 . . . . 64.129999999999995 111.245 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.71 -18.35 22.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.846 0.355 . . . . 60.43 111.726 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.43 HD12 ' HG2' ' A' ' 152' ' ' GLU . 4.5 pp -86.28 -8.85 57.43 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.808 -0.357 . . . . 74.129999999999995 111.395 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 10.6 pt-20 -156.97 102.64 2.0 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.252 0.549 . . . . 73.349999999999994 110.775 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -134.54 136.69 43.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.706 -0.398 . . . . 73.409999999999997 110.586 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -122.42 19.07 10.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.029 -0.532 . . . . 74.310000000000002 110.538 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.544 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 96.9 m -62.17 120.85 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.852 -0.613 . . . . 62.32 110.732 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.32 79.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 74.530000000000001 111.743 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.85 -53.78 53.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.11 -0.495 . . . . 70.430000000000007 111.524 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -67.85 -37.2 81.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.661 -0.245 . . . . 71.209999999999994 110.95 -176.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 159' ' ' ARG . 11.8 mmt180 -58.68 -29.17 66.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.86 0.362 . . . . 72.219999999999999 111.312 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.02 -18.81 35.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.33 -0.395 . . . . 74.150000000000006 111.535 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.731 ' HB2' ' HE1' ' A' ' 101' ' ' PHE . 40.3 mt-10 -99.08 -6.7 27.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.68 0.276 . . . . 64.540000000000006 111.363 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 158' ' ' GLU . 89.8 t -69.75 -58.53 5.45 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.626 -0.261 . . . . 75.450000000000003 111.673 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 18.5 Cg_endo -59.58 -35.21 96.02 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.3 2.0 . . . . 72.439999999999998 112.878 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.6 p -62.1 -42.71 99.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 74.439999999999998 111.177 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.1 mt -65.62 -47.05 87.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 64.349999999999994 110.492 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.43 -50.84 78.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 44.219999999999999 111.48 -176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -60.79 -45.57 93.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.282 -0.417 . . . . 73.209999999999994 111.556 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -73.87 -26.23 60.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.696 0.284 . . . . 71.150000000000006 111.603 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.81 -28.06 68.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.526 -0.306 . . . . 61.119999999999997 111.465 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.51 -51.42 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.511 -0.313 . . . . 71.129999999999995 111.33 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.59 -46.69 88.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.122 0.487 . . . . 65.420000000000002 110.488 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.89 -47.26 78.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.807 -0.633 . . . . 75.129999999999995 111.601 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 32.7 m -64.09 -39.87 94.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 64.25 110.917 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.686 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 21.8 tt0 -61.14 -47.31 86.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.602 -0.272 . . . . 31.309999999999999 110.41 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 39.9 tp -68.26 -31.31 70.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 74.439999999999998 111.242 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.685 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.9 tt -62.73 -46.16 89.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.377 0.608 . . . . 75.5 109.551 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.682 HD13 HG11 ' A' ' 60' ' ' VAL . 79.2 mt -73.52 -25.26 20.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.235 -0.893 . . . . 70.140000000000001 110.4 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.24 -68.19 0.55 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.76 -0.654 . . . . 71.120000000000005 111.815 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -144.24 -40.58 0.27 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.856 0.687 . . . . 75.519999999999996 112.856 -172.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 176' ' ' LEU . . . -106.38 114.4 4.42 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.759 -1.21 . . . . 73.310000000000002 113.663 -170.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.454 ' HA ' ' HG ' ' A' ' 176' ' ' LEU . 6.1 tt -91.22 -54.41 3.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.456 -0.572 . . . . 53.200000000000003 109.456 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -70.31 -40.73 12.37 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 74.439999999999998 111.741 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -48.28 -38.8 34.46 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.026 1.817 . . . . 61.299999999999997 112.27 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -65.81 -43.33 88.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.095 -0.502 . . . . 73.049999999999997 110.636 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -57.81 -45.71 85.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.957 0.408 . . . . 72.299999999999997 110.508 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -66.03 -49.73 66.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 71.450000000000003 111.617 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 184' ' ' ALA . 12.1 t -60.54 -38.02 83.09 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.093 -0.243 . . . . 74.129999999999995 111.509 -174.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.731 ' HA ' ' HD1' ' A' ' 191' ' ' TRP . 72.0 t -60.23 -28.45 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.987 0.423 . . . . 72.200000000000003 111.106 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -76.34 -10.47 59.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.376 -0.375 . . . . 73.400000000000006 111.035 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -115.73 13.29 16.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.126 0.417 . . . . 50.200000000000003 112.126 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.731 ' HD1' ' HA ' ' A' ' 188' ' ' VAL . 93.1 m95 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.652 -0.689 . . . . 75.230000000000004 110.077 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 120.872 0.368 . . . . 54.219999999999999 110.275 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.9 126.99 48.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 73.120000000000005 110.483 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 13.5 mm-40 -86.5 126.12 65.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.184 -0.462 . . . . 64.329999999999998 110.695 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.483 ' HA ' ' HB2' ' A' ' 59' ' ' SER . 56.2 Cg_endo -92.55 107.26 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.187 2.591 . . . . 74.219999999999999 112.097 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.708 HD21 HG23 ' A' ' 177' ' ' ILE . 4.3 pp -89.21 157.71 18.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.307 -0.406 . . . . 75.140000000000001 110.647 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.419 ' HB2' HG11 ' A' ' 85' ' ' VAL . 47.5 tp -117.91 120.85 39.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.048 0.451 . . . . 74.150000000000006 111.281 -174.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.742 ' HB ' HD22 ' A' ' 62' ' ' LEU . 48.5 t -112.16 110.49 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.943 -0.571 . . . . 65.549999999999997 109.613 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.74 ' HB ' HG22 ' A' ' 92' ' ' VAL . 47.8 t -110.3 124.32 66.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 110.2 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.38 157.37 15.0 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.416 -0.897 . . . . 61.240000000000002 111.368 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.452 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -64.15 107.62 1.34 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.595 -0.891 . . . . 62.32 108.595 175.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -74.15 -176.89 35.76 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.673 -0.694 . . . . 61.420000000000002 113.523 -172.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -111.33 98.3 39.34 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.601 -0.518 . . . . 74.120000000000005 109.601 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.477 ' HB2' ' OH ' ' A' ' 17' ' ' TYR . 14.5 Cg_exo -67.8 -31.35 32.15 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.857 2.371 . . . . 71.439999999999998 112.445 -176.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.78 -176.22 43.83 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.589 -0.815 . . . . 71.109999999999999 112.248 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.37 -159.43 0.11 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.907 2.405 . . . . 70.439999999999998 112.312 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m 70.64 -70.82 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.081 -0.509 . . . . 75.299999999999997 111.324 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' OH ' ' HB2' ' A' ' 13' ' ' PRO . 28.7 p90 -88.63 3.51 50.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.965 0.412 . . . . 72.040000000000006 110.99 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.79 -1.57 4.04 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.879 -0.6 . . . . 35.509999999999998 112.371 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -100.62 18.5 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.33 . . . . 71.400000000000006 110.751 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.8 p -100.56 167.28 10.45 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.908 -0.405 . . . . 72.219999999999999 109.908 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 24' ' ' LEU . 22.4 ptt180 -84.38 -0.38 52.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.531 -0.304 . . . . 74.209999999999994 110.944 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.64 ' CD2' ' HA ' ' A' ' 150' ' ' VAL . 97.8 m-70 -86.21 -29.75 22.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.824 0.345 . . . . 65.040000000000006 110.944 -172.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -88.26 28.31 1.1 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.323 0.582 . . . . 61.5 109.88 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 2.4 pt? -67.28 -27.15 66.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.563 -0.744 . . . . 72.25 111.318 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.452 ' HA3' ' N ' ' A' ' 10' ' ' LEU . . . -59.23 -44.41 96.48 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.81 -0.709 . . . . 64.319999999999993 111.896 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.595 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 56.8 t80 -65.19 -35.8 82.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.743 0.306 . . . . 73.25 110.521 178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 82.9 mmm -83.26 -47.27 11.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.704 -0.68 . . . . 62.310000000000002 111.989 -171.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.4 t -63.41 -42.12 95.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.14 0.495 . . . . 63.229999999999997 110.256 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB3' ' HE2' ' A' ' 64' ' ' LYS . . . -67.18 -20.95 65.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.964 -0.562 . . . . 61.229999999999997 110.718 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 26' ' ' PHE . 21.7 t70 -77.16 -43.17 34.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.978 -0.555 . . . . 71.030000000000001 111.031 -178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 36.0 m -71.23 -37.87 67.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.53 -0.305 . . . . 72.420000000000002 111.568 -177.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.73 -24.83 62.71 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.042 0.449 . . . . 74.420000000000002 110.472 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 38' ' ' SER . . . -66.45 -46.74 75.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 64.319999999999993 110.158 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.76 -18.57 61.94 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.866 -0.607 . . . . 74.540000000000006 112.395 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 14.3 mmt85 -76.1 -58.15 3.45 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.766 0.284 . . . . 51.520000000000003 111.766 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.1 tp -77.29 -15.4 14.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.873 0.368 . . . . 73.120000000000005 111.199 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.09 45.86 2.97 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.653 -0.979 . . . . 51.409999999999997 110.653 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 33' ' ' ALA . 29.9 t -110.19 121.24 44.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.756 -0.722 . . . . 74.219999999999999 110.358 -173.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.83 126.62 55.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.347 -0.388 . . . . 72.25 110.242 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.463 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 48.4 p90 -106.0 137.81 43.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.044 0.45 . . . . 71.329999999999998 110.251 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -127.41 168.07 15.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.947 -0.57 . . . . 70.109999999999999 110.369 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.753 HG22 ' HG2' ' A' ' 49' ' ' GLU . 38.8 t -86.07 102.38 11.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.46 -0.57 . . . . 75.439999999999998 109.46 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.457 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 21.1 t-80 -79.58 85.03 5.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.921 -0.77 . . . . 75.230000000000004 108.921 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -66.55 96.8 0.4 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.559 0.695 . . . . 75.319999999999993 111.017 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 167.78 -55.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.47 -2.048 . . . . 73.120000000000005 105.47 -173.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.3 p -105.53 28.91 6.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 112.569 -2.105 . . . . 74.150000000000006 107.348 168.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 43' ' ' HIS . . . -49.92 43.27 0.01 OUTLIER Glycine 0 N--CA 1.476 1.356 0 N-CA-C 120.087 2.795 . . . . 71.450000000000003 120.087 -150.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.13 163.75 15.32 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.791 -1.189 . . . . 71.030000000000001 107.791 161.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.753 ' HG2' HG22 ' A' ' 42' ' ' VAL . 43.5 mt-10 -80.86 117.07 21.18 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.391 -0.524 . . . . 72.450000000000003 109.957 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.697 HG12 ' HA ' ' A' ' 63' ' ' ALA . 31.1 m -138.34 150.92 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 71.219999999999999 111.501 -173.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.28 137.71 56.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.774 -0.648 . . . . 73.120000000000005 109.961 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -111.3 125.64 54.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.688 0.28 . . . . 54.109999999999999 111.312 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.52 -167.75 24.46 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.007 -0.615 . . . . 74.230000000000004 111.621 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -136.96 104.38 5.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.084 0.442 . . . . 75.310000000000002 110.144 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.555 ' HG ' HG21 ' A' ' 60' ' ' VAL . 88.6 mt -89.78 131.19 35.86 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.619 -0.511 . . . . 63.420000000000002 109.619 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.85 9.01 4.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.228 -0.442 . . . . 73.340000000000003 111.564 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 107.75 -28.17 13.02 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.041 -0.599 . . . . 74.340000000000003 112.473 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.557 ' HB ' ' CG2' ' A' ' 177' ' ' ILE . 9.8 m -84.03 139.08 32.75 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.211 -0.292 . . . . 75.120000000000005 110.211 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 20.3 m -70.47 132.12 45.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.841 0.353 . . . . 45.530000000000001 110.601 -177.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.576 HG12 HD11 ' A' ' 5' ' ' LEU . 34.1 m -126.44 136.47 60.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.124 0.488 . . . . 65.439999999999998 111.132 -176.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.6 t -121.2 112.71 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.829 -0.623 . . . . 61.409999999999997 109.629 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.742 HD22 ' HB ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -94.99 119.78 34.08 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.358 -0.608 . . . . 62.119999999999997 109.358 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.697 ' HA ' HG12 ' A' ' 50' ' ' VAL . . . -111.87 124.28 52.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.962 0.41 . . . . 72.140000000000001 111.587 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' HE2' ' HB3' ' A' ' 29' ' ' ALA . 91.5 mttt -119.88 107.28 40.34 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.051 -0.522 . . . . 63.450000000000003 110.242 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.455 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 4.7 Cg_exo -75.12 151.57 39.17 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.961 2.441 . . . . 73.510000000000005 112.405 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -110.44 16.53 21.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.288 0.566 . . . . 72.5 109.714 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 58.4 m -112.8 168.86 9.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.722 -0.672 . . . . 73.209999999999994 110.882 -174.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -72.23 173.84 8.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.054 -0.521 . . . . 75.340000000000003 110.73 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -19.24 65.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.379 -0.373 . . . . 70.409999999999997 111.699 -175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -87.91 -19.99 26.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.359 0.599 . . . . 72.420000000000002 110.163 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 36.6 mt-10 -100.46 -28.16 13.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.021 -0.536 . . . . 72.239999999999995 110.957 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 76' ' ' VAL . 14.0 p -57.73 -37.62 73.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.421 -0.354 . . . . 50.229999999999997 111.177 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.24 -32.38 76.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.181 -0.533 . . . . 65.439999999999998 112.412 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.637 HH11 ' HB2' ' A' ' 124' ' ' ALA . 26.8 mmt180 -76.73 -31.36 57.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.748 0.309 . . . . 72.230000000000004 110.698 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 78.8 mm-40 -69.66 -28.66 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 72.540000000000006 110.861 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 72' ' ' SER . 46.6 t -66.52 -30.27 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 74.140000000000001 110.773 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -53.62 -67.1 2.32 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 116.044 -0.525 . . . . 41.32 113.154 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -59.54 -43.46 39.33 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.442 2.095 . . . . 73.049999999999997 112.227 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -54.88 -51.59 65.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.203 -0.453 . . . . 70.120000000000005 110.755 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.49 84.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.119 -0.492 . . . . 44.43 111.547 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -77.49 -31.87 53.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 111.724 0.268 . . . . 51.43 111.724 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -65.86 -46.45 78.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.615 0.245 . . . . 54.43 111.262 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -90.8 -17.08 27.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.669 -0.241 . . . . 71.230000000000004 111.313 -176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.0 t 59.98 72.77 0.51 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.443 0.639 . . . . 75.519999999999996 110.47 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 27.8 m -98.15 139.73 21.43 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.665 -0.698 . . . . 61.219999999999999 111.188 -177.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 13.1 Cg_exo -70.57 129.53 16.89 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.909 2.406 . . . . 71.349999999999994 111.797 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 86' ' ' PRO . 18.3 Cg_exo -67.33 -4.4 11.73 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.133 2.555 . . . . 73.420000000000002 113.292 -176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -89.6 -12.18 40.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.876 0.37 . . . . 53.219999999999999 110.745 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.439 ' HB3' ' CB ' ' A' ' 5' ' ' LEU . 9.3 mm-40 -129.73 45.01 2.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.414 0.626 . . . . 75.450000000000003 110.566 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.584 HG23 ' HB3' ' A' ' 131' ' ' HIS . 10.4 tt -120.54 127.7 75.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.819 -0.628 . . . . 74.319999999999993 109.864 175.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.37 146.21 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.131 -0.486 . . . . 55.0 110.456 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.74 HG22 ' HB ' ' A' ' 8' ' ' VAL . 86.1 t -134.07 124.23 45.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.848 0.356 . . . . 73.109999999999999 110.744 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.8 mm -75.23 130.65 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.61 -0.723 . . . . 73.109999999999999 111.689 -175.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -143.42 141.9 31.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 74.310000000000002 110.166 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.63 ' HB2' HG21 ' A' ' 137' ' ' VAL . 4.6 p-10 -87.29 122.32 30.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.928 -0.767 . . . . 73.439999999999998 108.928 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' H ' ' A' ' 99' ' ' ILE . 10.5 tp10 -99.62 118.63 36.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.675 -0.693 . . . . 62.43 110.982 -173.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 98' ' ' ASP . 3.3 pp -82.59 -20.7 35.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.474 -0.784 . . . . 70.049999999999997 111.253 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' N ' HD12 ' A' ' 97' ' ' LEU . 38.6 t70 -78.63 -20.45 50.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.1 0.476 . . . . 64.129999999999995 110.742 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.496 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 66.0 mt -102.28 122.92 55.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 109.777 176.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.463 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 13.6 m-20 -62.13 149.87 40.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.281 -0.418 . . . . 63.409999999999997 110.839 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.877 ' HD2' ' HA ' ' A' ' 137' ' ' VAL . 29.4 t80 -65.61 133.76 51.85 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.18 -0.464 . . . . 75.120000000000005 110.918 -174.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.93 -62.29 0.32 Allowed Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.827 -0.624 . . . . 53.520000000000003 112.294 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -126.3 165.38 19.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.716 0.293 . . . . 60.350000000000001 110.263 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.708 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -118.57 159.18 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.194 -0.457 . . . . 60.450000000000003 110.173 -178.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -144.82 163.0 35.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.029 0.442 . . . . 73.310000000000002 110.94 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 69.0 mt -108.62 152.56 24.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.737 -0.665 . . . . 64.230000000000004 109.602 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -129.58 105.1 7.84 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.835 -0.346 . . . . 71.319999999999993 110.914 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 181' ' ' LEU . 85.6 mt -110.33 91.84 3.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 75.510000000000005 109.987 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.454 ' H ' ' NH2' ' A' ' 132' ' ' ARG . . . 162.65 -132.18 2.71 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.058 -0.817 . . . . 33.240000000000002 111.058 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -105.63 109.58 3.24 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.718 -0.953 . . . . 63.399999999999999 110.718 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -158.75 161.33 31.77 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.074 -1.06 . . . . 55.350000000000001 112.977 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.62 171.01 10.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.279 -0.461 . . . . 72.129999999999995 110.413 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.93 45.36 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.187 -0.765 . . . . 54.219999999999999 111.187 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.35 81.72 1.31 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.58 -1.008 . . . . 74.439999999999998 110.58 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -52.07 -50.56 61.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.444 0.535 . . . . 75.430000000000007 112.444 -170.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.55 -3.03 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.808 -0.357 . . . . 40.43 111.409 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.1 -33.59 7.65 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.954 -0.859 . . . . 72.299999999999997 110.954 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.8 -30.19 65.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.531 -0.544 . . . . 73.040000000000006 109.531 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -51.33 -50.28 59.75 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.153 -0.93 . . . . 73.019999999999996 111.683 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.2 p -72.81 -45.35 58.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.891 0.377 . . . . 75.439999999999998 111.326 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.612 HG11 ' HE1' ' A' ' 131' ' ' HIS . 59.3 t -65.79 -47.96 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.069 -0.514 . . . . 60.119999999999997 111.87 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.454 ' HA ' HD21 ' A' ' 129' ' ' ASN . . . -63.3 -38.48 91.31 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.987 0.366 . . . . 51.229999999999997 111.987 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.9 p -76.6 -29.21 56.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.631 -0.259 . . . . 53.32 111.193 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.637 ' HB2' HH11 ' A' ' 74' ' ' ARG . . . -79.35 -49.46 12.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 111.676 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.5 mt -84.67 -41.78 15.96 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.352 -0.385 . . . . 64.049999999999997 111.536 -174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 88.95 -12.6 65.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.808 -0.711 . . . . 61.210000000000001 112.357 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.1 t -71.96 164.4 26.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.887 0.375 . . . . 52.020000000000003 110.793 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.86 -11.82 60.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 52.229999999999997 110.64 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.454 HD21 ' HA ' ' A' ' 122' ' ' ALA . 86.9 m-20 66.09 79.14 0.25 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.579 -0.737 . . . . 72.510000000000005 112.329 173.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.402 ' HB3' HD22 ' A' ' 108' ' ' LEU . 99.3 m-85 -83.56 -22.85 32.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.212 0.53 . . . . 71.010000000000005 110.032 174.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.612 ' HE1' HG11 ' A' ' 121' ' ' VAL . 13.1 p80 -68.63 87.61 0.34 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.445 -0.798 . . . . 70.310000000000002 112.347 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.454 ' NH2' ' H ' ' A' ' 109' ' ' GLY . 16.2 mtm180 -142.89 109.56 5.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.257 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.4 t -101.87 109.02 24.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.637 -0.875 . . . . 75.409999999999997 108.637 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.469 ' HD2' ' OE1' ' A' ' 96' ' ' GLU . 38.9 mtm180 -99.1 106.43 18.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.071 0.462 . . . . 75.530000000000001 110.93 -175.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.633 ' HA ' HG22 ' A' ' 104' ' ' ILE . 3.0 mp -85.1 114.78 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.701 -0.681 . . . . 74.219999999999999 109.362 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.747 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -65.29 101.93 0.61 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.768 -0.729 . . . . 35.5 111.583 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.877 ' HA ' ' HD2' ' A' ' 101' ' ' PHE . 3.5 m -111.2 -7.37 11.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.255 0.465 . . . . 60.43 112.255 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 86.87 167.68 44.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.699 -0.762 . . . . 63.340000000000003 112.72 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 8.5 ptm180 -111.48 124.34 32.82 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.044 0.449 . . . . 72.549999999999997 110.984 -178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 9.5 Cg_endo -90.07 115.37 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.57 2.846 . . . . 74.209999999999994 112.259 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -93.23 155.9 2.58 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.962 2.441 . . . . 64.510000000000005 113.18 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.62 -161.78 29.97 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.258 -0.737 . . . . 53.340000000000003 111.258 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -78.12 -19.31 54.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.196 0.522 . . . . 71.219999999999999 110.161 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 32.5 mmtp -108.38 150.74 26.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.478 -0.783 . . . . 75.049999999999997 109.451 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.23 164.02 56.65 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.325 -0.398 . . . . 55.0 110.251 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.571 ' HA ' ' CD1' ' A' ' 149' ' ' PHE . 62.6 Cg_exo -53.58 -14.33 4.88 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.14 2.56 . . . . 71.239999999999995 113.292 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.94 -22.79 63.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 74.030000000000001 111.567 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.75 -26.87 22.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.394 0.616 . . . . 62.329999999999998 110.473 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 146' ' ' PRO . 68.5 m-85 -64.42 -15.95 61.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.044 -0.98 . . . . 72.129999999999995 112.038 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 22' ' ' HIS . 33.6 m -55.48 -28.75 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 111.859 0.318 . . . . 62.32 111.859 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.543 ' HG ' HG23 ' A' ' 150' ' ' VAL . 86.6 mt -105.58 -27.15 11.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.921 0.391 . . . . 75.5 110.871 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -128.59 93.52 3.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.491 0.663 . . . . 72.319999999999993 110.272 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 149' ' ' PHE . 3.8 t30 -125.11 101.31 6.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.634 . . . . 74.5 110.491 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -132.13 102.13 5.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.286 0.565 . . . . 63.200000000000003 110.527 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.893 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 6.5 m -125.73 132.38 52.36 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.011 -0.541 . . . . 54.210000000000001 109.887 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.76 73.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.971 0.415 . . . . 72.049999999999997 110.868 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.65 -38.95 93.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.832 -0.622 . . . . 75.239999999999995 112.044 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.893 ' HG2' ' HB ' ' A' ' 155' ' ' THR . 10.5 pt-20 -72.58 -40.45 66.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.876 -0.33 . . . . 75.409999999999997 111.261 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.464 ' HA ' HG23 ' A' ' 162' ' ' VAL . 25.6 mmm180 -66.82 -34.34 77.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.85 0.357 . . . . 75.219999999999999 110.808 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.49 62.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.428 -0.805 . . . . 65.409999999999997 112.376 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.652 ' HB2' ' HE1' ' A' ' 101' ' ' PHE . 59.7 mm-40 -100.68 13.38 34.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.337 0.495 . . . . 73.340000000000003 112.337 -174.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.642 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 55.2 t -54.38 -52.47 68.96 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.035 -0.266 . . . . 74.310000000000002 110.798 174.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 53.9 Cg_exo -54.55 -25.89 43.0 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.142 1.895 . . . . 75.510000000000005 113.24 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.5 m -74.28 -48.21 29.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.057 0.456 . . . . 73.25 110.684 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.24 -33.59 64.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.962 -0.563 . . . . 72.120000000000005 111.34 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 162' ' ' VAL . 98.1 t -53.35 -39.1 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.835 0.35 . . . . 65.409999999999997 111.419 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -71.57 -50.07 34.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.46 -0.336 . . . . 60.409999999999997 111.29 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.531 ' HA ' ' OE1' ' A' ' 168' ' ' GLN . 9.1 mm-40 -60.84 -42.78 98.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.783 0.325 . . . . 62.119999999999997 111.385 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.13 -22.98 67.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.237 -0.438 . . . . 54.140000000000001 111.641 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.39 -44.16 15.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.855 0.36 . . . . 45.340000000000003 111.742 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -85.05 -36.29 21.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.555 -0.293 . . . . 73.530000000000001 111.618 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.33 -43.67 73.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.843 0.312 . . . . 70.239999999999995 111.843 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.533 ' HA ' HD13 ' A' ' 176' ' ' LEU . 22.0 p -63.05 -31.49 72.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 65.519999999999996 111.69 -175.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.45 -26.4 66.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.278 -0.419 . . . . 73.109999999999999 110.821 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.72 -29.76 66.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.708 0.29 . . . . 71.140000000000001 110.593 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' A' ' 173' ' ' THR . 8.3 mp -64.66 -36.5 84.47 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.482 0.658 . . . . 61.210000000000001 109.502 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.708 HG23 HD21 ' A' ' 5' ' ' LEU . 34.5 mt -76.99 -37.36 26.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.892 -1.049 . . . . 74.5 110.023 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.85 -48.84 67.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.57 -0.741 . . . . 54.450000000000003 111.364 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -133.22 -67.56 0.62 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.431 -0.35 . . . . 65.010000000000005 111.201 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -176.4 -178.32 46.09 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.749 -0.739 . . . . 70.340000000000003 111.886 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 108' ' ' LEU . 3.7 pp -89.87 -12.94 37.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.965 0.412 . . . . 74.019999999999996 110.584 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.71 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 6.5 tm-20 -53.68 -54.13 49.62 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.508 -0.769 . . . . 74.329999999999998 111.797 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.71 ' HD3' ' HB3' ' A' ' 182' ' ' GLU . 11.0 Cg_exo -71.19 -31.98 13.69 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 121.644 1.563 . . . . 62.200000000000003 112.176 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -75.59 -26.01 57.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 53.32 112.322 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 19.7 pt20 -62.29 -22.65 66.2 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.475 0.179 . . . . 74.150000000000006 111.444 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -85.98 -48.01 9.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.749 0.309 . . . . 72.140000000000001 110.657 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.6 m -53.22 -40.55 64.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.765 -0.652 . . . . 72.540000000000006 111.749 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.2 -12.75 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.62 0.6 . . . . 74.109999999999999 112.62 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -117.45 -28.58 6.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.614 0.245 . . . . 64.239999999999995 111.54 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -84.55 -17.15 39.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.586 -0.279 . . . . 72.319999999999993 111.607 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.3 m95 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.637 -0.697 . . . . 63.439999999999998 110.271 -179.535 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 121.242 0.544 . . . . 74.400000000000006 110.269 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 58' ' ' THR . . . -158.41 42.22 0.27 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.689 -0.687 . . . . 71.239999999999995 109.569 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.0 mp0 -84.44 142.93 40.82 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.611 -0.722 . . . . 73.310000000000002 110.554 -172.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 2.9 Cg_exo -76.21 117.85 4.77 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.137 2.558 . . . . 70.209999999999994 112.307 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.722 HD21 HG23 ' A' ' 177' ' ' ILE . 4.2 pp -121.89 149.25 43.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.291 -0.413 . . . . 73.040000000000006 110.246 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.473 ' HB3' HG12 ' A' ' 90' ' ' ILE . 64.8 tp -97.56 136.21 38.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.318 -0.401 . . . . 73.230000000000004 110.476 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.7 t -117.42 112.61 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.829 -0.434 . . . . 75.109999999999999 109.829 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.67 128.61 62.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 73.329999999999998 110.723 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.541 ' HA2' HG23 ' A' ' 93' ' ' ILE . . . -103.38 -177.06 26.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.198 -0.525 . . . . 72.519999999999996 112.095 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.568 HD13 ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -142.53 158.74 43.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.362 . . . . 73.099999999999994 110.926 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 22' ' ' HIS . . . 155.86 -158.28 28.43 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.449 -0.661 . . . . 60.399999999999999 111.449 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 61.0 t30 -163.08 105.32 1.01 Allowed Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.116 -0.328 . . . . 72.340000000000003 110.116 176.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 12' ' ' ASN . 56.2 Cg_endo -71.2 142.25 41.27 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.751 2.301 . . . . 53.140000000000001 112.271 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.62 177.92 39.9 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.754 -0.736 . . . . 42.439999999999998 111.849 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.4 -66.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.699 2.266 . . . . 62.109999999999999 112.083 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 m -76.7 -25.56 53.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.319 0.581 . . . . 65.239999999999995 110.113 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' HA ' HG23 ' A' ' 20' ' ' THR . 80.9 m-85 -70.71 -23.14 62.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.567 -0.742 . . . . 71.450000000000003 111.748 -175.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.4 -17.27 63.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.213 0.53 . . . . 73.120000000000005 110.28 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -106.73 20.63 18.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.604 -0.725 . . . . 74.230000000000004 111.277 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.627 HG23 ' HA ' ' A' ' 17' ' ' TYR . 72.2 p -99.95 166.91 10.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.238 0.542 . . . . 74.439999999999998 110.385 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.544 ' HB3' HG23 ' A' ' 150' ' ' VAL . 17.5 tpt85 -93.76 1.56 56.48 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.912 -0.586 . . . . 74.299999999999997 111.1 -175.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.461 ' O ' ' HA2' ' A' ' 11' ' ' GLY . 1.5 t-160 -106.81 11.04 30.56 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.909 -0.316 . . . . 65.319999999999993 111.549 -173.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -103.38 13.63 33.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 64.409999999999997 111.332 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.4 pt? -55.06 -39.96 69.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.837 -0.62 . . . . 74.319999999999993 112.144 -174.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 10' ' ' LEU . . . -61.2 -55.29 30.24 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.034 -0.603 . . . . 54.219999999999999 112.971 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.54 ' CE1' ' HD2' ' A' ' 65' ' ' PRO . 20.1 m-30 -61.4 -39.52 91.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.717 0.294 . . . . 44.420000000000002 111.315 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.527 ' HA ' ' CE ' ' A' ' 27' ' ' MET . 16.3 mmt -68.83 -49.58 57.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.376 -0.374 . . . . 54.439999999999998 111.457 -176.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.27 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.359 . . . . 42.229999999999997 110.673 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -63.62 -34.93 78.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 73.099999999999994 111.446 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.38 -40.7 50.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.215 -0.448 . . . . 71.030000000000001 111.164 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.5 m -79.56 -21.13 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.547 0.573 . . . . 63.450000000000003 112.547 -174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.419 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -70.37 -26.05 63.54 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.326 -0.549 . . . . 62.219999999999999 110.712 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.419 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -71.54 -24.26 61.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.352 0.596 . . . . 33.509999999999998 110.158 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.64 -18.12 67.71 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.451 -0.795 . . . . 65.219999999999999 112.6 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -69.56 -32.44 71.22 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.046 0.45 . . . . 75.310000000000002 111.186 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 36' ' ' ILE . 4.2 mp -86.03 -15.57 10.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.989 -0.745 . . . . 71.25 108.989 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.76 41.04 15.97 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.711 -1.356 . . . . 73.299999999999997 109.711 -171.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 t -126.55 135.54 51.4 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.887 -0.656 . . . . 62.32 111.038 -169.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.04 128.31 9.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.045 -0.525 . . . . 75.25 110.215 174.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.537 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 7.3 t80 -107.86 -158.1 0.64 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.731 -0.47 . . . . 75.439999999999998 109.731 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -135.19 173.07 12.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.999 0.428 . . . . 72.230000000000004 111.474 -171.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HB ' ' OE2' ' A' ' 49' ' ' GLU . 2.7 p -70.52 108.26 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.585 -0.734 . . . . 64.430000000000007 111.216 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -102.25 75.67 1.51 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.256 -1.016 . . . . 74.409999999999997 108.256 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -56.31 122.29 11.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.598 -0.728 . . . . 63.329999999999998 112.174 -168.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -134.76 -90.93 0.33 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.662 -0.699 . . . . 71.340000000000003 109.496 168.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.419 ' OG ' ' HB2' ' A' ' 78' ' ' PRO . 8.6 m -107.83 -41.25 5.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 118.898 -1.121 . . . . 73.239999999999995 111.556 171.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.79 1.68 4.73 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.369 -0.443 . . . . 73.540000000000006 112.573 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . -75.58 99.4 4.26 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 115.585 1.698 . . . . 64.049999999999997 115.585 -154.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.654 ' HB3' ' HE3' ' A' ' 64' ' ' LYS . 20.7 mt-10 -116.28 115.46 25.98 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.357 -1.72 . . . . 74.5 106.357 151.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 31.8 m -137.56 151.27 26.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.257 -0.577 . . . . 62.229999999999997 112.384 -167.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 62' ' ' LEU . 5.9 p -124.63 125.83 70.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.418 -0.956 . . . . 74.239999999999995 108.418 166.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.5 m -103.17 113.08 26.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.078 0.466 . . . . 73.019999999999996 111.169 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.29 -161.22 8.97 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.811 -0.916 . . . . 60.140000000000001 110.811 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -138.34 129.68 27.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.291 0.545 . . . . 75.420000000000002 110.953 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.9 mt -102.87 117.03 33.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.035 -0.728 . . . . 71.219999999999999 109.035 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 70.44 -46.46 0.62 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.98 0.8 . . . . 72.239999999999995 111.66 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.83 -37.79 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.206 -0.521 . . . . 64.239999999999995 111.881 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -71.28 133.68 46.24 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.878 0.37 . . . . 70.329999999999998 111.294 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.5 p -74.07 125.74 28.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.298 -0.41 . . . . 72.230000000000004 110.756 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.597 HG12 HD11 ' A' ' 5' ' ' LEU . 33.6 m -111.23 136.44 47.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.102 -0.499 . . . . 71.420000000000002 110.896 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 t -102.76 101.17 11.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.759 -0.83 . . . . 75.150000000000006 108.759 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.579 HD11 ' HB1' ' A' ' 29' ' ' ALA . 3.3 tm? -91.09 111.57 23.1 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.169 -0.678 . . . . 73.310000000000002 109.169 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 49' ' ' GLU . . . -109.33 123.58 49.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.981 -0.554 . . . . 64.540000000000006 111.297 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.654 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -122.99 90.2 50.42 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 121.677 0.751 . . . . 75.230000000000004 109.674 175.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.54 ' HD2' ' CE1' ' A' ' 26' ' ' PHE . 16.4 Cg_exo -68.95 166.67 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.704 2.269 . . . . 64.530000000000001 112.679 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -105.0 14.41 29.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.663 0.744 . . . . 75.329999999999998 109.06 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 63.3 m -102.16 138.51 39.01 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.73 -1.123 . . . . 33.140000000000001 108.866 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 70' ' ' ASN . 15.8 p90 -66.65 166.8 12.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.093 0.473 . . . . 73.329999999999998 111.545 -176.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.4 ptp -46.68 -31.56 2.99 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.39 1.256 . . . . 55.130000000000003 114.39 -169.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.411 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 62.4 t30 -77.99 -50.44 12.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.872 0.368 . . . . 72.299999999999997 111.142 -176.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -78.56 -24.45 45.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.286 -0.416 . . . . 71.219999999999999 111.454 -175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.3 t -56.68 -39.4 73.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.388 -0.369 . . . . 74.540000000000006 110.433 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.07 -29.37 74.72 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.932 -0.576 . . . . 72.239999999999995 113.077 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -41.85 88.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.157 0.503 . . . . 74.219999999999999 110.914 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -84.22 -0.05 50.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.803 -0.635 . . . . 74.430000000000007 111.86 -171.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.2 t -70.74 -40.46 76.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.803 0.335 . . . . 61.409999999999997 110.444 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.97 -59.03 11.56 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-N 115.964 -0.562 . . . . 73.019999999999996 112.822 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HB2' ' OG ' ' A' ' 46' ' ' SER . 10.1 Cg_endo -56.2 -37.82 95.99 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.7 2.267 . . . . 71.450000000000003 112.749 175.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 48' ' ' ALA . 2.9 tm? -69.11 -44.61 72.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.647 -0.251 . . . . 74.349999999999994 111.255 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.52 86.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.0 0.37 . . . . 53.420000000000002 112.0 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -72.9 -20.43 61.08 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.822 0.304 . . . . 75.019999999999996 111.822 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -71.07 -28.7 64.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.854 0.359 . . . . 74.340000000000003 110.753 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -101.02 0.01 37.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 72.129999999999995 110.169 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t 62.24 24.29 14.44 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.443 -0.798 . . . . 34.299999999999997 111.426 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.483 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 18.5 m -88.04 131.85 41.67 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.887 0.375 . . . . 74.120000000000005 111.09 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 19.4 Cg_exo -67.38 127.94 17.45 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.832 2.354 . . . . 75.439999999999998 111.605 176.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.632 ' HA ' HD12 ' A' ' 90' ' ' ILE . 39.7 Cg_exo -57.63 -27.51 77.46 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.991 2.46 . . . . 71.25 113.055 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -64.46 -27.68 69.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.48 -0.327 . . . . 71.030000000000001 111.659 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -103.88 17.59 23.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.159 0.504 . . . . 72.329999999999998 110.761 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.721 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 58.9 mt -90.45 145.45 7.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.403 -0.591 . . . . 65.5 109.403 175.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 m -118.12 134.67 61.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.164 0.507 . . . . 73.530000000000001 110.254 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.79 115.92 47.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.086 -0.506 . . . . 75.420000000000002 110.543 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.541 HG23 ' HA2' ' A' ' 9' ' ' GLY . 6.8 tt -87.67 126.02 41.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.923 -0.58 . . . . 73.230000000000004 109.542 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.99 173.5 11.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.399 0.618 . . . . 73.439999999999998 110.649 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -85.55 152.61 23.02 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.176 -0.92 . . . . 72.530000000000001 110.521 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 22.5 tt0 -123.35 94.72 4.34 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.423 0.63 . . . . 75.120000000000005 110.169 174.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.847 ' H ' HD23 ' A' ' 97' ' ' LEU . 1.9 pt? -83.57 -0.33 49.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.332 -0.849 . . . . 71.340000000000003 110.073 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.409 ' CG ' HH12 ' A' ' 134' ' ' ARG . 1.6 m-20 -68.42 -36.42 79.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.711 . . . . 71.510000000000005 109.678 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 mm -123.29 149.19 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.515 -0.766 . . . . 75.109999999999999 110.244 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.787 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 8.8 p-10 -75.42 155.03 36.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 61.0 110.973 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.639 ' HD2' ' HB2' ' A' ' 158' ' ' GLU . 6.0 t80 -68.03 138.73 56.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.718 -0.674 . . . . 73.530000000000001 111.577 -173.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 160.07 -35.62 0.45 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.342 -0.845 . . . . 45.43 111.081 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -148.55 164.89 32.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 70.340000000000003 110.455 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.618 HD11 HG21 ' A' ' 188' ' ' VAL . 2.4 pp -118.21 162.97 15.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.382 -0.599 . . . . 74.129999999999995 109.382 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.407 ' HE ' ' CD ' ' A' ' 96' ' ' GLU . 29.8 ptt180 -141.0 153.32 45.5 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.702 -0.399 . . . . 74.129999999999995 110.446 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' A' ' 181' ' ' LEU . 60.3 tp -113.04 124.9 53.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.844 -0.616 . . . . 73.329999999999998 109.434 176.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -155.41 126.69 7.21 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.002 -0.74 . . . . 74.310000000000002 109.002 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 130' ' ' PHE . 88.0 mt -76.73 88.0 3.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.579 0.704 . . . . 74.310000000000002 109.638 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.6 147.72 5.16 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.31 -1.116 . . . . 63.340000000000003 110.31 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.462 ' HA3' ' HG2' ' A' ' 132' ' ' ARG . . . 178.86 112.44 0.34 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.692 -1.242 . . . . 54.219999999999999 113.061 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -163.57 76.06 0.17 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.308 -0.717 . . . . 73.200000000000003 111.308 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -171.77 149.73 2.57 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.201 -0.666 . . . . 44.030000000000001 109.201 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.22 -67.77 2.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.959 -0.639 . . . . 72.120000000000005 111.825 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.93 69.3 3.27 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.901 -0.88 . . . . 65.019999999999996 110.901 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -48.45 -54.86 12.59 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.661 0.784 . . . . 73.230000000000004 111.734 -173.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -85.6 -41.6 15.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.258 -0.428 . . . . 55.520000000000003 110.981 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.81 -37.26 90.07 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 116.13 -0.487 . . . . 74.0 113.703 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.3 -27.89 29.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.972 0.386 . . . . 64.439999999999998 111.347 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -79.43 -36.7 38.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.499 -0.318 . . . . 63.109999999999999 111.568 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.9 m -58.76 -38.21 77.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 72.310000000000002 111.138 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.02 -42.93 82.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.987 0.422 . . . . 50.420000000000002 110.477 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.61 82.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.022 -0.536 . . . . 72.230000000000004 110.766 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t -63.42 -41.77 98.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 44.439999999999998 110.768 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.3 -32.09 69.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.31 -0.405 . . . . 61.439999999999998 111.672 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.53 -7.71 40.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.789 0.328 . . . . 74.420000000000002 111.669 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 94.45 -11.77 69.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.851 -0.69 . . . . 72.420000000000002 113.408 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 129' ' ' ASN . 15.4 t -169.88 177.97 4.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.832 0.316 . . . . 52.219999999999999 110.184 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.872 ' H ' ' HD2' ' A' ' 128' ' ' LYS . 8.9 mptt -56.13 -57.3 12.78 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.088 -0.708 . . . . 70.099999999999994 109.088 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.441 ' HB2' HG23 ' A' ' 127' ' ' THR . 8.9 t-20 67.32 24.35 9.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.337 -0.847 . . . . 64.420000000000002 111.946 166.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.512 ' HB3' HD22 ' A' ' 108' ' ' LEU . 54.9 m-85 63.52 -130.72 0.44 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.074 -0.512 . . . . 75.230000000000004 111.817 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.721 ' HB3' ' O ' ' A' ' 90' ' ' ILE . 4.6 p80 34.44 85.95 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.456 1.28 . . . . 73.519999999999996 114.456 -173.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 131' ' ' HIS . 9.3 mpt_? -135.58 108.46 7.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.867 -0.606 . . . . 75.340000000000003 110.187 171.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' A' ' 93' ' ' ILE . 46.4 t -112.7 100.2 10.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.431 -0.952 . . . . 71.049999999999997 108.431 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.892 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 69.7 mtp180 -109.98 124.85 52.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 72.349999999999994 112.021 -169.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 135' ' ' ILE . 3.1 mp -97.0 107.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.293 -0.867 . . . . 74.109999999999999 109.282 174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -62.56 111.99 4.52 Favored Glycine 0 C--O 1.226 -0.399 0 C-N-CA 120.977 -0.63 . . . . 72.150000000000006 111.7 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.41 -10.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 111.968 0.359 . . . . 72.299999999999997 111.968 -175.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.787 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 151.89 130.08 1.58 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.063 -1.065 . . . . 65.230000000000004 112.433 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 28.5 ptt180 -86.03 159.69 53.73 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 110.238 -0.282 . . . . 74.340000000000003 110.238 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.554 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 51.6 Cg_exo -53.47 122.17 10.77 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.764 2.309 . . . . 73.230000000000004 112.799 -177.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.91 8.06 3.98 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.942 2.428 . . . . 71.349999999999994 112.24 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.0 -128.0 1.7 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 121.076 -0.583 . . . . 74.030000000000001 111.934 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -46.1 17.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.008 0.432 . . . . 73.439999999999998 110.543 -177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 17.3 mmtp -87.69 133.14 33.89 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.533 0.683 . . . . 73.129999999999995 110.531 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.608 ' HB2' HD12 ' A' ' 97' ' ' LEU . 2.6 p-10 -74.63 158.64 84.7 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 114.773 -1.103 . . . . 61.130000000000003 110.781 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.554 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 32.5 Cg_exo -58.69 -16.22 29.71 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.958 2.438 . . . . 72.409999999999997 113.26 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.512 ' HB3' ' OD2' ' A' ' 145' ' ' ASP . . . -68.39 -21.19 64.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.671 0.272 . . . . 72.329999999999998 111.317 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.41 -34.55 18.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.9 0.381 . . . . 65.140000000000001 111.233 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -84.35 -19.16 34.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.078 0.466 . . . . 73.120000000000005 111.331 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 21' ' ' ARG . 5.2 p -72.17 5.15 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.596 -0.729 . . . . 73.340000000000003 112.391 -172.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.92 -5.86 37.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.013 0.375 . . . . 71.209999999999994 112.013 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -160.89 144.53 13.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.911 0.386 . . . . 64.219999999999999 111.492 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 67.31 -173.92 0.19 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.15 -0.932 . . . . 72.319999999999993 112.621 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -156.72 171.48 20.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 73.310000000000002 109.51 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.828 ' HB ' ' HG3' ' A' ' 158' ' ' GLU . 25.1 m -102.5 120.07 39.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.864 0.364 . . . . 65.25 110.944 -175.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.58 -34.69 67.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 71.120000000000005 111.523 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.39 70.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 71.140000000000001 111.504 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.828 ' HG3' ' HB ' ' A' ' 155' ' ' THR . 1.5 pp20? -79.83 -20.83 45.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.692 0.282 . . . . 75.099999999999994 111.208 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.46 ' HA ' HG23 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -61.4 -20.36 62.97 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.241 0.543 . . . . 75.530000000000001 110.199 177.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -63.76 -35.61 81.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.62 -0.718 . . . . 42.539999999999999 111.318 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -85.66 -7.86 58.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.41 . . . . 73.340000000000003 111.501 -174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.802 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 93.8 t -57.74 -59.07 14.23 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 111.953 0.353 . . . . 74.010000000000005 111.953 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.802 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 44.6 Cg_exo -57.37 -36.0 98.87 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.047 1.831 . . . . 65.540000000000006 112.129 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.5 m -71.35 -44.78 64.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.85 -0.614 . . . . 64.019999999999996 111.291 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 162' ' ' VAL . 7.1 tp -67.52 -30.1 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 73.319999999999993 111.035 -175.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 162' ' ' VAL . 92.8 t -64.88 -48.82 82.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.318 . . . . 73.099999999999994 110.473 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -63.21 -44.25 95.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 72.310000000000002 110.332 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.47 -45.45 90.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.767 -0.651 . . . . 71.439999999999998 111.093 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.6 -30.91 69.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 70.510000000000005 111.432 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -56.82 -49.35 75.64 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.143 0.277 . . . . 45.009999999999998 111.61 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.69 -43.1 98.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.4 . . . . 73.439999999999998 111.094 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.68 69.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.817 -0.629 . . . . 51.509999999999998 111.573 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.476 ' O ' HG12 ' A' ' 177' ' ' ILE . 18.2 p -69.0 -39.04 79.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.964 0.357 . . . . 71.450000000000003 111.964 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -66.17 -40.26 90.38 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.029 -0.268 . . . . 72.219999999999999 110.87 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.4 tp -73.19 -30.89 63.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.986 0.422 . . . . 75.209999999999994 110.158 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.6 -49.3 77.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.554 -0.748 . . . . 70.200000000000003 109.427 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.722 HG23 HD21 ' A' ' 5' ' ' LEU . 45.1 mm -64.67 -31.37 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.143 -0.935 . . . . 62.32 111.207 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.5 -68.71 0.15 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.23 -0.441 . . . . 70.230000000000004 111.804 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -158.06 -38.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.751 0.31 . . . . 71.239999999999995 111.388 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -115.37 116.32 3.67 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.284 -0.96 . . . . 63.130000000000003 113.303 -173.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.648 ' HB2' HD21 ' A' ' 106' ' ' LEU . 4.2 pp -89.59 -20.51 23.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.363 0.601 . . . . 74.430000000000007 109.894 174.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 41.0 mt-10 -63.99 -50.13 71.19 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.39 -0.823 . . . . 52.409999999999997 111.691 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 13.9 Cg_endo -58.28 -32.38 95.82 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.91 1.74 . . . . 73.409999999999997 111.924 174.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.529 ' HA ' HG22 ' A' ' 187' ' ' THR . . . -64.28 -41.88 96.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.022 -0.535 . . . . 74.450000000000003 110.464 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.569 ' HG2' ' HB3' ' A' ' 106' ' ' LEU . 25.3 mt-30 -57.76 -34.69 69.83 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.098 -0.501 . . . . 72.129999999999995 110.553 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.49 -53.32 6.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.715 -0.675 . . . . 60.5 111.23 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 184' ' ' ALA . 8.8 t -62.46 -48.18 80.78 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.011 0.375 . . . . 65.409999999999997 112.011 -173.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.618 HG21 HD11 ' A' ' 104' ' ' ILE . 5.1 p -68.7 -14.07 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.96 0.41 . . . . 61.310000000000002 111.56 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -86.59 -8.18 57.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.117 0.484 . . . . 62.130000000000003 109.98 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -102.58 -17.7 15.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 74.420000000000002 111.878 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.584 ' HD1' ' HA ' ' A' ' 188' ' ' VAL . 90.8 m95 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.654 -0.688 . . . . 74.549999999999997 110.738 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptp . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 120.884 0.373 . . . . 62.119999999999997 110.709 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.45 147.83 49.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.091 -0.504 . . . . 63.109999999999999 110.468 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.2 pm0 -91.72 153.66 43.85 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.975 -0.557 . . . . 52.420000000000002 110.132 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 59' ' ' SER . 9.5 Cg_endo -52.75 129.81 34.32 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.3 2.667 . . . . 65.540000000000006 113.228 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.33 143.16 30.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 72.239999999999995 110.329 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 HG22 ' A' ' 90' ' ' ILE . 59.3 tp -96.93 109.95 22.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.911 -0.403 . . . . 74.430000000000007 109.911 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.8 115.31 31.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.723 -0.473 . . . . 74.450000000000003 109.723 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.86 114.26 45.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.107 -0.497 . . . . 63.229999999999997 110.251 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.29 134.33 7.78 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.688 -0.768 . . . . 65.420000000000002 111.241 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 10' ' ' LEU . 4.3 mm? -63.14 115.81 4.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.919 0.39 . . . . 64.329999999999998 110.044 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.857 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -87.04 -145.65 9.63 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.581 -0.736 . . . . 75.340000000000003 112.82 -174.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -102.41 136.5 19.37 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 110.618 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -89.52 -153.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.883 2.389 . . . . 65.299999999999997 111.239 172.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.04 -174.03 33.34 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.842 -0.694 . . . . 62.039999999999999 112.54 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.25 160.21 20.17 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.005 2.47 . . . . 75.25 112.344 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.2 m 72.77 -58.22 0.61 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.155 -0.475 . . . . 71.409999999999997 111.821 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -73.87 -13.58 60.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.382 . . . . 75.230000000000004 111.509 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.12 0.6 31.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.212 0.529 . . . . 73.219999999999999 110.715 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -105.09 20.41 18.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.691 -0.686 . . . . 73.340000000000003 109.957 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.6 p -100.33 175.4 5.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.965 -0.561 . . . . 74.409999999999997 110.791 -176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.56 ' HD3' ' O ' ' A' ' 153' ' ' ASN . 0.7 OUTLIER -81.59 1.66 32.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.468 -0.333 . . . . 71.219999999999999 111.734 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -105.92 11.82 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.41 0.522 . . . . 71.400000000000006 112.41 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -96.2 14.17 24.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.087 0.47 . . . . 63.119999999999997 110.032 176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.6 pt? -59.96 -33.08 71.44 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.61 -0.723 . . . . 70.230000000000004 111.987 -174.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.06 -48.5 85.77 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.666 -0.778 . . . . 73.109999999999999 111.691 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.857 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 85.9 t80 -60.67 -46.11 91.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.831 0.348 . . . . 62.219999999999999 110.904 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 96.2 mmm -59.23 -50.41 74.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.835 -0.621 . . . . 63.299999999999997 111.704 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.45 -40.12 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 73.430000000000007 111.025 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.59 ' HB1' HD21 ' A' ' 62' ' ' LEU . . . -66.07 -34.76 78.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.858 0.361 . . . . 53.420000000000002 111.362 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -71.69 -44.67 63.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.254 -0.43 . . . . 71.409999999999997 111.428 -176.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.0 m -65.59 -34.25 69.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.159 0.429 . . . . 72.219999999999999 112.159 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.5 pp -79.92 -29.03 39.72 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.539 -0.464 . . . . 54.130000000000003 110.73 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -67.77 -40.46 84.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.995 0.426 . . . . 60.340000000000003 110.035 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.33 -18.9 70.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.988 -0.625 . . . . 64.409999999999997 112.364 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -75.78 -54.32 7.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.723 0.297 . . . . 70.239999999999995 111.751 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 tp -67.13 -15.44 19.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.028 -0.533 . . . . 72.040000000000006 111.229 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.82 62.54 0.93 Allowed Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.592 -1.003 . . . . 73.349999999999994 110.592 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.553 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 32.1 m -151.86 156.17 39.62 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.087 0.47 . . . . 74.319999999999993 111.786 -169.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.4 144.49 31.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.623 -0.717 . . . . 50.0 109.089 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.7 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 40.4 p90 -108.01 149.43 28.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.108 0.48 . . . . 72.319999999999993 111.575 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -155.16 172.93 17.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.353 -0.84 . . . . 73.109999999999999 109.67 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.9 126.33 5.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.676 0.75 . . . . 63.450000000000003 112.125 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -137.18 158.95 43.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.364 -0.835 . . . . 73.540000000000006 110.715 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.686 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 1.6 tpmt? 63.22 -87.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 72.239999999999995 111.845 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.39 -87.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.745 1.387 . . . . 41.509999999999998 114.745 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 78' ' ' PRO . 51.8 p -91.45 -37.0 13.45 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.826 1.787 . . . . 53.119999999999997 115.826 -156.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.19 -7.49 4.46 Favored Glycine 0 CA--C 1.508 -0.372 0 C-N-CA 119.459 -1.353 . . . . 75.209999999999994 114.223 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.529 ' HB1' HG23 ' A' ' 50' ' ' VAL . . . -95.61 110.37 22.48 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 114.27 1.211 . . . . 74.019999999999996 114.27 -160.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.761 ' HG3' ' HD2' ' A' ' 66' ' ' ARG . 53.6 mt-10 -97.94 114.32 26.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.709 -1.589 . . . . 70.340000000000003 106.709 155.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.529 HG23 ' HB1' ' A' ' 48' ' ' ALA . 66.9 t -124.24 139.24 51.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.11 0.481 . . . . 63.310000000000002 111.823 -166.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.7 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 2.8 p -115.9 115.29 48.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.298 -1.001 . . . . 72.400000000000006 108.298 168.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.2 m -96.32 117.45 30.85 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.147 -0.479 . . . . 72.219999999999999 110.889 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.57 -169.96 22.64 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.032 -0.827 . . . . 63.130000000000003 111.032 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 54' ' ' ARG . 14.8 ptt180 -141.3 139.72 33.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.04 0.448 . . . . 74.409999999999997 110.61 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 57' ' ' GLY . 96.5 mt -118.42 136.98 53.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.198 -0.668 . . . . 63.140000000000001 109.198 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 72.1 -29.56 0.2 Allowed 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.739 0.649 . . . . 70.120000000000005 112.212 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . 145.15 -14.18 1.89 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.106 -0.568 . . . . 62.520000000000003 111.701 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.4 m -102.35 132.45 48.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.615 0.245 . . . . 74.109999999999999 110.492 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 17.4 m -69.85 145.15 52.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.255 -0.429 . . . . 53.32 110.656 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 177' ' ' ILE . 15.5 m -136.78 143.59 34.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.077 0.465 . . . . 71.5 110.919 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.07 101.98 13.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.741 -0.663 . . . . 65.439999999999998 109.673 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.59 HD21 ' HB1' ' A' ' 29' ' ' ALA . 53.0 tp -94.9 98.95 11.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.258 0.551 . . . . 74.319999999999993 110.996 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.447 ' HB2' HG22 ' A' ' 50' ' ' VAL . . . -117.12 167.5 11.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.643 -0.708 . . . . 74.340000000000003 110.213 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -154.45 134.0 7.63 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.573 0.225 . . . . 65.420000000000002 110.653 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 26.4 Cg_exo -63.98 142.19 80.5 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.809 2.34 . . . . 75.349999999999994 111.502 173.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.761 ' HD2' ' HG3' ' A' ' 49' ' ' GLU . 42.8 mtp180 -110.34 16.67 21.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.797 0.808 . . . . 74.150000000000006 109.751 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 70.1 m -133.62 161.46 34.58 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.767 -1.106 . . . . 64.0 109.026 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -70.04 165.87 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.18 0.514 . . . . 71.239999999999995 112.163 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.615 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . 21.9 ptt? -46.47 -44.77 17.81 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.787 1.403 . . . . 73.549999999999997 114.787 -167.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -67.09 -33.07 74.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.099 0.409 . . . . 73.239999999999995 111.24 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -96.96 0.97 49.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 73.400000000000006 111.094 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.6 t -65.12 -22.45 66.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.376 -0.375 . . . . 75.420000000000002 111.151 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.14 -30.13 76.9 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.975 -0.631 . . . . 51.43 112.605 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -85.04 -3.17 58.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.955 0.407 . . . . 75.510000000000005 110.909 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.439 ' HG3' ' HB3' ' A' ' 65' ' ' PRO . 22.8 mm-40 -82.31 -52.36 7.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.23 -0.441 . . . . 64.549999999999997 110.298 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.43 -21.44 6.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.803 -0.635 . . . . 72.400000000000006 110.679 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.36 -73.29 0.38 Allowed Glycine 0 C--N 1.335 0.492 0 CA-C-N 116.159 -0.473 . . . . 44.039999999999999 113.525 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.494 ' HB2' ' OG ' ' A' ' 46' ' ' SER . 50.6 Cg_exo -56.01 -35.63 94.85 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.63 2.22 . . . . 53.229999999999997 112.008 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.619 HD12 ' HG2' ' A' ' 44' ' ' LYS . 64.1 tp -57.94 -54.29 48.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.574 -0.739 . . . . 71.5 111.856 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.705 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . . . -62.81 -30.15 71.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.018 0.437 . . . . 71.340000000000003 111.892 -175.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.942 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 9.4 mmpt? -73.23 -24.21 60.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.248 -0.433 . . . . 72.319999999999993 111.677 -176.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -72.39 -58.69 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.8 0.296 . . . . 73.109999999999999 111.8 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.705 ' CE1' ' HA ' ' A' ' 80' ' ' ALA . 1.5 p90 -77.74 -11.37 59.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.631 -0.428 . . . . 74.010000000000005 111.176 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.1 t 65.93 34.55 7.08 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.808 0.67 . . . . 63.32 112.808 166.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.584 HG22 ' CD1' ' A' ' 83' ' ' TYR . 18.4 m -101.65 136.0 19.67 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 120.043 -0.663 . . . . 70.040000000000006 110.024 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 85' ' ' VAL . 20.0 Cg_exo -66.47 150.83 84.07 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.69 2.26 . . . . 75.319999999999993 111.976 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.94 41.35 0.64 Allowed 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.099 2.533 . . . . 72.340000000000003 112.57 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -95.47 -47.76 6.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.954 -0.566 . . . . 70.540000000000006 109.897 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -83.46 34.86 0.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.627 -0.715 . . . . 62.210000000000001 111.266 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 131' ' ' HIS . 46.3 pt -105.74 143.32 17.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 65.099999999999994 110.708 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.69 118.13 44.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.819 -0.628 . . . . 61.340000000000003 109.847 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.0 t -96.92 120.11 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 71.239999999999995 111.263 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 6.1 tt -98.54 111.42 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.534 0.683 . . . . 62.140000000000001 109.481 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -154.69 164.8 38.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 74.549999999999997 109.944 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.81 153.74 25.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.474 0.654 . . . . 74.129999999999995 111.444 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.492 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 30.0 tt0 -119.88 94.54 4.43 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.113 -1.069 . . . . 63.229999999999997 108.113 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.639 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 2.4 pt? -60.78 -27.99 68.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.244 -0.889 . . . . 53.43 112.552 -170.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.39 -10.76 60.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.134 0.492 . . . . 73.409999999999997 110.858 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.2 mm -107.92 135.51 46.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.126 -0.488 . . . . 73.450000000000003 109.841 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.449 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 14.8 m-20 -66.44 154.22 40.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.102 0.477 . . . . 71.349999999999994 111.686 -176.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.698 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 34.7 p90 -65.41 143.51 57.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.216 -0.902 . . . . 55.310000000000002 111.164 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.03 -67.57 0.51 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.408 -0.901 . . . . 75.129999999999995 112.689 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -116.74 155.67 28.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.795 0.331 . . . . 74.109999999999999 110.196 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.588 HG22 ' HA ' ' A' ' 135' ' ' ILE . 40.9 pt -116.75 165.4 12.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.134 -0.485 . . . . 75.420000000000002 110.692 -178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.466 ' HG3' ' HB2' ' A' ' 134' ' ' ARG . 38.4 ptt180 -142.52 170.21 16.13 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.077 -0.712 . . . . 73.120000000000005 109.077 176.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.731 HD22 ' HB2' ' A' ' 181' ' ' LEU . 5.7 mp -128.75 119.32 24.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.061 0.458 . . . . 74.299999999999997 110.8 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -143.05 127.03 17.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.778 -0.646 . . . . 72.109999999999999 109.912 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.779 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.0 pt? -72.48 121.75 20.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.798 -0.637 . . . . 53.310000000000002 109.936 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.68 -173.6 41.35 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.874 -0.679 . . . . 32.039999999999999 111.488 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.12 -154.32 16.17 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.437 -0.411 . . . . 75.310000000000002 112.789 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.492 ' HA3' HD12 ' A' ' 118' ' ' LEU . . . -110.78 81.49 0.29 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.764 -0.731 . . . . 71.329999999999998 112.221 177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -53.83 142.65 23.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.782 0.325 . . . . 74.430000000000007 110.434 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.34 -48.43 4.03 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.918 -0.658 . . . . 54.009999999999998 112.536 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.03 -59.46 3.65 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.994 -0.622 . . . . 61.43 111.816 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.4 m80 65.62 -74.49 0.06 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.378 0.671 . . . . 73.230000000000004 112.492 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -38.03 -56.89 1.11 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.242 1.017 . . . . 54.340000000000003 113.472 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.615 ' HA3' ' HB2' ' A' ' 69' ' ' MET . . . -62.45 -64.78 3.59 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.798 -0.715 . . . . 74.109999999999999 113.679 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.492 HD12 ' HA3' ' A' ' 111' ' ' GLY . 85.5 mt -68.09 -28.36 67.29 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.83 0.307 . . . . 75.400000000000006 111.83 -173.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -67.0 -39.92 87.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.31 -0.256 . . . . 61.350000000000001 110.31 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.2 t -64.13 -43.83 94.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.978 0.418 . . . . 40.420000000000002 110.08 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 t -67.18 -46.22 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 70.420000000000002 110.711 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -61.81 -41.48 97.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.743 -0.662 . . . . 61.229999999999997 111.754 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 m -66.26 -29.36 69.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.476 -0.329 . . . . 73.409999999999997 111.496 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.97 -46.94 17.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.903 0.382 . . . . 72.099999999999994 111.077 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.34 -35.81 54.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.066 -0.516 . . . . 63.450000000000003 111.731 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.37 40.12 4.3 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.487 -0.863 . . . . 64.420000000000002 111.367 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.485 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 11.5 t -129.88 176.29 8.16 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.244 -0.28 . . . . 75.530000000000001 110.244 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -138.48 21.73 2.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.79 0.329 . . . . 74.340000000000003 110.148 177.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.402 ' N ' HD22 ' A' ' 129' ' ' ASN . 0.9 OUTLIER 63.42 78.93 0.27 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.446 -0.797 . . . . 74.340000000000003 110.233 -178.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -71.83 -25.21 61.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.715 -0.675 . . . . 71.150000000000006 111.404 -176.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 90' ' ' ILE . 85.4 m-70 -140.85 120.49 13.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.724 -0.473 . . . . 75.099999999999994 109.724 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -153.49 152.12 30.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.945 0.402 . . . . 73.400000000000006 110.767 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.0 t -94.22 143.46 11.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.785 -0.643 . . . . 62.210000000000001 109.744 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.492 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 12.0 mmt180 -103.82 93.5 4.93 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.412 -0.588 . . . . 64.340000000000003 109.412 178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.588 ' HA ' HG22 ' A' ' 104' ' ' ILE . 65.1 mt -92.7 108.14 19.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.186 -0.461 . . . . 73.010000000000005 110.627 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.698 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -71.17 109.74 2.96 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.637 -0.792 . . . . 45.350000000000001 111.855 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.0 m -109.61 -6.95 11.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.013 0.435 . . . . 34.340000000000003 110.602 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 87.2 170.57 46.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.828 -0.701 . . . . 50.409999999999997 112.321 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.639 ' HD2' ' O ' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -141.49 131.67 12.93 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.592 -0.521 . . . . 72.319999999999993 109.592 176.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.461 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 28.9 Cg_endo -64.81 110.78 1.54 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.526 2.151 . . . . 64.200000000000003 111.93 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 6.1 Cg_exo -78.3 69.44 7.6 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.067 2.511 . . . . 60.32 111.82 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.03 -176.68 42.31 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.699 -0.682 . . . . 45.219999999999999 111.429 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.47 -15.25 29.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.006 0.432 . . . . 75.420000000000002 109.914 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -93.67 159.22 15.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.041 -0.527 . . . . 71.129999999999995 109.66 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.49 142.42 91.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.719 -0.475 . . . . 71.310000000000002 109.719 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.434 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 7.4 Cg_endo -52.08 -11.92 1.2 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.434 2.756 . . . . 63.420000000000002 113.744 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.14 -31.23 51.82 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.802 0.334 . . . . 63.43 111.403 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.73 -31.48 19.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.385 -0.37 . . . . 75.230000000000004 111.636 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.434 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 96.7 m-85 -84.16 -19.68 33.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.245 -0.434 . . . . 53.520000000000003 111.713 -175.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.01 -23.39 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.386 -0.37 . . . . 64.140000000000001 111.92 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.7 mt -94.15 -11.46 30.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.447 -0.342 . . . . 71.319999999999993 111.91 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.13 110.72 2.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.339 0.59 . . . . 71.010000000000005 111.015 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.56 ' O ' ' HD3' ' A' ' 21' ' ' ARG . 22.9 t-20 -160.28 121.97 3.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.801 -0.636 . . . . 70.25 110.562 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -164.76 100.28 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.835 0.71 . . . . 72.019999999999996 109.727 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.24 175.52 5.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.882 -0.599 . . . . 75.319999999999993 111.063 -174.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.65 -20.6 46.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.145 -0.48 . . . . 50.119999999999997 111.628 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.453 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -66.13 -50.26 64.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.176 -0.465 . . . . 51.119999999999997 111.477 -175.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.55 ' O ' HG23 ' A' ' 162' ' ' VAL . 1.6 mp0 -60.54 -30.36 69.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 71.340000000000003 111.206 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -55.75 -28.76 57.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.195 -0.457 . . . . 75.319999999999993 112.078 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.9 -24.22 60.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.674 0.273 . . . . 62.119999999999997 111.658 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -111.92 -7.86 14.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.351 0.5 . . . . 74.329999999999998 112.351 -174.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 158' ' ' GLU . 92.3 t -56.46 -56.68 29.35 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 121.111 -0.235 . . . . 74.5 110.916 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 20.1 Cg_endo -61.47 -34.47 85.96 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.983 1.789 . . . . 51.329999999999998 111.844 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.5 m -59.49 -42.14 91.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.865 -0.607 . . . . 75.329999999999998 110.904 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.6 mt -77.32 -52.83 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.003 -0.544 . . . . 75.439999999999998 111.378 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 162' ' ' VAL . 96.1 t -53.9 -47.41 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.382 0.512 . . . . 53.530000000000001 112.382 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -56.89 -52.11 66.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.984 0.421 . . . . 73.340000000000003 110.478 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -74.26 -41.62 60.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.789 -0.641 . . . . 74.129999999999995 111.604 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.52 -56.48 21.63 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.957 0.355 . . . . 73.25 111.957 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.94 -31.37 66.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.035 0.445 . . . . 71.230000000000004 111.66 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -80.92 -45.85 16.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.939 -0.573 . . . . 72.319999999999993 111.144 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.81 -30.87 65.98 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.374 0.509 . . . . 65.439999999999998 112.374 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.635 ' HA ' HD13 ' A' ' 176' ' ' LEU . 86.2 m -54.02 -32.0 52.93 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.219 0.451 . . . . 62.310000000000002 112.219 -175.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.98 -33.27 75.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 75.439999999999998 110.638 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.3 tp -73.14 -27.13 61.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 72.010000000000005 111.268 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 173' ' ' THR . 8.6 mp -66.93 -35.77 80.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.066 0.46 . . . . 73.409999999999997 110.112 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.555 HD13 HG11 ' A' ' 60' ' ' VAL . 50.0 mt -80.45 -25.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.604 -0.726 . . . . 55.399999999999999 109.899 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.16 -43.19 68.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.615 -0.72 . . . . 71.230000000000004 111.075 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -134.6 -73.17 0.47 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.371 -0.377 . . . . 71.140000000000001 110.405 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 176' ' ' LEU . . . -177.55 -157.97 19.59 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.248 -0.977 . . . . 74.439999999999998 112.789 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.764 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -89.83 -5.09 57.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.556 -0.322 . . . . 71.129999999999995 110.799 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.777 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 7.0 mm-40 -55.15 -56.97 22.52 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.853 -0.612 . . . . 64.340000000000003 111.859 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.777 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 2.9 Cg_exo -75.2 -26.58 10.47 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.744 1.629 . . . . 74.439999999999998 111.633 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 188' ' ' VAL . . . -65.15 -53.3 47.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.65 -0.705 . . . . 65.219999999999999 111.232 -177.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -60.97 -21.12 63.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 64.340000000000003 111.157 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -78.35 -55.28 5.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.371 -0.377 . . . . 71.140000000000001 110.591 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.9 t -71.64 -30.18 65.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.323 0.49 . . . . 71.230000000000004 112.323 -173.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 184' ' ' ALA . 22.8 m -82.18 -12.55 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.117 -0.364 . . . . 72.129999999999995 111.56 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -109.42 -31.49 7.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.389 -0.368 . . . . 63.130000000000003 110.945 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.44 -24.24 46.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.365 -0.379 . . . . 42.310000000000002 112.02 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 72.3 m95 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.469 -0.777 . . . . 74.239999999999995 110.175 179.425 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.84 0.352 . . . . 74.120000000000005 110.502 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.88 -165.58 1.24 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.237 -0.438 . . . . 54.509999999999998 110.197 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.405 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 42.9 mt-10 -89.47 165.3 26.28 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.465 -0.568 . . . . 73.129999999999995 109.465 175.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 3' ' ' GLU . 71.3 Cg_exo -50.17 108.21 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.486 2.124 . . . . 65.010000000000005 112.295 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.72 152.69 18.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.007 -0.542 . . . . 63.219999999999999 111.157 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.3 tp -97.39 116.87 30.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.968 -0.56 . . . . 75.340000000000003 109.49 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.29 110.41 31.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 72.099999999999994 110.048 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.551 HG11 HG22 ' A' ' 76' ' ' VAL . 43.5 t -121.89 132.82 70.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.588 -0.278 . . . . 64.329999999999998 110.504 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 93' ' ' ILE . . . -122.13 130.78 8.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.936 -0.649 . . . . 31.41 111.8 178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -72.63 144.19 47.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.238 0.542 . . . . 73.450000000000003 111.116 -176.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 26' ' ' PHE . . . -156.94 -177.67 30.28 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.786 -0.721 . . . . 65.549999999999997 111.709 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 86.7 m-20 -127.37 83.25 66.53 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 110.248 -0.278 . . . . 73.519999999999996 110.248 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.9 93.62 0.1 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.8 2.334 . . . . 74.099999999999994 112.224 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.51 158.93 31.02 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.698 -0.683 . . . . 52.549999999999997 111.401 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.16 -68.1 0.07 OUTLIER 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 123.163 2.575 . . . . 75.310000000000002 113.106 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 p -75.66 -26.74 57.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.934 0.397 . . . . 74.319999999999993 111.523 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.427 ' HB3' ' HB3' ' A' ' 12' ' ' ASN . 18.4 m-85 -70.24 -24.19 63.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.981 -0.554 . . . . 73.549999999999997 111.282 -176.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.414 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . . . -73.61 -9.35 58.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.262 -0.426 . . . . 71.450000000000003 111.405 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -94.8 18.6 11.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.245 -0.434 . . . . 63.32 110.773 -177.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.6 p -111.34 148.87 32.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.043 0.449 . . . . 63.009999999999998 111.016 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.567 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 30.5 ptt-85 -71.31 -5.73 34.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.066 -0.515 . . . . 74.420000000000002 110.557 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.534 ' CG ' HG23 ' A' ' 150' ' ' VAL . 30.6 t-80 -91.45 2.29 56.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.294 0.569 . . . . 70.25 109.949 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 18' ' ' ALA . 63.5 t30 -98.8 18.07 17.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.818 0.818 . . . . 73.129999999999995 109.206 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.4 -38.16 88.58 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.247 -0.888 . . . . 75.510000000000005 112.318 -173.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' HD22 ' A' ' 24' ' ' LEU . . . -62.51 -46.24 94.2 Favored Glycine 0 C--N 1.329 0.152 0 C-N-CA 120.529 -0.843 . . . . 60.149999999999999 112.426 -176.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.604 ' HB2' ' HA3' ' A' ' 11' ' ' GLY . 82.5 t80 -65.08 -38.77 91.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.163 0.506 . . . . 75.319999999999993 110.706 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.4 mmt -81.92 -37.69 26.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.913 -0.585 . . . . 73.549999999999997 112.534 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 31' ' ' VAL . 53.3 t -62.23 -37.75 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.951 0.405 . . . . 61.25 110.34 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.54 78.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.023 -0.535 . . . . 63.409999999999997 110.696 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -75.61 -48.95 20.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.109 -0.496 . . . . 65.230000000000004 111.289 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 28' ' ' VAL . 35.1 m -63.15 -40.78 90.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.538 -0.301 . . . . 72.299999999999997 111.654 -176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 169' ' ' ALA . 66.8 mt -66.06 -41.34 90.92 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.695 0.283 . . . . 74.409999999999997 110.814 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.83 -47.5 85.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.062 -0.517 . . . . 44.210000000000001 110.468 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.89 -27.94 71.06 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.884 -0.674 . . . . 44.520000000000003 112.857 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 18.0 mmm180 -73.18 -42.83 62.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.006 0.373 . . . . 72.200000000000003 112.006 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.71 -14.89 13.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.441 0.639 . . . . 74.109999999999999 110.264 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.12 58.91 1.43 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 110.539 -1.024 . . . . 62.310000000000002 110.539 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.6 m -137.98 126.59 23.59 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.045 -0.577 . . . . 65.140000000000001 111.718 -171.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.88 143.03 24.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.591 -0.732 . . . . 73.040000000000006 109.429 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.608 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 2.7 t80 -141.8 -146.0 0.18 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.246 -0.279 . . . . 65.140000000000001 110.246 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -155.51 173.26 16.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.788 0.327 . . . . 73.140000000000001 111.579 -169.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 47' ' ' GLY . 2.6 p -54.09 132.2 16.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.509 -0.768 . . . . 71.019999999999996 110.079 169.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.408 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 34.7 t60 -137.23 133.98 35.72 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.713 -0.395 . . . . 63.210000000000001 111.676 -173.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp 64.27 -172.79 0.17 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.565 -0.743 . . . . 72.019999999999996 112.195 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' C ' ' H ' ' A' ' 47' ' ' GLY . 33.5 ttpt -79.92 -15.01 58.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.802 0.81 . . . . 62.219999999999999 109.079 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 82' ' ' PHE . 9.7 p -81.75 25.4 0.55 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.638 -1.164 . . . . 74.310000000000002 109.238 170.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 45' ' ' LYS . . . -54.23 43.68 0.01 OUTLIER Glycine 0 C--N 1.34 0.769 0 N-CA-C 118.253 2.061 . . . . 73.530000000000001 118.253 -167.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.13 174.36 6.43 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 118.268 1.034 . . . . 63.240000000000002 108.212 165.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 58.0 mt-10 -72.1 116.52 12.61 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.065 -0.654 . . . . 74.140000000000001 109.866 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.608 ' O ' ' HB3' ' A' ' 40' ' ' PHE . 58.6 t -124.96 135.68 63.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 110.125 -0.324 . . . . 73.510000000000005 110.125 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 62' ' ' LEU . 3.1 p -125.71 110.97 25.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.339 0.59 . . . . 71.140000000000001 110.006 172.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 m -84.26 111.85 19.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.974 -0.557 . . . . 74.239999999999995 110.121 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -138.58 171.43 23.5 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.884 -0.675 . . . . 64.430000000000007 111.737 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -131.31 110.53 11.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.224 0.535 . . . . 75.140000000000001 111.137 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.526 ' HB3' ' HG2' ' A' ' 174' ' ' GLU . 6.9 mp -111.94 153.33 26.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.136 -0.69 . . . . 53.310000000000002 109.136 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 63.97 -73.36 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.844 0.715 . . . . 70.299999999999997 111.331 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.67 23.11 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.051 -0.595 . . . . 44.020000000000003 112.477 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.7 m -140.88 141.38 34.62 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.548 -0.383 . . . . 75.409999999999997 110.62 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.8 p -83.73 118.53 23.95 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.993 0.425 . . . . 54.0 110.008 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.5 m -116.52 155.72 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.168 -0.469 . . . . 55.039999999999999 110.975 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -97.03 100.54 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.907 -0.588 . . . . 62.310000000000002 109.731 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 51' ' ' VAL . 48.6 tp -95.05 115.28 27.22 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.339 -0.615 . . . . 75.329999999999998 109.339 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HB3' HG22 ' A' ' 8' ' ' VAL . . . -124.82 145.17 49.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.467 0.651 . . . . 73.439999999999998 112.295 -173.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -111.11 142.11 25.64 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 114.939 -1.028 . . . . 73.129999999999995 108.42 173.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 18.8 Cg_exo -65.95 152.59 81.0 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.368 2.045 . . . . 74.049999999999997 111.904 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -93.95 5.46 51.63 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.626 -0.879 . . . . 71.219999999999999 108.626 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.903 ' HB3' ' HG3' ' A' ' 71' ' ' GLU . 77.3 m -134.59 173.84 11.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.368 -1.287 . . . . 71.150000000000006 109.824 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.455 ' HD2' ' SD ' ' A' ' 69' ' ' MET . 17.3 p90 -85.35 -173.71 4.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.856 -0.611 . . . . 74.200000000000003 110.542 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.455 ' SD ' ' HD2' ' A' ' 68' ' ' TYR . 1.7 pmm? -48.55 -46.24 38.69 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.388 0.885 . . . . 74.430000000000007 113.388 -170.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -66.16 -62.35 1.53 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 75.519999999999996 111.735 -173.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.903 ' HG3' ' HB3' ' A' ' 67' ' ' CYS . 6.2 pt-20 -87.48 18.91 3.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.469 . . . . 71.019999999999996 111.299 -175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.1 t -65.33 -39.2 92.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.342 -0.614 . . . . 73.230000000000004 109.342 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.51 -23.57 66.93 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.738 -0.665 . . . . 72.549999999999997 112.188 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -71.92 -17.27 62.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.74 0.305 . . . . 71.329999999999998 110.425 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -95.88 -42.62 8.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 64.519999999999996 110.537 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.551 HG22 HG11 ' A' ' 8' ' ' VAL . 25.7 t -62.23 -38.54 81.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.983 -0.553 . . . . 63.399999999999999 111.236 -177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.33 -64.56 4.27 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.879 -0.6 . . . . 65.209999999999994 113.257 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.05 -41.23 70.17 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.646 2.23 . . . . 74.109999999999999 112.31 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.1 tp -54.85 -48.65 72.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.28 -0.418 . . . . 54.43 111.113 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.83 88.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.167 -0.47 . . . . 51.039999999999999 111.334 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -75.98 -35.22 59.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.177 -0.465 . . . . 72.400000000000006 111.291 -175.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' HD2' ' HB3' ' A' ' 46' ' ' SER . 21.5 m-85 -71.74 -20.14 61.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.78 0.324 . . . . 72.420000000000002 111.086 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -98.74 -1.37 40.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.292 -0.413 . . . . 75.430000000000007 110.871 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m 59.73 29.61 19.18 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.643 -0.708 . . . . 72.150000000000006 111.767 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.23 149.06 35.29 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.643 -0.253 . . . . 61.119999999999997 110.601 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 90' ' ' ILE . 14.1 Cg_exo -70.35 110.31 2.64 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.079 2.519 . . . . 71.329999999999998 112.046 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.523 ' HB3' HD22 ' A' ' 125' ' ' LEU . 23.1 Cg_exo -65.1 -11.92 32.21 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.158 2.572 . . . . 75.420000000000002 112.42 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mp0 -78.94 -43.29 24.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.261 -0.427 . . . . 63.439999999999998 110.174 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -96.63 0.71 50.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.12 -0.491 . . . . 71.420000000000002 112.155 -170.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 131' ' ' HIS . 40.2 pt -75.47 174.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.806 -0.357 . . . . 54.520000000000003 110.425 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 p -119.88 125.26 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.331 0.586 . . . . 73.510000000000005 110.98 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.477 HG23 ' HB2' ' A' ' 131' ' ' HIS . 98.1 t -119.32 123.8 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 53.219999999999999 110.448 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.522 ' HB ' ' HA2' ' A' ' 9' ' ' GLY . 48.8 mm -75.57 130.63 36.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.693 -0.685 . . . . 74.140000000000001 109.6 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.403 ' HE1' ' HA3' ' A' ' 114' ' ' GLY . 31.5 t-80 -136.6 157.58 46.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.118 0.485 . . . . 71.549999999999997 110.469 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -86.77 152.76 22.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.875 -0.602 . . . . 71.530000000000001 110.688 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.747 ' HB2' ' HB3' ' A' ' 134' ' ' ARG . 26.9 tt0 -128.07 93.78 3.76 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.915 -0.772 . . . . 65.230000000000004 108.915 168.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 139' ' ' ARG . 4.0 pp -84.02 0.09 49.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.027 -0.988 . . . . 60.219999999999999 112.04 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.438 ' HB2' ' HA2' ' A' ' 113' ' ' GLY . 27.9 t70 -87.08 -38.94 16.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.163 0.506 . . . . 74.219999999999999 110.351 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.3 mm -89.44 152.06 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.462 -0.79 . . . . 53.219999999999999 109.852 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.503 ' HA ' ' HA2' ' A' ' 138' ' ' GLY . 5.1 p-10 -64.39 159.97 20.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.377 0.608 . . . . 70.519999999999996 111.61 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 0.8 OUTLIER -72.59 135.69 45.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.132 -0.94 . . . . 64.329999999999998 112.027 -176.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.02 -64.06 0.53 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.235 -0.983 . . . . 62.310000000000002 113.278 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -85.88 145.62 27.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.797 0.332 . . . . 72.409999999999997 110.839 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.568 HG12 HG21 ' A' ' 188' ' ' VAL . 30.7 pt -117.27 149.85 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.481 -0.562 . . . . 70.200000000000003 109.481 174.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -157.03 137.22 12.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.852 0.358 . . . . 70.219999999999999 110.949 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 133' ' ' VAL . 4.0 pp -96.68 153.47 17.85 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.757 -0.46 . . . . 62.340000000000003 109.757 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -147.39 115.54 6.56 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.771 -0.455 . . . . 71.230000000000004 109.771 -175.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 129' ' ' ASN . 0.7 OUTLIER -80.91 90.12 5.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.828 0.823 . . . . 73.519999999999996 110.326 177.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.28 -127.09 1.63 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.385 -0.825 . . . . 62.509999999999998 111.385 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.08 163.17 32.96 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.299 -0.721 . . . . 75.420000000000002 111.299 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.8 94.66 0.68 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.641 -0.79 . . . . 64.409999999999997 112.492 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.91 142.12 12.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.136 0.494 . . . . 72.299999999999997 111.334 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 98' ' ' ASP . . . 96.88 -76.12 0.7 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.041 -0.599 . . . . 63.25 112.972 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.403 ' HA3' ' HE1' ' A' ' 94' ' ' HIS . . . -80.28 63.78 4.09 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.046 -0.597 . . . . 71.099999999999994 112.93 -174.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -62.67 -27.1 69.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.778 0.288 . . . . 74.140000000000001 111.778 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -65.51 -29.93 70.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.312 0.577 . . . . 73.319999999999993 110.786 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -108.43 20.56 29.97 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.59 -0.814 . . . . 64.420000000000002 112.308 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 118' ' ' LEU . 33.5 mt -84.5 -59.51 2.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.881 -0.328 . . . . 72.430000000000007 111.276 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HD2' ' N ' ' A' ' 119' ' ' ARG . 3.7 mpt_? -73.65 -35.78 65.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.35 -0.386 . . . . 74.540000000000006 110.58 -174.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 p -56.42 -43.96 79.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 54.43 111.233 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.461 ' HB ' HH22 ' A' ' 132' ' ' ARG . 48.9 t -85.33 -41.62 15.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 54.530000000000001 111.889 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.37 -47.16 71.2 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.051 0.389 . . . . 64.140000000000001 112.051 -172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.2 m -66.93 -24.53 66.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.659 0.266 . . . . 61.109999999999999 111.18 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.43 -45.6 37.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.758 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.523 HD22 ' HB3' ' A' ' 87' ' ' PRO . 90.6 mt -72.58 -34.98 67.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 73.430000000000007 110.384 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 114.61 -12.56 20.86 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.907 -0.663 . . . . 73.239999999999995 113.15 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -169.56 177.57 4.53 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.167 0.508 . . . . 72.049999999999997 111.579 -178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 2.5 mptt -110.34 -110.97 0.33 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.587 -0.894 . . . . 75.439999999999998 108.587 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.477 ' H ' ' HB2' ' A' ' 128' ' ' LYS . 4.3 t-20 64.96 -9.89 0.18 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.708 0.803 . . . . 64.120000000000005 113.054 174.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.408 ' H ' ' C ' ' A' ' 128' ' ' LYS . 10.4 t80 -179.79 -157.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.659 -0.867 . . . . 71.140000000000001 108.659 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.593 ' O ' ' HD2' ' A' ' 132' ' ' ARG . 11.6 p-80 44.87 41.08 4.86 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.937 0.895 . . . . 65.319999999999993 113.067 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.593 ' HD2' ' O ' ' A' ' 131' ' ' HIS . 2.7 mpt_? -131.01 107.03 8.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.786 -0.643 . . . . 71.540000000000006 109.906 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 106' ' ' LEU . 58.8 t -119.18 109.95 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.943 -0.762 . . . . 64.230000000000004 108.943 174.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.747 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 90.2 mtm180 -92.14 122.64 34.83 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.088 0.471 . . . . 61.409999999999997 111.651 -172.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 135' ' ' ILE . 2.1 mp -99.88 115.03 40.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.946 -0.761 . . . . 44.32 108.946 172.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -63.52 109.13 2.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.881 -0.676 . . . . 71.150000000000006 111.472 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.567 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 30.8 m -101.4 -18.7 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.562 0.22 . . . . 74.409999999999997 111.491 -176.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 100' ' ' ASP . . . 107.92 139.66 9.08 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.424 -0.893 . . . . 75.219999999999999 112.664 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 6.1 ptp180 -80.88 133.5 54.86 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.032 0.444 . . . . 73.420000000000002 111.586 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 22.3 Cg_exo -65.23 128.99 21.66 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 123.303 2.669 . . . . 64.409999999999997 112.499 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' A' ' 140' ' ' PRO . 5.9 Cg_exo -78.86 45.67 1.97 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.191 2.594 . . . . 73.510000000000005 112.272 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.87 143.74 10.95 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.044 -0.823 . . . . 71.140000000000001 111.044 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 143' ' ' ARG . 18.1 mmt180 -89.58 58.39 4.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.513 0.673 . . . . 62.100000000000001 111.446 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -131.0 160.49 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.101 -0.954 . . . . 73.400000000000006 109.296 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -66.49 141.09 96.9 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.263 -0.643 . . . . 71.120000000000005 109.263 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.8 -14.37 1.22 Allowed 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.552 2.835 . . . . 71.230000000000004 113.915 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.32 28.62 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.588 0.355 . . . . 75.239999999999995 111.813 174.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.75 -41.63 13.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.146 0.498 . . . . 74.409999999999997 111.228 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -73.61 -19.81 60.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 61.25 111.76 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.534 HG23 ' CG ' ' A' ' 22' ' ' HIS . 14.5 p -65.21 -22.52 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.246 -0.434 . . . . 74.340000000000003 111.49 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.52 -27.76 13.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.62 -0.264 . . . . 72.140000000000001 111.36 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -165.43 109.7 0.86 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.259 0.552 . . . . 71.239999999999995 111.467 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -164.27 31.79 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.823 -0.626 . . . . 65.349999999999994 110.125 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -60.23 124.57 20.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.311 0.577 . . . . 74.150000000000006 111.142 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.17 176.32 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.459 -0.791 . . . . 64.319999999999993 110.289 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -80.65 -54.46 5.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.837 0.351 . . . . 74.439999999999998 111.741 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.39 -23.77 66.37 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.208 0.818 . . . . 54.340000000000003 113.208 -171.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.71 -23.7 66.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.067 0.461 . . . . 74.310000000000002 110.698 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.452 ' HA ' HG23 ' A' ' 162' ' ' VAL . 22.7 mmm180 -69.41 -22.37 63.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.747 -0.661 . . . . 72.530000000000001 111.417 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.36 -33.21 73.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.281 -0.418 . . . . 61.0 111.711 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 165' ' ' ILE . 8.9 mm-40 -97.04 1.48 50.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.885 0.328 . . . . 62.509999999999998 111.885 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' A' ' 163' ' ' PRO . 95.1 t -60.82 -53.39 64.65 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.772 -0.194 . . . . 73.209999999999994 111.373 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 30.7 Cg_endo -64.64 -25.62 61.78 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.772 1.648 . . . . 74.439999999999998 111.794 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.1 m -63.32 -51.17 67.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.624 -0.716 . . . . 75.430000000000007 110.945 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 161' ' ' GLU . 78.9 mt -54.49 -38.17 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.938 -0.573 . . . . 64.239999999999995 111.727 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.25 -51.44 55.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.096 -0.502 . . . . 63.240000000000002 111.363 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -80.97 -30.44 35.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.406 -0.361 . . . . 74.319999999999993 111.563 -176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -67.12 -43.18 83.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.043 0.449 . . . . 72.200000000000003 110.961 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.418 ' HB3' HD21 ' A' ' 32' ' ' LEU . . . -60.09 -37.9 81.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 73.310000000000002 111.29 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.78 92.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.896 0.379 . . . . 55.420000000000002 111.548 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.81 -41.61 78.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.85 0.357 . . . . 74.420000000000002 110.977 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.75 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.042 -0.527 . . . . 61.420000000000002 112.279 -176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 23.6 p -62.86 -48.63 78.19 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.218 0.451 . . . . 65.239999999999995 112.218 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.526 ' HG2' ' HB3' ' A' ' 55' ' ' LEU . 40.3 mt-10 -64.99 -29.66 70.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.742 -0.208 . . . . 75.129999999999995 111.347 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.522 HD23 ' HA ' ' A' ' 184' ' ' ALA . 22.0 tp -74.54 -31.77 62.23 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.749 -0.38 . . . . 53.420000000000002 110.38 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 181' ' ' LEU . 70.6 mt -62.18 -45.1 94.91 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.245 0.545 . . . . 65.239999999999995 110.121 173.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 59.8 mt -71.02 -28.63 33.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.367 -0.833 . . . . 62.43 110.274 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.96 -59.06 5.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.556 -0.747 . . . . 62.350000000000001 111.186 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -178.1 -49.61 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 N-CA-C 111.849 0.314 . . . . 70.329999999999998 111.849 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.14 116.82 5.35 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.637 -0.792 . . . . 55.229999999999997 113.71 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.682 ' HA ' HD23 ' A' ' 176' ' ' LEU . 10.2 mp -77.63 -44.24 28.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.01 0.433 . . . . 63.43 110.658 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.588 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 45.5 mt-10 -72.56 -44.07 9.34 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.195 -0.457 . . . . 73.150000000000006 111.697 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 182' ' ' GLU . 74.8 Cg_exo -52.12 -35.89 64.03 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.532 1.488 . . . . 75.109999999999999 111.918 170.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.522 ' HA ' HD23 ' A' ' 175' ' ' LEU . . . -73.31 -38.01 65.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.38 -0.373 . . . . 70.209999999999994 111.682 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 3.4 pt20 -71.36 -27.49 63.39 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.535 -0.466 . . . . 71.510000000000005 109.906 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -86.34 -32.09 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 72.120000000000005 111.69 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 184' ' ' ALA . 13.1 t -61.87 -50.42 72.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.96 -0.296 . . . . 61.420000000000002 111.062 -176.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.568 HG21 HG12 ' A' ' 104' ' ' ILE . 9.4 p -67.39 -26.45 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 121.569 0.7 . . . . 55.399999999999999 110.299 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -69.69 -31.7 69.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.377 -0.829 . . . . 51.140000000000001 110.318 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -93.61 -6.58 46.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.886 -0.597 . . . . 23.329999999999998 111.75 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.9 m95 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.664 -0.684 . . . . 73.349999999999994 110.585 175.843 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.747 -0.464 . . . . 75.219999999999999 109.747 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.52 88.04 7.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.942 0.401 . . . . 64.329999999999998 110.558 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 8.8 pt-20 -101.81 105.59 42.24 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.755 -0.657 . . . . 64.439999999999998 109.778 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.907 ' HB2' HG23 ' A' ' 61' ' ' VAL . 56.4 Cg_endo -92.27 117.28 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.987 2.458 . . . . 73.409999999999997 113.318 -175.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.646 ' HB2' HG12 ' A' ' 60' ' ' VAL . 70.9 mt -67.67 145.17 55.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 71.340000000000003 109.935 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.581 HD23 HG12 ' A' ' 90' ' ' ILE . 57.3 tp -93.32 109.36 20.91 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.107 -0.331 . . . . 72.420000000000002 110.107 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.58 113.12 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.496 . . . . 63.530000000000001 110.366 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.02 164.1 22.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.232 -0.44 . . . . 74.239999999999995 110.602 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.29 -178.66 39.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.601 -0.809 . . . . 51.039999999999999 112.25 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.476 HD21 ' CE1' ' A' ' 94' ' ' HIS . 86.3 mt -67.55 126.48 29.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.69 0.281 . . . . 73.540000000000006 110.966 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.98 177.73 52.09 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.934 -0.651 . . . . 30.109999999999999 113.149 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 30.0 t-20 -124.63 108.06 28.94 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 110.048 -0.353 . . . . 64.439999999999998 110.048 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 12' ' ' ASN . 4.6 Cg_exo -76.75 -33.26 3.05 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.41 2.74 . . . . 43.340000000000003 114.117 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.92 147.81 15.01 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.889 -1.148 . . . . 44.530000000000001 113.104 -174.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.02 -31.83 94.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.553 2.835 . . . . 73.349999999999994 113.34 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 m -61.05 -39.14 88.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.293 0.568 . . . . 72.420000000000002 110.879 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.573 ' HB3' ' CE1' ' A' ' 22' ' ' HIS . 91.0 m-85 -97.17 2.5 51.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.53 -0.759 . . . . 74.109999999999999 110.52 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.426 ' CB ' HD21 ' A' ' 12' ' ' ASN . . . -71.28 -18.46 62.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.763 0.653 . . . . 72.040000000000006 112.763 -171.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -92.53 18.84 7.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.697 0.284 . . . . 73.430000000000007 111.228 -175.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.636 HG21 ' O ' ' A' ' 151' ' ' LEU . 59.8 p -113.95 -174.08 2.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.277 0.56 . . . . 71.549999999999997 111.904 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.601 ' HD2' ' HB ' ' A' ' 137' ' ' VAL . 5.0 ptt180 -94.47 1.53 55.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.513 -0.767 . . . . 73.200000000000003 112.85 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.617 ' HB3' HG22 ' A' ' 150' ' ' VAL . 3.6 p-80 -94.74 10.8 33.68 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.414 -0.515 . . . . 74.329999999999998 111.496 -176.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -139.15 35.04 2.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.075 0.464 . . . . 74.540000000000006 110.757 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.9 mt -56.04 -46.56 78.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.427 -0.806 . . . . 73.519999999999996 111.796 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.94 -51.19 60.67 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.999 -0.546 . . . . 70.030000000000001 113.013 -174.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -57.82 -38.3 75.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 73.310000000000002 111.289 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 90.1 mtp -73.01 -54.43 8.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.56 -0.291 . . . . 74.299999999999997 111.388 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.468 HG12 HD23 ' A' ' 32' ' ' LEU . 57.7 t -61.21 -44.2 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 71.519999999999996 111.558 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.516 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -58.78 -53.24 60.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 51.109999999999999 112.138 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.73 -37.12 81.77 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.169 0.433 . . . . 60.039999999999999 112.169 -175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.63 -32.02 34.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.603 -0.439 . . . . 53.130000000000003 112.117 -175.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 33' ' ' ALA . 4.6 pp -76.41 -33.27 58.82 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.462 -0.495 . . . . 71.329999999999998 110.577 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' N ' HD12 ' A' ' 32' ' ' LEU . . . -70.0 -34.04 72.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.263 0.554 . . . . 51.009999999999998 110.279 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.88 -18.68 57.51 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.508 -0.769 . . . . 63.509999999999998 113.088 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -64.02 -39.38 93.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.026 0.413 . . . . 73.319999999999993 111.651 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 36' ' ' ILE . 3.9 mp -83.11 -14.47 11.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.702 0.763 . . . . 74.439999999999998 109.553 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.98 13.69 54.04 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.87 -1.292 . . . . 71.010000000000005 109.87 -171.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.2 m -87.71 113.19 23.16 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.307 -0.946 . . . . 75.439999999999998 111.197 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -153.91 128.32 9.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.282 -0.417 . . . . 73.319999999999993 110.782 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.534 ' CD1' HG23 ' A' ' 51' ' ' VAL . 4.5 m-85 -102.76 -157.36 0.61 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.973 -0.558 . . . . 65.319999999999993 109.721 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -140.91 172.36 12.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.818 -0.353 . . . . 74.239999999999995 110.961 -173.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.797 ' HA ' ' HG2' ' A' ' 49' ' ' GLU . 3.3 p -55.83 105.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.748 0.785 . . . . 74.340000000000003 110.464 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.571 ' HD2' ' HG2' ' A' ' 45' ' ' LYS . 8.0 t60 -104.76 145.05 30.91 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.501 -0.772 . . . . 74.120000000000005 109.433 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -65.97 -77.11 0.07 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.176 -0.466 . . . . 54.210000000000001 111.277 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.587 ' HE3' ' HD2' ' A' ' 82' ' ' PHE . 28.8 mmmt 47.26 -133.27 1.18 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.501 -0.555 . . . . 54.350000000000001 109.501 -172.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 p -105.97 -39.46 6.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.389 -0.925 . . . . 65.409999999999997 112.725 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.726 ' HA3' ' HB3' ' A' ' 75' ' ' GLN . . . -133.01 -24.18 0.73 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 118.4 -1.857 . . . . 53.240000000000002 117.055 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.72 162.01 36.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 114.678 1.362 . . . . 51.520000000000003 114.678 -160.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.797 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 23.0 mt-10 -74.94 135.98 41.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.182 -1.372 . . . . 73.540000000000006 108.75 170.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.61 140.11 49.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.002 0.43 . . . . 72.299999999999997 111.654 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.779 HG13 ' HB3' ' A' ' 62' ' ' LEU . 2.4 p -124.41 114.76 42.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.717 -0.674 . . . . 75.409999999999997 109.953 171.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 m -95.65 131.22 42.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.863 -0.608 . . . . 74.430000000000007 110.505 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.23 -161.16 29.38 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.374 -0.69 . . . . 74.140000000000001 111.374 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -131.41 132.69 44.55 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.896 0.379 . . . . 73.310000000000002 110.458 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.1 mt -102.93 126.56 50.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.983 -0.553 . . . . 64.420000000000002 109.593 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 178' ' ' ALA . . . 68.97 -47.92 0.58 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 124.009 0.818 . . . . 65.420000000000002 111.778 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.11 -41.62 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.079 -0.581 . . . . 62.32 112.397 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.685 ' HB ' HG22 ' A' ' 177' ' ' ILE . 6.8 m -84.46 141.52 30.73 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.781 0.324 . . . . 44.329999999999998 110.965 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 3.7 p -70.22 143.3 52.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 74.109999999999999 111.353 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 177' ' ' ILE . 20.5 m -143.67 158.14 16.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.081 0.467 . . . . 52.039999999999999 111.297 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.907 HG23 ' HB2' ' A' ' 4' ' ' PRO . 85.0 t -112.07 104.93 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.675 -0.693 . . . . 65.340000000000003 109.186 172.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.779 ' HB3' HG13 ' A' ' 51' ' ' VAL . 3.0 tm? -95.84 118.72 33.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.552 -0.536 . . . . 71.25 109.552 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -134.64 131.15 37.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.733 -0.667 . . . . 71.209999999999994 109.96 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -127.59 135.23 27.15 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.942 0.401 . . . . 64.239999999999995 110.882 -178.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 1.4 Cg_endo -83.8 164.45 13.86 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.104 2.536 . . . . 61.119999999999997 111.918 176.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 68.3 mtt180 -112.19 17.1 19.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.37 0.605 . . . . 72.099999999999994 109.82 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 52.9 m -112.03 164.2 13.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.477 -0.783 . . . . 62.310000000000002 110.146 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -66.18 167.95 9.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.282 -0.417 . . . . 63.409999999999997 110.998 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 19.3 ptp -55.23 -32.44 62.28 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.855 0.687 . . . . 74.340000000000003 112.855 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -72.1 -24.33 61.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.11 0.481 . . . . 75.519999999999996 110.585 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 12.5 mm-40 -102.91 -10.3 19.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.923 -0.581 . . . . 72.019999999999996 110.996 -175.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.432 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.5 m -61.56 -51.8 67.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 73.030000000000001 111.676 -173.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.872 ' HA3' ' HA ' ' A' ' 121' ' ' VAL . . . -62.03 -23.83 64.25 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.193 -0.527 . . . . 53.0 113.276 -174.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -61.97 -37.9 86.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.039 0.447 . . . . 73.540000000000006 110.974 -176.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.726 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 12.9 mm100 -92.19 -20.43 21.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.931 -0.577 . . . . 74.319999999999993 110.996 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 72' ' ' SER . 95.7 t -73.69 -36.27 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 72.030000000000001 111.015 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.716 ' HA2' ' HB3' ' A' ' 125' ' ' LEU . . . -52.12 -68.45 1.56 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.991 -0.549 . . . . 74.019999999999996 112.973 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -58.11 -28.85 85.21 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.629 2.22 . . . . 74.310000000000002 112.495 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.94 -48.78 77.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 73.519999999999996 110.24 -177.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.55 90.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.004 -0.544 . . . . 63.530000000000001 111.491 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.66 -20.19 59.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.288 -0.415 . . . . 45.229999999999997 111.564 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HD2' ' HE3' ' A' ' 45' ' ' LYS . 4.8 m-30 -74.21 -20.19 60.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.497 -0.32 . . . . 74.230000000000004 110.728 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -106.99 -11.74 15.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.51 -0.314 . . . . 70.099999999999994 110.833 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.0 t 61.74 36.3 16.41 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.627 -0.715 . . . . 64.420000000000002 110.529 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.4 m -74.11 142.76 79.53 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 110.619 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.89 128.32 25.12 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.869 2.38 . . . . 54.43 112.079 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.55 -9.39 18.0 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.02 2.48 . . . . 65.340000000000003 112.633 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -83.68 -12.75 55.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.113 -0.494 . . . . 73.450000000000003 110.903 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -105.31 24.79 11.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.347 -0.388 . . . . 75.230000000000004 111.186 -175.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.581 HG12 HD23 ' A' ' 6' ' ' LEU . 62.6 mt -89.07 109.84 20.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.412 . . . . 70.319999999999993 111.196 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.785 HG12 ' HB3' ' A' ' 131' ' ' HIS . 32.6 m -113.42 141.7 28.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.468 -0.568 . . . . 61.100000000000001 109.468 174.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.01 130.16 51.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.318 0.58 . . . . 63.030000000000001 111.989 -175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.1 mm -85.28 118.0 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.55 -0.75 . . . . 74.329999999999998 109.291 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.476 ' CE1' HD21 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -137.61 170.26 16.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.411 0.624 . . . . 73.219999999999999 111.482 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -90.35 145.71 24.74 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.703 -1.135 . . . . 65.019999999999996 111.973 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 7.2 mm-40 -140.43 119.42 12.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.624 -0.716 . . . . 73.310000000000002 109.778 169.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.541 ' HB2' ' HG2' ' A' ' 139' ' ' ARG . 1.7 pp -83.77 -0.15 49.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.523 -0.762 . . . . 55.229999999999997 112.529 -174.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.416 ' OD2' HG13 ' A' ' 99' ' ' ILE . 3.4 p-10 -77.29 -10.85 59.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 71.209999999999994 111.383 -174.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.416 HG13 ' OD2' ' A' ' 98' ' ' ASP . 61.3 mt -135.17 149.72 29.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.956 -0.757 . . . . 64.299999999999997 108.956 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.05 179.1 7.94 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.453 -0.573 . . . . 75.349999999999994 109.453 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -66.17 123.79 20.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.091 0.472 . . . . 73.150000000000006 110.382 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 166.18 -118.13 0.78 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.789 -0.925 . . . . 74.299999999999997 110.789 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.568 ' HA ' HE22 ' A' ' 168' ' ' GLN . 7.8 ppt_? -83.4 132.99 34.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.265 0.533 . . . . 73.530000000000001 110.064 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 29.3 pt -97.69 166.16 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.995 -0.548 . . . . 63.509999999999998 110.703 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -126.6 127.85 45.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.235 0.54 . . . . 75.010000000000005 110.785 178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.692 HD13 HG21 ' A' ' 188' ' ' VAL . 10.0 mp -104.71 111.88 24.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.979 -0.555 . . . . 62.0 110.947 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -143.58 135.77 26.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.581 -0.736 . . . . 65.25 109.201 176.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.5 pp -85.75 125.73 33.45 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 61.200000000000003 110.015 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.58 179.26 38.56 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.654 -0.703 . . . . 61.149999999999999 111.544 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.1 -156.95 6.8 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.011 -0.614 . . . . 74.549999999999997 112.594 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.62 ' HA3' HD13 ' A' ' 118' ' ' LEU . . . -78.8 130.98 10.34 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.021 -0.609 . . . . 75.099999999999994 112.141 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -105.91 -30.92 9.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.77 0.319 . . . . 64.019999999999996 110.467 -176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -93.79 -4.86 63.26 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.843 -0.694 . . . . 75.010000000000005 112.862 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.2 103.58 0.09 OUTLIER Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.019 -0.61 . . . . 61.210000000000001 112.525 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.652 ' HB2' ' HG ' ' A' ' 118' ' ' LEU . 32.0 m-70 -138.83 142.42 38.66 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.04 -0.356 . . . . 74.099999999999994 110.04 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -66.89 -44.84 79.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 72.530000000000001 111.243 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.34 11.91 3.69 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.056 -0.592 . . . . 74.510000000000005 113.664 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.652 ' HG ' ' HB2' ' A' ' 115' ' ' HIS . 95.9 mt -84.28 -51.35 7.07 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.606 -0.35 . . . . 75.310000000000002 110.599 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -79.02 -28.78 43.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.928 -0.578 . . . . 70.209999999999994 110.821 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.6 m -61.86 -32.72 73.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.081 0.467 . . . . 74.239999999999995 110.777 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.872 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 68.3 t -84.4 -47.26 17.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.445 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' HA ' ' CG2' ' A' ' 127' ' ' THR . . . -57.5 -55.79 30.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.759 -0.655 . . . . 73.129999999999995 112.45 -174.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.6 m -66.52 -21.64 66.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.024 0.379 . . . . 75.510000000000005 112.024 -174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.82 -52.09 64.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.803 0.297 . . . . 73.120000000000005 111.803 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.716 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 1.4 pt? -110.17 3.75 20.42 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.786 -0.366 . . . . 72.310000000000002 111.385 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.92 20.04 61.98 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.68 -0.772 . . . . 64.099999999999994 112.852 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.465 ' CG2' ' HA ' ' A' ' 122' ' ' ALA . 13.0 t -85.91 167.47 15.08 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.927 -0.397 . . . . 74.019999999999996 109.927 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 12.0 mptt -119.82 8.21 11.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.438 -0.346 . . . . 70.120000000000005 110.16 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 59.58 62.99 1.61 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.756 -0.656 . . . . 70.340000000000003 109.67 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -57.91 -70.58 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.282 -0.872 . . . . 64.299999999999997 111.718 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.785 ' HB3' HG12 ' A' ' 91' ' ' VAL . 34.8 t60 -99.55 86.71 3.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.115 0.483 . . . . 60.350000000000001 109.964 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -96.16 121.94 38.47 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.833 -0.621 . . . . 70.5 110.402 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.3 t -83.24 126.96 40.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.158 -0.682 . . . . 52.140000000000001 109.158 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -106.64 103.03 12.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.111 -0.495 . . . . 64.109999999999999 110.833 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 66.8 mt -96.53 128.06 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.879 -0.6 . . . . 64.420000000000002 109.857 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.95 115.3 7.11 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.818 -0.706 . . . . 74.200000000000003 111.81 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.601 ' HB ' ' HD2' ' A' ' 21' ' ' ARG . 35.0 m -100.88 -20.38 5.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.703 0.287 . . . . 74.439999999999998 111.061 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.31 151.4 1.73 Allowed Glycine 0 CA--C 1.518 0.278 0 CA-C-N 116.067 -0.515 . . . . 74.109999999999999 112.857 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.541 ' HG2' ' HB2' ' A' ' 97' ' ' LEU . 1.6 ppt_? -158.52 138.06 8.47 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.635 -0.332 . . . . 74.519999999999996 110.174 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 22.9 Cg_endo -93.54 134.14 0.97 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.218 2.612 . . . . 73.239999999999995 112.036 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.33 132.12 24.99 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.224 1.95 . . . . 73.140000000000001 111.718 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -159.04 179.17 34.86 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.562 -0.828 . . . . 74.109999999999999 111.858 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 143' ' ' ARG . 2.9 mpt_? -87.62 9.89 19.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.494 0.664 . . . . 74.150000000000006 110.106 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -124.73 131.59 53.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.873 -1.058 . . . . 74.329999999999998 108.431 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.9 149.95 62.61 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.944 0.402 . . . . 74.519999999999996 110.82 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.712 ' HA ' ' HD2' ' A' ' 149' ' ' PHE . 41.4 Cg_endo -66.92 4.6 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.345 2.697 . . . . 64.030000000000001 114.093 -172.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 151' ' ' LEU . . . -61.24 -39.22 89.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.917 0.389 . . . . 53.030000000000001 110.636 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.72 -36.17 62.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.166 0.508 . . . . 72.239999999999995 110.543 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.712 ' HD2' ' HA ' ' A' ' 146' ' ' PRO . 95.8 m-85 -71.29 -24.61 62.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 73.439999999999998 111.513 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 22' ' ' HIS . 9.0 p -85.31 -15.21 10.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.887 0.375 . . . . 73.230000000000004 110.872 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.636 ' O ' HG21 ' A' ' 20' ' ' THR . 87.4 mt -84.01 -37.83 21.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.415 -0.357 . . . . 64.120000000000005 111.766 -177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -162.96 101.28 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.401 0.619 . . . . 73.530000000000001 111.482 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -160.06 115.21 2.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.714 -0.675 . . . . 73.219999999999999 110.196 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -134.19 145.04 48.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.727 -0.669 . . . . 54.100000000000001 109.612 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 0.2 OUTLIER -137.68 -160.01 1.01 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.226 -0.287 . . . . 74.530000000000001 110.226 -175.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.463 ' H ' HG22 ' A' ' 155' ' ' THR . . . -82.45 -29.0 30.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.835 0.35 . . . . 63.140000000000001 111.31 176.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.15 -60.54 2.19 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.095 0.776 . . . . 65.319999999999993 113.095 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -34.7 69.1 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.966 0.358 . . . . 70.099999999999994 111.966 -171.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 155' ' ' THR . 7.2 mmp_? -60.79 -31.31 70.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.906 0.384 . . . . 74.340000000000003 110.678 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.38 -28.03 65.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 64.129999999999995 111.391 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -87.87 -19.05 27.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.011 -0.54 . . . . 61.43 111.102 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.658 ' HB ' ' HD3' ' A' ' 163' ' ' PRO . 88.7 t -50.63 -55.37 27.08 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 112.821 0.675 . . . . 73.010000000000005 112.821 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 162' ' ' VAL . 77.5 Cg_exo -51.48 -33.8 48.87 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 122.364 2.043 . . . . 72.540000000000006 112.992 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.0 m -80.21 -46.7 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.458 . . . . 73.439999999999998 110.787 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.482 ' HA ' ' HB3' ' A' ' 168' ' ' GLN . 1.6 mp -59.51 -34.57 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 70.5 111.906 -177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 162' ' ' VAL . 85.6 t -55.37 -46.54 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 120.902 0.382 . . . . 52.549999999999997 111.152 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -79.11 -37.56 38.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.073 0.463 . . . . 73.030000000000001 110.221 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.568 HE22 ' HA ' ' A' ' 103' ' ' ARG . 47.3 tt0 -61.3 -46.86 88.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.478 -0.783 . . . . 74.540000000000006 111.462 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.47 90.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 65.450000000000003 110.623 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.45 90.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.6 . . . . 63.450000000000003 110.729 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -61.52 -36.08 79.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.229 0.538 . . . . 75.010000000000005 110.605 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 176' ' ' LEU . . . -68.21 -47.74 67.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.717 -0.674 . . . . 72.209999999999994 111.026 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 21.5 p -66.77 -42.69 85.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.577 -0.283 . . . . 74.219999999999999 111.407 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -57.1 -56.42 21.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 73.239999999999995 111.202 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.35 -29.16 67.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.596 -0.274 . . . . 74.340000000000003 111.428 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.566 HD22 ' HA ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -60.48 -46.63 89.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.305 0.574 . . . . 74.430000000000007 109.576 178.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.705 HD13 HG11 ' A' ' 60' ' ' VAL . 62.9 mt -80.09 -30.34 12.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.356 -0.838 . . . . 74.040000000000006 110.809 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.469 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . . . -71.66 -47.39 54.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 61.130000000000003 111.838 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.15 -75.14 0.6 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.3 -0.409 . . . . 63.100000000000001 110.638 -174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -172.58 -172.78 38.63 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.42 -0.895 . . . . 53.310000000000002 112.385 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 181' ' ' LEU . 1.1 pt? -94.31 -26.25 16.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.606 0.241 . . . . 50.420000000000002 111.184 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 39.8 mt-10 -66.91 -47.29 54.0 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 111.981 0.363 . . . . 74.140000000000001 111.981 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 182' ' ' GLU . 32.9 Cg_endo -65.94 -29.51 49.35 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.373 1.382 . . . . 72.219999999999999 111.877 174.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.66 -48.93 62.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.862 -0.608 . . . . 50.439999999999998 111.304 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.568 ' HA ' HG22 ' A' ' 188' ' ' VAL . 8.2 pt20 -60.99 -33.08 72.69 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.831 0.348 . . . . 63.409999999999997 111.062 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -69.97 -26.17 63.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.933 0.397 . . . . 73.420000000000002 110.628 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 31.4 m -86.28 -41.82 14.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.094 -0.503 . . . . 75.299999999999997 111.203 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.692 HG21 HD13 ' A' ' 106' ' ' LEU . 33.2 m -71.0 -20.24 21.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.871 0.367 . . . . 62.100000000000001 111.47 -178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -97.23 16.03 21.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.453 0.644 . . . . 62.020000000000003 109.79 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -105.59 17.03 24.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.909 -0.587 . . . . 72.129999999999995 110.286 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 87.3 m95 . . . . . 0 C--O 1.247 0.948 0 CA-C-N 115.681 -0.69 . . . . 73.5 109.962 179.719 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 121.138 0.494 . . . . 75.140000000000001 110.689 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.09 90.62 2.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.638 -0.71 . . . . 74.099999999999994 109.505 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 6.6 pt-20 -116.69 151.54 47.31 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.678 -0.692 . . . . 73.219999999999999 110.68 -173.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 59' ' ' SER . 21.5 Cg_exo -64.69 108.82 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.901 2.401 . . . . 72.219999999999999 112.862 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.676 HD12 HG22 ' A' ' 177' ' ' ILE . 87.8 mt -95.24 156.64 16.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.92 -0.582 . . . . 70.530000000000001 109.652 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.594 HD23 HD12 ' A' ' 90' ' ' ILE . 34.1 tp -108.25 120.75 43.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.941 0.4 . . . . 74.140000000000001 110.75 -177.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.7 t -118.53 116.97 53.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.862 -0.608 . . . . 72.420000000000002 109.883 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.741 ' HB ' HG22 ' A' ' 92' ' ' VAL . 35.3 t -114.81 143.7 23.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.474 -0.33 . . . . 75.450000000000003 110.473 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -126.58 157.11 20.25 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.824 -0.703 . . . . 62.43 111.553 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.492 ' H ' ' HA3' ' A' ' 25' ' ' GLY . 61.9 mt -66.43 115.78 6.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 73.409999999999997 109.688 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' A' ' 26' ' ' PHE . . . -83.96 -179.07 51.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.029 -0.605 . . . . 71.129999999999995 113.565 -171.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -94.16 124.16 56.79 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 120.963 0.411 . . . . 74.25 110.456 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.495 ' HG2' ' HB2' ' A' ' 17' ' ' TYR . 74.2 Cg_endo -88.54 -6.28 6.05 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.759 2.306 . . . . 72.319999999999993 113.469 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.5 171.21 28.39 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.722 -0.751 . . . . 75.439999999999998 112.131 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.4 -52.18 3.51 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.167 2.578 . . . . 74.230000000000004 113.034 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.7 m -61.31 -34.84 75.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 70.099999999999994 111.561 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.535 ' HE1' ' HB3' ' A' ' 151' ' ' LEU . 98.1 m-85 -89.22 -9.39 50.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.316 -0.402 . . . . 73.239999999999995 111.634 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.98 -6.87 45.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.342 . . . . 70.409999999999997 110.954 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.5 11.42 36.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 63.420000000000002 111.101 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -101.88 147.66 26.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.72 -0.845 . . . . 64.430000000000007 108.72 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -0.44 37.71 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.502 -0.479 . . . . 75.120000000000005 111.449 -173.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -76.91 -6.33 52.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.101 0.477 . . . . 61.229999999999997 111.021 -174.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -118.45 34.38 5.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.375 0.607 . . . . 75.219999999999999 110.005 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pp -63.81 -12.67 37.79 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.6 -0.727 . . . . 62.240000000000002 111.451 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.492 ' HA3' ' H ' ' A' ' 10' ' ' LEU . . . -61.09 -47.23 92.22 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.124 -0.79 . . . . 54.350000000000001 111.124 175.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.637 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 83.4 t80 -65.26 -39.65 92.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.825 -0.435 . . . . 75.219999999999999 109.825 175.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 65.2 mtt -59.87 -56.8 17.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.672 -0.694 . . . . 63.210000000000001 110.96 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.442 ' HA ' HG22 ' A' ' 31' ' ' VAL . 94.7 t -59.03 -44.0 90.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.474 -0.33 . . . . 54.399999999999999 110.946 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.656 ' HB1' HD21 ' A' ' 62' ' ' LEU . . . -58.91 -45.24 90.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.948 0.404 . . . . 72.239999999999995 111.023 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.22 -44.6 68.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 63.530000000000001 111.559 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 32.8 m -69.17 -31.73 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.956 -0.298 . . . . 71.230000000000004 111.581 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 60.1 mt -71.8 -58.73 3.22 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.939 -0.304 . . . . 71.409999999999997 110.609 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.49 -46.72 88.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 52.340000000000003 110.728 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.14 -20.76 69.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.081 -0.58 . . . . 73.140000000000001 113.179 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 40.1 ttp180 -84.44 -33.4 23.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.068 0.434 . . . . 73.430000000000007 110.645 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.51 -36.09 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.191 0.52 . . . . 43.25 110.04 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.47 68.75 0.29 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.629 -0.989 . . . . 71.150000000000006 110.629 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 57.8 m -152.46 119.91 5.99 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.502 -0.349 . . . . 54.420000000000002 110.793 -170.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.82 127.95 16.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.52 -0.309 . . . . 60.399999999999999 110.404 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.632 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 14.3 m-85 -141.63 172.85 12.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 72.519999999999996 110.123 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -142.84 176.31 9.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.145 -0.479 . . . . 75.439999999999998 111.123 -171.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.8 t -48.06 130.94 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 112.795 0.665 . . . . 75.239999999999995 112.795 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.518 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 72.1 t60 -109.28 115.46 30.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.49 -0.777 . . . . 53.32 109.658 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 2.5 tmtp? -68.89 99.92 1.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.944 0.35 . . . . 70.319999999999993 111.944 -171.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 80.2 tttt 160.2 -51.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.1 -1.444 . . . . 73.439999999999998 107.1 173.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 48' ' ' ALA . 13.8 p -102.91 28.6 6.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.218 -1.81 . . . . 65.510000000000005 108.076 173.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 43' ' ' HIS . . . -48.85 44.08 0.01 OUTLIER Glycine 0 N--CA 1.474 1.18 0 N-CA-C 119.81 2.684 . . . . 41.420000000000002 119.81 -150.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 46' ' ' SER . . . -96.47 179.76 4.9 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.333 -1.358 . . . . 64.439999999999998 107.333 159.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.895 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 32.3 mt-10 -80.34 118.0 21.59 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 119.998 -0.681 . . . . 71.510000000000005 109.565 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.5 m -121.11 137.73 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.978 0.418 . . . . 73.129999999999995 110.768 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.874 HG13 ' HB3' ' A' ' 62' ' ' LEU . 1.6 p -124.35 110.64 25.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.253 0.549 . . . . 72.510000000000005 110.265 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.4 HG22 HG22 ' A' ' 61' ' ' VAL . 24.7 p -92.52 107.93 19.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.733 -0.667 . . . . 73.239999999999995 110.202 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.02 165.01 28.57 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.35 -0.7 . . . . 52.240000000000002 111.35 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 54' ' ' ARG . 15.5 ptt-85 -104.91 103.85 13.5 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.537 0.684 . . . . 61.140000000000001 110.611 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.43 135.57 38.12 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.676 -0.861 . . . . 72.049999999999997 108.676 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 62.53 10.74 4.24 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.463 0.477 . . . . 53.340000000000003 111.149 -174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.56 -22.91 34.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.989 -0.624 . . . . 73.439999999999998 112.623 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 m -89.59 122.52 32.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.676 0.274 . . . . 64.099999999999994 110.845 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 19.3 m -68.49 116.47 9.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.441 -0.345 . . . . 74.0 110.414 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.422 HG11 HG21 ' A' ' 177' ' ' ILE . 31.0 m -127.68 164.05 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.957 0.408 . . . . 72.430000000000007 110.689 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.4 HG22 HG22 ' A' ' 52' ' ' THR . 41.3 t -110.01 111.05 34.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.93 -0.577 . . . . 55.450000000000003 109.808 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.874 ' HB3' HG13 ' A' ' 51' ' ' VAL . 64.4 tp -96.82 129.83 44.19 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.534 -0.543 . . . . 74.129999999999995 109.534 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 65' ' ' PRO . . . -108.91 129.27 55.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.217 0.532 . . . . 60.049999999999997 112.049 -175.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.895 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 45.3 mtpt -110.92 92.05 14.05 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.2 -0.909 . . . . 71.209999999999994 109.691 175.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.563 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 1.7 Cg_endo -83.54 173.03 9.86 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.992 2.461 . . . . 74.5 112.143 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -110.82 12.98 22.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.428 0.633 . . . . 64.219999999999999 109.48 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 71' ' ' GLU . 60.0 m -130.08 175.15 9.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.558 -0.746 . . . . 75.420000000000002 110.633 -175.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.483 ' CE2' ' HG3' ' A' ' 13' ' ' PRO . 45.9 m-85 -100.25 -169.82 1.78 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.109 -0.496 . . . . 71.099999999999994 110.96 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.607 ' HA ' ' HB2' ' A' ' 72' ' ' SER . 24.9 ptt? -66.8 -20.16 65.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.876 -0.602 . . . . 43.409999999999997 111.537 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.4 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 14.2 t30 -71.87 -25.22 61.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.211 0.529 . . . . 74.129999999999995 109.897 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 18.0 mp0 -105.89 2.42 27.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.717 -0.674 . . . . 75.310000000000002 110.525 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 69' ' ' MET . 27.0 t -60.24 -38.57 83.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.438 -0.346 . . . . 65.230000000000004 110.681 -175.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.82 -20.34 64.14 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.005 -0.617 . . . . 72.239999999999995 112.393 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -85.05 -31.4 23.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.863 0.363 . . . . 60.420000000000002 110.609 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -89.6 -40.65 12.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 62.240000000000002 111.42 -175.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.97 -32.33 53.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.33 -0.395 . . . . 61.509999999999998 111.102 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -50.8 -67.83 1.75 Allowed Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.908 -0.587 . . . . 61.32 113.261 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.07 -39.26 32.55 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.531 2.154 . . . . 63.030000000000001 112.409 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.9 tp -55.32 -58.47 7.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 74.129999999999995 111.731 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.48 68.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.957 0.408 . . . . 75.239999999999995 111.153 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -73.04 -32.7 65.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.817 -0.629 . . . . 72.019999999999996 111.638 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -81.96 -41.78 20.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.873 0.323 . . . . 64.319999999999993 111.873 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -85.45 -17.13 37.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.13 0.418 . . . . 72.540000000000006 112.13 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 t 62.72 71.8 0.51 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.237 0.541 . . . . 52.229999999999997 110.863 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 6' ' ' LEU . 28.0 m -118.17 158.24 46.86 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.798 -0.637 . . . . 72.030000000000001 109.821 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.425 ' HB2' ' HB2' ' A' ' 89' ' ' GLN . 35.6 Cg_exo -61.11 111.52 1.11 Allowed 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.515 2.143 . . . . 71.140000000000001 112.001 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.38 -6.77 19.38 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.707 2.272 . . . . 75.349999999999994 112.267 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -98.27 -12.43 21.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.993 -0.549 . . . . 70.230000000000004 110.457 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 86' ' ' PRO . 79.0 mm-40 -114.49 20.14 15.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 71.219999999999999 110.8 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.594 HD12 HD23 ' A' ' 6' ' ' LEU . 5.8 tt -83.31 134.51 26.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.185 -0.461 . . . . 65.430000000000007 110.224 177.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 131' ' ' HIS . 21.6 m -120.9 141.35 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.835 0.35 . . . . 71.299999999999997 110.68 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.741 HG22 ' HB ' ' A' ' 8' ' ' VAL . 45.9 t -132.78 127.34 55.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.316 -0.402 . . . . 73.299999999999997 110.465 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.6 mm -75.15 139.23 19.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.887 -0.597 . . . . 75.310000000000002 110.708 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -142.45 152.89 43.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.506 -0.316 . . . . 75.430000000000007 110.521 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.97 135.55 42.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.479 -0.934 . . . . 65.430000000000007 108.479 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 99' ' ' ILE . 10.1 tp10 -104.37 127.68 52.07 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.377 0.608 . . . . 71.0 111.001 -174.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.568 HD22 ' HG3' ' A' ' 146' ' ' PRO . 3.2 pp -84.26 -13.83 51.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.05 -0.977 . . . . 75.109999999999999 110.775 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.94 -47.67 20.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.173 -0.467 . . . . 52.210000000000001 111.157 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.49 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 56.7 mt -89.74 142.13 13.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.089 -0.505 . . . . 52.200000000000003 110.789 -176.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -82.89 166.46 18.9 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.509 . . . . 72.530000000000001 110.607 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.652 ' HA ' ' O ' ' A' ' 136' ' ' GLY . 15.4 p90 -64.45 128.72 36.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.247 0.546 . . . . 75.299999999999997 112.164 -174.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.62 -22.94 3.84 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.726 -0.75 . . . . 74.310000000000002 112.958 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 17.0 mmt180 -132.35 128.34 37.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.265 0.555 . . . . 75.209999999999994 112.451 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.558 HG22 HG23 ' A' ' 135' ' ' ILE . 47.3 pt -107.79 146.77 13.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.334 -0.848 . . . . 73.530000000000001 109.414 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -157.73 125.2 5.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.908 0.385 . . . . 74.540000000000006 110.46 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.83 HD23 ' H ' ' A' ' 106' ' ' LEU . 1.9 pt? -97.91 144.62 27.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.442 -0.344 . . . . 73.129999999999995 110.092 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 104.44 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.179 -0.674 . . . . 53.520000000000003 109.179 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.845 HD23 ' H ' ' A' ' 108' ' ' LEU . 1.6 pt? -93.37 97.47 10.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.396 0.617 . . . . 71.439999999999998 110.758 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.94 -155.21 26.33 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.271 -0.732 . . . . 64.409999999999997 111.271 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.38 123.91 7.95 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.012 -0.613 . . . . 72.319999999999993 112.378 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.31 -176.61 44.64 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.55 -0.62 . . . . 52.439999999999998 111.55 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.609 ' HG2' ' H ' ' A' ' 113' ' ' GLY . 16.7 tt0 -142.76 -152.41 0.41 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.878 -0.415 . . . . 63.240000000000002 109.878 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.609 ' H ' ' HG2' ' A' ' 112' ' ' GLU . . . 139.75 -74.18 0.38 Allowed Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.299 -0.72 . . . . 25.050000000000001 111.299 -175.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.08 -6.57 87.54 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.971 -0.633 . . . . 60.229999999999997 111.829 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.8 t60 62.74 -87.3 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.774 0.829 . . . . 73.230000000000004 112.595 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -67.08 -46.55 73.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.792 0.329 . . . . 74.409999999999997 111.481 -168.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 121' ' ' VAL . . . -60.99 -29.19 70.19 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 120.835 -0.698 . . . . 74.230000000000004 112.464 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.501 ' HB3' HH21 ' A' ' 132' ' ' ARG . 89.6 mt -82.88 -23.77 33.49 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.815 -0.227 . . . . 55.0 111.099 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -79.11 -39.7 32.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.235 -0.439 . . . . 74.200000000000003 110.634 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 27.5 t -61.59 -54.31 44.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.802 -0.635 . . . . 61.229999999999997 110.795 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 117' ' ' GLY . 48.4 t -59.5 -41.69 85.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.433 -0.349 . . . . 65.329999999999998 111.101 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.46 -52.09 67.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 64.519999999999996 111.209 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.8 m -71.46 -34.02 69.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.853 -0.612 . . . . 62.340000000000003 111.553 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.08 -36.84 78.04 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.833 0.349 . . . . 65.030000000000001 111.286 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.7 mt -87.31 -31.27 20.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.47 -0.332 . . . . 75.310000000000002 111.138 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.64 40.33 5.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.517 -0.849 . . . . 41.439999999999998 111.951 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 129' ' ' ASN . 9.7 t -148.06 176.61 10.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.948 -0.39 . . . . 72.409999999999997 109.948 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 1.1 mptm? -77.62 -5.87 51.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.72 0.295 . . . . 54.310000000000002 110.462 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.408 ' H ' HG23 ' A' ' 127' ' ' THR . 56.7 t30 72.01 81.31 0.15 Allowed 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.327 -0.851 . . . . 73.430000000000007 111.896 172.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -71.2 -148.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.798 -0.637 . . . . 75.340000000000003 110.118 174.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.589 ' HB3' ' O ' ' A' ' 90' ' ' ILE . 32.1 p80 45.13 40.02 4.46 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.86 0.689 . . . . 62.109999999999999 112.86 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.501 HH21 ' HB3' ' A' ' 118' ' ' LEU . 50.3 mtt85 -91.65 107.97 19.58 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.433 -0.58 . . . . 71.25 109.433 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.04 109.43 28.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.628 -0.714 . . . . 62.210000000000001 109.88 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.408 ' HG2' ' OE1' ' A' ' 96' ' ' GLU . 95.4 mtt180 -88.71 100.75 13.37 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.019 -0.537 . . . . 74.409999999999997 110.889 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.558 HG23 HG22 ' A' ' 104' ' ' ILE . 55.7 mt -93.74 108.64 20.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.035 -0.529 . . . . 73.519999999999996 110.046 175.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 101' ' ' PHE . . . -73.33 98.0 0.89 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.032 -0.604 . . . . 65.239999999999995 112.322 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 135' ' ' ILE . 3.5 m -110.95 0.97 9.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.702 0.287 . . . . 61.420000000000002 111.484 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 131.88 140.1 4.47 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.264 -0.969 . . . . 50.450000000000003 112.843 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.472 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . 7.8 ptp85 -99.46 139.49 20.94 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.656 0.265 . . . . 74.430000000000007 110.506 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 3.0 Cg_exo -75.29 141.36 25.74 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.803 2.336 . . . . 64.409999999999997 111.88 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.38 149.1 88.52 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.575 2.183 . . . . 64.530000000000001 111.58 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.19 44.42 2.15 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.323 -0.465 . . . . 51.140000000000001 113.626 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -82.27 -67.73 0.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.673 -1.232 . . . . 73.230000000000004 107.673 175.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 22.5 mmtm -131.36 147.97 52.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.621 -1.172 . . . . 73.239999999999995 108.289 166.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.581 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 1.7 p-10 -58.91 157.45 20.35 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 123.335 0.397 . . . . 52.409999999999997 110.699 -175.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 145' ' ' ASP . 4.8 Cg_endo -46.1 -28.76 5.66 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 124.192 3.261 . . . . 72.109999999999999 114.149 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.69 -32.11 28.63 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.186 0.439 . . . . 61.140000000000001 112.186 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.57 -57.97 2.75 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.355 0.502 . . . . 65.239999999999995 112.355 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 144' ' ' LYS . 67.6 m-85 -84.03 -19.99 33.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.654 0.983 . . . . 73.200000000000003 113.654 -168.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.0 p -71.63 -5.97 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.169 0.433 . . . . 73.319999999999993 112.169 -171.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.535 ' HB3' ' HE1' ' A' ' 17' ' ' TYR . 87.9 mt -91.12 -1.91 57.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 61.210000000000001 111.424 -176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -138.91 103.06 4.7 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.752 -0.833 . . . . 74.310000000000002 108.752 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -129.34 119.33 23.71 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.613 -0.722 . . . . 61.509999999999998 112.024 -164.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -169.1 103.08 0.37 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.642 0.734 . . . . 64.230000000000004 110.12 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.538 ' HB ' ' HG2' ' A' ' 158' ' ' GLU . 3.1 m -134.99 131.77 37.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.515 . . . . 73.349999999999994 109.928 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.87 -38.02 86.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.758 0.313 . . . . 72.239999999999995 111.085 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.2 92.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.764 -0.653 . . . . 71.409999999999997 112.31 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.538 ' HG2' ' HB ' ' A' ' 155' ' ' THR . 15.2 pt-20 -82.21 -32.85 29.62 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.968 -0.293 . . . . 72.109999999999999 111.155 -175.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.592 ' HA ' HG23 ' A' ' 162' ' ' VAL . 49.5 mtm180 -71.6 -20.09 62.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.754 0.312 . . . . 74.310000000000002 110.694 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.86 -38.71 76.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.933 -0.576 . . . . 63.240000000000002 112.041 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -103.02 7.58 39.02 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.197 0.443 . . . . 72.519999999999996 112.197 -176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 159' ' ' ARG . 77.3 t -58.19 -51.64 80.35 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 121.058 -0.257 . . . . 72.109999999999999 111.34 177.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 162' ' ' VAL . 12.5 Cg_endo -56.71 -27.61 71.69 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.326 2.018 . . . . 61.020000000000003 112.354 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' A' ' 168' ' ' GLN . 9.4 m -68.32 -55.47 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.36 -0.382 . . . . 54.210000000000001 110.121 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.456 HG13 HG23 ' A' ' 104' ' ' ILE . 1.7 mp -56.06 -43.17 74.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.524 -0.762 . . . . 75.310000000000002 111.503 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 162' ' ' VAL . 92.4 t -58.04 -49.94 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.618 0.247 . . . . 75.400000000000006 111.369 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -70.69 -33.15 70.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.563 -0.289 . . . . 73.530000000000001 111.318 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 164' ' ' THR . 98.7 mt-30 -62.52 -48.13 80.87 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.099 0.476 . . . . 64.439999999999998 109.89 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -64.14 -41.13 97.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.656 -0.702 . . . . 74.209999999999994 111.194 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.09 87.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.401 -0.363 . . . . 74.340000000000003 111.102 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.09 -36.52 83.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 73.230000000000004 110.784 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.29 -45.93 44.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 70.109999999999999 111.335 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.839 ' HA ' HD12 ' A' ' 176' ' ' LEU . 80.1 m -58.3 -40.57 82.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.228 -0.442 . . . . 64.340000000000003 111.541 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -53.71 -45.31 70.37 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.263 -0.426 . . . . 60.119999999999997 111.249 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 183' ' ' PRO . 30.7 tp -81.88 -28.33 33.0 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.059 -0.257 . . . . 74.230000000000004 111.534 -174.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.839 HD12 ' HA ' ' A' ' 173' ' ' THR . 74.0 mt -52.2 -55.95 17.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.26 0.552 . . . . 74.349999999999994 110.665 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.676 HG22 HD12 ' A' ' 5' ' ' LEU . 6.9 pt -80.97 -23.48 10.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.376 -0.829 . . . . 73.439999999999998 111.78 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 175' ' ' LEU . . . -65.77 -45.69 81.56 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 111.748 0.277 . . . . 53.32 111.748 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -136.65 -61.63 0.67 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.83 0.348 . . . . 73.420000000000002 111.277 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -168.59 170.31 42.17 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.541 -0.838 . . . . 53.329999999999998 112.307 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.757 ' HA ' HD23 ' A' ' 176' ' ' LEU . 3.3 pp -82.71 -31.54 28.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.225 0.454 . . . . 73.430000000000007 112.225 -175.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 14.6 mm-40 -60.66 -54.26 56.43 Favored Pre-proline 0 N--CA 1.468 0.439 0 N-CA-C 112.559 0.577 . . . . 74.120000000000005 112.559 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.462 ' HB2' HD21 ' A' ' 175' ' ' LEU . 19.6 Cg_endo -60.75 -31.19 91.61 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.426 1.417 . . . . 63.119999999999997 111.856 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 188' ' ' VAL . . . -72.15 -45.77 59.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.539 . . . . 50.009999999999998 111.266 -178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 182' ' ' GLU . 1.2 pp0? -67.77 -20.92 65.27 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.145 0.498 . . . . 51.149999999999999 110.542 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.616 ' HA ' ' CE1' ' A' ' 189' ' ' HIS . 0.9 OUTLIER -67.48 -46.94 71.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.032 -0.531 . . . . 71.349999999999994 109.873 171.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 56.2 m -62.35 -33.52 74.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 63.439999999999998 111.143 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 184' ' ' ALA . 94.6 t -54.45 -38.47 41.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 74.120000000000005 111.426 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.616 ' CE1' ' HA ' ' A' ' 186' ' ' ASN . 10.2 p-80 -100.22 9.04 43.35 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.554 -0.459 . . . . 74.540000000000006 110.947 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -87.51 -34.17 18.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.302 -0.408 . . . . 64.019999999999996 109.946 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 38.7 m95 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.554 -0.748 . . . . 60.100000000000001 110.309 174.923 . . . . . . . . 0 0 . 1 stop_ save_